data_2mod_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mod _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.506 ' HE1' ' HA ' ' A' ' 22' ' ' MET . 2.8 mmt . . . . . 0 C--O 1.233 0.199 0 N-CA-C 109.296 -0.631 . . . . 55.12 109.296 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.422 HG12 ' OE2' ' A' ' 64' ' ' GLU . 3.6 mm -82.84 81.74 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.55 -0.908 . . . . 72.23 108.55 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 77' ' ' TYR . 7.4 tp10 -69.47 161.54 29.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.728 -0.669 . . . . 72.42 111.807 -170.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.75 138.69 33.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.01 -0.541 . . . . 74.35 110.901 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.7 pt -148.53 169.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.18 0.514 . . . . 71.42 111.158 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.15 -163.95 11.46 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 109.922 -1.271 . . . . 53.41 109.922 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -63.33 -39.64 95.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 117.56 0.68 . . . . 75.31 110.298 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -64.47 -38.35 90.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.576 -0.738 . . . . 72.14 111.706 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -83.89 -29.08 27.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.688 -0.233 . . . . 64.21 110.897 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -47.61 -61.64 1.83 Allowed 'General case' 0 C--O 1.238 0.471 0 O-C-N 123.482 0.489 . . . . 70.43 111.426 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -56.08 -45.1 79.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 75.15 110.928 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -58.46 -53.8 54.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.0 -0.545 . . . . 73.04 111.206 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -65.31 -38.72 91.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.066 -0.516 . . . . 70.21 111.117 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.522 ' HA ' HG13 ' A' ' 44' ' ' ILE . 56.8 t -72.64 -42.01 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.302 0.482 . . . . 73.22 112.302 -176.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.2 p -85.96 -45.29 11.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.116 0.413 . . . . 70.32 112.116 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t -86.87 10.47 16.02 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.28 -0.418 . . . . 73.44 112.096 -172.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.561 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 7.5 p -71.29 81.49 0.74 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.88 0.371 . . . . 71.51 111.261 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 29.9 -93.89 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.776 1.231 . . . . 72.34 113.355 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -161.72 132.32 5.04 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.637 0.375 . . . . 74.41 110.526 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 54.98 14.69 0.98 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.544 0.572 . . . . 64.12 112.544 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.9 mm -74.45 115.55 15.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.857 0.36 . . . . 74.02 110.13 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 102' ' ' PHE . 42.2 tp -76.55 110.29 10.99 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.475 0.655 . . . . 73.12 110.72 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.522 HG13 ' HA ' ' A' ' 35' ' ' VAL . 23.6 mm -88.98 117.63 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.873 -1.058 . . . . 70.04 109.744 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 74' ' ' VAL . 4.8 mp -106.68 127.85 53.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.439 -0.949 . . . . 52.51 108.439 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 57.6 t -110.97 104.39 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.273 -0.64 . . . . 74.02 109.273 175.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.02 114.37 28.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.744 -0.662 . . . . 73.04 110.141 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 . . . . . 0 C--O 1.234 0.261 0 CA-C-N 116.3 -0.409 . . . . 72.32 110.03 177.233 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 121.076 0.465 . . . . 73.34 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.637 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 28.7 t -74.57 -30.53 61.75 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.652 0.739 . . . . 71.33 110.128 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.506 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 mm? -64.29 -20.73 66.27 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.76 -0.654 . . . . 62.15 110.872 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.503 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 54.5 mt-10 -54.92 -67.11 0.73 Allowed Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.767 -0.457 . . . . 64.54 109.767 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.503 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 53.6 Cg_endo -66.64 -37.27 22.28 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 121.735 1.623 . . . . 62.53 112.387 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.637 ' HG3' ' O ' ' A' ' 58' ' ' SER . 40.2 mt-30 -59.98 -55.9 28.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.355 -0.538 . . . . 74.51 111.062 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.58 -51.85 63.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.522 -0.308 . . . . 72.24 111.117 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 15.8 mm-40 -50.73 -45.63 58.78 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.86 0.362 . . . . 70.32 110.94 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.457 ' CB ' ' HZ3' ' A' ' 65' ' ' LYS . 4.4 ttpm? -69.04 -47.63 64.89 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.387 -0.369 . . . . 74.04 111.252 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.532 HD12 HD13 ' A' ' 116' ' ' ILE . 16.9 mt -62.29 -31.34 71.92 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.632 -0.427 . . . . 73.14 110.455 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 71' ' ' THR . . . -66.55 -47.33 73.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.792 -0.447 . . . . 55.41 109.792 175.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 96.5 mt-30 -59.79 -30.59 69.0 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.101 0.477 . . . . 75.31 110.801 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -76.33 -45.22 33.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.047 -0.524 . . . . 73.22 111.086 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -103.75 5.21 35.97 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.928 0.714 . . . . 72.44 112.928 -169.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.89 -19.41 2.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.705 0.402 . . . . 75.13 112.072 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -55.14 -40.48 70.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 74.21 110.708 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -127.58 -5.88 5.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.82 -0.627 . . . . 74.11 111.398 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.452 HG13 HD11 ' A' ' 45' ' ' LEU . 42.1 t -117.06 136.28 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.921 0.391 . . . . 71.24 111.485 -175.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -141.33 120.11 12.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.686 -0.688 . . . . 64.21 109.52 173.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.419 HG22 HG21 ' A' ' 23' ' ' ILE . 50.0 mt -99.55 143.02 14.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.367 -0.379 . . . . 63.41 109.994 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 24' ' ' GLU . 96.8 m-85 -135.61 154.55 51.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.839 -0.618 . . . . 75.45 109.877 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -141.26 144.1 34.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.302 -0.629 . . . . 63.03 109.302 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 tt -77.03 135.43 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.303 -0.408 . . . . 72.41 110.317 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -107.25 -37.54 6.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.105 -0.498 . . . . 73.4 110.411 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.495 ' N ' HD11 ' A' ' 81' ' ' ILE . 2.8 mp -81.43 103.43 8.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.906 -0.588 . . . . 74.32 110.387 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.1 -25.22 61.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 63.32 111.806 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.23 -21.22 62.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.641 0.258 . . . . 75.44 111.187 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -102.3 12.88 35.97 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.594 -0.275 . . . . 72.1 111.511 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -69.8 -9.38 54.43 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.032 0.444 . . . . 74.32 110.094 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -54.46 -30.92 54.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.434 -0.803 . . . . 71.22 110.591 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -53.03 -38.82 30.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.754 -0.657 . . . . 71.34 110.409 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.438 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . . . -57.3 -54.48 46.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.38 -0.827 . . . . 62.03 110.547 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -60.41 -39.33 87.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.624 -0.716 . . . . 73.44 110.769 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -64.37 -44.87 90.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.741 -0.663 . . . . 75.54 111.831 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -80.09 -22.69 41.92 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.664 -0.244 . . . . 74.12 111.358 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.61 48.6 0.73 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.873 -0.679 . . . . 74.25 113.178 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 88' ' ' ALA . 88.5 t -94.61 111.44 25.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.934 -0.395 . . . . 74.23 109.934 176.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.2 t -110.32 19.74 18.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.286 -0.415 . . . . 65.41 111.082 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.78 149.42 30.5 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.069 -0.345 . . . . 73.2 110.069 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.64 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 62.6 mt -61.36 -54.93 48.22 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 123.011 0.195 . . . . 64.42 110.865 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.64 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 86.3 Cg_endo -86.68 98.2 0.52 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.781 1.654 . . . . 64.15 111.234 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 m -140.42 142.61 35.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.431 . . . . 75.41 110.327 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.629 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -113.25 117.99 56.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 73.23 110.268 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.406 HD23 ' HG3' ' A' ' 110' ' ' GLN . 98.7 mt -94.17 122.95 37.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.507 -0.923 . . . . 75.41 108.507 172.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.434 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 51.2 mtp -100.2 146.9 26.31 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.919 -0.4 . . . . 70.31 109.919 -177.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.556 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 98.6 m-85 -149.56 161.87 41.3 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.51 -0.552 . . . . 75.4 109.51 176.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -151.34 107.17 3.39 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.294 -0.254 . . . . 72.3 111.101 176.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.561 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 3.1 t-20 55.42 35.9 26.0 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.282 0.563 . . . . 63.0 111.273 173.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.33 -16.33 56.25 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.08 -0.509 . . . . 71.22 112.756 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -79.95 143.82 33.85 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.546 -0.538 . . . . 71.42 109.546 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -67.91 162.57 23.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.263 0.554 . . . . 73.13 110.949 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.61 168.3 21.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.763 -1.108 . . . . 72.33 108.117 -164.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -70.27 179.75 2.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.592 0.711 . . . . 75.02 112.458 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.406 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.8 tt0 -139.73 118.91 12.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.403 -0.817 . . . . 73.35 109.446 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.629 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.0 t -97.54 113.18 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 74.54 110.552 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.0 mp -88.22 108.37 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.394 -0.595 . . . . 74.14 109.394 177.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.85 143.24 10.65 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.775 -0.53 . . . . 52.15 111.775 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.506 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -74.65 72.04 1.94 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.936 0.398 . . . . 71.15 110.155 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.419 ' O ' HG13 ' A' ' 119' ' ' ILE . 19.4 t70 -111.08 105.35 14.06 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.893 -0.594 . . . . 73.22 110.69 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.532 HD13 HD12 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -59.08 -31.98 46.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.301 -0.863 . . . . 62.11 110.209 -176.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 m -62.4 -55.79 24.52 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.349 -0.387 . . . . 71.13 110.931 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -63.57 -41.34 98.39 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.544 0.212 . . . . 63.31 110.461 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 123' ' ' ILE . 80.6 mt -56.21 -56.28 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.307 -0.406 . . . . 64.31 110.482 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.75 -33.9 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.481 -0.327 . . . . 54.05 110.662 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.7 m -57.84 -49.49 76.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.433 -0.349 . . . . 74.12 110.242 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -69.74 -36.44 75.83 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.464 -0.335 . . . . 72.3 110.924 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 119' ' ' ILE . 70.8 mt -56.08 -55.95 15.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 64.31 109.779 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -58.49 -42.47 87.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.546 -0.752 . . . . 71.24 110.495 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -60.59 -33.7 73.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.319 -0.855 . . . . 75.22 111.263 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -102.42 -9.52 20.21 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.961 0.726 . . . . 72.55 112.961 -175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.5 mt -89.75 -60.51 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.705 -0.398 . . . . 73.13 110.35 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.158 -0.925 . . . . 74.5 110.154 -178.069 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.473 ' HE2' ' HA ' ' A' ' 68' ' ' GLN . 13.5 mmt . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.373 0.606 . . . . 55.12 109.418 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.428 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 8.3 mm -70.49 80.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.908 -1.042 . . . . 72.23 108.785 172.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 9.0 tp10 -66.51 157.01 33.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.247 -0.433 . . . . 72.42 111.211 -175.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.27 136.88 48.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.442 0.297 . . . . 74.35 110.718 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 31' ' ' PHE . 37.9 pt -147.38 176.26 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.001 0.429 . . . . 71.42 110.992 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.25 -167.27 11.9 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.915 -0.874 . . . . 53.41 110.915 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.22 -50.68 68.79 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.956 0.407 . . . . 75.31 111.425 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -68.94 -32.54 72.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.884 -0.598 . . . . 72.14 112.169 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -80.78 -22.43 40.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.823 -0.172 . . . . 64.21 110.783 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.45 ' HA ' HD12 ' A' ' 26' ' ' ILE . 91.9 t80 -51.88 -61.96 1.93 Allowed 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.52 0.513 . . . . 70.43 111.383 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -57.41 -47.17 82.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.099 -0.501 . . . . 75.15 110.653 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -56.15 -54.44 45.15 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.537 -0.756 . . . . 73.04 111.278 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -67.44 -33.03 74.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 70.21 111.343 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.5 HG11 ' HA2' ' A' ' 105' ' ' GLY . 65.5 t -72.03 -38.2 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.463 -0.335 . . . . 73.22 111.758 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -85.99 -41.82 14.54 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.024 0.44 . . . . 70.32 112.028 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 t -83.26 11.54 6.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.112 -0.494 . . . . 73.44 111.788 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 13.8 p -72.26 82.58 1.02 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.78 0.324 . . . . 71.51 111.85 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.0 t30 41.52 -93.65 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.367 -0.833 . . . . 72.34 112.462 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -162.04 121.94 2.47 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 110.412 -0.218 . . . . 74.41 110.412 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.432 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 48.0 m-80 55.36 18.96 2.8 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.779 0.659 . . . . 64.12 112.779 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.1 mm -71.96 133.62 31.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 120.893 0.378 . . . . 74.02 110.759 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.424 HD21 HG22 ' A' ' 74' ' ' VAL . 31.2 tp -80.28 114.97 19.57 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.828 -0.624 . . . . 73.12 110.389 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.491 HG23 HG22 ' A' ' 35' ' ' VAL . 29.1 mm -95.27 118.9 42.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 70.04 110.396 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.528 HD13 HG13 ' A' ' 74' ' ' VAL . 5.5 mp -104.19 125.25 50.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.384 -0.969 . . . . 52.51 108.384 170.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.446 HG23 ' HE1' ' A' ' 31' ' ' PHE . 59.3 t -112.08 104.47 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.454 -0.573 . . . . 74.02 109.454 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.47 118.3 35.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.659 -0.701 . . . . 73.04 110.806 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.369 0.604 . . . . 72.32 109.652 174.275 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 121.22 0.533 . . . . 73.34 110.851 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.631 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 21.5 t -74.78 -35.93 62.53 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-O 122.007 0.908 . . . . 71.33 109.611 174.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' A' ' 114' ' ' ALA . 3.6 mm? -65.06 -26.2 68.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.775 -1.102 . . . . 62.15 110.763 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.496 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 46.2 mt-10 -53.52 -64.25 1.88 Allowed Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.681 -0.408 . . . . 64.54 109.998 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.496 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 46.2 Cg_endo -66.83 -39.17 15.33 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 121.699 1.599 . . . . 62.53 112.441 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 58' ' ' SER . 37.0 mt-30 -61.63 -46.2 90.83 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.107 -0.637 . . . . 74.51 111.236 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.49 -37.53 60.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.331 -0.395 . . . . 72.24 110.997 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.493 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 3.0 mm-40 -57.31 -38.3 73.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.025 0.44 . . . . 70.32 110.132 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.91 -55.08 25.31 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.839 -0.619 . . . . 74.04 110.221 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.433 HD12 HD12 ' A' ' 116' ' ' ILE . 27.8 mt -60.94 -32.32 71.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.665 -0.698 . . . . 73.14 110.747 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.529 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.47 -53.71 26.49 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.154 -0.476 . . . . 55.41 109.937 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.7 mt-30 -59.1 -36.15 74.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.415 . . . . 75.31 111.04 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.94 -52.16 18.56 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.979 0.418 . . . . 73.22 111.374 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -95.22 4.7 53.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.618 0.599 . . . . 72.44 112.618 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.2 t -52.89 -22.86 6.03 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.816 0.673 . . . . 75.13 112.816 -170.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.3 -31.84 73.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.747 0.308 . . . . 74.21 110.818 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -125.69 -0.26 7.42 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.377 -0.374 . . . . 74.11 110.891 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.528 HG13 HD13 ' A' ' 45' ' ' LEU . 36.6 t -127.94 136.16 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.958 0.408 . . . . 71.24 111.421 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 71' ' ' THR . 39.8 mmtm -141.89 131.45 23.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.934 -0.575 . . . . 64.21 109.604 172.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.7 mt -104.97 143.12 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 63.41 110.444 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -131.46 143.35 50.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.077 -0.51 . . . . 75.45 110.156 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 25.1 pttm -124.18 127.84 48.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.943 -0.571 . . . . 63.03 109.667 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.7 tt -80.09 107.18 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.157 0.503 . . . . 72.41 109.67 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -86.08 -31.96 21.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.234 -0.439 . . . . 73.4 111.084 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.518 ' N ' HD13 ' A' ' 81' ' ' ILE . 3.0 mp -81.56 85.83 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.32 0.581 . . . . 74.32 110.286 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -27.34 62.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.359 -0.837 . . . . 63.32 111.277 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.36 -21.97 61.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 75.44 111.064 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -113.44 41.22 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 72.1 110.172 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -80.63 22.5 0.58 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.858 -0.61 . . . . 74.32 111.149 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 37.3 t70 -54.03 -35.93 62.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.625 0.37 . . . . 71.22 110.714 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.3 t -52.74 -40.33 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.709 -0.678 . . . . 71.34 110.539 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.42 -54.32 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 62.03 110.51 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 m -62.88 -29.63 70.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 73.44 110.967 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 33.6 mm-40 -69.13 -56.04 8.87 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.343 -0.39 . . . . 75.54 111.174 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -75.0 -9.54 58.63 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.791 0.329 . . . . 74.12 111.231 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.81 45.4 7.77 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.031 -0.604 . . . . 74.25 112.498 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.0 103.58 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.543 -0.54 . . . . 74.23 109.543 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.7 t -86.37 -52.36 5.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.298 -0.41 . . . . 65.41 109.928 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.19 150.99 46.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.251 -0.431 . . . . 73.2 110.092 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.661 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 66.4 mt -72.97 -59.53 2.17 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 119.742 -0.171 . . . . 64.42 111.145 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 86.6 Cg_endo -82.74 63.62 8.0 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.952 1.768 . . . . 64.15 112.01 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.5 m -100.92 145.67 28.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.121 -0.49 . . . . 75.41 110.486 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.585 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -112.16 122.67 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.265 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.495 HD23 ' HG3' ' A' ' 110' ' ' GLN . 84.7 mt -93.2 123.12 36.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.906 -0.776 . . . . 75.41 108.906 173.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 109' ' ' SER . 42.0 mtp -98.29 143.22 29.0 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.778 -0.453 . . . . 70.31 109.778 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.628 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.5 m-85 -149.09 161.39 42.04 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.328 -0.619 . . . . 75.4 109.328 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -142.63 109.3 5.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.034 -0.266 . . . . 72.3 110.646 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.542 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 60.6 t30 57.03 29.01 15.74 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.353 0.596 . . . . 63.0 111.061 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.5 ' HA2' HG11 ' A' ' 35' ' ' VAL . . . 89.4 -2.72 83.42 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.235 -0.507 . . . . 71.22 112.92 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -91.7 146.79 23.48 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.784 -0.45 . . . . 71.42 109.784 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -60.84 154.62 21.56 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.277 0.561 . . . . 73.13 112.117 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.628 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.16 167.62 23.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.695 -1.138 . . . . 72.33 108.217 -169.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 101' ' ' MET . 5.2 m -70.99 171.48 10.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.744 0.783 . . . . 75.02 112.692 -170.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.495 ' HG3' HD23 ' A' ' 100' ' ' LEU . 26.8 tt0 -126.04 127.28 45.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.233 -0.894 . . . . 73.35 109.775 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 61.3 t -97.52 107.61 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.074 -0.343 . . . . 74.54 110.074 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.492 HD13 ' N ' ' A' ' 112' ' ' ILE . 2.9 mp -81.46 106.95 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 74.14 109.906 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.56 136.7 7.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.297 -0.477 . . . . 52.15 112.142 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.513 ' HB3' ' HG ' ' A' ' 59' ' ' LEU . . . -57.61 92.13 0.01 OUTLIER 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.929 0.395 . . . . 71.15 110.814 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.417 ' O ' HG13 ' A' ' 119' ' ' ILE . 12.4 t70 -127.22 99.33 5.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 73.22 109.963 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.486 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -59.07 -33.68 51.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.846 -0.616 . . . . 62.11 110.728 -174.389 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.8 m -61.06 -54.02 49.88 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.755 0.312 . . . . 71.13 110.487 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -63.71 -40.88 97.87 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.57 -0.286 . . . . 63.31 110.543 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.6 mt -58.76 -55.06 25.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.145 -0.48 . . . . 64.31 110.683 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.9 tt -63.33 -34.11 65.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 116.617 -0.265 . . . . 54.05 110.341 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.6 m -59.44 -45.69 90.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.668 0.27 . . . . 74.12 110.318 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -69.99 -38.05 75.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.625 -0.261 . . . . 72.3 111.186 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.0 mt -57.14 -53.72 39.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.956 0.408 . . . . 64.31 110.012 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -59.59 -39.58 84.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.755 -0.657 . . . . 71.24 109.988 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -63.65 -31.86 73.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.652 -0.703 . . . . 75.22 111.511 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -90.11 -30.12 17.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.184 0.438 . . . . 72.55 112.184 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 74' ' ' VAL . 68.5 mt -86.31 -45.97 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.059 0.457 . . . . 73.13 110.577 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.44 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.455 -0.783 . . . . 74.5 109.65 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.426 ' HG3' ' CG ' ' A' ' 68' ' ' GLN . 93.9 mmm . . . . . 0 C--O 1.233 0.236 0 N-CA-C 109.898 -0.408 . . . . 72.34 109.898 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.434 HG12 ' OE2' ' A' ' 64' ' ' GLU . 32.9 mm -67.83 99.38 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.587 -0.894 . . . . 71.0 108.587 174.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 16.2 tt0 -74.85 112.36 10.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.342 0.592 . . . . 75.23 109.936 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.445 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 8.5 tt0 -88.99 131.14 35.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.488 -0.778 . . . . 62.01 110.717 -170.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.525 HG21 ' HG3' ' A' ' 34' ' ' LYS . 47.6 pt -144.94 -179.85 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.756 0.312 . . . . 73.51 111.201 -175.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.64 -174.42 15.6 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.209 -0.451 . . . . 71.54 112.534 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.455 ' OD1' HG21 ' A' ' 87' ' ' VAL . 20.0 t70 -50.84 -57.01 9.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.502 0.721 . . . . 71.11 112.649 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -69.25 -27.13 65.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 71.5 110.919 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -74.21 -15.59 61.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 65.01 110.642 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -52.56 -61.38 2.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.912 -0.586 . . . . 73.14 111.017 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -55.21 -53.43 56.1 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.433 -0.349 . . . . 60.1 111.167 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -53.34 -55.92 20.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.844 -0.616 . . . . 70.33 111.211 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.705 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 11.0 mmpt? -61.66 -45.61 93.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.864 -0.607 . . . . 71.23 111.33 -176.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.429 ' HA ' HD11 ' A' ' 44' ' ' ILE . 70.4 t -64.29 -40.66 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.448 -0.342 . . . . 74.33 111.347 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.1 p -78.26 -25.02 46.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.703 0.287 . . . . 72.0 111.009 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -61.78 -14.95 37.21 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.261 -0.427 . . . . 75.51 111.459 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 22.8 p -49.48 114.45 1.04 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 123.148 0.28 . . . . 73.23 110.798 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.8 -70.3 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.164 -0.471 . . . . 74.43 111.183 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -156.01 122.17 5.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.374 -0.375 . . . . 73.41 110.474 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 58.82 17.69 5.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.94 -0.573 . . . . 74.31 111.655 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.4 mm -74.74 97.96 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.661 -0.496 . . . . 74.53 109.661 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.81 111.47 9.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.708 -0.678 . . . . 64.44 109.499 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 35' ' ' VAL . 58.3 mt -101.51 115.1 42.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.181 -0.918 . . . . 62.33 110.459 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.1 mp -103.07 106.41 16.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.817 -0.628 . . . . 72.1 109.619 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.81 105.0 16.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.731 -0.213 . . . . 73.52 110.47 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -83.16 151.44 25.7 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.142 0.496 . . . . 65.24 110.688 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.0 t80 . . . . . 0 C--O 1.24 0.586 0 CA-C-N 115.63 -0.713 . . . . 73.45 111.694 -174.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 110.085 -0.339 . . . . 65.43 110.085 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.567 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 38.9 t -75.59 -44.0 45.34 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.527 0.68 . . . . 62.42 111.478 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.65 -45.59 93.53 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.852 0.686 . . . . 75.15 112.852 -171.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.52 -56.31 28.24 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 117.609 0.186 . . . . 74.24 111.171 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 58' ' ' SER . 18.9 Cg_endo -60.25 -40.49 58.9 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.781 1.654 . . . . 74.34 112.087 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 58' ' ' SER . 36.8 mt-30 -58.31 -39.1 78.47 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.681 -0.408 . . . . 63.34 111.756 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.43 -41.35 80.47 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.009 -0.367 . . . . 70.3 110.009 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 19.7 mm-40 -59.47 -41.14 89.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 73.51 110.415 174.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.651 ' HZ3' ' HB2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -60.56 -57.13 14.04 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.379 0.609 . . . . 63.23 110.329 178.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.45 -28.76 70.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.489 -0.778 . . . . 72.31 110.232 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.536 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.08 -50.6 65.5 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.123 -0.49 . . . . 61.24 109.869 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 91.4 mt-30 -59.77 -41.22 90.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.028 -0.533 . . . . 74.51 111.115 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -74.32 -54.87 6.77 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.011 0.434 . . . . 64.12 111.288 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -84.81 4.4 33.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.894 -0.594 . . . . 72.13 112.475 -172.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.7 t -52.97 -19.57 2.73 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 111.887 0.329 . . . . 63.51 111.887 -173.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -58.71 -38.92 79.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 52.23 110.585 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -134.89 10.95 3.63 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.225 -0.443 . . . . 74.14 111.407 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 127' ' ' ILE . 31.8 t -128.83 142.14 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.22 0.533 . . . . 62.51 112.347 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -143.6 119.97 10.93 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.194 -0.912 . . . . 72.13 109.762 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.473 HD11 ' N ' ' A' ' 76' ' ' ILE . 3.6 mp -98.75 136.74 28.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 109.614 -0.513 . . . . 74.31 109.614 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 77.3 m-85 -124.31 164.52 19.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 72.2 109.912 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -153.4 132.58 12.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 74.32 109.638 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 64.9 mt -75.51 118.43 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.885 -0.413 . . . . 73.12 109.885 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.445 ' HB3' ' CG ' ' A' ' 25' ' ' GLN . 4.2 p-10 -91.46 -40.34 11.46 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.801 0.334 . . . . 74.35 111.379 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.4 tt -83.54 99.24 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.732 0.777 . . . . 72.31 110.971 -174.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -17.51 62.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.418 -0.81 . . . . 73.31 111.663 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -70.2 -27.05 64.19 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.572 -0.529 . . . . 74.31 109.572 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 16.0 m120 -128.13 86.9 2.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.885 -0.598 . . . . 75.34 109.894 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -138.41 27.94 2.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.728 -0.669 . . . . 65.05 109.495 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 33.8 t70 -56.76 -35.32 68.5 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.187 -0.915 . . . . 65.35 111.709 -172.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.455 HG21 ' OD1' ' A' ' 28' ' ' ASP . 90.2 t -52.53 -35.98 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.073 0.463 . . . . 73.54 110.489 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.68 71.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.941 -0.572 . . . . 65.34 110.497 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.8 m -59.67 -37.94 80.13 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.286 0.565 . . . . 74.13 110.492 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 19.8 mm-40 -64.5 -48.23 75.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.43 -0.804 . . . . 72.12 110.798 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -76.74 -18.3 58.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.56 -0.291 . . . . 73.01 111.155 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.32 36.51 8.11 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 121.365 -0.445 . . . . 71.23 112.922 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.86 117.99 39.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 122.411 0.284 . . . . 75.44 110.422 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.6 m -133.4 13.75 4.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.921 0.391 . . . . 75.23 110.776 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.19 136.23 39.45 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.549 -0.537 . . . . 73.11 109.549 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.719 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 49.3 mm -56.19 -54.91 47.55 Favored Pre-proline 0 CA--C 1.542 0.642 0 O-C-N 123.274 0.359 . . . . 71.24 111.679 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.719 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 94.5 Cg_endo -94.2 105.3 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.295 1.996 . . . . 61.25 111.322 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.504 HG21 HG13 ' A' ' 112' ' ' ILE . 27.9 m -148.53 118.24 7.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.284 -0.265 . . . . 71.54 110.284 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.428 ' N ' HD13 ' A' ' 99' ' ' ILE . 3.1 mp -109.51 110.71 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.189 -0.46 . . . . 63.34 109.949 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.473 HD11 ' N ' ' A' ' 100' ' ' LEU . 5.5 mp -92.46 123.3 35.67 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.176 -0.676 . . . . 75.34 109.176 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 53.3 mtp -98.73 142.31 30.43 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.854 -0.424 . . . . 63.4 109.854 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.563 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.8 m-85 -144.89 151.03 38.08 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.549 -0.537 . . . . 70.31 109.549 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -149.32 123.56 9.55 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.741 -0.384 . . . . 61.5 110.984 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.627 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.5 m-20 62.21 25.45 15.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.265 0.555 . . . . 71.32 110.325 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.71 -2.89 52.56 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.775 -0.648 . . . . 75.02 111.988 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -88.17 145.06 26.11 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.846 -0.428 . . . . 65.04 109.846 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.577 ' HZ3' ' HB2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -59.48 145.61 43.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 124.047 0.842 . . . . 74.45 110.903 -176.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -150.67 168.02 25.57 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.182 -1.414 . . . . 74.23 107.182 -170.188 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.3 m -70.29 177.89 3.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.19 0.519 . . . . 51.33 112.352 -165.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -142.49 119.38 11.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 60.43 110.057 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -100.63 107.42 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.248 -0.433 . . . . 72.53 110.112 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.532 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -96.16 121.6 46.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.304 -0.628 . . . . 71.32 109.304 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.87 162.5 32.26 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.794 -0.523 . . . . 41.41 111.794 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.66 89.93 2.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.753 0.311 . . . . 71.33 111.175 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 57.4 t0 -132.45 82.23 2.0 Allowed 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.681 0.753 . . . . 75.0 109.848 174.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.87 -29.04 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 114.993 -1.003 . . . . 74.45 110.021 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.4 m -60.82 -50.33 73.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.615 -0.513 . . . . 52.41 109.615 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.798 ' HZ2' ' HB2' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -61.68 -46.3 90.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.648 -0.706 . . . . 53.54 110.183 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 123' ' ' ILE . 78.3 mt -55.57 -56.54 11.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.762 -0.654 . . . . 61.35 111.201 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -66.69 -34.7 71.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.374 -0.376 . . . . 53.31 110.629 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.3 t -59.3 -51.88 68.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.885 -0.413 . . . . 75.45 109.885 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -63.67 -36.01 82.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.435 -0.348 . . . . 75.05 111.232 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.1 mt -56.56 -56.28 14.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.05 0.452 . . . . 71.01 110.41 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -69.6 -29.06 66.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 73.23 110.682 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -65.88 -43.8 87.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 64.45 110.887 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -93.41 -17.95 22.92 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.541 0.571 . . . . 55.14 112.541 -172.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.554 HD11 HG21 ' A' ' 74' ' ' VAL . 58.6 mt -78.27 -59.83 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 120.543 -0.463 . . . . 64.11 110.284 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.303 -0.856 . . . . 75.03 110.205 -176.459 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.467 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 95.4 mmm . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.735 0.302 . . . . 75.44 110.591 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -111.85 126.16 69.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.206 -0.452 . . . . 63.52 110.422 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -87.4 151.37 23.13 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.446 -0.343 . . . . 72.55 110.618 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -114.83 129.68 56.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.436 -0.347 . . . . 71.32 110.067 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.522 HD13 ' HA ' ' A' ' 31' ' ' PHE . 45.7 pt -144.88 169.72 7.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.2 0.524 . . . . 75.43 111.751 -174.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' HA2' HD12 ' A' ' 79' ' ' ILE . . . -136.33 -173.71 13.06 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.298 -0.865 . . . . 64.33 111.274 174.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 7.3 t70 -45.16 -47.22 12.33 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.053 0.454 . . . . 72.1 111.353 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -62.61 -29.35 70.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.712 -0.676 . . . . 63.04 112.424 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -102.87 -17.77 15.38 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 122.395 -0.191 . . . . 53.33 111.435 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.522 ' HA ' HD13 ' A' ' 26' ' ' ILE . 88.4 t80 -50.49 -62.01 1.85 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 112.439 0.533 . . . . 70.01 112.439 -169.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.627 ' O ' HG21 ' A' ' 36' ' ' THR . 10.6 m-20 -56.96 -55.46 34.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 53.43 110.537 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -54.63 -55.84 25.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.731 -0.668 . . . . 62.02 111.447 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HG3' HG21 ' A' ' 26' ' ' ILE . 63.7 mmtt -57.74 -40.82 80.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 71.24 111.386 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.88 -59.72 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.47 -0.332 . . . . 74.11 111.326 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.627 HG21 ' O ' ' A' ' 32' ' ' ASP . 9.0 t -81.38 -0.27 40.55 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.62 -0.263 . . . . 62.32 111.522 -173.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.6 t -61.74 -19.25 62.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.047 0.451 . . . . 73.25 109.978 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.814 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 21.3 p -55.8 137.19 50.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.655 -0.702 . . . . 73.1 110.648 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -74.46 -72.22 0.3 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.453 0.168 . . . . 71.11 110.701 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -136.2 121.91 19.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.559 0.219 . . . . 72.01 111.372 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 48.78 26.56 1.3 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.515 0.726 . . . . 73.34 112.895 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.739 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.7 mm -71.22 126.15 31.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 110.009 -0.367 . . . . 63.01 110.009 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.513 HD11 HD12 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -75.63 107.49 7.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 72.03 109.641 -178.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.496 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 36.5 mm -92.64 133.3 34.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.225 -0.898 . . . . 74.23 109.887 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.513 HD12 HD11 ' A' ' 43' ' ' LEU . 4.1 mp -121.66 149.66 42.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.994 -0.743 . . . . 73.53 108.994 173.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 66.9 t -136.79 104.76 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.239 -0.652 . . . . 63.54 109.239 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -90.97 154.54 19.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.33 0.586 . . . . 65.51 110.499 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.0 t80 . . . . . 0 C--N 1.318 -0.782 0 N-CA-C 107.345 -1.354 . . . . 74.43 107.345 169.225 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.436 ' C ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.101 0 CA-C-O 121.021 0.439 . . . . 72.03 110.016 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.688 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.6 m -75.06 -39.62 60.81 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.255 0.55 . . . . 74.42 110.646 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.524 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.2 mm? -58.59 -37.83 76.66 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.673 0.62 . . . . 70.33 112.673 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 45.1 mt-10 -56.85 -61.02 7.72 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.057 0.389 . . . . 74.22 110.988 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 18.3 Cg_endo -60.2 -38.9 73.11 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.599 1.533 . . . . 72.0 111.942 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.688 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.6 mt-30 -61.45 -41.15 96.76 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.688 -0.405 . . . . 75.24 111.012 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 66.7 mt -65.92 -50.91 62.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 63.14 110.302 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 22.7 mt-10 -65.04 -27.57 68.89 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.68 -0.408 . . . . 74.24 110.88 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -72.59 -49.45 32.18 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.819 0.343 . . . . 72.11 110.442 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.01 -31.55 72.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.841 -0.429 . . . . 62.51 109.841 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.37 -48.2 80.82 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.939 -0.573 . . . . 62.52 109.711 174.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.467 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 96.0 mt-30 -57.52 -42.21 82.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.902 0.382 . . . . 74.25 110.981 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -69.16 -42.67 75.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.593 . . . . 73.42 111.443 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -105.15 5.96 32.71 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.131 0.789 . . . . 74.13 113.131 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.5 t -52.98 -19.91 3.0 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.977 1.103 . . . . 65.11 113.977 -168.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -73.42 -29.24 62.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.016 0.436 . . . . 64.2 110.685 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -115.97 -13.85 11.26 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.669 -0.696 . . . . 71.12 111.346 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.425 HG22 HD12 ' A' ' 127' ' ' ILE . 35.5 t -120.43 133.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.791 0.329 . . . . 65.24 111.677 -173.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -136.16 119.81 17.17 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.769 -0.651 . . . . 71.03 109.299 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.43 HG12 HD13 ' A' ' 45' ' ' LEU . 43.3 mt -104.82 137.19 35.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.162 0.506 . . . . 72.55 110.639 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 73.9 m-85 -125.9 169.19 12.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.607 -0.886 . . . . 74.25 108.607 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.752 ' HZ1' ' HB3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -139.72 129.93 25.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.898 0.38 . . . . 75.4 110.54 172.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.515 HD12 ' HA2' ' A' ' 27' ' ' GLY . 5.7 tp -79.87 78.7 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.614 0.721 . . . . 75.41 109.252 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -112.54 -17.41 12.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.766 -0.652 . . . . 54.25 111.76 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.401 ' HB ' ' HA3' ' A' ' 27' ' ' GLY . 54.0 mt -64.46 92.44 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.464 0.65 . . . . 73.24 109.889 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 85' ' ' GLN . 10.3 pt-20 -54.72 -29.21 52.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.654 -1.157 . . . . 72.03 112.842 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.42 -19.25 62.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.394 0.616 . . . . 71.34 110.272 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 30.0 m-20 -134.66 42.81 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.068 -0.969 . . . . 74.34 108.943 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.415 ' NE2' HG13 ' A' ' 79' ' ' ILE . 17.5 tp60 -71.95 -14.73 61.99 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.895 -1.048 . . . . 71.21 111.464 -176.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 34.6 t70 -46.14 -39.66 9.87 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.288 0.847 . . . . 71.34 113.288 -168.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 80.0 t -52.94 -40.96 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.903 0.383 . . . . 74.52 111.313 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.14 93.11 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.101 -0.499 . . . . 73.04 110.36 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 m -69.79 -33.73 72.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.681 -0.69 . . . . 72.14 110.622 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 45.0 mt-30 -65.43 -56.52 12.05 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.153 -0.476 . . . . 74.13 110.622 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -70.53 -25.22 63.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.158 -0.474 . . . . 75.0 110.938 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.23 60.89 1.1 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.889 -0.672 . . . . 62.35 113.222 173.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -82.4 94.79 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.669 -0.493 . . . . 54.5 109.669 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 t -107.12 -12.17 15.46 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.165 -0.47 . . . . 74.34 111.375 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.58 147.67 25.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.639 -0.255 . . . . 74.52 110.68 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.704 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 67.2 mt -57.32 -51.76 79.32 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.315 -0.402 . . . . 75.33 110.887 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.704 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 69.8 Cg_endo -102.5 100.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.942 2.428 . . . . 71.34 111.751 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.1 m -124.97 116.21 21.8 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.284 -0.26 . . . . 73.05 110.906 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.64 113.95 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.421 -0.354 . . . . 75.24 110.39 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.2 mp -92.05 143.18 26.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.257 -0.645 . . . . 50.41 109.257 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 109' ' ' SER . 47.1 mtp -113.97 146.22 40.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.892 0.377 . . . . 71.51 110.042 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.576 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.7 m-85 -145.73 160.03 42.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.371 -0.974 . . . . 65.43 108.371 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -149.8 117.47 6.2 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.494 -0.483 . . . . 74.13 110.863 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.814 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.0 t30 60.15 25.3 14.63 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.805 -0.634 . . . . 72.41 110.731 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.61 -14.66 63.42 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 116.121 -0.49 . . . . 44.41 112.445 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -83.38 152.75 24.89 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 122.51 0.324 . . . . 72.3 110.374 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -64.93 157.22 28.67 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.65 0.738 . . . . 63.44 111.206 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.576 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.32 168.78 21.69 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.965 -1.494 . . . . 71.12 106.965 -166.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 101' ' ' MET . 58.5 m -69.9 -177.67 1.36 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.066 0.46 . . . . 72.51 111.69 -167.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -148.83 120.15 7.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.031 -0.359 . . . . 54.44 110.031 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.4 t -93.62 107.48 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.999 -0.546 . . . . 64.51 110.106 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -88.82 102.07 12.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.109 -0.7 . . . . 74.1 109.109 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 117.49 162.79 12.66 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.618 -0.593 . . . . 71.33 111.618 -177.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.524 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -88.43 72.19 8.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.954 0.407 . . . . 75.05 110.224 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.38 94.46 4.98 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 116.025 -0.534 . . . . 73.22 110.113 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.403 ' O ' HD11 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.37 -33.95 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 115.673 -0.694 . . . . 73.0 110.172 -175.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -59.61 -47.62 84.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.247 -0.433 . . . . 73.03 110.631 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -69.15 -42.02 76.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 71.13 110.269 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 123' ' ' ILE . 78.9 mt -55.54 -56.21 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.736 0.303 . . . . 72.13 110.897 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.1 tt -66.01 -33.9 66.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.784 0.326 . . . . 70.03 110.387 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.6 t -55.14 -52.32 63.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.044 -0.525 . . . . 64.52 110.477 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 18.6 mm-40 -72.18 -37.17 69.38 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.248 -0.433 . . . . 74.33 110.664 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 119' ' ' ILE . 49.3 mt -52.32 -56.12 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.898 0.38 . . . . 75.42 110.09 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.75 -43.66 92.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.159 -0.473 . . . . 64.21 110.196 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 8.3 t30 -58.12 -30.25 66.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.96 -0.564 . . . . 73.42 111.65 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -99.17 -29.27 12.94 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.645 0.609 . . . . 71.24 112.645 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.425 HD12 HG22 ' A' ' 74' ' ' VAL . 66.3 mt -72.74 -48.83 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 117.947 0.339 . . . . 71.32 110.301 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.4 p30 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.41 -0.805 . . . . 62.21 110.466 178.782 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 79.9 mmm . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 108.782 -0.821 . . . . 73.41 108.782 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 mm -59.75 108.81 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 114.725 -1.125 . . . . 73.13 109.046 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -73.08 154.14 40.54 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.874 0.369 . . . . 74.32 111.115 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -118.88 134.67 55.02 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.167 0.587 . . . . 74.05 110.309 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.52 HD13 ' HA ' ' A' ' 31' ' ' PHE . 41.7 pt -150.09 179.63 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.348 0.594 . . . . 33.13 111.421 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.67 -159.16 9.34 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.323 -0.853 . . . . 72.21 111.036 172.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 11.0 p-10 -65.96 -46.2 78.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.026 0.441 . . . . 55.43 110.916 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.3 m -65.71 -29.16 69.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.703 -0.68 . . . . 74.34 110.668 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -95.39 -10.18 30.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.963 -0.562 . . . . 74.21 111.118 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.52 ' HA ' HD13 ' A' ' 26' ' ' ILE . 88.1 t80 -61.77 -61.87 2.2 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.543 -0.54 . . . . 72.35 109.543 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -57.76 -47.6 82.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.915 -0.584 . . . . 52.23 110.058 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -51.22 -57.74 8.0 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.577 -0.738 . . . . 74.13 110.84 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -80.08 -26.18 39.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.972 -1.013 . . . . 63.21 111.683 -168.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.442 ' HA ' HD12 ' A' ' 44' ' ' ILE . 79.4 t -78.81 -39.37 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.735 -0.212 . . . . 62.3 111.401 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.5 p -84.89 -37.14 20.96 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.934 0.346 . . . . 65.1 111.934 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.5 t -69.06 -13.07 62.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.472 0.545 . . . . 72.24 112.472 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.903 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 28.4 p -57.13 142.0 44.13 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.166 -0.309 . . . . 71.14 110.166 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -61.65 -82.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.387 0.514 . . . . 43.41 112.387 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -160.46 143.41 13.33 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.641 -0.254 . . . . 75.02 110.492 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 61.3 8.2 2.01 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.654 0.596 . . . . 71.23 111.796 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 mm -73.24 102.52 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.193 0.521 . . . . 72.23 110.51 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.85 108.16 4.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.191 -0.913 . . . . 75.14 109.165 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 35' ' ' VAL . 70.3 mt -102.01 137.18 30.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.437 -0.801 . . . . 73.44 111.005 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.614 HD12 HG13 ' A' ' 76' ' ' ILE . 3.4 mp -118.14 148.94 41.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.924 -0.769 . . . . 71.53 108.924 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.5 t -130.59 104.82 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.535 -0.542 . . . . 74.35 109.535 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -88.11 126.63 35.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 75.51 110.599 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 100' ' ' LEU . 17.7 m-85 . . . . . 0 C--N 1.33 -0.245 0 N-CA-C 109.116 -0.698 . . . . 74.45 109.116 169.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.93 0.395 . . . . 71.3 110.545 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.5 m -75.72 -32.5 60.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.133 -0.485 . . . . 73.44 111.223 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -57.95 -45.5 86.55 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.518 0.933 . . . . 50.53 113.518 -164.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 7.9 mp0 -53.77 -60.47 7.14 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-N 118.734 0.697 . . . . 71.23 110.529 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 39.3 Cg_endo -67.31 -19.72 49.66 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.792 1.661 . . . . 71.51 112.548 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.481 ' NE2' HG23 ' A' ' 116' ' ' ILE . 3.4 mm100 -66.47 -52.78 42.52 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 110.263 -0.273 . . . . 72.31 110.263 174.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.508 HD22 HD12 ' A' ' 119' ' ' ILE . 97.2 mt -62.48 -40.9 98.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.474 -0.565 . . . . 73.32 109.474 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.6 mm-40 -58.17 -42.83 86.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.666 -0.697 . . . . 74.13 111.025 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.448 ' HZ2' ' HA ' ' A' ' 62' ' ' GLN . 7.1 ttpm? -63.91 -50.74 67.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.898 0.38 . . . . 71.32 110.244 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.5 mt -64.9 -32.42 74.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.953 -0.567 . . . . 61.45 110.248 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.6 -53.9 44.39 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.197 -0.456 . . . . 43.2 109.824 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 55.2 mt-30 -57.28 -38.94 74.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.014 -0.539 . . . . 73.44 111.019 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.49 -42.55 52.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.887 -0.597 . . . . 75.5 111.389 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -104.86 5.07 32.71 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.743 0.646 . . . . 71.2 112.743 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.8 t -52.88 -21.31 4.13 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.747 0.647 . . . . 60.1 112.747 -169.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.73 -39.13 90.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.822 0.344 . . . . 71.24 110.408 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -120.69 -1.86 9.96 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.77 -0.65 . . . . 74.52 111.575 -176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.518 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 43.0 t -128.44 131.58 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 112.054 0.391 . . . . 73.1 112.054 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' A' ' 74' ' ' VAL . 13.6 mptt -138.92 122.96 17.91 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.034 -0.53 . . . . 71.13 109.939 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.614 HG13 HD12 ' A' ' 45' ' ' LEU . 3.3 mp -99.21 146.12 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.7 -0.481 . . . . 72.11 109.7 176.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -132.0 142.74 49.69 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.738 0.415 . . . . 74.23 110.318 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -111.22 132.42 54.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.861 0.465 . . . . 74.43 110.015 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -86.29 99.16 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.549 -0.908 . . . . 73.43 108.549 174.133 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -80.66 -48.36 12.73 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.539 0.57 . . . . 75.31 112.539 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.525 ' HB ' ' OD1' ' A' ' 84' ' ' ASN . 49.7 mt -78.56 106.92 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 74.44 111.093 -173.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.79 -17.91 52.13 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.168 -0.469 . . . . 74.13 111.464 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.446 ' HB2' HG23 ' A' ' 81' ' ' ILE . 2.7 m-20 -70.02 -20.36 63.27 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.041 0.448 . . . . 71.3 109.827 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.525 ' OD1' ' HB ' ' A' ' 81' ' ' ILE . 10.3 m120 -84.17 41.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.786 -0.643 . . . . 65.23 109.723 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -55.07 -24.92 27.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.424 -0.807 . . . . 74.45 111.265 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -40.36 -55.94 2.11 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.55 -0.75 . . . . 75.4 112.119 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.08 -37.82 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.31 -0.404 . . . . 65.21 111.035 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.88 -54.79 16.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.066 0.46 . . . . 41.45 110.595 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 m -67.36 -35.89 80.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.753 -0.658 . . . . 40.24 111.141 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 14.0 mm-40 -75.27 -41.34 57.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.595 . . . . 74.04 111.537 -175.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -88.79 -12.13 42.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.796 0.331 . . . . 72.31 110.779 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.48 45.33 8.75 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.917 -0.659 . . . . 72.41 112.576 172.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.08 94.84 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.469 -0.567 . . . . 75.04 109.469 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.1 m -58.93 -39.24 80.99 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.751 -0.659 . . . . 73.21 112.047 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.18 144.83 51.15 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.16 -0.311 . . . . 74.34 110.16 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.461 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 59.9 mt -54.67 -49.67 90.01 Favored Pre-proline 0 CA--C 1.541 0.597 0 O-C-N 123.21 0.319 . . . . 74.34 111.792 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 96' ' ' ILE . 56.5 Cg_endo -69.37 82.02 0.69 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 121.868 1.712 . . . . 75.43 112.125 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.6 m -146.54 142.64 28.23 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.231 0.538 . . . . 72.34 111.543 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 mp -115.71 120.65 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.268 -0.878 . . . . 74.53 109.369 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' A' ' 48' ' ' PHE . 9.3 mp -97.43 135.13 39.75 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.895 -0.409 . . . . 72.43 109.895 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.492 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 42.0 mtp -101.87 146.8 27.32 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.077 -0.342 . . . . 73.14 110.077 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -148.04 158.47 44.08 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.398 -0.593 . . . . 74.33 109.398 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -141.89 106.73 4.9 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 120.729 -0.388 . . . . 72.23 111.371 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.903 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.6 t-20 60.78 27.56 17.33 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.481 0.657 . . . . 65.45 110.579 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.84 -10.11 75.28 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.777 -0.647 . . . . 44.22 112.33 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -70.08 132.04 45.23 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 109.593 -0.521 . . . . 75.23 109.593 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -62.07 143.33 56.78 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 124.132 0.895 . . . . 64.31 109.348 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.7 tp -155.84 168.28 27.71 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.102 -0.703 . . . . 75.42 109.102 -164.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.1 m -69.8 171.92 8.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.42 0.629 . . . . 72.22 112.49 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -131.05 133.91 46.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.717 -0.674 . . . . 74.04 110.489 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.77 120.36 53.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.907 -0.588 . . . . 74.34 109.725 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.48 HD11 ' N ' ' A' ' 112' ' ' ILE . 3.1 mp -97.79 125.05 51.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.664 -0.495 . . . . 72.24 109.664 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.25 -174.27 53.52 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.292 -0.48 . . . . 44.34 112.33 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -87.16 86.4 7.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.687 0.279 . . . . 61.41 110.436 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 119' ' ' ILE . 65.4 t0 -123.79 87.83 2.81 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.605 0.717 . . . . 75.03 109.776 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.481 HG23 ' NE2' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -65.56 -29.39 46.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.263 -0.88 . . . . 74.23 109.532 -176.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.9 t -61.86 -48.74 79.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.917 -0.583 . . . . 71.55 109.716 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -63.22 -43.3 98.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.132 -0.486 . . . . 73.31 110.167 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.508 HD12 HD22 ' A' ' 63' ' ' LEU . 82.7 mt -56.62 -56.46 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.225 -0.443 . . . . 53.35 111.293 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.26 -34.13 68.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.662 0.267 . . . . 75.52 110.472 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.7 t -56.53 -51.56 68.09 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.109 -0.496 . . . . 73.21 109.868 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -65.64 -40.17 92.21 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.155 -0.475 . . . . 72.51 110.728 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 119' ' ' ILE . 64.8 mt -54.85 -55.9 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.657 0.265 . . . . 70.3 110.417 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -64.46 -36.93 85.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.6 -0.273 . . . . 73.44 110.321 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -67.11 -26.4 66.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.041 -0.527 . . . . 63.32 111.257 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -101.03 -13.74 18.11 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.878 0.325 . . . . 70.14 111.878 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 123' ' ' ILE . 54.5 mt -85.94 -54.48 8.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.722 0.296 . . . . 71.12 110.395 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.661 -0.685 . . . . 54.0 110.922 -177.328 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.779 0.324 . . . . 71.02 110.918 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -105.19 100.56 10.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 109.66 -0.496 . . . . 74.22 109.66 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 30.3 tt0 -93.62 112.11 23.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.938 0.399 . . . . 65.13 110.435 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 133.2 40.72 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.938 0.399 . . . . 73.41 110.889 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 39.6 pt -144.8 179.64 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.271 -0.422 . . . . 71.31 110.806 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.48 -176.09 15.59 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.969 -0.852 . . . . 54.12 110.969 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.72 -28.63 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.014 0.435 . . . . 55.42 110.334 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.9 m -65.58 -34.86 79.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.779 -0.646 . . . . 75.14 110.718 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 2.3 mp0 -92.38 -22.24 19.78 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.575 -0.284 . . . . 73.15 110.824 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HE1' HG23 ' A' ' 46' ' ' VAL . 70.4 t80 -46.77 -61.46 1.84 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.314 0.383 . . . . 73.52 111.932 -173.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -63.05 -40.91 99.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.444 -0.344 . . . . 53.33 110.497 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 37' ' ' SER . 36.9 m-80 -58.65 -41.68 86.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.796 -0.638 . . . . 63.22 110.678 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -72.04 -43.72 64.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.886 -0.597 . . . . 74.53 110.156 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 31' ' ' PHE . 91.0 t -62.6 -40.68 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.954 -0.566 . . . . 61.12 110.809 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.4 p -80.65 -25.61 38.2 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.148 0.425 . . . . 74.44 112.148 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 22.3 t -67.69 -14.23 62.77 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.92 0.341 . . . . 63.31 111.92 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.773 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 27.6 p -56.84 129.79 42.92 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.102 -0.332 . . . . 72.11 110.102 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.39 -71.38 0.14 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.675 0.274 . . . . 64.33 110.781 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -161.59 135.57 6.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.453 -0.34 . . . . 62.41 110.45 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 61.37 2.31 0.63 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.957 0.725 . . . . 74.32 112.957 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.0 mm -62.29 130.7 27.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.895 0.378 . . . . 75.24 110.388 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER -93.01 112.85 24.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 72.42 109.612 -178.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 38' ' ' CYS . 73.7 mt -107.67 123.06 62.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.819 -0.628 . . . . 61.13 110.313 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.625 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -105.97 146.14 30.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.142 -0.688 . . . . 75.23 109.142 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.616 HG23 ' HE1' ' A' ' 31' ' ' PHE . 61.8 t -125.26 104.72 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.724 -0.473 . . . . 70.04 109.724 177.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -94.83 112.85 24.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.669 . . . . 63.32 109.768 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.459 ' CZ ' HG22 ' A' ' 93' ' ' VAL . 17.1 m-85 . . . . . 0 C--O 1.236 0.375 0 CA-C-O 120.939 0.399 . . . . 64.25 111.099 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.525 0.202 . . . . 74.12 110.579 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.643 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 9.6 m -74.84 -40.47 61.01 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.773 0.797 . . . . 72.11 110.289 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.01 -38.67 76.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.22 -0.9 . . . . 73.41 111.415 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 55.2 mt-10 -54.64 -63.2 3.05 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 119.399 -0.334 . . . . 52.34 111.339 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.416 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 17.8 Cg_endo -60.24 -38.86 72.99 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 121.827 1.684 . . . . 73.13 112.118 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.4 mt-30 -57.73 -42.54 84.09 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.548 -0.461 . . . . 74.13 111.184 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.455 HD22 HD12 ' A' ' 119' ' ' ILE . 93.9 mt -68.97 -45.75 69.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.391 . . . . 65.44 110.467 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 44.7 mt-10 -56.84 -36.77 70.38 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.065 0.46 . . . . 74.31 109.904 176.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -66.89 -52.4 43.81 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.661 -0.699 . . . . 73.14 110.471 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 36.4 mt -59.75 -34.14 72.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.584 . . . . 64.41 109.891 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.453 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -60.64 -53.56 55.95 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.666 -0.697 . . . . 52.41 109.353 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 51.5 mt-30 -53.77 -42.13 67.91 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.235 -0.439 . . . . 75.31 110.961 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -65.88 -46.31 78.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.805 -0.634 . . . . 71.14 111.37 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -104.98 4.7 32.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.772 0.656 . . . . 73.01 112.772 -171.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.4 t -53.29 -20.59 4.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.232 1.197 . . . . 73.42 114.232 -168.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -73.12 -23.54 60.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.95 0.405 . . . . 73.34 110.835 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -118.83 -16.17 9.33 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.808 -0.633 . . . . 75.42 110.629 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.601 HG23 HD12 ' A' ' 127' ' ' ILE . 20.6 t -119.38 133.4 66.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.096 -0.502 . . . . 75.34 111.387 -173.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -131.76 119.85 21.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.511 -0.768 . . . . 73.35 109.239 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.625 HG12 ' HB2' ' A' ' 45' ' ' LEU . 71.7 mt -99.32 139.44 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.972 -0.381 . . . . 71.2 109.972 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 96.5 m-85 -129.82 151.47 50.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.951 -0.568 . . . . 75.54 110.032 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -134.14 109.93 9.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.041 0.448 . . . . 71.14 110.466 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.3 pp -78.56 70.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.733 0.778 . . . . 72.11 110.368 176.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.57 -13.0 60.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.385 -0.825 . . . . 75.14 111.077 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.437 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 60.4 mt -67.12 108.56 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 110.105 -0.331 . . . . 74.54 110.105 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -36.12 64.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.101 -0.5 . . . . 73.3 111.888 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.63 -22.22 61.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.542 . . . . 43.13 110.927 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.437 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.9 OUTLIER -102.62 23.12 12.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.945 -0.571 . . . . 61.01 111.539 -175.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -76.51 12.81 1.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.84 0.311 . . . . 72.21 111.84 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 30.4 t70 -53.11 -36.78 61.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.864 0.364 . . . . 73.11 110.637 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -52.75 -35.25 21.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.817 -0.629 . . . . 75.54 110.638 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.97 -50.23 71.59 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.903 -0.589 . . . . 74.13 110.335 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.1 m -66.7 -31.33 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.656 -0.702 . . . . 75.45 110.781 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 32.6 mm-40 -67.98 -53.85 22.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.21 -0.45 . . . . 63.2 110.928 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -91.71 -2.36 57.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.165 -0.47 . . . . 65.43 112.028 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.46 71.37 1.16 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.814 -0.708 . . . . 75.54 112.384 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.459 HG22 ' CZ ' ' A' ' 48' ' ' PHE . 98.4 t -104.51 101.04 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 63.04 110.363 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.8 t -94.6 -35.22 12.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 61.21 109.904 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.94 146.07 37.78 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.924 -0.58 . . . . 73.24 110.783 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.683 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 65.2 mt -69.09 -54.54 11.79 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.481 -0.327 . . . . 64.23 110.937 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.683 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 5.1 Cg_endo -85.0 93.79 0.68 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.142 1.895 . . . . 62.3 110.943 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 90.7 m -127.65 132.6 49.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.042 0.449 . . . . 74.41 111.208 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.51 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.6 mp -115.78 122.65 69.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.629 -0.714 . . . . 73.03 109.829 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.483 HD22 ' HG3' ' A' ' 110' ' ' GLN . 90.6 mt -98.68 125.26 43.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.664 -0.495 . . . . 74.4 109.664 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.533 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 52.9 mtp -98.46 147.73 24.45 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.964 -0.384 . . . . 63.42 109.964 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.73 150.78 36.88 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.096 -0.705 . . . . 74.14 109.096 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.463 ' HB2' HD22 ' A' ' 108' ' ' LEU . 61.9 tttp -139.54 106.78 5.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 120.907 -0.317 . . . . 74.21 111.024 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.773 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.4 t30 59.08 30.9 20.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.698 0.761 . . . . 51.21 110.444 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.87 -13.99 61.48 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.639 -0.71 . . . . 70.04 112.25 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -70.37 138.07 51.06 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 110.038 -0.356 . . . . 63.41 110.038 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -56.86 152.73 12.12 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.231 0.957 . . . . 72.24 109.447 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.533 ' HB3' ' C ' ' A' ' 101' ' ' MET . 11.5 tp -162.82 168.79 20.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.512 -0.767 . . . . 75.42 109.893 -165.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.7 m -69.19 164.04 23.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.787 0.803 . . . . 73.33 112.411 -164.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.483 ' HG3' HD22 ' A' ' 100' ' ' LEU . 61.8 tt0 -127.65 124.14 37.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.11 -0.95 . . . . 74.12 109.593 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.8 t -97.66 111.89 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 70.03 110.234 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.483 HD11 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -97.52 109.99 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.805 -0.634 . . . . 73.31 109.801 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.08 -174.68 23.39 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.043 -0.598 . . . . 44.31 112.284 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.4 72.29 4.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.188 0.518 . . . . 33.24 110.808 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.419 ' O ' HG13 ' A' ' 119' ' ' ILE . 0.9 OUTLIER -110.79 77.79 1.07 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.91 -0.586 . . . . 72.42 109.915 177.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -34.72 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.627 -0.715 . . . . 54.14 110.024 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.1 t -63.52 -42.66 98.45 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.163 -0.471 . . . . 73.24 110.224 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -65.48 -41.38 93.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 72.35 109.991 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 123' ' ' ILE . 77.0 mt -59.18 -56.69 15.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.028 -0.533 . . . . 73.53 110.807 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.7 tt -62.9 -37.08 78.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 116.466 -0.334 . . . . 74.23 110.439 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.0 t -58.19 -51.9 67.8 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 116.289 -0.414 . . . . 74.55 110.128 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.87 -39.45 91.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.448 -0.342 . . . . 73.01 110.633 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 119' ' ' ILE . 74.4 mt -57.54 -56.51 14.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 121.109 -0.236 . . . . 71.43 111.159 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -71.07 -24.99 62.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.755 -0.378 . . . . 53.12 110.356 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -66.61 -38.55 87.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.163 0.506 . . . . 75.32 110.43 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -92.51 -12.79 31.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.291 -0.413 . . . . 65.53 111.922 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.601 HD12 HG23 ' A' ' 74' ' ' VAL . 62.4 mt -95.97 -60.47 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.769 0.318 . . . . 71.14 111.431 173.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.492 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.751 -0.642 . . . . 62.51 110.364 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.405 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 85.5 mmm . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.843 0.354 . . . . 54.23 110.265 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.524 HG21 ' HB2' ' A' ' 78' ' ' LYS . 21.0 mm -81.09 123.17 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.026 -0.534 . . . . 73.32 109.561 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -88.99 126.16 35.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.923 0.392 . . . . 73.15 111.158 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.76 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 10.2 pt20 -82.76 130.94 35.2 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.208 -0.451 . . . . 74.02 110.402 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 31' ' ' PHE . 47.2 pt -141.83 168.17 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.294 0.568 . . . . 71.3 111.87 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.75 -170.0 12.64 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.188 -0.915 . . . . 22.14 111.093 173.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.58 -45.28 92.33 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.181 0.515 . . . . 73.4 110.991 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.8 m -57.38 -28.45 63.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.385 -0.825 . . . . 65.21 111.592 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.4 mp0 -106.52 -20.42 13.37 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.693 -0.231 . . . . 64.15 111.582 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.432 ' O ' HG22 ' A' ' 35' ' ' VAL . 91.2 t80 -52.0 -62.01 1.9 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 111.949 0.352 . . . . 74.33 111.949 -171.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.33 -44.31 79.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.265 -0.425 . . . . 64.12 110.252 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -59.59 -57.4 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.767 -0.651 . . . . 72.04 110.883 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 35.7 mmtp -59.31 -32.12 69.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.873 -0.603 . . . . 74.45 111.342 -174.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 31' ' ' PHE . 96.3 t -78.52 -44.76 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.874 0.324 . . . . 72.2 111.874 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.3 p -86.01 -14.99 42.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.609 0.596 . . . . 70.33 112.609 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.3 m -78.11 9.69 3.52 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.804 0.335 . . . . 73.31 111.605 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.901 ' SG ' ' HB ' ' A' ' 42' ' ' ILE . 41.6 t -67.36 169.1 9.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 75.43 110.208 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.456 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 45.0 t-20 -114.01 -62.47 1.59 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.951 -0.389 . . . . 75.12 109.951 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -162.38 138.59 7.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.483 -0.326 . . . . 72.33 111.368 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 60.15 1.71 0.37 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.092 1.145 . . . . 53.41 114.092 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.901 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 50.7 mm -79.73 107.03 11.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 118.325 0.511 . . . . 73.33 110.33 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.6 tp -75.47 129.39 37.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.648 -0.705 . . . . 73.35 110.274 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.5 mt -116.56 119.92 63.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.631 -0.713 . . . . 64.31 110.488 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.458 HD11 ' N ' ' A' ' 45' ' ' LEU . 4.3 mp -108.13 143.57 36.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.908 -0.775 . . . . 64.2 108.908 175.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.41 HG23 ' HB2' ' A' ' 77' ' ' TYR . 64.3 t -130.0 110.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.719 -0.475 . . . . 74.42 109.719 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.407 ' OD2' ' NZ ' ' A' ' 78' ' ' LYS . 16.4 t70 -88.96 143.01 27.16 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.043 0.449 . . . . 73.53 111.607 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.0 t80 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 115.717 -0.674 . . . . 64.04 109.912 176.076 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.5 0.19 . . . . 74.51 111.01 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.625 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.7 m -75.39 -43.49 49.88 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.606 0.717 . . . . 71.22 111.415 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.441 HD22 ' HB2' ' A' ' 114' ' ' ALA . 4.3 mm? -64.88 -33.8 76.88 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.53 -0.759 . . . . 74.32 112.093 -170.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -59.34 -59.96 12.12 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 121.043 -0.263 . . . . 70.44 110.567 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.6 -42.17 49.72 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 121.829 1.686 . . . . 70.11 111.992 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.5 mt-30 -57.37 -46.46 83.37 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 120.599 -0.44 . . . . 52.45 111.422 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.75 -43.82 78.98 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.394 -0.367 . . . . 71.11 110.617 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.458 ' HG2' HG12 ' A' ' 23' ' ' ILE . 36.0 mt-10 -63.48 -33.83 76.43 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.648 0.261 . . . . 55.22 110.509 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -63.18 -54.71 33.39 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.23 0.538 . . . . 74.5 110.146 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.455 HD11 HD12 ' A' ' 120' ' ' ILE . 22.4 mt -63.19 -34.06 76.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.772 -0.649 . . . . 73.24 110.132 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.498 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -61.58 -43.48 98.78 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.99 -0.55 . . . . 74.24 110.076 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.405 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 97.2 mt-30 -63.7 -48.34 77.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.932 0.396 . . . . 74.12 110.61 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.85 -43.29 99.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.868 -0.605 . . . . 74.0 111.12 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.499 ' HH ' HD11 ' A' ' 120' ' ' ILE . 68.8 m-85 -104.91 5.72 33.11 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 112.995 0.739 . . . . 75.24 112.995 -169.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.6 t -52.87 -23.47 7.12 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.383 0.882 . . . . 71.13 113.383 -170.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.65 -18.77 60.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.84 0.352 . . . . 73.23 111.313 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.29 -6.65 4.29 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.964 -0.562 . . . . 63.15 111.191 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.524 HG22 HD13 ' A' ' 127' ' ' ILE . 39.6 t -128.97 138.42 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.048 0.452 . . . . 63.32 111.535 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -135.93 127.59 28.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.596 -0.729 . . . . 74.32 109.063 170.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.1 mt -113.42 114.52 47.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.943 0.401 . . . . 73.45 110.311 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.41 ' HB2' HG23 ' A' ' 46' ' ' VAL . 98.7 m-85 -93.71 167.32 11.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.747 -0.66 . . . . 73.53 109.868 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.524 ' HB2' HG21 ' A' ' 23' ' ' ILE . 31.9 tttp -145.15 140.97 28.35 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.348 -0.612 . . . . 65.04 109.348 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.0 tt -64.01 108.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.215 0.531 . . . . 71.31 110.811 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.76 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 41.2 t30 -89.62 -52.94 4.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.733 -0.667 . . . . 74.24 110.32 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.4 mm -74.14 112.6 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.36 -0.836 . . . . 72.13 110.687 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -59.95 -30.11 68.86 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.551 0.691 . . . . 73.23 110.381 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.74 -22.65 61.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.512 -0.767 . . . . 62.5 110.497 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -88.95 45.37 1.29 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.454 0.645 . . . . 72.34 110.721 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.428 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 3.0 pt20 -88.94 -7.53 55.88 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.963 -0.754 . . . . 72.32 108.963 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 21.5 t70 -48.75 -51.42 29.06 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.252 -0.885 . . . . 50.44 110.599 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -54.57 -33.9 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.946 -0.57 . . . . 74.13 111.445 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.508 ' HB2' ' HB ' ' A' ' 93' ' ' VAL . . . -66.3 -41.52 89.62 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.427 -0.583 . . . . 72.0 109.427 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.7 m -70.46 -29.72 66.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.615 -0.72 . . . . 74.4 110.716 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 83.1 mm-40 -70.6 -48.9 52.82 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.224 -0.443 . . . . 63.21 111.179 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -82.91 -24.81 32.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.353 -0.385 . . . . 73.42 111.442 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.82 64.67 0.85 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.962 -0.637 . . . . 51.33 112.593 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 88' ' ' ALA . 90.8 t -102.5 102.2 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.615 -0.513 . . . . 71.32 109.615 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -113.8 8.67 17.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 74.32 110.429 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.92 151.98 44.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.495 -0.558 . . . . 50.41 109.495 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.653 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 68.0 mt -63.37 -57.51 19.91 Favored Pre-proline 0 CA--C 1.538 0.493 0 O-C-N 123.077 0.236 . . . . 43.2 111.114 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.653 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 96.6 Cg_endo -86.62 100.78 0.57 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.757 1.638 . . . . 53.22 111.614 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.4 m -137.36 121.59 18.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.775 0.322 . . . . 74.22 110.576 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.437 ' N ' HD13 ' A' ' 99' ' ' ILE . 3.0 mp -110.17 110.9 33.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.801 -0.636 . . . . 74.32 109.941 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -88.31 126.04 34.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.625 -0.509 . . . . 74.23 109.625 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.452 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 33.5 mtp -106.67 140.76 39.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.963 -0.384 . . . . 74.14 109.963 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -147.27 155.37 41.99 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.993 -0.743 . . . . 75.25 108.993 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -129.07 105.49 8.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.674 -0.41 . . . . 72.23 110.611 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.543 ' HA ' ' HB3' ' A' ' 38' ' ' CYS . 8.9 t30 61.27 25.67 15.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.593 0.711 . . . . 64.33 110.566 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.24 -12.2 70.25 Favored Glycine 0 N--CA 1.454 -0.103 0 CA-C-N 115.831 -0.622 . . . . 62.54 112.071 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -75.08 139.21 42.65 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 110.02 -0.363 . . . . 65.21 110.02 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -58.62 145.96 37.83 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 124.405 1.066 . . . . 75.01 110.813 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 101' ' ' MET . 0.9 OUTLIER -162.34 168.92 21.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 72.32 109.52 -167.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.4 m -69.96 172.32 8.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.143 0.577 . . . . 62.52 111.927 -168.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.463 ' OE1' ' HG ' ' A' ' 100' ' ' LEU . 26.0 tt0 -142.03 118.48 10.9 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.995 -0.548 . . . . 72.02 109.613 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.85 107.19 17.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.409 -0.36 . . . . 74.33 110.064 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 65.0 mt -95.57 104.89 16.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.288 -0.415 . . . . 73.31 110.243 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.41 148.01 6.8 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.656 -0.578 . . . . 62.33 111.656 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.441 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -80.1 71.78 6.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.094 0.473 . . . . 52.45 109.958 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 119' ' ' ILE . 29.5 t70 -122.2 95.72 4.76 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.473 0.654 . . . . 72.21 109.812 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -62.42 -28.43 44.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.984 -1.007 . . . . 75.41 110.019 -174.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.9 m -62.34 -48.67 78.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.146 -0.479 . . . . 75.21 110.561 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -67.54 -37.65 83.03 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.725 0.298 . . . . 52.24 110.207 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.433 ' O ' HG13 ' A' ' 123' ' ' ILE . 75.2 mt -58.25 -56.33 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.217 -0.447 . . . . 64.51 110.904 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.499 HD11 ' HH ' ' A' ' 70' ' ' TYR . 7.9 tp -64.74 -34.46 70.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.773 0.321 . . . . 73.45 110.642 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.7 t -58.68 -45.02 90.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 73.15 110.125 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.438 ' HB3' ' HE2' ' A' ' 101' ' ' MET . 48.8 mm-40 -70.86 -37.29 73.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.449 -0.341 . . . . 64.45 111.143 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 119' ' ' ILE . 68.6 mt -54.75 -55.9 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.124 0.488 . . . . 74.05 109.975 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -60.24 -41.91 94.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 74.35 110.642 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 33.3 t30 -58.26 -38.4 76.86 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.654 -0.703 . . . . 65.43 111.505 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -99.58 -11.99 20.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.227 0.454 . . . . 75.12 112.227 -174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.524 HD13 HG22 ' A' ' 74' ' ' VAL . 55.6 mt -92.82 -59.54 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 120.902 0.382 . . . . 70.34 111.075 173.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.592 -0.718 . . . . 51.33 110.276 -174.263 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.1 mmm . . . . . 0 C--O 1.232 0.157 0 N-CA-C 108.951 -0.759 . . . . 74.41 108.951 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mm -91.75 136.49 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.83 -1.077 . . . . 71.43 108.764 174.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.0 tp10 -112.8 144.07 42.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.725 0.298 . . . . 74.54 110.725 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -114.26 132.01 56.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.781 -0.451 . . . . 71.35 109.781 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.1 pt -140.27 178.27 3.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 120.867 0.365 . . . . 73.53 111.126 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.59 172.95 25.48 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 115.89 -0.595 . . . . 52.03 111.869 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.655 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 10.5 t70 -52.24 -56.82 12.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.978 0.418 . . . . 72.35 111.504 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -64.21 -19.98 65.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.821 -0.627 . . . . 74.23 111.695 -174.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -78.08 -29.22 49.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.663 -0.244 . . . . 73.11 111.202 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -52.68 -49.39 65.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.731 0.301 . . . . 74.42 110.515 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.17 -55.85 26.59 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.969 -0.56 . . . . 60.44 109.916 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -53.27 -57.56 10.1 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.162 -0.927 . . . . 72.34 110.884 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -64.07 -41.52 97.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.423 -1.262 . . . . 62.54 111.211 -169.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.56 -41.14 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.537 -0.301 . . . . 62.32 110.973 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 p -75.82 -19.28 59.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.784 0.326 . . . . 75.11 111.324 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -76.37 -14.57 60.08 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.434 -0.348 . . . . 75.14 110.717 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.733 ' SG ' HD11 ' A' ' 44' ' ' ILE . 66.6 m -70.93 101.16 2.1 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.879 0.371 . . . . 73.44 110.256 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -67.41 -47.93 68.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 72.23 112.371 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -153.82 133.27 12.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.092 0.472 . . . . 63.23 111.853 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 67.28 2.13 2.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.915 -1.039 . . . . 73.12 113.421 165.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.691 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 48.0 mm -80.63 97.16 3.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.367 0.603 . . . . 61.11 110.325 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.407 HD22 ' HE1' ' A' ' 101' ' ' MET . 2.5 tt -80.77 113.13 18.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.33 -0.85 . . . . 72.32 108.944 176.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.733 HD11 ' SG ' ' A' ' 38' ' ' CYS . 47.3 mt -98.26 133.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.08 -0.509 . . . . 74.42 111.29 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.9 mp -114.56 124.88 52.99 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.57 -0.9 . . . . 64.44 108.57 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 92.4 t -106.37 110.02 30.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 110.205 -0.294 . . . . 73.12 110.205 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -99.71 131.92 45.38 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.236 0.541 . . . . 65.24 111.337 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--N 1.326 -0.454 0 N-CA-C 108.356 -0.979 . . . . 75.22 108.356 168.038 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.821 0.343 . . . . 74.51 111.174 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.623 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 17.5 m -75.41 -59.13 2.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.03 -0.532 . . . . 75.44 111.558 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' A' ' 114' ' ' ALA . 4.5 mm? -64.06 -29.25 70.4 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.751 0.649 . . . . 73.54 112.751 -169.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.436 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 41.0 mt-10 -57.01 -63.9 3.13 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 120.56 -0.456 . . . . 51.55 110.454 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.436 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 38.0 Cg_endo -65.44 -36.86 32.69 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 121.761 1.641 . . . . 73.12 112.132 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 58' ' ' SER . 37.9 mt-30 -58.8 -48.9 79.66 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.537 -0.465 . . . . 74.04 111.234 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.89 -46.59 74.43 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.922 -0.127 . . . . 70.02 110.699 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 30.9 mt-10 -63.41 -30.56 71.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.493 -0.483 . . . . 65.24 110.685 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -64.71 -57.17 9.72 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.186 0.517 . . . . 70.44 109.935 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.48 HD12 HD13 ' A' ' 120' ' ' ILE . 37.7 mt -58.97 -34.81 72.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.489 -0.778 . . . . 72.41 109.597 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.477 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.65 -49.47 75.02 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.52 -0.764 . . . . 74.44 110.258 176.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.1 mt-30 -60.06 -35.87 76.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.784 0.326 . . . . 72.03 111.03 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.86 -41.93 42.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.012 -0.54 . . . . 61.22 111.393 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -105.06 4.95 32.08 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 113.132 0.79 . . . . 75.43 113.132 -171.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.5 t -53.14 -19.96 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.901 0.704 . . . . 75.32 112.901 -170.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -64.52 -33.71 76.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.046 0.451 . . . . 72.12 110.486 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -129.43 8.76 5.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.78 -0.645 . . . . 75.34 111.983 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.544 HG21 HD11 ' A' ' 127' ' ' ILE . 43.0 t -133.64 142.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.206 -0.309 . . . . 74.14 111.653 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.4 tppt? -151.69 133.77 15.1 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.053 -0.721 . . . . 73.21 109.053 175.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.441 HD11 ' N ' ' A' ' 76' ' ' ILE . 4.2 mp -108.17 136.67 42.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.718 0.294 . . . . 74.22 110.423 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 74.4 m-85 -128.39 158.18 38.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 70.34 109.935 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.704 ' HB2' ' HZ3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -152.33 172.74 16.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.653 -0.499 . . . . 73.32 109.653 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.42 142.56 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.765 -0.457 . . . . 53.54 109.765 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -103.56 -9.67 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 74.13 110.834 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 83' ' ' ASP . 8.5 tp -153.88 118.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.345 0.593 . . . . 72.14 110.77 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -58.81 -18.38 31.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.565 -0.743 . . . . 73.32 111.924 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.467 ' H ' HG13 ' A' ' 81' ' ' ILE . 4.4 m-20 -71.09 -7.9 49.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.544 -0.298 . . . . 74.15 111.57 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.655 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 3.9 m120 -125.63 78.53 1.74 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 74.43 110.441 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -114.3 10.37 17.15 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.483 -0.78 . . . . 72.24 110.088 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 2.8 m-20 -49.32 -45.98 46.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.506 -0.77 . . . . 72.52 109.991 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.0 p -55.02 -39.68 50.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.539 -0.755 . . . . 71.33 111.258 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.97 -33.25 74.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.31 0.576 . . . . 75.14 109.743 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.8 m -73.53 -32.31 64.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.21 -0.904 . . . . 74.41 110.142 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.8 mm-40 -70.86 -39.57 72.83 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.904 -0.589 . . . . 74.24 111.019 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -83.39 -23.73 32.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.539 0.209 . . . . 75.02 111.148 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.67 57.82 2.51 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.186 -0.53 . . . . 74.44 112.639 175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.02 124.0 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.504 0.192 . . . . 75.42 110.56 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.1 m -69.81 -62.52 1.35 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.142 -0.481 . . . . 64.51 111.879 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.81 161.87 17.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 63.23 110.253 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.475 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 47.5 mm -61.9 -54.62 49.1 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 123.224 0.328 . . . . 72.34 111.178 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 73.1 Cg_endo -74.74 80.6 2.32 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.809 1.673 . . . . 54.34 112.225 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.5 m -137.01 137.03 38.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 50.2 111.016 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.42 HD11 ' N ' ' A' ' 99' ' ' ILE . 2.7 mp -110.82 114.55 47.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.067 -0.515 . . . . 63.31 109.645 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.2 mp -90.66 154.01 19.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.417 -0.586 . . . . 72.32 109.417 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.407 ' HE1' HD22 ' A' ' 43' ' ' LEU . 57.6 mtp -119.22 144.73 46.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.06 -0.348 . . . . 60.31 110.06 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.524 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.7 m-85 -149.13 149.76 31.57 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.171 -0.677 . . . . 54.22 109.171 176.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 ttpt -145.15 113.77 6.74 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.054 -0.658 . . . . 72.4 111.594 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 59.32 25.72 14.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.816 0.817 . . . . 70.34 110.663 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.24 -16.33 49.02 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.802 -0.635 . . . . 75.35 111.876 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.511 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 8.2 tmtm? -72.83 135.3 45.17 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.579 -0.897 . . . . 75.1 108.579 177.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.511 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 34.2 mmtp -65.87 145.84 55.46 Favored 'General case' 0 N--CA 1.46 0.038 0 CA-C-O 121.577 0.703 . . . . 73.2 111.37 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -145.38 167.81 22.01 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.66 -1.155 . . . . 73.41 108.979 -167.027 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.6 m -70.99 -177.65 1.7 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.539 0.685 . . . . 74.33 112.352 -169.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -141.32 121.0 13.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.684 -0.689 . . . . 72.13 109.77 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.7 t -95.89 116.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.0 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.482 HD11 ' N ' ' A' ' 112' ' ' ILE . 2.9 mp -91.62 115.63 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 75.31 109.974 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.46 169.68 41.91 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.12 -0.562 . . . . 74.1 112.575 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.516 ' HB3' ' HG ' ' A' ' 59' ' ' LEU . . . -83.33 76.02 9.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.447 0.299 . . . . 73.12 110.767 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.418 ' O ' HG13 ' A' ' 119' ' ' ILE . 23.6 t0 -115.1 95.89 5.42 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.483 0.659 . . . . 62.45 110.75 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -60.81 -28.19 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.091 -0.959 . . . . 73.34 110.089 -177.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.3 t -62.32 -53.81 49.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.943 0.401 . . . . 72.11 110.146 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -62.99 -41.43 99.57 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.308 -0.405 . . . . 71.05 110.23 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.47 ' O ' HG13 ' A' ' 123' ' ' ILE . 74.0 mt -55.45 -56.46 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.944 -0.571 . . . . 71.24 111.159 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.48 HD13 HD12 ' A' ' 66' ' ' LEU . 8.3 tp -65.58 -34.7 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.755 0.312 . . . . 72.43 110.651 -177.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 t -57.17 -52.18 66.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.125 -0.488 . . . . 61.42 110.35 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -72.04 -31.44 66.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.471 -0.331 . . . . 53.02 111.53 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 119' ' ' ILE . 49.5 mt -57.26 -55.71 19.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 120.62 -0.432 . . . . 65.41 110.006 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -68.53 -35.74 77.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.199 -0.455 . . . . 74.03 110.486 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -65.11 -34.95 79.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.861 -0.609 . . . . 64.43 111.335 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -101.16 -14.46 17.73 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.7 0.63 . . . . 61.24 112.7 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.544 HD11 HG21 ' A' ' 74' ' ' VAL . 58.9 mt -82.8 -48.5 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.549 -0.538 . . . . 73.03 109.549 171.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.316 -0.85 . . . . 62.41 109.455 178.313 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 95.1 mmm . . . . . 0 C--O 1.235 0.312 0 CA-C-O 120.441 0.162 . . . . 72.24 110.973 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.0 mm -62.74 116.89 3.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.394 -0.366 . . . . 75.15 110.183 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -86.37 151.27 23.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.299 -0.409 . . . . 74.24 110.12 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 14.1 pt20 -123.29 130.91 53.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 72.24 110.629 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.51 HG23 ' HG3' ' A' ' 34' ' ' LYS . 37.5 pt -139.38 174.1 9.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.056 -0.52 . . . . 61.13 110.309 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.22 160.35 19.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.205 -0.521 . . . . 52.3 112.131 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.689 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 13.8 t70 -53.68 -38.64 64.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.493 0.663 . . . . 71.04 110.72 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.2 m -76.52 1.63 16.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.315 -0.857 . . . . 71.12 111.788 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 35.5 mt-10 -113.45 -6.08 13.48 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.344 -0.222 . . . . 73.42 111.056 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 35' ' ' VAL . 89.2 t80 -50.21 -61.57 2.09 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.382 0.426 . . . . 72.31 111.501 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -56.98 -42.91 81.06 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.221 -0.445 . . . . 72.41 110.488 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -55.75 -57.06 13.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.671 -0.695 . . . . 72.33 110.461 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.51 ' HG3' HG23 ' A' ' 26' ' ' ILE . 72.5 mmtt -65.6 -37.08 85.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 64.24 111.061 -174.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.617 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 88.0 t -71.72 -29.18 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.716 0.293 . . . . 74.31 111.241 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.9 p -86.32 -21.0 27.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.891 0.377 . . . . 75.32 110.839 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -72.74 -9.5 58.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.046 -0.524 . . . . 63.25 111.266 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.801 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 26.0 p -82.32 77.71 9.07 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.38 -0.6 . . . . 64.32 109.38 175.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.52 -40.43 94.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.618 -0.719 . . . . 70.3 112.86 -173.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 42' ' ' ILE . 5.6 m-20 -135.9 121.23 19.18 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.098 0.407 . . . . 74.42 112.098 -173.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 55.85 2.22 0.07 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.776 1.398 . . . . 64.44 114.776 166.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.801 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 46.9 mm -80.86 109.49 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.328 0.513 . . . . 71.52 110.451 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.9 tt -82.52 115.9 21.72 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.171 -0.677 . . . . 73.25 109.171 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.494 HG22 HG23 ' A' ' 35' ' ' VAL . 32.7 mm -87.11 115.04 27.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.793 -0.64 . . . . 72.5 110.991 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.413 HD11 ' N ' ' A' ' 45' ' ' LEU . 6.2 mp -102.47 148.1 25.93 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.5 -0.926 . . . . 71.2 108.5 171.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 60.5 t -133.35 106.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.617 -0.142 . . . . 73.42 110.617 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.52 143.13 26.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.987 0.423 . . . . 74.23 110.557 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.4 ' HE1' ' HG ' ' A' ' 100' ' ' LEU . 82.6 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.093 0.473 . . . . 75.31 111.562 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 120.551 0.215 . . . . 62.11 110.851 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.537 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.3 m -75.11 -35.17 61.76 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.212 0.53 . . . . 73.44 110.695 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.38 -42.85 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.716 -0.674 . . . . 71.32 111.629 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.44 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 37.6 mt-10 -54.89 -60.53 7.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.758 -0.163 . . . . 72.34 111.011 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 20.1 Cg_endo -61.7 -34.66 83.2 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.688 1.592 . . . . 73.34 112.211 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.537 ' HG3' ' O ' ' A' ' 58' ' ' SER . 14.9 mt-30 -63.9 -38.24 90.36 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.702 -0.399 . . . . 70.14 110.83 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.4 mt -68.62 -42.6 77.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.764 -0.458 . . . . 51.22 109.764 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -67.79 -26.79 66.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 54.42 110.71 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.434 ' HE2' ' HA ' ' A' ' 62' ' ' GLN . 33.4 ttpt -65.71 -56.78 10.24 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.725 0.774 . . . . 72.52 109.957 175.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.455 HD23 HD11 ' A' ' 120' ' ' ILE . 37.6 mt -59.13 -32.91 70.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.936 -1.029 . . . . 75.31 109.534 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.508 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.5 -51.27 66.28 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.692 -0.686 . . . . 71.23 109.562 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -55.89 -48.6 75.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.651 -0.704 . . . . 70.24 111.781 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -73.85 -39.68 63.83 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.44 -0.504 . . . . 73.33 111.169 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -101.04 4.93 42.77 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 113.021 0.748 . . . . 74.45 113.021 -171.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.9 t -53.25 -19.18 2.91 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.519 0.563 . . . . 74.2 112.519 -171.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -69.23 -34.68 75.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.656 0.265 . . . . 74.22 110.717 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.26 3.61 8.51 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.246 -0.434 . . . . 72.4 111.624 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.6 t -130.94 136.77 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.794 0.33 . . . . 74.43 111.368 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -138.36 131.28 29.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 70.32 109.624 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.0 mt -112.01 135.55 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.572 -0.529 . . . . 74.12 109.572 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 95.7 m-85 -129.26 147.93 51.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 73.32 110.469 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -133.99 145.14 49.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.061 -0.518 . . . . 71.5 109.849 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 84' ' ' ASN . 52.0 mt -70.21 112.52 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.958 -0.756 . . . . 74.15 108.958 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 66.9 t30 -75.31 -12.85 60.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.984 -0.553 . . . . 62.34 112.371 -170.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.47 HG22 ' H ' ' A' ' 83' ' ' ASP . 56.9 mt -130.89 119.97 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.683 0.277 . . . . 74.14 110.665 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -18.78 65.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.096 -0.502 . . . . 61.02 111.796 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.47 ' H ' HG22 ' A' ' 81' ' ' ILE . 24.8 t70 -71.37 -18.64 62.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.41 0.624 . . . . 61.31 109.833 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 16.6 m120 -103.9 121.66 43.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.223 -0.898 . . . . 75.45 108.758 175.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -163.27 15.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.959 0.725 . . . . 73.03 112.959 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 1.8 m-20 -54.96 -42.46 72.39 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.061 -0.348 . . . . 73.24 110.061 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.15 -38.96 31.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.822 -0.627 . . . . 54.25 110.532 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.46 77.52 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.347 0.594 . . . . 72.45 110.003 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.6 m -67.32 -37.49 83.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.022 -0.99 . . . . 74.1 110.564 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 93.5 mt-30 -69.97 -53.47 17.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.827 -0.624 . . . . 74.14 111.061 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.42 -13.0 55.79 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.023 -0.535 . . . . 74.43 111.696 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.53 78.97 0.79 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.88 -0.676 . . . . 64.04 112.849 171.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.9 t -75.54 93.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.316 0.579 . . . . 73.12 109.797 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.7 m -71.76 -59.4 2.77 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.363 -0.835 . . . . 73.12 110.925 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.5 152.85 21.88 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.5 -0.556 . . . . 65.43 109.5 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.686 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 43.0 mm -55.35 -54.27 52.79 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 123.18 0.3 . . . . 72.44 111.087 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.686 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 19.8 Cg_endo -89.32 99.74 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.256 1.971 . . . . 73.25 111.318 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.3 m -118.62 146.49 44.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.136 -0.484 . . . . 74.33 110.567 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 3.5 mp -123.16 116.17 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.599 -0.728 . . . . 61.41 109.913 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 64.6 mt -90.24 143.05 27.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.301 -0.629 . . . . 74.45 109.301 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 109' ' ' SER . 48.0 mtp -117.48 136.28 53.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.985 -0.376 . . . . 72.44 109.985 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.616 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 95.3 m-85 -148.96 160.39 43.34 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.451 -0.944 . . . . 74.52 108.451 174.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -153.82 111.25 3.47 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.846 -0.742 . . . . 73.41 112.315 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.474 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 56.9 t30 55.57 37.59 29.08 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.721 0.772 . . . . 65.32 110.978 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.76 -16.35 50.93 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.411 -0.813 . . . . 64.13 112.575 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -77.72 138.84 39.26 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.669 0.271 . . . . 61.25 110.633 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -62.41 139.92 58.56 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.339 -0.846 . . . . 74.13 110.619 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.616 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -144.14 167.67 21.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.975 -1.12 . . . . 74.03 107.975 -174.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 101' ' ' MET . 69.1 m -70.75 -179.72 2.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.612 0.72 . . . . 74.44 112.759 -165.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.431 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.1 tt0 -142.26 118.71 10.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.718 -0.674 . . . . 64.5 110.013 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 49.7 t -100.02 107.72 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.272 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.503 HD11 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -94.31 104.46 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.601 -0.518 . . . . 75.24 109.601 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.76 177.99 23.82 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.714 -0.555 . . . . 52.14 111.714 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.22 80.85 7.57 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.992 0.425 . . . . 70.23 110.936 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.427 ' O ' HG13 ' A' ' 119' ' ' ILE . 21.6 m-20 -117.51 73.7 0.89 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.031 -0.531 . . . . 63.35 110.146 175.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.404 ' O ' HD11 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.39 -33.03 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.551 -0.537 . . . . 62.22 109.551 -177.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.5 t -59.0 -46.21 88.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.879 -0.6 . . . . 74.22 110.192 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -70.06 -36.37 74.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.168 -0.469 . . . . 75.3 110.095 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 123' ' ' ILE . 81.3 mt -58.78 -56.25 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 72.04 110.591 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.455 HD11 HD23 ' A' ' 66' ' ' LEU . 6.9 tp -64.68 -38.06 81.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.638 -0.256 . . . . 73.1 110.401 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.8 t -57.04 -48.5 78.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.248 -0.433 . . . . 62.2 109.951 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 65.6 mm-40 -69.6 -36.76 76.5 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.458 -0.337 . . . . 72.03 111.507 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 119' ' ' ILE . 56.3 mt -57.12 -56.19 16.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.241 0.543 . . . . 73.13 109.767 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -64.16 -35.81 82.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.652 -0.704 . . . . 70.33 110.468 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 23.6 t30 -65.28 -39.12 92.18 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.935 -0.575 . . . . 71.32 111.468 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -103.28 -5.2 23.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.571 0.582 . . . . 71.52 112.571 -172.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.43 HG22 ' ND2' ' A' ' 128' ' ' ASN . 55.8 mt -91.94 -54.05 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.895 -0.322 . . . . 71.22 110.698 170.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.43 ' ND2' HG22 ' A' ' 127' ' ' ILE . 13.2 m120 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.477 -0.773 . . . . 64.54 110.71 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 91.3 mmm . . . . . 0 C--O 1.234 0.248 0 N-CA-C 110.164 -0.31 . . . . 73.11 110.164 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.462 HG21 ' HE3' ' A' ' 78' ' ' LYS . 28.1 mm -58.28 107.48 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.029 -0.532 . . . . 71.32 110.036 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.537 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 9.4 tp10 -75.0 141.1 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 60.14 110.173 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.459 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . 78.1 mt-30 -109.09 122.51 47.42 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.316 -0.253 . . . . 65.24 110.316 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 47.3 pt -145.06 179.96 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.901 0.381 . . . . 70.02 111.468 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -125.82 -165.83 12.14 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.632 -0.713 . . . . 63.44 111.424 175.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.37 -45.91 68.21 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.957 0.378 . . . . 54.11 110.966 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.0 t -59.55 -29.74 68.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.92 -0.582 . . . . 75.42 109.906 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.517 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 12.0 mm-40 -85.98 -31.89 21.82 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.006 -0.543 . . . . 71.21 110.725 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.426 ' HA ' HD11 ' A' ' 26' ' ' ILE . 85.1 t80 -47.92 -61.62 1.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.359 0.503 . . . . 74.31 112.359 -171.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.84 -43.5 98.19 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.604 0.24 . . . . 64.5 110.412 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -57.65 -53.98 52.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.181 -0.463 . . . . 75.32 110.418 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.493 ' HG3' HG22 ' A' ' 26' ' ' ILE . 75.7 mmtt -60.71 -41.52 95.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.752 -0.658 . . . . 63.11 111.063 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 31' ' ' PHE . 98.3 t -67.74 -53.07 33.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 70.22 110.687 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.7 p -65.46 -18.68 65.5 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.497 -0.32 . . . . 63.43 111.761 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -77.02 3.35 12.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.632 -0.258 . . . . 63.53 111.259 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.532 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 25.0 p -62.46 113.39 2.91 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.928 -0.397 . . . . 75.32 109.928 175.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -52.84 -64.16 0.91 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.348 -0.387 . . . . 74.52 111.357 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -156.36 121.63 4.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 75.21 110.614 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.512 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 48.2 m-80 49.96 24.66 1.4 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.945 0.72 . . . . 73.21 112.945 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.4 mm -73.61 127.59 35.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 110.323 -0.251 . . . . 65.13 110.323 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 28.0 tp -85.79 107.78 17.79 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.722 0.772 . . . . 72.1 110.444 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.43 HG21 ' CD1' ' A' ' 77' ' ' TYR . 72.7 mt -108.44 113.47 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.112 -0.949 . . . . 62.11 110.205 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.54 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.8 mp -97.06 152.63 18.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.192 -0.669 . . . . 73.14 109.192 177.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 77' ' ' TYR . 58.5 t -138.08 118.53 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 110.034 -0.358 . . . . 72.11 110.034 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -95.35 154.59 17.12 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.082 0.468 . . . . 74.34 110.618 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.716 -0.674 . . . . 72.23 110.354 173.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 N--CA 1.464 0.241 0 N-CA-C 111.307 0.114 . . . . 65.44 111.307 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 22.7 t -75.96 -46.44 29.69 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.8 0.81 . . . . 74.24 110.983 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.69 -34.02 75.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.155 -0.93 . . . . 74.02 112.402 -171.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.418 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 38.7 mt-10 -60.27 -62.46 5.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.406 -0.518 . . . . 71.35 110.227 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.418 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 19.6 Cg_endo -58.75 -38.87 86.71 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.727 1.618 . . . . 55.54 112.258 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.1 mt-30 -57.44 -55.65 32.04 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.834 -0.346 . . . . 70.11 111.179 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.462 HD12 HD11 ' A' ' 119' ' ' ILE . 30.2 mt -71.98 -25.29 61.79 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.723 -0.217 . . . . 64.53 111.313 -176.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' OE1' HG12 ' A' ' 23' ' ' ILE . 4.5 mm-40 -62.26 -44.98 95.31 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.216 0.531 . . . . 71.41 109.837 172.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -62.36 -50.64 70.79 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.531 -0.759 . . . . 53.52 109.909 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.2 mt -62.9 -32.02 73.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.63 . . . . 72.24 110.776 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.82 -53.75 45.84 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.726 -0.472 . . . . 64.42 109.726 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -58.94 -35.64 73.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.959 -0.564 . . . . 74.14 110.84 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -65.72 -49.29 69.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 63.31 110.825 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.91 5.18 32.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.625 -0.716 . . . . 72.21 112.716 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 8.9 t -53.18 -19.88 3.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.787 0.662 . . . . 62.21 112.787 -171.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.05 -29.86 65.72 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.291 -0.256 . . . . 72.13 111.424 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -131.13 -10.63 3.74 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.466 -0.334 . . . . 74.52 111.336 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 71' ' ' THR . 40.9 t -116.96 134.65 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.823 0.344 . . . . 65.13 111.835 -172.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HE2' ' HB2' ' A' ' 24' ' ' GLU . 21.1 tptm -143.59 127.12 16.92 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.128 -0.487 . . . . 63.24 109.802 173.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.54 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.2 mp -99.69 141.05 17.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.953 -0.388 . . . . 75.21 109.953 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.467 ' HB2' HG22 ' A' ' 46' ' ' VAL . 62.9 m-85 -123.67 150.31 44.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 74.33 109.444 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HE3' HG21 ' A' ' 23' ' ' ILE . 39.9 ttmt -129.2 122.14 29.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.672 -0.492 . . . . 74.52 109.672 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.5 mm -78.91 73.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.772 -0.825 . . . . 74.02 108.772 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 25' ' ' GLN . 3.4 p-10 -72.46 -30.4 64.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.525 -0.761 . . . . 55.33 110.367 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.4 mt -62.68 100.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.989 -0.551 . . . . 74.02 109.929 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.479 ' HA ' ' HG3' ' A' ' 85' ' ' GLN . 10.5 pt-20 -56.51 -27.94 58.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.744 -0.662 . . . . 74.43 111.191 -177.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -71.58 -24.52 61.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.758 -0.656 . . . . 74.45 110.006 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.08 15.76 27.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.307 -0.86 . . . . 75.22 111.315 -175.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.479 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 92.9 mt-30 -71.32 1.42 6.22 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.636 0.255 . . . . 72.02 111.085 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -46.53 -37.96 8.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.977 -0.556 . . . . 71.23 110.361 172.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.7 t -52.7 -43.28 43.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.562 -0.744 . . . . 74.22 110.502 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.8 -53.35 58.47 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.642 -0.708 . . . . 74.35 110.273 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.4 m -59.13 -34.81 72.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.62 . . . . 71.15 110.985 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.06 -56.66 13.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.218 -0.446 . . . . 60.15 111.163 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -72.3 -15.68 61.89 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.58 0.228 . . . . 62.03 111.148 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.9 40.01 5.67 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.234 -0.508 . . . . 73.02 112.724 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.64 93.9 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.111 0.482 . . . . 71.42 110.562 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.9 t -90.65 -37.14 13.96 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.637 -0.71 . . . . 72.21 109.536 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.21 136.28 33.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.035 -0.728 . . . . 73.44 109.035 174.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.624 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 50.8 mm -58.87 -58.84 16.38 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 111.411 0.152 . . . . 63.23 111.411 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 83.3 Cg_endo -80.77 72.3 6.6 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.797 1.665 . . . . 73.4 112.262 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.1 m -102.96 133.07 48.69 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.963 0.411 . . . . 73.44 110.796 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.622 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -116.52 121.0 66.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.537 -0.756 . . . . 73.23 109.846 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.474 HD22 ' HG3' ' A' ' 110' ' ' GLN . 88.7 mt -98.14 123.48 42.22 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.775 -0.454 . . . . 73.33 109.775 175.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 59.9 mtp -96.06 139.95 31.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.375 -0.602 . . . . 55.41 109.375 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -138.6 147.69 43.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.904 -0.776 . . . . 74.23 108.904 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.553 ' HE2' ' HB3' ' A' ' 126' ' ' ASN . 29.0 ttpp -147.47 121.36 9.34 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.306 -0.558 . . . . 70.33 111.225 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.532 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 6.0 t30 61.17 25.69 15.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.542 -0.754 . . . . 62.14 110.24 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.46 6.87 86.95 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.727 -0.669 . . . . 33.45 112.127 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -101.38 150.34 23.12 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 120.701 0.286 . . . . 61.04 110.61 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.492 ' HB3' ' HZ2' ' A' ' 107' ' ' LYS . 3.4 mmmp? -56.49 128.47 36.28 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.076 -0.966 . . . . 74.21 111.489 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.92 168.54 18.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.869 -1.514 . . . . 74.44 106.932 -177.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.7 m -69.53 157.16 37.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.795 0.807 . . . . 71.23 112.72 -158.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.474 ' HG3' HD22 ' A' ' 100' ' ' LEU . 53.8 tt0 -114.4 118.41 33.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.136 -0.938 . . . . 70.2 109.851 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 44.6 t -96.95 107.17 19.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.185 -0.461 . . . . 72.22 110.097 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.454 HD11 ' N ' ' A' ' 112' ' ' ILE . 3.6 mp -92.35 105.12 16.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.366 -0.605 . . . . 73.25 109.366 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.508 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 105.06 158.55 23.27 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.575 -0.61 . . . . 63.32 111.575 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.45 83.54 3.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.79 0.328 . . . . 61.23 110.679 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 33.8 t70 -121.51 90.12 3.25 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.703 0.763 . . . . 71.13 110.262 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.447 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -59.02 -30.63 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 114.795 -1.093 . . . . 52.01 109.425 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.8 t -56.32 -53.36 58.17 Favored 'General case' 0 CA--C 1.526 0.045 0 CA-C-N 116.13 -0.486 . . . . 64.33 110.159 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.762 ' HZ2' ' HB2' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -60.59 -48.03 83.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.144 -0.48 . . . . 72.24 109.941 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.496 ' O ' HG13 ' A' ' 123' ' ' ILE . 65.5 mt -56.69 -56.31 14.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.719 -0.673 . . . . 75.13 111.128 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 116' ' ' ILE . 13.7 tt -64.33 -35.7 74.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.767 0.317 . . . . 71.42 110.247 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.4 t -55.82 -52.32 64.42 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.797 -0.638 . . . . 53.14 110.278 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 24.7 mm-40 -74.54 -30.0 61.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.911 -0.586 . . . . 73.44 111.301 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.3 mt -58.42 -56.03 18.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.961 0.41 . . . . 74.41 110.064 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -71.33 -29.26 64.8 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.94 -0.304 . . . . 75.42 110.223 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.453 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 19.7 t30 -61.11 -44.38 97.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.103 -0.499 . . . . 73.34 110.971 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.553 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 32.1 m-80 -84.93 -27.1 26.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 62.21 112.137 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.4 mt -73.71 -48.7 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 120.915 0.388 . . . . 75.42 110.479 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.808 -0.615 . . . . 41.43 110.125 -179.783 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 92.0 mmm . . . . . 0 C--O 1.232 0.179 0 CA-C-O 121.103 0.477 . . . . 50.3 110.428 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.499 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 26.7 mm -119.34 104.69 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.756 -0.657 . . . . 72.44 109.826 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.34 160.49 18.78 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.336 -0.393 . . . . 71.03 111.054 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -137.72 133.81 34.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.01 -0.367 . . . . 71.13 110.01 172.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.517 HG21 ' HG3' ' A' ' 34' ' ' LYS . 32.0 pt -138.86 179.95 2.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 122.53 0.332 . . . . 64.33 111.211 -174.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.06 176.85 22.96 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.055 -0.521 . . . . 71.01 112.965 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -51.86 -56.62 12.91 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.366 0.666 . . . . 53.25 111.737 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -62.81 -27.57 69.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 74.13 111.481 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -79.55 -23.36 42.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.806 0.298 . . . . 72.55 111.806 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.427 ' O ' HG21 ' A' ' 35' ' ' VAL . 92.4 t80 -47.68 -61.7 1.81 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.278 0.361 . . . . 71.0 111.85 -174.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.56 ' O ' HG22 ' A' ' 36' ' ' THR . 10.0 m-20 -54.63 -53.59 52.79 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.246 0.546 . . . . 54.15 110.504 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -55.92 -57.41 12.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.076 -0.965 . . . . 72.44 111.378 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.2 mmtt -58.51 -35.39 72.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 74.32 111.055 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 31' ' ' PHE . 40.6 t -64.98 -56.58 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.298 -0.41 . . . . 63.34 111.336 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 32' ' ' ASP . 7.9 t -86.08 -0.29 55.25 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.145 0.424 . . . . 63.23 112.145 -175.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.2 t -71.14 -5.93 35.46 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.892 0.377 . . . . 75.13 111.131 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.853 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 8.5 p -66.14 158.08 29.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.946 -0.57 . . . . 72.52 111.747 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.58 -79.65 0.11 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.903 -0.59 . . . . 63.31 110.61 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -161.82 148.67 14.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.216 -0.447 . . . . 73.43 109.981 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 63.46 2.28 1.16 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.115 0.566 . . . . 71.32 111.34 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 42.6 mm -74.93 108.32 6.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 120.88 0.372 . . . . 74.33 110.276 -178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' A' ' 123' ' ' ILE . 30.9 tp -80.28 109.05 14.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.627 -0.715 . . . . 73.04 110.024 174.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 36.9 mt -102.7 116.69 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.501 -0.772 . . . . 64.31 110.376 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.525 ' HB2' HG13 ' A' ' 76' ' ' ILE . 3.4 mp -99.99 153.04 19.51 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.623 -0.881 . . . . 63.21 108.623 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 77' ' ' TYR . 60.8 t -135.36 104.35 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.311 -0.255 . . . . 72.43 110.311 175.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.87 96.78 10.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.901 -1.148 . . . . 72.54 107.901 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 112.375 0.509 . . . . 73.3 112.375 -171.222 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 120.766 0.317 . . . . 73.24 110.716 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.564 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 46.8 t -75.6 -49.36 18.75 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.752 0.787 . . . . 73.41 110.494 172.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.89 -43.13 90.92 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.198 -0.91 . . . . 73.01 112.3 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.442 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 40.6 mt-10 -52.82 -60.39 6.71 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 117.807 0.276 . . . . 72.12 111.074 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.442 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 29.9 Cg_endo -64.14 -35.11 54.65 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.616 1.544 . . . . 75.31 112.254 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 58' ' ' SER . 26.7 mt-30 -61.26 -42.44 98.64 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.418 -0.513 . . . . 74.23 111.1 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.43 -42.99 67.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 73.31 110.321 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 28.1 mt-10 -63.69 -36.45 83.9 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.855 -0.338 . . . . 74.1 110.415 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -57.05 -57.16 13.76 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.464 0.65 . . . . 75.1 109.819 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 62' ' ' GLN . 36.6 mt -61.52 -36.55 80.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.05 -0.977 . . . . 63.24 109.909 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.541 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.05 -27.97 67.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 43.53 110.93 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.1 mt-30 -77.01 -48.34 18.2 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.851 0.358 . . . . 65.2 110.955 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -72.63 -37.75 67.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.183 0.516 . . . . 64.24 110.668 -176.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -97.61 5.85 48.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.765 -0.652 . . . . 73.14 111.891 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.541 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -52.74 -19.94 2.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.778 0.659 . . . . 72.52 112.778 -172.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.64 -31.2 70.18 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.274 -0.266 . . . . 74.12 110.794 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.407 ' HA ' HD12 ' A' ' 42' ' ' ILE . 91.6 m-20 -131.75 1.61 4.02 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.048 -0.524 . . . . 64.53 112.098 -174.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.512 HG21 HD11 ' A' ' 127' ' ' ILE . 72.5 t -131.76 134.03 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 122.257 -0.277 . . . . 74.13 111.527 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 26.8 mmtp -147.08 136.62 22.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.095 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.525 HG13 ' HB2' ' A' ' 45' ' ' LEU . 4.1 mp -115.83 146.65 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.664 -0.244 . . . . 73.45 110.636 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.491 ' HB2' HG21 ' A' ' 46' ' ' VAL . 40.4 m-85 -124.53 164.55 19.55 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.038 0.535 . . . . 75.14 110.516 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 23' ' ' ILE . 33.6 mtmm -143.61 178.82 7.52 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.816 0.446 . . . . 73.34 110.091 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.4 tt -151.76 158.6 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.839 -0.43 . . . . 72.23 109.839 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -142.57 -3.26 1.03 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.528 0.204 . . . . 73.44 111.511 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 40.4 mt -84.52 110.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 74.52 110.668 -174.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -49.48 -55.4 13.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.66 -0.7 . . . . 72.21 111.851 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.62 6.72 5.44 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.358 -0.383 . . . . 70.01 111.876 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.591 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.9 OUTLIER -107.3 22.13 16.46 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.057 0.456 . . . . 74.32 109.902 176.249 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -81.12 -10.85 59.59 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.003 -0.544 . . . . 64.44 111.498 -176.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -45.27 -56.96 4.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.709 0.29 . . . . 71.2 111.219 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.444 ' O ' ' HD1' ' A' ' 91' ' ' TYR . 7.5 p -53.1 -34.19 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.862 -0.608 . . . . 70.13 111.036 -178.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -67.75 -50.67 55.98 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.085 0.469 . . . . 70.11 109.967 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.2 m -60.42 -29.62 69.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.598 -0.728 . . . . 65.15 110.529 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.67 -55.89 8.76 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.867 -0.606 . . . . 52.43 111.32 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.444 ' HD1' ' O ' ' A' ' 87' ' ' VAL . 85.6 m-85 -77.22 -9.84 59.04 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.707 0.262 . . . . 73.02 111.707 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.29 53.61 1.14 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.801 -0.714 . . . . 72.41 113.391 170.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.48 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 80.6 t -93.92 111.84 25.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.993 -0.373 . . . . 52.15 109.993 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 m -121.97 25.17 9.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.362 0.601 . . . . 73.11 110.065 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.38 154.69 36.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.376 -0.829 . . . . 51.24 109.661 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.58 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 46.4 mm -67.71 -56.05 12.82 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.758 -0.46 . . . . 51.33 109.758 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 90.0 Cg_endo -82.09 67.67 8.08 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.007 1.804 . . . . 62.21 111.813 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.404 HG21 HG23 ' A' ' 93' ' ' VAL . 67.5 m -105.43 121.36 43.75 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.876 -0.602 . . . . 55.22 110.456 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.522 ' N ' HD13 ' A' ' 99' ' ' ILE . 3.3 mp -110.27 112.68 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.558 -0.746 . . . . 51.32 110.102 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 110' ' ' GLN . 36.9 mt -90.23 131.22 36.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.441 -0.577 . . . . 64.02 109.441 173.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.504 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 38.7 mtp -110.23 138.99 45.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.493 -0.558 . . . . 72.35 109.493 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -144.03 144.54 31.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.531 -0.544 . . . . 72.13 109.531 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.476 ' HD3' ' HB3' ' A' ' 126' ' ' ASN . 39.6 ttpt -118.8 104.93 11.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.85 -0.34 . . . . 62.05 110.578 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.853 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 60.6 t30 59.25 30.55 20.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.594 0.711 . . . . 70.41 110.353 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.8 -16.4 60.36 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.887 -0.597 . . . . 73.42 112.083 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -73.34 142.72 47.07 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 110.133 -0.321 . . . . 63.22 110.133 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -63.68 145.77 55.09 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.529 -0.76 . . . . 71.15 111.181 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.504 ' HB3' ' O ' ' A' ' 101' ' ' MET . 1.3 tp -162.14 169.88 20.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.374 -0.83 . . . . 73.4 110.563 -164.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.6 m -69.63 167.93 15.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.039 0.935 . . . . 74.51 113.044 -163.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.436 ' HG3' HD21 ' A' ' 100' ' ' LEU . 57.2 tt0 -126.61 118.66 25.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.674 -1.148 . . . . 71.43 109.418 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 23.0 t -96.03 107.23 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.565 -0.531 . . . . 72.53 109.565 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.475 HD13 ' N ' ' A' ' 112' ' ' ILE . 3.8 mp -96.68 101.69 12.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.592 -0.521 . . . . 64.33 109.592 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.1 167.29 18.82 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.613 -0.595 . . . . 73.14 111.613 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.67 86.3 7.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.799 -0.236 . . . . 60.25 111.102 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -124.79 86.65 2.59 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 121.82 0.819 . . . . 63.43 109.717 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -62.63 -27.64 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 114.887 -1.052 . . . . 54.0 110.048 -174.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -63.42 -47.83 80.31 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.34 -0.391 . . . . 62.22 110.145 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.523 ' HE2' ' HG2' ' A' ' 122' ' ' GLU . 10.6 tptm -69.38 -39.64 77.91 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.152 -0.314 . . . . 75.32 110.152 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.3 mt -55.39 -56.23 12.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.07 0.462 . . . . 71.55 110.624 177.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 116' ' ' ILE . 13.5 tt -65.98 -33.81 66.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 116.027 -0.533 . . . . 75.4 110.569 -178.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.1 t -54.95 -51.85 64.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.03 -0.532 . . . . 52.11 109.673 176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.523 ' HG2' ' HE2' ' A' ' 118' ' ' LYS . 60.2 mm-40 -63.25 -40.11 96.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.034 -0.53 . . . . 74.22 110.494 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.486 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 63.9 mt -52.04 -56.43 6.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.719 0.295 . . . . 72.53 110.889 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 128' ' ' ASN . 10.2 p30 -71.88 -25.39 61.92 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 120.536 -0.466 . . . . 72.13 110.709 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 34.3 t30 -63.21 -33.93 76.55 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.06 0.457 . . . . 72.31 110.85 177.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.476 ' HB3' ' HD3' ' A' ' 103' ' ' LYS . 38.6 m-80 -94.55 -37.05 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.01 -0.541 . . . . 75.13 111.874 -176.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 74' ' ' VAL . 66.7 mt -72.14 -48.98 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 64.14 110.862 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.505 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.533 -0.746 . . . . 64.45 110.27 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 93.7 mmm . . . . . 0 C--O 1.234 0.255 0 N-CA-C 109.451 -0.574 . . . . 71.32 109.451 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -73.71 115.79 15.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.678 -0.86 . . . . 73.24 108.678 171.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -74.38 146.47 42.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.99 0.424 . . . . 74.12 111.516 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.54 118.86 37.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.602 -0.727 . . . . 74.24 109.348 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.482 HG23 ' HG3' ' A' ' 34' ' ' LYS . 46.9 pt -144.58 175.12 3.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 120.826 0.346 . . . . 73.02 110.924 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.12 175.17 15.59 Favored Glycine 0 CA--C 1.521 0.406 0 CA-C-N 115.912 -0.585 . . . . 74.34 112.418 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.479 ' OD2' HG23 ' A' ' 87' ' ' VAL . 13.5 t70 -51.78 -45.86 63.95 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.466 0.706 . . . . 75.34 111.623 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 t -66.27 -28.57 68.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.15 110.806 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.97 -13.33 58.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 61.1 111.352 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.51 ' O ' HG22 ' A' ' 35' ' ' VAL . 87.2 t80 -51.43 -61.88 1.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.13 0.269 . . . . 73.31 111.14 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.18 -48.2 81.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.17 0.51 . . . . 70.21 110.76 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -60.81 -53.32 58.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.522 -0.763 . . . . 70.32 111.487 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HG3' HG23 ' A' ' 26' ' ' ILE . 35.0 mmtp -67.28 -31.82 72.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.102 -0.499 . . . . 74.22 111.293 -175.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 31' ' ' PHE . 74.5 t -66.3 -45.49 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.899 0.38 . . . . 74.43 109.979 174.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.5 p -75.11 -16.15 60.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.314 -0.403 . . . . 73.41 111.22 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -75.6 0.16 18.43 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.286 -0.415 . . . . 75.35 111.205 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.748 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.2 p -56.68 122.1 11.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.698 -0.228 . . . . 72.12 110.633 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -56.07 -76.17 0.03 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.332 -0.394 . . . . 73.24 110.889 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -161.98 145.31 12.0 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.358 -0.608 . . . . 72.33 109.358 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 45.0 27.47 0.29 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.001 0.813 . . . . 71.13 111.727 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 47.0 mm -87.84 123.79 40.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.984 -0.553 . . . . 73.42 110.221 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -89.97 110.34 21.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.575 -0.738 . . . . 71.35 109.101 178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.453 HG23 HG23 ' A' ' 35' ' ' VAL . 22.8 mm -89.07 109.11 19.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.59 -0.732 . . . . 62.51 110.384 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.495 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.5 mp -99.04 146.97 25.5 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.541 -0.911 . . . . 71.21 108.541 172.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 70.1 t -139.13 113.15 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.348 -0.242 . . . . 75.54 110.348 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -91.69 137.55 32.27 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.716 -0.475 . . . . 52.22 109.716 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.618 ' HE2' ' HG ' ' A' ' 100' ' ' LEU . 79.5 m-85 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.352 -0.385 . . . . 74.51 111.991 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 57' ' ' ARG . 43.3 ttt-85 . . . . . 0 CA--C 1.534 0.34 0 CA-C-O 120.575 0.226 . . . . 53.41 110.853 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.549 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 33.0 t -75.75 -40.06 56.06 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.504 0.669 . . . . 55.12 111.084 174.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.456 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 3.8 mm? -57.51 -49.74 75.32 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.252 -0.885 . . . . 70.44 112.918 -171.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.472 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 49.9 mt-10 -56.39 -53.95 58.51 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 117.914 0.324 . . . . 71.44 111.147 -176.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 31.2 Cg_exo -50.29 -50.98 11.91 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.944 1.763 . . . . 63.45 111.74 172.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.0 mt-30 -54.35 -41.98 69.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.141 -0.481 . . . . 74.54 111.798 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 75.0 mt -68.36 -38.92 81.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.48 -0.327 . . . . 74.1 110.42 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 37.7 mt-10 -68.06 -29.59 68.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.145 -0.479 . . . . 63.32 110.26 177.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -54.04 37.08 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.131 -0.692 . . . . 74.52 109.131 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.07 -32.78 73.35 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.306 -0.861 . . . . 53.34 110.068 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.514 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.54 -50.73 70.21 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.946 -0.57 . . . . 70.14 109.781 177.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.5 mt-30 -54.63 -47.99 72.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.174 0.511 . . . . 74.31 110.245 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -63.92 -45.21 90.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.408 -0.815 . . . . 70.21 111.767 -178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -104.98 4.26 31.53 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 113.239 0.829 . . . . 74.32 113.239 -170.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 14.0 t -53.33 -24.89 13.08 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.791 0.663 . . . . 75.22 112.791 -171.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.593 ' HG3' ' ND2' ' A' ' 73' ' ' ASN . 5.6 pt-20 -64.15 -25.41 68.07 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.005 0.431 . . . . 71.45 111.135 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.593 ' ND2' ' HG3' ' A' ' 72' ' ' GLU . 5.5 m-80 -127.95 -0.76 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.334 -0.394 . . . . 74.33 111.257 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 127' ' ' ILE . 25.8 t -130.51 139.12 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.043 0.449 . . . . 72.22 112.161 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -145.26 119.73 9.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 73.34 109.801 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.495 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.7 mp -98.68 140.06 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.181 -0.674 . . . . 54.32 109.181 174.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 73.7 m-85 -125.95 149.01 49.08 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.107 -0.701 . . . . 74.53 109.107 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.47 135.06 44.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.885 -0.413 . . . . 72.53 109.885 176.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.0 mt -76.9 91.78 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.203 -0.665 . . . . 64.13 109.203 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -82.16 -18.5 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.917 -0.583 . . . . 65.1 110.477 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.1 mm -69.53 89.2 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.367 0.603 . . . . 70.23 109.882 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -48.98 -35.95 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.876 -1.057 . . . . 65.23 111.549 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.79 -22.76 60.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.327 -0.851 . . . . 74.14 112.313 -173.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -131.06 108.51 9.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.699 0.285 . . . . 71.35 110.826 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.99 32.36 1.02 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.839 -0.619 . . . . 72.41 110.416 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -52.37 -37.27 55.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.558 -0.746 . . . . 64.23 111.141 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.479 HG23 ' OD2' ' A' ' 28' ' ' ASP . 97.7 t -52.8 -36.28 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.757 -0.656 . . . . 73.44 111.17 -178.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.49 -54.91 24.99 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.064 0.459 . . . . 74.22 110.952 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.7 m -63.2 -40.94 98.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.802 -0.636 . . . . 70.32 110.903 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -67.77 -51.33 50.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.257 -0.429 . . . . 65.15 111.758 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -70.87 -29.13 65.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.777 -0.192 . . . . 65.13 111.286 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.09 57.14 0.57 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.653 -0.784 . . . . 72.33 112.657 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -92.66 99.63 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.937 0.399 . . . . 73.22 109.989 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -79.9 -50.65 10.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.848 -0.614 . . . . 72.15 110.543 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.13 136.33 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.596 -0.52 . . . . 33.34 109.596 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.657 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 62.3 mt -51.96 -55.38 31.18 Favored Pre-proline 0 CA--C 1.54 0.559 0 O-C-N 123.21 0.319 . . . . 72.54 111.56 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 4.4 Cg_exo -73.61 82.36 1.69 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.94 1.76 . . . . 71.12 111.852 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.0 m -122.6 138.89 54.44 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.132 -0.485 . . . . 72.33 110.03 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 99' ' ' ILE . 3.9 mp -119.56 118.81 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.014 -0.539 . . . . 74.22 110.235 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.618 ' HG ' ' HE2' ' A' ' 48' ' ' PHE . 49.4 mt -88.53 141.85 28.19 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.646 -0.502 . . . . 73.11 109.646 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.572 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 52.6 mtp -114.08 144.92 42.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.204 -0.665 . . . . 73.43 109.204 175.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.447 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 97.2 m-85 -146.64 160.22 42.47 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.777 -0.823 . . . . 72.43 108.777 174.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -148.15 109.52 4.37 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 120.077 -0.649 . . . . 73.31 111.789 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.748 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.9 m-20 56.47 31.79 19.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.012 0.434 . . . . 74.31 111.178 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.55 -15.22 61.96 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.108 -0.568 . . . . 51.13 112.657 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -67.94 132.67 47.76 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 109.645 -0.502 . . . . 75.23 109.645 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.6 147.49 45.5 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 124.045 0.841 . . . . 75.05 108.943 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.572 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.2 tp -156.48 168.44 27.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.093 -0.706 . . . . 63.34 109.093 -164.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.3 m -69.65 172.31 7.64 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.493 0.717 . . . . 74.32 112.512 -164.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.501 ' HG3' HD21 ' A' ' 100' ' ' LEU . 23.2 tt0 -131.01 131.81 44.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.23 -0.895 . . . . 74.3 109.91 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.79 111.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.915 -0.402 . . . . 73.22 109.915 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.516 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.2 mp -85.95 113.54 24.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.245 -0.65 . . . . 65.13 109.245 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.31 142.81 7.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.983 -0.627 . . . . 75.42 111.763 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.455 ' HB3' ' HG ' ' A' ' 59' ' ' LEU . . . -72.07 87.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.701 0.286 . . . . 72.34 110.765 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 119' ' ' ILE . 14.3 t70 -119.53 111.01 17.56 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.23 -0.441 . . . . 74.11 110.35 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -33.54 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.716 -0.675 . . . . 73.31 110.549 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -64.82 -53.25 49.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.984 0.421 . . . . 75.34 110.355 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -60.79 -45.6 93.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.162 -0.472 . . . . 73.52 110.331 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 115' ' ' ASP . 81.8 mt -58.66 -56.15 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.026 -0.534 . . . . 72.22 110.972 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -61.2 -36.32 71.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 120.772 0.32 . . . . 62.34 110.549 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.6 t -59.63 -52.05 67.19 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.117 -0.492 . . . . 61.52 110.015 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -62.56 -40.58 97.29 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.32 -0.4 . . . . 74.15 110.691 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 127' ' ' ILE . 57.3 mt -55.36 -56.11 13.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.288 -0.415 . . . . 64.3 110.644 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -66.1 -33.18 75.19 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.028 0.442 . . . . 72.51 110.343 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -69.36 -28.45 66.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 43.15 111.547 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.523 ' OD1' HD13 ' A' ' 108' ' ' LEU . 65.1 m-80 -107.86 -8.91 15.85 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.789 0.663 . . . . 74.05 112.789 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 123' ' ' ILE . 61.3 mt -85.93 -51.58 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.883 -0.414 . . . . 75.01 109.883 170.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-N 115.824 -0.626 . . . . 53.21 109.956 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.473 ' SD ' ' HG2' ' A' ' 68' ' ' GLN . 19.2 ptm . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 121.573 0.702 . . . . 70.23 109.137 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -80.44 107.07 12.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.024 -0.989 . . . . 71.41 109.704 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -62.82 152.52 35.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.258 0.552 . . . . 72.2 111.762 -172.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 3.6 pt20 -124.67 125.56 44.3 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.613 -0.721 . . . . 72.45 109.528 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 31' ' ' PHE . 25.6 pt -135.7 158.11 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.697 0.284 . . . . 74.33 111.409 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.52 -179.93 52.34 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.202 -0.454 . . . . 74.35 112.442 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HB2' ' ND2' ' A' ' 84' ' ' ASN . 18.3 t70 -58.9 -56.3 24.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.098 0.475 . . . . 72.31 111.341 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.0 m -69.76 -15.61 63.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 72.51 111.344 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -84.7 -10.99 56.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 74.42 111.4 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 35' ' ' VAL . 79.5 t80 -55.28 -62.47 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.664 0.246 . . . . 74.0 111.664 -173.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.95 -45.32 95.18 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.902 0.382 . . . . 72.12 110.925 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.27 -49.82 76.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.749 -0.66 . . . . 73.25 111.421 -176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HG3' ' CG2' ' A' ' 26' ' ' ILE . 33.1 mmtp -69.34 -33.92 73.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.257 -0.429 . . . . 71.13 110.944 -176.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 31' ' ' PHE . 72.3 t -65.47 -43.2 94.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 120.876 0.37 . . . . 72.22 110.4 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.5 p -75.1 -18.51 60.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.878 0.37 . . . . 73.41 110.898 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.8 t -67.69 -2.79 7.52 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.211 -0.45 . . . . 63.12 111.329 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.736 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.3 p -57.8 148.93 23.62 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.639 -0.255 . . . . 62.44 110.567 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.5 -84.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.437 -0.347 . . . . 71.5 110.32 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -162.07 135.92 6.5 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.237 -0.653 . . . . 73.54 109.237 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 m120 65.68 9.43 5.93 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.684 0.615 . . . . 64.42 110.999 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.736 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.2 mm -76.48 115.97 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 73.34 110.552 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.7 110.8 9.29 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.121 -0.696 . . . . 74.12 109.121 175.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' A' ' 38' ' ' CYS . 27.9 mm -93.21 106.85 18.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.342 -0.844 . . . . 75.34 110.037 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.641 ' HB2' HG13 ' A' ' 76' ' ' ILE . 5.3 mp -92.38 149.63 21.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.945 -0.761 . . . . 73.41 108.945 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 58.5 t -132.23 110.99 17.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.906 -0.775 . . . . 70.13 108.906 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -94.31 159.95 14.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.259 0.552 . . . . 52.35 111.123 -173.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.113 -0.949 . . . . 71.54 109.004 165.37 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.746 0.308 . . . . 75.3 111.051 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.633 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 13.0 m -74.45 -38.35 63.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.382 0.61 . . . . 72.03 110.563 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.522 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 mm? -61.03 -26.86 67.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.673 -0.694 . . . . 73.43 110.92 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 30.3 tt0 -56.52 -67.75 0.74 Allowed Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 119.333 -0.365 . . . . 73.14 110.238 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.476 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 27.8 Cg_endo -61.63 -39.41 54.33 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 121.484 1.456 . . . . 64.41 112.089 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.7 mt-30 -53.87 -52.7 59.62 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.74 -0.384 . . . . 70.35 111.433 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.91 -28.28 55.25 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.792 0.293 . . . . 63.23 111.792 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 93.2 mt-10 -65.37 -41.75 93.47 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.085 0.469 . . . . 74.53 109.828 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -67.34 -46.85 72.2 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.062 -0.517 . . . . 72.34 110.285 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.3 mt -62.85 -29.78 71.0 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.848 -0.341 . . . . 73.12 110.623 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.74 -51.34 67.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.433 -0.58 . . . . 73.51 109.433 175.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.473 ' HG2' ' SD ' ' A' ' 22' ' ' MET . 92.2 mt-30 -60.58 -32.2 71.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.837 -0.619 . . . . 72.55 111.062 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -77.16 -40.34 45.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 75.34 111.296 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -104.69 4.44 32.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.288 -0.415 . . . . 74.32 111.833 -174.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.8 t -53.01 -19.67 2.86 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.167 0.432 . . . . 71.11 112.167 -172.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -54.89 -41.91 71.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.093 -0.503 . . . . 75.24 110.187 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.438 ' HA ' HD13 ' A' ' 42' ' ' ILE . 52.3 m-80 -135.18 11.93 3.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.912 -0.586 . . . . 70.24 111.721 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.469 HG21 HD11 ' A' ' 127' ' ' ILE . 24.1 t -126.25 139.17 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 122.242 -0.286 . . . . 64.14 111.506 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -143.67 129.16 19.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.983 -0.747 . . . . 74.24 108.983 172.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.641 HG13 ' HB2' ' A' ' 45' ' ' LEU . 4.5 mp -105.63 138.28 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.08 0.466 . . . . 73.23 110.635 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 16.0 m-85 -127.42 165.06 20.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.277 -0.874 . . . . 74.42 108.963 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -161.81 165.01 28.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.344 -0.389 . . . . 74.55 110.149 173.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.4 tp -68.37 129.53 32.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 75.31 110.437 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 3.0 t-20 -95.19 -15.98 22.88 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.13 -0.486 . . . . 64.0 110.554 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.4 mt -102.62 103.31 14.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.884 -0.598 . . . . 74.44 109.908 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.3 -18.46 63.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.012 0.434 . . . . 73.05 110.901 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.43 -14.11 60.43 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.816 -0.629 . . . . 74.1 111.006 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 28' ' ' ASP . 24.4 t-20 -102.2 119.52 38.93 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.906 0.384 . . . . 74.12 111.436 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -119.31 -3.51 10.51 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.543 -0.54 . . . . 73.41 109.543 169.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.2 m-20 -48.08 -49.66 30.88 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.482 -0.781 . . . . 61.3 111.457 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -54.97 -38.9 47.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 116.224 -0.443 . . . . 74.33 110.694 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . . . -69.01 -42.75 76.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.221 -0.445 . . . . 53.13 109.866 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -61.2 -38.44 86.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.564 -0.744 . . . . 62.42 110.576 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 78.3 mm-40 -69.71 -49.81 49.77 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.079 -0.509 . . . . 75.33 111.298 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -89.49 -2.45 58.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.286 -0.416 . . . . 71.54 112.027 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.19 57.09 5.34 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.137 -0.554 . . . . 33.24 112.977 171.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 88' ' ' ALA . 86.6 t -82.42 92.77 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.698 -0.482 . . . . 74.43 109.698 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.3 t -89.41 -34.12 16.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.775 -0.648 . . . . 75.31 110.617 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.66 143.83 28.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 61.41 110.149 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.735 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 50.2 mm -59.29 -52.64 72.97 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.494 -0.321 . . . . 74.44 110.691 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.735 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 58.2 Cg_endo -93.52 112.38 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.472 2.115 . . . . 73.12 111.145 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.414 ' C ' HD13 ' A' ' 99' ' ' ILE . 64.2 m -136.97 141.91 42.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.92 0.39 . . . . 74.44 111.247 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.559 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -123.44 119.19 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.606 -0.724 . . . . 71.31 109.939 174.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.476 HD22 ' HG3' ' A' ' 110' ' ' GLN . 91.3 mt -94.83 129.43 41.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.063 -0.717 . . . . 74.23 109.063 174.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 109' ' ' SER . 44.4 mtp -106.47 138.53 42.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.036 -0.357 . . . . 73.34 110.036 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 100.0 m-85 -143.63 165.44 27.62 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.467 -0.568 . . . . 73.14 109.467 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.456 ' HZ3' ' HB3' ' A' ' 126' ' ' ASN . 40.0 ttmt -151.78 104.87 3.06 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 122.245 -0.284 . . . . 63.1 110.948 175.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.722 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 57.6 t30 47.68 56.07 7.6 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.368 0.604 . . . . 64.22 110.914 177.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.88 -16.78 3.11 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.441 -0.8 . . . . 54.34 113.791 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 63.2 tttp -80.88 143.43 32.71 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 117.082 0.441 . . . . 62.22 110.141 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -71.97 145.59 48.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.58 0.705 . . . . 71.52 111.076 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -146.39 167.75 22.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.587 -1.264 . . . . 70.33 107.587 -172.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 101' ' ' MET . 60.1 m -70.19 -177.79 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.419 0.628 . . . . 72.02 112.66 -164.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.476 ' HG3' HD22 ' A' ' 100' ' ' LEU . 54.7 tt0 -138.46 129.52 26.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 75.22 109.51 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.559 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.0 t -100.53 107.51 21.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.069 0.461 . . . . 64.04 110.231 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.476 HD13 ' N ' ' A' ' 112' ' ' ILE . 3.3 mp -86.71 110.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.567 -0.742 . . . . 73.33 109.435 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.406 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 99.43 155.08 28.48 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.56 -0.616 . . . . 30.23 111.56 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.522 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -80.04 72.16 6.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.844 0.354 . . . . 43.44 110.95 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.449 ' O ' HG13 ' A' ' 119' ' ' ILE . 18.0 t70 -111.08 96.95 6.45 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.598 0.713 . . . . 74.11 110.505 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -34.41 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.141 -0.936 . . . . 73.1 110.263 -173.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.1 p -63.13 -43.34 98.64 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.274 -0.421 . . . . 62.2 111.056 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.84 -43.85 78.57 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.715 -0.476 . . . . 75.41 109.715 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 115' ' ' ASP . 70.8 mt -56.05 -56.48 12.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-N 116.015 -0.539 . . . . 74.14 110.838 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.7 tt -65.52 -33.87 66.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.854 -0.612 . . . . 72.25 110.586 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.5 t -57.33 -51.93 67.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.229 -0.441 . . . . 61.23 110.111 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -60.66 -45.3 94.63 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.589 -0.278 . . . . 73.41 110.372 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 119' ' ' ILE . 72.7 mt -52.56 -56.04 8.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 116.107 -0.497 . . . . 71.3 111.182 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -68.21 -32.96 73.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.658 0.266 . . . . 74.24 110.632 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -61.75 -36.49 81.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.145 0.498 . . . . 72.13 110.228 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.456 ' HB3' ' HZ3' ' A' ' 103' ' ' LYS . 27.2 m-80 -85.4 -28.78 24.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 72.24 112.144 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.469 HD11 HG21 ' A' ' 74' ' ' VAL . 52.6 mt -103.74 -60.69 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.142 0.496 . . . . 72.41 112.232 -178.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.383 -0.826 . . . . 65.44 110.921 -166.784 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 88.1 mmm . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 121.248 0.547 . . . . 54.3 110.483 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.434 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 13.0 mm -83.19 123.26 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.367 -0.833 . . . . 51.53 109.878 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG3' HG22 ' A' ' 26' ' ' ILE . 6.2 tp10 -74.27 160.24 31.38 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 123.165 0.29 . . . . 75.43 110.245 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.413 ' N ' ' HG3' ' A' ' 24' ' ' GLU . 25.4 pt20 -133.85 115.89 15.0 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 110.026 -0.361 . . . . 65.13 110.026 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.514 HG21 ' HG3' ' A' ' 34' ' ' LYS . 21.5 pt -139.9 179.98 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.305 0.483 . . . . 63.42 112.305 -170.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.0 -157.14 9.9 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.392 -0.822 . . . . 70.42 111.293 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -68.21 -51.03 50.03 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.147 0.474 . . . . 64.14 111.24 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 t -58.21 -43.84 87.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 61.41 110.356 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -83.12 -13.11 56.29 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.502 -0.317 . . . . 71.21 111.691 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.478 ' HA ' HD11 ' A' ' 26' ' ' ILE . 89.3 t80 -58.18 -57.7 11.69 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.961 -0.755 . . . . 74.34 108.961 175.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.61 -51.43 69.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 65.32 110.638 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -52.73 -57.42 10.18 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.307 0.379 . . . . 73.44 111.215 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HG3' HG21 ' A' ' 26' ' ' ILE . 34.6 mmtp -69.38 -37.02 77.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 73.32 111.59 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.38 -45.17 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 121.197 -0.201 . . . . 73.1 110.704 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.5 p -75.2 -24.7 57.81 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.881 -0.328 . . . . 63.32 111.243 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.7 t -70.04 -7.88 44.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.501 -0.318 . . . . 61.43 111.699 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.921 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 26.8 p -59.35 137.28 58.05 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.652 -0.499 . . . . 63.34 109.652 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -48.38 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.415 0.447 . . . . 72.41 111.142 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -161.98 145.37 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.449 -0.574 . . . . 74.31 109.449 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 48.22 13.14 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.084 0.954 . . . . 74.42 113.32 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.65 136.66 26.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.275 -0.268 . . . . 75.44 110.275 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -85.35 113.15 21.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.459 0.647 . . . . 70.2 109.301 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.1 mt -106.95 139.39 28.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.152 -0.931 . . . . 73.42 110.624 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.552 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -120.82 139.48 53.09 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.172 -1.047 . . . . 63.31 108.172 170.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 77' ' ' TYR . 97.1 t -127.26 104.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.192 -0.67 . . . . 71.45 109.192 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -101.39 150.52 22.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.012 -0.54 . . . . 62.13 109.724 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.426 -0.352 . . . . 72.12 110.328 177.406 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 . . . . . 0 N--CA 1.463 0.205 0 CA-C-O 120.792 0.329 . . . . 65.13 110.559 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.565 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 47.2 t -74.95 -36.27 62.1 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.518 0.675 . . . . 62.41 110.52 177.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.51 ' HG ' ' HB2' ' A' ' 114' ' ' ALA . 1.3 mm? -55.03 -44.6 74.8 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.475 -0.784 . . . . 74.14 112.059 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.05 -56.86 30.68 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 119.374 -0.346 . . . . 72.34 111.543 -176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HG2' ' O ' ' A' ' 58' ' ' SER . 10.0 Cg_endo -54.14 -38.14 87.53 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.739 1.626 . . . . 61.12 111.748 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 58' ' ' SER . 36.8 mt-30 -61.94 -39.64 92.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.753 -0.379 . . . . 74.4 110.956 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 80.3 mt -67.33 -36.92 82.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.425 -0.352 . . . . 63.44 110.147 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 42.8 mt-10 -59.4 -47.85 83.89 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.491 -0.559 . . . . 71.22 109.491 174.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -55.31 -50.61 69.13 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.578 -0.737 . . . . 74.21 110.566 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 116' ' ' ILE . 23.1 mt -65.43 -37.14 86.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 64.41 110.443 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.518 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.98 -31.83 72.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 65.41 110.742 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 54.7 mt-30 -76.81 -50.59 13.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.001 0.429 . . . . 65.23 110.541 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -64.11 -41.19 97.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.745 -0.661 . . . . 74.43 110.715 -175.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -99.11 5.56 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 72.53 112.178 -174.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.3 t -52.73 -19.57 2.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.762 0.653 . . . . 55.13 112.762 -170.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.16 -33.7 75.98 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.839 0.352 . . . . 64.1 110.971 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -126.2 -4.5 6.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.317 -0.401 . . . . 73.25 112.072 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.63 138.69 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.956 0.407 . . . . 72.22 111.726 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -142.95 121.68 12.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.703 -0.68 . . . . 74.03 109.833 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.552 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.1 mt -111.55 144.49 19.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 120.939 0.4 . . . . 75.24 111.197 -177.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.475 ' CE1' ' HB3' ' A' ' 34' ' ' LYS . 96.3 m-85 -130.56 136.36 48.83 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.558 -0.746 . . . . 75.25 110.213 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HG3' ' CG2' ' A' ' 23' ' ' ILE . 29.4 mtpp -107.97 134.04 51.45 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.582 -0.525 . . . . 64.22 109.582 173.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.3 mt -73.42 104.65 2.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.805 -0.813 . . . . 71.34 108.805 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 23.9 t-20 -98.95 -39.75 8.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.172 -0.467 . . . . 72.33 111.685 -173.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.4 mm -79.64 105.24 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.492 -0.322 . . . . 62.12 110.899 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -24.74 64.06 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.795 -0.638 . . . . 75.23 111.986 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -71.4 -5.1 30.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.127 0.489 . . . . 54.34 110.621 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -124.59 29.12 6.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 44.54 111.136 -176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -69.07 -7.34 34.92 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.352 -0.385 . . . . 64.25 110.916 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -47.11 -38.71 11.94 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.047 -0.524 . . . . 71.3 110.909 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -53.06 -41.67 42.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 115.703 -0.681 . . . . 53.22 110.894 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.0 -41.48 96.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.619 -0.719 . . . . 75.44 110.499 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.5 m -69.5 -38.04 77.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.738 -0.665 . . . . 75.44 110.454 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -58.5 -51.69 68.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.972 -0.558 . . . . 75.22 110.842 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -77.11 -25.69 52.44 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 121.013 -0.275 . . . . 74.32 111.201 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 51.84 9.35 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.572 -0.823 . . . . 71.05 111.045 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.412 HG23 HG21 ' A' ' 98' ' ' THR . 7.7 p -59.71 135.77 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.258 -0.471 . . . . 71.14 111.305 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -69.84 -38.12 76.41 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.883 -0.598 . . . . 73.0 111.913 -174.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.42 164.03 34.64 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.464 -0.148 . . . . 73.13 110.874 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.605 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 48.2 mm -61.41 -48.69 90.21 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.543 -0.299 . . . . 54.15 110.836 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 3.6 Cg_exo -80.13 101.49 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.978 1.785 . . . . 75.44 110.552 172.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.412 HG21 HG23 ' A' ' 93' ' ' VAL . 97.1 m -153.2 146.63 24.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.326 -0.397 . . . . 73.44 110.576 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.578 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -118.37 116.26 50.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.035 -0.53 . . . . 72.41 110.089 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.439 HD23 ' HG3' ' A' ' 110' ' ' GLN . 89.1 mt -94.91 123.43 38.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.21 -0.663 . . . . 74.02 109.21 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 109' ' ' SER . 51.4 mtp -92.77 147.97 22.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.144 -0.317 . . . . 73.02 110.144 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.2 m-85 -144.92 161.09 40.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.551 -0.537 . . . . 75.41 109.551 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 20.7 ttmm -148.5 105.01 3.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.629 0.252 . . . . 73.12 110.568 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.921 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 65.7 t30 57.02 39.72 29.13 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.32 0.581 . . . . 71.33 110.692 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.98 -16.05 23.72 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.944 -0.571 . . . . 61.0 112.768 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 62.1 tttp -75.96 148.93 37.78 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 110.132 -0.321 . . . . 71.43 110.132 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -65.1 157.25 29.07 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.411 0.624 . . . . 71.1 110.903 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.26 167.9 23.2 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.358 -1.349 . . . . 72.55 107.358 -167.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 101' ' ' MET . 38.7 m -70.44 178.64 2.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.425 0.631 . . . . 61.43 112.369 -167.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.439 ' HG3' HD23 ' A' ' 100' ' ' LEU . 59.0 tt0 -134.25 130.39 37.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.734 -0.666 . . . . 63.1 110.621 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.4 t -101.1 107.31 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.044 -0.724 . . . . 73.44 109.044 173.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.8 mt -87.48 109.14 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.095 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.8 -147.75 16.42 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.395 -0.682 . . . . 62.22 111.395 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.51 ' HB2' ' HG ' ' A' ' 59' ' ' LEU . . . -132.21 96.26 3.84 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.413 -0.217 . . . . 74.3 110.413 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -139.56 103.48 4.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.213 0.53 . . . . 70.41 110.473 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.482 HD13 HD12 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -63.34 -28.32 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 64.1 110.143 -175.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.3 m -62.9 -53.45 53.88 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.974 -0.557 . . . . 60.02 110.224 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -60.8 -44.36 96.95 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.09 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.459 HD12 HD22 ' A' ' 63' ' ' LEU . 66.0 mt -55.45 -56.12 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.964 -0.562 . . . . 64.3 111.316 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.6 tp -64.21 -34.46 69.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.526 0.203 . . . . 61.41 110.717 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.4 m -58.14 -50.69 72.61 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.538 -0.301 . . . . 61.15 110.468 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.82 -38.12 85.83 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.593 -0.276 . . . . 74.32 111.472 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.6 mt -58.65 -56.01 19.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.962 0.41 . . . . 64.3 110.115 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.78 -39.11 83.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 63.43 110.365 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -60.29 -39.84 88.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.486 -0.779 . . . . 73.12 111.215 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -100.57 -2.4 33.01 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 112.173 0.434 . . . . 72.41 112.173 -174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.0 mt -90.92 -55.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.671 -0.492 . . . . 53.32 109.671 168.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--O 1.251 1.149 0 CA-C-N 115.811 -0.631 . . . . 54.51 109.548 -179.841 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 C--O 1.24 0.555 0 N-CA-C 108.556 -0.905 . . . . 73.14 108.556 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.442 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 10.7 mm -75.89 99.78 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 114.995 -1.002 . . . . 73.15 108.788 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.03 161.57 24.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.231 -0.44 . . . . 73.43 110.786 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.68 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 4.3 pm0 -125.67 122.82 37.45 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.885 0.374 . . . . 73.1 110.24 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.514 HD11 ' HA ' ' A' ' 31' ' ' PHE . 34.4 pt -139.09 -179.75 2.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 122.942 0.497 . . . . 73.43 110.834 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.484 ' HA3' ' ND2' ' A' ' 84' ' ' ASN . . . -129.45 -157.57 9.22 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.904 -0.589 . . . . 64.21 111.944 176.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.4 -56.7 7.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.952 0.406 . . . . 73.21 111.123 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.5 m -62.78 -19.3 63.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 64.31 111.358 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -96.07 -22.11 17.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.51 -0.314 . . . . 74.03 110.89 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.514 ' HA ' HD11 ' A' ' 26' ' ' ILE . 93.1 t80 -56.36 -62.32 1.8 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.81 0.338 . . . . 73.44 111.409 -174.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -59.21 -46.8 87.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 74.43 110.366 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -54.3 -55.83 24.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.064 -0.971 . . . . 73.2 111.404 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -65.68 -41.43 92.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.057 -0.519 . . . . 73.35 111.51 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.482 HG21 HG22 ' A' ' 44' ' ' ILE . 91.1 t -70.04 -29.24 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.116 0.26 . . . . 64.11 111.646 -177.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.5 p -85.95 -31.11 22.28 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.936 0.398 . . . . 74.13 111.142 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -76.86 10.97 1.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.031 -0.531 . . . . 75.23 111.25 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.964 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 9.3 p -73.2 -0.18 13.57 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.864 0.32 . . . . 73.34 111.864 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 t30 70.87 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.173 0.589 . . . . 71.04 111.869 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -162.17 137.35 7.17 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.531 0.567 . . . . 74.42 112.531 -177.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 61.56 2.72 0.72 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 60.32 113.614 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.774 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.9 mm -79.91 114.69 21.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.928 -0.397 . . . . 75.52 109.928 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tt -79.33 115.99 19.3 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.854 -0.612 . . . . 74.31 109.662 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.482 HG22 HG21 ' A' ' 35' ' ' VAL . 15.6 mm -99.2 120.04 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.458 -0.792 . . . . 74.4 110.214 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.592 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.2 mp -107.48 113.75 27.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.959 -0.756 . . . . 74.01 108.959 174.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -104.82 104.91 17.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.862 0.363 . . . . 51.21 110.963 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.657 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 7.7 t70 -80.55 148.05 30.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.758 -0.656 . . . . 61.21 109.464 172.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 109.208 -0.664 . . . . 71.32 109.208 172.257 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.889 0.376 . . . . 75.42 110.449 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.528 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 11.5 t -75.26 -26.78 59.09 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.481 0.658 . . . . 71.31 110.551 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 114' ' ' ALA . 9.4 tp -64.22 -41.06 97.18 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.762 -0.653 . . . . 71.13 111.877 -171.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.465 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 49.2 mt-10 -55.92 -53.22 65.5 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 120.782 -0.367 . . . . 72.01 110.183 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 12.0 Cg_exo -52.65 -43.13 57.73 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.889 1.726 . . . . 63.23 112.255 170.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 58' ' ' SER . 35.3 mt-30 -65.72 -32.9 74.71 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.114 -0.635 . . . . 64.54 110.781 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.416 HD22 HD12 ' A' ' 119' ' ' ILE . 53.9 mt -70.11 -37.57 75.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.447 -0.797 . . . . 73.32 109.715 178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.415 ' OE2' HG12 ' A' ' 23' ' ' ILE . 18.4 mm-40 -58.13 -46.37 85.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.352 -0.385 . . . . 73.0 109.973 171.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -55.87 -54.46 44.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.009 -0.542 . . . . 73.21 110.392 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.5 HD13 HD13 ' A' ' 116' ' ' ILE . 18.8 mt -63.55 -36.56 84.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.022 -0.535 . . . . 63.13 110.568 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.489 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.79 -33.26 75.27 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.784 -0.644 . . . . 65.32 110.629 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -78.33 -47.67 17.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 65.13 110.947 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -61.42 -38.94 88.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.079 -0.51 . . . . 74.15 110.873 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -104.88 5.76 33.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.42 -0.809 . . . . 72.34 112.269 -173.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.2 t -52.48 -23.26 5.87 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.811 1.041 . . . . 72.45 113.811 -166.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.95 -36.46 77.96 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.595 -0.442 . . . . 74.34 110.67 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -114.33 -4.73 12.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 70.11 111.676 -175.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.7 t -130.34 150.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.005 0.372 . . . . 73.23 112.005 -174.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -151.69 125.46 9.04 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.905 -0.589 . . . . 75.32 109.735 172.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.592 HG12 ' HB2' ' A' ' 45' ' ' LEU . 62.3 mt -101.54 142.56 15.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 120.889 0.376 . . . . 75.32 110.593 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.407 ' CD2' HD13 ' A' ' 26' ' ' ILE . 34.7 m-85 -128.02 168.49 15.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.554 -0.748 . . . . 74.23 109.188 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.657 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 8.4 ptpp? -147.39 163.15 37.37 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.705 -0.48 . . . . 63.25 109.705 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mt -81.87 114.32 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.253 -0.647 . . . . 74.34 109.253 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.68 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 11.9 t30 -73.14 -36.79 66.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.927 -0.578 . . . . 74.04 112.272 -173.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.494 HG13 ' H ' ' A' ' 83' ' ' ASP . 9.2 tp -135.62 143.26 37.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.951 0.405 . . . . 73.21 111.281 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.46 -18.73 60.3 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.673 -0.694 . . . . 71.21 112.009 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.494 ' H ' HG13 ' A' ' 81' ' ' ILE . 8.3 m-20 -71.27 -22.64 61.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.313 0.578 . . . . 74.33 110.288 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.484 ' ND2' ' HA3' ' A' ' 27' ' ' GLY . 92.3 m-20 -96.88 20.9 10.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.778 -0.646 . . . . 74.33 110.534 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.63 -13.96 61.91 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.813 -0.631 . . . . 70.15 110.201 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -44.69 -42.41 7.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.471 -0.786 . . . . 54.21 111.742 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.4 t -53.17 -42.23 45.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.14 -0.482 . . . . 72.51 111.196 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.22 80.8 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.957 -0.565 . . . . 72.3 110.495 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.8 m -66.54 -35.46 80.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.711 -0.677 . . . . 73.41 110.992 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.49 -47.96 71.34 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.253 -0.431 . . . . 74.01 110.839 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -71.13 -24.12 62.21 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.206 -0.452 . . . . 72.21 110.984 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.67 39.44 7.65 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 121.071 -0.585 . . . . 73.02 112.77 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.8 t -90.66 125.59 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.53 -0.544 . . . . 65.43 109.53 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.1 t -104.39 17.64 23.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.701 0.286 . . . . 75.31 111.362 -174.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.88 139.8 52.81 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.221 -0.289 . . . . 71.42 110.221 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.534 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 2.2 mp -78.04 -56.45 1.05 Allowed Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.663 -0.244 . . . . 74.45 110.985 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.534 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 90.9 Cg_endo -79.87 78.67 3.61 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.716 1.611 . . . . 74.51 111.515 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.6 m -127.34 135.25 50.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.864 -0.607 . . . . 71.22 111.164 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 99' ' ' ILE . 2.8 mp -110.22 111.74 37.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.472 -0.786 . . . . 64.41 109.702 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.432 HD11 ' N ' ' A' ' 100' ' ' LEU . 6.4 mp -88.64 141.27 28.65 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.318 -0.623 . . . . 70.03 109.318 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.529 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 36.2 mtp -110.18 140.46 44.27 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.854 -0.425 . . . . 65.13 109.854 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -146.66 144.49 29.52 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.569 -0.9 . . . . 72.3 108.569 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HB2' HD21 ' A' ' 108' ' ' LEU . 38.2 ttpt -126.47 104.91 8.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.16 -0.616 . . . . 63.45 110.596 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.964 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.8 t30 50.79 47.51 24.42 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.561 0.696 . . . . 74.01 110.809 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.26 -16.19 35.39 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.559 -0.746 . . . . 73.3 112.955 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -70.07 134.25 48.03 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.917 0.358 . . . . 61.52 110.475 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -61.42 144.32 54.32 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.044 0.84 . . . . 71.34 109.132 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.6 tp -158.73 168.43 26.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.944 -0.571 . . . . 43.11 109.636 -163.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 101' ' ' MET . 37.8 m -69.47 179.64 2.0 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.069 0.548 . . . . 64.32 111.845 -167.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -144.44 124.76 13.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 72.33 110.057 -174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.43 108.88 22.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.41 . . . . 73.14 110.227 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.483 HD13 ' N ' ' A' ' 112' ' ' ILE . 3.3 mp -87.55 101.72 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.048 -0.524 . . . . 74.15 109.651 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.88 -176.76 20.79 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.154 -0.546 . . . . 31.3 112.816 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.435 ' HB3' HD13 ' A' ' 59' ' ' LEU . . . -92.86 76.82 4.82 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.834 0.453 . . . . 73.03 111.271 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -117.79 83.52 2.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.499 0.666 . . . . 73.21 109.458 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.511 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -59.14 -30.47 43.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.093 -0.958 . . . . 72.14 110.241 -174.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.6 m -58.66 -53.22 60.84 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.13 -0.487 . . . . 63.53 110.478 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -65.39 -41.25 93.9 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 116.48 -0.327 . . . . 74.13 110.359 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 123' ' ' ILE . 76.2 mt -55.72 -56.24 13.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.246 -0.434 . . . . 75.32 110.808 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.85 -34.33 69.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 116.443 -0.344 . . . . 75.53 110.418 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 t -58.7 -52.09 67.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.061 -0.518 . . . . 73.21 109.736 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -62.33 -40.36 96.09 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.343 -0.389 . . . . 74.22 111.108 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.462 HD12 HD11 ' A' ' 66' ' ' LEU . 64.9 mt -52.66 -55.76 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.769 0.319 . . . . 75.13 110.379 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -68.96 -29.82 68.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 75.3 110.777 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -68.34 -33.91 75.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 63.33 111.368 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.504 ' OD1' HD13 ' A' ' 108' ' ' LEU . 66.0 m-80 -98.49 -24.15 15.26 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.119 0.415 . . . . 72.33 112.119 -175.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 123' ' ' ILE . 61.6 mt -71.49 -59.5 3.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.951 0.405 . . . . 72.22 110.153 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.726 -0.67 . . . . 71.03 110.434 -177.713 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 91.4 mmm . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 121.12 0.486 . . . . 73.53 110.498 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.5 mm -83.37 105.86 13.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.651 -0.704 . . . . 75.13 109.131 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -78.25 161.48 27.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 62.35 109.994 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.674 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 10.1 pt20 -137.21 133.13 34.8 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.858 0.361 . . . . 74.14 110.924 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 32.6 pt -144.69 179.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.169 -0.469 . . . . 65.32 110.984 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.548 ' HA3' HD11 ' A' ' 81' ' ' ILE . . . -117.96 -165.54 13.53 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.131 -0.486 . . . . 72.43 112.02 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.67 -51.28 51.57 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.693 0.397 . . . . 74.4 110.687 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 m -56.16 -24.79 43.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.879 -0.6 . . . . 74.24 110.754 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 42.6 mt-10 -95.07 -31.25 13.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.784 -0.644 . . . . 72.24 110.421 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.46 ' HA ' HD12 ' A' ' 26' ' ' ILE . 92.8 t80 -50.14 -61.91 1.88 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.968 -0.56 . . . . 74.24 111.843 -171.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 36' ' ' THR . 8.4 t70 -53.56 -56.44 17.05 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 123.382 0.426 . . . . 72.22 110.516 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 37' ' ' SER . 0.9 OUTLIER -54.09 -57.3 11.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 73.4 111.509 -176.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 75.5 mmtt -56.43 -38.79 72.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.848 0.356 . . . . 73.31 110.33 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.464 ' HA ' HD13 ' A' ' 44' ' ' ILE . 3.9 t -66.79 -54.81 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.93 -0.577 . . . . 73.32 111.915 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 32' ' ' ASP . 9.4 t -76.51 -7.48 55.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.699 0.285 . . . . 73.0 111.039 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 22.6 t -74.58 -5.0 40.37 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.392 -0.367 . . . . 65.55 111.667 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 35' ' ' VAL . 62.1 m -57.11 96.35 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 110.165 -0.309 . . . . 65.3 110.165 176.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -51.11 -44.63 61.33 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.502 0.501 . . . . 71.41 111.24 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -155.78 121.39 4.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.697 0.284 . . . . 75.33 110.981 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 41.89 24.9 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.547 1.314 . . . . 73.21 114.547 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.8 mm -70.09 100.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.475 -0.565 . . . . 73.11 109.475 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.78 114.88 6.74 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.239 0.542 . . . . 75.04 110.333 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 35' ' ' VAL . 34.9 mt -104.05 120.5 54.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.299 -0.864 . . . . 74.11 110.833 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.485 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.5 mp -105.13 110.87 23.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.11 -0.7 . . . . 61.35 109.11 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 61.1 t -95.55 110.16 23.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.525 -0.176 . . . . 73.02 110.525 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.426 ' CG ' ' HZ3' ' A' ' 78' ' ' LYS . 2.1 p-10 -91.08 129.65 37.06 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.291 0.567 . . . . 53.12 110.656 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 108.388 -0.967 . . . . 74.22 108.388 170.423 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.946 0.403 . . . . 75.24 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.623 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 46.0 t -74.89 -39.09 61.69 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.666 0.746 . . . . 62.42 110.583 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 114' ' ' ALA . 3.3 mm? -52.88 -45.72 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.113 -0.949 . . . . 72.21 111.989 -175.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 32.3 mt-10 -59.01 -58.57 18.56 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 119.133 -0.46 . . . . 75.24 111.58 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.401 ' HG2' ' O ' ' A' ' 58' ' ' SER . 9.8 Cg_endo -54.78 -40.53 84.4 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 121.81 1.673 . . . . 73.53 112.165 176.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.3 mt-30 -58.28 -46.49 85.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.145 0.497 . . . . 71.55 110.427 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 81.8 mt -69.65 -28.45 65.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.86 -0.609 . . . . 62.41 110.6 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 44.6 mt-10 -63.78 -44.22 94.01 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.575 -0.528 . . . . 73.24 109.575 175.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -63.32 -49.93 72.03 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.394 -0.366 . . . . 63.52 110.211 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.418 HD11 HD12 ' A' ' 116' ' ' ILE . 28.1 mt -60.56 -32.95 72.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.455 . . . . 74.43 110.465 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.482 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.28 -50.36 70.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.52 -0.548 . . . . 64.5 109.52 176.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.3 mt-30 -57.78 -39.16 76.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.249 0.547 . . . . 75.52 110.734 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -70.05 -45.39 67.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.259 -0.882 . . . . 71.12 111.249 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -104.58 5.02 33.49 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.874 -0.603 . . . . 74.33 112.373 -171.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.6 t -52.88 -19.85 2.86 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.223 0.824 . . . . 75.22 113.223 -169.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.12 -37.36 84.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.008 0.432 . . . . 54.31 110.63 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -124.0 -2.83 8.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.771 -0.649 . . . . 71.53 111.639 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -127.07 136.88 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.184 0.516 . . . . 54.24 112.209 -173.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 20.6 mmtt -146.1 127.23 14.69 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.345 -0.843 . . . . 62.35 109.538 173.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' ' 76' ' ' ILE . 3.3 mp -99.23 137.91 25.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.692 -0.485 . . . . 73.51 109.692 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 71.8 m-85 -123.83 144.45 49.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.286 -0.415 . . . . 75.14 110.031 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.426 ' HZ3' ' CG ' ' A' ' 47' ' ' ASP . 3.1 ttmp? -121.47 137.96 54.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.885 -0.598 . . . . 65.03 110.05 -177.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' A' ' 85' ' ' GLN . 12.4 tt -70.34 117.36 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.884 -0.413 . . . . 64.41 109.884 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.674 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 22.9 t-20 -113.9 -50.33 2.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.175 -0.466 . . . . 75.04 111.71 -173.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.548 HD11 ' HA3' ' A' ' 27' ' ' GLY . 52.1 mt -66.47 106.69 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 121.052 0.453 . . . . 73.24 110.861 -175.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -49.19 -40.87 34.98 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.961 -1.018 . . . . 71.25 112.907 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -71.38 -25.65 62.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.986 0.422 . . . . 70.34 110.9 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.438 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.9 OUTLIER -90.43 30.63 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.876 -0.602 . . . . 74.43 110.927 -173.184 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.463 ' HA ' HD12 ' A' ' 79' ' ' ILE . 32.4 tt0 -70.5 -12.81 61.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.74 -0.664 . . . . 64.32 110.976 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 15.7 m-20 -49.81 -30.07 9.05 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.86 -0.609 . . . . 73.14 112.469 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -52.61 -39.3 29.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.101 0.476 . . . . 72.12 110.379 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.86 -49.24 75.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.813 -0.63 . . . . 72.51 110.267 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -61.29 -41.38 96.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.648 -0.705 . . . . 65.42 111.077 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.1 mm100 -70.78 -44.69 66.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.002 -0.545 . . . . 73.34 111.454 -174.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -87.44 -9.66 54.05 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.416 -0.356 . . . . 74.11 111.594 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.31 55.68 5.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.801 -0.714 . . . . 21.13 112.584 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.0 t -81.09 98.82 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.203 -0.666 . . . . 70.02 109.203 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t -60.38 -58.83 6.83 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.012 -0.54 . . . . 74.11 110.913 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.99 136.28 45.93 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.227 -0.657 . . . . 55.22 109.227 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.423 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 72.9 mt -51.8 -54.36 40.99 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 123.389 0.43 . . . . 73.53 111.874 -176.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 96' ' ' ILE . 41.6 Cg_endo -65.37 87.58 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.614 1.542 . . . . 61.43 111.866 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 112' ' ' ILE . 56.4 m -151.77 143.02 23.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.737 -0.665 . . . . 72.22 110.09 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 99' ' ' ILE . 2.5 mp -109.83 114.05 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.848 -0.426 . . . . 64.4 109.848 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.1 mp -95.83 124.91 40.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.146 -0.479 . . . . 73.31 109.756 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.406 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . 61.8 mtp -93.25 143.72 25.99 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.682 -0.488 . . . . 73.23 109.682 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.0 m-85 -146.92 158.17 43.84 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.673 -0.491 . . . . 72.11 109.673 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -151.21 105.15 3.18 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.943 -0.303 . . . . 61.51 111.164 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 56.6 44.22 24.3 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.363 0.601 . . . . 74.43 110.381 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.5 -16.51 7.75 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.82 -0.627 . . . . 61.41 112.752 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 14.0 tmtt? -79.66 139.78 37.28 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.45 -0.574 . . . . 73.12 109.45 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -68.97 136.74 52.98 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 122.104 0.954 . . . . 72.33 112.302 -174.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -133.36 168.22 18.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.623 -1.626 . . . . 60.32 107.794 -175.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 m -70.27 -178.77 1.78 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.312 0.486 . . . . 51.14 112.312 -167.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -138.44 121.83 17.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.513 -0.312 . . . . 74.23 110.497 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.1 t -97.87 107.41 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.83 -0.433 . . . . 73.33 109.83 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.547 ' HA ' HG22 ' A' ' 98' ' ' THR . 64.7 mt -80.15 135.25 25.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.364 -0.38 . . . . 71.0 110.509 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.5 -137.64 15.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.995 -0.622 . . . . 72.03 111.846 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.507 ' HB2' ' HG ' ' A' ' 59' ' ' LEU . . . -144.6 76.76 1.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 74.12 110.375 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.444 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.3 t70 -117.3 103.36 10.08 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.128 -0.487 . . . . 61.45 109.991 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.478 HD13 ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -63.34 -36.74 77.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 72.15 110.382 -174.001 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -63.49 -42.94 98.54 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.249 -0.432 . . . . 52.32 110.151 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -66.06 -41.16 91.17 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.363 -0.38 . . . . 55.24 110.198 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 115' ' ' ASP . 69.1 mt -59.81 -56.35 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.443 -0.344 . . . . 63.01 111.048 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.1 tt -62.73 -33.97 62.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 120.818 0.342 . . . . 72.4 110.339 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 t -55.75 -51.66 66.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.86 -0.609 . . . . 74.14 109.596 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -62.01 -40.86 97.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 74.21 110.891 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 119' ' ' ILE . 73.0 mt -56.04 -55.85 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.663 0.268 . . . . 71.32 110.934 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -71.67 -29.42 64.58 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.803 -0.359 . . . . 74.11 110.77 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -68.24 -39.96 82.15 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.031 0.443 . . . . 74.4 111.022 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -90.06 -24.84 21.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.919 -0.582 . . . . 73.0 111.29 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.7 mt -77.75 -54.15 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.757 0.313 . . . . 63.53 110.795 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.569 -0.729 . . . . 75.52 110.313 -176.471 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.413 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 94.0 mmm . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 120.888 0.375 . . . . 74.1 110.379 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.435 HG12 ' HG2' ' A' ' 64' ' ' GLU . 24.6 mm -87.55 119.69 35.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.785 -0.643 . . . . 73.42 109.471 177.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 154.0 18.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.97 0.414 . . . . 73.24 111.213 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -110.63 141.77 43.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.899 -0.591 . . . . 73.35 110.216 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.498 HG22 ' HG3' ' A' ' 34' ' ' LYS . 34.7 pt -140.31 161.26 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.902 0.382 . . . . 65.12 110.978 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.38 169.18 37.4 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.825 -0.625 . . . . 34.13 111.954 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.798 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 18.2 t70 -57.04 -42.43 80.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.116 0.484 . . . . 74.54 110.763 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.3 t -72.29 -16.19 61.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 73.3 110.924 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.597 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 11.1 mm-40 -83.16 -24.41 32.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 74.51 111.845 -176.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.402 ' O ' HG23 ' A' ' 35' ' ' VAL . 88.7 t80 -45.33 -61.94 1.46 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.559 0.577 . . . . 71.42 112.559 -170.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.91 -46.11 91.95 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.727 0.298 . . . . 73.5 110.653 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -48.37 -57.14 6.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 64.33 110.588 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 9.8 mmpt? -64.62 -49.64 70.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 53.41 110.11 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.541 HG12 ' HA2' ' A' ' 105' ' ' GLY . 95.5 t -62.18 -36.8 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.735 -0.666 . . . . 62.12 111.839 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -77.76 -47.03 19.97 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.838 0.31 . . . . 73.43 111.838 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.2 p -77.15 11.03 2.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.273 0.842 . . . . 70.02 113.273 -171.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.501 ' HB3' HD12 ' A' ' 44' ' ' ILE . 24.9 p -76.78 79.93 3.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.289 . . . . 62.33 111.686 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.9 t30 32.28 -94.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.147 0.979 . . . . 73.31 112.763 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -161.72 140.34 9.49 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.789 -0.449 . . . . 60.32 109.789 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 53.19 21.04 2.04 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.223 0.609 . . . . 73.21 112.474 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 103' ' ' LYS . 47.9 mm -75.68 128.84 37.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 120.784 0.326 . . . . 64.22 110.481 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -84.76 111.12 19.31 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.013 -0.736 . . . . 72.23 109.013 178.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 38' ' ' CYS . 52.9 mt -106.84 129.12 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.971 -0.559 . . . . 73.44 110.932 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.531 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.9 mp -113.97 109.73 18.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.101 -0.703 . . . . 75.14 109.101 174.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 77' ' ' TYR . 48.7 t -101.54 104.84 16.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.951 -0.388 . . . . 72.42 109.951 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 17.8 t70 -85.26 146.6 26.98 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.068 0.461 . . . . 74.22 109.878 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.4 t80 . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 115.784 -0.644 . . . . 73.53 111.495 -173.439 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.564 ' HD3' ' N ' ' A' ' 58' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 111.74 0.274 . . . . 72.24 111.74 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.564 ' N ' ' HD3' ' A' ' 57' ' ' ARG . 20.2 m -75.87 -30.63 58.93 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.569 0.699 . . . . 73.0 110.935 173.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' A' ' 114' ' ' ALA . 4.5 mm? -66.2 -42.58 88.62 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.479 -0.782 . . . . 74.12 112.522 -173.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.61 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 3.0 mp0 -49.72 -57.52 11.97 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 118.697 0.681 . . . . 72.34 110.255 177.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 23.2 Cg_exo -55.43 -55.5 3.04 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.885 1.723 . . . . 74.33 112.327 175.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.5 mt-30 -51.33 -49.7 60.88 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.175 0.435 . . . . 71.22 112.175 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.73 -40.54 76.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.875 -0.602 . . . . 73.44 111.058 -173.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 32.4 mt-10 -64.05 -34.84 78.93 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.881 -0.328 . . . . 65.02 110.307 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -62.54 -54.99 31.62 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.176 0.513 . . . . 73.34 110.04 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.4 mt -62.08 -32.95 73.54 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.849 -0.614 . . . . 64.42 109.928 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -61.93 -40.74 96.56 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.993 -0.549 . . . . 74.11 109.933 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.0 mt-30 -64.28 -45.45 87.96 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.885 0.374 . . . . 74.43 110.66 177.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -65.89 -38.18 88.07 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.962 -0.563 . . . . 62.52 111.225 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -104.63 4.58 32.88 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.185 -0.461 . . . . 74.12 112.242 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.0 t -53.23 -19.91 3.59 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.07 0.767 . . . . 75.04 113.07 -169.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.66 -34.54 75.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 74.32 110.824 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -123.37 -20.41 5.63 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.796 -0.638 . . . . 72.25 111.612 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.14 128.25 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.946 0.403 . . . . 64.21 112.051 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.617 ' HZ2' ' HB3' ' A' ' 75' ' ' LYS . 2.2 mmmp? -131.69 138.22 48.6 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.99 -0.744 . . . . 61.31 108.99 173.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 45' ' ' LEU . 60.6 mt -118.09 114.38 45.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.011 0.434 . . . . 74.54 110.655 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 46' ' ' VAL . 56.7 m-85 -101.45 163.99 11.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 73.1 109.809 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 20.5 ttmm -139.16 138.09 36.64 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.869 0.366 . . . . 71.12 111.279 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -126.57 100.8 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.472 -0.936 . . . . 73.44 108.472 174.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -124.47 7.63 8.33 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.045 -0.525 . . . . 72.31 112.033 -172.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.5 mt -76.47 112.44 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.273 -0.269 . . . . 70.34 110.273 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.75 -31.19 70.53 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.839 0.352 . . . . 52.23 111.331 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.29 -23.29 61.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.161 0.505 . . . . 72.33 110.957 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.798 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 33.5 m-80 -123.92 91.94 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 55.05 110.509 -174.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -140.25 14.63 2.41 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.537 0.569 . . . . 61.35 112.537 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.67 -44.77 63.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.206 0.527 . . . . 74.34 110.043 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.59 -38.92 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.272 -0.877 . . . . 73.22 110.897 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.99 -41.06 91.58 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.213 0.53 . . . . 62.15 110.269 -175.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.1 m -72.25 -35.91 68.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.51 -0.768 . . . . 64.0 110.932 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -68.55 -45.96 70.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.473 -0.33 . . . . 74.1 111.841 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -86.86 -23.54 25.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.617 0.229 . . . . 64.24 111.617 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.49 80.38 1.51 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.717 -0.754 . . . . 72.12 113.062 173.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.4 t -99.63 138.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.271 -0.641 . . . . 61.22 109.271 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.4 m -141.49 18.29 2.21 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.997 0.369 . . . . 75.23 111.997 -174.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.87 152.53 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.652 -0.249 . . . . 51.23 110.444 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.682 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 60.1 mt -59.68 -50.03 88.93 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.416 -0.356 . . . . 74.22 110.526 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.682 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 73.1 Cg_endo -95.37 112.67 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.695 2.264 . . . . 72.44 111.061 169.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.42 HG22 HD12 ' A' ' 112' ' ' ILE . 54.8 m -145.82 118.68 8.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.005 -0.369 . . . . 55.31 110.005 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.5 mp -109.7 110.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.316 -0.402 . . . . 64.41 110.129 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.438 HD13 ' N ' ' A' ' 100' ' ' LEU . 6.0 mp -90.21 123.31 33.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.767 -0.827 . . . . 75.53 108.767 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.426 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 45.2 mtp -101.0 145.43 28.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.851 -0.426 . . . . 74.4 109.851 -176.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 97.1 m-85 -148.22 160.81 42.56 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.354 -0.609 . . . . 74.55 109.354 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 39.3 ttpt -143.93 114.34 7.52 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.917 -0.313 . . . . 75.2 110.596 175.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.5 t30 62.19 25.68 15.38 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.536 0.684 . . . . 72.13 109.711 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.541 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 84.61 -14.41 47.13 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.699 -0.682 . . . . 73.04 111.965 -176.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -69.33 142.31 54.06 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.832 -0.433 . . . . 74.2 109.832 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -58.3 150.93 20.68 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 124.1 0.875 . . . . 73.21 111.097 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -162.36 168.74 21.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.909 -1.042 . . . . 74.01 108.995 -169.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -70.19 167.71 17.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.384 0.611 . . . . 63.15 112.356 -167.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -130.48 118.57 21.32 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.81 -0.632 . . . . 70.53 109.945 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.0 t -86.8 119.43 34.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 74.43 110.29 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 98' ' ' THR . 50.0 mm -100.13 102.47 13.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.222 -0.445 . . . . 74.34 110.2 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.476 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 107.46 166.25 21.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.267 -0.492 . . . . 34.23 112.217 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.528 ' HB3' ' HG ' ' A' ' 59' ' ' LEU . . . -80.79 72.2 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.863 0.363 . . . . 64.12 111.107 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 61.2 t0 -112.07 92.88 4.19 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.374 0.607 . . . . 64.02 110.185 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.484 ' O ' HD11 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -59.22 -34.97 55.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.276 -0.875 . . . . 75.54 110.153 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.6 t -62.68 -46.21 89.2 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.133 -0.485 . . . . 75.22 110.077 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.756 ' HZ3' ' HB2' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -65.29 -42.96 92.6 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.859 -0.61 . . . . 74.1 109.937 -179.316 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 123' ' ' ILE . 74.0 mt -57.22 -56.14 16.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 115.419 -0.81 . . . . 71.14 111.098 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.2 tt -65.4 -35.21 74.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 121.063 -0.255 . . . . 74.22 110.788 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 t -56.72 -52.05 66.47 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.103 -0.499 . . . . 75.32 110.027 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -70.46 -31.63 68.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 65.3 111.477 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 119' ' ' ILE . 62.0 mt -57.34 -56.52 14.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.686 -0.406 . . . . 72.02 110.229 176.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -69.8 -32.82 71.48 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.757 -0.377 . . . . 74.25 110.21 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -62.06 -49.67 75.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.137 -0.483 . . . . 64.43 111.153 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -86.98 -20.24 27.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 73.22 112.219 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.9 mt -78.62 -52.76 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.853 -0.339 . . . . 72.24 110.619 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.536 -0.745 . . . . 74.4 110.288 -177.392 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 80.1 mmm . . . . . 0 C--O 1.235 0.321 0 N-CA-C 108.227 -1.027 . . . . 62.11 108.227 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.581 HG23 ' HZ1' ' A' ' 78' ' ' LYS . 17.2 mm -54.99 107.79 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.642 -1.163 . . . . 74.34 109.222 174.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 77' ' ' TYR . 35.9 tt0 -76.26 112.22 12.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.353 0.597 . . . . 65.22 110.62 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -70.16 127.22 32.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.043 -0.981 . . . . 72.24 110.873 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.506 HG23 ' HG3' ' A' ' 34' ' ' LYS . 44.3 pt -136.27 159.04 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.04 0.447 . . . . 71.13 111.274 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.96 176.29 30.58 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.973 -0.558 . . . . 74.12 112.232 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' CB ' ' HB3' ' A' ' 84' ' ' ASN . 16.9 t70 -55.29 -38.38 68.54 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.157 0.583 . . . . 61.5 111.346 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -84.48 -8.65 58.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 75.14 112.132 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -94.37 -12.94 26.92 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.267 0.469 . . . . 74.22 112.267 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.422 ' O ' HG21 ' A' ' 35' ' ' VAL . 31.1 m-85 -50.2 -61.79 1.96 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.29 0.478 . . . . 74.42 112.29 -175.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.08 -36.58 80.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.461 -0.336 . . . . 70.3 110.544 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.48 -57.3 13.26 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.699 0.761 . . . . 74.21 109.075 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.641 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 10.2 mmpt? -62.52 -39.17 92.67 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.363 -1.29 . . . . 62.31 111.01 -172.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 31' ' ' PHE . 96.7 t -66.34 -49.8 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.909 -0.587 . . . . 75.21 110.329 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -67.85 -17.93 64.65 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 111.711 0.263 . . . . 73.54 111.711 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -66.27 -8.88 27.62 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.962 0.356 . . . . 72.42 111.962 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.738 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.8 t -60.72 117.36 5.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.726 0.298 . . . . 71.44 110.823 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.65 -50.95 12.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 72.23 110.66 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -161.67 121.9 2.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.331 -0.395 . . . . 62.12 111.21 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 51.42 16.01 0.38 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.263 0.838 . . . . 64.33 113.263 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.711 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 44.5 mm -70.1 104.48 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.629 -0.508 . . . . 72.23 109.629 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.419 HD23 ' HE1' ' A' ' 101' ' ' MET . 0.9 OUTLIER -76.06 108.04 8.69 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.526 -0.761 . . . . 74.11 109.032 179.121 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.461 HG22 ' CE2' ' A' ' 77' ' ' TYR . 76.0 mt -100.31 113.58 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.965 -1.016 . . . . 75.32 110.814 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 4.0 mp -105.24 142.75 34.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.731 -0.668 . . . . 74.33 109.291 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.96 109.44 17.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.391 -0.596 . . . . 75.14 109.391 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -90.54 143.83 26.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.072 0.463 . . . . 75.45 110.111 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.2 t80 . . . . . 0 C--N 1.322 -0.622 0 N-CA-C 108.954 -0.758 . . . . 70.14 108.954 177.582 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.405 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 53.9 ttt-85 . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.724 0.297 . . . . 70.03 111.095 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 15.2 m -65.11 -34.36 78.22 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.736 0.779 . . . . 72.34 110.905 -177.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.42 HD23 ' HB1' ' A' ' 114' ' ' ALA . 4.2 mm? -65.65 -24.14 66.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.364 -0.835 . . . . 64.24 111.623 -175.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.437 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 40.7 tt0 -62.69 -63.69 3.89 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 120.578 -0.449 . . . . 72.44 109.842 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.437 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 31.0 Cg_endo -63.44 -31.64 71.92 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.724 1.616 . . . . 53.13 112.541 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 58' ' ' SER . 28.0 mt-30 -66.52 -52.94 40.42 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.38 -0.528 . . . . 60.22 111.687 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.95 -35.26 80.1 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.176 -0.305 . . . . 74.22 110.176 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.5 ' OE1' HG12 ' A' ' 23' ' ' ILE . 5.2 mm-40 -59.92 -42.92 94.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.877 -0.601 . . . . 70.43 110.811 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -59.31 -55.14 38.54 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.334 0.588 . . . . 75.13 109.892 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.6 mt -59.47 -33.63 71.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.028 -0.987 . . . . 63.13 110.102 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.554 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.7 -44.73 92.8 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.82 -0.627 . . . . 64.02 110.105 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.419 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 51.8 mt-30 -63.82 -47.12 82.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.087 -0.506 . . . . 72.15 111.134 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -69.42 -41.37 76.44 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.216 -0.447 . . . . 61.23 111.614 -175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -102.72 5.72 39.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.641 0.608 . . . . 72.42 112.641 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.554 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.35 -19.42 2.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.189 0.811 . . . . 62.43 113.189 -169.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.88 -42.3 93.47 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.599 0.238 . . . . 70.43 110.771 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -128.03 -2.84 5.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.377 -0.374 . . . . 73.04 111.886 -175.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.9 t -112.36 131.94 62.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.923 0.392 . . . . 74.44 110.821 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -135.65 120.12 18.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.773 -0.649 . . . . 64.12 110.201 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 45' ' ' LEU . 3.6 mp -106.32 137.34 37.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.65 -0.5 . . . . 74.3 109.65 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.532 ' CE1' ' HD3' ' A' ' 34' ' ' LYS . 76.0 m-85 -131.3 165.77 22.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 72.24 109.993 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' HZ1' HG23 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -158.16 166.72 31.73 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.158 0.504 . . . . 75.42 110.91 169.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 tp -73.0 147.51 9.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.077 -0.965 . . . . 72.23 112.211 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.484 ' C ' HD21 ' A' ' 80' ' ' ASN . 0.2 OUTLIER -108.05 -58.32 2.0 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.402 -0.817 . . . . 61.53 110.452 175.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.1 mt -70.58 105.43 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.992 0.425 . . . . 63.31 111.235 -173.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -56.3 -33.9 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.674 -0.694 . . . . 74.24 111.2 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -87.83 2.67 50.78 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.193 -0.458 . . . . 74.4 111.466 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.41 ' HB3' ' CB ' ' A' ' 28' ' ' ASP . 11.2 m120 -139.38 90.18 2.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.034 0.445 . . . . 73.32 110.263 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -117.94 13.59 14.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.486 -0.779 . . . . 73.34 109.418 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 32.7 t70 -49.52 -50.97 39.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.432 -0.804 . . . . 73.44 110.943 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.2 t -53.15 -37.75 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.655 -0.702 . . . . 73.05 110.871 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.38 -43.9 84.59 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.294 0.569 . . . . 74.44 109.828 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.2 m -66.65 -30.1 70.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.489 -0.778 . . . . 64.31 110.686 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.546 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 18.5 mm-40 -74.13 -41.65 61.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.893 -0.594 . . . . 73.14 111.089 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -74.51 -31.34 62.13 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 111.718 0.266 . . . . 74.44 111.718 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.53 43.58 0.26 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.286 -0.959 . . . . 73.45 113.781 172.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.2 t -90.55 107.38 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.569 -0.53 . . . . 72.11 109.569 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 t -135.2 21.15 3.44 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.203 0.525 . . . . 70.04 110.551 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.66 168.47 19.21 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.065 -0.516 . . . . 72.23 110.05 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.755 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 48.0 mm -67.86 -53.04 22.37 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.56 -0.291 . . . . 74.01 110.646 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.755 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 58.6 Cg_endo -102.75 107.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 123.1 2.533 . . . . 73.11 111.834 172.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.5 m -132.14 118.92 20.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.791 -0.186 . . . . 61.43 110.798 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.453 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.8 mp -110.48 115.25 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 110.262 -0.273 . . . . 74.33 110.262 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.59 137.3 32.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.399 -0.593 . . . . 60.24 109.399 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.504 ' HE2' ' HB3' ' A' ' 122' ' ' GLU . 51.6 mtp -115.92 143.48 45.37 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.817 0.28 . . . . 72.01 110.429 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -142.78 152.86 42.71 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.267 -0.642 . . . . 71.43 109.267 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -143.49 107.49 4.71 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.508 -0.477 . . . . 73.13 111.597 176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.738 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 10.5 t30 53.0 36.2 21.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.48 0.657 . . . . 74.32 111.584 174.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.41 -16.63 55.63 Favored Glycine 0 N--CA 1.454 -0.117 0 CA-C-N 115.759 -0.655 . . . . 63.13 112.644 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -81.6 145.17 30.75 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.363 -0.606 . . . . 73.12 109.363 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -61.86 160.5 11.95 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.516 0.674 . . . . 51.12 110.826 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.28 167.36 24.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.364 -1.347 . . . . 74.45 107.364 -168.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.1 m -70.96 178.29 3.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.958 0.885 . . . . 63.55 112.687 -165.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -140.84 118.44 11.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.854 -1.067 . . . . 73.15 108.912 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 42.5 t -93.81 107.12 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.171 0.51 . . . . 75.23 110.02 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.1 mt -92.72 107.31 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.623 -0.717 . . . . 74.14 109.471 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.611 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 110.97 158.44 15.49 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.46 -0.656 . . . . 52.52 111.46 -175.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.42 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -81.92 78.53 8.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.721 0.296 . . . . 64.11 110.844 -178.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.413 ' O ' HG13 ' A' ' 119' ' ' ILE . 19.3 m-20 -117.1 80.96 1.56 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.079 0.466 . . . . 74.13 110.048 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -59.11 -32.09 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.773 -0.648 . . . . 72.43 109.799 -177.195 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.8 m -58.36 -50.0 75.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.91 -0.587 . . . . 50.42 110.39 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -69.45 -35.8 76.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.219 -0.446 . . . . 75.25 110.313 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 123' ' ' ILE . 76.4 mt -58.33 -56.39 16.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.188 -0.46 . . . . 72.04 110.513 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.31 -34.74 71.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.129 -0.487 . . . . 74.05 110.346 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.5 t -57.06 -49.72 74.98 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.153 -0.476 . . . . 72.15 109.787 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.504 ' HB3' ' HE2' ' A' ' 101' ' ' MET . 63.9 mm-40 -62.31 -38.54 89.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.476 -0.329 . . . . 63.23 110.573 177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 119' ' ' ILE . 58.3 mt -57.62 -56.5 15.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.672 0.272 . . . . 64.23 110.938 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -71.33 -25.16 62.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.761 0.315 . . . . 74.2 110.626 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.48 -44.11 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 73.15 111.132 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -93.0 -18.06 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 73.2 111.975 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.5 mt -76.78 -53.28 15.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 120.929 0.395 . . . . 74.31 110.054 173.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.1 m120 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.377 -0.821 . . . . 75.42 110.392 -178.664 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.1 mmm . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.61 0.243 . . . . 74.21 110.664 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.508 HG12 ' OE2' ' A' ' 64' ' ' GLU . 12.9 mm -69.73 97.61 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 109.653 -0.499 . . . . 74.42 109.653 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.8 124.11 24.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 75.53 110.81 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.497 ' NE2' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -90.72 128.98 36.85 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.687 -0.486 . . . . 72.33 109.687 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 39.9 pt -141.77 179.85 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.12 -0.491 . . . . 64.04 110.735 -176.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.2 -177.74 15.15 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.643 -0.983 . . . . 75.44 110.643 171.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 13.3 t70 -52.73 -43.12 65.51 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.856 0.36 . . . . 75.44 110.973 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 p -63.17 -24.01 67.7 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.013 -0.54 . . . . 74.14 112.26 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -96.99 -32.39 12.03 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.761 -0.199 . . . . 71.21 111.117 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.458 ' HA ' HD11 ' A' ' 26' ' ' ILE . 85.0 t80 -41.24 -61.8 0.96 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.002 0.742 . . . . 74.54 113.002 -166.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.4 -50.27 65.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.715 0.293 . . . . 75.41 111.116 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.407 ' N ' HD21 ' A' ' 33' ' ' ASN . 0.9 OUTLIER -60.36 -51.56 68.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.031 -0.531 . . . . 71.11 110.734 -177.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HG3' HG22 ' A' ' 26' ' ' ILE . 70.7 mmtt -59.45 -36.66 76.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.812 -0.631 . . . . 65.12 111.049 -176.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.3 -54.66 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.13 -0.487 . . . . 55.34 111.309 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.8 p -62.92 -25.65 68.43 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.564 0.221 . . . . 63.31 111.559 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.6 t -75.35 5.51 5.6 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.589 -0.278 . . . . 73.41 111.674 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.569 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 24.4 p -62.52 140.83 58.63 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.875 -0.417 . . . . 52.11 109.875 175.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -58.41 -83.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.556 -0.293 . . . . 61.31 110.837 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -161.95 152.54 17.44 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.082 -0.71 . . . . 73.5 109.082 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 45.84 22.07 0.11 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.702 0.801 . . . . 75.14 112.685 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 mm -81.95 127.25 39.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 120.607 0.241 . . . . 75.31 110.427 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.9 tp -88.43 108.59 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.143 0.497 . . . . 63.52 110.041 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 38' ' ' CYS . 57.4 mt -101.33 114.36 40.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.652 -0.704 . . . . 72.5 110.366 178.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 5.5 mp -99.04 118.77 36.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.182 -0.673 . . . . 70.13 109.182 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 67.0 t -104.34 105.02 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 110.002 -0.37 . . . . 61.4 110.002 175.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.81 156.53 20.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.95 0.405 . . . . 74.4 110.526 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.3 t80 . . . . . 0 C--N 1.327 -0.401 0 N-CA-C 109.118 -0.697 . . . . 74.31 109.118 174.469 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.478 ' O ' ' HD3' ' A' ' 57' ' ' ARG . 2.3 tmt_? . . . . . 0 C--O 1.223 -0.309 0 CA-C-O 120.487 0.184 . . . . 75.45 110.637 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.62 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 16.6 m -75.67 -57.12 4.07 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.484 0.659 . . . . 62.43 111.388 175.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.2 mm? -60.57 -42.55 96.86 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.498 -0.774 . . . . 74.53 112.625 -168.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.1 -59.18 12.52 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 117.917 0.326 . . . . 64.41 111.226 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.4 -33.24 58.83 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.678 1.585 . . . . 65.44 112.691 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.6 mt-30 -59.46 -45.85 90.44 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.021 -0.672 . . . . 75.31 110.7 173.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 84.5 mt -62.7 -43.74 98.02 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.155 -0.475 . . . . 74.52 110.33 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.588 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 25.7 mm-40 -53.63 -53.25 54.51 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.053 -0.521 . . . . 70.32 110.377 174.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -51.34 -52.9 41.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.989 -0.551 . . . . 62.53 110.709 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.0 -31.69 72.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 75.14 110.694 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.633 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -71.7 -25.15 61.97 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.267 -0.424 . . . . 75.01 110.725 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 89.3 mt-30 -85.21 -37.93 19.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.992 0.425 . . . . 61.2 110.493 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -74.41 -50.54 18.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 71.21 110.936 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -90.45 5.09 49.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.553 -0.749 . . . . 74.44 112.159 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.633 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.6 t -53.04 -24.34 9.57 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.639 0.607 . . . . 64.4 112.639 -172.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -59.35 -18.79 41.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.069 0.462 . . . . 74.01 110.859 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -133.44 -29.31 1.39 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.748 -0.66 . . . . 72.23 111.365 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.409 HG22 HD11 ' A' ' 127' ' ' ILE . 66.0 t -105.49 144.36 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 112.285 0.476 . . . . 75.15 112.285 -169.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 45.6 mmtm -142.53 140.04 31.65 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.689 -0.856 . . . . 74.44 108.689 170.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 45' ' ' LEU . 42.3 mt -117.06 138.3 48.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.012 0.434 . . . . 71.33 111.027 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 57.0 m-85 -131.29 162.62 29.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.374 -0.83 . . . . 73.15 109.072 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -157.03 136.18 11.93 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.897 0.38 . . . . 75.03 110.902 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.617 HG12 HG13 ' A' ' 87' ' ' VAL . 2.3 mp -71.09 100.2 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.221 -0.659 . . . . 64.0 109.221 177.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -103.7 -1.64 27.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.761 -0.654 . . . . 74.11 109.856 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.6 mm -95.93 96.72 5.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.789 -0.642 . . . . 63.43 110.405 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.79 -22.1 63.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.939 -0.573 . . . . 75.24 110.921 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.1 -23.57 62.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.113 0.482 . . . . 72.5 110.045 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 30.3 m-80 -111.53 77.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.226 -0.657 . . . . 73.45 109.226 176.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -100.34 -21.84 15.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.683 -0.689 . . . . 73.2 111.77 -170.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 4.4 m-20 -52.26 -34.55 46.71 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.703 0.631 . . . . 75.22 112.703 -174.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.617 HG13 HG12 ' A' ' 79' ' ' ILE . 14.7 p -53.36 -39.79 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.155 0.503 . . . . 75.15 110.543 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.42 -41.13 93.9 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.876 -0.602 . . . . 62.14 110.274 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 m -62.07 -40.66 96.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.553 -0.748 . . . . 63.24 109.824 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 30.0 mm-40 -64.67 -46.5 82.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.288 -0.869 . . . . 45.05 110.988 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -80.77 -15.54 56.17 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 121.108 -0.237 . . . . 71.24 111.383 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.18 52.48 31.72 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.059 -0.591 . . . . 64.14 112.644 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.65 112.5 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.958 0.408 . . . . 71.11 110.36 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.5 t -90.24 -55.97 3.4 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.211 -0.45 . . . . 74.32 110.641 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.62 155.88 33.14 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.172 -0.467 . . . . 72.24 110.437 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.74 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 45.1 mm -69.68 -59.77 4.38 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.669 -0.241 . . . . 73.41 110.741 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.74 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 1.9 Cg_endo -80.28 74.57 5.48 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.048 1.832 . . . . 72.05 111.098 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.7 m -113.1 124.92 53.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 70.23 110.701 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -110.06 117.5 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.41 -0.359 . . . . 34.34 110.173 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.515 HD23 ' HG3' ' A' ' 110' ' ' GLN . 86.9 mt -88.35 122.98 32.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.907 -0.775 . . . . 73.23 108.907 174.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.458 ' HE1' ' HB3' ' A' ' 122' ' ' GLU . 56.9 mtp -96.93 143.66 27.6 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.931 -0.396 . . . . 72.35 109.931 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -141.38 144.93 34.78 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.283 -0.636 . . . . 71.53 109.283 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 22.3 tptm -129.68 104.38 7.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.194 -0.299 . . . . 74.14 110.194 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.569 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 65.8 t30 46.22 46.94 13.43 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.971 0.508 . . . . 75.25 111.934 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.13 -15.51 57.97 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.401 -0.428 . . . . 73.3 113.806 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 52.6 tttp -82.84 144.57 30.01 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.622 0.369 . . . . 74.54 110.894 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -68.97 142.25 54.73 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.021 0.439 . . . . 71.01 110.098 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.58 169.05 19.18 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.126 0.971 . . . . 75.42 108.907 -169.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.8 m -69.22 173.2 5.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.529 0.681 . . . . 75.34 112.539 -162.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.515 ' HG3' HD23 ' A' ' 100' ' ' LEU . 20.0 tt0 -125.9 122.42 35.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 74.42 109.673 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.4 t -92.73 110.36 22.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.971 -0.381 . . . . 74.33 109.971 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.5 mp -94.2 122.15 45.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.74 -0.467 . . . . 64.15 109.74 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.86 146.7 20.87 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 116.32 -0.4 . . . . 75.24 112.249 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.64 77.74 1.09 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.929 0.395 . . . . 72.32 110.203 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -125.2 97.06 5.07 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.366 0.603 . . . . 62.1 109.905 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -26.42 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.33 -0.85 . . . . 71.24 109.882 -174.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.7 t -63.4 -47.21 82.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.195 -0.457 . . . . 73.12 109.881 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -65.37 -43.97 89.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.11 110.272 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.503 ' O ' HG13 ' A' ' 123' ' ' ILE . 73.8 mt -55.79 -56.26 13.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.17 -0.468 . . . . 63.24 110.663 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.1 tt -64.31 -33.83 65.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.326 -0.397 . . . . 73.33 110.422 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.4 t -57.3 -52.36 65.66 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.203 -0.453 . . . . 70.4 110.071 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.458 ' HB3' ' HE1' ' A' ' 101' ' ' MET . 7.1 mm-40 -65.2 -37.23 86.65 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.457 -0.338 . . . . 74.44 110.411 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 119' ' ' ILE . 65.7 mt -56.42 -56.39 13.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 120.716 0.293 . . . . 61.11 111.098 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -71.52 -27.54 63.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.991 -0.284 . . . . 74.32 110.441 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -65.76 -34.55 78.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.805 0.336 . . . . 75.45 110.505 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -79.14 -42.94 25.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.316 -0.402 . . . . 62.42 111.339 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 74' ' ' VAL . 56.6 mt -69.74 -46.06 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 75.43 110.738 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.426 -0.797 . . . . 74.23 109.815 -177.329 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.3 ptm . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.984 0.421 . . . . 75.23 109.884 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.51 129.43 35.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 70.51 109.906 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -83.4 150.31 26.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.335 -0.393 . . . . 73.25 110.146 -176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -119.71 130.14 54.86 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.966 0.413 . . . . 72.13 110.652 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.9 pt -138.81 177.01 5.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.795 -0.638 . . . . 74.35 110.3 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.88 -179.06 16.46 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.163 -0.542 . . . . 61.43 112.422 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.01 -47.24 71.68 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.301 0.64 . . . . 74.2 111.173 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.9 t -75.32 -20.45 59.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.821 -0.627 . . . . 33.31 111.711 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -91.61 -8.58 46.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.432 0.158 . . . . 74.33 110.961 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -53.67 -62.5 1.61 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.224 -0.444 . . . . 74.42 111.938 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -61.24 -47.68 84.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.979 0.419 . . . . 52.12 110.872 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -55.42 -55.3 33.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.591 -0.731 . . . . 71.34 111.411 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.27 -32.17 68.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.56 -0.291 . . . . 72.12 111.563 -174.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.93 -38.6 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.805 0.336 . . . . 73.52 110.882 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.0 p -82.58 -20.6 36.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.812 0.339 . . . . 61.34 110.994 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -71.67 5.66 2.35 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.21 -0.45 . . . . 63.42 112.101 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.734 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 25.5 p -56.95 142.38 41.86 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.154 -0.313 . . . . 61.12 110.154 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -58.93 -74.46 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.572 0.225 . . . . 72.25 110.53 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -153.12 122.0 6.49 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.874 -0.417 . . . . 43.45 109.874 175.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 55.48 21.82 4.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.512 0.56 . . . . 74.12 112.512 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.734 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.0 mm -74.69 113.45 13.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 110.121 -0.326 . . . . 74.15 110.121 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.04 113.68 9.33 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.036 -0.728 . . . . 44.11 109.036 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 47.8 mt -106.48 114.4 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.736 -0.665 . . . . 75.24 110.9 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.43 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -92.55 154.21 18.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.266 -0.642 . . . . 75.12 109.266 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 63.0 t -132.61 104.96 8.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.459 -0.571 . . . . 65.52 109.459 176.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.48 161.73 14.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.171 -0.468 . . . . 65.21 110.459 -176.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.8 t80 . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.742 -0.663 . . . . 70.1 110.121 168.149 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.97 0.414 . . . . 75.43 110.309 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.666 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 31.5 t -74.89 -38.14 61.94 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.438 0.637 . . . . 63.21 109.944 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.538 HD11 ' HG ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -55.68 -28.32 54.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.299 -0.864 . . . . 65.41 110.487 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.572 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 41.2 mt-10 -59.19 -67.7 0.93 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.738 -0.21 . . . . 75.13 110.776 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.572 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 32.6 Cg_endo -62.62 -28.5 77.08 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 121.518 1.478 . . . . 41.13 111.972 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.666 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.0 mt-30 -62.35 -47.3 84.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.711 -0.396 . . . . 63.34 111.646 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.538 ' HG ' HD11 ' A' ' 59' ' ' LEU . 22.1 mt -66.92 -39.98 87.53 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.962 -0.295 . . . . 64.12 110.561 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -64.58 -31.13 72.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.455 -0.338 . . . . 75.2 110.357 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.6 -53.63 48.66 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.334 0.588 . . . . 74.34 109.589 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.426 HD12 ' CD1' ' A' ' 116' ' ' ILE . 19.5 mt -61.76 -31.13 71.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.339 -0.846 . . . . 74.21 110.128 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.416 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.73 -53.54 39.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.039 -0.528 . . . . 62.12 110.11 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -61.78 -34.44 75.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.299 -0.41 . . . . 74.52 111.202 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -75.87 -40.7 54.1 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.129 -0.487 . . . . 72.21 111.101 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -104.66 5.27 33.45 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.049 0.54 . . . . 75.34 112.359 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.1 t -53.3 -18.89 2.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.37 0.507 . . . . 74.13 112.37 -173.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.15 -43.45 82.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.822 0.344 . . . . 74.44 110.441 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -129.25 8.13 5.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.939 -0.573 . . . . 64.34 111.73 -175.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t -125.81 138.42 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.008 0.432 . . . . 74.1 111.774 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 24.4 tptp -141.6 120.0 12.33 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.713 -0.676 . . . . 72.42 109.217 174.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 45' ' ' LEU . 55.6 mt -96.92 141.19 16.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 120.757 0.313 . . . . 74.13 110.855 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 30.6 m-85 -126.13 162.44 25.35 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.614 0.766 . . . . 71.54 109.784 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.738 ' HB2' ' HZ1' ' A' ' 78' ' ' LYS . 4.4 ttmp? -135.62 125.65 26.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.543 -0.54 . . . . 75.14 109.543 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.3 pt -91.4 117.83 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.948 0.404 . . . . 73.14 111.023 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.97 93.3 5.06 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.462 0.649 . . . . 71.1 110.58 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.441 HD13 ' NE2' ' A' ' 85' ' ' GLN . 41.7 pt -54.92 -23.93 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.355 -0.839 . . . . 74.32 111.969 -177.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -48.16 -40.94 25.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.729 0.411 . . . . 75.44 111.631 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.18 -33.75 67.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.924 0.392 . . . . 74.52 110.916 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 177.68 144.22 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.514 -0.921 . . . . 62.3 108.514 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.441 ' NE2' HD13 ' A' ' 81' ' ' ILE . 5.7 tt0 -124.48 -0.92 8.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.806 0.298 . . . . 74.23 111.806 -168.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.553 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 1.2 m-20 -49.08 -48.74 43.97 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.161 -0.472 . . . . 73.31 111.829 -175.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.8 t -53.79 -38.35 35.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-O 120.909 0.385 . . . . 54.01 110.934 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.06 88.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.138 0.494 . . . . 55.41 110.064 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.1 m -68.75 -36.75 78.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.679 -0.692 . . . . 75.42 110.618 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 97.5 mt-30 -60.82 -57.78 11.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.274 -0.421 . . . . 74.4 110.61 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -75.01 -24.47 58.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 71.12 111.292 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.75 73.19 1.14 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.94 -0.648 . . . . 53.31 113.08 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.0 t -89.72 91.49 3.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.88 -0.785 . . . . 71.22 108.88 172.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.4 p -74.52 -47.9 30.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.648 -0.706 . . . . 61.3 111.779 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.16 164.57 11.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 62.33 110.506 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.708 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 49.2 mm -62.08 -55.45 40.67 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 123.184 0.302 . . . . 72.42 110.605 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.708 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 2.1 Cg_endo -81.0 104.44 1.55 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.968 1.779 . . . . 75.41 110.978 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.404 ' C ' HD11 ' A' ' 99' ' ' ILE . 69.9 m -139.15 138.5 37.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.812 0.339 . . . . 73.54 110.852 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.439 HG12 HD13 ' A' ' 63' ' ' LEU . 2.0 mp -120.34 114.59 44.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 115.829 -0.623 . . . . 65.01 110.26 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.446 HD13 ' N ' ' A' ' 100' ' ' LEU . 5.9 mp -90.6 156.09 18.39 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.254 -0.647 . . . . 65.02 109.254 173.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.415 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . 48.8 mtp -126.27 139.5 53.27 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.965 -0.754 . . . . 73.13 108.965 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.448 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.3 m-85 -147.63 157.02 43.37 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.668 -0.493 . . . . 73.32 109.668 176.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 40.6 ttpt -151.1 109.41 3.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.491 -0.483 . . . . 74.03 111.595 175.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.707 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 66.2 t30 55.9 36.9 28.17 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.485 0.66 . . . . 73.45 111.24 174.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.66 -16.68 58.65 Favored Glycine 0 CA--C 1.518 0.275 0 CA-C-N 115.647 -0.706 . . . . 71.52 112.829 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 12.8 ttmt -74.33 135.21 42.53 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 116.813 0.306 . . . . 70.24 110.393 177.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -77.9 88.05 4.1 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.19 0.995 . . . . 73.11 110.751 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -71.84 168.85 17.02 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.35 -1.75 . . . . 74.52 109.782 172.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 101' ' ' MET . 38.9 m -69.87 -177.61 1.34 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.277 0.631 . . . . 74.31 112.353 -166.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -142.38 121.41 12.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.206 -0.452 . . . . 63.23 110.214 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.45 115.81 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 70.2 110.135 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.1 mt -89.51 128.23 41.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.579 . . . . 63.31 110.38 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.17 -155.77 30.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.172 -0.537 . . . . 64.12 112.3 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -105.99 112.62 25.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.783 -0.451 . . . . 65.45 109.783 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 119' ' ' ILE . 5.4 t70 -154.05 82.58 1.14 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.376 0.608 . . . . 70.1 110.246 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.523 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -60.24 -29.53 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.356 -0.838 . . . . 74.01 110.67 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.9 t -66.39 -54.25 26.56 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.124 0.488 . . . . 75.3 110.086 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -57.77 -46.21 84.88 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.814 -0.63 . . . . 72.33 110.167 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.502 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.7 mt -56.47 -56.34 14.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.879 -0.601 . . . . 75.23 111.091 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -63.21 -34.18 65.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 120.56 0.219 . . . . 75.34 110.696 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 t -60.1 -52.15 66.59 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.369 -0.378 . . . . 75.23 110.063 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.3 -40.31 93.68 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.212 -0.449 . . . . 75.1 110.149 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.552 ' O ' HG13 ' A' ' 127' ' ' ILE . 53.2 mt -57.12 -56.33 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.859 -0.61 . . . . 64.01 111.273 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.82 -33.41 72.29 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 120.42 -0.512 . . . . 73.42 110.198 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -58.66 -36.26 73.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.12 -0.491 . . . . 62.44 110.362 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.445 ' CG ' HD11 ' A' ' 108' ' ' LEU . 39.2 m-80 -108.81 1.31 20.87 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.369 0.877 . . . . 62.11 113.369 -175.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 123' ' ' ILE . 46.6 mt -84.12 -52.95 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.378 -0.971 . . . . 74.34 108.378 166.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.408 -0.814 . . . . 74.11 109.688 175.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.884 0.374 . . . . 71.43 110.057 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.62 116.14 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 52.41 110.732 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -63.73 131.48 48.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.015 -0.539 . . . . 64.41 110.905 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -138.38 150.89 46.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.067 -0.515 . . . . 71.32 110.248 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -62.03 153.07 30.72 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.48 -0.327 . . . . 74.44 110.217 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -96.56 149.91 21.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.186 0.517 . . . . 75.41 111.417 -172.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.908 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 44.0 m80 -145.77 -179.27 6.58 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.127 -1.064 . . . . 75.5 108.127 172.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -162.73 145.75 10.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.887 0.312 . . . . 72.01 111.186 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.0 mmt -93.74 150.87 20.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 71.21 109.846 175.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.45 -64.24 4.57 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.464 -0.654 . . . . 73.21 111.464 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 t -156.17 133.91 11.06 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.76 -0.83 . . . . 73.01 108.76 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.4 tp -87.33 90.97 8.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.936 0.398 . . . . 71.42 111.194 -172.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -137.23 176.36 8.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.742 -0.663 . . . . 72.34 109.451 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.98 85.38 0.7 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.83 -0.804 . . . . 63.13 108.83 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -83.71 171.79 12.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.423 -0.808 . . . . 73.25 111.589 -174.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.5 m -90.84 26.15 2.17 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.904 0.859 . . . . 75.21 109.858 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -160.32 111.1 1.86 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.149 -0.932 . . . . 73.35 109.839 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.41 177.72 15.4 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 111.819 -0.512 . . . . 71.32 111.819 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -88.43 13.9 2.43 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.064 2.509 . . . . 62.4 112.46 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.02 -170.46 29.05 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.83 -0.508 . . . . 74.25 111.83 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 p -82.99 118.36 23.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.567 0.222 . . . . 74.41 110.822 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.506 ' HE1' ' HA ' ' A' ' 22' ' ' MET . 2.8 mmt -78.13 -49.01 14.71 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.296 -0.631 . . . . 55.12 109.296 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.422 HG12 ' OE2' ' A' ' 64' ' ' GLU . 3.6 mm -82.84 81.74 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.55 -0.908 . . . . 72.23 108.55 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 77' ' ' TYR . 7.4 tp10 -69.47 161.54 29.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.728 -0.669 . . . . 72.42 111.807 -170.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.75 138.69 33.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.01 -0.541 . . . . 74.35 110.901 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.7 pt -148.53 169.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.18 0.514 . . . . 71.42 111.158 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.15 -163.95 11.46 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 109.922 -1.271 . . . . 53.41 109.922 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -63.33 -39.64 95.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 117.56 0.68 . . . . 75.31 110.298 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -64.47 -38.35 90.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.576 -0.738 . . . . 72.14 111.706 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -83.89 -29.08 27.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.688 -0.233 . . . . 64.21 110.897 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -47.61 -61.64 1.83 Allowed 'General case' 0 C--O 1.238 0.471 0 O-C-N 123.482 0.489 . . . . 70.43 111.426 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -56.08 -45.1 79.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 75.15 110.928 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -58.46 -53.8 54.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.0 -0.545 . . . . 73.04 111.206 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -65.31 -38.72 91.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.066 -0.516 . . . . 70.21 111.117 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.522 ' HA ' HG13 ' A' ' 44' ' ' ILE . 56.8 t -72.64 -42.01 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.302 0.482 . . . . 73.22 112.302 -176.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.2 p -85.96 -45.29 11.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.116 0.413 . . . . 70.32 112.116 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t -86.87 10.47 16.02 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.28 -0.418 . . . . 73.44 112.096 -172.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.561 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 7.5 p -71.29 81.49 0.74 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.88 0.371 . . . . 71.51 111.261 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 29.9 -93.89 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.776 1.231 . . . . 72.34 113.355 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -161.72 132.32 5.04 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.637 0.375 . . . . 74.41 110.526 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 54.98 14.69 0.98 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.544 0.572 . . . . 64.12 112.544 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.9 mm -74.45 115.55 15.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.857 0.36 . . . . 74.02 110.13 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.43 HD11 ' O ' ' A' ' 102' ' ' PHE . 42.2 tp -76.55 110.29 10.99 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.475 0.655 . . . . 73.12 110.72 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.522 HG13 ' HA ' ' A' ' 35' ' ' VAL . 23.6 mm -88.98 117.63 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.873 -1.058 . . . . 70.04 109.744 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.452 HD11 HG13 ' A' ' 74' ' ' VAL . 4.8 mp -106.68 127.85 53.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.439 -0.949 . . . . 52.51 108.439 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 57.6 t -110.97 104.39 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.273 -0.64 . . . . 74.02 109.273 175.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.02 114.37 28.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.744 -0.662 . . . . 73.04 110.141 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -76.82 133.28 39.42 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.3 -0.409 . . . . 72.32 110.03 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -116.51 168.04 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.839 -0.619 . . . . 72.1 111.165 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . . . -161.32 130.46 3.15 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.669 . . . . 72.03 109.77 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 50' ' ' ALA . 25.7 Cg_exo -63.75 -14.18 41.36 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.732 2.288 . . . . 65.54 111.816 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 31.6 t90 -118.14 80.6 1.54 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.563 -0.744 . . . . 72.21 109.446 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 56' ' ' CYS . 41.2 t -164.97 119.06 1.28 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.688 -0.687 . . . . 75.13 110.074 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.03 -63.31 5.17 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 116.273 -0.421 . . . . 31.21 113.226 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.453 ' O ' HD22 ' A' ' 59' ' ' LEU . 40.8 Cg_exo -57.06 -47.91 20.66 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.567 2.178 . . . . 75.32 111.986 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 36.4 m -50.91 -33.62 25.01 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.865 -0.607 . . . . 74.2 111.74 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -65.06 -36.93 85.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 73.34 110.69 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.637 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 28.7 t -74.57 -30.53 61.75 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.652 0.739 . . . . 71.33 110.128 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.506 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 mm? -64.29 -20.73 66.27 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.76 -0.654 . . . . 62.15 110.872 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.503 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 54.5 mt-10 -54.92 -67.11 0.73 Allowed Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.767 -0.457 . . . . 64.54 109.767 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.908 ' HG3' ' HB2' ' A' ' 7' ' ' HIS . 53.6 Cg_endo -66.64 -37.27 22.28 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 121.735 1.623 . . . . 62.53 112.387 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.637 ' HG3' ' O ' ' A' ' 58' ' ' SER . 40.2 mt-30 -59.98 -55.9 28.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.355 -0.538 . . . . 74.51 111.062 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.58 -51.85 63.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.522 -0.308 . . . . 72.24 111.117 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.554 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 15.8 mm-40 -50.73 -45.63 58.78 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.86 0.362 . . . . 70.32 110.94 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' CB ' ' HZ3' ' A' ' 65' ' ' LYS . 4.4 ttpm? -69.04 -47.63 64.89 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.387 -0.369 . . . . 74.04 111.252 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.532 HD12 HD13 ' A' ' 116' ' ' ILE . 16.9 mt -62.29 -31.34 71.92 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.632 -0.427 . . . . 73.14 110.455 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 71' ' ' THR . . . -66.55 -47.33 73.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.792 -0.447 . . . . 55.41 109.792 175.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 96.5 mt-30 -59.79 -30.59 69.0 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.101 0.477 . . . . 75.31 110.801 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -76.33 -45.22 33.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.047 -0.524 . . . . 73.22 111.086 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -103.75 5.21 35.97 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.928 0.714 . . . . 72.44 112.928 -169.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.89 -19.41 2.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.705 0.402 . . . . 75.13 112.072 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -55.14 -40.48 70.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 74.21 110.708 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -127.58 -5.88 5.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.82 -0.627 . . . . 74.11 111.398 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.452 HG13 HD11 ' A' ' 45' ' ' LEU . 42.1 t -117.06 136.28 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.921 0.391 . . . . 71.24 111.485 -175.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -141.33 120.11 12.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.686 -0.688 . . . . 64.21 109.52 173.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.419 HG22 HG21 ' A' ' 23' ' ' ILE . 50.0 mt -99.55 143.02 14.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.367 -0.379 . . . . 63.41 109.994 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 24' ' ' GLU . 96.8 m-85 -135.61 154.55 51.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.839 -0.618 . . . . 75.45 109.877 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -141.26 144.1 34.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.302 -0.629 . . . . 63.03 109.302 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 tt -77.03 135.43 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.303 -0.408 . . . . 72.41 110.317 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -107.25 -37.54 6.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.105 -0.498 . . . . 73.4 110.411 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.495 ' N ' HD11 ' A' ' 81' ' ' ILE . 2.8 mp -81.43 103.43 8.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.906 -0.588 . . . . 74.32 110.387 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.1 -25.22 61.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 63.32 111.806 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.23 -21.22 62.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.641 0.258 . . . . 75.44 111.187 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -102.3 12.88 35.97 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.594 -0.275 . . . . 72.1 111.511 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -69.8 -9.38 54.43 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.032 0.444 . . . . 74.32 110.094 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -54.46 -30.92 54.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.434 -0.803 . . . . 71.22 110.591 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -53.03 -38.82 30.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.754 -0.657 . . . . 71.34 110.409 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.438 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . . . -57.3 -54.48 46.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.38 -0.827 . . . . 62.03 110.547 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -60.41 -39.33 87.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.624 -0.716 . . . . 73.44 110.769 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -64.37 -44.87 90.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.741 -0.663 . . . . 75.54 111.831 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -80.09 -22.69 41.92 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.664 -0.244 . . . . 74.12 111.358 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.61 48.6 0.73 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.873 -0.679 . . . . 74.25 113.178 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 88' ' ' ALA . 88.5 t -94.61 111.44 25.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.934 -0.395 . . . . 74.23 109.934 176.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.2 t -110.32 19.74 18.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.286 -0.415 . . . . 65.41 111.082 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.78 149.42 30.5 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.069 -0.345 . . . . 73.2 110.069 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.64 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 62.6 mt -61.36 -54.93 48.22 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 123.011 0.195 . . . . 64.42 110.865 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.64 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 86.3 Cg_endo -86.68 98.2 0.52 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.781 1.654 . . . . 64.15 111.234 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 m -140.42 142.61 35.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.431 . . . . 75.41 110.327 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.629 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -113.25 117.99 56.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 73.23 110.268 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.406 HD23 ' HG3' ' A' ' 110' ' ' GLN . 98.7 mt -94.17 122.95 37.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.507 -0.923 . . . . 75.41 108.507 172.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.434 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 51.2 mtp -100.2 146.9 26.31 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.919 -0.4 . . . . 70.31 109.919 -177.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.556 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 98.6 m-85 -149.56 161.87 41.3 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.51 -0.552 . . . . 75.4 109.51 176.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -151.34 107.17 3.39 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.294 -0.254 . . . . 72.3 111.101 176.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.561 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 3.1 t-20 55.42 35.9 26.0 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.282 0.563 . . . . 63.0 111.273 173.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.33 -16.33 56.25 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.08 -0.509 . . . . 71.22 112.756 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -79.95 143.82 33.85 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.546 -0.538 . . . . 71.42 109.546 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -67.91 162.57 23.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.263 0.554 . . . . 73.13 110.949 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.556 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.61 168.3 21.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.763 -1.108 . . . . 72.33 108.117 -164.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -70.27 179.75 2.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.592 0.711 . . . . 75.02 112.458 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.406 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.8 tt0 -139.73 118.91 12.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.403 -0.817 . . . . 73.35 109.446 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.629 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.0 t -97.54 113.18 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 74.54 110.552 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.0 mp -88.22 108.37 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.394 -0.595 . . . . 74.14 109.394 177.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.85 143.24 10.65 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.775 -0.53 . . . . 52.15 111.775 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.506 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -74.65 72.04 1.94 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.936 0.398 . . . . 71.15 110.155 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.419 ' O ' HG13 ' A' ' 119' ' ' ILE . 19.4 t70 -111.08 105.35 14.06 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.893 -0.594 . . . . 73.22 110.69 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.532 HD13 HD12 ' A' ' 66' ' ' LEU . 0.2 OUTLIER -59.08 -31.98 46.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.301 -0.863 . . . . 62.11 110.209 -176.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 m -62.4 -55.79 24.52 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.349 -0.387 . . . . 71.13 110.931 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -63.57 -41.34 98.39 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.544 0.212 . . . . 63.31 110.461 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 123' ' ' ILE . 80.6 mt -56.21 -56.28 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.307 -0.406 . . . . 64.31 110.482 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.75 -33.9 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.481 -0.327 . . . . 54.05 110.662 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.7 m -57.84 -49.49 76.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.433 -0.349 . . . . 74.12 110.242 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -69.74 -36.44 75.83 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.464 -0.335 . . . . 72.3 110.924 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 119' ' ' ILE . 70.8 mt -56.08 -55.95 15.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 64.31 109.779 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -58.49 -42.47 87.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.546 -0.752 . . . . 71.24 110.495 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -60.59 -33.7 73.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.319 -0.855 . . . . 75.22 111.263 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -102.42 -9.52 20.21 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.961 0.726 . . . . 72.55 112.961 -175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.5 mt -89.75 -60.51 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.705 -0.398 . . . . 73.13 110.35 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.158 -0.925 . . . . 74.5 110.154 -178.069 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.449 ' H3 ' ' HB2' ' A' ' 115' ' ' ASP . 8.0 tpt . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.766 -0.457 . . . . 71.43 109.766 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.83 155.01 16.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.34 -0.391 . . . . 52.41 111.107 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -144.64 103.82 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 64.41 110.072 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.458 ' HB3' ' OG ' ' A' ' 58' ' ' SER . 9.2 t60 -113.47 -75.73 0.59 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.218 -0.29 . . . . 71.32 110.218 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -147.03 -172.0 3.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 110.257 -0.275 . . . . 74.44 110.257 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -130.68 97.79 4.46 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.113 0.483 . . . . 75.41 112.001 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.458 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 11.9 m170 -106.52 -160.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.939 -1.134 . . . . 75.5 107.939 170.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -179.44 133.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.002 -0.37 . . . . 72.01 110.002 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.607 ' HE1' ' HG3' ' A' ' 64' ' ' GLU . 21.6 mmt -92.18 131.78 37.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.207 -0.451 . . . . 71.21 109.824 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.05 -47.86 43.48 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.315 -0.714 . . . . 73.21 111.315 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -172.12 157.61 4.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.82 -0.437 . . . . 73.01 109.82 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 21' ' ' SER . 31.9 tp -132.72 78.96 1.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.376 0.607 . . . . 71.42 109.994 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -103.88 -158.44 0.67 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.889 -1.051 . . . . 72.34 108.607 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.18 78.66 0.09 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.118 0.485 . . . . 63.13 109.859 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -79.57 138.67 37.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.745 -0.661 . . . . 73.25 110.321 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.8 m -77.72 73.9 4.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.168 0.509 . . . . 75.21 110.072 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -176.88 109.37 0.08 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.6 -0.727 . . . . 73.35 110.098 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.67 -124.75 37.11 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.338 -0.458 . . . . 71.32 112.827 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.549 ' HG3' ' HE3' ' A' ' 22' ' ' MET . 78.8 Cg_endo -83.69 -179.46 4.17 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.989 2.459 . . . . 62.4 112.251 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.2 -121.16 4.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.212 -0.518 . . . . 74.25 112.247 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.409 ' HA ' ' HG ' ' A' ' 12' ' ' LEU . 9.1 p -75.26 93.47 2.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 74.41 111.911 -176.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.549 ' HE3' ' HG3' ' A' ' 19' ' ' PRO . 13.5 mmt -64.85 -70.4 0.23 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.373 0.606 . . . . 55.12 109.418 170.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.428 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 8.3 mm -70.49 80.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.908 -1.042 . . . . 72.23 108.785 172.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 9.0 tp10 -66.51 157.01 33.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.247 -0.433 . . . . 72.42 111.211 -175.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.27 136.88 48.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.442 0.297 . . . . 74.35 110.718 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 31' ' ' PHE . 37.9 pt -147.38 176.26 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.001 0.429 . . . . 71.42 110.992 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.25 -167.27 11.9 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.915 -0.874 . . . . 53.41 110.915 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.22 -50.68 68.79 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.956 0.407 . . . . 75.31 111.425 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -68.94 -32.54 72.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.884 -0.598 . . . . 72.14 112.169 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -80.78 -22.43 40.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.823 -0.172 . . . . 64.21 110.783 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.45 ' HA ' HD12 ' A' ' 26' ' ' ILE . 91.9 t80 -51.88 -61.96 1.93 Allowed 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.52 0.513 . . . . 70.43 111.383 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -57.41 -47.17 82.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.099 -0.501 . . . . 75.15 110.653 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -56.15 -54.44 45.15 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.537 -0.756 . . . . 73.04 111.278 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -67.44 -33.03 74.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 70.21 111.343 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.5 HG11 ' HA2' ' A' ' 105' ' ' GLY . 65.5 t -72.03 -38.2 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.463 -0.335 . . . . 73.22 111.758 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -85.99 -41.82 14.54 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.024 0.44 . . . . 70.32 112.028 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 t -83.26 11.54 6.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.112 -0.494 . . . . 73.44 111.788 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 13.8 p -72.26 82.58 1.02 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.78 0.324 . . . . 71.51 111.85 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.0 t30 41.52 -93.65 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.367 -0.833 . . . . 72.34 112.462 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -162.04 121.94 2.47 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 110.412 -0.218 . . . . 74.41 110.412 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.432 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 48.0 m-80 55.36 18.96 2.8 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.779 0.659 . . . . 64.12 112.779 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.1 mm -71.96 133.62 31.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 120.893 0.378 . . . . 74.02 110.759 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.424 HD21 HG22 ' A' ' 74' ' ' VAL . 31.2 tp -80.28 114.97 19.57 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.828 -0.624 . . . . 73.12 110.389 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.491 HG23 HG22 ' A' ' 35' ' ' VAL . 29.1 mm -95.27 118.9 42.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 70.04 110.396 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.528 HD13 HG13 ' A' ' 74' ' ' VAL . 5.5 mp -104.19 125.25 50.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.384 -0.969 . . . . 52.51 108.384 170.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.446 HG23 ' HE1' ' A' ' 31' ' ' PHE . 59.3 t -112.08 104.47 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.454 -0.573 . . . . 74.02 109.454 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.47 118.3 35.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.659 -0.701 . . . . 73.04 110.806 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -73.97 89.77 1.93 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.369 0.604 . . . . 72.32 109.652 174.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -65.27 150.03 48.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.983 -1.008 . . . . 72.1 111.336 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.79 116.88 5.83 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.757 -0.656 . . . . 72.03 109.549 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.41 -18.01 62.64 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.659 2.24 . . . . 65.54 111.972 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -115.43 86.38 2.45 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.716 -0.675 . . . . 72.21 109.208 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.2 t -169.09 105.04 0.39 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.757 -0.656 . . . . 75.13 110.306 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -54.15 -55.28 27.03 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.932 -0.576 . . . . 31.21 112.986 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.503 ' O ' HD23 ' A' ' 59' ' ' LEU . 52.3 Cg_exo -56.57 -50.61 11.29 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.566 2.177 . . . . 75.32 112.19 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 33.7 m -54.89 -33.81 62.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.293 -0.412 . . . . 74.2 111.077 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -62.09 -30.54 71.07 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.932 -0.576 . . . . 73.34 110.851 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.631 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 21.5 t -74.78 -35.93 62.53 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-O 122.007 0.908 . . . . 71.33 109.611 174.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' A' ' 114' ' ' ALA . 3.6 mm? -65.06 -26.2 68.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.775 -1.102 . . . . 62.15 110.763 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.496 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 46.2 mt-10 -53.52 -64.25 1.88 Allowed Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.681 -0.408 . . . . 64.54 109.998 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.496 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 46.2 Cg_endo -66.83 -39.17 15.33 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 121.699 1.599 . . . . 62.53 112.441 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 58' ' ' SER . 37.0 mt-30 -61.63 -46.2 90.83 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.107 -0.637 . . . . 74.51 111.236 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.49 -37.53 60.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.331 -0.395 . . . . 72.24 110.997 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.607 ' HG3' ' HE1' ' A' ' 9' ' ' MET . 3.0 mm-40 -57.31 -38.3 73.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.025 0.44 . . . . 70.32 110.132 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.91 -55.08 25.31 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.839 -0.619 . . . . 74.04 110.221 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.433 HD12 HD12 ' A' ' 116' ' ' ILE . 27.8 mt -60.94 -32.32 71.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.665 -0.698 . . . . 73.14 110.747 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.529 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.47 -53.71 26.49 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.154 -0.476 . . . . 55.41 109.937 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.7 mt-30 -59.1 -36.15 74.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.415 . . . . 75.31 111.04 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.94 -52.16 18.56 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.979 0.418 . . . . 73.22 111.374 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -95.22 4.7 53.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.618 0.599 . . . . 72.44 112.618 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.2 t -52.89 -22.86 6.03 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.816 0.673 . . . . 75.13 112.816 -170.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.3 -31.84 73.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.747 0.308 . . . . 74.21 110.818 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -125.69 -0.26 7.42 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.377 -0.374 . . . . 74.11 110.891 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.528 HG13 HD13 ' A' ' 45' ' ' LEU . 36.6 t -127.94 136.16 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.958 0.408 . . . . 71.24 111.421 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 71' ' ' THR . 39.8 mmtm -141.89 131.45 23.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.934 -0.575 . . . . 64.21 109.604 172.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.7 mt -104.97 143.12 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 63.41 110.444 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -131.46 143.35 50.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.077 -0.51 . . . . 75.45 110.156 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 25.1 pttm -124.18 127.84 48.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.943 -0.571 . . . . 63.03 109.667 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.7 tt -80.09 107.18 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.157 0.503 . . . . 72.41 109.67 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -86.08 -31.96 21.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.234 -0.439 . . . . 73.4 111.084 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.518 ' N ' HD13 ' A' ' 81' ' ' ILE . 3.0 mp -81.56 85.83 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.32 0.581 . . . . 74.32 110.286 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -27.34 62.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.359 -0.837 . . . . 63.32 111.277 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.36 -21.97 61.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 75.44 111.064 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -113.44 41.22 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 72.1 110.172 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -80.63 22.5 0.58 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.858 -0.61 . . . . 74.32 111.149 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 37.3 t70 -54.03 -35.93 62.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.625 0.37 . . . . 71.22 110.714 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.3 t -52.74 -40.33 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.709 -0.678 . . . . 71.34 110.539 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.42 -54.32 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 62.03 110.51 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 m -62.88 -29.63 70.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 73.44 110.967 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 33.6 mm-40 -69.13 -56.04 8.87 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.343 -0.39 . . . . 75.54 111.174 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -75.0 -9.54 58.63 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.791 0.329 . . . . 74.12 111.231 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.81 45.4 7.77 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.031 -0.604 . . . . 74.25 112.498 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.0 103.58 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.543 -0.54 . . . . 74.23 109.543 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.7 t -86.37 -52.36 5.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.298 -0.41 . . . . 65.41 109.928 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.19 150.99 46.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.251 -0.431 . . . . 73.2 110.092 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.661 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 66.4 mt -72.97 -59.53 2.17 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 119.742 -0.171 . . . . 64.42 111.145 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.661 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 86.6 Cg_endo -82.74 63.62 8.0 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.952 1.768 . . . . 64.15 112.01 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.5 m -100.92 145.67 28.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.121 -0.49 . . . . 75.41 110.486 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.585 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -112.16 122.67 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 73.23 110.265 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.495 HD23 ' HG3' ' A' ' 110' ' ' GLN . 84.7 mt -93.2 123.12 36.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.906 -0.776 . . . . 75.41 108.906 173.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 109' ' ' SER . 42.0 mtp -98.29 143.22 29.0 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.778 -0.453 . . . . 70.31 109.778 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.628 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.5 m-85 -149.09 161.39 42.04 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.328 -0.619 . . . . 75.4 109.328 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -142.63 109.3 5.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.034 -0.266 . . . . 72.3 110.646 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.542 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 60.6 t30 57.03 29.01 15.74 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.353 0.596 . . . . 63.0 111.061 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.5 ' HA2' HG11 ' A' ' 35' ' ' VAL . . . 89.4 -2.72 83.42 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.235 -0.507 . . . . 71.22 112.92 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -91.7 146.79 23.48 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.784 -0.45 . . . . 71.42 109.784 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -60.84 154.62 21.56 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.277 0.561 . . . . 73.13 112.117 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.628 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.16 167.62 23.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.695 -1.138 . . . . 72.33 108.217 -169.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 101' ' ' MET . 5.2 m -70.99 171.48 10.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.744 0.783 . . . . 75.02 112.692 -170.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.495 ' HG3' HD23 ' A' ' 100' ' ' LEU . 26.8 tt0 -126.04 127.28 45.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.233 -0.894 . . . . 73.35 109.775 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 61.3 t -97.52 107.61 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.074 -0.343 . . . . 74.54 110.074 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.492 HD13 ' N ' ' A' ' 112' ' ' ILE . 2.9 mp -81.46 106.95 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 74.14 109.906 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.56 136.7 7.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.297 -0.477 . . . . 52.15 112.142 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.513 ' HB3' ' HG ' ' A' ' 59' ' ' LEU . . . -57.61 92.13 0.01 OUTLIER 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.929 0.395 . . . . 71.15 110.814 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.449 ' HB2' ' H3 ' ' A' ' 1' ' ' MET . 12.4 t70 -127.22 99.33 5.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 73.22 109.963 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.486 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -59.07 -33.68 51.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.846 -0.616 . . . . 62.11 110.728 -174.389 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.8 m -61.06 -54.02 49.88 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.755 0.312 . . . . 71.13 110.487 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -63.71 -40.88 97.87 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.57 -0.286 . . . . 63.31 110.543 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.6 mt -58.76 -55.06 25.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.145 -0.48 . . . . 64.31 110.683 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.9 tt -63.33 -34.11 65.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 116.617 -0.265 . . . . 54.05 110.341 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.6 m -59.44 -45.69 90.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.668 0.27 . . . . 74.12 110.318 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -69.99 -38.05 75.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.625 -0.261 . . . . 72.3 111.186 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.0 mt -57.14 -53.72 39.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.956 0.408 . . . . 64.31 110.012 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -59.59 -39.58 84.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.755 -0.657 . . . . 71.24 109.988 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -63.65 -31.86 73.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.652 -0.703 . . . . 75.22 111.511 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -90.11 -30.12 17.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.184 0.438 . . . . 72.55 112.184 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 74' ' ' VAL . 68.5 mt -86.31 -45.97 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.059 0.457 . . . . 73.13 110.577 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.44 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.455 -0.783 . . . . 74.5 109.65 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.808 -0.441 . . . . 74.05 109.808 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.72 115.25 11.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.652 0.263 . . . . 71.21 111.021 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -78.03 60.56 2.41 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.45 0.643 . . . . 75.43 109.861 176.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.94 138.5 57.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.882 -1.054 . . . . 63.3 111.553 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -157.83 137.47 12.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.772 -0.649 . . . . 74.54 109.547 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -143.44 128.15 18.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.409 -0.589 . . . . 73.43 109.409 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -74.78 122.29 23.09 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.532 -0.544 . . . . 70.45 109.532 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -79.18 105.52 10.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 74.34 110.236 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.6 ttt -120.55 88.11 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.584 -0.735 . . . . 74.15 109.163 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.0 43.76 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.625 -0.59 . . . . 62.2 111.625 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.2 p -81.92 97.99 8.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.332 . . . . 74.44 110.206 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -157.68 111.96 2.61 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.223 -0.658 . . . . 62.52 109.223 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.81 177.4 7.98 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.465 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.84 167.18 21.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.139 -0.482 . . . . 72.22 110.505 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -138.19 144.1 40.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.407 -0.59 . . . . 65.21 109.407 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -149.71 -179.94 7.51 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.716 0.293 . . . . 63.31 110.855 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -126.21 167.44 15.43 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.335 -0.393 . . . . 73.24 111.012 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.55 177.71 52.58 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 116.093 -0.503 . . . . 43.33 113.092 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.69 -3.6 13.98 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.155 2.57 . . . . 63.0 112.482 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.17 -88.25 0.53 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 121.321 -0.466 . . . . 21.13 112.751 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 p -87.1 152.85 22.0 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.8 0.334 . . . . 74.02 111.241 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.426 ' HG3' ' CG ' ' A' ' 68' ' ' GLN . 93.9 mmm -90.55 -29.48 17.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.075 -0.511 . . . . 72.34 109.898 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.434 HG12 ' OE2' ' A' ' 64' ' ' GLU . 32.9 mm -67.83 99.38 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.587 -0.894 . . . . 71.0 108.587 174.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 16.2 tt0 -74.85 112.36 10.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.342 0.592 . . . . 75.23 109.936 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.445 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 8.5 tt0 -88.99 131.14 35.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.488 -0.778 . . . . 62.01 110.717 -170.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.525 HG21 ' HG3' ' A' ' 34' ' ' LYS . 47.6 pt -144.94 -179.85 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.756 0.312 . . . . 73.51 111.201 -175.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.64 -174.42 15.6 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.209 -0.451 . . . . 71.54 112.534 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.455 ' OD1' HG21 ' A' ' 87' ' ' VAL . 20.0 t70 -50.84 -57.01 9.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.502 0.721 . . . . 71.11 112.649 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -69.25 -27.13 65.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 71.5 110.919 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -74.21 -15.59 61.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 65.01 110.642 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -52.56 -61.38 2.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.912 -0.586 . . . . 73.14 111.017 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -55.21 -53.43 56.1 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.433 -0.349 . . . . 60.1 111.167 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -53.34 -55.92 20.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.844 -0.616 . . . . 70.33 111.211 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.705 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 11.0 mmpt? -61.66 -45.61 93.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.864 -0.607 . . . . 71.23 111.33 -176.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.429 ' HA ' HD11 ' A' ' 44' ' ' ILE . 70.4 t -64.29 -40.66 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.448 -0.342 . . . . 74.33 111.347 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.1 p -78.26 -25.02 46.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.703 0.287 . . . . 72.0 111.009 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -61.78 -14.95 37.21 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.261 -0.427 . . . . 75.51 111.459 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 22.8 p -49.48 114.45 1.04 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 123.148 0.28 . . . . 73.23 110.798 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.8 -70.3 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.164 -0.471 . . . . 74.43 111.183 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -156.01 122.17 5.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.374 -0.375 . . . . 73.41 110.474 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 58.82 17.69 5.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.94 -0.573 . . . . 74.31 111.655 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.4 mm -74.74 97.96 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.661 -0.496 . . . . 74.53 109.661 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.81 111.47 9.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.708 -0.678 . . . . 64.44 109.499 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 35' ' ' VAL . 58.3 mt -101.51 115.1 42.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.181 -0.918 . . . . 62.33 110.459 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.1 mp -103.07 106.41 16.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.817 -0.628 . . . . 72.1 109.619 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.81 105.0 16.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.731 -0.213 . . . . 73.52 110.47 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -83.16 151.44 25.7 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.142 0.496 . . . . 65.24 110.688 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -71.69 170.81 12.73 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.63 -0.713 . . . . 73.45 111.694 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -61.12 105.04 0.44 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.665 -0.698 . . . . 73.22 110.129 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -161.04 97.48 1.34 Allowed Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.731 -0.668 . . . . 75.44 109.669 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.37 -18.04 7.33 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.95 2.433 . . . . 72.24 111.947 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -166.74 137.36 3.24 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.912 -0.586 . . . . 74.3 109.816 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.46 156.28 8.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 72.23 110.141 175.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -43.21 -72.49 0.31 Allowed Glycine 0 C--N 1.335 0.502 0 O-C-N 123.683 0.614 . . . . 41.43 114.236 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.487 ' O ' HD23 ' A' ' 59' ' ' LEU . 41.8 Cg_endo -66.31 -22.07 53.51 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.412 2.075 . . . . 74.31 112.2 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.539 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 31.6 m -65.35 -19.06 65.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.027 -0.533 . . . . 71.34 111.216 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -54.05 -48.22 70.81 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.306 -0.406 . . . . 65.43 110.085 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.567 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 38.9 t -75.59 -44.0 45.34 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.527 0.68 . . . . 62.42 111.478 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -60.65 -45.59 93.53 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.852 0.686 . . . . 75.15 112.852 -171.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.52 -56.31 28.24 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 117.609 0.186 . . . . 74.24 111.171 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 58' ' ' SER . 18.9 Cg_endo -60.25 -40.49 58.9 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.781 1.654 . . . . 74.34 112.087 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 58' ' ' SER . 36.8 mt-30 -58.31 -39.1 78.47 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.681 -0.408 . . . . 63.34 111.756 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.43 -41.35 80.47 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.009 -0.367 . . . . 70.3 110.009 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 19.7 mm-40 -59.47 -41.14 89.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 73.51 110.415 174.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.651 ' HZ3' ' HB2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -60.56 -57.13 14.04 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.379 0.609 . . . . 63.23 110.329 178.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.45 -28.76 70.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.489 -0.778 . . . . 72.31 110.232 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.536 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.08 -50.6 65.5 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.123 -0.49 . . . . 61.24 109.869 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 91.4 mt-30 -59.77 -41.22 90.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.028 -0.533 . . . . 74.51 111.115 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -74.32 -54.87 6.77 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.011 0.434 . . . . 64.12 111.288 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -84.81 4.4 33.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.894 -0.594 . . . . 72.13 112.475 -172.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.7 t -52.97 -19.57 2.73 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 111.887 0.329 . . . . 63.51 111.887 -173.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -58.71 -38.92 79.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 52.23 110.585 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -134.89 10.95 3.63 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.225 -0.443 . . . . 74.14 111.407 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 127' ' ' ILE . 31.8 t -128.83 142.14 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.22 0.533 . . . . 62.51 112.347 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -143.6 119.97 10.93 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.194 -0.912 . . . . 72.13 109.762 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.473 HD11 ' N ' ' A' ' 76' ' ' ILE . 3.6 mp -98.75 136.74 28.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 109.614 -0.513 . . . . 74.31 109.614 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 77.3 m-85 -124.31 164.52 19.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 72.2 109.912 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -153.4 132.58 12.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 74.32 109.638 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 64.9 mt -75.51 118.43 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.885 -0.413 . . . . 73.12 109.885 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.445 ' HB3' ' CG ' ' A' ' 25' ' ' GLN . 4.2 p-10 -91.46 -40.34 11.46 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.801 0.334 . . . . 74.35 111.379 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.4 tt -83.54 99.24 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.732 0.777 . . . . 72.31 110.971 -174.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -17.51 62.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.418 -0.81 . . . . 73.31 111.663 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -70.2 -27.05 64.19 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.572 -0.529 . . . . 74.31 109.572 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 16.0 m120 -128.13 86.9 2.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.885 -0.598 . . . . 75.34 109.894 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -138.41 27.94 2.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.728 -0.669 . . . . 65.05 109.495 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 33.8 t70 -56.76 -35.32 68.5 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.187 -0.915 . . . . 65.35 111.709 -172.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.455 HG21 ' OD1' ' A' ' 28' ' ' ASP . 90.2 t -52.53 -35.98 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.073 0.463 . . . . 73.54 110.489 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.68 71.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.941 -0.572 . . . . 65.34 110.497 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.8 m -59.67 -37.94 80.13 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.286 0.565 . . . . 74.13 110.492 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 19.8 mm-40 -64.5 -48.23 75.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.43 -0.804 . . . . 72.12 110.798 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -76.74 -18.3 58.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.56 -0.291 . . . . 73.01 111.155 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.32 36.51 8.11 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 121.365 -0.445 . . . . 71.23 112.922 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.86 117.99 39.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 122.411 0.284 . . . . 75.44 110.422 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.6 m -133.4 13.75 4.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.921 0.391 . . . . 75.23 110.776 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.19 136.23 39.45 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.549 -0.537 . . . . 73.11 109.549 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.719 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 49.3 mm -56.19 -54.91 47.55 Favored Pre-proline 0 CA--C 1.542 0.642 0 O-C-N 123.274 0.359 . . . . 71.24 111.679 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.719 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 94.5 Cg_endo -94.2 105.3 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.295 1.996 . . . . 61.25 111.322 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.504 HG21 HG13 ' A' ' 112' ' ' ILE . 27.9 m -148.53 118.24 7.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.284 -0.265 . . . . 71.54 110.284 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.428 ' N ' HD13 ' A' ' 99' ' ' ILE . 3.1 mp -109.51 110.71 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.189 -0.46 . . . . 63.34 109.949 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.473 HD11 ' N ' ' A' ' 100' ' ' LEU . 5.5 mp -92.46 123.3 35.67 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.176 -0.676 . . . . 75.34 109.176 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 53.3 mtp -98.73 142.31 30.43 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.854 -0.424 . . . . 63.4 109.854 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.563 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.8 m-85 -144.89 151.03 38.08 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.549 -0.537 . . . . 70.31 109.549 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -149.32 123.56 9.55 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.741 -0.384 . . . . 61.5 110.984 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.627 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.5 m-20 62.21 25.45 15.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.265 0.555 . . . . 71.32 110.325 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.71 -2.89 52.56 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.775 -0.648 . . . . 75.02 111.988 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -88.17 145.06 26.11 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.846 -0.428 . . . . 65.04 109.846 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.577 ' HZ3' ' HB2' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -59.48 145.61 43.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 124.047 0.842 . . . . 74.45 110.903 -176.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -150.67 168.02 25.57 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.182 -1.414 . . . . 74.23 107.182 -170.188 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.3 m -70.29 177.89 3.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.19 0.519 . . . . 51.33 112.352 -165.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -142.49 119.38 11.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 60.43 110.057 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -100.63 107.42 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.248 -0.433 . . . . 72.53 110.112 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.532 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -96.16 121.6 46.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.304 -0.628 . . . . 71.32 109.304 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.87 162.5 32.26 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.794 -0.523 . . . . 41.41 111.794 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.66 89.93 2.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.753 0.311 . . . . 71.33 111.175 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 57.4 t0 -132.45 82.23 2.0 Allowed 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.681 0.753 . . . . 75.0 109.848 174.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.87 -29.04 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 114.993 -1.003 . . . . 74.45 110.021 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.4 m -60.82 -50.33 73.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.615 -0.513 . . . . 52.41 109.615 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.798 ' HZ2' ' HB2' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -61.68 -46.3 90.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.648 -0.706 . . . . 53.54 110.183 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 123' ' ' ILE . 78.3 mt -55.57 -56.54 11.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.762 -0.654 . . . . 61.35 111.201 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -66.69 -34.7 71.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.374 -0.376 . . . . 53.31 110.629 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.3 t -59.3 -51.88 68.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.885 -0.413 . . . . 75.45 109.885 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -63.67 -36.01 82.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.435 -0.348 . . . . 75.05 111.232 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.1 mt -56.56 -56.28 14.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.05 0.452 . . . . 71.01 110.41 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -69.6 -29.06 66.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 73.23 110.682 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -65.88 -43.8 87.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 64.45 110.887 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -93.41 -17.95 22.92 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.541 0.571 . . . . 55.14 112.541 -172.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.554 HD11 HG21 ' A' ' 74' ' ' VAL . 58.6 mt -78.27 -59.83 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 120.543 -0.463 . . . . 64.11 110.284 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.303 -0.856 . . . . 75.03 110.205 -176.459 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.885 0.374 . . . . 74.24 110.843 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.25 14.49 2.11 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.094 0.775 . . . . 52.12 113.094 172.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -102.49 111.04 23.18 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.827 0.346 . . . . 73.31 110.864 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -78.48 89.01 4.44 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.885 -0.783 . . . . 73.04 108.885 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -70.01 168.78 14.71 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.67 0.619 . . . . 73.52 112.67 -173.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -74.57 140.54 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.784 -1.098 . . . . 64.12 111.023 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -120.48 -53.43 2.11 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.493 0.183 . . . . 61.01 111.493 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -63.87 89.84 0.05 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.805 0.336 . . . . 75.31 110.916 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.8 ttt -104.37 78.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.596 -0.52 . . . . 73.14 109.596 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.91 95.26 1.95 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.631 -0.713 . . . . 34.51 111.905 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -99.64 147.3 25.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.993 0.425 . . . . 72.23 111.103 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 85' ' ' GLN . 3.1 mm? -123.62 -167.85 1.69 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.854 -0.795 . . . . 74.12 108.854 174.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.99 111.31 8.47 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.873 0.368 . . . . 74.24 110.37 174.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -176.17 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.211 -0.449 . . . . 52.52 111.843 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -65.68 106.67 1.54 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.421 0.629 . . . . 74.51 110.942 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.2 p -109.09 123.01 48.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 74.23 109.967 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -88.84 -75.19 0.44 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.857 0.361 . . . . 60.52 111.021 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.05 -163.43 33.18 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 111.424 -0.67 . . . . 75.51 111.424 -174.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.1 -45.85 5.28 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.473 2.115 . . . . 74.44 111.482 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.12 29.96 63.27 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.623 -0.717 . . . . 75.02 112.565 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.3 m -77.39 -38.94 48.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.995 0.426 . . . . 63.25 110.058 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.467 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 95.4 mmm -122.41 -1.55 9.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.961 -0.563 . . . . 75.44 110.591 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -111.85 126.16 69.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.206 -0.452 . . . . 63.52 110.422 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -87.4 151.37 23.13 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.446 -0.343 . . . . 72.55 110.618 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -114.83 129.68 56.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.436 -0.347 . . . . 71.32 110.067 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.522 HD13 ' HA ' ' A' ' 31' ' ' PHE . 45.7 pt -144.88 169.72 7.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.2 0.524 . . . . 75.43 111.751 -174.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' HA2' HD12 ' A' ' 79' ' ' ILE . . . -136.33 -173.71 13.06 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.298 -0.865 . . . . 64.33 111.274 174.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 7.3 t70 -45.16 -47.22 12.33 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.053 0.454 . . . . 72.1 111.353 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -62.61 -29.35 70.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.712 -0.676 . . . . 63.04 112.424 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -102.87 -17.77 15.38 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 122.395 -0.191 . . . . 53.33 111.435 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.522 ' HA ' HD13 ' A' ' 26' ' ' ILE . 88.4 t80 -50.49 -62.01 1.85 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 112.439 0.533 . . . . 70.01 112.439 -169.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.627 ' O ' HG21 ' A' ' 36' ' ' THR . 10.6 m-20 -56.96 -55.46 34.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 53.43 110.537 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -54.63 -55.84 25.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.731 -0.668 . . . . 62.02 111.447 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HG3' HG21 ' A' ' 26' ' ' ILE . 63.7 mmtt -57.74 -40.82 80.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 71.24 111.386 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.88 -59.72 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.47 -0.332 . . . . 74.11 111.326 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.627 HG21 ' O ' ' A' ' 32' ' ' ASP . 9.0 t -81.38 -0.27 40.55 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.62 -0.263 . . . . 62.32 111.522 -173.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.6 t -61.74 -19.25 62.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.047 0.451 . . . . 73.25 109.978 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.814 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 21.3 p -55.8 137.19 50.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.655 -0.702 . . . . 73.1 110.648 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -74.46 -72.22 0.3 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.453 0.168 . . . . 71.11 110.701 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -136.2 121.91 19.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.559 0.219 . . . . 72.01 111.372 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 48.78 26.56 1.3 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.515 0.726 . . . . 73.34 112.895 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.739 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.7 mm -71.22 126.15 31.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 110.009 -0.367 . . . . 63.01 110.009 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.513 HD11 HD12 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -75.63 107.49 7.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 72.03 109.641 -178.557 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.496 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 36.5 mm -92.64 133.3 34.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.225 -0.898 . . . . 74.23 109.887 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.513 HD12 HD11 ' A' ' 43' ' ' LEU . 4.1 mp -121.66 149.66 42.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.994 -0.743 . . . . 73.53 108.994 173.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 66.9 t -136.79 104.76 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.239 -0.652 . . . . 63.54 109.239 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -90.97 154.54 19.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.33 0.586 . . . . 65.51 110.499 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -131.4 111.69 12.05 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.345 -1.354 . . . . 74.43 107.345 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -120.84 141.78 50.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.241 0.543 . . . . 75.32 110.789 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.625 ' HB1' HG22 ' A' ' 96' ' ' ILE . . . -128.01 126.41 23.75 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.317 -0.856 . . . . 72.32 108.988 173.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.45 76.37 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.5 2.134 . . . . 73.11 111.927 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -163.94 27.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.704 0.764 . . . . 74.14 109.391 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 3.6 p -130.06 167.43 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.784 . . . . 74.12 110.521 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.95 -68.83 0.98 Allowed Glycine 0 CA--C 1.522 0.485 0 CA-C-N 116.205 -0.452 . . . . 72.42 112.853 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -52.95 -23.04 20.03 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.251 2.634 . . . . 75.01 113.507 -175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.657 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 3.6 p -61.7 -25.47 67.44 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.67 -0.241 . . . . 43.24 110.976 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.436 ' C ' ' HD3' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.14 -50.27 67.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.021 0.439 . . . . 72.03 110.016 176.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.688 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.6 m -75.06 -39.62 60.81 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.255 0.55 . . . . 74.42 110.646 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.657 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 3.2 mm? -58.59 -37.83 76.66 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.673 0.62 . . . . 70.33 112.673 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.409 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 45.1 mt-10 -56.85 -61.02 7.72 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.057 0.389 . . . . 74.22 110.988 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 18.3 Cg_endo -60.2 -38.9 73.11 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.599 1.533 . . . . 72.0 111.942 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.688 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.6 mt-30 -61.45 -41.15 96.76 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.688 -0.405 . . . . 75.24 111.012 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 66.7 mt -65.92 -50.91 62.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 63.14 110.302 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 22.7 mt-10 -65.04 -27.57 68.89 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.68 -0.408 . . . . 74.24 110.88 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -72.59 -49.45 32.18 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.819 0.343 . . . . 72.11 110.442 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.01 -31.55 72.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.841 -0.429 . . . . 62.51 109.841 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.37 -48.2 80.82 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.939 -0.573 . . . . 62.52 109.711 174.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.467 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 96.0 mt-30 -57.52 -42.21 82.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.902 0.382 . . . . 74.25 110.981 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -69.16 -42.67 75.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.593 . . . . 73.42 111.443 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -105.15 5.96 32.71 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.131 0.789 . . . . 74.13 113.131 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.5 t -52.98 -19.91 3.0 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.977 1.103 . . . . 65.11 113.977 -168.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -73.42 -29.24 62.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.016 0.436 . . . . 64.2 110.685 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -115.97 -13.85 11.26 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.669 -0.696 . . . . 71.12 111.346 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.425 HG22 HD12 ' A' ' 127' ' ' ILE . 35.5 t -120.43 133.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.791 0.329 . . . . 65.24 111.677 -173.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -136.16 119.81 17.17 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.769 -0.651 . . . . 71.03 109.299 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.43 HG12 HD13 ' A' ' 45' ' ' LEU . 43.3 mt -104.82 137.19 35.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.162 0.506 . . . . 72.55 110.639 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 73.9 m-85 -125.9 169.19 12.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.607 -0.886 . . . . 74.25 108.607 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.752 ' HZ1' ' HB3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -139.72 129.93 25.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.898 0.38 . . . . 75.4 110.54 172.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.515 HD12 ' HA2' ' A' ' 27' ' ' GLY . 5.7 tp -79.87 78.7 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.614 0.721 . . . . 75.41 109.252 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -112.54 -17.41 12.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.766 -0.652 . . . . 54.25 111.76 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.401 ' HB ' ' HA3' ' A' ' 27' ' ' GLY . 54.0 mt -64.46 92.44 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.464 0.65 . . . . 73.24 109.889 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 85' ' ' GLN . 10.3 pt-20 -54.72 -29.21 52.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.654 -1.157 . . . . 72.03 112.842 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.42 -19.25 62.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.394 0.616 . . . . 71.34 110.272 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 30.0 m-20 -134.66 42.81 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.068 -0.969 . . . . 74.34 108.943 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.555 ' HB3' HD23 ' A' ' 12' ' ' LEU . 17.5 tp60 -71.95 -14.73 61.99 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.895 -1.048 . . . . 71.21 111.464 -176.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 34.6 t70 -46.14 -39.66 9.87 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.288 0.847 . . . . 71.34 113.288 -168.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 80.0 t -52.94 -40.96 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.903 0.383 . . . . 74.52 111.313 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.14 93.11 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.101 -0.499 . . . . 73.04 110.36 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 m -69.79 -33.73 72.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.681 -0.69 . . . . 72.14 110.622 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 45.0 mt-30 -65.43 -56.52 12.05 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.153 -0.476 . . . . 74.13 110.622 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -70.53 -25.22 63.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.158 -0.474 . . . . 75.0 110.938 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.23 60.89 1.1 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.889 -0.672 . . . . 62.35 113.222 173.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -82.4 94.79 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.669 -0.493 . . . . 54.5 109.669 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 t -107.12 -12.17 15.46 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.165 -0.47 . . . . 74.34 111.375 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.58 147.67 25.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.639 -0.255 . . . . 74.52 110.68 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.704 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 67.2 mt -57.32 -51.76 79.32 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.315 -0.402 . . . . 75.33 110.887 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.704 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 69.8 Cg_endo -102.5 100.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.942 2.428 . . . . 71.34 111.751 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.1 m -124.97 116.21 21.8 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.284 -0.26 . . . . 73.05 110.906 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.64 113.95 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.421 -0.354 . . . . 75.24 110.39 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.2 mp -92.05 143.18 26.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.257 -0.645 . . . . 50.41 109.257 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 109' ' ' SER . 47.1 mtp -113.97 146.22 40.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.892 0.377 . . . . 71.51 110.042 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.576 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.7 m-85 -145.73 160.03 42.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.371 -0.974 . . . . 65.43 108.371 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -149.8 117.47 6.2 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.494 -0.483 . . . . 74.13 110.863 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.814 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.0 t30 60.15 25.3 14.63 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.805 -0.634 . . . . 72.41 110.731 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.61 -14.66 63.42 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 116.121 -0.49 . . . . 44.41 112.445 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -83.38 152.75 24.89 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 122.51 0.324 . . . . 72.3 110.374 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -64.93 157.22 28.67 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.65 0.738 . . . . 63.44 111.206 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.576 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.32 168.78 21.69 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.965 -1.494 . . . . 71.12 106.965 -166.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 101' ' ' MET . 58.5 m -69.9 -177.67 1.36 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.066 0.46 . . . . 72.51 111.69 -167.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -148.83 120.15 7.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.031 -0.359 . . . . 54.44 110.031 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.4 t -93.62 107.48 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.999 -0.546 . . . . 64.51 110.106 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -88.82 102.07 12.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.109 -0.7 . . . . 74.1 109.109 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.534 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 117.49 162.79 12.66 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.618 -0.593 . . . . 71.33 111.618 -177.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.524 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -88.43 72.19 8.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.954 0.407 . . . . 75.05 110.224 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.38 94.46 4.98 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 116.025 -0.534 . . . . 73.22 110.113 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.403 ' O ' HD11 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.37 -33.95 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 115.673 -0.694 . . . . 73.0 110.172 -175.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -59.61 -47.62 84.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.247 -0.433 . . . . 73.03 110.631 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -69.15 -42.02 76.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 71.13 110.269 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 123' ' ' ILE . 78.9 mt -55.54 -56.21 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.736 0.303 . . . . 72.13 110.897 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.1 tt -66.01 -33.9 66.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.784 0.326 . . . . 70.03 110.387 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.6 t -55.14 -52.32 63.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.044 -0.525 . . . . 64.52 110.477 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 18.6 mm-40 -72.18 -37.17 69.38 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.248 -0.433 . . . . 74.33 110.664 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 119' ' ' ILE . 49.3 mt -52.32 -56.12 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.898 0.38 . . . . 75.42 110.09 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.75 -43.66 92.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.159 -0.473 . . . . 64.21 110.196 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 8.3 t30 -58.12 -30.25 66.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.96 -0.564 . . . . 73.42 111.65 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -99.17 -29.27 12.94 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.645 0.609 . . . . 71.24 112.645 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.425 HD12 HG22 ' A' ' 74' ' ' VAL . 66.3 mt -72.74 -48.83 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 117.947 0.339 . . . . 71.32 110.301 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.4 p30 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.41 -0.805 . . . . 62.21 110.466 178.782 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.85 -0.426 . . . . 74.33 109.85 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.13 127.25 22.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 75.34 110.286 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -128.93 -48.09 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 75.24 110.602 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -151.32 119.44 6.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.494 -0.321 . . . . 74.32 110.171 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -91.04 154.6 19.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 74.43 110.712 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -76.06 130.64 38.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.724 -0.671 . . . . 71.32 111.095 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -138.2 125.5 21.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.957 -0.757 . . . . 64.12 108.957 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -85.46 126.25 33.66 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.848 -0.427 . . . . 72.23 109.848 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.2 ttm -72.59 93.62 1.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.822 -0.436 . . . . 70.34 109.822 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.94 179.74 28.98 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.733 -0.667 . . . . 72.32 111.655 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.5 m -146.57 121.02 9.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.913 -0.403 . . . . 62.43 109.913 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.8 mt -130.23 166.13 20.96 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.982 0.42 . . . . 60.31 111.155 -173.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.54 -177.66 6.63 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.856 -0.611 . . . . 75.1 109.862 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.38 -68.86 0.64 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.849 0.357 . . . . 71.05 110.565 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.67 141.84 47.54 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.486 -0.561 . . . . 74.3 109.486 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.452 ' HB ' ' OE1' ' A' ' 17' ' ' GLN . 5.7 m -63.74 -52.19 61.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.252 -0.431 . . . . 75.32 111.427 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.452 ' OE1' ' HB ' ' A' ' 16' ' ' THR . 4.2 pm0 -126.17 -169.06 1.95 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 71.3 110.842 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.53 168.22 19.64 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.899 -0.881 . . . . 61.51 110.899 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.87 13.41 1.0 Allowed 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.791 2.328 . . . . 75.23 112.995 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.69 35.2 66.86 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.405 -0.678 . . . . 74.15 111.405 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 p -65.4 151.64 45.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.3 -0.45 . . . . 60.53 111.497 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 79.9 mmm -57.04 -36.37 70.41 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.782 -0.821 . . . . 73.41 108.782 171.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 mm -59.75 108.81 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 114.725 -1.125 . . . . 73.13 109.046 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -73.08 154.14 40.54 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.874 0.369 . . . . 74.32 111.115 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -118.88 134.67 55.02 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.167 0.587 . . . . 74.05 110.309 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.52 HD13 ' HA ' ' A' ' 31' ' ' PHE . 41.7 pt -150.09 179.63 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.348 0.594 . . . . 33.13 111.421 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.67 -159.16 9.34 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.323 -0.853 . . . . 72.21 111.036 172.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 11.0 p-10 -65.96 -46.2 78.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.026 0.441 . . . . 55.43 110.916 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.3 m -65.71 -29.16 69.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.703 -0.68 . . . . 74.34 110.668 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -95.39 -10.18 30.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.963 -0.562 . . . . 74.21 111.118 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.52 ' HA ' HD13 ' A' ' 26' ' ' ILE . 88.1 t80 -61.77 -61.87 2.2 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.543 -0.54 . . . . 72.35 109.543 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -57.76 -47.6 82.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.915 -0.584 . . . . 52.23 110.058 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -51.22 -57.74 8.0 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.577 -0.738 . . . . 74.13 110.84 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -80.08 -26.18 39.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.972 -1.013 . . . . 63.21 111.683 -168.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.442 ' HA ' HD12 ' A' ' 44' ' ' ILE . 79.4 t -78.81 -39.37 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.735 -0.212 . . . . 62.3 111.401 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.5 p -84.89 -37.14 20.96 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.934 0.346 . . . . 65.1 111.934 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.5 t -69.06 -13.07 62.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.472 0.545 . . . . 72.24 112.472 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.903 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 28.4 p -57.13 142.0 44.13 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.166 -0.309 . . . . 71.14 110.166 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -61.65 -82.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.387 0.514 . . . . 43.41 112.387 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -160.46 143.41 13.33 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.641 -0.254 . . . . 75.02 110.492 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 61.3 8.2 2.01 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.654 0.596 . . . . 71.23 111.796 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 mm -73.24 102.52 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.193 0.521 . . . . 72.23 110.51 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.85 108.16 4.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.191 -0.913 . . . . 75.14 109.165 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.442 HD12 ' HA ' ' A' ' 35' ' ' VAL . 70.3 mt -102.01 137.18 30.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.437 -0.801 . . . . 73.44 111.005 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.614 HD12 HG13 ' A' ' 76' ' ' ILE . 3.4 mp -118.14 148.94 41.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.924 -0.769 . . . . 71.53 108.924 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.5 t -130.59 104.82 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.535 -0.542 . . . . 74.35 109.535 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -88.11 126.63 35.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 75.51 110.599 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 100' ' ' LEU . 17.7 m-85 -89.85 133.14 34.9 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.116 -0.698 . . . . 74.45 109.116 169.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -56.31 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.32 0.581 . . . . 74.54 111.252 -175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 97' ' ' PRO . . . -78.21 141.99 62.98 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.132 -0.94 . . . . 41.52 111.297 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.67 115.36 2.39 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.923 1.749 . . . . 61.45 110.1 169.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -51.49 101.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.086 0.47 . . . . 75.33 111.433 -172.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 20.1 p -86.75 -174.69 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.604 -0.725 . . . . 75.14 110.777 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.45 -64.4 3.63 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.156 -0.475 . . . . 54.41 112.007 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.69 -28.71 57.97 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.783 2.322 . . . . 65.05 111.945 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.557 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 72.5 m -54.5 -25.76 27.47 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.638 -0.71 . . . . 61.22 111.612 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -53.37 -45.83 69.38 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.93 0.395 . . . . 71.3 110.545 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.5 m -75.72 -32.5 60.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.133 -0.485 . . . . 73.44 111.223 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 1.4 mm? -57.95 -45.5 86.55 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.518 0.933 . . . . 50.53 113.518 -164.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 7.9 mp0 -53.77 -60.47 7.14 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-N 118.734 0.697 . . . . 71.23 110.529 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 39.3 Cg_endo -67.31 -19.72 49.66 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.792 1.661 . . . . 71.51 112.548 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.481 ' NE2' HG23 ' A' ' 116' ' ' ILE . 3.4 mm100 -66.47 -52.78 42.52 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 110.263 -0.273 . . . . 72.31 110.263 174.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.508 HD22 HD12 ' A' ' 119' ' ' ILE . 97.2 mt -62.48 -40.9 98.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.474 -0.565 . . . . 73.32 109.474 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.6 mm-40 -58.17 -42.83 86.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.666 -0.697 . . . . 74.13 111.025 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.448 ' HZ2' ' HA ' ' A' ' 62' ' ' GLN . 7.1 ttpm? -63.91 -50.74 67.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.898 0.38 . . . . 71.32 110.244 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.5 mt -64.9 -32.42 74.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.953 -0.567 . . . . 61.45 110.248 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.6 -53.9 44.39 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.197 -0.456 . . . . 43.2 109.824 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 55.2 mt-30 -57.28 -38.94 74.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.014 -0.539 . . . . 73.44 111.019 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.49 -42.55 52.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.887 -0.597 . . . . 75.5 111.389 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -104.86 5.07 32.71 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.743 0.646 . . . . 71.2 112.743 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.8 t -52.88 -21.31 4.13 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.747 0.647 . . . . 60.1 112.747 -169.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.73 -39.13 90.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.822 0.344 . . . . 71.24 110.408 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -120.69 -1.86 9.96 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.77 -0.65 . . . . 74.52 111.575 -176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.518 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 43.0 t -128.44 131.58 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 112.054 0.391 . . . . 73.1 112.054 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' A' ' 74' ' ' VAL . 13.6 mptt -138.92 122.96 17.91 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.034 -0.53 . . . . 71.13 109.939 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.614 HG13 HD12 ' A' ' 45' ' ' LEU . 3.3 mp -99.21 146.12 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.7 -0.481 . . . . 72.11 109.7 176.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -132.0 142.74 49.69 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.738 0.415 . . . . 74.23 110.318 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -111.22 132.42 54.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.861 0.465 . . . . 74.43 110.015 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -86.29 99.16 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.549 -0.908 . . . . 73.43 108.549 174.133 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -80.66 -48.36 12.73 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.539 0.57 . . . . 75.31 112.539 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.525 ' HB ' ' OD1' ' A' ' 84' ' ' ASN . 49.7 mt -78.56 106.92 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 74.44 111.093 -173.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.79 -17.91 52.13 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.168 -0.469 . . . . 74.13 111.464 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.446 ' HB2' HG23 ' A' ' 81' ' ' ILE . 2.7 m-20 -70.02 -20.36 63.27 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.041 0.448 . . . . 71.3 109.827 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.525 ' OD1' ' HB ' ' A' ' 81' ' ' ILE . 10.3 m120 -84.17 41.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.786 -0.643 . . . . 65.23 109.723 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -55.07 -24.92 27.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.424 -0.807 . . . . 74.45 111.265 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -40.36 -55.94 2.11 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.55 -0.75 . . . . 75.4 112.119 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.08 -37.82 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.31 -0.404 . . . . 65.21 111.035 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.88 -54.79 16.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.066 0.46 . . . . 41.45 110.595 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 m -67.36 -35.89 80.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.753 -0.658 . . . . 40.24 111.141 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 14.0 mm-40 -75.27 -41.34 57.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.595 . . . . 74.04 111.537 -175.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -88.79 -12.13 42.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.796 0.331 . . . . 72.31 110.779 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.48 45.33 8.75 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.917 -0.659 . . . . 72.41 112.576 172.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.08 94.84 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.469 -0.567 . . . . 75.04 109.469 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.1 m -58.93 -39.24 80.99 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.751 -0.659 . . . . 73.21 112.047 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.18 144.83 51.15 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.16 -0.311 . . . . 74.34 110.16 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.461 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 59.9 mt -54.67 -49.67 90.01 Favored Pre-proline 0 CA--C 1.541 0.597 0 O-C-N 123.21 0.319 . . . . 74.34 111.792 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 56.5 Cg_endo -69.37 82.02 0.69 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 121.868 1.712 . . . . 75.43 112.125 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.6 m -146.54 142.64 28.23 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.231 0.538 . . . . 72.34 111.543 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 mp -115.71 120.65 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.268 -0.878 . . . . 74.53 109.369 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' A' ' 48' ' ' PHE . 9.3 mp -97.43 135.13 39.75 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.895 -0.409 . . . . 72.43 109.895 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.492 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 42.0 mtp -101.87 146.8 27.32 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.077 -0.342 . . . . 73.14 110.077 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -148.04 158.47 44.08 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.398 -0.593 . . . . 74.33 109.398 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -141.89 106.73 4.9 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 120.729 -0.388 . . . . 72.23 111.371 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.903 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.6 t-20 60.78 27.56 17.33 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.481 0.657 . . . . 65.45 110.579 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.84 -10.11 75.28 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.777 -0.647 . . . . 44.22 112.33 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -70.08 132.04 45.23 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 109.593 -0.521 . . . . 75.23 109.593 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -62.07 143.33 56.78 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 124.132 0.895 . . . . 64.31 109.348 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.7 tp -155.84 168.28 27.71 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.102 -0.703 . . . . 75.42 109.102 -164.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.1 m -69.8 171.92 8.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.42 0.629 . . . . 72.22 112.49 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -131.05 133.91 46.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.717 -0.674 . . . . 74.04 110.489 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.77 120.36 53.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.907 -0.588 . . . . 74.34 109.725 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.48 HD11 ' N ' ' A' ' 112' ' ' ILE . 3.1 mp -97.79 125.05 51.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.664 -0.495 . . . . 72.24 109.664 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.25 -174.27 53.52 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.292 -0.48 . . . . 44.34 112.33 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -87.16 86.4 7.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.687 0.279 . . . . 61.41 110.436 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 119' ' ' ILE . 65.4 t0 -123.79 87.83 2.81 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.605 0.717 . . . . 75.03 109.776 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.481 HG23 ' NE2' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -65.56 -29.39 46.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.263 -0.88 . . . . 74.23 109.532 -176.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.9 t -61.86 -48.74 79.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.917 -0.583 . . . . 71.55 109.716 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -63.22 -43.3 98.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.132 -0.486 . . . . 73.31 110.167 177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.508 HD12 HD22 ' A' ' 63' ' ' LEU . 82.7 mt -56.62 -56.46 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.225 -0.443 . . . . 53.35 111.293 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.26 -34.13 68.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.662 0.267 . . . . 75.52 110.472 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.7 t -56.53 -51.56 68.09 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.109 -0.496 . . . . 73.21 109.868 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -65.64 -40.17 92.21 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.155 -0.475 . . . . 72.51 110.728 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 119' ' ' ILE . 64.8 mt -54.85 -55.9 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.657 0.265 . . . . 70.3 110.417 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -64.46 -36.93 85.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.6 -0.273 . . . . 73.44 110.321 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -67.11 -26.4 66.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.041 -0.527 . . . . 63.32 111.257 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -101.03 -13.74 18.11 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.878 0.325 . . . . 70.14 111.878 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 123' ' ' ILE . 54.5 mt -85.94 -54.48 8.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.722 0.296 . . . . 71.12 110.395 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.661 -0.685 . . . . 54.0 110.922 -177.328 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.183 -0.303 . . . . 75.21 110.183 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.6 87.85 0.22 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.247 -0.433 . . . . 44.55 111.792 -175.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -75.49 72.46 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.214 -1.032 . . . . 73.5 108.214 171.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -57.37 114.15 2.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.178 -0.919 . . . . 73.13 111.755 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -65.25 102.26 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.384 -0.825 . . . . 75.1 109.458 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -82.37 93.45 7.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.005 -0.543 . . . . 71.53 110.941 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -99.4 121.79 41.61 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.087 -0.506 . . . . 73.23 110.294 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -158.87 99.8 1.56 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.592 -0.522 . . . . 72.24 109.592 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.486 ' SD ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -113.86 143.22 45.04 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.964 -0.754 . . . . 74.02 108.964 178.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' O ' ' SD ' ' A' ' 9' ' ' MET . . . -98.85 160.83 20.2 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.175 -0.536 . . . . 34.55 112.817 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.0 p -91.99 -68.54 0.79 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.88 0.372 . . . . 75.15 110.016 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.548 ' H ' HD23 ' A' ' 12' ' ' LEU . 2.4 pt? -118.99 123.96 45.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.415 -0.587 . . . . 73.42 109.415 172.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -65.55 -57.96 6.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 75.21 110.75 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -169.86 160.4 8.48 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.391 -0.368 . . . . 62.31 110.881 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -136.52 160.0 40.09 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.35 -0.611 . . . . 65.13 109.35 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.7 p -121.72 -73.35 0.65 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.855 -0.157 . . . . 64.34 110.982 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 59.61 36.55 22.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.258 0.551 . . . . 74.12 110.084 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.78 172.1 46.61 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.527 -0.761 . . . . 72.34 113.603 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.543 ' HG2' ' HE2' ' A' ' 22' ' ' MET . 32.6 Cg_endo -90.88 -157.47 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.625 2.884 . . . . 61.04 112.795 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.0 56.75 4.59 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 114.839 0.696 . . . . 71.23 114.839 -170.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t 64.99 120.73 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.357 0.598 . . . . 74.4 112.553 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.543 ' HE2' ' HG2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -75.64 -71.54 0.36 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.537 -0.756 . . . . 71.02 110.918 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -105.19 100.56 10.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 109.66 -0.496 . . . . 74.22 109.66 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 30.3 tt0 -93.62 112.11 23.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.938 0.399 . . . . 65.13 110.435 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 133.2 40.72 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.938 0.399 . . . . 73.41 110.889 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 39.6 pt -144.8 179.64 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.271 -0.422 . . . . 71.31 110.806 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.48 -176.09 15.59 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.969 -0.852 . . . . 54.12 110.969 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -66.72 -28.63 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.014 0.435 . . . . 55.42 110.334 -178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.9 m -65.58 -34.86 79.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.779 -0.646 . . . . 75.14 110.718 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 2.3 mp0 -92.38 -22.24 19.78 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.575 -0.284 . . . . 73.15 110.824 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.616 ' HE1' HG23 ' A' ' 46' ' ' VAL . 70.4 t80 -46.77 -61.46 1.84 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.314 0.383 . . . . 73.52 111.932 -173.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -63.05 -40.91 99.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.444 -0.344 . . . . 53.33 110.497 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 37' ' ' SER . 36.9 m-80 -58.65 -41.68 86.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.796 -0.638 . . . . 63.22 110.678 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -72.04 -43.72 64.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.886 -0.597 . . . . 74.53 110.156 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 31' ' ' PHE . 91.0 t -62.6 -40.68 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.954 -0.566 . . . . 61.12 110.809 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.4 p -80.65 -25.61 38.2 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.148 0.425 . . . . 74.44 112.148 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 22.3 t -67.69 -14.23 62.77 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.92 0.341 . . . . 63.31 111.92 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.773 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 27.6 p -56.84 129.79 42.92 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.102 -0.332 . . . . 72.11 110.102 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.39 -71.38 0.14 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.675 0.274 . . . . 64.33 110.781 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -161.59 135.57 6.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.453 -0.34 . . . . 62.41 110.45 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 61.37 2.31 0.63 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.957 0.725 . . . . 74.32 112.957 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.0 mm -62.29 130.7 27.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.895 0.378 . . . . 75.24 110.388 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER -93.01 112.85 24.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 72.42 109.612 -178.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 38' ' ' CYS . 73.7 mt -107.67 123.06 62.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.819 -0.628 . . . . 61.13 110.313 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.625 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -105.97 146.14 30.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.142 -0.688 . . . . 75.23 109.142 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.616 HG23 ' HE1' ' A' ' 31' ' ' PHE . 61.8 t -125.26 104.72 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.724 -0.473 . . . . 70.04 109.724 177.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -94.83 112.85 24.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.669 . . . . 63.32 109.768 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.459 ' CZ ' HG22 ' A' ' 93' ' ' VAL . 17.1 m-85 -65.61 169.97 5.63 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.939 0.399 . . . . 64.25 111.099 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -94.54 130.99 40.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.064 -0.516 . . . . 73.5 110.536 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.88 101.14 31.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 73.5 110.117 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.04 -34.59 97.97 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.707 2.271 . . . . 63.32 111.981 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -153.77 129.59 10.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 74.33 109.89 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.6 t -173.74 125.12 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.351 -0.386 . . . . 43.43 110.253 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -65.48 -75.57 0.4 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 121.39 -0.433 . . . . 74.2 112.663 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.54 -28.46 45.49 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.165 2.577 . . . . 65.02 112.913 -175.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 70.9 m -57.25 -22.62 42.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 72.23 111.875 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 7.0 ptp85 -57.37 -36.82 71.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.525 0.202 . . . . 74.12 110.579 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.643 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 9.6 m -74.84 -40.47 61.01 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.773 0.797 . . . . 72.11 110.289 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.01 -38.67 76.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.22 -0.9 . . . . 73.41 111.415 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 55.2 mt-10 -54.64 -63.2 3.05 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 119.399 -0.334 . . . . 52.34 111.339 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.416 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 17.8 Cg_endo -60.24 -38.86 72.99 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 121.827 1.684 . . . . 73.13 112.118 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.4 mt-30 -57.73 -42.54 84.09 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.548 -0.461 . . . . 74.13 111.184 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.455 HD22 HD12 ' A' ' 119' ' ' ILE . 93.9 mt -68.97 -45.75 69.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.391 . . . . 65.44 110.467 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.426 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 44.7 mt-10 -56.84 -36.77 70.38 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.065 0.46 . . . . 74.31 109.904 176.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -66.89 -52.4 43.81 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.661 -0.699 . . . . 73.14 110.471 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 36.4 mt -59.75 -34.14 72.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.584 . . . . 64.41 109.891 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.453 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -60.64 -53.56 55.95 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.666 -0.697 . . . . 52.41 109.353 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 51.5 mt-30 -53.77 -42.13 67.91 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.235 -0.439 . . . . 75.31 110.961 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -65.88 -46.31 78.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.805 -0.634 . . . . 71.14 111.37 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -104.98 4.7 32.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.772 0.656 . . . . 73.01 112.772 -171.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.4 t -53.29 -20.59 4.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.232 1.197 . . . . 73.42 114.232 -168.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -73.12 -23.54 60.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.95 0.405 . . . . 73.34 110.835 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -118.83 -16.17 9.33 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.808 -0.633 . . . . 75.42 110.629 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.601 HG23 HD12 ' A' ' 127' ' ' ILE . 20.6 t -119.38 133.4 66.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.096 -0.502 . . . . 75.34 111.387 -173.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -131.76 119.85 21.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.511 -0.768 . . . . 73.35 109.239 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.625 HG12 ' HB2' ' A' ' 45' ' ' LEU . 71.7 mt -99.32 139.44 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.972 -0.381 . . . . 71.2 109.972 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 96.5 m-85 -129.82 151.47 50.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.951 -0.568 . . . . 75.54 110.032 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -134.14 109.93 9.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.041 0.448 . . . . 71.14 110.466 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.3 pp -78.56 70.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.733 0.778 . . . . 72.11 110.368 176.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.57 -13.0 60.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.385 -0.825 . . . . 75.14 111.077 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.437 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 60.4 mt -67.12 108.56 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 110.105 -0.331 . . . . 74.54 110.105 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -36.12 64.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.101 -0.5 . . . . 73.3 111.888 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.63 -22.22 61.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.542 . . . . 43.13 110.927 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.437 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.9 OUTLIER -102.62 23.12 12.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.945 -0.571 . . . . 61.01 111.539 -175.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -76.51 12.81 1.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.84 0.311 . . . . 72.21 111.84 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 30.4 t70 -53.11 -36.78 61.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.864 0.364 . . . . 73.11 110.637 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -52.75 -35.25 21.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.817 -0.629 . . . . 75.54 110.638 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.97 -50.23 71.59 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.903 -0.589 . . . . 74.13 110.335 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.1 m -66.7 -31.33 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.656 -0.702 . . . . 75.45 110.781 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 32.6 mm-40 -67.98 -53.85 22.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.21 -0.45 . . . . 63.2 110.928 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -91.71 -2.36 57.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.165 -0.47 . . . . 65.43 112.028 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.46 71.37 1.16 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.814 -0.708 . . . . 75.54 112.384 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.459 HG22 ' CZ ' ' A' ' 48' ' ' PHE . 98.4 t -104.51 101.04 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 63.04 110.363 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.8 t -94.6 -35.22 12.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 61.21 109.904 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.94 146.07 37.78 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.924 -0.58 . . . . 73.24 110.783 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.683 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 65.2 mt -69.09 -54.54 11.79 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.481 -0.327 . . . . 64.23 110.937 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.683 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 5.1 Cg_endo -85.0 93.79 0.68 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.142 1.895 . . . . 62.3 110.943 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 90.7 m -127.65 132.6 49.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.042 0.449 . . . . 74.41 111.208 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.51 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.6 mp -115.78 122.65 69.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.629 -0.714 . . . . 73.03 109.829 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.483 HD22 ' HG3' ' A' ' 110' ' ' GLN . 90.6 mt -98.68 125.26 43.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.664 -0.495 . . . . 74.4 109.664 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.533 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 52.9 mtp -98.46 147.73 24.45 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.964 -0.384 . . . . 63.42 109.964 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.73 150.78 36.88 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.096 -0.705 . . . . 74.14 109.096 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.463 ' HB2' HD22 ' A' ' 108' ' ' LEU . 61.9 tttp -139.54 106.78 5.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 120.907 -0.317 . . . . 74.21 111.024 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.773 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.4 t30 59.08 30.9 20.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.698 0.761 . . . . 51.21 110.444 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.87 -13.99 61.48 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.639 -0.71 . . . . 70.04 112.25 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -70.37 138.07 51.06 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 110.038 -0.356 . . . . 63.41 110.038 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -56.86 152.73 12.12 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.231 0.957 . . . . 72.24 109.447 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.533 ' HB3' ' C ' ' A' ' 101' ' ' MET . 11.5 tp -162.82 168.79 20.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.512 -0.767 . . . . 75.42 109.893 -165.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.7 m -69.19 164.04 23.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.787 0.803 . . . . 73.33 112.411 -164.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.483 ' HG3' HD22 ' A' ' 100' ' ' LEU . 61.8 tt0 -127.65 124.14 37.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.11 -0.95 . . . . 74.12 109.593 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.51 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.8 t -97.66 111.89 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 70.03 110.234 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.483 HD11 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -97.52 109.99 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.805 -0.634 . . . . 73.31 109.801 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.08 -174.68 23.39 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.043 -0.598 . . . . 44.31 112.284 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.4 72.29 4.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.188 0.518 . . . . 33.24 110.808 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.419 ' O ' HG13 ' A' ' 119' ' ' ILE . 0.9 OUTLIER -110.79 77.79 1.07 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.91 -0.586 . . . . 72.42 109.915 177.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -34.72 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.627 -0.715 . . . . 54.14 110.024 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.1 t -63.52 -42.66 98.45 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.163 -0.471 . . . . 73.24 110.224 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -65.48 -41.38 93.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 72.35 109.991 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.469 ' O ' HG13 ' A' ' 123' ' ' ILE . 77.0 mt -59.18 -56.69 15.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.028 -0.533 . . . . 73.53 110.807 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.7 tt -62.9 -37.08 78.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 116.466 -0.334 . . . . 74.23 110.439 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.0 t -58.19 -51.9 67.8 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 116.289 -0.414 . . . . 74.55 110.128 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.87 -39.45 91.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.448 -0.342 . . . . 73.01 110.633 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 119' ' ' ILE . 74.4 mt -57.54 -56.51 14.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 121.109 -0.236 . . . . 71.43 111.159 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -71.07 -24.99 62.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.755 -0.378 . . . . 53.12 110.356 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -66.61 -38.55 87.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.163 0.506 . . . . 75.32 110.43 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -92.51 -12.79 31.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.291 -0.413 . . . . 65.53 111.922 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.601 HD12 HG23 ' A' ' 74' ' ' VAL . 62.4 mt -95.97 -60.47 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.769 0.318 . . . . 71.14 111.431 173.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.492 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.751 -0.642 . . . . 62.51 110.364 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 110.026 -0.361 . . . . 63.42 110.026 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.8 97.39 7.12 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.174 -0.466 . . . . 61.21 110.69 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -113.29 51.1 0.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.472 0.653 . . . . 74.4 109.444 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -56.56 137.42 53.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.985 -1.007 . . . . 71.22 111.416 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -98.22 154.52 17.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.824 -0.626 . . . . 71.42 109.529 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -149.78 148.86 29.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.516 0.198 . . . . 74.12 110.548 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -108.77 169.76 8.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 65.31 109.763 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -147.42 86.03 1.6 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.667 -0.494 . . . . 71.14 109.667 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.0 ptm -143.36 136.38 27.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.571 -0.74 . . . . 54.53 109.885 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.21 152.29 7.94 Favored Glycine 0 C--O 1.234 0.153 0 C-N-CA 121.193 -0.527 . . . . 51.55 111.808 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.9 m -95.95 104.96 16.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.03 0.443 . . . . 72.54 110.078 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -78.09 95.41 4.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.895 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -143.36 122.43 12.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.914 -0.585 . . . . 74.42 109.681 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -137.39 74.69 1.49 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.17 0.51 . . . . 72.45 111.106 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -89.69 90.56 8.28 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.281 -0.637 . . . . 74.45 109.281 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.0 p -74.23 -2.01 23.01 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.445 -0.798 . . . . 72.34 112.97 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -115.64 135.71 53.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 74.31 110.657 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.06 156.37 28.09 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.358 -0.697 . . . . 74.43 111.358 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.09 -26.28 50.45 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.429 2.086 . . . . 72.24 111.979 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.84 -88.55 0.22 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.97 -0.559 . . . . 65.34 112.691 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.8 t -152.57 85.84 1.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.917 0.389 . . . . 62.25 110.137 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.405 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 85.5 mmm -91.13 -31.92 16.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.481 . . . . 54.23 110.265 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.524 HG21 ' HB2' ' A' ' 78' ' ' LYS . 21.0 mm -81.09 123.17 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.026 -0.534 . . . . 73.32 109.561 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -88.99 126.16 35.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.923 0.392 . . . . 73.15 111.158 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.76 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 10.2 pt20 -82.76 130.94 35.2 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.208 -0.451 . . . . 74.02 110.402 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 31' ' ' PHE . 47.2 pt -141.83 168.17 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.294 0.568 . . . . 71.3 111.87 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.75 -170.0 12.64 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.188 -0.915 . . . . 22.14 111.093 173.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.58 -45.28 92.33 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.181 0.515 . . . . 73.4 110.991 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.8 m -57.38 -28.45 63.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.385 -0.825 . . . . 65.21 111.592 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.4 mp0 -106.52 -20.42 13.37 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.693 -0.231 . . . . 64.15 111.582 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.432 ' O ' HG22 ' A' ' 35' ' ' VAL . 91.2 t80 -52.0 -62.01 1.9 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 111.949 0.352 . . . . 74.33 111.949 -171.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.33 -44.31 79.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.265 -0.425 . . . . 64.12 110.252 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -59.59 -57.4 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.767 -0.651 . . . . 72.04 110.883 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 35.7 mmtp -59.31 -32.12 69.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.873 -0.603 . . . . 74.45 111.342 -174.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 31' ' ' PHE . 96.3 t -78.52 -44.76 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.874 0.324 . . . . 72.2 111.874 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.3 p -86.01 -14.99 42.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.609 0.596 . . . . 70.33 112.609 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.3 m -78.11 9.69 3.52 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.804 0.335 . . . . 73.31 111.605 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.901 ' SG ' ' HB ' ' A' ' 42' ' ' ILE . 41.6 t -67.36 169.1 9.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 75.43 110.208 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.456 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 45.0 t-20 -114.01 -62.47 1.59 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.951 -0.389 . . . . 75.12 109.951 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -162.38 138.59 7.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.483 -0.326 . . . . 72.33 111.368 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 60.15 1.71 0.37 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.092 1.145 . . . . 53.41 114.092 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.901 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 50.7 mm -79.73 107.03 11.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 118.325 0.511 . . . . 73.33 110.33 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.6 tp -75.47 129.39 37.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.648 -0.705 . . . . 73.35 110.274 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.5 mt -116.56 119.92 63.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.631 -0.713 . . . . 64.31 110.488 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.458 HD11 ' N ' ' A' ' 45' ' ' LEU . 4.3 mp -108.13 143.57 36.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.908 -0.775 . . . . 64.2 108.908 175.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.41 HG23 ' HB2' ' A' ' 77' ' ' TYR . 64.3 t -130.0 110.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.719 -0.475 . . . . 74.42 109.719 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.407 ' OD2' ' NZ ' ' A' ' 78' ' ' LYS . 16.4 t70 -88.96 143.01 27.16 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.043 0.449 . . . . 73.53 111.607 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -95.38 118.32 31.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.717 -0.674 . . . . 64.04 109.912 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.63 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 26.3 t90 -89.27 -55.69 3.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.177 -0.465 . . . . 72.43 111.915 -172.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 70.44 155.94 0.15 Allowed Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.645 0.591 . . . . 53.31 110.8 -175.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.8 -29.86 73.86 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.558 2.172 . . . . 72.14 111.874 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -139.35 106.26 5.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 73.13 109.805 175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.447 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 1.8 p -85.92 -66.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 73.13 110.767 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.11 -94.12 0.85 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.102 -0.57 . . . . 75.42 112.429 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 53' ' ' CYS . 31.2 Cg_endo -62.72 -5.37 7.19 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.893 2.395 . . . . 73.03 112.088 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 8.9 p -55.31 -20.76 12.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.469 -0.787 . . . . 71.43 111.495 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -53.72 -46.99 70.99 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.639 -0.255 . . . . 74.51 111.01 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.625 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.7 m -75.39 -43.49 49.88 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.606 0.717 . . . . 71.22 111.415 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.441 HD22 ' HB2' ' A' ' 114' ' ' ALA . 4.3 mm? -64.88 -33.8 76.88 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.53 -0.759 . . . . 74.32 112.093 -170.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 13.4 mm-40 -59.34 -59.96 12.12 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 121.043 -0.263 . . . . 70.44 110.567 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.6 -42.17 49.72 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 121.829 1.686 . . . . 70.11 111.992 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.5 mt-30 -57.37 -46.46 83.37 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 120.599 -0.44 . . . . 52.45 111.422 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.75 -43.82 78.98 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.394 -0.367 . . . . 71.11 110.617 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' HG2' HG12 ' A' ' 23' ' ' ILE . 36.0 mt-10 -63.48 -33.83 76.43 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.648 0.261 . . . . 55.22 110.509 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -63.18 -54.71 33.39 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.23 0.538 . . . . 74.5 110.146 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.455 HD11 HD12 ' A' ' 120' ' ' ILE . 22.4 mt -63.19 -34.06 76.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.772 -0.649 . . . . 73.24 110.132 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.498 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -61.58 -43.48 98.78 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.99 -0.55 . . . . 74.24 110.076 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 97.2 mt-30 -63.7 -48.34 77.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.932 0.396 . . . . 74.12 110.61 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.85 -43.29 99.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.868 -0.605 . . . . 74.0 111.12 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.499 ' HH ' HD11 ' A' ' 120' ' ' ILE . 68.8 m-85 -104.91 5.72 33.11 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 112.995 0.739 . . . . 75.24 112.995 -169.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.6 t -52.87 -23.47 7.12 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.383 0.882 . . . . 71.13 113.383 -170.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.65 -18.77 60.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.84 0.352 . . . . 73.23 111.313 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.29 -6.65 4.29 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.964 -0.562 . . . . 63.15 111.191 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.524 HG22 HD13 ' A' ' 127' ' ' ILE . 39.6 t -128.97 138.42 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.048 0.452 . . . . 63.32 111.535 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -135.93 127.59 28.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.596 -0.729 . . . . 74.32 109.063 170.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.1 mt -113.42 114.52 47.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.943 0.401 . . . . 73.45 110.311 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.41 ' HB2' HG23 ' A' ' 46' ' ' VAL . 98.7 m-85 -93.71 167.32 11.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.747 -0.66 . . . . 73.53 109.868 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.63 ' HE3' ' HB2' ' A' ' 49' ' ' TRP . 31.9 tttp -145.15 140.97 28.35 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.348 -0.612 . . . . 65.04 109.348 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.0 tt -64.01 108.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.215 0.531 . . . . 71.31 110.811 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.76 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 41.2 t30 -89.62 -52.94 4.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.733 -0.667 . . . . 74.24 110.32 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.4 mm -74.14 112.6 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.36 -0.836 . . . . 72.13 110.687 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -59.95 -30.11 68.86 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.551 0.691 . . . . 73.23 110.381 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.74 -22.65 61.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.512 -0.767 . . . . 62.5 110.497 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -88.95 45.37 1.29 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.454 0.645 . . . . 72.34 110.721 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.428 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 3.0 pt20 -88.94 -7.53 55.88 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.963 -0.754 . . . . 72.32 108.963 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 21.5 t70 -48.75 -51.42 29.06 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.252 -0.885 . . . . 50.44 110.599 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -54.57 -33.9 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.946 -0.57 . . . . 74.13 111.445 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.508 ' HB2' ' HB ' ' A' ' 93' ' ' VAL . . . -66.3 -41.52 89.62 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.427 -0.583 . . . . 72.0 109.427 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.7 m -70.46 -29.72 66.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.615 -0.72 . . . . 74.4 110.716 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 83.1 mm-40 -70.6 -48.9 52.82 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.224 -0.443 . . . . 63.21 111.179 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -82.91 -24.81 32.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.353 -0.385 . . . . 73.42 111.442 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.82 64.67 0.85 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.962 -0.637 . . . . 51.33 112.593 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 88' ' ' ALA . 90.8 t -102.5 102.2 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.615 -0.513 . . . . 71.32 109.615 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -113.8 8.67 17.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 74.32 110.429 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.92 151.98 44.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.495 -0.558 . . . . 50.41 109.495 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.653 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 68.0 mt -63.37 -57.51 19.91 Favored Pre-proline 0 CA--C 1.538 0.493 0 O-C-N 123.077 0.236 . . . . 43.2 111.114 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.653 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 96.6 Cg_endo -86.62 100.78 0.57 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.757 1.638 . . . . 53.22 111.614 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.4 m -137.36 121.59 18.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.775 0.322 . . . . 74.22 110.576 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.437 ' N ' HD13 ' A' ' 99' ' ' ILE . 3.0 mp -110.17 110.9 33.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.801 -0.636 . . . . 74.32 109.941 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -88.31 126.04 34.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.625 -0.509 . . . . 74.23 109.625 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.452 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 33.5 mtp -106.67 140.76 39.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.963 -0.384 . . . . 74.14 109.963 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -147.27 155.37 41.99 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.993 -0.743 . . . . 75.25 108.993 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -129.07 105.49 8.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.674 -0.41 . . . . 72.23 110.611 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.543 ' HA ' ' HB3' ' A' ' 38' ' ' CYS . 8.9 t30 61.27 25.67 15.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.593 0.711 . . . . 64.33 110.566 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.24 -12.2 70.25 Favored Glycine 0 N--CA 1.454 -0.103 0 CA-C-N 115.831 -0.622 . . . . 62.54 112.071 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -75.08 139.21 42.65 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 110.02 -0.363 . . . . 65.21 110.02 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -58.62 145.96 37.83 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 124.405 1.066 . . . . 75.01 110.813 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 101' ' ' MET . 0.9 OUTLIER -162.34 168.92 21.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 72.32 109.52 -167.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.4 m -69.96 172.32 8.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.143 0.577 . . . . 62.52 111.927 -168.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.463 ' OE1' ' HG ' ' A' ' 100' ' ' LEU . 26.0 tt0 -142.03 118.48 10.9 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.995 -0.548 . . . . 72.02 109.613 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.85 107.19 17.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.409 -0.36 . . . . 74.33 110.064 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 65.0 mt -95.57 104.89 16.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.288 -0.415 . . . . 73.31 110.243 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.41 148.01 6.8 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.656 -0.578 . . . . 62.33 111.656 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.441 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -80.1 71.78 6.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.094 0.473 . . . . 52.45 109.958 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.412 ' O ' HG13 ' A' ' 119' ' ' ILE . 29.5 t70 -122.2 95.72 4.76 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.473 0.654 . . . . 72.21 109.812 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -62.42 -28.43 44.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.984 -1.007 . . . . 75.41 110.019 -174.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.9 m -62.34 -48.67 78.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.146 -0.479 . . . . 75.21 110.561 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -67.54 -37.65 83.03 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.725 0.298 . . . . 52.24 110.207 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.433 ' O ' HG13 ' A' ' 123' ' ' ILE . 75.2 mt -58.25 -56.33 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.217 -0.447 . . . . 64.51 110.904 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.499 HD11 ' HH ' ' A' ' 70' ' ' TYR . 7.9 tp -64.74 -34.46 70.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.773 0.321 . . . . 73.45 110.642 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.7 t -58.68 -45.02 90.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 73.15 110.125 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.438 ' HB3' ' HE2' ' A' ' 101' ' ' MET . 48.8 mm-40 -70.86 -37.29 73.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.449 -0.341 . . . . 64.45 111.143 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 119' ' ' ILE . 68.6 mt -54.75 -55.9 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.124 0.488 . . . . 74.05 109.975 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -60.24 -41.91 94.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 74.35 110.642 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 33.3 t30 -58.26 -38.4 76.86 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.654 -0.703 . . . . 65.43 111.505 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -99.58 -11.99 20.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.227 0.454 . . . . 75.12 112.227 -174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.524 HD13 HG22 ' A' ' 74' ' ' VAL . 55.6 mt -92.82 -59.54 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 120.902 0.382 . . . . 70.34 111.075 173.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.592 -0.718 . . . . 51.33 110.276 -174.263 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.835 0.35 . . . . 54.55 110.32 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.96 123.44 28.33 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.087 -0.506 . . . . 51.53 110.546 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -113.21 -3.93 13.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.473 -0.33 . . . . 75.14 110.822 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -171.27 144.21 1.99 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.44 -0.345 . . . . 75.44 110.548 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -115.11 120.16 38.84 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.339 -0.615 . . . . 72.35 109.339 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -139.88 94.33 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.665 0.269 . . . . 72.31 111.046 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -159.54 165.41 32.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.52 . . . . 64.14 110.326 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -115.92 126.22 53.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.071 -0.513 . . . . 73.42 109.764 175.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptm -89.09 139.35 30.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.524 -0.547 . . . . 72.13 109.524 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.65 81.08 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.487 -0.645 . . . . 74.43 111.487 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 m -147.92 -34.68 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.497 0.189 . . . . 75.31 110.865 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp 70.37 -58.06 0.56 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.26 0.624 . . . . 54.2 110.239 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 66.38 105.66 0.04 OUTLIER 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.427 0.691 . . . . 71.35 111.355 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB1' ' CD1' ' A' ' 49' ' ' TRP . . . -82.41 96.26 7.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 71.52 109.849 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -56.61 110.1 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 74.44 110.383 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -59.67 92.83 0.02 OUTLIER 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.225 -0.443 . . . . 71.54 111.404 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -76.98 72.34 3.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.895 -0.593 . . . . 72.2 110.178 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.78 159.03 47.44 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 116.002 -0.545 . . . . 72.23 112.744 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.55 50.41 2.96 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.561 2.841 . . . . 74.33 111.526 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.94 61.29 0.38 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 108.66 -1.776 . . . . 71.31 108.66 -166.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.0 p -42.31 107.35 0.08 Allowed 'General case' 0 C--O 1.234 0.281 0 N-CA-C 113.314 0.857 . . . . 74.54 113.314 -166.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.1 mmm -74.63 -19.52 60.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.951 -0.759 . . . . 74.41 108.951 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mm -91.75 136.49 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.83 -1.077 . . . . 71.43 108.764 174.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.0 tp10 -112.8 144.07 42.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.725 0.298 . . . . 74.54 110.725 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -114.26 132.01 56.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.781 -0.451 . . . . 71.35 109.781 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.1 pt -140.27 178.27 3.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 120.867 0.365 . . . . 73.53 111.126 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.59 172.95 25.48 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 115.89 -0.595 . . . . 52.03 111.869 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.655 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 10.5 t70 -52.24 -56.82 12.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.978 0.418 . . . . 72.35 111.504 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -64.21 -19.98 65.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.821 -0.627 . . . . 74.23 111.695 -174.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -78.08 -29.22 49.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.663 -0.244 . . . . 73.11 111.202 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -52.68 -49.39 65.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.731 0.301 . . . . 74.42 110.515 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.17 -55.85 26.59 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.969 -0.56 . . . . 60.44 109.916 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -53.27 -57.56 10.1 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.162 -0.927 . . . . 72.34 110.884 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -64.07 -41.52 97.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.423 -1.262 . . . . 62.54 111.211 -169.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.56 -41.14 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.537 -0.301 . . . . 62.32 110.973 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 p -75.82 -19.28 59.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.784 0.326 . . . . 75.11 111.324 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -76.37 -14.57 60.08 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.434 -0.348 . . . . 75.14 110.717 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.733 ' SG ' HD11 ' A' ' 44' ' ' ILE . 66.6 m -70.93 101.16 2.1 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.879 0.371 . . . . 73.44 110.256 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -67.41 -47.93 68.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 72.23 112.371 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -153.82 133.27 12.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.092 0.472 . . . . 63.23 111.853 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 67.28 2.13 2.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.915 -1.039 . . . . 73.12 113.421 165.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.691 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 48.0 mm -80.63 97.16 3.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.367 0.603 . . . . 61.11 110.325 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.407 HD22 ' HE1' ' A' ' 101' ' ' MET . 2.5 tt -80.77 113.13 18.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.33 -0.85 . . . . 72.32 108.944 176.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.733 HD11 ' SG ' ' A' ' 38' ' ' CYS . 47.3 mt -98.26 133.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.08 -0.509 . . . . 74.42 111.29 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.9 mp -114.56 124.88 52.99 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.57 -0.9 . . . . 64.44 108.57 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 92.4 t -106.37 110.02 30.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 110.205 -0.294 . . . . 73.12 110.205 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -99.71 131.92 45.38 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.236 0.541 . . . . 65.24 111.337 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -103.49 107.6 18.51 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.356 -0.979 . . . . 75.22 108.356 168.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.407 ' CD1' ' HB1' ' A' ' 14' ' ' ALA . 14.8 t-105 -81.13 137.01 35.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.245 0.545 . . . . 74.42 110.572 -170.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.628 ' HB2' ' HB3' ' A' ' 97' ' ' PRO . . . -76.92 129.22 79.41 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.781 -0.645 . . . . 64.24 111.356 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.95 -24.46 67.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.314 2.01 . . . . 74.23 110.412 172.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -87.95 88.54 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.446 -0.946 . . . . 74.24 108.446 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.1 t -76.96 144.2 38.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.24 0.543 . . . . 74.43 111.887 -171.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -154.63 -80.84 0.03 OUTLIER Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.345 -0.843 . . . . 72.15 111.185 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.71 16.56 1.56 Allowed 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.832 2.355 . . . . 71.14 112.428 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.1 m -54.96 -48.42 73.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.166 -0.47 . . . . 73.45 110.654 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -53.91 -36.28 62.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.934 -1.03 . . . . 74.51 111.174 -173.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.623 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 17.5 m -75.41 -59.13 2.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.03 -0.532 . . . . 75.44 111.558 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' A' ' 114' ' ' ALA . 4.5 mm? -64.06 -29.25 70.4 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.751 0.649 . . . . 73.54 112.751 -169.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.436 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 41.0 mt-10 -57.01 -63.9 3.13 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 120.56 -0.456 . . . . 51.55 110.454 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.436 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 38.0 Cg_endo -65.44 -36.86 32.69 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 121.761 1.641 . . . . 73.12 112.132 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 58' ' ' SER . 37.9 mt-30 -58.8 -48.9 79.66 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.537 -0.465 . . . . 74.04 111.234 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.89 -46.59 74.43 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.922 -0.127 . . . . 70.02 110.699 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 30.9 mt-10 -63.41 -30.56 71.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.493 -0.483 . . . . 65.24 110.685 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -64.71 -57.17 9.72 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.186 0.517 . . . . 70.44 109.935 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.48 HD12 HD13 ' A' ' 120' ' ' ILE . 37.7 mt -58.97 -34.81 72.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.489 -0.778 . . . . 72.41 109.597 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.477 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.65 -49.47 75.02 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.52 -0.764 . . . . 74.44 110.258 176.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.1 mt-30 -60.06 -35.87 76.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.784 0.326 . . . . 72.03 111.03 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.86 -41.93 42.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.012 -0.54 . . . . 61.22 111.393 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -105.06 4.95 32.08 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 113.132 0.79 . . . . 75.43 113.132 -171.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.5 t -53.14 -19.96 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.901 0.704 . . . . 75.32 112.901 -170.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -64.52 -33.71 76.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.046 0.451 . . . . 72.12 110.486 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -129.43 8.76 5.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.78 -0.645 . . . . 75.34 111.983 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.544 HG21 HD11 ' A' ' 127' ' ' ILE . 43.0 t -133.64 142.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.206 -0.309 . . . . 74.14 111.653 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.4 tppt? -151.69 133.77 15.1 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.053 -0.721 . . . . 73.21 109.053 175.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.441 HD11 ' N ' ' A' ' 76' ' ' ILE . 4.2 mp -108.17 136.67 42.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.718 0.294 . . . . 74.22 110.423 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 74.4 m-85 -128.39 158.18 38.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 70.34 109.935 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.704 ' HB2' ' HZ3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -152.33 172.74 16.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.653 -0.499 . . . . 73.32 109.653 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.42 142.56 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.765 -0.457 . . . . 53.54 109.765 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -103.56 -9.67 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 74.13 110.834 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.467 HG13 ' H ' ' A' ' 83' ' ' ASP . 8.5 tp -153.88 118.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.345 0.593 . . . . 72.14 110.77 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -58.81 -18.38 31.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.565 -0.743 . . . . 73.32 111.924 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.467 ' H ' HG13 ' A' ' 81' ' ' ILE . 4.4 m-20 -71.09 -7.9 49.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.544 -0.298 . . . . 74.15 111.57 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.655 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 3.9 m120 -125.63 78.53 1.74 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 74.43 110.441 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -114.3 10.37 17.15 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.483 -0.78 . . . . 72.24 110.088 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.511 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 2.8 m-20 -49.32 -45.98 46.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.506 -0.77 . . . . 72.52 109.991 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.0 p -55.02 -39.68 50.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.539 -0.755 . . . . 71.33 111.258 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.97 -33.25 74.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.31 0.576 . . . . 75.14 109.743 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.8 m -73.53 -32.31 64.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.21 -0.904 . . . . 74.41 110.142 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.8 mm-40 -70.86 -39.57 72.83 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.904 -0.589 . . . . 74.24 111.019 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -83.39 -23.73 32.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.539 0.209 . . . . 75.02 111.148 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.67 57.82 2.51 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.186 -0.53 . . . . 74.44 112.639 175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.02 124.0 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.504 0.192 . . . . 75.42 110.56 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.1 m -69.81 -62.52 1.35 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.142 -0.481 . . . . 64.51 111.879 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.81 161.87 17.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 63.23 110.253 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.475 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 47.5 mm -61.9 -54.62 49.1 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 123.224 0.328 . . . . 72.34 111.178 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.628 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 73.1 Cg_endo -74.74 80.6 2.32 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.809 1.673 . . . . 54.34 112.225 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.5 m -137.01 137.03 38.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 50.2 111.016 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.42 HD11 ' N ' ' A' ' 99' ' ' ILE . 2.7 mp -110.82 114.55 47.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.067 -0.515 . . . . 63.31 109.645 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.2 mp -90.66 154.01 19.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.417 -0.586 . . . . 72.32 109.417 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.407 ' HE1' HD22 ' A' ' 43' ' ' LEU . 57.6 mtp -119.22 144.73 46.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.06 -0.348 . . . . 60.31 110.06 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.524 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.7 m-85 -149.13 149.76 31.57 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.171 -0.677 . . . . 54.22 109.171 176.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 ttpt -145.15 113.77 6.74 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.054 -0.658 . . . . 72.4 111.594 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 59.32 25.72 14.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.816 0.817 . . . . 70.34 110.663 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.24 -16.33 49.02 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.802 -0.635 . . . . 75.35 111.876 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.511 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 8.2 tmtm? -72.83 135.3 45.17 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.579 -0.897 . . . . 75.1 108.579 177.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.511 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 34.2 mmtp -65.87 145.84 55.46 Favored 'General case' 0 N--CA 1.46 0.038 0 CA-C-O 121.577 0.703 . . . . 73.2 111.37 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -145.38 167.81 22.01 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.66 -1.155 . . . . 73.41 108.979 -167.027 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.6 m -70.99 -177.65 1.7 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.539 0.685 . . . . 74.33 112.352 -169.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -141.32 121.0 13.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.684 -0.689 . . . . 72.13 109.77 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.7 t -95.89 116.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.0 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.482 HD11 ' N ' ' A' ' 112' ' ' ILE . 2.9 mp -91.62 115.63 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 75.31 109.974 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.46 169.68 41.91 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.12 -0.562 . . . . 74.1 112.575 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.516 ' HB3' ' HG ' ' A' ' 59' ' ' LEU . . . -83.33 76.02 9.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.447 0.299 . . . . 73.12 110.767 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.418 ' O ' HG13 ' A' ' 119' ' ' ILE . 23.6 t0 -115.1 95.89 5.42 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.483 0.659 . . . . 62.45 110.75 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -60.81 -28.19 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.091 -0.959 . . . . 73.34 110.089 -177.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.3 t -62.32 -53.81 49.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.943 0.401 . . . . 72.11 110.146 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -62.99 -41.43 99.57 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.308 -0.405 . . . . 71.05 110.23 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.47 ' O ' HG13 ' A' ' 123' ' ' ILE . 74.0 mt -55.45 -56.46 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.944 -0.571 . . . . 71.24 111.159 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.48 HD13 HD12 ' A' ' 66' ' ' LEU . 8.3 tp -65.58 -34.7 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.755 0.312 . . . . 72.43 110.651 -177.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 t -57.17 -52.18 66.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.125 -0.488 . . . . 61.42 110.35 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -72.04 -31.44 66.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.471 -0.331 . . . . 53.02 111.53 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 119' ' ' ILE . 49.5 mt -57.26 -55.71 19.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 120.62 -0.432 . . . . 65.41 110.006 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -68.53 -35.74 77.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.199 -0.455 . . . . 74.03 110.486 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -65.11 -34.95 79.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.861 -0.609 . . . . 64.43 111.335 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -101.16 -14.46 17.73 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.7 0.63 . . . . 61.24 112.7 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.544 HD11 HG21 ' A' ' 74' ' ' VAL . 58.9 mt -82.8 -48.5 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.549 -0.538 . . . . 73.03 109.549 171.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.316 -0.85 . . . . 62.41 109.455 178.313 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.859 0.361 . . . . 64.21 110.392 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.71 143.92 30.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.262 -0.426 . . . . 74.45 110.3 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -142.96 146.76 34.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 72.04 109.796 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -132.7 115.43 15.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 72.2 110.453 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -164.25 114.42 1.23 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.162 0.505 . . . . 71.5 109.913 172.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -158.28 90.36 1.03 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.718 . . . . 73.51 109.154 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -161.37 104.31 1.26 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.403 -0.817 . . . . 75.33 109.763 -172.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -153.37 132.51 12.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.541 -0.3 . . . . 74.43 110.713 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.5 tpp -157.64 111.21 2.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.149 -0.478 . . . . 63.22 109.871 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.44 77.24 0.21 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.306 -0.473 . . . . 34.42 112.152 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 t -168.3 107.08 0.5 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.942 0.401 . . . . 71.41 110.574 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.2 tp -171.73 81.76 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.104 0.478 . . . . 74.22 110.19 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -92.68 43.69 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 74.24 110.784 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.85 97.35 9.69 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.03 -0.532 . . . . 64.35 110.793 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -100.63 109.61 21.69 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.053 -0.521 . . . . 71.43 111.232 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.1 p -105.2 84.51 2.12 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.031 -0.531 . . . . 74.42 111.091 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.731 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 77.6 mt-30 -138.22 161.33 37.14 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.06 -0.518 . . . . 73.32 109.767 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.88 -172.38 24.46 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.474 -0.393 . . . . 74.22 113.357 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -89.89 -165.22 0.18 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.556 2.837 . . . . 72.24 112.751 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.19 49.2 0.01 OUTLIER Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.959 -0.638 . . . . 65.32 112.97 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 t 49.3 77.52 0.11 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.251 0.548 . . . . 74.21 110.996 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 95.1 mmm -117.0 -32.07 5.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.872 -0.604 . . . . 72.24 110.973 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.0 mm -62.74 116.89 3.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.394 -0.366 . . . . 75.15 110.183 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -86.37 151.27 23.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.299 -0.409 . . . . 74.24 110.12 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 14.1 pt20 -123.29 130.91 53.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 72.24 110.629 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.51 HG23 ' HG3' ' A' ' 34' ' ' LYS . 37.5 pt -139.38 174.1 9.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.056 -0.52 . . . . 61.13 110.309 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.22 160.35 19.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.205 -0.521 . . . . 52.3 112.131 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.689 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 13.8 t70 -53.68 -38.64 64.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.493 0.663 . . . . 71.04 110.72 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.2 m -76.52 1.63 16.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.315 -0.857 . . . . 71.12 111.788 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 35.5 mt-10 -113.45 -6.08 13.48 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.344 -0.222 . . . . 73.42 111.056 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 35' ' ' VAL . 89.2 t80 -50.21 -61.57 2.09 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.382 0.426 . . . . 72.31 111.501 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -56.98 -42.91 81.06 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.221 -0.445 . . . . 72.41 110.488 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -55.75 -57.06 13.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.671 -0.695 . . . . 72.33 110.461 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.51 ' HG3' HG23 ' A' ' 26' ' ' ILE . 72.5 mmtt -65.6 -37.08 85.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 64.24 111.061 -174.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.617 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 88.0 t -71.72 -29.18 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.716 0.293 . . . . 74.31 111.241 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.9 p -86.32 -21.0 27.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.891 0.377 . . . . 75.32 110.839 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -72.74 -9.5 58.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.046 -0.524 . . . . 63.25 111.266 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.801 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 26.0 p -82.32 77.71 9.07 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.38 -0.6 . . . . 64.32 109.38 175.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.52 -40.43 94.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.618 -0.719 . . . . 70.3 112.86 -173.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 42' ' ' ILE . 5.6 m-20 -135.9 121.23 19.18 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.098 0.407 . . . . 74.42 112.098 -173.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 55.85 2.22 0.07 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.776 1.398 . . . . 64.44 114.776 166.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.801 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 46.9 mm -80.86 109.49 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.328 0.513 . . . . 71.52 110.451 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.9 tt -82.52 115.9 21.72 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.171 -0.677 . . . . 73.25 109.171 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.494 HG22 HG23 ' A' ' 35' ' ' VAL . 32.7 mm -87.11 115.04 27.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.793 -0.64 . . . . 72.5 110.991 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.413 HD11 ' N ' ' A' ' 45' ' ' LEU . 6.2 mp -102.47 148.1 25.93 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.5 -0.926 . . . . 71.2 108.5 171.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 60.5 t -133.35 106.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.617 -0.142 . . . . 73.42 110.617 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.52 143.13 26.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.987 0.423 . . . . 74.23 110.557 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.4 ' HE1' ' HG ' ' A' ' 100' ' ' LEU . 82.6 m-85 -103.52 179.37 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.093 0.473 . . . . 75.31 111.562 176.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 30.6 m95 -77.91 167.4 21.56 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.64 -0.709 . . . . 74.52 111.263 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.07 93.36 1.66 Allowed Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.123 -0.49 . . . . 65.4 110.737 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.624 ' HD2' HG21 ' A' ' 96' ' ' ILE . 46.5 Cg_endo -68.96 -37.77 10.61 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.446 2.097 . . . . 51.23 111.307 175.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -141.86 140.63 32.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.433 -0.803 . . . . 74.14 109.199 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p 179.57 -55.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.744 -0.465 . . . . 64.32 109.744 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.16 -91.78 0.47 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 116.018 -0.537 . . . . 53.42 112.83 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.41 -16.45 18.2 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 123.376 2.717 . . . . 64.41 113.749 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 26.2 m -51.22 -30.66 18.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.346 0.258 . . . . 63.34 111.516 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -55.74 -40.96 73.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.289 -0.414 . . . . 62.11 110.851 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.537 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.3 m -75.11 -35.17 61.76 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.212 0.53 . . . . 73.44 110.695 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.38 -42.85 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.716 -0.674 . . . . 71.32 111.629 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.44 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 37.6 mt-10 -54.89 -60.53 7.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.758 -0.163 . . . . 72.34 111.011 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 20.1 Cg_endo -61.7 -34.66 83.2 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.688 1.592 . . . . 73.34 112.211 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.537 ' HG3' ' O ' ' A' ' 58' ' ' SER . 14.9 mt-30 -63.9 -38.24 90.36 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.702 -0.399 . . . . 70.14 110.83 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 75.4 mt -68.62 -42.6 77.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.764 -0.458 . . . . 51.22 109.764 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -67.79 -26.79 66.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 54.42 110.71 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.731 ' HG3' ' HB2' ' A' ' 17' ' ' GLN . 33.4 ttpt -65.71 -56.78 10.24 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.725 0.774 . . . . 72.52 109.957 175.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.455 HD23 HD11 ' A' ' 120' ' ' ILE . 37.6 mt -59.13 -32.91 70.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.936 -1.029 . . . . 75.31 109.534 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.508 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.5 -51.27 66.28 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.692 -0.686 . . . . 71.23 109.562 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -55.89 -48.6 75.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.651 -0.704 . . . . 70.24 111.781 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -73.85 -39.68 63.83 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.44 -0.504 . . . . 73.33 111.169 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -101.04 4.93 42.77 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 113.021 0.748 . . . . 74.45 113.021 -171.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.9 t -53.25 -19.18 2.91 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.519 0.563 . . . . 74.2 112.519 -171.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -69.23 -34.68 75.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.656 0.265 . . . . 74.22 110.717 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.26 3.61 8.51 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.246 -0.434 . . . . 72.4 111.624 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.6 t -130.94 136.77 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.794 0.33 . . . . 74.43 111.368 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -138.36 131.28 29.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 70.32 109.624 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.0 mt -112.01 135.55 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.572 -0.529 . . . . 74.12 109.572 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 95.7 m-85 -129.26 147.93 51.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 73.32 110.469 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -133.99 145.14 49.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.061 -0.518 . . . . 71.5 109.849 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 84' ' ' ASN . 52.0 mt -70.21 112.52 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.958 -0.756 . . . . 74.15 108.958 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 66.9 t30 -75.31 -12.85 60.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.984 -0.553 . . . . 62.34 112.371 -170.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.47 HG22 ' H ' ' A' ' 83' ' ' ASP . 56.9 mt -130.89 119.97 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.683 0.277 . . . . 74.14 110.665 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -18.78 65.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.096 -0.502 . . . . 61.02 111.796 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.47 ' H ' HG22 ' A' ' 81' ' ' ILE . 24.8 t70 -71.37 -18.64 62.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.41 0.624 . . . . 61.31 109.833 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.689 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 16.6 m120 -103.9 121.66 43.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.223 -0.898 . . . . 75.45 108.758 175.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -163.27 15.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.959 0.725 . . . . 73.03 112.959 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 1.8 m-20 -54.96 -42.46 72.39 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.061 -0.348 . . . . 73.24 110.061 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.15 -38.96 31.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.822 -0.627 . . . . 54.25 110.532 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.46 77.52 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.347 0.594 . . . . 72.45 110.003 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.6 m -67.32 -37.49 83.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.022 -0.99 . . . . 74.1 110.564 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 93.5 mt-30 -69.97 -53.47 17.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.827 -0.624 . . . . 74.14 111.061 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.42 -13.0 55.79 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.023 -0.535 . . . . 74.43 111.696 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.53 78.97 0.79 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.88 -0.676 . . . . 64.04 112.849 171.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.9 t -75.54 93.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.316 0.579 . . . . 73.12 109.797 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.7 m -71.76 -59.4 2.77 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.363 -0.835 . . . . 73.12 110.925 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.5 152.85 21.88 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.5 -0.556 . . . . 65.43 109.5 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.686 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 43.0 mm -55.35 -54.27 52.79 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 123.18 0.3 . . . . 72.44 111.087 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.686 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 19.8 Cg_endo -89.32 99.74 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.256 1.971 . . . . 73.25 111.318 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.3 m -118.62 146.49 44.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.136 -0.484 . . . . 74.33 110.567 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 3.5 mp -123.16 116.17 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.599 -0.728 . . . . 61.41 109.913 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 64.6 mt -90.24 143.05 27.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.301 -0.629 . . . . 74.45 109.301 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 109' ' ' SER . 48.0 mtp -117.48 136.28 53.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.985 -0.376 . . . . 72.44 109.985 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.616 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 95.3 m-85 -148.96 160.39 43.34 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.451 -0.944 . . . . 74.52 108.451 174.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -153.82 111.25 3.47 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.846 -0.742 . . . . 73.41 112.315 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.474 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 56.9 t30 55.57 37.59 29.08 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.721 0.772 . . . . 65.32 110.978 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.76 -16.35 50.93 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.411 -0.813 . . . . 64.13 112.575 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -77.72 138.84 39.26 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.669 0.271 . . . . 61.25 110.633 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -62.41 139.92 58.56 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.339 -0.846 . . . . 74.13 110.619 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.616 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -144.14 167.67 21.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.975 -1.12 . . . . 74.03 107.975 -174.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 101' ' ' MET . 69.1 m -70.75 -179.72 2.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.612 0.72 . . . . 74.44 112.759 -165.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.431 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.1 tt0 -142.26 118.71 10.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.718 -0.674 . . . . 64.5 110.013 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 49.7 t -100.02 107.72 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.459 . . . . 73.24 110.272 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.503 HD11 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -94.31 104.46 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.601 -0.518 . . . . 75.24 109.601 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.76 177.99 23.82 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.714 -0.555 . . . . 52.14 111.714 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.22 80.85 7.57 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.992 0.425 . . . . 70.23 110.936 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.427 ' O ' HG13 ' A' ' 119' ' ' ILE . 21.6 m-20 -117.51 73.7 0.89 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.031 -0.531 . . . . 63.35 110.146 175.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.404 ' O ' HD11 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.39 -33.03 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.551 -0.537 . . . . 62.22 109.551 -177.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.5 t -59.0 -46.21 88.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.879 -0.6 . . . . 74.22 110.192 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -70.06 -36.37 74.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.168 -0.469 . . . . 75.3 110.095 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 123' ' ' ILE . 81.3 mt -58.78 -56.25 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 72.04 110.591 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.455 HD11 HD23 ' A' ' 66' ' ' LEU . 6.9 tp -64.68 -38.06 81.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.638 -0.256 . . . . 73.1 110.401 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.8 t -57.04 -48.5 78.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.248 -0.433 . . . . 62.2 109.951 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 65.6 mm-40 -69.6 -36.76 76.5 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.458 -0.337 . . . . 72.03 111.507 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 119' ' ' ILE . 56.3 mt -57.12 -56.19 16.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.241 0.543 . . . . 73.13 109.767 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -64.16 -35.81 82.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.652 -0.704 . . . . 70.33 110.468 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.403 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 23.6 t30 -65.28 -39.12 92.18 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.935 -0.575 . . . . 71.32 111.468 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -103.28 -5.2 23.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.571 0.582 . . . . 71.52 112.571 -172.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.43 HG22 ' ND2' ' A' ' 128' ' ' ASN . 55.8 mt -91.94 -54.05 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.895 -0.322 . . . . 71.22 110.698 170.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.43 ' ND2' HG22 ' A' ' 127' ' ' ILE . 13.2 m120 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.477 -0.773 . . . . 64.54 110.71 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.505 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.881 -0.415 . . . . 71.34 109.881 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.62 76.95 9.93 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.717 -0.475 . . . . 73.22 109.717 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -83.18 105.27 14.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.673 -0.694 . . . . 73.31 111.114 -174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 65.45 71.79 0.43 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.856 -0.611 . . . . 73.23 110.898 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -143.23 107.25 4.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.474 -0.785 . . . . 70.04 109.619 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -156.5 142.95 18.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.905 -0.406 . . . . 71.43 109.905 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -79.12 148.46 32.36 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.854 0.359 . . . . 74.25 110.752 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -103.88 166.2 10.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.044 -0.526 . . . . 74.31 111.369 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -87.02 176.42 7.64 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.545 -0.752 . . . . 63.35 110.349 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.73 168.71 25.16 Favored Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 111.666 -0.573 . . . . 44.21 111.666 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.8 m -123.71 121.71 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.912 0.356 . . . . 65.43 110.291 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -139.66 96.77 3.13 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.051 -0.722 . . . . 70.41 109.051 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -98.21 116.46 30.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.138 -0.483 . . . . 65.04 110.079 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.15 129.2 37.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.407 -0.36 . . . . 73.25 110.541 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -72.56 100.08 2.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.394 . . . . 64.15 110.273 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 p -82.64 141.71 32.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.988 -0.551 . . . . 74.51 110.311 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -82.58 126.55 32.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.006 0.432 . . . . 73.12 111.509 -174.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.53 123.44 7.53 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.771 -0.932 . . . . 74.23 110.771 172.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.66 166.31 23.88 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.497 2.132 . . . . 60.43 112.634 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.94 159.19 14.07 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.835 -0.62 . . . . 44.3 111.713 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.3 m -62.54 121.11 12.49 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.144 0.497 . . . . 64.54 111.904 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 91.3 mmm -93.78 -30.71 14.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.6 -0.727 . . . . 73.11 110.164 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.462 HG21 ' HE3' ' A' ' 78' ' ' LYS . 28.1 mm -58.28 107.48 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.029 -0.532 . . . . 71.32 110.036 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.537 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 9.4 tp10 -75.0 141.1 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 60.14 110.173 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.459 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . 78.1 mt-30 -109.09 122.51 47.42 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.316 -0.253 . . . . 65.24 110.316 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 47.3 pt -145.06 179.96 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.901 0.381 . . . . 70.02 111.468 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -125.82 -165.83 12.14 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.632 -0.713 . . . . 63.44 111.424 175.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.37 -45.91 68.21 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.957 0.378 . . . . 54.11 110.966 -177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.0 t -59.55 -29.74 68.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.92 -0.582 . . . . 75.42 109.906 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.517 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 12.0 mm-40 -85.98 -31.89 21.82 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.006 -0.543 . . . . 71.21 110.725 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.426 ' HA ' HD11 ' A' ' 26' ' ' ILE . 85.1 t80 -47.92 -61.62 1.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.359 0.503 . . . . 74.31 112.359 -171.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.84 -43.5 98.19 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.604 0.24 . . . . 64.5 110.412 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -57.65 -53.98 52.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.181 -0.463 . . . . 75.32 110.418 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.493 ' HG3' HG22 ' A' ' 26' ' ' ILE . 75.7 mmtt -60.71 -41.52 95.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.752 -0.658 . . . . 63.11 111.063 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 31' ' ' PHE . 98.3 t -67.74 -53.07 33.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 70.22 110.687 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.7 p -65.46 -18.68 65.5 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.497 -0.32 . . . . 63.43 111.761 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -77.02 3.35 12.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.632 -0.258 . . . . 63.53 111.259 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.532 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 25.0 p -62.46 113.39 2.91 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.928 -0.397 . . . . 75.32 109.928 175.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -52.84 -64.16 0.91 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.348 -0.387 . . . . 74.52 111.357 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -156.36 121.63 4.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 75.21 110.614 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.512 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 48.2 m-80 49.96 24.66 1.4 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.945 0.72 . . . . 73.21 112.945 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.4 mm -73.61 127.59 35.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 110.323 -0.251 . . . . 65.13 110.323 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 28.0 tp -85.79 107.78 17.79 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.722 0.772 . . . . 72.1 110.444 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.43 HG21 ' CD1' ' A' ' 77' ' ' TYR . 72.7 mt -108.44 113.47 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.112 -0.949 . . . . 62.11 110.205 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.54 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.8 mp -97.06 152.63 18.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.192 -0.669 . . . . 73.14 109.192 177.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 77' ' ' TYR . 58.5 t -138.08 118.53 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 110.034 -0.358 . . . . 72.11 110.034 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -95.35 154.59 17.12 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.082 0.468 . . . . 74.34 110.618 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -126.3 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.716 -0.674 . . . . 72.23 110.354 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.479 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 20.6 m0 -57.94 -44.12 86.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.37 -0.377 . . . . 75.14 111.225 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.551 ' HB2' ' HD2' ' A' ' 51' ' ' PRO . . . 66.93 165.98 0.12 Allowed Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.178 -0.464 . . . . 71.04 111.018 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 18.5 Cg_endo -59.38 -32.06 95.95 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.087 1.858 . . . . 74.52 111.854 176.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -96.25 89.69 5.2 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.072 -0.714 . . . . 73.44 109.072 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 49' ' ' TRP . 2.5 p -132.46 -67.61 0.64 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.475 -0.33 . . . . 72.41 111.823 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.56 -94.38 1.03 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.189 -0.529 . . . . 43.45 112.568 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.78 -16.36 8.35 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.217 2.611 . . . . 74.13 112.411 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 19.0 p -50.7 -27.73 7.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.424 -0.807 . . . . 65.15 111.322 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -54.14 -43.45 70.54 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.174 -0.466 . . . . 65.44 111.307 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 22.7 t -75.96 -46.44 29.69 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.8 0.81 . . . . 74.24 110.983 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.69 -34.02 75.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.155 -0.93 . . . . 74.02 112.402 -171.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.469 ' HG2' ' CZ3' ' A' ' 49' ' ' TRP . 38.7 mt-10 -60.27 -62.46 5.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.406 -0.518 . . . . 71.35 110.227 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.418 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 19.6 Cg_endo -58.75 -38.87 86.71 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.727 1.618 . . . . 55.54 112.258 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.1 mt-30 -57.44 -55.65 32.04 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.834 -0.346 . . . . 70.11 111.179 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.462 HD12 HD11 ' A' ' 119' ' ' ILE . 30.2 mt -71.98 -25.29 61.79 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.723 -0.217 . . . . 64.53 111.313 -176.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' OE1' HG12 ' A' ' 23' ' ' ILE . 4.5 mm-40 -62.26 -44.98 95.31 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.216 0.531 . . . . 71.41 109.837 172.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -62.36 -50.64 70.79 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.531 -0.759 . . . . 53.52 109.909 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.2 mt -62.9 -32.02 73.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.63 . . . . 72.24 110.776 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.426 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.82 -53.75 45.84 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.726 -0.472 . . . . 64.42 109.726 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -58.94 -35.64 73.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.959 -0.564 . . . . 74.14 110.84 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -65.72 -49.29 69.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 63.31 110.825 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.91 5.18 32.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.625 -0.716 . . . . 72.21 112.716 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 8.9 t -53.18 -19.88 3.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.787 0.662 . . . . 62.21 112.787 -171.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.05 -29.86 65.72 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.291 -0.256 . . . . 72.13 111.424 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -131.13 -10.63 3.74 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.466 -0.334 . . . . 74.52 111.336 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 71' ' ' THR . 40.9 t -116.96 134.65 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.823 0.344 . . . . 65.13 111.835 -172.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.537 ' HE2' ' HB2' ' A' ' 24' ' ' GLU . 21.1 tptm -143.59 127.12 16.92 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.128 -0.487 . . . . 63.24 109.802 173.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.54 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.2 mp -99.69 141.05 17.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.953 -0.388 . . . . 75.21 109.953 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.467 ' HB2' HG22 ' A' ' 46' ' ' VAL . 62.9 m-85 -123.67 150.31 44.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 74.33 109.444 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HE3' HG21 ' A' ' 23' ' ' ILE . 39.9 ttmt -129.2 122.14 29.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.672 -0.492 . . . . 74.52 109.672 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.5 mm -78.91 73.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.772 -0.825 . . . . 74.02 108.772 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 25' ' ' GLN . 3.4 p-10 -72.46 -30.4 64.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.525 -0.761 . . . . 55.33 110.367 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.4 mt -62.68 100.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.989 -0.551 . . . . 74.02 109.929 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.479 ' HA ' ' HG3' ' A' ' 85' ' ' GLN . 10.5 pt-20 -56.51 -27.94 58.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.744 -0.662 . . . . 74.43 111.191 -177.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -71.58 -24.52 61.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.758 -0.656 . . . . 74.45 110.006 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.08 15.76 27.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.307 -0.86 . . . . 75.22 111.315 -175.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.479 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 92.9 mt-30 -71.32 1.42 6.22 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.636 0.255 . . . . 72.02 111.085 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -46.53 -37.96 8.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.977 -0.556 . . . . 71.23 110.361 172.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.7 t -52.7 -43.28 43.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.562 -0.744 . . . . 74.22 110.502 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.8 -53.35 58.47 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.642 -0.708 . . . . 74.35 110.273 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.4 m -59.13 -34.81 72.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.62 . . . . 71.15 110.985 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.06 -56.66 13.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.218 -0.446 . . . . 60.15 111.163 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -72.3 -15.68 61.89 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.58 0.228 . . . . 62.03 111.148 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.9 40.01 5.67 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.234 -0.508 . . . . 73.02 112.724 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.64 93.9 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.111 0.482 . . . . 71.42 110.562 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.9 t -90.65 -37.14 13.96 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.637 -0.71 . . . . 72.21 109.536 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.21 136.28 33.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.035 -0.728 . . . . 73.44 109.035 174.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.624 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 50.8 mm -58.87 -58.84 16.38 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 111.411 0.152 . . . . 63.23 111.411 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.624 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 83.3 Cg_endo -80.77 72.3 6.6 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.797 1.665 . . . . 73.4 112.262 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.1 m -102.96 133.07 48.69 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.963 0.411 . . . . 73.44 110.796 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.622 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -116.52 121.0 66.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.537 -0.756 . . . . 73.23 109.846 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.474 HD22 ' HG3' ' A' ' 110' ' ' GLN . 88.7 mt -98.14 123.48 42.22 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.775 -0.454 . . . . 73.33 109.775 175.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 59.9 mtp -96.06 139.95 31.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.375 -0.602 . . . . 55.41 109.375 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -138.6 147.69 43.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.904 -0.776 . . . . 74.23 108.904 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.553 ' HE2' ' HB3' ' A' ' 126' ' ' ASN . 29.0 ttpp -147.47 121.36 9.34 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.306 -0.558 . . . . 70.33 111.225 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.532 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 6.0 t30 61.17 25.69 15.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.542 -0.754 . . . . 62.14 110.24 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.46 6.87 86.95 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.727 -0.669 . . . . 33.45 112.127 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -101.38 150.34 23.12 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 120.701 0.286 . . . . 61.04 110.61 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.492 ' HB3' ' HZ2' ' A' ' 107' ' ' LYS . 3.4 mmmp? -56.49 128.47 36.28 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.076 -0.966 . . . . 74.21 111.489 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.92 168.54 18.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.869 -1.514 . . . . 74.44 106.932 -177.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.7 m -69.53 157.16 37.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.795 0.807 . . . . 71.23 112.72 -158.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.474 ' HG3' HD22 ' A' ' 100' ' ' LEU . 53.8 tt0 -114.4 118.41 33.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.136 -0.938 . . . . 70.2 109.851 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 44.6 t -96.95 107.17 19.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.185 -0.461 . . . . 72.22 110.097 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.454 HD11 ' N ' ' A' ' 112' ' ' ILE . 3.6 mp -92.35 105.12 16.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.366 -0.605 . . . . 73.25 109.366 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.508 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 105.06 158.55 23.27 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.575 -0.61 . . . . 63.32 111.575 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.45 83.54 3.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.79 0.328 . . . . 61.23 110.679 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 33.8 t70 -121.51 90.12 3.25 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.703 0.763 . . . . 71.13 110.262 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.447 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -59.02 -30.63 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 114.795 -1.093 . . . . 52.01 109.425 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.8 t -56.32 -53.36 58.17 Favored 'General case' 0 CA--C 1.526 0.045 0 CA-C-N 116.13 -0.486 . . . . 64.33 110.159 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.762 ' HZ2' ' HB2' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -60.59 -48.03 83.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.144 -0.48 . . . . 72.24 109.941 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.496 ' O ' HG13 ' A' ' 123' ' ' ILE . 65.5 mt -56.69 -56.31 14.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.719 -0.673 . . . . 75.13 111.128 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 116' ' ' ILE . 13.7 tt -64.33 -35.7 74.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.767 0.317 . . . . 71.42 110.247 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.4 t -55.82 -52.32 64.42 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.797 -0.638 . . . . 53.14 110.278 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 24.7 mm-40 -74.54 -30.0 61.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.911 -0.586 . . . . 73.44 111.301 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.3 mt -58.42 -56.03 18.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.961 0.41 . . . . 74.41 110.064 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -71.33 -29.26 64.8 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.94 -0.304 . . . . 75.42 110.223 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.453 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 19.7 t30 -61.11 -44.38 97.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.103 -0.499 . . . . 73.34 110.971 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.553 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 32.1 m-80 -84.93 -27.1 26.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 62.21 112.137 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.4 mt -73.71 -48.7 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 120.915 0.388 . . . . 75.42 110.479 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.808 -0.615 . . . . 41.43 110.125 -179.783 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.7 mmm . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.975 0.417 . . . . 63.14 110.227 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.1 -167.09 2.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.759 -0.655 . . . . 72.24 109.528 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -136.63 172.18 13.4 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.716 -0.476 . . . . 75.13 109.716 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -124.34 141.81 51.78 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.865 -0.152 . . . . 70.43 110.637 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.1 p-80 -75.52 125.91 29.95 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.699 -0.852 . . . . 71.14 108.699 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -97.65 -41.13 8.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.571 0.212 . . . . 73.33 111.571 -175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.9 138.35 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.617 0.573 . . . . 74.35 110.379 -174.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.584 ' HB3' HG23 ' A' ' 112' ' ' ILE . 6.2 t60 -139.72 -95.15 0.16 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.043 -0.354 . . . . 75.34 110.043 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.0 ttm 177.15 154.01 0.24 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.531 -0.544 . . . . 72.43 109.531 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.27 62.93 0.02 OUTLIER Glycine 0 C--O 1.234 0.137 0 N-CA-C 111.343 -0.703 . . . . 55.52 111.343 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.6 m -93.17 120.45 33.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.847 0.356 . . . . 75.13 110.666 -176.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.9 tp -137.08 113.05 9.67 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.259 -0.645 . . . . 54.02 109.259 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -76.62 75.97 3.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.744 0.307 . . . . 71.32 110.656 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -162.95 93.41 0.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.608 . . . . 71.14 109.434 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -91.84 154.68 18.74 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.978 -0.555 . . . . 61.43 111.166 -174.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.5 t -153.52 -179.0 7.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.598 -0.728 . . . . 75.21 109.728 174.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.14 -40.5 0.47 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.137 -0.69 . . . . 72.45 109.137 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.78 -139.15 44.87 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.571 -0.74 . . . . 61.55 112.528 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.39 -77.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.777 2.318 . . . . 54.32 110.857 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.25 36.11 81.31 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.384 -0.436 . . . . 73.14 112.926 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.8 t -68.67 -31.73 71.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.211 0.529 . . . . 73.13 110.251 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 92.0 mmm -93.23 4.25 54.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.826 -0.624 . . . . 50.3 110.428 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.499 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 26.7 mm -119.34 104.69 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.756 -0.657 . . . . 72.44 109.826 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.34 160.49 18.78 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.336 -0.393 . . . . 71.03 111.054 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -137.72 133.81 34.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.01 -0.367 . . . . 71.13 110.01 172.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.517 HG21 ' HG3' ' A' ' 34' ' ' LYS . 32.0 pt -138.86 179.95 2.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 122.53 0.332 . . . . 64.33 111.211 -174.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.06 176.85 22.96 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.055 -0.521 . . . . 71.01 112.965 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -51.86 -56.62 12.91 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.366 0.666 . . . . 53.25 111.737 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -62.81 -27.57 69.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 74.13 111.481 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -79.55 -23.36 42.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.806 0.298 . . . . 72.55 111.806 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.427 ' O ' HG21 ' A' ' 35' ' ' VAL . 92.4 t80 -47.68 -61.7 1.81 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.278 0.361 . . . . 71.0 111.85 -174.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.56 ' O ' HG22 ' A' ' 36' ' ' THR . 10.0 m-20 -54.63 -53.59 52.79 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.246 0.546 . . . . 54.15 110.504 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -55.92 -57.41 12.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.076 -0.965 . . . . 72.44 111.378 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.2 mmtt -58.51 -35.39 72.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 74.32 111.055 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 31' ' ' PHE . 40.6 t -64.98 -56.58 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.298 -0.41 . . . . 63.34 111.336 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.56 HG22 ' O ' ' A' ' 32' ' ' ASP . 7.9 t -86.08 -0.29 55.25 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.145 0.424 . . . . 63.23 112.145 -175.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.2 t -71.14 -5.93 35.46 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.892 0.377 . . . . 75.13 111.131 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.853 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 8.5 p -66.14 158.08 29.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.946 -0.57 . . . . 72.52 111.747 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.58 -79.65 0.11 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.903 -0.59 . . . . 63.31 110.61 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -161.82 148.67 14.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.216 -0.447 . . . . 73.43 109.981 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 63.46 2.28 1.16 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.115 0.566 . . . . 71.32 111.34 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 42.6 mm -74.93 108.32 6.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 120.88 0.372 . . . . 74.33 110.276 -178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.486 ' CD2' ' HA ' ' A' ' 123' ' ' ILE . 30.9 tp -80.28 109.05 14.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.627 -0.715 . . . . 73.04 110.024 174.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 36.9 mt -102.7 116.69 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.501 -0.772 . . . . 64.31 110.376 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.525 ' HB2' HG13 ' A' ' 76' ' ' ILE . 3.4 mp -99.99 153.04 19.51 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.623 -0.881 . . . . 63.21 108.623 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.491 HG21 ' HB2' ' A' ' 77' ' ' TYR . 60.8 t -135.36 104.35 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.311 -0.255 . . . . 72.43 110.311 175.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.87 96.78 10.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.901 -1.148 . . . . 72.54 107.901 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -54.5 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.375 0.509 . . . . 73.3 112.375 -171.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.407 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 73.1 m95 -108.61 129.11 55.32 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.87 -0.419 . . . . 74.04 109.87 -177.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 109.74 40.04 Favored Pre-proline 0 C--O 1.234 0.272 0 CA-C-N 116.466 -0.334 . . . . 72.14 110.767 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 49' ' ' TRP . 67.5 Cg_endo -90.44 156.41 4.46 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.896 2.397 . . . . 42.24 112.089 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -97.41 119.32 35.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.047 -0.723 . . . . 74.15 109.047 176.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 56' ' ' CYS . 13.1 p -158.35 174.16 15.56 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 110.355 -0.239 . . . . 71.2 110.355 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.608 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -56.32 -62.86 5.87 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.057 -0.52 . . . . 75.13 112.566 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.422 ' HD2' ' SG ' ' A' ' 53' ' ' CYS . 50.6 Cg_exo -55.74 -34.49 91.02 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.407 2.071 . . . . 74.52 112.152 176.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.434 ' HB2' ' H ' ' A' ' 53' ' ' CYS . 77.5 m -56.08 -49.91 72.51 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.099 -0.5 . . . . 72.2 111.773 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -60.7 -26.42 67.13 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.766 0.317 . . . . 73.24 110.716 -176.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.564 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 46.8 t -75.6 -49.36 18.75 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.752 0.787 . . . . 73.41 110.494 172.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 55' ' ' PRO . 3.5 mm? -58.89 -43.13 90.92 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.198 -0.91 . . . . 73.01 112.3 -173.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.442 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 40.6 mt-10 -52.82 -60.39 6.71 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 117.807 0.276 . . . . 72.12 111.074 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 29.9 Cg_endo -64.14 -35.11 54.65 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.616 1.544 . . . . 75.31 112.254 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 58' ' ' SER . 26.7 mt-30 -61.26 -42.44 98.64 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.418 -0.513 . . . . 74.23 111.1 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.43 -42.99 67.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 73.31 110.321 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 28.1 mt-10 -63.69 -36.45 83.9 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.855 -0.338 . . . . 74.1 110.415 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -57.05 -57.16 13.76 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.464 0.65 . . . . 75.1 109.819 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 62' ' ' GLN . 36.6 mt -61.52 -36.55 80.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.05 -0.977 . . . . 63.24 109.909 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.541 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.05 -27.97 67.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 43.53 110.93 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.1 mt-30 -77.01 -48.34 18.2 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.851 0.358 . . . . 65.2 110.955 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -72.63 -37.75 67.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.183 0.516 . . . . 64.24 110.668 -176.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -97.61 5.85 48.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.765 -0.652 . . . . 73.14 111.891 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.541 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -52.74 -19.94 2.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.778 0.659 . . . . 72.52 112.778 -172.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.64 -31.2 70.18 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.274 -0.266 . . . . 74.12 110.794 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.407 ' HA ' HD12 ' A' ' 42' ' ' ILE . 91.6 m-20 -131.75 1.61 4.02 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.048 -0.524 . . . . 64.53 112.098 -174.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.512 HG21 HD11 ' A' ' 127' ' ' ILE . 72.5 t -131.76 134.03 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 122.257 -0.277 . . . . 74.13 111.527 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 26.8 mmtp -147.08 136.62 22.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.173 -0.467 . . . . 74.44 110.095 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.525 HG13 ' HB2' ' A' ' 45' ' ' LEU . 4.1 mp -115.83 146.65 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.664 -0.244 . . . . 73.45 110.636 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.491 ' HB2' HG21 ' A' ' 46' ' ' VAL . 40.4 m-85 -124.53 164.55 19.55 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.038 0.535 . . . . 75.14 110.516 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 23' ' ' ILE . 33.6 mtmm -143.61 178.82 7.52 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.816 0.446 . . . . 73.34 110.091 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.4 tt -151.76 158.6 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.839 -0.43 . . . . 72.23 109.839 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -142.57 -3.26 1.03 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.528 0.204 . . . . 73.44 111.511 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 40.4 mt -84.52 110.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 74.52 110.668 -174.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -49.48 -55.4 13.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.66 -0.7 . . . . 72.21 111.851 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.62 6.72 5.44 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.358 -0.383 . . . . 70.01 111.876 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.591 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.9 OUTLIER -107.3 22.13 16.46 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.057 0.456 . . . . 74.32 109.902 176.249 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -81.12 -10.85 59.59 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.003 -0.544 . . . . 64.44 111.498 -176.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -45.27 -56.96 4.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.709 0.29 . . . . 71.2 111.219 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.444 ' O ' ' HD1' ' A' ' 91' ' ' TYR . 7.5 p -53.1 -34.19 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.862 -0.608 . . . . 70.13 111.036 -178.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -67.75 -50.67 55.98 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.085 0.469 . . . . 70.11 109.967 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.2 m -60.42 -29.62 69.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.598 -0.728 . . . . 65.15 110.529 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.67 -55.89 8.76 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.867 -0.606 . . . . 52.43 111.32 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.444 ' HD1' ' O ' ' A' ' 87' ' ' VAL . 85.6 m-85 -77.22 -9.84 59.04 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.707 0.262 . . . . 73.02 111.707 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.29 53.61 1.14 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.801 -0.714 . . . . 72.41 113.391 170.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.48 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 80.6 t -93.92 111.84 25.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.993 -0.373 . . . . 52.15 109.993 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 m -121.97 25.17 9.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.362 0.601 . . . . 73.11 110.065 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.38 154.69 36.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.376 -0.829 . . . . 51.24 109.661 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.58 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 46.4 mm -67.71 -56.05 12.82 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.758 -0.46 . . . . 51.33 109.758 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.58 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 90.0 Cg_endo -82.09 67.67 8.08 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.007 1.804 . . . . 62.21 111.813 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.404 HG21 HG23 ' A' ' 93' ' ' VAL . 67.5 m -105.43 121.36 43.75 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.876 -0.602 . . . . 55.22 110.456 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.522 ' N ' HD13 ' A' ' 99' ' ' ILE . 3.3 mp -110.27 112.68 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.558 -0.746 . . . . 51.32 110.102 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 110' ' ' GLN . 36.9 mt -90.23 131.22 36.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.441 -0.577 . . . . 64.02 109.441 173.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.504 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 38.7 mtp -110.23 138.99 45.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.493 -0.558 . . . . 72.35 109.493 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -144.03 144.54 31.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.531 -0.544 . . . . 72.13 109.531 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.476 ' HD3' ' HB3' ' A' ' 126' ' ' ASN . 39.6 ttpt -118.8 104.93 11.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.85 -0.34 . . . . 62.05 110.578 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.853 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 60.6 t30 59.25 30.55 20.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.594 0.711 . . . . 70.41 110.353 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.8 -16.4 60.36 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.887 -0.597 . . . . 73.42 112.083 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -73.34 142.72 47.07 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 110.133 -0.321 . . . . 63.22 110.133 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -63.68 145.77 55.09 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.529 -0.76 . . . . 71.15 111.181 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.504 ' HB3' ' O ' ' A' ' 101' ' ' MET . 1.3 tp -162.14 169.88 20.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.374 -0.83 . . . . 73.4 110.563 -164.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.6 m -69.63 167.93 15.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.039 0.935 . . . . 74.51 113.044 -163.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.436 ' HG3' HD21 ' A' ' 100' ' ' LEU . 57.2 tt0 -126.61 118.66 25.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.674 -1.148 . . . . 71.43 109.418 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.52 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 23.0 t -96.03 107.23 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.565 -0.531 . . . . 72.53 109.565 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.584 HG23 ' HB3' ' A' ' 8' ' ' HIS . 3.8 mp -96.68 101.69 12.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.592 -0.521 . . . . 64.33 109.592 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.1 167.29 18.82 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.613 -0.595 . . . . 73.14 111.613 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.67 86.3 7.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.799 -0.236 . . . . 60.25 111.102 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -124.79 86.65 2.59 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 121.82 0.819 . . . . 63.43 109.717 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.406 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -62.63 -27.64 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 114.887 -1.052 . . . . 54.0 110.048 -174.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -63.42 -47.83 80.31 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.34 -0.391 . . . . 62.22 110.145 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.523 ' HE2' ' HG2' ' A' ' 122' ' ' GLU . 10.6 tptm -69.38 -39.64 77.91 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.152 -0.314 . . . . 75.32 110.152 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.3 mt -55.39 -56.23 12.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.07 0.462 . . . . 71.55 110.624 177.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 116' ' ' ILE . 13.5 tt -65.98 -33.81 66.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 116.027 -0.533 . . . . 75.4 110.569 -178.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.1 t -54.95 -51.85 64.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.03 -0.532 . . . . 52.11 109.673 176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.523 ' HG2' ' HE2' ' A' ' 118' ' ' LYS . 60.2 mm-40 -63.25 -40.11 96.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.034 -0.53 . . . . 74.22 110.494 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.486 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 63.9 mt -52.04 -56.43 6.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.719 0.295 . . . . 72.53 110.889 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 128' ' ' ASN . 10.2 p30 -71.88 -25.39 61.92 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 120.536 -0.466 . . . . 72.13 110.709 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 34.3 t30 -63.21 -33.93 76.55 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.06 0.457 . . . . 72.31 110.85 177.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.476 ' HB3' ' HD3' ' A' ' 103' ' ' LYS . 38.6 m-80 -94.55 -37.05 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.01 -0.541 . . . . 75.13 111.874 -176.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 74' ' ' VAL . 66.7 mt -72.14 -48.98 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 64.14 110.862 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.505 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.533 -0.746 . . . . 64.45 110.27 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.54 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 120.611 0.243 . . . . 74.35 110.495 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.04 96.95 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 41.52 110.248 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -130.19 92.13 3.23 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.753 -0.462 . . . . 74.14 109.753 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -129.7 83.47 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.245 0.545 . . . . 75.13 109.946 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -147.78 86.89 1.6 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.353 -0.839 . . . . 73.02 109.953 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -157.98 130.06 7.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.456 . . . . 75.52 110.712 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -139.01 161.26 37.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.755 -0.657 . . . . 72.21 109.245 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -93.92 90.94 6.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.443 -0.577 . . . . 74.22 109.443 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.4 ptm -139.28 101.46 4.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.882 -0.599 . . . . 65.31 110.38 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.75 53.0 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.019 -0.832 . . . . 70.21 111.019 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.5 t -107.29 151.53 25.35 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.072 0.463 . . . . 63.04 110.568 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 pp -158.76 161.59 37.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.737 -0.665 . . . . 72.23 109.761 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -104.98 -58.1 1.93 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.449 -0.574 . . . . 72.25 109.449 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.81 143.18 32.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 75.14 110.66 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -100.69 34.36 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 71.05 110.537 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.4 p -58.84 97.29 0.03 OUTLIER 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.093 0.473 . . . . 72.54 111.252 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -150.27 171.51 16.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.365 -0.834 . . . . 75.43 109.962 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.43 126.02 5.32 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.165 -0.541 . . . . 34.3 111.99 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.67 155.51 27.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.628 2.218 . . . . 61.31 112.119 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.62 36.08 1.09 Allowed Glycine 0 C--O 1.235 0.208 0 N-CA-C 111.614 -0.594 . . . . 60.0 111.614 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -81.5 168.79 17.89 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.911 0.484 . . . . 53.31 110.922 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 93.7 mmm -67.42 -29.17 68.58 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.451 -0.574 . . . . 71.32 109.451 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -73.71 115.79 15.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.678 -0.86 . . . . 73.24 108.678 171.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -74.38 146.47 42.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.99 0.424 . . . . 74.12 111.516 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.54 118.86 37.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.602 -0.727 . . . . 74.24 109.348 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.482 HG23 ' HG3' ' A' ' 34' ' ' LYS . 46.9 pt -144.58 175.12 3.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 120.826 0.346 . . . . 73.02 110.924 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.12 175.17 15.59 Favored Glycine 0 CA--C 1.521 0.406 0 CA-C-N 115.912 -0.585 . . . . 74.34 112.418 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.479 ' OD2' HG23 ' A' ' 87' ' ' VAL . 13.5 t70 -51.78 -45.86 63.95 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.466 0.706 . . . . 75.34 111.623 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 t -66.27 -28.57 68.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.15 110.806 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -80.97 -13.33 58.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 61.1 111.352 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.51 ' O ' HG22 ' A' ' 35' ' ' VAL . 87.2 t80 -51.43 -61.88 1.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.13 0.269 . . . . 73.31 111.14 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.18 -48.2 81.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.17 0.51 . . . . 70.21 110.76 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -60.81 -53.32 58.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.522 -0.763 . . . . 70.32 111.487 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HG3' HG23 ' A' ' 26' ' ' ILE . 35.0 mmtp -67.28 -31.82 72.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.102 -0.499 . . . . 74.22 111.293 -175.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 31' ' ' PHE . 74.5 t -66.3 -45.49 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.899 0.38 . . . . 74.43 109.979 174.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.5 p -75.11 -16.15 60.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.314 -0.403 . . . . 73.41 111.22 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -75.6 0.16 18.43 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.286 -0.415 . . . . 75.35 111.205 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.748 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.2 p -56.68 122.1 11.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.698 -0.228 . . . . 72.12 110.633 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -56.07 -76.17 0.03 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.332 -0.394 . . . . 73.24 110.889 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -161.98 145.31 12.0 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.358 -0.608 . . . . 72.33 109.358 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 45.0 27.47 0.29 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.001 0.813 . . . . 71.13 111.727 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 47.0 mm -87.84 123.79 40.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.984 -0.553 . . . . 73.42 110.221 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -89.97 110.34 21.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.575 -0.738 . . . . 71.35 109.101 178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.453 HG23 HG23 ' A' ' 35' ' ' VAL . 22.8 mm -89.07 109.11 19.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.59 -0.732 . . . . 62.51 110.384 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.495 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.5 mp -99.04 146.97 25.5 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.541 -0.911 . . . . 71.21 108.541 172.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 70.1 t -139.13 113.15 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.348 -0.242 . . . . 75.54 110.348 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -91.69 137.55 32.27 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.716 -0.475 . . . . 52.22 109.716 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.618 ' HE2' ' HG ' ' A' ' 100' ' ' LEU . 79.5 m-85 -93.08 106.94 18.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.352 -0.385 . . . . 74.51 111.991 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 63.2 t-105 49.33 51.15 16.85 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.349 -0.841 . . . . 71.44 111.76 170.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.5 91.1 3.75 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.287 -0.415 . . . . 73.41 109.996 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 52' ' ' TRP . 89.7 Cg_endo -84.76 -31.64 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.674 2.249 . . . . 63.23 111.794 175.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.471 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 49.2 p-90 170.33 155.18 0.06 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.868 0.867 . . . . 72.33 109.24 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.531 ' N ' ' HB2' ' A' ' 56' ' ' CYS . 3.7 p -171.99 -177.03 1.81 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.691 -0.855 . . . . 60.43 108.691 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -48.84 -69.47 0.99 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.415 -0.422 . . . . 64.2 112.561 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.438 ' HG2' ' SG ' ' A' ' 53' ' ' CYS . 30.4 Cg_endo -65.15 -43.61 11.04 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.206 1.937 . . . . 60.14 112.04 175.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.531 ' HB2' ' N ' ' A' ' 53' ' ' CYS . 13.0 m -51.3 -30.06 16.91 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.967 0.413 . . . . 64.05 111.195 -176.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 57' ' ' ARG . 43.3 ttt-85 -54.02 -58.22 8.14 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.621 -0.718 . . . . 53.41 110.853 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.549 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 33.0 t -75.75 -40.06 56.06 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.504 0.669 . . . . 55.12 111.084 174.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.456 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 3.8 mm? -57.51 -49.74 75.32 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.252 -0.885 . . . . 70.44 112.918 -171.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.472 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 49.9 mt-10 -56.39 -53.95 58.51 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 117.914 0.324 . . . . 71.44 111.147 -176.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 31.2 Cg_exo -50.29 -50.98 11.91 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.944 1.763 . . . . 63.45 111.74 172.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.0 mt-30 -54.35 -41.98 69.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.141 -0.481 . . . . 74.54 111.798 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 75.0 mt -68.36 -38.92 81.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.48 -0.327 . . . . 74.1 110.42 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.526 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 37.7 mt-10 -68.06 -29.59 68.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.145 -0.479 . . . . 63.32 110.26 177.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -54.04 37.08 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.131 -0.692 . . . . 74.52 109.131 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.07 -32.78 73.35 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.306 -0.861 . . . . 53.34 110.068 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.514 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.54 -50.73 70.21 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.946 -0.57 . . . . 70.14 109.781 177.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.526 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.5 mt-30 -54.63 -47.99 72.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.174 0.511 . . . . 74.31 110.245 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -63.92 -45.21 90.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.408 -0.815 . . . . 70.21 111.767 -178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -104.98 4.26 31.53 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 113.239 0.829 . . . . 74.32 113.239 -170.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 14.0 t -53.33 -24.89 13.08 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.791 0.663 . . . . 75.22 112.791 -171.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.593 ' HG3' ' ND2' ' A' ' 73' ' ' ASN . 5.6 pt-20 -64.15 -25.41 68.07 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.005 0.431 . . . . 71.45 111.135 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.593 ' ND2' ' HG3' ' A' ' 72' ' ' GLU . 5.5 m-80 -127.95 -0.76 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.334 -0.394 . . . . 74.33 111.257 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.428 HG22 HD12 ' A' ' 127' ' ' ILE . 25.8 t -130.51 139.12 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.043 0.449 . . . . 72.22 112.161 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -145.26 119.73 9.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 73.34 109.801 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.495 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.7 mp -98.68 140.06 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.181 -0.674 . . . . 54.32 109.181 174.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 73.7 m-85 -125.95 149.01 49.08 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.107 -0.701 . . . . 74.53 109.107 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.47 135.06 44.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.885 -0.413 . . . . 72.53 109.885 176.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.0 mt -76.9 91.78 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.203 -0.665 . . . . 64.13 109.203 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -82.16 -18.5 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.917 -0.583 . . . . 65.1 110.477 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.1 mm -69.53 89.2 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.367 0.603 . . . . 70.23 109.882 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -48.98 -35.95 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.876 -1.057 . . . . 65.23 111.549 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.79 -22.76 60.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.327 -0.851 . . . . 74.14 112.313 -173.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -131.06 108.51 9.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.699 0.285 . . . . 71.35 110.826 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.99 32.36 1.02 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.839 -0.619 . . . . 72.41 110.416 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -52.37 -37.27 55.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.558 -0.746 . . . . 64.23 111.141 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.479 HG23 ' OD2' ' A' ' 28' ' ' ASP . 97.7 t -52.8 -36.28 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.757 -0.656 . . . . 73.44 111.17 -178.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.49 -54.91 24.99 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.064 0.459 . . . . 74.22 110.952 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.7 m -63.2 -40.94 98.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.802 -0.636 . . . . 70.32 110.903 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -67.77 -51.33 50.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.257 -0.429 . . . . 65.15 111.758 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -70.87 -29.13 65.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.777 -0.192 . . . . 65.13 111.286 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.09 57.14 0.57 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.653 -0.784 . . . . 72.33 112.657 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -92.66 99.63 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.937 0.399 . . . . 73.22 109.989 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -79.9 -50.65 10.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.848 -0.614 . . . . 72.15 110.543 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.13 136.33 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.596 -0.52 . . . . 33.34 109.596 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.657 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 62.3 mt -51.96 -55.38 31.18 Favored Pre-proline 0 CA--C 1.54 0.559 0 O-C-N 123.21 0.319 . . . . 72.54 111.56 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 4.4 Cg_exo -73.61 82.36 1.69 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.94 1.76 . . . . 71.12 111.852 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.0 m -122.6 138.89 54.44 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.132 -0.485 . . . . 72.33 110.03 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 99' ' ' ILE . 3.9 mp -119.56 118.81 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.014 -0.539 . . . . 74.22 110.235 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.618 ' HG ' ' HE2' ' A' ' 48' ' ' PHE . 49.4 mt -88.53 141.85 28.19 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.646 -0.502 . . . . 73.11 109.646 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.572 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 52.6 mtp -114.08 144.92 42.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.204 -0.665 . . . . 73.43 109.204 175.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.447 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 97.2 m-85 -146.64 160.22 42.47 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.777 -0.823 . . . . 72.43 108.777 174.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -148.15 109.52 4.37 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 120.077 -0.649 . . . . 73.31 111.789 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.748 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.9 m-20 56.47 31.79 19.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.012 0.434 . . . . 74.31 111.178 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.55 -15.22 61.96 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.108 -0.568 . . . . 51.13 112.657 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -67.94 132.67 47.76 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 109.645 -0.502 . . . . 75.23 109.645 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.6 147.49 45.5 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 124.045 0.841 . . . . 75.05 108.943 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.572 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.2 tp -156.48 168.44 27.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.093 -0.706 . . . . 63.34 109.093 -164.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.3 m -69.65 172.31 7.64 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.493 0.717 . . . . 74.32 112.512 -164.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.501 ' HG3' HD21 ' A' ' 100' ' ' LEU . 23.2 tt0 -131.01 131.81 44.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.23 -0.895 . . . . 74.3 109.91 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.79 111.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.915 -0.402 . . . . 73.22 109.915 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.516 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.2 mp -85.95 113.54 24.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.245 -0.65 . . . . 65.13 109.245 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.31 142.81 7.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.983 -0.627 . . . . 75.42 111.763 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.455 ' HB3' ' HG ' ' A' ' 59' ' ' LEU . . . -72.07 87.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.701 0.286 . . . . 72.34 110.765 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.432 ' O ' HG13 ' A' ' 119' ' ' ILE . 14.3 t70 -119.53 111.01 17.56 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.23 -0.441 . . . . 74.11 110.35 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -33.54 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.716 -0.675 . . . . 73.31 110.549 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -64.82 -53.25 49.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.984 0.421 . . . . 75.34 110.355 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -60.79 -45.6 93.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.162 -0.472 . . . . 73.52 110.331 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 115' ' ' ASP . 81.8 mt -58.66 -56.15 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.026 -0.534 . . . . 72.22 110.972 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -61.2 -36.32 71.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 120.772 0.32 . . . . 62.34 110.549 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.6 t -59.63 -52.05 67.19 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.117 -0.492 . . . . 61.52 110.015 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -62.56 -40.58 97.29 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.32 -0.4 . . . . 74.15 110.691 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 127' ' ' ILE . 57.3 mt -55.36 -56.11 13.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.288 -0.415 . . . . 64.3 110.644 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -66.1 -33.18 75.19 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.028 0.442 . . . . 72.51 110.343 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -69.36 -28.45 66.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 43.15 111.547 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.523 ' OD1' HD13 ' A' ' 108' ' ' LEU . 65.1 m-80 -107.86 -8.91 15.85 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.789 0.663 . . . . 74.05 112.789 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 123' ' ' ILE . 61.3 mt -85.93 -51.58 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.883 -0.414 . . . . 75.01 109.883 170.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.535 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-N 115.824 -0.626 . . . . 53.21 109.956 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.7 mmm . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.543 0.211 . . . . 70.41 110.657 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.66 -169.68 2.68 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.55 -0.296 . . . . 63.4 110.997 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.3 m170 70.89 10.24 6.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.14 0.576 . . . . 70.42 111.929 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -84.29 53.99 2.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.695 0.759 . . . . 70.12 109.978 177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.0 105.94 0.19 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.79 -1.095 . . . . 70.2 111.752 -177.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -83.83 -49.27 9.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.517 0.675 . . . . 73.33 109.203 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -123.7 103.78 8.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.188 -0.915 . . . . 74.24 109.104 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -97.65 -177.28 3.74 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.175 -0.466 . . . . 71.31 110.992 -173.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.5 ttm -151.48 158.16 43.28 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.927 -0.398 . . . . 75.32 109.927 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.83 121.24 3.89 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 111.424 -0.67 . . . . 34.3 111.424 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.7 m -68.71 151.47 46.63 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.6 0.238 . . . . 71.11 111.114 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.654 ' HG ' HD13 ' A' ' 120' ' ' ILE . 6.3 mp -68.66 87.87 0.34 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.469 -0.332 . . . . 74.32 110.46 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -90.15 78.74 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 54.21 111.021 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.28 66.35 4.71 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.354 -0.61 . . . . 72.31 109.354 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -82.24 -177.05 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.355 -0.839 . . . . 72.32 111.801 -172.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.0 p -77.54 -172.79 2.68 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.681 -0.69 . . . . 71.25 110.89 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -70.1 89.51 0.63 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.039 0.447 . . . . 72.21 110.55 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.53 123.82 6.6 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.675 -0.97 . . . . 51.41 110.675 174.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.29 137.12 25.36 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.513 2.142 . . . . 73.55 112.952 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.06 45.93 0.42 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.562 -1.015 . . . . 41.04 110.562 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.1 m -59.73 88.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.401 0.62 . . . . 75.41 112.306 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.473 ' SD ' ' HG2' ' A' ' 68' ' ' GLN . 19.2 ptm -124.11 16.77 9.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.1 -0.955 . . . . 70.23 109.137 173.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -80.44 107.07 12.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.024 -0.989 . . . . 71.41 109.704 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -62.82 152.52 35.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.258 0.552 . . . . 72.2 111.762 -172.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 3.6 pt20 -124.67 125.56 44.3 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.613 -0.721 . . . . 72.45 109.528 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 31' ' ' PHE . 25.6 pt -135.7 158.11 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.697 0.284 . . . . 74.33 111.409 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.52 -179.93 52.34 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.202 -0.454 . . . . 74.35 112.442 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HB2' ' ND2' ' A' ' 84' ' ' ASN . 18.3 t70 -58.9 -56.3 24.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.098 0.475 . . . . 72.31 111.341 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.0 m -69.76 -15.61 63.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 72.51 111.344 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -84.7 -10.99 56.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 74.42 111.4 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 35' ' ' VAL . 79.5 t80 -55.28 -62.47 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.664 0.246 . . . . 74.0 111.664 -173.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.95 -45.32 95.18 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.902 0.382 . . . . 72.12 110.925 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.27 -49.82 76.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.749 -0.66 . . . . 73.25 111.421 -176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HG3' ' CG2' ' A' ' 26' ' ' ILE . 33.1 mmtp -69.34 -33.92 73.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.257 -0.429 . . . . 71.13 110.944 -176.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 31' ' ' PHE . 72.3 t -65.47 -43.2 94.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 120.876 0.37 . . . . 72.22 110.4 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.5 p -75.1 -18.51 60.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.878 0.37 . . . . 73.41 110.898 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.8 t -67.69 -2.79 7.52 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.211 -0.45 . . . . 63.12 111.329 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.736 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.3 p -57.8 148.93 23.62 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.639 -0.255 . . . . 62.44 110.567 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.5 -84.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.437 -0.347 . . . . 71.5 110.32 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -162.07 135.92 6.5 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.237 -0.653 . . . . 73.54 109.237 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 m120 65.68 9.43 5.93 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.684 0.615 . . . . 64.42 110.999 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.736 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.2 mm -76.48 115.97 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 73.34 110.552 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.7 110.8 9.29 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.121 -0.696 . . . . 74.12 109.121 175.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' A' ' 38' ' ' CYS . 27.9 mm -93.21 106.85 18.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.342 -0.844 . . . . 75.34 110.037 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.641 ' HB2' HG13 ' A' ' 76' ' ' ILE . 5.3 mp -92.38 149.63 21.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.945 -0.761 . . . . 73.41 108.945 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 58.5 t -132.23 110.99 17.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.906 -0.775 . . . . 70.13 108.906 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -94.31 159.95 14.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.259 0.552 . . . . 52.35 111.123 -173.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -128.54 83.27 2.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.113 -0.949 . . . . 71.54 109.004 165.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.467 ' CH2' HD11 ' A' ' 63' ' ' LEU . 5.5 m95 -51.37 -35.66 39.64 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.124 -0.489 . . . . 62.41 110.883 177.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 66.01 112.51 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 115.219 -0.9 . . . . 63.1 110.201 -175.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.79 -23.5 11.65 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.926 2.417 . . . . 52.41 112.811 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -127.06 88.59 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.53 . . . . 74.01 109.866 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.3 t -147.39 158.38 43.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.081 -0.509 . . . . 73.14 110.202 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.51 -77.34 1.37 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.437 -0.411 . . . . 65.43 112.701 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.47 -24.61 75.57 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.008 2.472 . . . . 73.33 112.538 -175.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 97' ' ' PRO . 57.5 m -55.58 -27.38 48.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.153 -0.476 . . . . 72.31 110.647 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -55.28 -45.02 76.17 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.94 -0.573 . . . . 75.3 111.051 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.633 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 13.0 m -74.45 -38.35 63.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.382 0.61 . . . . 72.03 110.563 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.522 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 mm? -61.03 -26.86 67.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.673 -0.694 . . . . 73.43 110.92 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 30.3 tt0 -56.52 -67.75 0.74 Allowed Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 119.333 -0.365 . . . . 73.14 110.238 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.476 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 27.8 Cg_endo -61.63 -39.41 54.33 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 121.484 1.456 . . . . 64.41 112.089 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.7 mt-30 -53.87 -52.7 59.62 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.74 -0.384 . . . . 70.35 111.433 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.467 HD11 ' CH2' ' A' ' 49' ' ' TRP . 53.7 mt -76.91 -28.28 55.25 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.792 0.293 . . . . 63.23 111.792 -175.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 93.2 mt-10 -65.37 -41.75 93.47 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.085 0.469 . . . . 74.53 109.828 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -67.34 -46.85 72.2 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.062 -0.517 . . . . 72.34 110.285 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 21.3 mt -62.85 -29.78 71.0 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.848 -0.341 . . . . 73.12 110.623 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.74 -51.34 67.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.433 -0.58 . . . . 73.51 109.433 175.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.473 ' HG2' ' SD ' ' A' ' 22' ' ' MET . 92.2 mt-30 -60.58 -32.2 71.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.837 -0.619 . . . . 72.55 111.062 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -77.16 -40.34 45.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 75.34 111.296 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -104.69 4.44 32.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.288 -0.415 . . . . 74.32 111.833 -174.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.8 t -53.01 -19.67 2.86 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.167 0.432 . . . . 71.11 112.167 -172.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -54.89 -41.91 71.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.093 -0.503 . . . . 75.24 110.187 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.438 ' HA ' HD13 ' A' ' 42' ' ' ILE . 52.3 m-80 -135.18 11.93 3.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.912 -0.586 . . . . 70.24 111.721 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.469 HG21 HD11 ' A' ' 127' ' ' ILE . 24.1 t -126.25 139.17 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 122.242 -0.286 . . . . 64.14 111.506 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -143.67 129.16 19.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.983 -0.747 . . . . 74.24 108.983 172.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.641 HG13 ' HB2' ' A' ' 45' ' ' LEU . 4.5 mp -105.63 138.28 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.08 0.466 . . . . 73.23 110.635 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 16.0 m-85 -127.42 165.06 20.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.277 -0.874 . . . . 74.42 108.963 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -161.81 165.01 28.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.344 -0.389 . . . . 74.55 110.149 173.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.4 tp -68.37 129.53 32.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 75.31 110.437 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 3.0 t-20 -95.19 -15.98 22.88 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.13 -0.486 . . . . 64.0 110.554 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.4 mt -102.62 103.31 14.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.884 -0.598 . . . . 74.44 109.908 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.3 -18.46 63.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.012 0.434 . . . . 73.05 110.901 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.43 -14.11 60.43 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.816 -0.629 . . . . 74.1 111.006 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 28' ' ' ASP . 24.4 t-20 -102.2 119.52 38.93 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.906 0.384 . . . . 74.12 111.436 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -119.31 -3.51 10.51 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.543 -0.54 . . . . 73.41 109.543 169.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.2 m-20 -48.08 -49.66 30.88 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.482 -0.781 . . . . 61.3 111.457 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -54.97 -38.9 47.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 116.224 -0.443 . . . . 74.33 110.694 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' A' ' 93' ' ' VAL . . . -69.01 -42.75 76.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.221 -0.445 . . . . 53.13 109.866 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -61.2 -38.44 86.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.564 -0.744 . . . . 62.42 110.576 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 78.3 mm-40 -69.71 -49.81 49.77 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.079 -0.509 . . . . 75.33 111.298 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -89.49 -2.45 58.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.286 -0.416 . . . . 71.54 112.027 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.19 57.09 5.34 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.137 -0.554 . . . . 33.24 112.977 171.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 88' ' ' ALA . 86.6 t -82.42 92.77 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.698 -0.482 . . . . 74.43 109.698 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.3 t -89.41 -34.12 16.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.775 -0.648 . . . . 75.31 110.617 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.66 143.83 28.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 61.41 110.149 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.735 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 50.2 mm -59.29 -52.64 72.97 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.494 -0.321 . . . . 74.44 110.691 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.735 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 58.2 Cg_endo -93.52 112.38 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.472 2.115 . . . . 73.12 111.145 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.414 ' C ' HD13 ' A' ' 99' ' ' ILE . 64.2 m -136.97 141.91 42.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.92 0.39 . . . . 74.44 111.247 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.559 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -123.44 119.19 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.606 -0.724 . . . . 71.31 109.939 174.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.476 HD22 ' HG3' ' A' ' 110' ' ' GLN . 91.3 mt -94.83 129.43 41.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.063 -0.717 . . . . 74.23 109.063 174.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 109' ' ' SER . 44.4 mtp -106.47 138.53 42.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.036 -0.357 . . . . 73.34 110.036 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.485 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 100.0 m-85 -143.63 165.44 27.62 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.467 -0.568 . . . . 73.14 109.467 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.456 ' HZ3' ' HB3' ' A' ' 126' ' ' ASN . 40.0 ttmt -151.78 104.87 3.06 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 122.245 -0.284 . . . . 63.1 110.948 175.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.722 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 57.6 t30 47.68 56.07 7.6 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.368 0.604 . . . . 64.22 110.914 177.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.88 -16.78 3.11 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.441 -0.8 . . . . 54.34 113.791 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 63.2 tttp -80.88 143.43 32.71 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 117.082 0.441 . . . . 62.22 110.141 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -71.97 145.59 48.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.58 0.705 . . . . 71.52 111.076 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -146.39 167.75 22.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.587 -1.264 . . . . 70.33 107.587 -172.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 101' ' ' MET . 60.1 m -70.19 -177.79 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.419 0.628 . . . . 72.02 112.66 -164.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.476 ' HG3' HD22 ' A' ' 100' ' ' LEU . 54.7 tt0 -138.46 129.52 26.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 75.22 109.51 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.559 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.0 t -100.53 107.51 21.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.069 0.461 . . . . 64.04 110.231 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.476 HD13 ' N ' ' A' ' 112' ' ' ILE . 3.3 mp -86.71 110.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.567 -0.742 . . . . 73.33 109.435 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.406 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 99.43 155.08 28.48 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.56 -0.616 . . . . 30.23 111.56 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.522 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -80.04 72.16 6.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.844 0.354 . . . . 43.44 110.95 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.449 ' O ' HG13 ' A' ' 119' ' ' ILE . 18.0 t70 -111.08 96.95 6.45 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.598 0.713 . . . . 74.11 110.505 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.59 -34.41 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.141 -0.936 . . . . 73.1 110.263 -173.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.1 p -63.13 -43.34 98.64 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.274 -0.421 . . . . 62.2 111.056 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.84 -43.85 78.57 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.715 -0.476 . . . . 75.41 109.715 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 115' ' ' ASP . 70.8 mt -56.05 -56.48 12.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-N 116.015 -0.539 . . . . 74.14 110.838 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.654 HD13 ' HG ' ' A' ' 12' ' ' LEU . 15.7 tt -65.52 -33.87 66.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.854 -0.612 . . . . 72.25 110.586 -176.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.5 t -57.33 -51.93 67.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.229 -0.441 . . . . 61.23 110.111 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -60.66 -45.3 94.63 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.589 -0.278 . . . . 73.41 110.372 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 119' ' ' ILE . 72.7 mt -52.56 -56.04 8.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 116.107 -0.497 . . . . 71.3 111.182 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -68.21 -32.96 73.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.658 0.266 . . . . 74.24 110.632 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -61.75 -36.49 81.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.145 0.498 . . . . 72.13 110.228 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.456 ' HB3' ' HZ3' ' A' ' 103' ' ' LYS . 27.2 m-80 -85.4 -28.78 24.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 72.24 112.144 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.469 HD11 HG21 ' A' ' 74' ' ' VAL . 52.6 mt -103.74 -60.69 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.142 0.496 . . . . 72.41 112.232 -178.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.383 -0.826 . . . . 65.44 110.921 -166.784 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 tpp . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 121.001 0.429 . . . . 63.42 110.451 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.61 135.69 43.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 74.15 110.671 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -156.21 145.88 21.0 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.284 -1.006 . . . . 75.03 108.284 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -83.63 164.68 19.56 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.094 -0.335 . . . . 70.53 110.094 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -121.98 34.99 5.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.23 -1.026 . . . . 74.02 108.23 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -101.74 91.77 4.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.894 -1.503 . . . . 74.22 109.754 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -75.24 111.33 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 71.31 109.937 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -93.73 111.82 23.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.488 -0.778 . . . . 73.1 110.228 -173.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -136.48 158.52 44.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.967 0.413 . . . . 72.35 110.969 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.12 116.24 0.39 Allowed Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.023 -0.831 . . . . 62.4 111.023 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -124.83 159.82 30.16 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.84 0.352 . . . . 73.41 110.836 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.584 ' H ' ' NE2' ' A' ' 85' ' ' GLN . 97.8 mt -131.0 -67.38 0.71 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.946 -0.57 . . . . 64.53 109.93 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -120.31 154.24 35.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.25 -0.432 . . . . 71.11 109.918 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.08 129.04 36.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.2 -0.296 . . . . 15.35 110.2 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.494 ' HG3' ' HB3' ' A' ' 82' ' ' GLU . 23.7 mt-30 -99.16 158.33 15.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.573 -0.285 . . . . 72.2 110.769 -177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 p -83.58 -77.97 0.24 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.176 -0.466 . . . . 74.24 111.885 -176.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -174.44 -177.5 1.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.837 0.351 . . . . 71.13 110.429 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.27 161.04 20.66 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.263 -0.735 . . . . 62.43 111.263 171.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.05 -10.48 19.55 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.518 2.145 . . . . 70.01 112.333 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.87 68.91 1.47 Allowed Glycine 0 C--N 1.334 0.425 0 N-CA-C 111.109 -0.797 . . . . 75.15 111.109 -176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -142.51 -167.19 2.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.46 0.172 . . . . 72.33 110.689 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 88.1 mmm -59.73 -16.88 30.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.248 0.547 . . . . 54.3 110.483 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.434 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 13.0 mm -83.19 123.26 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.367 -0.833 . . . . 51.53 109.878 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HG3' HG22 ' A' ' 26' ' ' ILE . 6.2 tp10 -74.27 160.24 31.38 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 123.165 0.29 . . . . 75.43 110.245 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.413 ' N ' ' HG3' ' A' ' 24' ' ' GLU . 25.4 pt20 -133.85 115.89 15.0 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 110.026 -0.361 . . . . 65.13 110.026 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.514 HG21 ' HG3' ' A' ' 34' ' ' LYS . 21.5 pt -139.9 179.98 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.305 0.483 . . . . 63.42 112.305 -170.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.0 -157.14 9.9 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.392 -0.822 . . . . 70.42 111.293 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -68.21 -51.03 50.03 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.147 0.474 . . . . 64.14 111.24 -176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 t -58.21 -43.84 87.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 61.41 110.356 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -83.12 -13.11 56.29 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.502 -0.317 . . . . 71.21 111.691 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.478 ' HA ' HD11 ' A' ' 26' ' ' ILE . 89.3 t80 -58.18 -57.7 11.69 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.961 -0.755 . . . . 74.34 108.961 175.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.61 -51.43 69.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 65.32 110.638 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -52.73 -57.42 10.18 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.307 0.379 . . . . 73.44 111.215 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HG3' HG21 ' A' ' 26' ' ' ILE . 34.6 mmtp -69.38 -37.02 77.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 73.32 111.59 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.38 -45.17 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 121.197 -0.201 . . . . 73.1 110.704 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.5 p -75.2 -24.7 57.81 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.881 -0.328 . . . . 63.32 111.243 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.7 t -70.04 -7.88 44.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.501 -0.318 . . . . 61.43 111.699 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.921 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 26.8 p -59.35 137.28 58.05 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.652 -0.499 . . . . 63.34 109.652 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -48.38 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.415 0.447 . . . . 72.41 111.142 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -161.98 145.37 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.449 -0.574 . . . . 74.31 109.449 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 48.22 13.14 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.084 0.954 . . . . 74.42 113.32 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.65 136.66 26.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.275 -0.268 . . . . 75.44 110.275 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -85.35 113.15 21.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.459 0.647 . . . . 70.2 109.301 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.1 mt -106.95 139.39 28.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.152 -0.931 . . . . 73.42 110.624 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.552 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -120.82 139.48 53.09 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.172 -1.047 . . . . 63.31 108.172 170.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.452 HG23 ' HB2' ' A' ' 77' ' ' TYR . 97.1 t -127.26 104.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.192 -0.67 . . . . 71.45 109.192 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -101.39 150.52 22.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.012 -0.54 . . . . 62.13 109.724 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -85.22 157.39 20.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.426 -0.352 . . . . 72.12 110.328 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -51.35 -37.98 50.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.121 -0.49 . . . . 75.33 111.866 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 68.17 144.09 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 123.842 0.714 . . . . 73.41 111.622 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -90.81 -167.58 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.773 2.316 . . . . 74.3 111.888 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -60.52 97.7 0.06 Allowed 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.533 -0.543 . . . . 74.23 109.533 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 11.5 t -132.69 127.52 34.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.881 -0.6 . . . . 74.02 111.016 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.54 -67.8 2.01 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.909 -0.587 . . . . 61.12 113.327 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -56.6 -38.49 95.4 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.45 2.1 . . . . 73.52 111.574 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 21.7 m -61.76 -32.12 72.35 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.905 -0.589 . . . . 60.44 110.804 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.57 -47.46 73.25 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.975 -0.557 . . . . 65.13 110.559 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.565 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 47.2 t -74.95 -36.27 62.1 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.518 0.675 . . . . 62.41 110.52 177.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 1.3 mm? -55.03 -44.6 74.8 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.475 -0.784 . . . . 74.14 112.059 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.05 -56.86 30.68 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 119.374 -0.346 . . . . 72.34 111.543 -176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HG2' ' O ' ' A' ' 58' ' ' SER . 10.0 Cg_endo -54.14 -38.14 87.53 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.739 1.626 . . . . 61.12 111.748 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 58' ' ' SER . 36.8 mt-30 -61.94 -39.64 92.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.753 -0.379 . . . . 74.4 110.956 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 80.3 mt -67.33 -36.92 82.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.425 -0.352 . . . . 63.44 110.147 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 42.8 mt-10 -59.4 -47.85 83.89 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.491 -0.559 . . . . 71.22 109.491 174.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -55.31 -50.61 69.13 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.578 -0.737 . . . . 74.21 110.566 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.482 HD12 HD13 ' A' ' 116' ' ' ILE . 23.1 mt -65.43 -37.14 86.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 64.41 110.443 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.518 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.98 -31.83 72.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 65.41 110.742 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 54.7 mt-30 -76.81 -50.59 13.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.001 0.429 . . . . 65.23 110.541 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -64.11 -41.19 97.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.745 -0.661 . . . . 74.43 110.715 -175.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -99.11 5.56 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 72.53 112.178 -174.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.518 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.3 t -52.73 -19.57 2.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.762 0.653 . . . . 55.13 112.762 -170.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.16 -33.7 75.98 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.839 0.352 . . . . 64.1 110.971 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -126.2 -4.5 6.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.317 -0.401 . . . . 73.25 112.072 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.63 138.69 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.956 0.407 . . . . 72.22 111.726 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -142.95 121.68 12.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.703 -0.68 . . . . 74.03 109.833 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.552 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.1 mt -111.55 144.49 19.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 120.939 0.4 . . . . 75.24 111.197 -177.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.475 ' CE1' ' HB3' ' A' ' 34' ' ' LYS . 96.3 m-85 -130.56 136.36 48.83 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.558 -0.746 . . . . 75.25 110.213 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HG3' ' CG2' ' A' ' 23' ' ' ILE . 29.4 mtpp -107.97 134.04 51.45 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.582 -0.525 . . . . 64.22 109.582 173.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.3 mt -73.42 104.65 2.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.805 -0.813 . . . . 71.34 108.805 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.41 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 23.9 t-20 -98.95 -39.75 8.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.172 -0.467 . . . . 72.33 111.685 -173.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.4 mm -79.64 105.24 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.492 -0.322 . . . . 62.12 110.899 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -59.61 -24.74 64.06 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.795 -0.638 . . . . 75.23 111.986 -178.536 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -71.4 -5.1 30.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.127 0.489 . . . . 54.34 110.621 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -124.59 29.12 6.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 44.54 111.136 -176.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.584 ' NE2' ' H ' ' A' ' 12' ' ' LEU . 40.3 mt-30 -69.07 -7.34 34.92 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.352 -0.385 . . . . 64.25 110.916 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -47.11 -38.71 11.94 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.047 -0.524 . . . . 71.3 110.909 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -53.06 -41.67 42.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 115.703 -0.681 . . . . 53.22 110.894 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.0 -41.48 96.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.619 -0.719 . . . . 75.44 110.499 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.5 m -69.5 -38.04 77.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.738 -0.665 . . . . 75.44 110.454 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -58.5 -51.69 68.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.972 -0.558 . . . . 75.22 110.842 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -77.11 -25.69 52.44 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 121.013 -0.275 . . . . 74.32 111.201 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 51.84 9.35 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.572 -0.823 . . . . 71.05 111.045 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.412 HG23 HG21 ' A' ' 98' ' ' THR . 7.7 p -59.71 135.77 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.258 -0.471 . . . . 71.14 111.305 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -69.84 -38.12 76.41 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.883 -0.598 . . . . 73.0 111.913 -174.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.42 164.03 34.64 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.464 -0.148 . . . . 73.13 110.874 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.605 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 48.2 mm -61.41 -48.69 90.21 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.543 -0.299 . . . . 54.15 110.836 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 3.6 Cg_exo -80.13 101.49 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.978 1.785 . . . . 75.44 110.552 172.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.412 HG21 HG23 ' A' ' 93' ' ' VAL . 97.1 m -153.2 146.63 24.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.326 -0.397 . . . . 73.44 110.576 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.578 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -118.37 116.26 50.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.035 -0.53 . . . . 72.41 110.089 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.439 HD23 ' HG3' ' A' ' 110' ' ' GLN . 89.1 mt -94.91 123.43 38.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.21 -0.663 . . . . 74.02 109.21 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 109' ' ' SER . 51.4 mtp -92.77 147.97 22.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.144 -0.317 . . . . 73.02 110.144 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.2 m-85 -144.92 161.09 40.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.551 -0.537 . . . . 75.41 109.551 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 20.7 ttmm -148.5 105.01 3.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.629 0.252 . . . . 73.12 110.568 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.921 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 65.7 t30 57.02 39.72 29.13 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.32 0.581 . . . . 71.33 110.692 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.98 -16.05 23.72 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.944 -0.571 . . . . 61.0 112.768 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 62.1 tttp -75.96 148.93 37.78 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 110.132 -0.321 . . . . 71.43 110.132 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -65.1 157.25 29.07 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.411 0.624 . . . . 71.1 110.903 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.26 167.9 23.2 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.358 -1.349 . . . . 72.55 107.358 -167.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 101' ' ' MET . 38.7 m -70.44 178.64 2.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.425 0.631 . . . . 61.43 112.369 -167.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.439 ' HG3' HD23 ' A' ' 100' ' ' LEU . 59.0 tt0 -134.25 130.39 37.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.734 -0.666 . . . . 63.1 110.621 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.578 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.4 t -101.1 107.31 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.044 -0.724 . . . . 73.44 109.044 173.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.8 mt -87.48 109.14 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.144 -0.48 . . . . 75.22 110.095 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.8 -147.75 16.42 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.395 -0.682 . . . . 62.22 111.395 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.51 ' HB2' ' HG ' ' A' ' 59' ' ' LEU . . . -132.21 96.26 3.84 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.413 -0.217 . . . . 74.3 110.413 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -139.56 103.48 4.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.213 0.53 . . . . 70.41 110.473 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.482 HD13 HD12 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -63.34 -28.32 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 64.1 110.143 -175.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.3 m -62.9 -53.45 53.88 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.974 -0.557 . . . . 60.02 110.224 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -60.8 -44.36 96.95 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.09 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.459 HD12 HD22 ' A' ' 63' ' ' LEU . 66.0 mt -55.45 -56.12 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.964 -0.562 . . . . 64.3 111.316 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.6 tp -64.21 -34.46 69.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.526 0.203 . . . . 61.41 110.717 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.4 m -58.14 -50.69 72.61 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.538 -0.301 . . . . 61.15 110.468 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.82 -38.12 85.83 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.593 -0.276 . . . . 74.32 111.472 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.6 mt -58.65 -56.01 19.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.962 0.41 . . . . 64.3 110.115 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.78 -39.11 83.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 63.43 110.365 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -60.29 -39.84 88.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.486 -0.779 . . . . 73.12 111.215 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -100.57 -2.4 33.01 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 112.173 0.434 . . . . 72.41 112.173 -174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.0 mt -90.92 -55.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.671 -0.492 . . . . 53.32 109.671 168.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--O 1.251 1.149 0 CA-C-N 115.811 -0.631 . . . . 54.51 109.548 -179.841 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 3' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.874 -0.417 . . . . 71.14 109.874 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.68 79.91 1.53 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.142 0.496 . . . . 71.53 110.486 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.465 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 3.9 t-160 -103.97 101.7 11.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.516 -0.766 . . . . 74.52 110.643 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -67.94 142.56 55.98 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.545 -0.298 . . . . 72.23 110.273 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -120.14 75.29 1.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.709 0.29 . . . . 75.25 110.292 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.23 149.78 0.16 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.399 0.68 . . . . 65.34 109.3 177.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -157.49 163.76 38.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.861 0.362 . . . . 73.1 110.782 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -128.02 163.97 23.38 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.279 -0.637 . . . . 74.15 109.279 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.8 tpt -134.08 131.0 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.807 0.337 . . . . 74.31 110.102 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.9 112.34 3.57 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.063 -0.517 . . . . 62.02 112.175 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -92.2 98.97 11.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.661 0.267 . . . . 75.45 110.554 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.78 133.25 53.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.071 0.462 . . . . 74.24 110.609 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.02 -178.63 3.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.63 -0.714 . . . . 74.21 109.413 176.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.14 111.21 5.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.899 0.381 . . . . 63.22 111.66 -176.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -92.85 108.04 19.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.252 -0.647 . . . . 52.43 109.252 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.0 p -122.24 145.74 47.93 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.969 0.414 . . . . 74.45 111.423 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -133.23 172.83 12.15 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.807 -0.633 . . . . 74.25 109.583 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.87 162.45 28.32 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.921 -0.657 . . . . 62.43 112.726 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.92 -168.95 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.941 2.427 . . . . 71.45 111.965 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.99 144.43 7.2 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.198 -0.525 . . . . 61.15 112.203 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 t 76.83 14.59 2.08 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.412 0.685 . . . . 64.52 111.621 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 90.7 mmm -80.02 -36.24 36.14 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.556 -0.905 . . . . 73.14 108.556 172.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.442 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 10.7 mm -75.89 99.78 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 114.995 -1.002 . . . . 73.15 108.788 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.03 161.57 24.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.231 -0.44 . . . . 73.43 110.786 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.68 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 4.3 pm0 -125.67 122.82 37.45 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.885 0.374 . . . . 73.1 110.24 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.514 HD11 ' HA ' ' A' ' 31' ' ' PHE . 34.4 pt -139.09 -179.75 2.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 122.942 0.497 . . . . 73.43 110.834 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.484 ' HA3' ' ND2' ' A' ' 84' ' ' ASN . . . -129.45 -157.57 9.22 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.904 -0.589 . . . . 64.21 111.944 176.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.4 -56.7 7.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.952 0.406 . . . . 73.21 111.123 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.5 m -62.78 -19.3 63.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 64.31 111.358 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -96.07 -22.11 17.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.51 -0.314 . . . . 74.03 110.89 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.514 ' HA ' HD11 ' A' ' 26' ' ' ILE . 93.1 t80 -56.36 -62.32 1.8 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.81 0.338 . . . . 73.44 111.409 -174.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -59.21 -46.8 87.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 74.43 110.366 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -54.3 -55.83 24.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.064 -0.971 . . . . 73.2 111.404 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -65.68 -41.43 92.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.057 -0.519 . . . . 73.35 111.51 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.482 HG21 HG22 ' A' ' 44' ' ' ILE . 91.1 t -70.04 -29.24 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.116 0.26 . . . . 64.11 111.646 -177.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.5 p -85.95 -31.11 22.28 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.936 0.398 . . . . 74.13 111.142 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -76.86 10.97 1.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.031 -0.531 . . . . 75.23 111.25 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.964 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 9.3 p -73.2 -0.18 13.57 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.864 0.32 . . . . 73.34 111.864 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 t30 70.87 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.173 0.589 . . . . 71.04 111.869 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -162.17 137.35 7.17 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.531 0.567 . . . . 74.42 112.531 -177.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 61.56 2.72 0.72 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 60.32 113.614 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.774 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.9 mm -79.91 114.69 21.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.928 -0.397 . . . . 75.52 109.928 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tt -79.33 115.99 19.3 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.854 -0.612 . . . . 74.31 109.662 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.482 HG22 HG21 ' A' ' 35' ' ' VAL . 15.6 mm -99.2 120.04 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.458 -0.792 . . . . 74.4 110.214 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.592 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.2 mp -107.48 113.75 27.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.959 -0.756 . . . . 74.01 108.959 174.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -104.82 104.91 17.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.862 0.363 . . . . 51.21 110.963 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.657 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 7.7 t70 -80.55 148.05 30.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.758 -0.656 . . . . 61.21 109.464 172.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -74.24 -74.55 0.19 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.208 -0.664 . . . . 71.32 109.208 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.519 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 36.9 p90 179.54 138.7 0.11 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.384 -0.826 . . . . 74.34 109.06 174.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.06 100.7 9.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.544 -0.298 . . . . 73.02 110.224 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 49' ' ' TRP . 72.2 Cg_endo -92.26 -95.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.936 2.424 . . . . 64.24 112.277 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -104.72 112.1 25.06 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.623 -0.51 . . . . 72.24 109.623 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.499 ' HB3' ' HB2' ' A' ' 56' ' ' CYS . 21.1 t -172.37 167.05 5.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.131 -0.486 . . . . 73.22 110.327 -175.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.468 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -76.48 -95.94 0.17 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.917 -0.659 . . . . 31.21 112.171 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.19 -17.4 56.55 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.836 2.357 . . . . 72.12 112.478 -175.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 55.9 m -57.63 -34.95 69.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 74.11 111.206 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 10.4 ptp180 -64.44 -36.98 85.92 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.889 0.376 . . . . 75.42 110.449 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.528 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 11.5 t -75.26 -26.78 59.09 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.481 0.658 . . . . 71.31 110.551 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 114' ' ' ALA . 9.4 tp -64.22 -41.06 97.18 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.762 -0.653 . . . . 71.13 111.877 -171.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.465 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 49.2 mt-10 -55.92 -53.22 65.5 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 120.782 -0.367 . . . . 72.01 110.183 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 12.0 Cg_exo -52.65 -43.13 57.73 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.889 1.726 . . . . 63.23 112.255 170.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 58' ' ' SER . 35.3 mt-30 -65.72 -32.9 74.71 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.114 -0.635 . . . . 64.54 110.781 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.416 HD22 HD12 ' A' ' 119' ' ' ILE . 53.9 mt -70.11 -37.57 75.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.447 -0.797 . . . . 73.32 109.715 178.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.415 ' OE2' HG12 ' A' ' 23' ' ' ILE . 18.4 mm-40 -58.13 -46.37 85.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.352 -0.385 . . . . 73.0 109.973 171.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -55.87 -54.46 44.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.009 -0.542 . . . . 73.21 110.392 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.5 HD13 HD13 ' A' ' 116' ' ' ILE . 18.8 mt -63.55 -36.56 84.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.022 -0.535 . . . . 63.13 110.568 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.489 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.79 -33.26 75.27 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.784 -0.644 . . . . 65.32 110.629 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -78.33 -47.67 17.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 65.13 110.947 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -61.42 -38.94 88.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.079 -0.51 . . . . 74.15 110.873 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -104.88 5.76 33.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.42 -0.809 . . . . 72.34 112.269 -173.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.2 t -52.48 -23.26 5.87 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.811 1.041 . . . . 72.45 113.811 -166.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.95 -36.46 77.96 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.595 -0.442 . . . . 74.34 110.67 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -114.33 -4.73 12.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 70.11 111.676 -175.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.7 t -130.34 150.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.005 0.372 . . . . 73.23 112.005 -174.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -151.69 125.46 9.04 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.905 -0.589 . . . . 75.32 109.735 172.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.592 HG12 ' HB2' ' A' ' 45' ' ' LEU . 62.3 mt -101.54 142.56 15.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 120.889 0.376 . . . . 75.32 110.593 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.407 ' CD2' HD13 ' A' ' 26' ' ' ILE . 34.7 m-85 -128.02 168.49 15.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.554 -0.748 . . . . 74.23 109.188 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.657 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 8.4 ptpp? -147.39 163.15 37.37 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.705 -0.48 . . . . 63.25 109.705 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mt -81.87 114.32 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.253 -0.647 . . . . 74.34 109.253 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.68 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 11.9 t30 -73.14 -36.79 66.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.927 -0.578 . . . . 74.04 112.272 -173.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.494 HG13 ' H ' ' A' ' 83' ' ' ASP . 9.2 tp -135.62 143.26 37.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.951 0.405 . . . . 73.21 111.281 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.46 -18.73 60.3 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.673 -0.694 . . . . 71.21 112.009 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.494 ' H ' HG13 ' A' ' 81' ' ' ILE . 8.3 m-20 -71.27 -22.64 61.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.313 0.578 . . . . 74.33 110.288 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.484 ' ND2' ' HA3' ' A' ' 27' ' ' GLY . 92.3 m-20 -96.88 20.9 10.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.778 -0.646 . . . . 74.33 110.534 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.63 -13.96 61.91 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.813 -0.631 . . . . 70.15 110.201 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -44.69 -42.41 7.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.471 -0.786 . . . . 54.21 111.742 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.4 t -53.17 -42.23 45.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.14 -0.482 . . . . 72.51 111.196 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.22 80.8 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.957 -0.565 . . . . 72.3 110.495 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.8 m -66.54 -35.46 80.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.711 -0.677 . . . . 73.41 110.992 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.49 -47.96 71.34 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.253 -0.431 . . . . 74.01 110.839 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -71.13 -24.12 62.21 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.206 -0.452 . . . . 72.21 110.984 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.67 39.44 7.65 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 121.071 -0.585 . . . . 73.02 112.77 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.8 t -90.66 125.59 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.53 -0.544 . . . . 65.43 109.53 177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.1 t -104.39 17.64 23.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.701 0.286 . . . . 75.31 111.362 -174.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -126.88 139.8 52.81 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.221 -0.289 . . . . 71.42 110.221 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.534 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 2.2 mp -78.04 -56.45 1.05 Allowed Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.663 -0.244 . . . . 74.45 110.985 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.534 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 90.9 Cg_endo -79.87 78.67 3.61 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.716 1.611 . . . . 74.51 111.515 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.6 m -127.34 135.25 50.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.864 -0.607 . . . . 71.22 111.164 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 99' ' ' ILE . 2.8 mp -110.22 111.74 37.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.472 -0.786 . . . . 64.41 109.702 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.432 HD11 ' N ' ' A' ' 100' ' ' LEU . 6.4 mp -88.64 141.27 28.65 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.318 -0.623 . . . . 70.03 109.318 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.529 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 36.2 mtp -110.18 140.46 44.27 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.854 -0.425 . . . . 65.13 109.854 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -146.66 144.49 29.52 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.569 -0.9 . . . . 72.3 108.569 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HB2' HD21 ' A' ' 108' ' ' LEU . 38.2 ttpt -126.47 104.91 8.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.16 -0.616 . . . . 63.45 110.596 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.964 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.8 t30 50.79 47.51 24.42 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.561 0.696 . . . . 74.01 110.809 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.26 -16.19 35.39 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.559 -0.746 . . . . 73.3 112.955 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -70.07 134.25 48.03 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.917 0.358 . . . . 61.52 110.475 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -61.42 144.32 54.32 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.044 0.84 . . . . 71.34 109.132 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.6 tp -158.73 168.43 26.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.944 -0.571 . . . . 43.11 109.636 -163.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 101' ' ' MET . 37.8 m -69.47 179.64 2.0 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.069 0.548 . . . . 64.32 111.845 -167.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -144.44 124.76 13.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 72.33 110.057 -174.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.43 108.88 22.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.41 . . . . 73.14 110.227 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.483 HD13 ' N ' ' A' ' 112' ' ' ILE . 3.3 mp -87.55 101.72 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.048 -0.524 . . . . 74.15 109.651 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.88 -176.76 20.79 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.154 -0.546 . . . . 31.3 112.816 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . . . -92.86 76.82 4.82 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.834 0.453 . . . . 73.03 111.271 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -117.79 83.52 2.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.499 0.666 . . . . 73.21 109.458 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.511 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -59.14 -30.47 43.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.093 -0.958 . . . . 72.14 110.241 -174.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.6 m -58.66 -53.22 60.84 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.13 -0.487 . . . . 63.53 110.478 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -65.39 -41.25 93.9 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 116.48 -0.327 . . . . 74.13 110.359 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 123' ' ' ILE . 76.2 mt -55.72 -56.24 13.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.246 -0.434 . . . . 75.32 110.808 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.85 -34.33 69.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 116.443 -0.344 . . . . 75.53 110.418 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 t -58.7 -52.09 67.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.061 -0.518 . . . . 73.21 109.736 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -62.33 -40.36 96.09 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.343 -0.389 . . . . 74.22 111.108 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.462 HD12 HD11 ' A' ' 66' ' ' LEU . 64.9 mt -52.66 -55.76 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.769 0.319 . . . . 75.13 110.379 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -68.96 -29.82 68.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 75.3 110.777 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -68.34 -33.91 75.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 63.33 111.368 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.504 ' OD1' HD13 ' A' ' 108' ' ' LEU . 66.0 m-80 -98.49 -24.15 15.26 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.119 0.415 . . . . 72.33 112.119 -175.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 123' ' ' ILE . 61.6 mt -71.49 -59.5 3.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.951 0.405 . . . . 72.22 110.153 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.726 -0.67 . . . . 71.03 110.434 -177.713 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.88 -0.415 . . . . 73.33 109.88 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.75 124.0 23.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 72.53 111.247 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -122.06 99.39 6.41 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.034 -0.728 . . . . 73.4 109.034 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -101.34 152.73 20.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 73.0 111.531 -174.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -133.54 129.69 37.43 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.264 -0.643 . . . . 53.4 109.264 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -140.28 161.84 36.71 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.975 0.417 . . . . 73.13 111.464 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -157.46 172.51 18.44 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.422 -0.808 . . . . 74.23 109.19 175.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -117.46 92.58 3.88 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.258 0.551 . . . . 73.53 110.661 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptm 176.13 174.3 0.33 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.085 -0.961 . . . . 72.21 109.028 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.4 ' HA2' ' OD1' ' A' ' 83' ' ' ASP . . . 107.61 48.27 0.92 Allowed Glycine 0 C--O 1.237 0.311 0 C-N-CA 120.702 -0.761 . . . . 41.45 112.326 177.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 t -172.15 123.07 0.49 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.185 0.516 . . . . 64.33 112.309 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -154.52 -50.26 0.09 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.692 -0.685 . . . . 71.0 109.618 167.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 173.22 110.61 0.01 OUTLIER 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.844 0.458 . . . . 72.34 110.738 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.555 ' HB1' ' HB3' ' A' ' 82' ' ' GLU . . . -154.28 138.17 16.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 71.42 109.98 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -68.67 132.0 46.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.414 -0.357 . . . . 74.05 110.054 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.6 p -60.4 94.11 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.009 -0.541 . . . . 74.31 112.408 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 62.61 -169.7 0.18 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.334 -0.848 . . . . 74.24 112.513 169.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.89 -88.86 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 110.644 -0.982 . . . . 60.22 110.644 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.73 -171.22 0.94 Allowed 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.87 2.38 . . . . 75.31 111.46 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.7 63.41 0.01 OUTLIER Glycine 0 C--N 1.33 0.222 0 N-CA-C 111.421 -0.672 . . . . 65.44 111.421 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -134.53 -138.0 0.17 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.885 -0.413 . . . . 74.54 109.885 -172.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 91.4 mmm -56.55 -24.79 49.39 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.12 0.486 . . . . 73.53 110.498 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.5 mm -83.37 105.86 13.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.651 -0.704 . . . . 75.13 109.131 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -78.25 161.48 27.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 62.35 109.994 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.674 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 10.1 pt20 -137.21 133.13 34.8 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.858 0.361 . . . . 74.14 110.924 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.489 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 32.6 pt -144.69 179.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.169 -0.469 . . . . 65.32 110.984 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.548 ' HA3' HD11 ' A' ' 81' ' ' ILE . . . -117.96 -165.54 13.53 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.131 -0.486 . . . . 72.43 112.02 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.67 -51.28 51.57 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.693 0.397 . . . . 74.4 110.687 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 m -56.16 -24.79 43.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.879 -0.6 . . . . 74.24 110.754 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.519 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 42.6 mt-10 -95.07 -31.25 13.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.784 -0.644 . . . . 72.24 110.421 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.46 ' HA ' HD12 ' A' ' 26' ' ' ILE . 92.8 t80 -50.14 -61.91 1.88 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.968 -0.56 . . . . 74.24 111.843 -171.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 36' ' ' THR . 8.4 t70 -53.56 -56.44 17.05 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 123.382 0.426 . . . . 72.22 110.516 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 37' ' ' SER . 0.9 OUTLIER -54.09 -57.3 11.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 73.4 111.509 -176.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 75.5 mmtt -56.43 -38.79 72.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.848 0.356 . . . . 73.31 110.33 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.464 ' HA ' HD13 ' A' ' 44' ' ' ILE . 3.9 t -66.79 -54.81 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.93 -0.577 . . . . 73.32 111.915 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 32' ' ' ASP . 9.4 t -76.51 -7.48 55.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.699 0.285 . . . . 73.0 111.039 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 22.6 t -74.58 -5.0 40.37 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.392 -0.367 . . . . 65.55 111.667 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.418 ' SG ' ' O ' ' A' ' 35' ' ' VAL . 62.1 m -57.11 96.35 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 110.165 -0.309 . . . . 65.3 110.165 176.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -51.11 -44.63 61.33 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.502 0.501 . . . . 71.41 111.24 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -155.78 121.39 4.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.697 0.284 . . . . 75.33 110.981 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 41.89 24.9 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.547 1.314 . . . . 73.21 114.547 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.8 mm -70.09 100.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.475 -0.565 . . . . 73.11 109.475 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.78 114.88 6.74 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.239 0.542 . . . . 75.04 110.333 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.464 HD13 ' HA ' ' A' ' 35' ' ' VAL . 34.9 mt -104.05 120.5 54.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.299 -0.864 . . . . 74.11 110.833 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.485 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.5 mp -105.13 110.87 23.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.11 -0.7 . . . . 61.35 109.11 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 61.1 t -95.55 110.16 23.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.525 -0.176 . . . . 73.02 110.525 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.426 ' CG ' ' HZ3' ' A' ' 78' ' ' LYS . 2.1 p-10 -91.08 129.65 37.06 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.291 0.567 . . . . 53.12 110.656 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -96.34 85.0 3.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.388 -0.967 . . . . 74.22 108.388 170.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.459 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 3.7 p-90 -63.73 147.76 50.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.965 -1.016 . . . . 73.35 112.092 -175.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.34 118.88 28.69 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.326 -0.852 . . . . 53.44 109.165 172.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.23 162.01 35.08 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.128 1.885 . . . . 74.23 111.516 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.7 m95 65.17 12.35 7.92 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.74 0.416 . . . . 72.34 111.246 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.0 t -87.19 138.2 31.69 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.343 -0.39 . . . . 40.44 110.92 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.69 -68.4 1.56 Allowed Glycine 0 CA--C 1.524 0.617 0 CA-C-N 116.113 -0.494 . . . . 73.13 112.823 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.92 -39.26 82.78 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.619 2.213 . . . . 60.34 112.386 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.9 m -54.05 -32.92 56.0 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.239 -0.437 . . . . 74.32 110.712 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -56.26 -46.4 79.67 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.428 -0.805 . . . . 75.24 110.908 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.623 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 46.0 t -74.89 -39.09 61.69 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.666 0.746 . . . . 62.42 110.583 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 114' ' ' ALA . 3.3 mm? -52.88 -45.72 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.113 -0.949 . . . . 72.21 111.989 -175.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 32.3 mt-10 -59.01 -58.57 18.56 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 119.133 -0.46 . . . . 75.24 111.58 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.401 ' HG2' ' O ' ' A' ' 58' ' ' SER . 9.8 Cg_endo -54.78 -40.53 84.4 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 121.81 1.673 . . . . 73.53 112.165 176.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.3 mt-30 -58.28 -46.49 85.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.145 0.497 . . . . 71.55 110.427 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 81.8 mt -69.65 -28.45 65.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.86 -0.609 . . . . 62.41 110.6 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 44.6 mt-10 -63.78 -44.22 94.01 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.575 -0.528 . . . . 73.24 109.575 175.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -63.32 -49.93 72.03 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.394 -0.366 . . . . 63.52 110.211 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.418 HD11 HD12 ' A' ' 116' ' ' ILE . 28.1 mt -60.56 -32.95 72.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.455 . . . . 74.43 110.465 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.482 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.28 -50.36 70.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.52 -0.548 . . . . 64.5 109.52 176.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.3 mt-30 -57.78 -39.16 76.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.249 0.547 . . . . 75.52 110.734 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -70.05 -45.39 67.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.259 -0.882 . . . . 71.12 111.249 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -104.58 5.02 33.49 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.874 -0.603 . . . . 74.33 112.373 -171.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.6 t -52.88 -19.85 2.86 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.223 0.824 . . . . 75.22 113.223 -169.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.12 -37.36 84.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.008 0.432 . . . . 54.31 110.63 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -124.0 -2.83 8.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.771 -0.649 . . . . 71.53 111.639 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -127.07 136.88 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.184 0.516 . . . . 54.24 112.209 -173.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 20.6 mmtt -146.1 127.23 14.69 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.345 -0.843 . . . . 62.35 109.538 173.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' ' 76' ' ' ILE . 3.3 mp -99.23 137.91 25.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.692 -0.485 . . . . 73.51 109.692 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 71.8 m-85 -123.83 144.45 49.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.286 -0.415 . . . . 75.14 110.031 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.459 ' HE3' ' HB3' ' A' ' 49' ' ' TRP . 3.1 ttmp? -121.47 137.96 54.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.885 -0.598 . . . . 65.03 110.05 -177.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.463 HD12 ' HA ' ' A' ' 85' ' ' GLN . 12.4 tt -70.34 117.36 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.884 -0.413 . . . . 64.41 109.884 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.674 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 22.9 t-20 -113.9 -50.33 2.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.175 -0.466 . . . . 75.04 111.71 -173.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.548 HD11 ' HA3' ' A' ' 27' ' ' GLY . 52.1 mt -66.47 106.69 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 121.052 0.453 . . . . 73.24 110.861 -175.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.555 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 10.9 pt-20 -49.19 -40.87 34.98 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.961 -1.018 . . . . 71.25 112.907 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.4 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 2.1 m-20 -71.38 -25.65 62.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.986 0.422 . . . . 70.34 110.9 -176.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.438 HD21 ' N ' ' A' ' 84' ' ' ASN . 0.9 OUTLIER -90.43 30.63 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.876 -0.602 . . . . 74.43 110.927 -173.184 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.463 ' HA ' HD12 ' A' ' 79' ' ' ILE . 32.4 tt0 -70.5 -12.81 61.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.74 -0.664 . . . . 64.32 110.976 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 15.7 m-20 -49.81 -30.07 9.05 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.86 -0.609 . . . . 73.14 112.469 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -52.61 -39.3 29.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.101 0.476 . . . . 72.12 110.379 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.86 -49.24 75.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.813 -0.63 . . . . 72.51 110.267 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -61.29 -41.38 96.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.648 -0.705 . . . . 65.42 111.077 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.1 mm100 -70.78 -44.69 66.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.002 -0.545 . . . . 73.34 111.454 -174.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -87.44 -9.66 54.05 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.416 -0.356 . . . . 74.11 111.594 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.31 55.68 5.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.801 -0.714 . . . . 21.13 112.584 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.0 t -81.09 98.82 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.203 -0.666 . . . . 70.02 109.203 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t -60.38 -58.83 6.83 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.012 -0.54 . . . . 74.11 110.913 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.99 136.28 45.93 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.227 -0.657 . . . . 55.22 109.227 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.423 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 72.9 mt -51.8 -54.36 40.99 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 123.389 0.43 . . . . 73.53 111.874 -176.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 96' ' ' ILE . 41.6 Cg_endo -65.37 87.58 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.614 1.542 . . . . 61.43 111.866 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 112' ' ' ILE . 56.4 m -151.77 143.02 23.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.737 -0.665 . . . . 72.22 110.09 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 99' ' ' ILE . 2.5 mp -109.83 114.05 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.848 -0.426 . . . . 64.4 109.848 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.1 mp -95.83 124.91 40.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.146 -0.479 . . . . 73.31 109.756 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.406 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . 61.8 mtp -93.25 143.72 25.99 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.682 -0.488 . . . . 73.23 109.682 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.458 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.0 m-85 -146.92 158.17 43.84 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.673 -0.491 . . . . 72.11 109.673 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -151.21 105.15 3.18 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.943 -0.303 . . . . 61.51 111.164 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 56.6 44.22 24.3 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.363 0.601 . . . . 74.43 110.381 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.5 -16.51 7.75 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.82 -0.627 . . . . 61.41 112.752 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 14.0 tmtt? -79.66 139.78 37.28 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.45 -0.574 . . . . 73.12 109.45 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.405 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -68.97 136.74 52.98 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 122.104 0.954 . . . . 72.33 112.302 -174.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -133.36 168.22 18.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.623 -1.626 . . . . 60.32 107.794 -175.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 m -70.27 -178.77 1.78 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.312 0.486 . . . . 51.14 112.312 -167.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -138.44 121.83 17.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.513 -0.312 . . . . 74.23 110.497 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.1 t -97.87 107.41 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.83 -0.433 . . . . 73.33 109.83 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.547 ' HA ' HG22 ' A' ' 98' ' ' THR . 64.7 mt -80.15 135.25 25.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.364 -0.38 . . . . 71.0 110.509 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.5 -137.64 15.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.995 -0.622 . . . . 72.03 111.846 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.507 ' HB2' ' HG ' ' A' ' 59' ' ' LEU . . . -144.6 76.76 1.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 74.12 110.375 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.444 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.3 t70 -117.3 103.36 10.08 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.128 -0.487 . . . . 61.45 109.991 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.478 HD13 ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -63.34 -36.74 77.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 72.15 110.382 -174.001 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -63.49 -42.94 98.54 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.249 -0.432 . . . . 52.32 110.151 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -66.06 -41.16 91.17 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.363 -0.38 . . . . 55.24 110.198 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 115' ' ' ASP . 69.1 mt -59.81 -56.35 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.443 -0.344 . . . . 63.01 111.048 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.1 tt -62.73 -33.97 62.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 120.818 0.342 . . . . 72.4 110.339 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 t -55.75 -51.66 66.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.86 -0.609 . . . . 74.14 109.596 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -62.01 -40.86 97.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 74.21 110.891 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 119' ' ' ILE . 73.0 mt -56.04 -55.85 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.663 0.268 . . . . 71.32 110.934 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -71.67 -29.42 64.58 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.803 -0.359 . . . . 74.11 110.77 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -68.24 -39.96 82.15 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.031 0.443 . . . . 74.4 111.022 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -90.06 -24.84 21.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.919 -0.582 . . . . 73.0 111.29 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.7 mt -77.75 -54.15 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.757 0.313 . . . . 63.53 110.795 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.569 -0.729 . . . . 75.52 110.313 -176.471 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.794 0.33 . . . . 72.13 110.665 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.48 110.67 1.75 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.717 0.636 . . . . 72.41 112.717 -170.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -106.34 36.97 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.761 -1.2 . . . . 74.52 107.761 167.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -67.26 -26.12 66.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.412 -1.267 . . . . 64.14 112.332 -169.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -71.61 96.87 1.61 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.51 0.672 . . . . 70.42 109.972 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -96.41 142.72 28.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.789 -0.642 . . . . 75.42 110.159 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -72.44 102.1 3.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 74.21 109.942 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -72.63 105.51 4.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.864 -0.607 . . . . 71.15 110.282 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.8 ptm -71.83 -26.85 62.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 71.44 109.917 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.83 -176.02 46.64 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.484 -0.78 . . . . 70.42 112.615 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 t -132.08 124.16 28.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.08 0.467 . . . . 73.21 110.289 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.0 mm? -97.94 91.55 5.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.581 -0.525 . . . . 73.24 109.581 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -89.56 95.05 10.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.534 . . . . 63.13 110.348 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -151.87 79.08 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.34 . . . . 64.41 111.345 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.402 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 25.5 pt20 -84.76 78.19 9.92 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.782 -0.822 . . . . 74.12 108.782 172.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.6 p -69.66 92.45 0.66 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.206 -0.906 . . . . 62.52 111.431 -175.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -132.98 152.08 51.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.629 -0.714 . . . . 64.24 109.588 175.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.84 -171.55 32.86 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 116.037 -0.529 . . . . 52.31 112.254 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.94 19.11 0.92 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.907 2.405 . . . . 65.22 112.716 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.64 -58.91 7.73 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.116 -0.793 . . . . 42.42 111.116 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.7 t 63.0 23.54 14.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.85 0.46 . . . . 52.33 111.397 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.413 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 94.0 mmm -78.66 -27.51 45.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.888 0.375 . . . . 74.1 110.379 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.435 HG12 ' HG2' ' A' ' 64' ' ' GLU . 24.6 mm -87.55 119.69 35.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.785 -0.643 . . . . 73.42 109.471 177.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 154.0 18.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.97 0.414 . . . . 73.24 111.213 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -110.63 141.77 43.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.899 -0.591 . . . . 73.35 110.216 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.498 HG22 ' HG3' ' A' ' 34' ' ' LYS . 34.7 pt -140.31 161.26 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.902 0.382 . . . . 65.12 110.978 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.38 169.18 37.4 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.825 -0.625 . . . . 34.13 111.954 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.798 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 18.2 t70 -57.04 -42.43 80.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.116 0.484 . . . . 74.54 110.763 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.3 t -72.29 -16.19 61.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 73.3 110.924 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.597 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 11.1 mm-40 -83.16 -24.41 32.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 74.51 111.845 -176.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.402 ' O ' HG23 ' A' ' 35' ' ' VAL . 88.7 t80 -45.33 -61.94 1.46 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.559 0.577 . . . . 71.42 112.559 -170.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.91 -46.11 91.95 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.727 0.298 . . . . 73.5 110.653 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -48.37 -57.14 6.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 64.33 110.588 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 9.8 mmpt? -64.62 -49.64 70.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 53.41 110.11 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.541 HG12 ' HA2' ' A' ' 105' ' ' GLY . 95.5 t -62.18 -36.8 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.735 -0.666 . . . . 62.12 111.839 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -77.76 -47.03 19.97 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.838 0.31 . . . . 73.43 111.838 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.2 p -77.15 11.03 2.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.273 0.842 . . . . 70.02 113.273 -171.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.501 ' HB3' HD12 ' A' ' 44' ' ' ILE . 24.9 p -76.78 79.93 3.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.289 . . . . 62.33 111.686 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.9 t30 32.28 -94.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.147 0.979 . . . . 73.31 112.763 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -161.72 140.34 9.49 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.789 -0.449 . . . . 60.32 109.789 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 53.19 21.04 2.04 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.223 0.609 . . . . 73.21 112.474 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 103' ' ' LYS . 47.9 mm -75.68 128.84 37.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 120.784 0.326 . . . . 64.22 110.481 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -84.76 111.12 19.31 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.013 -0.736 . . . . 72.23 109.013 178.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 38' ' ' CYS . 52.9 mt -106.84 129.12 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.971 -0.559 . . . . 73.44 110.932 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.531 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.9 mp -113.97 109.73 18.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.101 -0.703 . . . . 75.14 109.101 174.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 77' ' ' TYR . 48.7 t -101.54 104.84 16.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.951 -0.388 . . . . 72.42 109.951 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 17.8 t70 -85.26 146.6 26.98 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.068 0.461 . . . . 74.22 109.878 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' A' ' 49' ' ' TRP . 43.4 t80 -81.21 -100.07 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.784 -0.644 . . . . 73.53 111.495 -173.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.479 ' HB2' ' CD2' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -97.73 -83.72 0.39 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.699 0.285 . . . . 74.01 110.765 -168.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.541 ' N ' ' HD3' ' A' ' 51' ' ' PRO . . . 60.13 36.9 0.27 Allowed Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 114.462 1.282 . . . . 74.53 114.462 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 50' ' ' ALA . 45.0 Cg_endo -97.44 -5.06 1.18 Allowed 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 122.215 1.943 . . . . 72.33 111.373 174.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -141.47 83.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.174 -1.047 . . . . 73.22 108.174 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.0 t -152.14 151.41 31.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.523 -0.762 . . . . 50.12 110.467 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.42 -73.86 1.28 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.285 -0.483 . . . . 71.35 112.598 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.75 -22.02 69.61 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.898 2.398 . . . . 74.44 112.86 -173.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 79.6 m -56.16 -27.3 53.77 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.27 0.471 . . . . 74.02 112.27 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.564 ' HD3' ' N ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -53.95 -33.9 58.16 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.74 0.274 . . . . 72.24 111.74 -178.282 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.564 ' N ' ' HD3' ' A' ' 57' ' ' ARG . 20.2 m -75.87 -30.63 58.93 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.569 0.699 . . . . 73.0 110.935 173.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' A' ' 114' ' ' ALA . 4.5 mm? -66.2 -42.58 88.62 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.479 -0.782 . . . . 74.12 112.522 -173.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.61 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 3.0 mp0 -49.72 -57.52 11.97 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 118.697 0.681 . . . . 72.34 110.255 177.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 23.2 Cg_exo -55.43 -55.5 3.04 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.885 1.723 . . . . 74.33 112.327 175.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.532 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.5 mt-30 -51.33 -49.7 60.88 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.175 0.435 . . . . 71.22 112.175 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.73 -40.54 76.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.875 -0.602 . . . . 73.44 111.058 -173.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 32.4 mt-10 -64.05 -34.84 78.93 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.881 -0.328 . . . . 65.02 110.307 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -62.54 -54.99 31.62 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.176 0.513 . . . . 73.34 110.04 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.4 mt -62.08 -32.95 73.54 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.849 -0.614 . . . . 64.42 109.928 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -61.93 -40.74 96.56 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.993 -0.549 . . . . 74.11 109.933 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.0 mt-30 -64.28 -45.45 87.96 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.885 0.374 . . . . 74.43 110.66 177.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -65.89 -38.18 88.07 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.962 -0.563 . . . . 62.52 111.225 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -104.63 4.58 32.88 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.185 -0.461 . . . . 74.12 112.242 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.0 t -53.23 -19.91 3.59 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.07 0.767 . . . . 75.04 113.07 -169.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.66 -34.54 75.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 74.32 110.824 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -123.37 -20.41 5.63 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.796 -0.638 . . . . 72.25 111.612 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.14 128.25 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.946 0.403 . . . . 64.21 112.051 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.617 ' HZ2' ' HB3' ' A' ' 75' ' ' LYS . 2.2 mmmp? -131.69 138.22 48.6 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.99 -0.744 . . . . 61.31 108.99 173.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.531 HG12 ' HB2' ' A' ' 45' ' ' LEU . 60.6 mt -118.09 114.38 45.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.011 0.434 . . . . 74.54 110.655 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 46' ' ' VAL . 56.7 m-85 -101.45 163.99 11.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 73.1 109.809 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 20.5 ttmm -139.16 138.09 36.64 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.869 0.366 . . . . 71.12 111.279 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -126.57 100.8 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.472 -0.936 . . . . 73.44 108.472 174.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -124.47 7.63 8.33 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.045 -0.525 . . . . 72.31 112.033 -172.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.5 mt -76.47 112.44 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.273 -0.269 . . . . 70.34 110.273 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.75 -31.19 70.53 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.839 0.352 . . . . 52.23 111.331 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.29 -23.29 61.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.161 0.505 . . . . 72.33 110.957 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.798 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 33.5 m-80 -123.92 91.94 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 55.05 110.509 -174.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -140.25 14.63 2.41 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.537 0.569 . . . . 61.35 112.537 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.67 -44.77 63.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.206 0.527 . . . . 74.34 110.043 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.59 -38.92 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.272 -0.877 . . . . 73.22 110.897 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.99 -41.06 91.58 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.213 0.53 . . . . 62.15 110.269 -175.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.1 m -72.25 -35.91 68.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.51 -0.768 . . . . 64.0 110.932 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -68.55 -45.96 70.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.473 -0.33 . . . . 74.1 111.841 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -86.86 -23.54 25.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.617 0.229 . . . . 64.24 111.617 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.49 80.38 1.51 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.717 -0.754 . . . . 72.12 113.062 173.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.4 t -99.63 138.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.271 -0.641 . . . . 61.22 109.271 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.4 m -141.49 18.29 2.21 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.997 0.369 . . . . 75.23 111.997 -174.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.87 152.53 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.652 -0.249 . . . . 51.23 110.444 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.682 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 60.1 mt -59.68 -50.03 88.93 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.416 -0.356 . . . . 74.22 110.526 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.682 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 73.1 Cg_endo -95.37 112.67 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.695 2.264 . . . . 72.44 111.061 169.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.42 HG22 HD12 ' A' ' 112' ' ' ILE . 54.8 m -145.82 118.68 8.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.005 -0.369 . . . . 55.31 110.005 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.5 mp -109.7 110.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.316 -0.402 . . . . 64.41 110.129 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.438 HD13 ' N ' ' A' ' 100' ' ' LEU . 6.0 mp -90.21 123.31 33.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.767 -0.827 . . . . 75.53 108.767 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.426 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 45.2 mtp -101.0 145.43 28.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.851 -0.426 . . . . 74.4 109.851 -176.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.467 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 97.1 m-85 -148.22 160.81 42.56 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.354 -0.609 . . . . 74.55 109.354 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 39.3 ttpt -143.93 114.34 7.52 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.917 -0.313 . . . . 75.2 110.596 175.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.5 t30 62.19 25.68 15.38 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.536 0.684 . . . . 72.13 109.711 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.541 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 84.61 -14.41 47.13 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.699 -0.682 . . . . 73.04 111.965 -176.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -69.33 142.31 54.06 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.832 -0.433 . . . . 74.2 109.832 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -58.3 150.93 20.68 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 124.1 0.875 . . . . 73.21 111.097 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -162.36 168.74 21.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.909 -1.042 . . . . 74.01 108.995 -169.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -70.19 167.71 17.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.384 0.611 . . . . 63.15 112.356 -167.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -130.48 118.57 21.32 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.81 -0.632 . . . . 70.53 109.945 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.0 t -86.8 119.43 34.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 74.43 110.29 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 98' ' ' THR . 50.0 mm -100.13 102.47 13.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.222 -0.445 . . . . 74.34 110.2 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.476 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 107.46 166.25 21.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.267 -0.492 . . . . 34.23 112.217 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.528 ' HB3' ' HG ' ' A' ' 59' ' ' LEU . . . -80.79 72.2 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.863 0.363 . . . . 64.12 111.107 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 61.2 t0 -112.07 92.88 4.19 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.374 0.607 . . . . 64.02 110.185 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.484 ' O ' HD11 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -59.22 -34.97 55.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.276 -0.875 . . . . 75.54 110.153 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.6 t -62.68 -46.21 89.2 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.133 -0.485 . . . . 75.22 110.077 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.756 ' HZ3' ' HB2' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -65.29 -42.96 92.6 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.859 -0.61 . . . . 74.1 109.937 -179.316 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 123' ' ' ILE . 74.0 mt -57.22 -56.14 16.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 115.419 -0.81 . . . . 71.14 111.098 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.2 tt -65.4 -35.21 74.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 121.063 -0.255 . . . . 74.22 110.788 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 t -56.72 -52.05 66.47 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.103 -0.499 . . . . 75.32 110.027 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -70.46 -31.63 68.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 65.3 111.477 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 119' ' ' ILE . 62.0 mt -57.34 -56.52 14.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.686 -0.406 . . . . 72.02 110.229 176.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -69.8 -32.82 71.48 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.757 -0.377 . . . . 74.25 110.21 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -62.06 -49.67 75.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.137 -0.483 . . . . 64.43 111.153 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -86.98 -20.24 27.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 73.22 112.219 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.9 mt -78.62 -52.76 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.853 -0.339 . . . . 72.24 110.619 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.536 -0.745 . . . . 74.4 110.288 -177.392 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 110.085 -0.339 . . . . 62.22 110.085 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.96 139.41 49.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.223 -0.444 . . . . 73.22 110.136 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -86.82 91.12 8.54 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.494 -0.928 . . . . 74.13 108.494 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -47.97 -43.62 29.68 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.422 -0.808 . . . . 73.01 112.563 -167.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -137.98 144.73 41.29 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.607 -0.516 . . . . 74.11 109.607 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -54.68 -53.9 48.8 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.695 0.622 . . . . 74.42 111.702 -172.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 56.85 36.48 27.79 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.508 0.671 . . . . 71.23 110.233 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -113.51 77.05 1.02 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.048 -0.978 . . . . 72.21 110.402 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -107.48 93.86 4.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.762 0.792 . . . . 72.43 110.362 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.34 -60.82 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 109.918 -1.273 . . . . 65.53 109.918 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.425 HG23 ' HD2' ' A' ' 78' ' ' LYS . 89.2 m -75.02 81.79 2.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.355 -0.609 . . . . 74.11 109.355 169.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.8 127.01 33.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.756 -0.657 . . . . 71.5 110.062 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -65.88 99.23 0.46 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.68 -0.859 . . . . 75.31 108.68 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.079 0.77 . . . . 72.15 113.079 -167.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -134.69 93.4 3.03 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.071 0.462 . . . . 64.14 111.58 -167.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m 62.36 64.61 0.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.325 -0.852 . . . . 63.24 111.528 173.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.612 ' H ' ' NE2' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -72.1 -32.06 66.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.565 -0.743 . . . . 75.54 109.696 175.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 136.66 -121.81 2.47 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.542 -0.754 . . . . 65.22 111.672 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.502 ' HG3' ' NE2' ' A' ' 68' ' ' GLN . 90.6 Cg_endo -79.47 -21.99 8.39 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.876 2.384 . . . . 61.23 112.63 -177.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.32 141.5 3.62 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 110.404 -1.078 . . . . 74.45 110.404 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 p -46.53 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.096 0.776 . . . . 73.42 113.096 -172.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 80.1 mmm -69.88 -32.64 71.09 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.227 -1.027 . . . . 62.11 108.227 165.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.581 HG23 ' HZ1' ' A' ' 78' ' ' LYS . 17.2 mm -54.99 107.79 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.642 -1.163 . . . . 74.34 109.222 174.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 77' ' ' TYR . 35.9 tt0 -76.26 112.22 12.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.353 0.597 . . . . 65.22 110.62 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -70.16 127.22 32.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.043 -0.981 . . . . 72.24 110.873 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.506 HG23 ' HG3' ' A' ' 34' ' ' LYS . 44.3 pt -136.27 159.04 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.04 0.447 . . . . 71.13 111.274 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.96 176.29 30.58 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.973 -0.558 . . . . 74.12 112.232 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' CB ' ' HB3' ' A' ' 84' ' ' ASN . 16.9 t70 -55.29 -38.38 68.54 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.157 0.583 . . . . 61.5 111.346 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -84.48 -8.65 58.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 75.14 112.132 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -94.37 -12.94 26.92 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.267 0.469 . . . . 74.22 112.267 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.422 ' O ' HG21 ' A' ' 35' ' ' VAL . 31.1 m-85 -50.2 -61.79 1.96 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.29 0.478 . . . . 74.42 112.29 -175.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.08 -36.58 80.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.461 -0.336 . . . . 70.3 110.544 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.48 -57.3 13.26 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.699 0.761 . . . . 74.21 109.075 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.641 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 10.2 mmpt? -62.52 -39.17 92.67 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.363 -1.29 . . . . 62.31 111.01 -172.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 31' ' ' PHE . 96.7 t -66.34 -49.8 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.909 -0.587 . . . . 75.21 110.329 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -67.85 -17.93 64.65 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 111.711 0.263 . . . . 73.54 111.711 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -66.27 -8.88 27.62 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.962 0.356 . . . . 72.42 111.962 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.738 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.8 t -60.72 117.36 5.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.726 0.298 . . . . 71.44 110.823 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.65 -50.95 12.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 72.23 110.66 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -161.67 121.9 2.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.331 -0.395 . . . . 62.12 111.21 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 51.42 16.01 0.38 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.263 0.838 . . . . 64.33 113.263 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.711 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 44.5 mm -70.1 104.48 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.629 -0.508 . . . . 72.23 109.629 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.419 HD23 ' HE1' ' A' ' 101' ' ' MET . 0.9 OUTLIER -76.06 108.04 8.69 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.526 -0.761 . . . . 74.11 109.032 179.121 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.461 HG22 ' CE2' ' A' ' 77' ' ' TYR . 76.0 mt -100.31 113.58 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.965 -1.016 . . . . 75.32 110.814 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 4.0 mp -105.24 142.75 34.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.731 -0.668 . . . . 74.33 109.291 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.96 109.44 17.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.391 -0.596 . . . . 75.14 109.391 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -90.54 143.83 26.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.072 0.463 . . . . 75.45 110.111 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -134.66 105.45 6.49 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.954 -0.758 . . . . 70.14 108.954 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -116.1 128.09 55.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.922 -0.399 . . . . 73.53 109.922 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.667 ' HB3' HG21 ' A' ' 96' ' ' ILE . . . -74.67 140.78 75.2 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.609 -0.515 . . . . 64.33 109.609 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.95 -24.95 11.38 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.843 2.362 . . . . 64.45 112.852 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -92.73 80.41 4.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 71.01 109.586 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 42.6 t -153.59 164.59 37.99 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.115 -0.493 . . . . 72.11 110.507 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -119.43 -66.15 0.29 Allowed Glycine 0 CA--C 1.522 0.484 0 CA-C-N 115.813 -0.63 . . . . 53.1 112.144 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.86 -28.4 48.37 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.902 2.401 . . . . 65.24 112.632 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -53.58 -27.54 27.09 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.871 -0.604 . . . . 64.12 111.529 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 53.9 ttt-85 -56.17 -50.23 71.78 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.313 -0.403 . . . . 70.03 111.095 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 15.2 m -65.11 -34.36 78.22 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.736 0.779 . . . . 72.34 110.905 -177.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.42 HD23 ' HB1' ' A' ' 114' ' ' ALA . 4.2 mm? -65.65 -24.14 66.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.364 -0.835 . . . . 64.24 111.623 -175.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.437 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 40.7 tt0 -62.69 -63.69 3.89 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 120.578 -0.449 . . . . 72.44 109.842 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.437 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 31.0 Cg_endo -63.44 -31.64 71.92 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.724 1.616 . . . . 53.13 112.541 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 58' ' ' SER . 28.0 mt-30 -66.52 -52.94 40.42 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.38 -0.528 . . . . 60.22 111.687 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.95 -35.26 80.1 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.176 -0.305 . . . . 74.22 110.176 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.527 ' HG3' ' HB2' ' A' ' 17' ' ' GLN . 5.2 mm-40 -59.92 -42.92 94.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.877 -0.601 . . . . 70.43 110.811 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -59.31 -55.14 38.54 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.334 0.588 . . . . 75.13 109.892 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.6 mt -59.47 -33.63 71.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.028 -0.987 . . . . 63.13 110.102 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.554 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.7 -44.73 92.8 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.82 -0.627 . . . . 64.02 110.105 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.502 ' NE2' ' HG3' ' A' ' 19' ' ' PRO . 51.8 mt-30 -63.82 -47.12 82.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.087 -0.506 . . . . 72.15 111.134 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -69.42 -41.37 76.44 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.216 -0.447 . . . . 61.23 111.614 -175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -102.72 5.72 39.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.641 0.608 . . . . 72.42 112.641 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.554 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.35 -19.42 2.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.189 0.811 . . . . 62.43 113.189 -169.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.88 -42.3 93.47 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.599 0.238 . . . . 70.43 110.771 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -128.03 -2.84 5.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.377 -0.374 . . . . 73.04 111.886 -175.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.9 t -112.36 131.94 62.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.923 0.392 . . . . 74.44 110.821 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -135.65 120.12 18.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.773 -0.649 . . . . 64.12 110.201 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 45' ' ' LEU . 3.6 mp -106.32 137.34 37.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.65 -0.5 . . . . 74.3 109.65 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.532 ' CE1' ' HD3' ' A' ' 34' ' ' LYS . 76.0 m-85 -131.3 165.77 22.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 72.24 109.993 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' HZ1' HG23 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -158.16 166.72 31.73 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.158 0.504 . . . . 75.42 110.91 169.549 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 tp -73.0 147.51 9.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.077 -0.965 . . . . 72.23 112.211 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.484 ' C ' HD21 ' A' ' 80' ' ' ASN . 0.2 OUTLIER -108.05 -58.32 2.0 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.402 -0.817 . . . . 61.53 110.452 175.527 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.1 mt -70.58 105.43 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.992 0.425 . . . . 63.31 111.235 -173.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -56.3 -33.9 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.674 -0.694 . . . . 74.24 111.2 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -87.83 2.67 50.78 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.193 -0.458 . . . . 74.4 111.466 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.41 ' HB3' ' CB ' ' A' ' 28' ' ' ASP . 11.2 m120 -139.38 90.18 2.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.034 0.445 . . . . 73.32 110.263 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -117.94 13.59 14.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.486 -0.779 . . . . 73.34 109.418 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 32.7 t70 -49.52 -50.97 39.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.432 -0.804 . . . . 73.44 110.943 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.2 t -53.15 -37.75 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.655 -0.702 . . . . 73.05 110.871 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.38 -43.9 84.59 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.294 0.569 . . . . 74.44 109.828 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.2 m -66.65 -30.1 70.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.489 -0.778 . . . . 64.31 110.686 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.546 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 18.5 mm-40 -74.13 -41.65 61.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.893 -0.594 . . . . 73.14 111.089 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -74.51 -31.34 62.13 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 111.718 0.266 . . . . 74.44 111.718 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.53 43.58 0.26 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.286 -0.959 . . . . 73.45 113.781 172.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.2 t -90.55 107.38 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.569 -0.53 . . . . 72.11 109.569 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 t -135.2 21.15 3.44 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.203 0.525 . . . . 70.04 110.551 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.66 168.47 19.21 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.065 -0.516 . . . . 72.23 110.05 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.755 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 48.0 mm -67.86 -53.04 22.37 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.56 -0.291 . . . . 74.01 110.646 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.755 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 58.6 Cg_endo -102.75 107.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 123.1 2.533 . . . . 73.11 111.834 172.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.5 m -132.14 118.92 20.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.791 -0.186 . . . . 61.43 110.798 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.453 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.8 mp -110.48 115.25 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 110.262 -0.273 . . . . 74.33 110.262 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.59 137.3 32.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.399 -0.593 . . . . 60.24 109.399 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.504 ' HE2' ' HB3' ' A' ' 122' ' ' GLU . 51.6 mtp -115.92 143.48 45.37 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.817 0.28 . . . . 72.01 110.429 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -142.78 152.86 42.71 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.267 -0.642 . . . . 71.43 109.267 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -143.49 107.49 4.71 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.508 -0.477 . . . . 73.13 111.597 176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.738 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 10.5 t30 53.0 36.2 21.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.48 0.657 . . . . 74.32 111.584 174.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.41 -16.63 55.63 Favored Glycine 0 N--CA 1.454 -0.117 0 CA-C-N 115.759 -0.655 . . . . 63.13 112.644 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -81.6 145.17 30.75 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.363 -0.606 . . . . 73.12 109.363 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -61.86 160.5 11.95 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.516 0.674 . . . . 51.12 110.826 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.28 167.36 24.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.364 -1.347 . . . . 74.45 107.364 -168.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 73.1 m -70.96 178.29 3.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.958 0.885 . . . . 63.55 112.687 -165.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -140.84 118.44 11.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.854 -1.067 . . . . 73.15 108.912 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 42.5 t -93.81 107.12 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.171 0.51 . . . . 75.23 110.02 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.1 mt -92.72 107.31 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.623 -0.717 . . . . 74.14 109.471 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.611 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 110.97 158.44 15.49 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.46 -0.656 . . . . 52.52 111.46 -175.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.42 ' HB1' HD23 ' A' ' 59' ' ' LEU . . . -81.92 78.53 8.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.721 0.296 . . . . 64.11 110.844 -178.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.413 ' O ' HG13 ' A' ' 119' ' ' ILE . 19.3 m-20 -117.1 80.96 1.56 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.079 0.466 . . . . 74.13 110.048 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -59.11 -32.09 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.773 -0.648 . . . . 72.43 109.799 -177.195 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.8 m -58.36 -50.0 75.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.91 -0.587 . . . . 50.42 110.39 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -69.45 -35.8 76.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.219 -0.446 . . . . 75.25 110.313 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.428 ' O ' HG13 ' A' ' 123' ' ' ILE . 76.4 mt -58.33 -56.39 16.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.188 -0.46 . . . . 72.04 110.513 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.31 -34.74 71.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.129 -0.487 . . . . 74.05 110.346 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.5 t -57.06 -49.72 74.98 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.153 -0.476 . . . . 72.15 109.787 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.504 ' HB3' ' HE2' ' A' ' 101' ' ' MET . 63.9 mm-40 -62.31 -38.54 89.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.476 -0.329 . . . . 63.23 110.573 177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 119' ' ' ILE . 58.3 mt -57.62 -56.5 15.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.672 0.272 . . . . 64.23 110.938 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -71.33 -25.16 62.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.761 0.315 . . . . 74.2 110.626 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.48 -44.11 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 73.15 111.132 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -93.0 -18.06 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 73.2 111.975 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.5 mt -76.78 -53.28 15.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 120.929 0.395 . . . . 74.31 110.054 173.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.1 m120 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.377 -0.821 . . . . 75.42 110.392 -178.664 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.498 0.19 . . . . 71.22 110.739 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.47 96.15 0.02 OUTLIER 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.931 0.396 . . . . 62.53 111.023 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -64.82 103.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.82 -0.627 . . . . 72.45 109.929 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -137.76 90.01 2.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.198 -0.455 . . . . 74.41 110.606 -176.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -138.67 28.53 2.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.109 0.48 . . . . 74.21 110.269 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -65.53 88.7 0.09 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.019 -0.734 . . . . 75.41 109.019 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -139.16 125.19 19.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.953 -0.567 . . . . 73.11 111.626 -170.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -170.39 116.51 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.125 -0.694 . . . . 75.24 109.125 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.433 ' C ' ' SD ' ' A' ' 9' ' ' MET . 1.1 tmt? -150.1 140.04 21.92 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.385 -0.228 . . . . 74.5 110.385 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.36 -55.35 4.63 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.313 -0.47 . . . . 74.54 112.154 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 t -72.51 145.08 47.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.987 0.422 . . . . 54.04 110.569 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.49 ' N ' HD23 ' A' ' 12' ' ' LEU . 1.5 pt? -133.81 113.62 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 72.52 109.936 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -84.94 60.32 6.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.575 0.702 . . . . 74.32 109.706 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.98 87.53 3.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.45 -0.795 . . . . 74.5 110.7 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -167.58 147.39 5.11 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.796 -0.638 . . . . 75.12 110.565 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -173.13 143.32 1.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.488 -0.778 . . . . 74.33 108.922 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -83.76 87.88 7.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.511 -0.552 . . . . 73.21 109.511 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.14 -175.21 25.74 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.165 -0.925 . . . . 65.23 111.119 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.63 -20.88 52.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.322 2.014 . . . . 31.32 111.725 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.6 -120.44 0.92 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.509 -0.636 . . . . 34.24 111.509 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -167.2 107.66 0.61 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.805 -0.442 . . . . 73.22 109.805 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.1 mmm -88.11 -36.01 17.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.244 -0.435 . . . . 74.21 110.664 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.508 HG12 ' OE2' ' A' ' 64' ' ' GLU . 12.9 mm -69.73 97.61 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 109.653 -0.499 . . . . 74.42 109.653 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.8 124.11 24.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 75.53 110.81 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.497 ' NE2' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -90.72 128.98 36.85 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.687 -0.486 . . . . 72.33 109.687 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 39.9 pt -141.77 179.85 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.12 -0.491 . . . . 64.04 110.735 -176.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.2 -177.74 15.15 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.643 -0.983 . . . . 75.44 110.643 171.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 13.3 t70 -52.73 -43.12 65.51 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.856 0.36 . . . . 75.44 110.973 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 p -63.17 -24.01 67.7 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.013 -0.54 . . . . 74.14 112.26 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -96.99 -32.39 12.03 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.761 -0.199 . . . . 71.21 111.117 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.458 ' HA ' HD11 ' A' ' 26' ' ' ILE . 85.0 t80 -41.24 -61.8 0.96 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.002 0.742 . . . . 74.54 113.002 -166.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.4 -50.27 65.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.715 0.293 . . . . 75.41 111.116 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.407 ' N ' HD21 ' A' ' 33' ' ' ASN . 0.9 OUTLIER -60.36 -51.56 68.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.031 -0.531 . . . . 71.11 110.734 -177.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HG3' HG22 ' A' ' 26' ' ' ILE . 70.7 mmtt -59.45 -36.66 76.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.812 -0.631 . . . . 65.12 111.049 -176.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.3 -54.66 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.13 -0.487 . . . . 55.34 111.309 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.8 p -62.92 -25.65 68.43 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.564 0.221 . . . . 63.31 111.559 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.6 t -75.35 5.51 5.6 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.589 -0.278 . . . . 73.41 111.674 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.569 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 24.4 p -62.52 140.83 58.63 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.875 -0.417 . . . . 52.11 109.875 175.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -58.41 -83.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.556 -0.293 . . . . 61.31 110.837 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -161.95 152.54 17.44 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.082 -0.71 . . . . 73.5 109.082 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 45.84 22.07 0.11 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.702 0.801 . . . . 75.14 112.685 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 mm -81.95 127.25 39.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 120.607 0.241 . . . . 75.31 110.427 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.9 tp -88.43 108.59 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.143 0.497 . . . . 63.52 110.041 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 38' ' ' CYS . 57.4 mt -101.33 114.36 40.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.652 -0.704 . . . . 72.5 110.366 178.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 5.5 mp -99.04 118.77 36.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.182 -0.673 . . . . 70.13 109.182 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 67.0 t -104.34 105.02 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 110.002 -0.37 . . . . 61.4 110.002 175.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.81 156.53 20.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.95 0.405 . . . . 74.4 110.526 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -109.61 75.24 0.93 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.118 -0.697 . . . . 74.31 109.118 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.472 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 62.1 t90 -48.29 -45.52 34.94 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.323 -0.853 . . . . 71.42 111.154 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 66.55 151.81 0.12 Allowed Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 115.618 -0.719 . . . . 61.43 112.144 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.1 -24.7 27.8 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.184 1.923 . . . . 62.22 111.883 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -85.56 79.83 9.26 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.427 0.632 . . . . 75.54 109.353 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 35.6 t -85.05 149.9 25.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.159 -0.928 . . . . 65.41 111.874 -174.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -147.19 -88.0 0.07 OUTLIER Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.278 -0.874 . . . . 42.44 111.473 177.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.14 17.8 1.41 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.917 2.412 . . . . 74.45 112.7 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.77 -30.24 69.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.225 -0.443 . . . . 72.15 111.164 -175.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.478 ' O ' ' HD3' ' A' ' 57' ' ' ARG . 2.3 tmt_? -54.2 -41.68 68.9 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.105 -0.498 . . . . 75.45 110.637 -174.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.62 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 16.6 m -75.67 -57.12 4.07 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.484 0.659 . . . . 62.43 111.388 175.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.2 mm? -60.57 -42.55 96.86 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.498 -0.774 . . . . 74.53 112.625 -168.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.1 -59.18 12.52 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 117.917 0.326 . . . . 64.41 111.226 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.4 -33.24 58.83 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.678 1.585 . . . . 65.44 112.691 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.62 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.6 mt-30 -59.46 -45.85 90.44 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.021 -0.672 . . . . 75.31 110.7 173.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 84.5 mt -62.7 -43.74 98.02 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.155 -0.475 . . . . 74.52 110.33 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.588 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 25.7 mm-40 -53.63 -53.25 54.51 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.053 -0.521 . . . . 70.32 110.377 174.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -51.34 -52.9 41.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.989 -0.551 . . . . 62.53 110.709 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.0 -31.69 72.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 75.14 110.694 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.633 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -71.7 -25.15 61.97 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.267 -0.424 . . . . 75.01 110.725 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 89.3 mt-30 -85.21 -37.93 19.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.992 0.425 . . . . 61.2 110.493 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -74.41 -50.54 18.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 71.21 110.936 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -90.45 5.09 49.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.553 -0.749 . . . . 74.44 112.159 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.633 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.6 t -53.04 -24.34 9.57 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.639 0.607 . . . . 64.4 112.639 -172.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -59.35 -18.79 41.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.069 0.462 . . . . 74.01 110.859 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -133.44 -29.31 1.39 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.748 -0.66 . . . . 72.23 111.365 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.409 HG22 HD11 ' A' ' 127' ' ' ILE . 66.0 t -105.49 144.36 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 112.285 0.476 . . . . 75.15 112.285 -169.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 45.6 mmtm -142.53 140.04 31.65 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.689 -0.856 . . . . 74.44 108.689 170.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 45' ' ' LEU . 42.3 mt -117.06 138.3 48.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.012 0.434 . . . . 71.33 111.027 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 57.0 m-85 -131.29 162.62 29.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.374 -0.83 . . . . 73.15 109.072 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.472 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 17.6 pttp -157.03 136.18 11.93 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.897 0.38 . . . . 75.03 110.902 173.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.617 HG12 HG13 ' A' ' 87' ' ' VAL . 2.3 mp -71.09 100.2 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.221 -0.659 . . . . 64.0 109.221 177.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -103.7 -1.64 27.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.761 -0.654 . . . . 74.11 109.856 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.6 mm -95.93 96.72 5.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.789 -0.642 . . . . 63.43 110.405 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.79 -22.1 63.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.939 -0.573 . . . . 75.24 110.921 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.1 -23.57 62.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.113 0.482 . . . . 72.5 110.045 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 30.3 m-80 -111.53 77.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.226 -0.657 . . . . 73.45 109.226 176.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -100.34 -21.84 15.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.683 -0.689 . . . . 73.2 111.77 -170.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 4.4 m-20 -52.26 -34.55 46.71 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.703 0.631 . . . . 75.22 112.703 -174.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.617 HG13 HG12 ' A' ' 79' ' ' ILE . 14.7 p -53.36 -39.79 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.155 0.503 . . . . 75.15 110.543 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.42 -41.13 93.9 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.876 -0.602 . . . . 62.14 110.274 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 m -62.07 -40.66 96.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.553 -0.748 . . . . 63.24 109.824 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 30.0 mm-40 -64.67 -46.5 82.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.288 -0.869 . . . . 45.05 110.988 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -80.77 -15.54 56.17 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 121.108 -0.237 . . . . 71.24 111.383 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.18 52.48 31.72 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.059 -0.591 . . . . 64.14 112.644 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.65 112.5 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.958 0.408 . . . . 71.11 110.36 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.5 t -90.24 -55.97 3.4 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.211 -0.45 . . . . 74.32 110.641 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.62 155.88 33.14 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.172 -0.467 . . . . 72.24 110.437 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.74 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 45.1 mm -69.68 -59.77 4.38 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.669 -0.241 . . . . 73.41 110.741 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.74 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 1.9 Cg_endo -80.28 74.57 5.48 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.048 1.832 . . . . 72.05 111.098 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.7 m -113.1 124.92 53.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 70.23 110.701 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -110.06 117.5 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.41 -0.359 . . . . 34.34 110.173 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.515 HD23 ' HG3' ' A' ' 110' ' ' GLN . 86.9 mt -88.35 122.98 32.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.907 -0.775 . . . . 73.23 108.907 174.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.458 ' HE1' ' HB3' ' A' ' 122' ' ' GLU . 56.9 mtp -96.93 143.66 27.6 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.931 -0.396 . . . . 72.35 109.931 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -141.38 144.93 34.78 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.283 -0.636 . . . . 71.53 109.283 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 22.3 tptm -129.68 104.38 7.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.194 -0.299 . . . . 74.14 110.194 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.569 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 65.8 t30 46.22 46.94 13.43 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.971 0.508 . . . . 75.25 111.934 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.13 -15.51 57.97 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.401 -0.428 . . . . 73.3 113.806 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 52.6 tttp -82.84 144.57 30.01 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.622 0.369 . . . . 74.54 110.894 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -68.97 142.25 54.73 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.021 0.439 . . . . 71.01 110.098 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.58 169.05 19.18 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.126 0.971 . . . . 75.42 108.907 -169.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.8 m -69.22 173.2 5.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.529 0.681 . . . . 75.34 112.539 -162.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.515 ' HG3' HD23 ' A' ' 100' ' ' LEU . 20.0 tt0 -125.9 122.42 35.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 74.42 109.673 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.4 t -92.73 110.36 22.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.971 -0.381 . . . . 74.33 109.971 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.5 mp -94.2 122.15 45.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.74 -0.467 . . . . 64.15 109.74 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.86 146.7 20.87 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 116.32 -0.4 . . . . 75.24 112.249 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.64 77.74 1.09 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.929 0.395 . . . . 72.32 110.203 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -125.2 97.06 5.07 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.366 0.603 . . . . 62.1 109.905 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -26.42 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.33 -0.85 . . . . 71.24 109.882 -174.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.7 t -63.4 -47.21 82.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.195 -0.457 . . . . 73.12 109.881 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -65.37 -43.97 89.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.11 110.272 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.503 ' O ' HG13 ' A' ' 123' ' ' ILE . 73.8 mt -55.79 -56.26 13.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.17 -0.468 . . . . 63.24 110.663 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.1 tt -64.31 -33.83 65.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.326 -0.397 . . . . 73.33 110.422 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.4 t -57.3 -52.36 65.66 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.203 -0.453 . . . . 70.4 110.071 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.458 ' HB3' ' HE1' ' A' ' 101' ' ' MET . 7.1 mm-40 -65.2 -37.23 86.65 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.457 -0.338 . . . . 74.44 110.411 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 119' ' ' ILE . 65.7 mt -56.42 -56.39 13.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 120.716 0.293 . . . . 61.11 111.098 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -71.52 -27.54 63.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.991 -0.284 . . . . 74.32 110.441 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -65.76 -34.55 78.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.805 0.336 . . . . 75.45 110.505 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -79.14 -42.94 25.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.316 -0.402 . . . . 62.42 111.339 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 74' ' ' VAL . 56.6 mt -69.74 -46.06 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 75.43 110.738 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.426 -0.797 . . . . 74.23 109.815 -177.329 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.4 tpp . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.659 -0.497 . . . . 72.2 109.659 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.6 103.66 15.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.883 0.373 . . . . 71.42 111.691 -173.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -92.14 12.98 20.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.125 -0.489 . . . . 73.23 110.147 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -89.03 -70.35 0.66 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.098 -0.501 . . . . 70.45 109.888 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -155.19 152.99 30.04 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.984 -0.747 . . . . 75.13 108.984 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -105.5 174.58 5.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.743 0.306 . . . . 73.22 111.036 -173.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -117.83 108.38 15.28 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.17 -0.468 . . . . 73.31 110.551 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -88.4 114.81 25.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.001 -0.37 . . . . 74.33 110.001 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 mmt -65.63 157.91 28.69 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.166 -0.47 . . . . 74.31 111.095 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.44 -66.86 0.01 OUTLIER Glycine 0 C--N 1.331 0.266 0 CA-C-N 115.913 -0.585 . . . . 70.02 111.929 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.0 t -74.39 173.89 9.66 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 110.228 -0.286 . . . . 72.45 110.228 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.4 tp -160.28 -79.44 0.05 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.812 -0.176 . . . . 70.11 111.276 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 7.5 tp10 -172.64 158.76 4.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.887 0.375 . . . . 71.02 111.758 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.36 -154.57 0.41 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.291 0.637 . . . . 63.35 110.728 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -130.8 82.5 2.06 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.559 0.578 . . . . 71.45 112.559 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.2 p 47.38 -167.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.077 1.14 . . . . 44.32 114.077 167.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.465 ' HG3' ' HD3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER 178.85 -55.84 0.01 OUTLIER 'General case' 0 C--N 1.344 0.33 0 CA-C-N 115.752 -0.658 . . . . 71.45 110.464 172.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.482 ' H ' ' HB2' ' A' ' 61' ' ' PRO . . . 167.85 120.26 0.52 Allowed Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.904 -0.665 . . . . 62.32 112.401 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -87.22 165.46 8.28 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.989 2.459 . . . . 62.15 111.937 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.7 0.79 0.15 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.736 -0.745 . . . . 40.3 113.674 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.3 p 49.07 59.12 4.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.429 0.633 . . . . 74.25 110.971 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.3 ptm -114.82 2.19 14.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.556 -0.747 . . . . 75.23 109.884 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.51 129.43 35.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 70.51 109.906 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -83.4 150.31 26.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.335 -0.393 . . . . 73.25 110.146 -176.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -119.71 130.14 54.86 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.966 0.413 . . . . 72.13 110.652 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.9 pt -138.81 177.01 5.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.795 -0.638 . . . . 74.35 110.3 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.88 -179.06 16.46 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.163 -0.542 . . . . 61.43 112.422 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.01 -47.24 71.68 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.301 0.64 . . . . 74.2 111.173 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.9 t -75.32 -20.45 59.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.821 -0.627 . . . . 33.31 111.711 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -91.61 -8.58 46.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.432 0.158 . . . . 74.33 110.961 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -53.67 -62.5 1.61 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.224 -0.444 . . . . 74.42 111.938 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -61.24 -47.68 84.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.979 0.419 . . . . 52.12 110.872 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -55.42 -55.3 33.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.591 -0.731 . . . . 71.34 111.411 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.27 -32.17 68.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.56 -0.291 . . . . 72.12 111.563 -174.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.93 -38.6 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.805 0.336 . . . . 73.52 110.882 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.0 p -82.58 -20.6 36.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.812 0.339 . . . . 61.34 110.994 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -71.67 5.66 2.35 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.21 -0.45 . . . . 63.42 112.101 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.734 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 25.5 p -56.95 142.38 41.86 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.154 -0.313 . . . . 61.12 110.154 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -58.93 -74.46 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.572 0.225 . . . . 72.25 110.53 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -153.12 122.0 6.49 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.874 -0.417 . . . . 43.45 109.874 175.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 55.48 21.82 4.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.512 0.56 . . . . 74.12 112.512 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.734 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.0 mm -74.69 113.45 13.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 110.121 -0.326 . . . . 74.15 110.121 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.04 113.68 9.33 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.036 -0.728 . . . . 44.11 109.036 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 47.8 mt -106.48 114.4 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.736 -0.665 . . . . 75.24 110.9 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.43 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -92.55 154.21 18.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.266 -0.642 . . . . 75.12 109.266 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 63.0 t -132.61 104.96 8.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.459 -0.571 . . . . 65.52 109.459 176.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.48 161.73 14.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.171 -0.468 . . . . 65.21 110.459 -176.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -143.83 87.77 1.94 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.742 -0.663 . . . . 70.1 110.121 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.618 ' HZ3' HD12 ' A' ' 63' ' ' LEU . 1.6 p90 -105.8 169.8 8.27 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.132 -0.486 . . . . 72.05 109.748 171.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.52 153.21 17.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.483 -0.326 . . . . 70.23 110.721 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.33 -14.47 29.91 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.871 2.381 . . . . 74.11 112.359 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -86.79 17.23 4.14 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.034 -0.53 . . . . 74.23 110.444 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.1 t -124.01 150.82 44.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.668 -0.696 . . . . 74.12 109.964 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.62 -75.29 1.17 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 121.377 -0.439 . . . . 71.44 113.704 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.96 -42.69 42.44 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.615 2.21 . . . . 71.11 112.291 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 19.3 p -60.02 -10.71 4.52 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.734 -0.666 . . . . 50.22 111.518 -172.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -54.62 -34.18 61.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.97 0.414 . . . . 75.43 110.309 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.666 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 31.5 t -74.89 -38.14 61.94 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.438 0.637 . . . . 63.21 109.944 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.538 HD11 ' HG ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -55.68 -28.32 54.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.299 -0.864 . . . . 65.41 110.487 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.572 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 41.2 mt-10 -59.19 -67.7 0.93 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.738 -0.21 . . . . 75.13 110.776 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.572 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 32.6 Cg_endo -62.62 -28.5 77.08 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 121.518 1.478 . . . . 41.13 111.972 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.666 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.0 mt-30 -62.35 -47.3 84.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.711 -0.396 . . . . 63.34 111.646 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.618 HD12 ' HZ3' ' A' ' 49' ' ' TRP . 22.1 mt -66.92 -39.98 87.53 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.962 -0.295 . . . . 64.12 110.561 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -64.58 -31.13 72.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.455 -0.338 . . . . 75.2 110.357 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.465 ' HD3' ' HG3' ' A' ' 17' ' ' GLN . 35.3 ttpt -63.6 -53.63 48.66 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.334 0.588 . . . . 74.34 109.589 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.426 HD12 ' CD1' ' A' ' 116' ' ' ILE . 19.5 mt -61.76 -31.13 71.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.339 -0.846 . . . . 74.21 110.128 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.416 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.73 -53.54 39.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.039 -0.528 . . . . 62.12 110.11 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -61.78 -34.44 75.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.299 -0.41 . . . . 74.52 111.202 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -75.87 -40.7 54.1 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.129 -0.487 . . . . 72.21 111.101 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -104.66 5.27 33.45 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.049 0.54 . . . . 75.34 112.359 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.1 t -53.3 -18.89 2.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.37 0.507 . . . . 74.13 112.37 -173.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.15 -43.45 82.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.822 0.344 . . . . 74.44 110.441 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -129.25 8.13 5.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.939 -0.573 . . . . 64.34 111.73 -175.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t -125.81 138.42 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.008 0.432 . . . . 74.1 111.774 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 24.4 tptp -141.6 120.0 12.33 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.713 -0.676 . . . . 72.42 109.217 174.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.43 HG12 ' HB2' ' A' ' 45' ' ' LEU . 55.6 mt -96.92 141.19 16.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 120.757 0.313 . . . . 74.13 110.855 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 30.6 m-85 -126.13 162.44 25.35 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.614 0.766 . . . . 71.54 109.784 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.738 ' HB2' ' HZ1' ' A' ' 78' ' ' LYS . 4.4 ttmp? -135.62 125.65 26.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.543 -0.54 . . . . 75.14 109.543 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.3 pt -91.4 117.83 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.948 0.404 . . . . 73.14 111.023 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.97 93.3 5.06 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.462 0.649 . . . . 71.1 110.58 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.441 HD13 ' NE2' ' A' ' 85' ' ' GLN . 41.7 pt -54.92 -23.93 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.355 -0.839 . . . . 74.32 111.969 -177.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -48.16 -40.94 25.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.729 0.411 . . . . 75.44 111.631 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.18 -33.75 67.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.924 0.392 . . . . 74.52 110.916 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 177.68 144.22 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.514 -0.921 . . . . 62.3 108.514 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.441 ' NE2' HD13 ' A' ' 81' ' ' ILE . 5.7 tt0 -124.48 -0.92 8.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.806 0.298 . . . . 74.23 111.806 -168.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.553 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 1.2 m-20 -49.08 -48.74 43.97 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.161 -0.472 . . . . 73.31 111.829 -175.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.8 t -53.79 -38.35 35.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-O 120.909 0.385 . . . . 54.01 110.934 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.06 88.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.138 0.494 . . . . 55.41 110.064 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.1 m -68.75 -36.75 78.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.679 -0.692 . . . . 75.42 110.618 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 97.5 mt-30 -60.82 -57.78 11.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.274 -0.421 . . . . 74.4 110.61 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -75.01 -24.47 58.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 71.12 111.292 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.75 73.19 1.14 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.94 -0.648 . . . . 53.31 113.08 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.0 t -89.72 91.49 3.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.88 -0.785 . . . . 71.22 108.88 172.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.4 p -74.52 -47.9 30.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.648 -0.706 . . . . 61.3 111.779 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.16 164.57 11.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 62.33 110.506 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.708 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 49.2 mm -62.08 -55.45 40.67 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 123.184 0.302 . . . . 72.42 110.605 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.708 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 2.1 Cg_endo -81.0 104.44 1.55 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.968 1.779 . . . . 75.41 110.978 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.404 ' C ' HD11 ' A' ' 99' ' ' ILE . 69.9 m -139.15 138.5 37.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.812 0.339 . . . . 73.54 110.852 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.439 HG12 HD13 ' A' ' 63' ' ' LEU . 2.0 mp -120.34 114.59 44.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 115.829 -0.623 . . . . 65.01 110.26 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.446 HD13 ' N ' ' A' ' 100' ' ' LEU . 5.9 mp -90.6 156.09 18.39 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.254 -0.647 . . . . 65.02 109.254 173.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.415 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . 48.8 mtp -126.27 139.5 53.27 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.965 -0.754 . . . . 73.13 108.965 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.448 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.3 m-85 -147.63 157.02 43.37 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.668 -0.493 . . . . 73.32 109.668 176.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 40.6 ttpt -151.1 109.41 3.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.491 -0.483 . . . . 74.03 111.595 175.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.707 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 66.2 t30 55.9 36.9 28.17 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.485 0.66 . . . . 73.45 111.24 174.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.66 -16.68 58.65 Favored Glycine 0 CA--C 1.518 0.275 0 CA-C-N 115.647 -0.706 . . . . 71.52 112.829 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 12.8 ttmt -74.33 135.21 42.53 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 116.813 0.306 . . . . 70.24 110.393 177.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -77.9 88.05 4.1 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.19 0.995 . . . . 73.11 110.751 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -71.84 168.85 17.02 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.35 -1.75 . . . . 74.52 109.782 172.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 101' ' ' MET . 38.9 m -69.87 -177.61 1.34 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.277 0.631 . . . . 74.31 112.353 -166.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -142.38 121.41 12.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.206 -0.452 . . . . 63.23 110.214 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.45 115.81 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 70.2 110.135 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.1 mt -89.51 128.23 41.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.579 . . . . 63.31 110.38 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.17 -155.77 30.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.172 -0.537 . . . . 64.12 112.3 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -105.99 112.62 25.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.783 -0.451 . . . . 65.45 109.783 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 119' ' ' ILE . 5.4 t70 -154.05 82.58 1.14 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.376 0.608 . . . . 70.1 110.246 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.523 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -60.24 -29.53 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.356 -0.838 . . . . 74.01 110.67 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.9 t -66.39 -54.25 26.56 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.124 0.488 . . . . 75.3 110.086 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -57.77 -46.21 84.88 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.814 -0.63 . . . . 72.33 110.167 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.502 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.7 mt -56.47 -56.34 14.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.879 -0.601 . . . . 75.23 111.091 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -63.21 -34.18 65.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 120.56 0.219 . . . . 75.34 110.696 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 t -60.1 -52.15 66.59 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.369 -0.378 . . . . 75.23 110.063 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.3 -40.31 93.68 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.212 -0.449 . . . . 75.1 110.149 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.552 ' O ' HG13 ' A' ' 127' ' ' ILE . 53.2 mt -57.12 -56.33 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.859 -0.61 . . . . 64.01 111.273 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.82 -33.41 72.29 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 120.42 -0.512 . . . . 73.42 110.198 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -58.66 -36.26 73.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.12 -0.491 . . . . 62.44 110.362 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.445 ' CG ' HD11 ' A' ' 108' ' ' LEU . 39.2 m-80 -108.81 1.31 20.87 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.369 0.877 . . . . 62.11 113.369 -175.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 123' ' ' ILE . 46.6 mt -84.12 -52.95 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.378 -0.971 . . . . 74.34 108.378 166.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.408 -0.814 . . . . 74.11 109.688 175.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 C--O 1.233 0.199 0 N-CA-C 109.296 -0.631 . . . . 55.119999999999997 109.296 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 76' ' ' ILE . 3.6 mm -82.84 81.74 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.55 -0.908 . . . . 72.230000000000004 108.55 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 77' ' ' TYR . 7.4 tp10 -69.47 161.54 29.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.728 -0.669 . . . . 60.340000000000003 111.807 -170.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.404 ' H ' ' HG3' ' A' ' 25' ' ' GLN . 4.4 pp0? -96.75 138.69 33.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.01 -0.541 . . . . 74.349999999999994 110.901 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.7 pt -148.53 169.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.18 0.514 . . . . 71.420000000000002 111.158 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.15 -163.95 11.46 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 109.922 -1.271 . . . . 53.409999999999997 109.922 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -63.33 -39.64 95.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 117.56 0.68 . . . . 75.310000000000002 110.298 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -64.47 -38.35 90.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.576 -0.738 . . . . 72.140000000000001 111.706 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -83.89 -29.08 27.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.688 -0.233 . . . . 64.209999999999994 110.897 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -47.61 -61.64 1.83 Allowed 'General case' 0 C--O 1.238 0.471 0 O-C-N 123.482 0.489 . . . . 63.329999999999998 111.426 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -56.08 -45.1 79.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 75.150000000000006 110.928 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -58.46 -53.8 54.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.0 -0.545 . . . . 73.040000000000006 111.206 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -65.31 -38.72 91.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.066 -0.516 . . . . 70.209999999999994 111.117 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 44' ' ' ILE . 56.8 t -72.64 -42.01 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.302 0.482 . . . . 73.219999999999999 112.302 -176.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.2 p -85.96 -45.29 11.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.116 0.413 . . . . 55.030000000000001 112.116 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t -86.87 10.47 16.02 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.28 -0.418 . . . . 73.439999999999998 112.096 -172.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 7.5 p -71.29 81.49 0.74 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.88 0.371 . . . . 71.319999999999993 111.261 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 29.9 -93.89 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.776 1.231 . . . . 72.340000000000003 113.355 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -161.72 132.32 5.04 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.637 0.375 . . . . 74.409999999999997 110.526 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 54.98 14.69 0.98 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.544 0.572 . . . . 64.120000000000005 112.544 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.9 mm -74.45 115.55 15.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.857 0.36 . . . . 63.420000000000002 110.13 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 102' ' ' PHE . 42.2 tp -76.55 110.29 10.99 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.475 0.655 . . . . 73.120000000000005 110.72 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 23.6 mm -88.98 117.63 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.873 -1.058 . . . . 70.040000000000006 109.744 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.464 HD13 HG13 ' A' ' 74' ' ' VAL . 4.8 mp -106.68 127.85 53.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.439 -0.949 . . . . 52.509999999999998 108.439 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 57.6 t -110.97 104.39 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.273 -0.64 . . . . 74.019999999999996 109.273 175.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.02 114.37 28.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.744 -0.662 . . . . 73.040000000000006 110.141 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 . . . . . 0 C--O 1.234 0.261 0 CA-C-N 116.3 -0.409 . . . . 72.319999999999993 110.03 177.233 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 121.076 0.465 . . . . 73.340000000000003 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.639 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 28.7 t -74.57 -30.53 61.75 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.652 0.739 . . . . 53.130000000000003 110.128 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.514 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 mm? -64.29 -20.73 66.27 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.76 -0.654 . . . . 62.149999999999999 110.872 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.518 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 54.5 mt-10 -54.92 -67.11 0.73 Allowed Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.767 -0.457 . . . . 64.540000000000006 109.767 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.518 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 53.6 Cg_endo -66.64 -37.27 22.28 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 121.735 1.623 . . . . 62.530000000000001 112.387 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.639 ' HG3' ' O ' ' A' ' 58' ' ' SER . 45.5 mt-30 -59.98 -55.9 28.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.355 -0.538 . . . . 74.510000000000005 111.062 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.58 -51.85 63.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.522 -0.308 . . . . 72.239999999999995 111.117 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.555 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 15.8 mm-40 -50.73 -45.63 58.78 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.86 0.362 . . . . 64.329999999999998 110.94 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -69.04 -47.63 64.89 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.387 -0.369 . . . . 74.040000000000006 111.252 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.545 HD11 HD11 ' A' ' 116' ' ' ILE . 16.9 mt -62.29 -31.34 71.92 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.632 -0.427 . . . . 71.310000000000002 110.455 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 71' ' ' THR . . . -66.55 -47.33 73.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.792 -0.447 . . . . 51.030000000000001 109.792 175.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 96.5 mt-30 -59.79 -30.59 69.0 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.101 0.477 . . . . 75.310000000000002 110.801 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -76.33 -45.22 33.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.047 -0.524 . . . . 71.25 111.086 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -103.75 5.21 35.97 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.928 0.714 . . . . 72.439999999999998 112.928 -169.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.89 -19.41 2.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.705 0.402 . . . . 75.129999999999995 112.072 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -55.14 -40.48 70.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 74.209999999999994 110.708 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -127.58 -5.88 5.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.82 -0.627 . . . . 74.109999999999999 111.398 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.464 HG13 HD13 ' A' ' 45' ' ' LEU . 42.1 t -117.06 136.28 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.921 0.391 . . . . 71.239999999999995 111.485 -175.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -141.33 120.11 12.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.686 -0.688 . . . . 64.209999999999994 109.52 173.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.433 HG22 HG23 ' A' ' 23' ' ' ILE . 50.0 mt -99.55 143.02 14.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.367 -0.379 . . . . 63.409999999999997 109.994 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.465 ' CD1' ' HB3' ' A' ' 24' ' ' GLU . 96.8 m-85 -135.61 154.55 51.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.839 -0.618 . . . . 72.219999999999999 109.877 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -141.26 144.1 34.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.302 -0.629 . . . . 63.030000000000001 109.302 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 tt -77.03 135.43 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.303 -0.408 . . . . 71.120000000000005 110.317 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -107.25 -37.54 6.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.105 -0.498 . . . . 73.400000000000006 110.411 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 81' ' ' ILE . 2.8 mp -81.43 103.43 8.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.906 -0.588 . . . . 74.319999999999993 110.387 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.1 -25.22 61.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 63.32 111.806 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.23 -21.22 62.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.641 0.258 . . . . 75.439999999999998 111.187 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -102.3 12.88 35.97 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.594 -0.275 . . . . 72.099999999999994 111.511 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -69.8 -9.38 54.43 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.032 0.444 . . . . 74.319999999999993 110.094 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -54.46 -30.92 54.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.434 -0.803 . . . . 53.32 110.591 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -53.03 -38.82 30.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.754 -0.657 . . . . 71.340000000000003 110.409 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.445 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -57.3 -54.48 46.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.38 -0.827 . . . . 60.200000000000003 110.547 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -60.41 -39.33 87.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.624 -0.716 . . . . 73.439999999999998 110.769 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -64.37 -44.87 90.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.741 -0.663 . . . . 75.540000000000006 111.831 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -80.09 -22.69 41.92 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.664 -0.244 . . . . 74.120000000000005 111.358 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.61 48.6 0.73 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.873 -0.679 . . . . 74.25 113.178 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.445 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 88.5 t -94.61 111.44 25.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.934 -0.395 . . . . 73.219999999999999 109.934 176.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.2 t -110.32 19.74 18.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.286 -0.415 . . . . 65.409999999999997 111.082 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.78 149.42 30.5 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.069 -0.345 . . . . 73.200000000000003 110.069 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.657 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 62.6 mt -61.36 -54.93 48.22 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 123.011 0.195 . . . . 64.420000000000002 110.865 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 86.3 Cg_endo -86.68 98.2 0.52 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.781 1.654 . . . . 64.150000000000006 111.234 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 m -140.42 142.61 35.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.431 . . . . 75.409999999999997 110.327 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.646 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -113.25 117.99 56.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 73.230000000000004 110.268 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.405 HD23 ' HG3' ' A' ' 110' ' ' GLN . 98.7 mt -94.17 122.95 37.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.507 -0.923 . . . . 64.430000000000007 108.507 172.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.447 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 51.2 mtp -100.2 146.9 26.31 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.919 -0.4 . . . . 70.310000000000002 109.919 -177.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.562 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 98.6 m-85 -149.56 161.87 41.3 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.51 -0.552 . . . . 75.400000000000006 109.51 176.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -151.34 107.17 3.39 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.294 -0.254 . . . . 72.299999999999997 111.101 176.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.552 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 64.4 t30 55.42 35.9 26.0 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.282 0.563 . . . . 63.0 111.273 173.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.33 -16.33 56.25 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.08 -0.509 . . . . 71.219999999999999 112.756 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -79.95 143.82 33.85 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.546 -0.538 . . . . 71.209999999999994 109.546 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -67.91 162.57 23.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.263 0.554 . . . . 73.129999999999995 110.949 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.61 168.3 21.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.763 -1.108 . . . . 72.329999999999998 108.117 -164.029 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -70.27 179.75 2.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.592 0.711 . . . . 75.019999999999996 112.458 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.405 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.8 tt0 -139.73 118.91 12.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.403 -0.817 . . . . 73.349999999999994 109.446 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.646 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.0 t -97.54 113.18 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 74.540000000000006 110.552 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.0 mp -88.22 108.37 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.394 -0.595 . . . . 74.140000000000001 109.394 177.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.85 143.24 10.65 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.775 -0.53 . . . . 52.149999999999999 111.775 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.514 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -74.65 72.04 1.94 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.936 0.398 . . . . 54.32 110.155 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.415 ' O ' HG13 ' A' ' 119' ' ' ILE . 19.4 t70 -111.08 105.35 14.06 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.893 -0.594 . . . . 73.219999999999999 110.69 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.554 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -59.08 -31.98 46.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.301 -0.863 . . . . 61.130000000000003 110.209 -176.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 m -62.4 -55.79 24.52 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.349 -0.387 . . . . 71.129999999999995 110.931 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -63.57 -41.34 98.39 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.544 0.212 . . . . 63.310000000000002 110.461 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 123' ' ' ILE . 80.6 mt -56.21 -56.28 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.307 -0.406 . . . . 64.310000000000002 110.482 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.75 -33.9 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.481 -0.327 . . . . 54.049999999999997 110.662 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.7 m -57.84 -49.49 76.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.433 -0.349 . . . . 74.120000000000005 110.242 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -69.74 -36.44 75.83 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.464 -0.335 . . . . 72.299999999999997 110.924 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 119' ' ' ILE . 70.8 mt -56.08 -55.95 15.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 64.310000000000002 109.779 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -58.49 -42.47 87.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.546 -0.752 . . . . 71.239999999999995 110.495 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -60.59 -33.7 73.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.319 -0.855 . . . . 75.219999999999999 111.263 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.408 ' OD1' HD11 ' A' ' 108' ' ' LEU . 38.8 m-80 -102.42 -9.52 20.21 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.961 0.726 . . . . 72.549999999999997 112.961 -175.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.5 mt -89.75 -60.51 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.705 -0.398 . . . . 73.129999999999995 110.35 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.158 -0.925 . . . . 74.5 110.154 -178.069 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 13.5 mmt . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.373 0.606 . . . . 55.119999999999997 109.418 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.428 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 8.3 mm -70.49 80.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.908 -1.042 . . . . 72.230000000000004 108.785 172.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 9.0 tp10 -66.51 157.01 33.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.247 -0.433 . . . . 60.340000000000003 111.211 -175.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -109.27 136.88 48.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.442 0.297 . . . . 74.349999999999994 110.718 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 31' ' ' PHE . 37.9 pt -147.38 176.26 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.001 0.429 . . . . 71.420000000000002 110.992 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.25 -167.27 11.9 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.915 -0.874 . . . . 53.409999999999997 110.915 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.22 -50.68 68.79 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.956 0.407 . . . . 75.310000000000002 111.425 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -68.94 -32.54 72.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.884 -0.598 . . . . 72.140000000000001 112.169 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -80.78 -22.43 40.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.823 -0.172 . . . . 64.209999999999994 110.783 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.464 ' HE1' HG21 ' A' ' 46' ' ' VAL . 91.9 t80 -51.88 -61.96 1.93 Allowed 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.52 0.513 . . . . 63.329999999999998 111.383 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -57.41 -47.17 82.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.099 -0.501 . . . . 75.150000000000006 110.653 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -56.15 -54.44 45.15 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.537 -0.756 . . . . 73.040000000000006 111.278 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -67.44 -33.03 74.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 70.209999999999994 111.343 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.549 HG22 HG21 ' A' ' 44' ' ' ILE . 65.5 t -72.03 -38.2 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.463 -0.335 . . . . 73.219999999999999 111.758 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -85.99 -41.82 14.54 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.024 0.44 . . . . 55.030000000000001 112.028 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 t -83.26 11.54 6.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.112 -0.494 . . . . 73.439999999999998 111.788 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 13.8 p -72.26 82.58 1.02 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.78 0.324 . . . . 71.319999999999993 111.85 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.0 t30 41.52 -93.65 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.367 -0.833 . . . . 72.340000000000003 112.462 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -162.04 121.94 2.47 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 110.412 -0.218 . . . . 74.409999999999997 110.412 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 48.0 m-80 55.36 18.96 2.8 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.779 0.659 . . . . 64.120000000000005 112.779 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.1 mm -71.96 133.62 31.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 120.893 0.378 . . . . 63.420000000000002 110.759 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 74' ' ' VAL . 31.2 tp -80.28 114.97 19.57 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.828 -0.624 . . . . 73.120000000000005 110.389 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.549 HG21 HG22 ' A' ' 35' ' ' VAL . 29.1 mm -95.27 118.9 42.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 70.040000000000006 110.396 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.541 HD13 HG13 ' A' ' 74' ' ' VAL . 5.5 mp -104.19 125.25 50.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.384 -0.969 . . . . 52.509999999999998 108.384 170.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.464 HG21 ' HE1' ' A' ' 31' ' ' PHE . 59.3 t -112.08 104.47 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.454 -0.573 . . . . 74.019999999999996 109.454 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.47 118.3 35.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.659 -0.701 . . . . 73.040000000000006 110.806 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.369 0.604 . . . . 72.319999999999993 109.652 174.275 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 121.22 0.533 . . . . 73.340000000000003 110.851 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.627 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 21.5 t -74.78 -35.93 62.53 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-O 122.007 0.908 . . . . 53.130000000000003 109.611 174.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.534 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.6 mm? -65.06 -26.2 68.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.775 -1.102 . . . . 62.149999999999999 110.763 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.508 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 46.2 mt-10 -53.52 -64.25 1.88 Allowed Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.681 -0.408 . . . . 64.540000000000006 109.998 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.508 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 46.2 Cg_endo -66.83 -39.17 15.33 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 121.699 1.599 . . . . 62.530000000000001 112.441 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 58' ' ' SER . 37.0 mt-30 -61.63 -46.2 90.83 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.107 -0.637 . . . . 74.510000000000005 111.236 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.49 -37.53 60.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.331 -0.395 . . . . 72.239999999999995 110.997 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 3.0 mm-40 -57.31 -38.3 73.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.025 0.44 . . . . 64.329999999999998 110.132 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.91 -55.08 25.31 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.839 -0.619 . . . . 74.040000000000006 110.221 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 116' ' ' ILE . 27.8 mt -60.94 -32.32 71.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.665 -0.698 . . . . 71.310000000000002 110.747 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.547 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.47 -53.71 26.49 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.154 -0.476 . . . . 51.030000000000001 109.937 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.7 mt-30 -59.1 -36.15 74.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.415 . . . . 75.310000000000002 111.04 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -71.94 -52.16 18.56 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.979 0.418 . . . . 71.25 111.374 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -95.22 4.7 53.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.618 0.599 . . . . 72.439999999999998 112.618 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.2 t -52.89 -22.86 6.03 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.816 0.673 . . . . 75.129999999999995 112.816 -170.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.3 -31.84 73.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.747 0.308 . . . . 74.209999999999994 110.818 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -125.69 -0.26 7.42 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.377 -0.374 . . . . 74.109999999999999 110.891 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.541 HG13 HD13 ' A' ' 45' ' ' LEU . 36.6 t -127.94 136.16 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.958 0.408 . . . . 71.239999999999995 111.421 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 71' ' ' THR . 39.8 mmtm -141.89 131.45 23.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.934 -0.575 . . . . 64.209999999999994 109.604 172.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.7 mt -104.97 143.12 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 63.409999999999997 110.444 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -131.46 143.35 50.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.077 -0.51 . . . . 72.219999999999999 110.156 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 25.1 pttm -124.18 127.84 48.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.943 -0.571 . . . . 63.030000000000001 109.667 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.7 tt -80.09 107.18 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.157 0.503 . . . . 71.120000000000005 109.67 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -86.08 -31.96 21.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.234 -0.439 . . . . 73.400000000000006 111.084 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 81' ' ' ILE . 3.0 mp -81.56 85.83 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.32 0.581 . . . . 74.319999999999993 110.286 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -27.34 62.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.359 -0.837 . . . . 63.32 111.277 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.36 -21.97 61.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 75.439999999999998 111.064 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -113.44 41.22 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 72.099999999999994 110.172 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -80.63 22.5 0.58 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.858 -0.61 . . . . 74.319999999999993 111.149 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 37.3 t70 -54.03 -35.93 62.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.625 0.37 . . . . 53.32 110.714 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.3 t -52.74 -40.33 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.709 -0.678 . . . . 71.340000000000003 110.539 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.42 -54.32 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 60.200000000000003 110.51 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 m -62.88 -29.63 70.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 73.439999999999998 110.967 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 33.6 mm-40 -69.13 -56.04 8.87 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.343 -0.39 . . . . 75.540000000000006 111.174 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -75.0 -9.54 58.63 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.791 0.329 . . . . 74.120000000000005 111.231 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.81 45.4 7.77 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.031 -0.604 . . . . 74.25 112.498 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.0 103.58 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.543 -0.54 . . . . 73.219999999999999 109.543 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.7 t -86.37 -52.36 5.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.298 -0.41 . . . . 65.409999999999997 109.928 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.19 150.99 46.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.251 -0.431 . . . . 73.200000000000003 110.092 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.675 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 66.4 mt -72.97 -59.53 2.17 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 119.742 -0.171 . . . . 64.420000000000002 111.145 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 86.6 Cg_endo -82.74 63.62 8.0 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.952 1.768 . . . . 64.150000000000006 112.01 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.5 m -100.92 145.67 28.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.121 -0.49 . . . . 75.409999999999997 110.486 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.603 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -112.16 122.67 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 73.230000000000004 110.265 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.504 HD23 ' HG3' ' A' ' 110' ' ' GLN . 84.7 mt -93.2 123.12 36.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.906 -0.776 . . . . 64.430000000000007 108.906 173.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 109' ' ' SER . 42.0 mtp -98.29 143.22 29.0 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.778 -0.453 . . . . 70.310000000000002 109.778 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.626 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.5 m-85 -149.09 161.39 42.04 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.328 -0.619 . . . . 75.400000000000006 109.328 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -142.63 109.3 5.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.034 -0.266 . . . . 72.299999999999997 110.646 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.538 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 60.6 t30 57.03 29.01 15.74 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.353 0.596 . . . . 63.0 111.061 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.513 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 89.4 -2.72 83.42 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.235 -0.507 . . . . 71.219999999999999 112.92 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -91.7 146.79 23.48 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.784 -0.45 . . . . 71.209999999999994 109.784 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -60.84 154.62 21.56 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.277 0.561 . . . . 73.129999999999995 112.117 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.626 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.16 167.62 23.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.695 -1.138 . . . . 72.329999999999998 108.217 -169.537 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 101' ' ' MET . 5.2 m -70.99 171.48 10.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.744 0.783 . . . . 75.019999999999996 112.692 -170.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.504 ' HG3' HD23 ' A' ' 100' ' ' LEU . 26.8 tt0 -126.04 127.28 45.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.233 -0.894 . . . . 73.349999999999994 109.775 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.603 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 61.3 t -97.52 107.61 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.074 -0.343 . . . . 74.540000000000006 110.074 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 112' ' ' ILE . 2.9 mp -81.46 106.95 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 74.140000000000001 109.906 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.56 136.7 7.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.297 -0.477 . . . . 52.149999999999999 112.142 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.534 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -57.61 92.13 0.01 OUTLIER 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.929 0.395 . . . . 54.32 110.814 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.414 ' O ' HG13 ' A' ' 119' ' ' ILE . 12.4 t70 -127.22 99.33 5.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 73.219999999999999 109.963 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.514 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -59.07 -33.68 51.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.846 -0.616 . . . . 61.130000000000003 110.728 -174.389 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.8 m -61.06 -54.02 49.88 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.755 0.312 . . . . 71.129999999999995 110.487 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -63.71 -40.88 97.87 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.57 -0.286 . . . . 63.310000000000002 110.543 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.6 mt -58.76 -55.06 25.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.145 -0.48 . . . . 64.310000000000002 110.683 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.9 tt -63.33 -34.11 65.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 116.617 -0.265 . . . . 54.049999999999997 110.341 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.6 m -59.44 -45.69 90.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.668 0.27 . . . . 74.120000000000005 110.318 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -69.99 -38.05 75.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.625 -0.261 . . . . 72.299999999999997 111.186 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.0 mt -57.14 -53.72 39.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.956 0.408 . . . . 64.310000000000002 110.012 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -59.59 -39.58 84.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.755 -0.657 . . . . 71.239999999999995 109.988 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -63.65 -31.86 73.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.652 -0.703 . . . . 75.219999999999999 111.511 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -90.11 -30.12 17.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.184 0.438 . . . . 72.549999999999997 112.184 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.475 HD11 HG23 ' A' ' 74' ' ' VAL . 68.5 mt -86.31 -45.97 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.059 0.457 . . . . 73.129999999999995 110.577 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.455 -0.783 . . . . 74.5 109.65 -179.097 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.438 ' HG3' ' CG ' ' A' ' 68' ' ' GLN . 93.9 mmm . . . . . 0 C--O 1.233 0.236 0 N-CA-C 109.898 -0.408 . . . . 72.340000000000003 109.898 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.451 HG12 ' OE2' ' A' ' 64' ' ' GLU . 32.9 mm -67.83 99.38 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.587 -0.894 . . . . 71.0 108.587 174.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 16.2 tt0 -74.85 112.36 10.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.342 0.592 . . . . 75.230000000000004 109.936 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.454 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 8.5 tt0 -88.99 131.14 35.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.488 -0.778 . . . . 62.009999999999998 110.717 -170.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.546 HG21 ' HG3' ' A' ' 34' ' ' LYS . 47.6 pt -144.94 -179.85 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.756 0.312 . . . . 73.510000000000005 111.201 -175.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.64 -174.42 15.6 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.209 -0.451 . . . . 71.540000000000006 112.534 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' OD1' HG23 ' A' ' 87' ' ' VAL . 20.0 t70 -50.84 -57.01 9.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.502 0.721 . . . . 71.109999999999999 112.649 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -69.25 -27.13 65.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 71.5 110.919 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -74.21 -15.59 61.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 62.450000000000003 110.642 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . 90.0 t80 -52.56 -61.38 2.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.912 -0.586 . . . . 73.140000000000001 111.017 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -55.21 -53.43 56.1 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.433 -0.349 . . . . 60.100000000000001 111.167 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -53.34 -55.92 20.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.844 -0.616 . . . . 70.329999999999998 111.211 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.706 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 11.0 mmpt? -61.66 -45.61 93.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.864 -0.607 . . . . 71.230000000000004 111.33 -176.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.415 ' HA ' HD12 ' A' ' 44' ' ' ILE . 70.4 t -64.29 -40.66 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.448 -0.342 . . . . 74.329999999999998 111.347 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.1 p -78.26 -25.02 46.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.703 0.287 . . . . 72.0 111.009 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -61.78 -14.95 37.21 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.261 -0.427 . . . . 51.009999999999998 111.459 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.617 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 22.8 p -49.48 114.45 1.04 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 123.148 0.28 . . . . 73.230000000000004 110.798 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.8 -70.3 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 111.183 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -156.01 122.17 5.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.374 -0.375 . . . . 73.409999999999997 110.474 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 58.82 17.69 5.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.94 -0.573 . . . . 74.310000000000002 111.655 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.4 mm -74.74 97.96 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.661 -0.496 . . . . 74.530000000000001 109.661 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.81 111.47 9.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.708 -0.678 . . . . 64.439999999999998 109.499 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.426 HG23 ' CD1' ' A' ' 77' ' ' TYR . 58.3 mt -101.51 115.1 42.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.181 -0.918 . . . . 62.329999999999998 110.459 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.469 ' HB2' HG13 ' A' ' 76' ' ' ILE . 5.1 mp -103.07 106.41 16.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.817 -0.628 . . . . 72.099999999999994 109.619 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.81 105.0 16.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.731 -0.213 . . . . 73.519999999999996 110.47 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 20.8 t0 -83.16 151.44 25.7 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.142 0.496 . . . . 65.239999999999995 110.688 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.0 t80 . . . . . 0 C--O 1.24 0.586 0 CA-C-N 115.63 -0.713 . . . . 55.020000000000003 111.694 -174.963 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 110.085 -0.339 . . . . 65.430000000000007 110.085 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.571 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 38.9 t -75.59 -44.0 45.34 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.527 0.68 . . . . 53.119999999999997 111.478 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.3 mm? -60.65 -45.59 93.53 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.852 0.686 . . . . 75.150000000000006 112.852 -171.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.52 -56.31 28.24 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 117.609 0.186 . . . . 74.239999999999995 111.171 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HG2' ' O ' ' A' ' 58' ' ' SER . 18.9 Cg_endo -60.25 -40.49 58.9 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.781 1.654 . . . . 74.340000000000003 112.087 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.571 ' HG3' ' O ' ' A' ' 58' ' ' SER . 34.9 mt-30 -58.31 -39.1 78.47 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.681 -0.408 . . . . 63.340000000000003 111.756 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 85.5 mt -68.43 -41.35 80.47 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.009 -0.367 . . . . 70.299999999999997 110.009 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 19.7 mm-40 -59.47 -41.14 89.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 73.510000000000005 110.415 174.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.579 ' NZ ' ' HB2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -60.56 -57.13 14.04 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.379 0.609 . . . . 63.229999999999997 110.329 178.443 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.45 -28.76 70.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.489 -0.778 . . . . 72.310000000000002 110.232 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.555 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.08 -50.6 65.5 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.123 -0.49 . . . . 61.240000000000002 109.869 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 91.4 mt-30 -59.77 -41.22 90.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.028 -0.533 . . . . 74.510000000000005 111.115 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -74.32 -54.87 6.77 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.011 0.434 . . . . 64.120000000000005 111.288 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -84.81 4.4 33.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.894 -0.594 . . . . 72.129999999999995 112.475 -172.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.7 t -52.97 -19.57 2.73 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 111.887 0.329 . . . . 63.509999999999998 111.887 -173.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -58.71 -38.92 79.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 52.229999999999997 110.585 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -134.89 10.95 3.63 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 111.407 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.567 HG23 HD11 ' A' ' 127' ' ' ILE . 31.8 t -128.83 142.14 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.22 0.533 . . . . 53.520000000000003 112.347 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 45.9 mmtt -143.6 119.97 10.93 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.194 -0.912 . . . . 72.129999999999995 109.762 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.55 HD13 ' HB2' ' A' ' 67' ' ' ALA . 3.6 mp -98.75 136.74 28.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 109.614 -0.513 . . . . 74.310000000000002 109.614 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 77.3 m-85 -124.31 164.52 19.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 72.200000000000003 109.912 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -153.4 132.58 12.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 74.319999999999993 109.638 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 64.9 mt -75.51 118.43 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.885 -0.413 . . . . 53.310000000000002 109.885 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 25' ' ' GLN . 4.2 p-10 -91.46 -40.34 11.46 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.801 0.334 . . . . 74.349999999999994 111.379 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 81' ' ' ILE . 13.4 tt -83.54 99.24 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.732 0.777 . . . . 71.140000000000001 110.971 -174.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -17.51 62.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.418 -0.81 . . . . 73.310000000000002 111.663 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -70.2 -27.05 64.19 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.572 -0.529 . . . . 74.310000000000002 109.572 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 16.0 m120 -128.13 86.9 2.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.885 -0.598 . . . . 75.340000000000003 109.894 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -138.41 27.94 2.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.728 -0.669 . . . . 65.049999999999997 109.495 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 33.8 t70 -56.76 -35.32 68.5 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.187 -0.915 . . . . 65.349999999999994 111.709 -172.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.469 HG23 ' OD1' ' A' ' 28' ' ' ASP . 90.2 t -52.53 -35.98 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.073 0.463 . . . . 73.540000000000006 110.489 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.68 71.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.941 -0.572 . . . . 65.340000000000003 110.497 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.8 m -59.67 -37.94 80.13 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.286 0.565 . . . . 74.129999999999995 110.492 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 19.8 mm-40 -64.5 -48.23 75.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.43 -0.804 . . . . 72.120000000000005 110.798 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -76.74 -18.3 58.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.56 -0.291 . . . . 73.010000000000005 111.155 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.32 36.51 8.11 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 121.365 -0.445 . . . . 71.230000000000004 112.922 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.86 117.99 39.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 122.411 0.284 . . . . 71.310000000000002 110.422 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.6 m -133.4 13.75 4.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.921 0.391 . . . . 75.230000000000004 110.776 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.19 136.23 39.45 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.549 -0.537 . . . . 73.109999999999999 109.549 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.725 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 49.3 mm -56.19 -54.91 47.55 Favored Pre-proline 0 CA--C 1.542 0.642 0 O-C-N 123.274 0.359 . . . . 71.239999999999995 111.679 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 94.5 Cg_endo -94.2 105.3 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.295 1.996 . . . . 61.25 111.322 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.522 HG23 HG13 ' A' ' 112' ' ' ILE . 27.9 m -148.53 118.24 7.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.284 -0.265 . . . . 71.219999999999999 110.284 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.455 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.1 mp -109.51 110.71 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.189 -0.46 . . . . 63.340000000000003 109.949 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.5 mp -92.46 123.3 35.67 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.176 -0.676 . . . . 72.430000000000007 109.176 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 53.3 mtp -98.73 142.31 30.43 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.854 -0.424 . . . . 63.399999999999999 109.854 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.567 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.8 m-85 -144.89 151.03 38.08 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.549 -0.537 . . . . 70.310000000000002 109.549 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -149.32 123.56 9.55 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.741 -0.384 . . . . 61.5 110.984 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.617 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.5 m-20 62.21 25.45 15.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.265 0.555 . . . . 71.319999999999993 110.325 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.71 -2.89 52.56 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.775 -0.648 . . . . 75.019999999999996 111.988 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -88.17 145.06 26.11 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.846 -0.428 . . . . 65.040000000000006 109.846 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.48 145.61 43.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 124.047 0.842 . . . . 74.450000000000003 110.903 -176.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -150.67 168.02 25.57 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.182 -1.414 . . . . 70.099999999999994 107.182 -170.188 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.3 m -70.29 177.89 3.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.19 0.519 . . . . 51.329999999999998 112.352 -165.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -142.49 119.38 11.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 44.310000000000002 110.057 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -100.63 107.42 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.248 -0.433 . . . . 72.530000000000001 110.112 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -96.16 121.6 46.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.304 -0.628 . . . . 71.319999999999993 109.304 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.87 162.5 32.26 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.794 -0.523 . . . . 41.409999999999997 111.794 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.66 89.93 2.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.753 0.311 . . . . 71.329999999999998 111.175 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.501 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 57.4 t0 -132.45 82.23 2.0 Allowed 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.681 0.753 . . . . 75.0 109.848 174.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.87 -29.04 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 114.993 -1.003 . . . . 74.450000000000003 110.021 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.4 m -60.82 -50.33 73.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.615 -0.513 . . . . 52.409999999999997 109.615 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -61.68 -46.3 90.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.648 -0.706 . . . . 53.539999999999999 110.183 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 123' ' ' ILE . 78.3 mt -55.57 -56.54 11.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.762 -0.654 . . . . 61.350000000000001 111.201 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -66.69 -34.7 71.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.374 -0.376 . . . . 53.310000000000002 110.629 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.3 t -59.3 -51.88 68.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.885 -0.413 . . . . 75.450000000000003 109.885 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -63.67 -36.01 82.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.435 -0.348 . . . . 75.049999999999997 111.232 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.1 mt -56.56 -56.28 14.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.05 0.452 . . . . 71.010000000000005 110.41 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -69.6 -29.06 66.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 61.329999999999998 110.682 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -65.88 -43.8 87.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 64.450000000000003 110.887 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.42 ' CG ' HD11 ' A' ' 108' ' ' LEU . 46.8 m-80 -93.41 -17.95 22.92 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.541 0.571 . . . . 55.140000000000001 112.541 -172.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.567 HD11 HG23 ' A' ' 74' ' ' VAL . 58.6 mt -78.27 -59.83 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 120.543 -0.463 . . . . 64.109999999999999 110.284 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.303 -0.856 . . . . 75.030000000000001 110.205 -176.459 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.495 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 95.4 mmm . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.735 0.302 . . . . 75.439999999999998 110.591 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -111.85 126.16 69.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.206 -0.452 . . . . 63.520000000000003 110.422 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -87.4 151.37 23.13 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.446 -0.343 . . . . 72.549999999999997 110.618 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -114.83 129.68 56.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.436 -0.347 . . . . 71.319999999999993 110.067 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 31' ' ' PHE . 45.7 pt -144.88 169.72 7.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.2 0.524 . . . . 75.430000000000007 111.751 -174.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.527 ' HA2' HD12 ' A' ' 79' ' ' ILE . . . -136.33 -173.71 13.06 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.298 -0.865 . . . . 64.329999999999998 111.274 174.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 7.3 t70 -45.16 -47.22 12.33 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.053 0.454 . . . . 72.099999999999994 111.353 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -62.61 -29.35 70.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.712 -0.676 . . . . 63.039999999999999 112.424 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -102.87 -17.77 15.38 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 122.395 -0.191 . . . . 53.329999999999998 111.435 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 26' ' ' ILE . 88.4 t80 -50.49 -62.01 1.85 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 112.439 0.533 . . . . 70.010000000000005 112.439 -169.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.637 ' O ' HG22 ' A' ' 36' ' ' THR . 10.6 m-20 -56.96 -55.46 34.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 41.149999999999999 110.537 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -54.63 -55.84 25.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.731 -0.668 . . . . 62.020000000000003 111.447 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HG3' HG21 ' A' ' 26' ' ' ILE . 63.7 mmtt -57.74 -40.82 80.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 71.239999999999995 111.386 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.88 -59.72 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.47 -0.332 . . . . 74.109999999999999 111.326 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 32' ' ' ASP . 9.0 t -81.38 -0.27 40.55 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.62 -0.263 . . . . 62.32 111.522 -173.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.6 t -61.74 -19.25 62.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.047 0.451 . . . . 64.099999999999994 109.978 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.817 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 21.3 p -55.8 137.19 50.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.655 -0.702 . . . . 63.009999999999998 110.648 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -74.46 -72.22 0.3 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.453 0.168 . . . . 71.109999999999999 110.701 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -136.2 121.91 19.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.559 0.219 . . . . 72.010000000000005 111.372 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 48.78 26.56 1.3 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.515 0.726 . . . . 73.340000000000003 112.895 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.776 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.7 mm -71.22 126.15 31.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 110.009 -0.367 . . . . 63.009999999999998 110.009 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.501 HD12 HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -75.63 107.49 7.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 72.030000000000001 109.641 -178.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 36.5 mm -92.64 133.3 34.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.225 -0.898 . . . . 74.230000000000004 109.887 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.501 HD11 HD12 ' A' ' 43' ' ' LEU . 4.1 mp -121.66 149.66 42.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.994 -0.743 . . . . 73.530000000000001 108.994 173.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 66.9 t -136.79 104.76 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.239 -0.652 . . . . 63.539999999999999 109.239 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -90.97 154.54 19.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.33 0.586 . . . . 44.140000000000001 110.499 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.0 t80 . . . . . 0 C--N 1.318 -0.782 0 N-CA-C 107.345 -1.354 . . . . 74.430000000000007 107.345 169.225 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HD3' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.101 0 CA-C-O 121.021 0.439 . . . . 72.030000000000001 110.016 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.692 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.6 m -75.06 -39.62 60.81 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.255 0.55 . . . . 74.420000000000002 110.646 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.2 mm? -58.59 -37.83 76.66 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.673 0.62 . . . . 64.099999999999994 112.673 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 45.1 mt-10 -56.85 -61.02 7.72 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.057 0.389 . . . . 74.219999999999999 110.988 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 18.3 Cg_endo -60.2 -38.9 73.11 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.599 1.533 . . . . 72.0 111.942 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.692 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.6 mt-30 -61.45 -41.15 96.76 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.688 -0.405 . . . . 75.239999999999995 111.012 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 66.7 mt -65.92 -50.91 62.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 62.350000000000001 110.302 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 22.7 mt-10 -65.04 -27.57 68.89 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.68 -0.408 . . . . 74.099999999999994 110.88 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -72.59 -49.45 32.18 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.819 0.343 . . . . 72.109999999999999 110.442 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.01 -31.55 72.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.841 -0.429 . . . . 61.020000000000003 109.841 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.491 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.37 -48.2 80.82 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.939 -0.573 . . . . 62.520000000000003 109.711 174.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.495 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 96.0 mt-30 -57.52 -42.21 82.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.902 0.382 . . . . 74.25 110.981 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -69.16 -42.67 75.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.593 . . . . 73.420000000000002 111.443 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -105.15 5.96 32.71 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.131 0.789 . . . . 74.129999999999995 113.131 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.5 t -52.98 -19.91 3.0 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.977 1.103 . . . . 65.109999999999999 113.977 -168.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -73.42 -29.24 62.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.016 0.436 . . . . 64.200000000000003 110.685 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -115.97 -13.85 11.26 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.669 -0.696 . . . . 71.120000000000005 111.346 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.43 HG23 HD11 ' A' ' 127' ' ' ILE . 35.5 t -120.43 133.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.791 0.329 . . . . 65.239999999999995 111.677 -173.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -136.16 119.81 17.17 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.769 -0.651 . . . . 71.030000000000001 109.299 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.464 HG12 HD13 ' A' ' 45' ' ' LEU . 43.3 mt -104.82 137.19 35.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.162 0.506 . . . . 51.350000000000001 110.639 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.435 ' CE2' ' HB3' ' A' ' 34' ' ' LYS . 73.9 m-85 -125.9 169.19 12.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.607 -0.886 . . . . 74.25 108.607 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.519 ' HB3' ' HZ3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -139.72 129.93 25.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.898 0.38 . . . . 75.400000000000006 110.54 172.319 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.527 HD12 ' HA2' ' A' ' 27' ' ' GLY . 5.7 tp -79.87 78.7 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 109.252 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -112.54 -17.41 12.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.766 -0.652 . . . . 54.25 111.76 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.433 ' HB ' ' HA3' ' A' ' 27' ' ' GLY . 54.0 mt -64.46 92.44 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.464 0.65 . . . . 73.239999999999995 109.889 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 85' ' ' GLN . 10.3 pt-20 -54.72 -29.21 52.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.654 -1.157 . . . . 53.210000000000001 112.842 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.42 -19.25 62.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.394 0.616 . . . . 71.340000000000003 110.272 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 1.4 m120 -134.66 42.81 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.068 -0.969 . . . . 74.340000000000003 108.943 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 17.5 tp60 -71.95 -14.73 61.99 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.895 -1.048 . . . . 71.209999999999994 111.464 -176.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 34.6 t70 -46.14 -39.66 9.87 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.288 0.847 . . . . 71.340000000000003 113.288 -168.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 80.0 t -52.94 -40.96 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.903 0.383 . . . . 51.43 111.313 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.14 93.11 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.101 -0.499 . . . . 64.409999999999997 110.36 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 m -69.79 -33.73 72.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.681 -0.69 . . . . 72.140000000000001 110.622 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 45.0 mt-30 -65.43 -56.52 12.05 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 110.622 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -70.53 -25.22 63.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.158 -0.474 . . . . 75.0 110.938 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.23 60.89 1.1 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.889 -0.672 . . . . 62.350000000000001 113.222 173.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -82.4 94.79 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.669 -0.493 . . . . 54.5 109.669 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 t -107.12 -12.17 15.46 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.165 -0.47 . . . . 74.340000000000003 111.375 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.58 147.67 25.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.639 -0.255 . . . . 74.519999999999996 110.68 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.706 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 67.2 mt -57.32 -51.76 79.32 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.315 -0.402 . . . . 75.329999999999998 110.887 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.706 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 69.8 Cg_endo -102.5 100.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.942 2.428 . . . . 71.340000000000003 111.751 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.1 m -124.97 116.21 21.8 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.284 -0.26 . . . . 73.049999999999997 110.906 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.64 113.95 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.421 -0.354 . . . . 75.239999999999995 110.39 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.2 mp -92.05 143.18 26.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.257 -0.645 . . . . 50.409999999999997 109.257 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 109' ' ' SER . 47.1 mtp -113.97 146.22 40.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.892 0.377 . . . . 71.510000000000005 110.042 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.571 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.7 m-85 -145.73 160.03 42.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.371 -0.974 . . . . 51.109999999999999 108.371 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -149.8 117.47 6.2 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.494 -0.483 . . . . 74.129999999999995 110.863 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.817 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.0 t30 60.15 25.3 14.63 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.805 -0.634 . . . . 72.409999999999997 110.731 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.61 -14.66 63.42 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 116.121 -0.49 . . . . 44.409999999999997 112.445 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -83.38 152.75 24.89 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 122.51 0.324 . . . . 72.299999999999997 110.374 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -64.93 157.22 28.67 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.65 0.738 . . . . 63.439999999999998 111.206 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.32 168.78 21.69 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.965 -1.494 . . . . 71.120000000000005 106.965 -166.543 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 101' ' ' MET . 58.5 m -69.9 -177.67 1.36 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.066 0.46 . . . . 72.510000000000005 111.69 -167.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -148.83 120.15 7.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.031 -0.359 . . . . 54.340000000000003 110.031 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.4 t -93.62 107.48 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.999 -0.546 . . . . 64.510000000000005 110.106 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -88.82 102.07 12.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.109 -0.7 . . . . 74.099999999999994 109.109 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 117.49 162.79 12.66 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.618 -0.593 . . . . 71.329999999999998 111.618 -177.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.539 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -88.43 72.19 8.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.954 0.407 . . . . 72.510000000000005 110.224 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.38 94.46 4.98 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 116.025 -0.534 . . . . 73.219999999999999 110.113 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.405 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.37 -33.95 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 115.673 -0.694 . . . . 72.219999999999999 110.172 -175.184 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -59.61 -47.62 84.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.247 -0.433 . . . . 73.030000000000001 110.631 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -69.15 -42.02 76.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 71.129999999999995 110.269 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 123' ' ' ILE . 78.9 mt -55.54 -56.21 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.736 0.303 . . . . 72.129999999999995 110.897 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.1 tt -66.01 -33.9 66.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.784 0.326 . . . . 70.030000000000001 110.387 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.6 t -55.14 -52.32 63.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.044 -0.525 . . . . 64.519999999999996 110.477 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 18.6 mm-40 -72.18 -37.17 69.38 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.248 -0.433 . . . . 74.329999999999998 110.664 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 119' ' ' ILE . 49.3 mt -52.32 -56.12 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.898 0.38 . . . . 75.420000000000002 110.09 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.75 -43.66 92.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.159 -0.473 . . . . 64.209999999999994 110.196 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 8.3 t30 -58.12 -30.25 66.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.96 -0.564 . . . . 73.420000000000002 111.65 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -99.17 -29.27 12.94 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.645 0.609 . . . . 71.239999999999995 112.645 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 74' ' ' VAL . 66.3 mt -72.74 -48.83 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 117.947 0.339 . . . . 71.319999999999993 110.301 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.41 -0.805 . . . . 62.210000000000001 110.466 178.782 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 79.9 mmm . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 108.782 -0.821 . . . . 73.409999999999997 108.782 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 mm -59.75 108.81 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 114.725 -1.125 . . . . 71.120000000000005 109.046 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -73.08 154.14 40.54 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.874 0.369 . . . . 74.319999999999993 111.115 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -118.88 134.67 55.02 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.167 0.587 . . . . 73.510000000000005 110.309 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 31' ' ' PHE . 41.7 pt -150.09 179.63 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.348 0.594 . . . . 33.130000000000003 111.421 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 30' ' ' GLU . . . -131.67 -159.16 9.34 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.323 -0.853 . . . . 72.209999999999994 111.036 172.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 11.0 p-10 -65.96 -46.2 78.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.026 0.441 . . . . 55.43 110.916 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.3 m -65.71 -29.16 69.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.703 -0.68 . . . . 73.439999999999998 110.668 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.409 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 17.2 mm-40 -95.39 -10.18 30.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.963 -0.562 . . . . 74.209999999999994 111.118 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.536 ' HA ' HD12 ' A' ' 26' ' ' ILE . 88.1 t80 -61.77 -61.87 2.2 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.543 -0.54 . . . . 64.010000000000005 109.543 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -57.76 -47.6 82.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.915 -0.584 . . . . 52.229999999999997 110.058 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -51.22 -57.74 8.0 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.577 -0.738 . . . . 74.129999999999995 110.84 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -80.08 -26.18 39.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.972 -1.013 . . . . 63.210000000000001 111.683 -168.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.447 ' HA ' HD13 ' A' ' 44' ' ' ILE . 79.4 t -78.81 -39.37 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.735 -0.212 . . . . 62.299999999999997 111.401 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.5 p -84.89 -37.14 20.96 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.934 0.346 . . . . 60.210000000000001 111.934 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.5 t -69.06 -13.07 62.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.472 0.545 . . . . 64.230000000000004 112.472 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.903 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 28.4 p -57.13 142.0 44.13 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.166 -0.309 . . . . 71.140000000000001 110.166 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -61.65 -82.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.387 0.514 . . . . 43.409999999999997 112.387 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -160.46 143.41 13.33 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.641 -0.254 . . . . 72.109999999999999 110.492 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 61.3 8.2 2.01 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.654 0.596 . . . . 71.230000000000004 111.796 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 mm -73.24 102.52 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.193 0.521 . . . . 72.230000000000004 110.51 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.412 ' HB3' HG22 ' A' ' 74' ' ' VAL . 3.2 tm? -71.85 108.16 4.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.191 -0.913 . . . . 63.450000000000003 109.165 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 35' ' ' VAL . 70.3 mt -102.01 137.18 30.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.437 -0.801 . . . . 73.439999999999998 111.005 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.614 HD13 HG13 ' A' ' 76' ' ' ILE . 3.4 mp -118.14 148.94 41.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.924 -0.769 . . . . 71.530000000000001 108.924 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.5 t -130.59 104.82 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.535 -0.542 . . . . 74.349999999999994 109.535 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -88.11 126.63 35.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 75.510000000000005 110.599 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 100' ' ' LEU . 17.7 m-85 . . . . . 0 C--N 1.33 -0.245 0 N-CA-C 109.116 -0.698 . . . . 74.450000000000003 109.116 169.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.93 0.395 . . . . 71.299999999999997 110.545 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.5 m -75.72 -32.5 60.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.133 -0.485 . . . . 40.210000000000001 111.223 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 1.4 mm? -57.95 -45.5 86.55 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.518 0.933 . . . . 50.530000000000001 113.518 -164.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.521 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 7.9 mp0 -53.77 -60.47 7.14 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-N 118.734 0.697 . . . . 71.230000000000004 110.529 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.538 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 39.3 Cg_endo -67.31 -19.72 49.66 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.792 1.661 . . . . 71.510000000000005 112.548 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.492 ' NE2' HG21 ' A' ' 116' ' ' ILE . 3.4 mm100 -66.47 -52.78 42.52 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 110.263 -0.273 . . . . 72.310000000000002 110.263 174.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.486 HD21 HD13 ' A' ' 119' ' ' ILE . 97.2 mt -62.48 -40.9 98.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.474 -0.565 . . . . 73.319999999999993 109.474 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.6 mm-40 -58.17 -42.83 86.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.666 -0.697 . . . . 74.129999999999995 111.025 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.403 ' HB3' ' HZ3' ' A' ' 65' ' ' LYS . 7.1 ttpm? -63.91 -50.74 67.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.898 0.38 . . . . 71.319999999999993 110.244 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.5 mt -64.9 -32.42 74.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.953 -0.567 . . . . 61.450000000000003 110.248 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.477 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.6 -53.9 44.39 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.197 -0.456 . . . . 43.200000000000003 109.824 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 55.2 mt-30 -57.28 -38.94 74.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.014 -0.539 . . . . 73.439999999999998 111.019 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.49 -42.55 52.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.887 -0.597 . . . . 75.5 111.389 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -104.86 5.07 32.71 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.743 0.646 . . . . 71.200000000000003 112.743 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.8 t -52.88 -21.31 4.13 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.747 0.647 . . . . 60.100000000000001 112.747 -169.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.73 -39.13 90.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.822 0.344 . . . . 71.239999999999995 110.408 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -120.69 -1.86 9.96 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.77 -0.65 . . . . 74.519999999999996 111.575 -176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.542 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 43.0 t -128.44 131.58 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 112.054 0.391 . . . . 73.099999999999994 112.054 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HD2' ' O ' ' A' ' 74' ' ' VAL . 13.6 mptt -138.92 122.96 17.91 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.034 -0.53 . . . . 71.129999999999995 109.939 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.614 HG13 HD13 ' A' ' 45' ' ' LEU . 3.3 mp -99.21 146.12 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.7 -0.481 . . . . 72.109999999999999 109.7 176.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.407 ' CD1' HG23 ' A' ' 44' ' ' ILE . 97.5 m-85 -132.0 142.74 49.69 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.738 0.415 . . . . 74.230000000000004 110.318 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -111.22 132.42 54.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.861 0.465 . . . . 74.430000000000007 110.015 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -86.29 99.16 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.549 -0.908 . . . . 73.430000000000007 108.549 174.133 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -80.66 -48.36 12.73 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.539 0.57 . . . . 44.450000000000003 112.539 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.535 ' HB ' ' OD1' ' A' ' 84' ' ' ASN . 49.7 mt -78.56 106.92 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 74.439999999999998 111.093 -173.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.79 -17.91 52.13 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.168 -0.469 . . . . 74.129999999999995 111.464 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.441 ' HB2' HG22 ' A' ' 81' ' ' ILE . 2.7 m-20 -70.02 -20.36 63.27 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.041 0.448 . . . . 71.299999999999997 109.827 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.535 ' OD1' ' HB ' ' A' ' 81' ' ' ILE . 10.3 m120 -84.17 41.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.786 -0.643 . . . . 65.230000000000004 109.723 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -55.07 -24.92 27.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.424 -0.807 . . . . 74.450000000000003 111.265 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -40.36 -55.94 2.11 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.55 -0.75 . . . . 71.099999999999994 112.119 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.08 -37.82 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.31 -0.404 . . . . 61.219999999999999 111.035 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.88 -54.79 16.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.066 0.46 . . . . 41.450000000000003 110.595 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 m -67.36 -35.89 80.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.753 -0.658 . . . . 40.240000000000002 111.141 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.405 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 14.0 mm-40 -75.27 -41.34 57.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.595 . . . . 74.040000000000006 111.537 -175.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -88.79 -12.13 42.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.796 0.331 . . . . 72.310000000000002 110.779 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.48 45.33 8.75 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.917 -0.659 . . . . 72.409999999999997 112.576 172.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.08 94.84 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.469 -0.567 . . . . 75.040000000000006 109.469 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.1 m -58.93 -39.24 80.99 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.751 -0.659 . . . . 73.209999999999994 112.047 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.18 144.83 51.15 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.16 -0.311 . . . . 74.340000000000003 110.16 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.474 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 59.9 mt -54.67 -49.67 90.01 Favored Pre-proline 0 CA--C 1.541 0.597 0 O-C-N 123.21 0.319 . . . . 62.009999999999998 111.792 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 96' ' ' ILE . 56.5 Cg_endo -69.37 82.02 0.69 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 121.868 1.712 . . . . 75.430000000000007 112.125 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.6 m -146.54 142.64 28.23 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.231 0.538 . . . . 72.340000000000003 111.543 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 mp -115.71 120.65 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.268 -0.878 . . . . 74.530000000000001 109.369 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 48' ' ' PHE . 9.3 mp -97.43 135.13 39.75 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.895 -0.409 . . . . 72.430000000000007 109.895 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.505 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 42.0 mtp -101.87 146.8 27.32 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.077 -0.342 . . . . 73.140000000000001 110.077 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -148.04 158.47 44.08 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.398 -0.593 . . . . 72.310000000000002 109.398 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -141.89 106.73 4.9 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 120.729 -0.388 . . . . 71.409999999999997 111.371 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.903 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.4 t30 60.78 27.56 17.33 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.481 0.657 . . . . 65.450000000000003 110.579 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.84 -10.11 75.28 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.777 -0.647 . . . . 44.219999999999999 112.33 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -70.08 132.04 45.23 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 109.593 -0.521 . . . . 75.230000000000004 109.593 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -62.07 143.33 56.78 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 124.132 0.895 . . . . 64.310000000000002 109.348 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.505 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.7 tp -155.84 168.28 27.71 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.102 -0.703 . . . . 75.420000000000002 109.102 -164.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.1 m -69.8 171.92 8.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.42 0.629 . . . . 71.109999999999999 112.49 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -131.05 133.91 46.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.717 -0.674 . . . . 74.040000000000006 110.489 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.42 HG22 ' HG3' ' A' ' 118' ' ' LYS . 46.2 t -103.77 120.36 53.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.907 -0.588 . . . . 74.340000000000003 109.725 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.1 mp -97.79 125.05 51.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.664 -0.495 . . . . 72.239999999999995 109.664 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.25 -174.27 53.52 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.292 -0.48 . . . . 44.340000000000003 112.33 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -87.16 86.4 7.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.687 0.279 . . . . 61.409999999999997 110.436 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 119' ' ' ILE . 65.4 t0 -123.79 87.83 2.81 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.605 0.717 . . . . 75.030000000000001 109.776 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.492 HG21 ' NE2' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -65.56 -29.39 46.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.263 -0.88 . . . . 74.230000000000004 109.532 -176.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.9 t -61.86 -48.74 79.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.917 -0.583 . . . . 71.549999999999997 109.716 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HG3' HG22 ' A' ' 111' ' ' VAL . 58.4 tptt -63.22 -43.3 98.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.132 -0.486 . . . . 73.310000000000002 110.167 177.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.486 HD13 HD21 ' A' ' 63' ' ' LEU . 82.7 mt -56.62 -56.46 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.225 -0.443 . . . . 53.350000000000001 111.293 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.26 -34.13 68.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.662 0.267 . . . . 75.519999999999996 110.472 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.7 t -56.53 -51.56 68.09 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.109 -0.496 . . . . 73.209999999999994 109.868 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -65.64 -40.17 92.21 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.155 -0.475 . . . . 72.510000000000005 110.728 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 119' ' ' ILE . 64.8 mt -54.85 -55.9 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.657 0.265 . . . . 70.299999999999997 110.417 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -64.46 -36.93 85.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.6 -0.273 . . . . 73.439999999999998 110.321 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -67.11 -26.4 66.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.041 -0.527 . . . . 43.530000000000001 111.257 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -101.03 -13.74 18.11 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.878 0.325 . . . . 70.140000000000001 111.878 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 123' ' ' ILE . 54.5 mt -85.94 -54.48 8.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.722 0.296 . . . . 71.120000000000005 110.395 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.661 -0.685 . . . . 54.0 110.922 -177.328 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.779 0.324 . . . . 71.019999999999996 110.918 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -105.19 100.56 10.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 109.66 -0.496 . . . . 74.219999999999999 109.66 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 30.3 tt0 -93.62 112.11 23.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.938 0.399 . . . . 65.129999999999995 110.435 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -75.8 133.2 40.72 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.938 0.399 . . . . 73.409999999999997 110.889 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 39.6 pt -144.8 179.64 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.271 -0.422 . . . . 63.32 110.806 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.48 -176.09 15.59 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.969 -0.852 . . . . 54.119999999999997 110.969 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 84' ' ' ASN . 27.6 t70 -66.72 -28.63 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.014 0.435 . . . . 55.420000000000002 110.334 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.9 m -65.58 -34.86 79.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.779 -0.646 . . . . 75.140000000000001 110.718 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 2.3 mp0 -92.38 -22.24 19.78 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.575 -0.284 . . . . 73.150000000000006 110.824 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.622 ' HE1' HG21 ' A' ' 46' ' ' VAL . 70.4 t80 -46.77 -61.46 1.84 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.314 0.383 . . . . 73.519999999999996 111.932 -173.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -63.05 -40.91 99.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.444 -0.344 . . . . 53.329999999999998 110.497 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' SER . 36.9 m-80 -58.65 -41.68 86.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.796 -0.638 . . . . 63.219999999999999 110.678 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -72.04 -43.72 64.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.886 -0.597 . . . . 74.530000000000001 110.156 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 31' ' ' PHE . 91.0 t -62.6 -40.68 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.954 -0.566 . . . . 61.119999999999997 110.809 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.4 p -80.65 -25.61 38.2 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.148 0.425 . . . . 74.439999999999998 112.148 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 22.3 t -67.69 -14.23 62.77 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.92 0.341 . . . . 63.310000000000002 111.92 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.78 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 27.6 p -56.84 129.79 42.92 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.102 -0.332 . . . . 72.109999999999999 110.102 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.39 -71.38 0.14 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.675 0.274 . . . . 51.210000000000001 110.781 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -161.59 135.57 6.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.453 -0.34 . . . . 62.409999999999997 110.45 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.42 ' H ' ' HB2' ' A' ' 104' ' ' ASN . 96.0 m-20 61.37 2.31 0.63 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.957 0.725 . . . . 74.319999999999993 112.957 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.681 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.0 mm -62.29 130.7 27.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.895 0.378 . . . . 75.239999999999995 110.388 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER -93.01 112.85 24.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 72.420000000000002 109.612 -178.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 38' ' ' CYS . 73.7 mt -107.67 123.06 62.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.819 -0.628 . . . . 61.130000000000003 110.313 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.651 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -105.97 146.14 30.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.142 -0.688 . . . . 63.329999999999998 109.142 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.622 HG21 ' HE1' ' A' ' 31' ' ' PHE . 61.8 t -125.26 104.72 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.724 -0.473 . . . . 70.040000000000006 109.724 177.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -94.83 112.85 24.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.669 . . . . 63.32 109.768 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 17.1 m-85 . . . . . 0 C--O 1.236 0.375 0 CA-C-O 120.939 0.399 . . . . 64.25 111.099 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.525 0.202 . . . . 74.120000000000005 110.579 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.643 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 9.6 m -74.84 -40.47 61.01 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.773 0.797 . . . . 72.109999999999999 110.289 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.4 mm? -58.01 -38.67 76.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.22 -0.9 . . . . 73.409999999999997 111.415 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 55.2 mt-10 -54.64 -63.2 3.05 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 119.399 -0.334 . . . . 52.340000000000003 111.339 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.43 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 17.8 Cg_endo -60.24 -38.86 72.99 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 121.827 1.684 . . . . 73.129999999999995 112.118 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 58' ' ' SER . 46.4 mt-30 -57.73 -42.54 84.09 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.548 -0.461 . . . . 74.129999999999995 111.184 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.466 HD21 HD13 ' A' ' 119' ' ' ILE . 93.9 mt -68.97 -45.75 69.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.391 . . . . 54.310000000000002 110.467 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 44.7 mt-10 -56.84 -36.77 70.38 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.065 0.46 . . . . 74.310000000000002 109.904 176.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -66.89 -52.4 43.81 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.661 -0.699 . . . . 73.140000000000001 110.471 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 36.4 mt -59.75 -34.14 72.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.584 . . . . 64.409999999999997 109.891 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -60.64 -53.56 55.95 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.666 -0.697 . . . . 52.409999999999997 109.353 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 51.5 mt-30 -53.77 -42.13 67.91 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.235 -0.439 . . . . 75.310000000000002 110.961 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -65.88 -46.31 78.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.805 -0.634 . . . . 71.140000000000001 111.37 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -104.98 4.7 32.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.772 0.656 . . . . 73.010000000000005 112.772 -171.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.4 t -53.29 -20.59 4.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.232 1.197 . . . . 73.420000000000002 114.232 -168.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -73.12 -23.54 60.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.95 0.405 . . . . 73.340000000000003 110.835 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -118.83 -16.17 9.33 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.808 -0.633 . . . . 71.299999999999997 110.629 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.63 HG23 HD11 ' A' ' 127' ' ' ILE . 20.6 t -119.38 133.4 66.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.096 -0.502 . . . . 75.340000000000003 111.387 -173.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -131.76 119.85 21.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.511 -0.768 . . . . 73.349999999999994 109.239 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.651 HG12 ' HB2' ' A' ' 45' ' ' LEU . 71.7 mt -99.32 139.44 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.972 -0.381 . . . . 71.200000000000003 109.972 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 96.5 m-85 -129.82 151.47 50.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.951 -0.568 . . . . 75.540000000000006 110.032 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -134.14 109.93 9.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.041 0.448 . . . . 71.140000000000001 110.466 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.3 pp -78.56 70.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.733 0.778 . . . . 72.109999999999999 110.368 176.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.57 -13.0 60.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.385 -0.825 . . . . 75.140000000000001 111.077 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 60.4 mt -67.12 108.56 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 110.105 -0.331 . . . . 74.540000000000006 110.105 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -36.12 64.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.101 -0.5 . . . . 73.299999999999997 111.888 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.63 -22.22 61.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.542 . . . . 43.130000000000003 110.927 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.444 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.9 OUTLIER -102.62 23.12 12.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.945 -0.571 . . . . 60.509999999999998 111.539 -175.283 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.51 12.81 1.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.84 0.311 . . . . 72.209999999999994 111.84 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.592 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 30.4 t70 -53.11 -36.78 61.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.864 0.364 . . . . 73.109999999999999 110.637 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -52.75 -35.25 21.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.817 -0.629 . . . . 75.540000000000006 110.638 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.404 ' HB2' ' HE2' ' A' ' 48' ' ' PHE . . . -62.97 -50.23 71.59 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.903 -0.589 . . . . 52.200000000000003 110.335 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.1 m -66.7 -31.33 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.656 -0.702 . . . . 64.150000000000006 110.781 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 32.6 mm-40 -67.98 -53.85 22.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.21 -0.45 . . . . 63.200000000000003 110.928 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -91.71 -2.36 57.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.165 -0.47 . . . . 65.430000000000007 112.028 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.46 71.37 1.16 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.814 -0.708 . . . . 75.540000000000006 112.384 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' A' ' 48' ' ' PHE . 98.4 t -104.51 101.04 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 63.039999999999999 110.363 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.8 t -94.6 -35.22 12.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 61.210000000000001 109.904 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.94 146.07 37.78 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.924 -0.58 . . . . 70.450000000000003 110.783 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.684 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 65.2 mt -69.09 -54.54 11.79 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.481 -0.327 . . . . 64.230000000000004 110.937 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.684 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 5.1 Cg_endo -85.0 93.79 0.68 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.142 1.895 . . . . 61.509999999999998 110.943 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 90.7 m -127.65 132.6 49.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.042 0.449 . . . . 53.229999999999997 111.208 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.6 mp -115.78 122.65 69.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.629 -0.714 . . . . 73.030000000000001 109.829 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.487 HD23 ' HG3' ' A' ' 110' ' ' GLN . 90.6 mt -98.68 125.26 43.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.664 -0.495 . . . . 74.400000000000006 109.664 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.549 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 52.9 mtp -98.46 147.73 24.45 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.964 -0.384 . . . . 63.420000000000002 109.964 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.73 150.78 36.88 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.096 -0.705 . . . . 74.140000000000001 109.096 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.531 ' HB2' HD22 ' A' ' 108' ' ' LEU . 61.9 tttp -139.54 106.78 5.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 120.907 -0.317 . . . . 74.209999999999994 111.024 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.78 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.4 t30 59.08 30.9 20.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.698 0.761 . . . . 51.210000000000001 110.444 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.87 -13.99 61.48 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.639 -0.71 . . . . 70.040000000000006 112.25 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -70.37 138.07 51.06 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 110.038 -0.356 . . . . 63.409999999999997 110.038 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -56.86 152.73 12.12 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.231 0.957 . . . . 72.239999999999995 109.447 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.549 ' HB3' ' C ' ' A' ' 101' ' ' MET . 11.5 tp -162.82 168.79 20.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.512 -0.767 . . . . 75.420000000000002 109.893 -165.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.7 m -69.19 164.04 23.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.787 0.803 . . . . 73.329999999999998 112.411 -164.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.487 ' HG3' HD23 ' A' ' 100' ' ' LEU . 61.8 tt0 -127.65 124.14 37.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.11 -0.95 . . . . 74.120000000000005 109.593 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.8 t -97.66 111.89 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 70.030000000000001 110.234 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.491 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -97.52 109.99 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.805 -0.634 . . . . 73.310000000000002 109.801 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.08 -174.68 23.39 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.043 -0.598 . . . . 44.310000000000002 112.284 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.4 72.29 4.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.188 0.518 . . . . 31.199999999999999 110.808 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.418 ' O ' HG13 ' A' ' 119' ' ' ILE . 0.9 OUTLIER -110.79 77.79 1.07 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.91 -0.586 . . . . 72.420000000000002 109.915 177.288 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -34.72 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.627 -0.715 . . . . 51.340000000000003 110.024 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.1 t -63.52 -42.66 98.45 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.163 -0.471 . . . . 54.530000000000001 110.224 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -65.48 -41.38 93.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 72.349999999999994 109.991 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 123' ' ' ILE . 77.0 mt -59.18 -56.69 15.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.028 -0.533 . . . . 73.530000000000001 110.807 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.7 tt -62.9 -37.08 78.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 116.466 -0.334 . . . . 74.230000000000004 110.439 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.0 t -58.19 -51.9 67.8 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 116.289 -0.414 . . . . 74.549999999999997 110.128 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.87 -39.45 91.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.448 -0.342 . . . . 71.239999999999995 110.633 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 119' ' ' ILE . 74.4 mt -57.54 -56.51 14.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 121.109 -0.236 . . . . 62.219999999999999 111.159 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -71.07 -24.99 62.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.755 -0.378 . . . . 53.119999999999997 110.356 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -66.61 -38.55 87.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.163 0.506 . . . . 75.319999999999993 110.43 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -92.51 -12.79 31.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.291 -0.413 . . . . 65.530000000000001 111.922 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.63 HD11 HG23 ' A' ' 74' ' ' VAL . 62.4 mt -95.97 -60.47 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.769 0.318 . . . . 71.140000000000001 111.431 173.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.751 -0.642 . . . . 62.509999999999998 110.364 -174.913 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 85.5 mmm . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.843 0.354 . . . . 54.229999999999997 110.265 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 78' ' ' LYS . 21.0 mm -81.09 123.17 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.026 -0.534 . . . . 73.319999999999993 109.561 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -88.99 126.16 35.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.923 0.392 . . . . 73.150000000000006 111.158 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.763 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 10.2 pt20 -82.76 130.94 35.2 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.402 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 31' ' ' PHE . 47.2 pt -141.83 168.17 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.294 0.568 . . . . 71.299999999999997 111.87 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.75 -170.0 12.64 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.188 -0.915 . . . . 22.140000000000001 111.093 173.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.58 -45.28 92.33 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.181 0.515 . . . . 73.400000000000006 110.991 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.8 m -57.38 -28.45 63.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.385 -0.825 . . . . 51.539999999999999 111.592 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.4 mp0 -106.52 -20.42 13.37 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.693 -0.231 . . . . 64.150000000000006 111.582 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.454 ' O ' HG23 ' A' ' 35' ' ' VAL . 91.2 t80 -52.0 -62.01 1.9 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 111.949 0.352 . . . . 74.329999999999998 111.949 -171.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.33 -44.31 79.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.265 -0.425 . . . . 64.120000000000005 110.252 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -59.59 -57.4 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.767 -0.651 . . . . 62.509999999999998 110.883 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 35.7 mmtp -59.31 -32.12 69.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.873 -0.603 . . . . 74.450000000000003 111.342 -174.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 31' ' ' PHE . 96.3 t -78.52 -44.76 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.874 0.324 . . . . 71.530000000000001 111.874 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.3 p -86.01 -14.99 42.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.609 0.596 . . . . 52.409999999999997 112.609 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.3 m -78.11 9.69 3.52 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.804 0.335 . . . . 73.310000000000002 111.605 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.915 ' SG ' ' HB ' ' A' ' 42' ' ' ILE . 41.6 t -67.36 169.1 9.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 75.430000000000007 110.208 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.456 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 45.0 t-20 -114.01 -62.47 1.59 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.951 -0.389 . . . . 74.140000000000001 109.951 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -162.38 138.59 7.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.483 -0.326 . . . . 72.329999999999998 111.368 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 60.15 1.71 0.37 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.092 1.145 . . . . 53.409999999999997 114.092 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.915 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 50.7 mm -79.73 107.03 11.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 118.325 0.511 . . . . 73.329999999999998 110.33 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.6 tp -75.47 129.39 37.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.648 -0.705 . . . . 70.319999999999993 110.274 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.5 mt -116.56 119.92 63.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.631 -0.713 . . . . 62.25 110.488 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.3 mp -108.13 143.57 36.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.908 -0.775 . . . . 64.200000000000003 108.908 175.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.426 HG22 ' HB2' ' A' ' 77' ' ' TYR . 64.3 t -130.0 110.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.719 -0.475 . . . . 74.420000000000002 109.719 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -88.96 143.01 27.16 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.043 0.449 . . . . 73.530000000000001 111.607 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.0 t80 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 115.717 -0.674 . . . . 64.040000000000006 109.912 176.076 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.5 0.19 . . . . 74.510000000000005 111.01 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.622 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.7 m -75.39 -43.49 49.88 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.606 0.717 . . . . 71.219999999999999 111.415 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.477 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.3 mm? -64.88 -33.8 76.88 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.53 -0.759 . . . . 74.319999999999993 112.093 -170.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.402 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 13.4 mm-40 -59.34 -59.96 12.12 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 121.043 -0.263 . . . . 70.439999999999998 110.567 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 18.5 Cg_endo -59.6 -42.17 49.72 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 121.829 1.686 . . . . 70.109999999999999 111.992 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.5 mt-30 -57.37 -46.46 83.37 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 120.599 -0.44 . . . . 52.450000000000003 111.422 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.75 -43.82 78.98 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.394 -0.367 . . . . 71.109999999999999 110.617 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HG2' HG12 ' A' ' 23' ' ' ILE . 36.0 mt-10 -63.48 -33.83 76.43 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.648 0.261 . . . . 55.219999999999999 110.509 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -63.18 -54.71 33.39 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.23 0.538 . . . . 74.5 110.146 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.499 HD13 HD13 ' A' ' 120' ' ' ILE . 22.4 mt -63.19 -34.06 76.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.772 -0.649 . . . . 73.239999999999995 110.132 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.516 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -61.58 -43.48 98.78 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.99 -0.55 . . . . 74.239999999999995 110.076 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 97.2 mt-30 -63.7 -48.34 77.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.932 0.396 . . . . 74.120000000000005 110.61 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.85 -43.29 99.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.868 -0.605 . . . . 74.0 111.12 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.91 5.72 33.11 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 112.995 0.739 . . . . 63.140000000000001 112.995 -169.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.6 t -52.87 -23.47 7.12 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.383 0.882 . . . . 71.129999999999995 113.383 -170.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.65 -18.77 60.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.84 0.352 . . . . 73.230000000000004 111.313 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.29 -6.65 4.29 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.964 -0.562 . . . . 63.149999999999999 111.191 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.563 HG23 HD11 ' A' ' 127' ' ' ILE . 39.6 t -128.97 138.42 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.048 0.452 . . . . 53.210000000000001 111.535 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -135.93 127.59 28.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.596 -0.729 . . . . 74.109999999999999 109.063 170.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.1 mt -113.42 114.52 47.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.943 0.401 . . . . 73.450000000000003 110.311 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.426 ' HB2' HG22 ' A' ' 46' ' ' VAL . 98.7 m-85 -93.71 167.32 11.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.747 -0.66 . . . . 73.530000000000001 109.868 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.548 ' HB2' HG22 ' A' ' 23' ' ' ILE . 31.9 tttp -145.15 140.97 28.35 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.348 -0.612 . . . . 65.040000000000006 109.348 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.0 tt -64.01 108.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.215 0.531 . . . . 71.310000000000002 110.811 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.763 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 41.2 t30 -89.62 -52.94 4.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.733 -0.667 . . . . 74.239999999999995 110.32 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.4 mm -74.14 112.6 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.36 -0.836 . . . . 72.129999999999995 110.687 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -59.95 -30.11 68.86 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.551 0.691 . . . . 73.230000000000004 110.381 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.74 -22.65 61.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.512 -0.767 . . . . 62.5 110.497 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -88.95 45.37 1.29 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.454 0.645 . . . . 72.340000000000003 110.721 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.438 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 13.6 pt20 -88.94 -7.53 55.88 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.963 -0.754 . . . . 72.319999999999993 108.963 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 21.5 t70 -48.75 -51.42 29.06 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.252 -0.885 . . . . 50.439999999999998 110.599 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -54.57 -33.9 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.946 -0.57 . . . . 62.399999999999999 111.445 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -66.3 -41.52 89.62 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.427 -0.583 . . . . 72.0 109.427 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.7 m -70.46 -29.72 66.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.615 -0.72 . . . . 55.240000000000002 110.716 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 83.1 mm-40 -70.6 -48.9 52.82 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.224 -0.443 . . . . 63.210000000000001 111.179 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -82.91 -24.81 32.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.353 -0.385 . . . . 73.420000000000002 111.442 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.82 64.67 0.85 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.962 -0.637 . . . . 51.329999999999998 112.593 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.523 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 90.8 t -102.5 102.2 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.615 -0.513 . . . . 71.319999999999993 109.615 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -113.8 8.67 17.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 74.319999999999993 110.429 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.92 151.98 44.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.495 -0.558 . . . . 50.409999999999997 109.495 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.659 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 68.0 mt -63.37 -57.51 19.91 Favored Pre-proline 0 CA--C 1.538 0.493 0 O-C-N 123.077 0.236 . . . . 43.200000000000003 111.114 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 96.6 Cg_endo -86.62 100.78 0.57 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.757 1.638 . . . . 53.219999999999999 111.614 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.4 m -137.36 121.59 18.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.775 0.322 . . . . 73.299999999999997 110.576 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.0 mp -110.17 110.9 33.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.801 -0.636 . . . . 74.319999999999993 109.941 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -88.31 126.04 34.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.625 -0.509 . . . . 73.230000000000004 109.625 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.466 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 33.5 mtp -106.67 140.76 39.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.963 -0.384 . . . . 74.140000000000001 109.963 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -147.27 155.37 41.99 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.993 -0.743 . . . . 75.25 108.993 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -129.07 105.49 8.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.674 -0.41 . . . . 72.230000000000004 110.611 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.567 ' HA ' ' HB3' ' A' ' 38' ' ' CYS . 17.7 t-20 61.27 25.67 15.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.593 0.711 . . . . 64.329999999999998 110.566 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.24 -12.2 70.25 Favored Glycine 0 N--CA 1.454 -0.103 0 CA-C-N 115.831 -0.622 . . . . 62.539999999999999 112.071 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -75.08 139.21 42.65 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 110.02 -0.363 . . . . 65.209999999999994 110.02 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -58.62 145.96 37.83 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 124.405 1.066 . . . . 75.010000000000005 110.813 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 101' ' ' MET . 0.9 OUTLIER -162.34 168.92 21.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 72.319999999999993 109.52 -167.281 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.4 m -69.96 172.32 8.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.143 0.577 . . . . 62.520000000000003 111.927 -168.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.465 ' OE1' ' HG ' ' A' ' 100' ' ' LEU . 26.0 tt0 -142.03 118.48 10.9 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.995 -0.548 . . . . 72.019999999999996 109.613 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.85 107.19 17.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.409 -0.36 . . . . 74.329999999999998 110.064 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 65.0 mt -95.57 104.89 16.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.288 -0.415 . . . . 73.310000000000002 110.243 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.41 148.01 6.8 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.656 -0.578 . . . . 62.329999999999998 111.656 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.477 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -80.1 71.78 6.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.094 0.473 . . . . 52.450000000000003 109.958 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 119' ' ' ILE . 29.5 t70 -122.2 95.72 4.76 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.473 0.654 . . . . 72.209999999999994 109.812 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -62.42 -28.43 44.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.984 -1.007 . . . . 75.409999999999997 110.019 -174.025 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.9 m -62.34 -48.67 78.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.146 -0.479 . . . . 73.349999999999994 110.561 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -67.54 -37.65 83.03 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.725 0.298 . . . . 52.240000000000002 110.207 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 123' ' ' ILE . 75.2 mt -58.25 -56.33 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.217 -0.447 . . . . 64.510000000000005 110.904 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.499 HD13 HD13 ' A' ' 66' ' ' LEU . 7.9 tp -64.74 -34.46 70.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.773 0.321 . . . . 73.450000000000003 110.642 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.7 t -58.68 -45.02 90.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 54.310000000000002 110.125 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 48.8 mm-40 -70.86 -37.29 73.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.449 -0.341 . . . . 64.450000000000003 111.143 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 119' ' ' ILE . 68.6 mt -54.75 -55.9 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.124 0.488 . . . . 74.049999999999997 109.975 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -60.24 -41.91 94.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 74.349999999999994 110.642 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 33.3 t30 -58.26 -38.4 76.86 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.654 -0.703 . . . . 65.430000000000007 111.505 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -99.58 -11.99 20.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.227 0.454 . . . . 75.120000000000005 112.227 -174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.563 HD11 HG23 ' A' ' 74' ' ' VAL . 55.6 mt -92.82 -59.54 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 120.902 0.382 . . . . 70.340000000000003 111.075 173.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.592 -0.718 . . . . 51.329999999999998 110.276 -174.263 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.1 mmm . . . . . 0 C--O 1.232 0.157 0 N-CA-C 108.951 -0.759 . . . . 74.409999999999997 108.951 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mm -91.75 136.49 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.83 -1.077 . . . . 71.430000000000007 108.764 174.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.0 tp10 -112.8 144.07 42.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.725 0.298 . . . . 74.540000000000006 110.725 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -114.26 132.01 56.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.781 -0.451 . . . . 71.349999999999994 109.781 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 25.1 pt -140.27 178.27 3.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 120.867 0.365 . . . . 73.530000000000001 111.126 -177.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.59 172.95 25.48 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 115.89 -0.595 . . . . 52.030000000000001 111.869 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.68 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 10.5 t70 -52.24 -56.82 12.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.978 0.418 . . . . 72.349999999999994 111.504 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -64.21 -19.98 65.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.821 -0.627 . . . . 74.230000000000004 111.695 -174.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 37.5 mt-10 -78.08 -29.22 49.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.663 -0.244 . . . . 73.109999999999999 111.202 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -52.68 -49.39 65.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.731 0.301 . . . . 74.420000000000002 110.515 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.17 -55.85 26.59 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.969 -0.56 . . . . 60.439999999999998 109.916 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -53.27 -57.56 10.1 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.162 -0.927 . . . . 72.340000000000003 110.884 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 73.2 mmtt -64.07 -41.52 97.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.423 -1.262 . . . . 51.450000000000003 111.211 -169.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.56 -41.14 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.537 -0.301 . . . . 62.32 110.973 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 p -75.82 -19.28 59.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.784 0.326 . . . . 75.109999999999999 111.324 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -76.37 -14.57 60.08 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.434 -0.348 . . . . 75.140000000000001 110.717 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.756 ' SG ' HD11 ' A' ' 44' ' ' ILE . 66.6 m -70.93 101.16 2.1 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.879 0.371 . . . . 73.439999999999998 110.256 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -67.41 -47.93 68.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 72.230000000000004 112.371 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -153.82 133.27 12.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.092 0.472 . . . . 63.229999999999997 111.853 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 67.28 2.13 2.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.915 -1.039 . . . . 72.439999999999998 113.421 165.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.69 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 48.0 mm -80.63 97.16 3.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.367 0.603 . . . . 61.109999999999999 110.325 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 tt -80.77 113.13 18.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.33 -0.85 . . . . 72.319999999999993 108.944 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.756 HD11 ' SG ' ' A' ' 38' ' ' CYS . 47.3 mt -98.26 133.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.08 -0.509 . . . . 62.130000000000003 111.29 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.9 mp -114.56 124.88 52.99 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.57 -0.9 . . . . 63.240000000000002 108.57 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 92.4 t -106.37 110.02 30.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 110.205 -0.294 . . . . 73.120000000000005 110.205 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -99.71 131.92 45.38 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.236 0.541 . . . . 65.239999999999995 111.337 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--N 1.326 -0.454 0 N-CA-C 108.356 -0.979 . . . . 75.219999999999999 108.356 168.038 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.821 0.343 . . . . 74.510000000000005 111.174 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.628 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 17.5 m -75.41 -59.13 2.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.03 -0.532 . . . . 75.439999999999998 111.558 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.55 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.5 mm? -64.06 -29.25 70.4 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.751 0.649 . . . . 73.540000000000006 112.751 -169.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.45 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 41.0 mt-10 -57.01 -63.9 3.13 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 120.56 -0.456 . . . . 51.549999999999997 110.454 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.45 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 38.0 Cg_endo -65.44 -36.86 32.69 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 121.761 1.641 . . . . 73.120000000000005 112.132 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 58' ' ' SER . 37.9 mt-30 -58.8 -48.9 79.66 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.537 -0.465 . . . . 74.040000000000006 111.234 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.422 HD21 HD13 ' A' ' 119' ' ' ILE . 80.0 mt -66.89 -46.59 74.43 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.922 -0.127 . . . . 70.019999999999996 110.699 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 30.9 mt-10 -63.41 -30.56 71.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.493 -0.483 . . . . 65.239999999999995 110.685 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -64.71 -57.17 9.72 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.186 0.517 . . . . 70.439999999999998 109.935 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 120' ' ' ILE . 37.7 mt -58.97 -34.81 72.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.489 -0.778 . . . . 72.409999999999997 109.597 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.65 -49.47 75.02 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.52 -0.764 . . . . 74.439999999999998 110.258 176.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.1 mt-30 -60.06 -35.87 76.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.784 0.326 . . . . 72.030000000000001 111.03 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -76.86 -41.93 42.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.012 -0.54 . . . . 61.219999999999999 111.393 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -105.06 4.95 32.08 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 113.132 0.79 . . . . 75.430000000000007 113.132 -171.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.5 t -53.14 -19.96 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.901 0.704 . . . . 75.319999999999993 112.901 -170.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -64.52 -33.71 76.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.046 0.451 . . . . 72.120000000000005 110.486 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -129.43 8.76 5.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.78 -0.645 . . . . 75.340000000000003 111.983 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.562 HG23 HD11 ' A' ' 127' ' ' ILE . 43.0 t -133.64 142.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.206 -0.309 . . . . 74.140000000000001 111.653 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.4 tppt? -151.69 133.77 15.1 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.053 -0.721 . . . . 73.209999999999994 109.053 175.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 76' ' ' ILE . 4.2 mp -108.17 136.67 42.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.718 0.294 . . . . 74.219999999999999 110.423 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 74.4 m-85 -128.39 158.18 38.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 62.439999999999998 109.935 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.432 ' NZ ' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -152.33 172.74 16.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.653 -0.499 . . . . 73.319999999999993 109.653 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.42 142.56 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.765 -0.457 . . . . 53.539999999999999 109.765 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -103.56 -9.67 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 74.129999999999995 110.834 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.537 HG13 ' H ' ' A' ' 83' ' ' ASP . 8.5 tp -153.88 118.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.345 0.593 . . . . 71.040000000000006 110.77 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -58.81 -18.38 31.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.565 -0.743 . . . . 73.319999999999993 111.924 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.537 ' H ' HG13 ' A' ' 81' ' ' ILE . 4.4 m-20 -71.09 -7.9 49.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.544 -0.298 . . . . 74.150000000000006 111.57 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.68 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 58.5 m-20 -125.63 78.53 1.74 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 74.430000000000007 110.441 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -114.3 10.37 17.15 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.483 -0.78 . . . . 72.239999999999995 110.088 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 2.8 m-20 -49.32 -45.98 46.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.506 -0.77 . . . . 72.519999999999996 109.991 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.0 p -55.02 -39.68 50.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.539 -0.755 . . . . 71.329999999999998 111.258 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.97 -33.25 74.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.31 0.576 . . . . 71.310000000000002 109.743 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.8 m -73.53 -32.31 64.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.21 -0.904 . . . . 74.409999999999997 110.142 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.8 mm-40 -70.86 -39.57 72.83 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 111.019 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -83.39 -23.73 32.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.539 0.209 . . . . 73.409999999999997 111.148 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.67 57.82 2.51 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.186 -0.53 . . . . 74.439999999999998 112.639 175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.02 124.0 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.504 0.192 . . . . 75.420000000000002 110.56 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.1 m -69.81 -62.52 1.35 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.142 -0.481 . . . . 64.510000000000005 111.879 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.81 161.87 17.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 63.229999999999997 110.253 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.495 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 47.5 mm -61.9 -54.62 49.1 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 123.224 0.328 . . . . 72.340000000000003 111.178 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.495 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 73.1 Cg_endo -74.74 80.6 2.32 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.809 1.673 . . . . 53.32 112.225 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.5 m -137.01 137.03 38.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 50.200000000000003 111.016 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 99' ' ' ILE . 2.7 mp -110.82 114.55 47.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.067 -0.515 . . . . 53.439999999999998 109.645 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 100' ' ' LEU . 7.2 mp -90.66 154.01 19.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.417 -0.586 . . . . 65.420000000000002 109.417 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.406 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 57.6 mtp -119.22 144.73 46.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.06 -0.348 . . . . 60.310000000000002 110.06 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.529 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.7 m-85 -149.13 149.76 31.57 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.171 -0.677 . . . . 54.219999999999999 109.171 176.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 ttpt -145.15 113.77 6.74 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.054 -0.658 . . . . 72.400000000000006 111.594 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 59.32 25.72 14.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.816 0.817 . . . . 62.219999999999999 110.663 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.24 -16.33 49.02 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.802 -0.635 . . . . 75.349999999999994 111.876 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 8.2 tmtm? -72.83 135.3 45.17 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.579 -0.897 . . . . 75.099999999999994 108.579 177.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 34.2 mmtp -65.87 145.84 55.46 Favored 'General case' 0 N--CA 1.46 0.038 0 CA-C-O 121.577 0.703 . . . . 73.200000000000003 111.37 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -145.38 167.81 22.01 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.66 -1.155 . . . . 73.409999999999997 108.979 -167.027 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.6 m -70.99 -177.65 1.7 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.539 0.685 . . . . 74.329999999999998 112.352 -169.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -141.32 121.0 13.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.684 -0.689 . . . . 72.129999999999995 109.77 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.7 t -95.89 116.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.208 -0.451 . . . . 74.239999999999995 110.0 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 112' ' ' ILE . 2.9 mp -91.62 115.63 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 75.310000000000002 109.974 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.46 169.68 41.91 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.12 -0.562 . . . . 74.099999999999994 112.575 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.55 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -83.33 76.02 9.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.447 0.299 . . . . 73.120000000000005 110.767 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.417 ' O ' HG13 ' A' ' 119' ' ' ILE . 23.6 t0 -115.1 95.89 5.42 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.483 0.659 . . . . 62.240000000000002 110.75 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -60.81 -28.19 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.091 -0.959 . . . . 73.340000000000003 110.089 -177.56 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.3 t -62.32 -53.81 49.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.943 0.401 . . . . 72.109999999999999 110.146 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -62.99 -41.43 99.57 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.308 -0.405 . . . . 71.049999999999997 110.23 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 123' ' ' ILE . 74.0 mt -55.45 -56.46 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.944 -0.571 . . . . 63.409999999999997 111.159 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.492 HD13 HD13 ' A' ' 66' ' ' LEU . 8.3 tp -65.58 -34.7 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.755 0.312 . . . . 72.430000000000007 110.651 -177.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 t -57.17 -52.18 66.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.125 -0.488 . . . . 33.520000000000003 110.35 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -72.04 -31.44 66.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.471 -0.331 . . . . 52.219999999999999 111.53 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 119' ' ' ILE . 49.5 mt -57.26 -55.71 19.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 120.62 -0.432 . . . . 54.340000000000003 110.006 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -68.53 -35.74 77.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.486 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -65.11 -34.95 79.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.861 -0.609 . . . . 64.430000000000007 111.335 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -101.16 -14.46 17.73 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.7 0.63 . . . . 61.240000000000002 112.7 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.562 HD11 HG23 ' A' ' 74' ' ' VAL . 58.9 mt -82.8 -48.5 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.549 -0.538 . . . . 73.030000000000001 109.549 171.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.316 -0.85 . . . . 62.409999999999997 109.455 178.313 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 95.1 mmm . . . . . 0 C--O 1.235 0.312 0 CA-C-O 120.441 0.162 . . . . 72.239999999999995 110.973 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.0 mm -62.74 116.89 3.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.394 -0.366 . . . . 75.150000000000006 110.183 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -86.37 151.27 23.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.299 -0.409 . . . . 74.239999999999995 110.12 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 14.1 pt20 -123.29 130.91 53.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 72.239999999999995 110.629 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.518 HG21 ' HG3' ' A' ' 34' ' ' LYS . 37.5 pt -139.38 174.1 9.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.056 -0.52 . . . . 61.130000000000003 110.309 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.22 160.35 19.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.205 -0.521 . . . . 52.299999999999997 112.131 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.726 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 13.8 t70 -53.68 -38.64 64.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.493 0.663 . . . . 71.040000000000006 110.72 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.2 m -76.52 1.63 16.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.315 -0.857 . . . . 71.120000000000005 111.788 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 35.5 mt-10 -113.45 -6.08 13.48 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.344 -0.222 . . . . 73.420000000000002 111.056 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.43 ' O ' HG23 ' A' ' 35' ' ' VAL . 89.2 t80 -50.21 -61.57 2.09 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.382 0.426 . . . . 72.310000000000002 111.501 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -56.98 -42.91 81.06 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 110.488 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -55.75 -57.06 13.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.671 -0.695 . . . . 70.200000000000003 110.461 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.5 mmtt -65.6 -37.08 85.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 64.239999999999995 111.061 -174.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.611 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 88.0 t -71.72 -29.18 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.716 0.293 . . . . 74.310000000000002 111.241 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.9 p -86.32 -21.0 27.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.891 0.377 . . . . 75.319999999999993 110.839 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -72.74 -9.5 58.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.046 -0.524 . . . . 63.25 111.266 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.823 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 26.0 p -82.32 77.71 9.07 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.38 -0.6 . . . . 63.350000000000001 109.38 175.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.52 -40.43 94.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.618 -0.719 . . . . 70.299999999999997 112.86 -173.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 42' ' ' ILE . 5.6 m-20 -135.9 121.23 19.18 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.098 0.407 . . . . 74.420000000000002 112.098 -173.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 55.85 2.22 0.07 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.776 1.398 . . . . 64.439999999999998 114.776 166.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.823 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 46.9 mm -80.86 109.49 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.328 0.513 . . . . 71.519999999999996 110.451 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.9 tt -82.52 115.9 21.72 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.171 -0.677 . . . . 73.25 109.171 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.52 HG21 HG22 ' A' ' 35' ' ' VAL . 32.7 mm -87.11 115.04 27.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.793 -0.64 . . . . 72.5 110.991 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.2 mp -102.47 148.1 25.93 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.5 -0.926 . . . . 71.200000000000003 108.5 171.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 60.5 t -133.35 106.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.617 -0.142 . . . . 73.420000000000002 110.617 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.52 143.13 26.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.987 0.423 . . . . 74.230000000000004 110.557 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.093 0.473 . . . . 61.43 111.562 176.373 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 120.551 0.215 . . . . 62.109999999999999 110.851 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.3 m -75.11 -35.17 61.76 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.212 0.53 . . . . 71.310000000000002 110.695 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.1 mm? -58.38 -42.85 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.716 -0.674 . . . . 71.319999999999993 111.629 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.449 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 37.6 mt-10 -54.89 -60.53 7.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.758 -0.163 . . . . 72.340000000000003 111.011 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.449 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 20.1 Cg_endo -61.7 -34.66 83.2 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.688 1.592 . . . . 73.340000000000003 112.211 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 58' ' ' SER . 14.9 mt-30 -63.9 -38.24 90.36 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.702 -0.399 . . . . 70.140000000000001 110.83 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 75.4 mt -68.62 -42.6 77.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.764 -0.458 . . . . 51.219999999999999 109.764 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -67.79 -26.79 66.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 54.030000000000001 110.71 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 62' ' ' GLN . 33.4 ttpt -65.71 -56.78 10.24 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.725 0.774 . . . . 72.519999999999996 109.957 175.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.499 HD22 HD13 ' A' ' 120' ' ' ILE . 37.6 mt -59.13 -32.91 70.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.936 -1.029 . . . . 75.310000000000002 109.534 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.527 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.5 -51.27 66.28 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.692 -0.686 . . . . 71.230000000000004 109.562 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -55.89 -48.6 75.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.651 -0.704 . . . . 70.239999999999995 111.781 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -73.85 -39.68 63.83 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.44 -0.504 . . . . 73.329999999999998 111.169 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -101.04 4.93 42.77 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 113.021 0.748 . . . . 74.450000000000003 113.021 -171.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.9 t -53.25 -19.18 2.91 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.519 0.563 . . . . 74.200000000000003 112.519 -171.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -69.23 -34.68 75.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.656 0.265 . . . . 74.219999999999999 110.717 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.26 3.61 8.51 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.246 -0.434 . . . . 72.400000000000006 111.624 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.6 t -130.94 136.77 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.794 0.33 . . . . 74.430000000000007 111.368 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -138.36 131.28 29.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 70.319999999999993 109.624 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.405 HG12 ' HB2' ' A' ' 45' ' ' LEU . 50.0 mt -112.01 135.55 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.572 -0.529 . . . . 74.120000000000005 109.572 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 95.7 m-85 -129.26 147.93 51.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 73.319999999999993 110.469 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -133.99 145.14 49.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.061 -0.518 . . . . 71.5 109.849 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.436 HG21 ' O ' ' A' ' 84' ' ' ASN . 52.0 mt -70.21 112.52 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.958 -0.756 . . . . 74.150000000000006 108.958 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 66.9 t30 -75.31 -12.85 60.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.984 -0.553 . . . . 62.340000000000003 112.371 -170.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 83' ' ' ASP . 56.9 mt -130.89 119.97 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.683 0.277 . . . . 74.140000000000001 110.665 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -18.78 65.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.096 -0.502 . . . . 61.020000000000003 111.796 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.548 ' H ' HG22 ' A' ' 81' ' ' ILE . 24.8 t70 -71.37 -18.64 62.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.41 0.624 . . . . 60.450000000000003 109.833 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.726 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 92.2 m-20 -103.9 121.66 43.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.223 -0.898 . . . . 75.450000000000003 108.758 175.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -163.27 15.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.959 0.725 . . . . 63.329999999999998 112.959 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.548 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 1.8 m-20 -54.96 -42.46 72.39 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.061 -0.348 . . . . 64.409999999999997 110.061 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.402 HG23 ' OD2' ' A' ' 28' ' ' ASP . 77.4 t -53.15 -38.96 31.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.822 -0.627 . . . . 54.25 110.532 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.46 77.52 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.347 0.594 . . . . 72.450000000000003 110.003 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.6 m -67.32 -37.49 83.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.022 -0.99 . . . . 73.420000000000002 110.564 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 93.5 mt-30 -69.97 -53.47 17.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.827 -0.624 . . . . 74.140000000000001 111.061 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.42 -13.0 55.79 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.023 -0.535 . . . . 74.430000000000007 111.696 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.53 78.97 0.79 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.88 -0.676 . . . . 64.040000000000006 112.849 171.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.9 t -75.54 93.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.316 0.579 . . . . 73.120000000000005 109.797 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.7 m -71.76 -59.4 2.77 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.363 -0.835 . . . . 73.120000000000005 110.925 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.5 152.85 21.88 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.5 -0.556 . . . . 65.430000000000007 109.5 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.691 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 43.0 mm -55.35 -54.27 52.79 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 123.18 0.3 . . . . 52.439999999999998 111.087 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.691 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 19.8 Cg_endo -89.32 99.74 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.256 1.971 . . . . 73.25 111.318 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.3 m -118.62 146.49 44.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.136 -0.484 . . . . 74.329999999999998 110.567 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 3.5 mp -123.16 116.17 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.599 -0.728 . . . . 55.32 109.913 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 64.6 mt -90.24 143.05 27.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.301 -0.629 . . . . 73.439999999999998 109.301 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.407 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 48.0 mtp -117.48 136.28 53.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.985 -0.376 . . . . 72.439999999999998 109.985 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 95.3 m-85 -148.96 160.39 43.34 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.451 -0.944 . . . . 72.209999999999994 108.451 174.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -153.82 111.25 3.47 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.846 -0.742 . . . . 73.409999999999997 112.315 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.465 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 56.9 t30 55.57 37.59 29.08 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.721 0.772 . . . . 65.319999999999993 110.978 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.76 -16.35 50.93 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.411 -0.813 . . . . 64.129999999999995 112.575 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -77.72 138.84 39.26 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.669 0.271 . . . . 61.25 110.633 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -62.41 139.92 58.56 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.339 -0.846 . . . . 74.129999999999995 110.619 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -144.14 167.67 21.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.975 -1.12 . . . . 74.030000000000001 107.975 -174.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.1 m -70.75 -179.72 2.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.612 0.72 . . . . 74.439999999999998 112.759 -165.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.445 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.1 tt0 -142.26 118.71 10.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.718 -0.674 . . . . 64.5 110.013 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 49.7 t -100.02 107.72 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.459 . . . . 65.510000000000005 110.272 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -94.31 104.46 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.601 -0.518 . . . . 73.230000000000004 109.601 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.76 177.99 23.82 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.714 -0.555 . . . . 52.140000000000001 111.714 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.22 80.85 7.57 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.992 0.425 . . . . 70.230000000000004 110.936 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.425 ' O ' HG13 ' A' ' 119' ' ' ILE . 21.6 m-20 -117.51 73.7 0.89 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.031 -0.531 . . . . 63.350000000000001 110.146 175.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.407 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.39 -33.03 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.551 -0.537 . . . . 51.329999999999998 109.551 -177.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.5 t -59.0 -46.21 88.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.879 -0.6 . . . . 74.219999999999999 110.192 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -70.06 -36.37 74.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.095 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 123' ' ' ILE . 81.3 mt -58.78 -56.25 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 72.040000000000006 110.591 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.499 HD13 HD22 ' A' ' 66' ' ' LEU . 6.9 tp -64.68 -38.06 81.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.638 -0.256 . . . . 41.140000000000001 110.401 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.8 t -57.04 -48.5 78.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.248 -0.433 . . . . 62.200000000000003 109.951 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 65.6 mm-40 -69.6 -36.76 76.5 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.458 -0.337 . . . . 72.030000000000001 111.507 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 119' ' ' ILE . 56.3 mt -57.12 -56.19 16.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.241 0.543 . . . . 71.120000000000005 109.767 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -64.16 -35.81 82.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.652 -0.704 . . . . 70.329999999999998 110.468 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 23.6 t30 -65.28 -39.12 92.18 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.935 -0.575 . . . . 71.319999999999993 111.468 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -103.28 -5.2 23.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.571 0.582 . . . . 71.120000000000005 112.571 -172.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.8 mt -91.94 -54.05 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.895 -0.322 . . . . 71.219999999999999 110.698 170.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.477 -0.773 . . . . 64.540000000000006 110.71 -176.587 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 91.3 mmm . . . . . 0 C--O 1.234 0.248 0 N-CA-C 110.164 -0.31 . . . . 73.109999999999999 110.164 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.487 HG21 ' HE3' ' A' ' 78' ' ' LYS . 28.1 mm -58.28 107.48 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.029 -0.532 . . . . 71.319999999999993 110.036 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.552 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 9.4 tp10 -75.0 141.1 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 60.140000000000001 110.173 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.464 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . 78.1 mt-30 -109.09 122.51 47.42 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.316 -0.253 . . . . 65.239999999999995 110.316 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 47.3 pt -145.06 179.96 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.901 0.381 . . . . 70.019999999999996 111.468 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -125.82 -165.83 12.14 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.632 -0.713 . . . . 63.439999999999998 111.424 175.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' H ' ' HB3' ' A' ' 84' ' ' ASN . 27.2 t70 -69.37 -45.91 68.21 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.957 0.378 . . . . 54.109999999999999 110.966 -177.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.0 t -59.55 -29.74 68.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.92 -0.582 . . . . 75.420000000000002 109.906 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 12.0 mm-40 -85.98 -31.89 21.82 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.006 -0.543 . . . . 71.209999999999994 110.725 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.435 ' HA ' HD12 ' A' ' 26' ' ' ILE . 85.1 t80 -47.92 -61.62 1.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.359 0.503 . . . . 74.310000000000002 112.359 -171.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.84 -43.5 98.19 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.604 0.24 . . . . 64.5 110.412 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -57.65 -53.98 52.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.181 -0.463 . . . . 75.319999999999993 110.418 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HG3' HG21 ' A' ' 26' ' ' ILE . 75.7 mmtt -60.71 -41.52 95.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.752 -0.658 . . . . 63.109999999999999 111.063 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 31' ' ' PHE . 98.3 t -67.74 -53.07 33.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 61.310000000000002 110.687 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.7 p -65.46 -18.68 65.5 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.497 -0.32 . . . . 63.43 111.761 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -77.02 3.35 12.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.632 -0.258 . . . . 63.530000000000001 111.259 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.53 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 25.0 p -62.46 113.39 2.91 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.928 -0.397 . . . . 75.319999999999993 109.928 175.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -52.84 -64.16 0.91 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.348 -0.387 . . . . 74.519999999999996 111.357 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -156.36 121.63 4.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 75.209999999999994 110.614 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 48.2 m-80 49.96 24.66 1.4 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.945 0.72 . . . . 73.209999999999994 112.945 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.4 mm -73.61 127.59 35.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 110.323 -0.251 . . . . 54.399999999999999 110.323 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 28.0 tp -85.79 107.78 17.79 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.722 0.772 . . . . 71.519999999999996 110.444 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.442 HG23 ' CD1' ' A' ' 77' ' ' TYR . 72.7 mt -108.44 113.47 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.112 -0.949 . . . . 62.109999999999999 110.205 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.8 mp -97.06 152.63 18.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.192 -0.669 . . . . 70.120000000000005 109.192 177.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 77' ' ' TYR . 58.5 t -138.08 118.53 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 110.034 -0.358 . . . . 72.109999999999999 110.034 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -95.35 154.59 17.12 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.082 0.468 . . . . 74.340000000000003 110.618 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.716 -0.674 . . . . 72.230000000000004 110.354 173.952 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 N--CA 1.464 0.241 0 N-CA-C 111.307 0.114 . . . . 65.439999999999998 111.307 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 22.7 t -75.96 -46.44 29.69 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.8 0.81 . . . . 64.140000000000001 110.983 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.69 -34.02 75.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.155 -0.93 . . . . 74.019999999999996 112.402 -171.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 38.7 mt-10 -60.27 -62.46 5.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.406 -0.518 . . . . 71.349999999999994 110.227 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 19.6 Cg_endo -58.75 -38.87 86.71 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.727 1.618 . . . . 55.539999999999999 112.258 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 58' ' ' SER . 37.3 mt-30 -57.44 -55.65 32.04 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.834 -0.346 . . . . 70.109999999999999 111.179 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.475 HD11 HD13 ' A' ' 119' ' ' ILE . 30.2 mt -71.98 -25.29 61.79 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.723 -0.217 . . . . 64.530000000000001 111.313 -176.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.449 ' OE1' HG12 ' A' ' 23' ' ' ILE . 4.5 mm-40 -62.26 -44.98 95.31 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.216 0.531 . . . . 71.409999999999997 109.837 172.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -62.36 -50.64 70.79 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.531 -0.759 . . . . 53.520000000000003 109.909 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.2 mt -62.9 -32.02 73.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.63 . . . . 72.239999999999995 110.776 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.82 -53.75 45.84 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.726 -0.472 . . . . 64.420000000000002 109.726 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -58.94 -35.64 73.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.959 -0.564 . . . . 74.140000000000001 110.84 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -65.72 -49.29 69.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 63.310000000000002 110.825 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.91 5.18 32.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.625 -0.716 . . . . 72.209999999999994 112.716 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 8.9 t -53.18 -19.88 3.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.787 0.662 . . . . 62.210000000000001 112.787 -171.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.05 -29.86 65.72 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.291 -0.256 . . . . 72.129999999999995 111.424 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -131.13 -10.63 3.74 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.466 -0.334 . . . . 73.5 111.336 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 71' ' ' THR . 40.9 t -116.96 134.65 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.823 0.344 . . . . 65.129999999999995 111.835 -172.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HE2' ' HB2' ' A' ' 24' ' ' GLU . 21.1 tptm -143.59 127.12 16.92 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.128 -0.487 . . . . 63.240000000000002 109.802 173.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.2 mp -99.69 141.05 17.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.953 -0.388 . . . . 75.209999999999994 109.953 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.487 ' HB2' HG22 ' A' ' 46' ' ' VAL . 62.9 m-85 -123.67 150.31 44.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 73.420000000000002 109.444 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HE3' HG21 ' A' ' 23' ' ' ILE . 39.9 ttmt -129.2 122.14 29.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.672 -0.492 . . . . 74.519999999999996 109.672 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.403 HD13 HG13 ' A' ' 26' ' ' ILE . 42.5 mm -78.91 73.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.772 -0.825 . . . . 53.109999999999999 108.772 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 25' ' ' GLN . 3.4 p-10 -72.46 -30.4 64.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.525 -0.761 . . . . 55.329999999999998 110.367 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.4 mt -62.68 100.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.989 -0.551 . . . . 74.019999999999996 109.929 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.493 ' HA ' ' HG3' ' A' ' 85' ' ' GLN . 10.5 pt-20 -56.51 -27.94 58.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.744 -0.662 . . . . 74.430000000000007 111.191 -177.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -71.58 -24.52 61.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.758 -0.656 . . . . 74.450000000000003 110.006 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.429 ' HB3' ' H ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -104.08 15.76 27.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.307 -0.86 . . . . 75.219999999999999 111.315 -175.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.493 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 92.9 mt-30 -71.32 1.42 6.22 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.636 0.255 . . . . 72.019999999999996 111.085 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -46.53 -37.96 8.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.977 -0.556 . . . . 71.230000000000004 110.361 172.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.7 t -52.7 -43.28 43.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.562 -0.744 . . . . 74.219999999999999 110.502 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.8 -53.35 58.47 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.642 -0.708 . . . . 74.349999999999994 110.273 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.4 m -59.13 -34.81 72.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.62 . . . . 71.150000000000006 110.985 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.06 -56.66 13.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.218 -0.446 . . . . 60.149999999999999 111.163 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -72.3 -15.68 61.89 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.58 0.228 . . . . 55.420000000000002 111.148 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.9 40.01 5.67 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.234 -0.508 . . . . 73.019999999999996 112.724 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.64 93.9 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.111 0.482 . . . . 71.420000000000002 110.562 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.9 t -90.65 -37.14 13.96 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.637 -0.71 . . . . 64.209999999999994 109.536 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.21 136.28 33.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.035 -0.728 . . . . 73.439999999999998 109.035 174.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.637 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 50.8 mm -58.87 -58.84 16.38 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 111.411 0.152 . . . . 63.229999999999997 111.411 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.637 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 83.3 Cg_endo -80.77 72.3 6.6 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.797 1.665 . . . . 73.400000000000006 112.262 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.1 m -102.96 133.07 48.69 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.963 0.411 . . . . 62.43 110.796 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.63 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -116.52 121.0 66.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.537 -0.756 . . . . 73.230000000000004 109.846 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 110' ' ' GLN . 88.7 mt -98.14 123.48 42.22 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.775 -0.454 . . . . 73.329999999999998 109.775 175.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 59.9 mtp -96.06 139.95 31.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.375 -0.602 . . . . 55.409999999999997 109.375 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -138.6 147.69 43.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.904 -0.776 . . . . 72.209999999999994 108.904 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 126' ' ' ASN . 29.0 ttpp -147.47 121.36 9.34 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.306 -0.558 . . . . 70.329999999999998 111.225 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 6.0 t30 61.17 25.69 15.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.542 -0.754 . . . . 62.140000000000001 110.24 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.46 6.87 86.95 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.727 -0.669 . . . . 33.450000000000003 112.127 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -101.38 150.34 23.12 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 120.701 0.286 . . . . 61.039999999999999 110.61 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -56.49 128.47 36.28 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.076 -0.966 . . . . 73.209999999999994 111.489 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.92 168.54 18.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.869 -1.514 . . . . 74.439999999999998 106.932 -177.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.7 m -69.53 157.16 37.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.795 0.807 . . . . 71.230000000000004 112.72 -158.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.485 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.8 tt0 -114.4 118.41 33.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.136 -0.938 . . . . 70.200000000000003 109.851 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.63 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 44.6 t -96.95 107.17 19.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.185 -0.461 . . . . 72.219999999999999 110.097 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.6 mp -92.35 105.12 16.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.366 -0.605 . . . . 73.25 109.366 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 105.06 158.55 23.27 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.575 -0.61 . . . . 63.32 111.575 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.45 83.54 3.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.79 0.328 . . . . 61.229999999999997 110.679 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 33.8 t70 -121.51 90.12 3.25 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.703 0.763 . . . . 71.129999999999995 110.262 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -59.02 -30.63 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 114.795 -1.093 . . . . 43.399999999999999 109.425 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.8 t -56.32 -53.36 58.17 Favored 'General case' 0 CA--C 1.526 0.045 0 CA-C-N 116.13 -0.486 . . . . 64.329999999999998 110.159 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -60.59 -48.03 83.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.144 -0.48 . . . . 72.239999999999995 109.941 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 123' ' ' ILE . 65.5 mt -56.69 -56.31 14.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.719 -0.673 . . . . 75.129999999999995 111.128 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 116' ' ' ILE . 13.7 tt -64.33 -35.7 74.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.767 0.317 . . . . 71.420000000000002 110.247 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.4 t -55.82 -52.32 64.42 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.797 -0.638 . . . . 53.140000000000001 110.278 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 24.7 mm-40 -74.54 -30.0 61.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.911 -0.586 . . . . 73.439999999999998 111.301 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.3 mt -58.42 -56.03 18.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.961 0.41 . . . . 74.409999999999997 110.064 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -71.33 -29.26 64.8 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.94 -0.304 . . . . 75.420000000000002 110.223 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.478 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 19.7 t30 -61.11 -44.38 97.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.103 -0.499 . . . . 73.340000000000003 110.971 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.55 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 32.1 m-80 -84.93 -27.1 26.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 62.210000000000001 112.137 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.4 mt -73.71 -48.7 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 120.915 0.388 . . . . 75.420000000000002 110.479 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.808 -0.615 . . . . 41.43 110.125 -179.783 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 92.0 mmm . . . . . 0 C--O 1.232 0.179 0 CA-C-O 121.103 0.477 . . . . 50.299999999999997 110.428 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.499 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 26.7 mm -119.34 104.69 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.756 -0.657 . . . . 72.439999999999998 109.826 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.34 160.49 18.78 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.336 -0.393 . . . . 61.340000000000003 111.054 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.404 ' HA ' ' H ' ' A' ' 78' ' ' LYS . 26.6 tt0 -137.72 133.81 34.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.01 -0.367 . . . . 71.129999999999995 110.01 172.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.543 HG21 ' HG3' ' A' ' 34' ' ' LYS . 32.0 pt -138.86 179.95 2.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 122.53 0.332 . . . . 64.329999999999998 111.211 -174.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.06 176.85 22.96 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.055 -0.521 . . . . 71.010000000000005 112.965 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 12.4 t70 -51.86 -56.62 12.91 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.366 0.666 . . . . 41.439999999999998 111.737 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -62.81 -27.57 69.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 74.129999999999995 111.481 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -79.55 -23.36 42.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.806 0.298 . . . . 72.549999999999997 111.806 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 35' ' ' VAL . 92.4 t80 -47.68 -61.7 1.81 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.278 0.361 . . . . 71.0 111.85 -174.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.573 ' O ' HG22 ' A' ' 36' ' ' THR . 10.0 m-20 -54.63 -53.59 52.79 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.246 0.546 . . . . 54.149999999999999 110.504 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -55.92 -57.41 12.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.076 -0.965 . . . . 72.439999999999998 111.378 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.2 mmtt -58.51 -35.39 72.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 74.319999999999993 111.055 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 31' ' ' PHE . 40.6 t -64.98 -56.58 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.298 -0.41 . . . . 52.310000000000002 111.336 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 32' ' ' ASP . 7.9 t -86.08 -0.29 55.25 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.145 0.424 . . . . 63.229999999999997 112.145 -175.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.2 t -71.14 -5.93 35.46 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.892 0.377 . . . . 72.150000000000006 111.131 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.867 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 8.5 p -66.14 158.08 29.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.946 -0.57 . . . . 72.519999999999996 111.747 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.58 -79.65 0.11 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.903 -0.59 . . . . 63.310000000000002 110.61 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -161.82 148.67 14.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.216 -0.447 . . . . 73.430000000000007 109.981 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.0 t30 63.46 2.28 1.16 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.115 0.566 . . . . 71.319999999999993 111.34 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 42.6 mm -74.93 108.32 6.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 120.88 0.372 . . . . 61.240000000000002 110.276 -178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.498 ' CD2' ' HA ' ' A' ' 123' ' ' ILE . 30.9 tp -80.28 109.05 14.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.627 -0.715 . . . . 73.040000000000006 110.024 174.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 36.9 mt -102.7 116.69 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.501 -0.772 . . . . 64.310000000000002 110.376 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.55 ' HB2' HG13 ' A' ' 76' ' ' ILE . 3.4 mp -99.99 153.04 19.51 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.623 -0.881 . . . . 63.210000000000001 108.623 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 77' ' ' TYR . 60.8 t -135.36 104.35 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.311 -0.255 . . . . 72.430000000000007 110.311 175.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.87 96.78 10.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.901 -1.148 . . . . 72.540000000000006 107.901 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 112.375 0.509 . . . . 73.299999999999997 112.375 -171.222 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 120.766 0.317 . . . . 73.239999999999995 110.716 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 46.8 t -75.6 -49.36 18.75 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.752 0.787 . . . . 73.409999999999997 110.494 172.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.89 -43.13 90.92 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.198 -0.91 . . . . 73.010000000000005 112.3 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 40.6 mt-10 -52.82 -60.39 6.71 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 117.807 0.276 . . . . 72.120000000000005 111.074 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 29.9 Cg_endo -64.14 -35.11 54.65 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.616 1.544 . . . . 75.310000000000002 112.254 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 58' ' ' SER . 20.2 mt-30 -61.26 -42.44 98.64 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.418 -0.513 . . . . 74.230000000000004 111.1 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.43 -42.99 67.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 73.310000000000002 110.321 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 28.1 mt-10 -63.69 -36.45 83.9 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.855 -0.338 . . . . 74.099999999999994 110.415 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -57.05 -57.16 13.76 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.464 0.65 . . . . 75.099999999999994 109.819 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 62' ' ' GLN . 36.6 mt -61.52 -36.55 80.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.05 -0.977 . . . . 63.240000000000002 109.909 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.56 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.05 -27.97 67.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 33.530000000000001 110.93 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.1 mt-30 -77.01 -48.34 18.2 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.851 0.358 . . . . 65.200000000000003 110.955 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -72.63 -37.75 67.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.183 0.516 . . . . 64.239999999999995 110.668 -176.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -97.61 5.85 48.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.765 -0.652 . . . . 72.140000000000001 111.891 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -52.74 -19.94 2.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.778 0.659 . . . . 72.519999999999996 112.778 -172.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.64 -31.2 70.18 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.274 -0.266 . . . . 74.120000000000005 110.794 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.431 ' HA ' HD13 ' A' ' 42' ' ' ILE . 91.6 m-20 -131.75 1.61 4.02 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.048 -0.524 . . . . 64.530000000000001 112.098 -174.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.526 HG23 HD11 ' A' ' 127' ' ' ILE . 72.5 t -131.76 134.03 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 122.257 -0.277 . . . . 74.129999999999995 111.527 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 26.8 mmtp -147.08 136.62 22.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 110.095 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.55 HG13 ' HB2' ' A' ' 45' ' ' LEU . 4.1 mp -115.83 146.65 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.664 -0.244 . . . . 73.450000000000003 110.636 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.502 ' HB2' HG22 ' A' ' 46' ' ' VAL . 40.4 m-85 -124.53 164.55 19.55 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.038 0.535 . . . . 75.140000000000001 110.516 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 23' ' ' ILE . 33.6 mtmm -143.61 178.82 7.52 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.816 0.446 . . . . 73.340000000000003 110.091 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.4 tt -151.76 158.6 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.839 -0.43 . . . . 72.230000000000004 109.839 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -142.57 -3.26 1.03 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.528 0.204 . . . . 73.439999999999998 111.511 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 40.4 mt -84.52 110.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 74.519999999999996 110.668 -174.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -49.48 -55.4 13.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.66 -0.7 . . . . 72.209999999999994 111.851 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.62 6.72 5.44 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.358 -0.383 . . . . 70.010000000000005 111.876 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.596 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.9 OUTLIER -107.3 22.13 16.46 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.057 0.456 . . . . 74.319999999999993 109.902 176.249 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -81.12 -10.85 59.59 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.003 -0.544 . . . . 64.439999999999998 111.498 -176.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -45.27 -56.96 4.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.709 0.29 . . . . 71.200000000000003 111.219 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.445 ' O ' ' HD1' ' A' ' 91' ' ' TYR . 7.5 p -53.1 -34.19 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.862 -0.608 . . . . 70.129999999999995 111.036 -178.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -67.75 -50.67 55.98 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.085 0.469 . . . . 70.109999999999999 109.967 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.2 m -60.42 -29.62 69.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.598 -0.728 . . . . 65.150000000000006 110.529 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.67 -55.89 8.76 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.867 -0.606 . . . . 52.43 111.32 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.445 ' HD1' ' O ' ' A' ' 87' ' ' VAL . 85.6 m-85 -77.22 -9.84 59.04 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.707 0.262 . . . . 72.099999999999994 111.707 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.29 53.61 1.14 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.801 -0.714 . . . . 72.409999999999997 113.391 170.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.496 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 80.6 t -93.92 111.84 25.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.993 -0.373 . . . . 52.149999999999999 109.993 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 m -121.97 25.17 9.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.362 0.601 . . . . 73.109999999999999 110.065 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.38 154.69 36.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.376 -0.829 . . . . 51.240000000000002 109.661 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.601 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 46.4 mm -67.71 -56.05 12.82 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.758 -0.46 . . . . 51.329999999999998 109.758 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.601 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 90.0 Cg_endo -82.09 67.67 8.08 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.007 1.804 . . . . 62.210000000000001 111.813 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.426 HG21 HG22 ' A' ' 93' ' ' VAL . 67.5 m -105.43 121.36 43.75 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.876 -0.602 . . . . 55.219999999999999 110.456 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.535 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.3 mp -110.27 112.68 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.558 -0.746 . . . . 51.32 110.102 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.449 HD23 ' HG3' ' A' ' 110' ' ' GLN . 36.9 mt -90.23 131.22 36.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.441 -0.577 . . . . 64.019999999999996 109.441 173.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.517 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 38.7 mtp -110.23 138.99 45.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.493 -0.558 . . . . 72.349999999999994 109.493 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -144.03 144.54 31.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.531 -0.544 . . . . 72.129999999999995 109.531 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HD3' ' HB3' ' A' ' 126' ' ' ASN . 39.6 ttpt -118.8 104.93 11.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.85 -0.34 . . . . 62.049999999999997 110.578 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.867 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 60.6 t30 59.25 30.55 20.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.594 0.711 . . . . 64.219999999999999 110.353 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.8 -16.4 60.36 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.887 -0.597 . . . . 73.420000000000002 112.083 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -73.34 142.72 47.07 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 110.133 -0.321 . . . . 63.219999999999999 110.133 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -63.68 145.77 55.09 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.529 -0.76 . . . . 71.150000000000006 111.181 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.517 ' HB3' ' O ' ' A' ' 101' ' ' MET . 1.3 tp -162.14 169.88 20.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.374 -0.83 . . . . 73.400000000000006 110.563 -164.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.6 m -69.63 167.93 15.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.039 0.935 . . . . 74.510000000000005 113.044 -163.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.449 ' HG3' HD23 ' A' ' 100' ' ' LEU . 57.2 tt0 -126.61 118.66 25.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.674 -1.148 . . . . 71.430000000000007 109.418 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 23.0 t -96.03 107.23 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.565 -0.531 . . . . 72.530000000000001 109.565 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.8 mp -96.68 101.69 12.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.592 -0.521 . . . . 64.329999999999998 109.592 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.1 167.29 18.82 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.613 -0.595 . . . . 73.140000000000001 111.613 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.67 86.3 7.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.799 -0.236 . . . . 60.25 111.102 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -124.79 86.65 2.59 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 121.82 0.819 . . . . 63.43 109.717 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -62.63 -27.64 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 114.887 -1.052 . . . . 54.0 110.048 -174.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -63.42 -47.83 80.31 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.34 -0.391 . . . . 62.119999999999997 110.145 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.538 ' HE2' ' HG2' ' A' ' 122' ' ' GLU . 10.6 tptm -69.38 -39.64 77.91 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.152 -0.314 . . . . 75.319999999999993 110.152 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.3 mt -55.39 -56.23 12.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.07 0.462 . . . . 71.549999999999997 110.624 177.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 116' ' ' ILE . 13.5 tt -65.98 -33.81 66.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 116.027 -0.533 . . . . 75.400000000000006 110.569 -178.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.1 t -54.95 -51.85 64.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.03 -0.532 . . . . 44.310000000000002 109.673 176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.538 ' HG2' ' HE2' ' A' ' 118' ' ' LYS . 60.2 mm-40 -63.25 -40.11 96.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.034 -0.53 . . . . 74.219999999999999 110.494 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.498 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 63.9 mt -52.04 -56.43 6.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.719 0.295 . . . . 72.530000000000001 110.889 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 128' ' ' ASN . 2.0 p-10 -71.88 -25.39 61.92 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 120.536 -0.466 . . . . 63.299999999999997 110.709 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 34.3 t30 -63.21 -33.93 76.55 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.06 0.457 . . . . 72.310000000000002 110.85 177.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.474 ' HB3' ' HD3' ' A' ' 103' ' ' LYS . 38.6 m-80 -94.55 -37.05 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.01 -0.541 . . . . 75.129999999999995 111.874 -176.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.526 HD11 HG23 ' A' ' 74' ' ' VAL . 66.7 mt -72.14 -48.98 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 64.140000000000001 110.862 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 124' ' ' ASN . 6.2 m-20 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.533 -0.746 . . . . 63.130000000000003 110.27 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 93.7 mmm . . . . . 0 C--O 1.234 0.255 0 N-CA-C 109.451 -0.574 . . . . 71.319999999999993 109.451 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -73.71 115.79 15.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.678 -0.86 . . . . 73.239999999999995 108.678 171.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -74.38 146.47 42.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.99 0.424 . . . . 74.120000000000005 111.516 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.54 118.86 37.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.602 -0.727 . . . . 74.239999999999995 109.348 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.464 HG21 ' HG3' ' A' ' 34' ' ' LYS . 46.9 pt -144.58 175.12 3.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 120.826 0.346 . . . . 73.019999999999996 110.924 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.12 175.17 15.59 Favored Glycine 0 CA--C 1.521 0.406 0 CA-C-N 115.912 -0.585 . . . . 74.340000000000003 112.418 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.49 ' OD2' HG23 ' A' ' 87' ' ' VAL . 13.5 t70 -51.78 -45.86 63.95 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.466 0.706 . . . . 75.340000000000003 111.623 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 t -66.27 -28.57 68.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.150000000000006 110.806 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 43.0 mt-10 -80.97 -13.33 58.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 61.100000000000001 111.352 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.575 ' O ' HG23 ' A' ' 35' ' ' VAL . 87.2 t80 -51.43 -61.88 1.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.13 0.269 . . . . 73.310000000000002 111.14 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.18 -48.2 81.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.17 0.51 . . . . 70.209999999999994 110.76 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -60.81 -53.32 58.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.522 -0.763 . . . . 70.319999999999993 111.487 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HG3' HG21 ' A' ' 26' ' ' ILE . 35.0 mmtp -67.28 -31.82 72.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.102 -0.499 . . . . 74.219999999999999 111.293 -175.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 44' ' ' ILE . 74.5 t -66.3 -45.49 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.899 0.38 . . . . 65.010000000000005 109.979 174.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.5 p -75.11 -16.15 60.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.314 -0.403 . . . . 73.409999999999997 111.22 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -75.6 0.16 18.43 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.286 -0.415 . . . . 75.349999999999994 111.205 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.754 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.2 p -56.68 122.1 11.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.698 -0.228 . . . . 72.120000000000005 110.633 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -56.07 -76.17 0.03 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.332 -0.394 . . . . 71.150000000000006 110.889 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -161.98 145.31 12.0 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.358 -0.608 . . . . 72.329999999999998 109.358 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.4 p30 45.0 27.47 0.29 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.001 0.813 . . . . 71.129999999999995 111.727 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 47.0 mm -87.84 123.79 40.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.984 -0.553 . . . . 73.420000000000002 110.221 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -89.97 110.34 21.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.575 -0.738 . . . . 71.349999999999994 109.101 178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.602 HG21 HG22 ' A' ' 35' ' ' VAL . 22.8 mm -89.07 109.11 19.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.59 -0.732 . . . . 54.130000000000003 110.384 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.521 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.5 mp -99.04 146.97 25.5 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.541 -0.911 . . . . 71.209999999999994 108.541 172.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 70.1 t -139.13 113.15 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.348 -0.242 . . . . 75.540000000000006 110.348 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' OD2' ' HB3' ' A' ' 78' ' ' LYS . 1.6 p30 -91.69 137.55 32.27 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.716 -0.475 . . . . 52.219999999999999 109.716 176.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.62 ' HE2' ' HG ' ' A' ' 100' ' ' LEU . 79.5 m-85 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.352 -0.385 . . . . 74.510000000000005 111.991 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 57' ' ' ARG . 43.3 ttt-85 . . . . . 0 CA--C 1.534 0.34 0 CA-C-O 120.575 0.226 . . . . 53.409999999999997 110.853 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 33.0 t -75.75 -40.06 56.06 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.504 0.669 . . . . 55.119999999999997 111.084 174.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.523 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.8 mm? -57.51 -49.74 75.32 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.252 -0.885 . . . . 70.439999999999998 112.918 -171.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.51 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 49.9 mt-10 -56.39 -53.95 58.51 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 117.914 0.324 . . . . 71.439999999999998 111.147 -176.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 31.2 Cg_exo -50.29 -50.98 11.91 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.944 1.763 . . . . 63.450000000000003 111.74 172.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 58' ' ' SER . 45.2 mt-30 -54.35 -41.98 69.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.141 -0.481 . . . . 74.540000000000006 111.798 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 75.0 mt -68.36 -38.92 81.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.48 -0.327 . . . . 72.519999999999996 110.42 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 37.7 mt-10 -68.06 -29.59 68.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.145 -0.479 . . . . 63.32 110.26 177.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -64.91 -54.04 37.08 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.131 -0.692 . . . . 74.519999999999996 109.131 176.178 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.07 -32.78 73.35 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.306 -0.861 . . . . 53.340000000000003 110.068 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.531 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.54 -50.73 70.21 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.946 -0.57 . . . . 70.140000000000001 109.781 177.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.5 mt-30 -54.63 -47.99 72.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.174 0.511 . . . . 74.310000000000002 110.245 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -63.92 -45.21 90.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.408 -0.815 . . . . 41.420000000000002 111.767 -178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -104.98 4.26 31.53 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 113.239 0.829 . . . . 74.150000000000006 113.239 -170.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 14.0 t -53.33 -24.89 13.08 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.791 0.663 . . . . 54.439999999999998 112.791 -171.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.455 ' HG3' ' OD1' ' A' ' 73' ' ' ASN . 5.6 pt-20 -64.15 -25.41 68.07 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.005 0.431 . . . . 71.450000000000003 111.135 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.455 ' OD1' ' HG3' ' A' ' 72' ' ' GLU . 5.2 m120 -127.95 -0.76 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.334 -0.394 . . . . 74.329999999999998 111.257 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.461 HG23 HD11 ' A' ' 127' ' ' ILE . 25.8 t -130.51 139.12 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.043 0.449 . . . . 72.219999999999999 112.161 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -145.26 119.73 9.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 73.340000000000003 109.801 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.521 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.7 mp -98.68 140.06 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.181 -0.674 . . . . 54.32 109.181 174.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 73.7 m-85 -125.95 149.01 49.08 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.107 -0.701 . . . . 72.5 109.107 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HB3' ' OD2' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -133.47 135.06 44.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.885 -0.413 . . . . 72.530000000000001 109.885 176.365 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.0 mt -76.9 91.78 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.203 -0.665 . . . . 64.129999999999995 109.203 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -82.16 -18.5 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.917 -0.583 . . . . 65.099999999999994 110.477 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.1 mm -69.53 89.2 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.367 0.603 . . . . 70.230000000000004 109.882 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -48.98 -35.95 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.876 -1.057 . . . . 65.230000000000004 111.549 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.79 -22.76 60.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.327 -0.851 . . . . 74.140000000000001 112.313 -173.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -131.06 108.51 9.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.699 0.285 . . . . 71.349999999999994 110.826 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.99 32.36 1.02 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.839 -0.619 . . . . 72.409999999999997 110.416 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -52.37 -37.27 55.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.558 -0.746 . . . . 64.230000000000004 111.141 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.49 HG23 ' OD2' ' A' ' 28' ' ' ASP . 97.7 t -52.8 -36.28 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.757 -0.656 . . . . 73.439999999999998 111.17 -178.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.49 -54.91 24.99 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.064 0.459 . . . . 74.219999999999999 110.952 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.7 m -63.2 -40.94 98.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.802 -0.636 . . . . 70.319999999999993 110.903 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -67.77 -51.33 50.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.257 -0.429 . . . . 65.150000000000006 111.758 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -70.87 -29.13 65.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.777 -0.192 . . . . 65.129999999999995 111.286 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.09 57.14 0.57 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.653 -0.784 . . . . 72.329999999999998 112.657 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -92.66 99.63 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.937 0.399 . . . . 73.219999999999999 109.989 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -79.9 -50.65 10.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.848 -0.614 . . . . 72.150000000000006 110.543 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.13 136.33 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.596 -0.52 . . . . 33.340000000000003 109.596 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.649 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 62.3 mt -51.96 -55.38 31.18 Favored Pre-proline 0 CA--C 1.54 0.559 0 O-C-N 123.21 0.319 . . . . 72.540000000000006 111.56 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.649 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 4.4 Cg_exo -73.61 82.36 1.69 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.94 1.76 . . . . 62.32 111.852 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.0 m -122.6 138.89 54.44 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.132 -0.485 . . . . 72.329999999999998 110.03 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.9 mp -119.56 118.81 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.014 -0.539 . . . . 74.219999999999999 110.235 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HG ' ' HE2' ' A' ' 48' ' ' PHE . 49.4 mt -88.53 141.85 28.19 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.646 -0.502 . . . . 64.109999999999999 109.646 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.586 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 52.6 mtp -114.08 144.92 42.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.204 -0.665 . . . . 73.430000000000007 109.204 175.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.466 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 97.2 m-85 -146.64 160.22 42.47 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.777 -0.823 . . . . 72.430000000000007 108.777 174.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -148.15 109.52 4.37 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 120.077 -0.649 . . . . 73.310000000000002 111.789 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.754 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.9 m-20 56.47 31.79 19.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.012 0.434 . . . . 74.310000000000002 111.178 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.55 -15.22 61.96 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.108 -0.568 . . . . 51.130000000000003 112.657 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -67.94 132.67 47.76 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 109.645 -0.502 . . . . 75.230000000000004 109.645 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.6 147.49 45.5 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 124.045 0.841 . . . . 75.049999999999997 108.943 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.586 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.2 tp -156.48 168.44 27.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.093 -0.706 . . . . 63.340000000000003 109.093 -164.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.3 m -69.65 172.31 7.64 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.493 0.717 . . . . 74.319999999999993 112.512 -164.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.51 ' HG3' HD23 ' A' ' 100' ' ' LEU . 23.2 tt0 -131.01 131.81 44.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.23 -0.895 . . . . 72.450000000000003 109.91 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.79 111.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.915 -0.402 . . . . 73.219999999999999 109.915 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.2 mp -85.95 113.54 24.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.245 -0.65 . . . . 65.129999999999995 109.245 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.31 142.81 7.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.983 -0.627 . . . . 75.420000000000002 111.763 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.523 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -72.07 87.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.701 0.286 . . . . 72.030000000000001 110.765 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 119' ' ' ILE . 14.3 t70 -119.53 111.01 17.56 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.23 -0.441 . . . . 74.109999999999999 110.35 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -33.54 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.716 -0.675 . . . . 73.310000000000002 110.549 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -64.82 -53.25 49.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.984 0.421 . . . . 65.209999999999994 110.355 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -60.79 -45.6 93.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.162 -0.472 . . . . 73.519999999999996 110.331 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 115' ' ' ASP . 81.8 mt -58.66 -56.15 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.026 -0.534 . . . . 72.219999999999999 110.972 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -61.2 -36.32 71.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 120.772 0.32 . . . . 62.340000000000003 110.549 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.6 t -59.63 -52.05 67.19 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.117 -0.492 . . . . 61.520000000000003 110.015 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -62.56 -40.58 97.29 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.32 -0.4 . . . . 74.150000000000006 110.691 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 127' ' ' ILE . 57.3 mt -55.36 -56.11 13.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.288 -0.415 . . . . 64.299999999999997 110.644 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -66.1 -33.18 75.19 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.028 0.442 . . . . 72.510000000000005 110.343 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -69.36 -28.45 66.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 43.149999999999999 111.547 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.536 ' OD1' HD11 ' A' ' 108' ' ' LEU . 65.1 m-80 -107.86 -8.91 15.85 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.789 0.663 . . . . 71.019999999999996 112.789 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.461 HD11 HG23 ' A' ' 74' ' ' VAL . 61.3 mt -85.93 -51.58 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.883 -0.414 . . . . 63.32 109.883 170.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.25 1.097 0 CA-C-N 115.824 -0.626 . . . . 53.210000000000001 109.956 -178.741 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.492 ' SD ' ' HG2' ' A' ' 68' ' ' GLN . 19.2 ptm . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 121.573 0.702 . . . . 70.230000000000004 109.137 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -80.44 107.07 12.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.024 -0.989 . . . . 71.409999999999997 109.704 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -62.82 152.52 35.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.258 0.552 . . . . 72.200000000000003 111.762 -172.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 10.1 pt20 -124.67 125.56 44.3 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.613 -0.721 . . . . 72.450000000000003 109.528 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 31' ' ' PHE . 25.6 pt -135.7 158.11 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.697 0.284 . . . . 73.420000000000002 111.409 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.52 -179.93 52.34 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.202 -0.454 . . . . 74.349999999999994 112.442 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HB2' ' ND2' ' A' ' 84' ' ' ASN . 18.3 t70 -58.9 -56.3 24.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.098 0.475 . . . . 72.310000000000002 111.341 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.0 m -69.76 -15.61 63.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 65.310000000000002 111.344 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -84.7 -10.99 56.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 111.4 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 26' ' ' ILE . 79.5 t80 -55.28 -62.47 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.664 0.246 . . . . 64.409999999999997 111.664 -173.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.95 -45.32 95.18 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.902 0.382 . . . . 72.120000000000005 110.925 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.27 -49.82 76.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.749 -0.66 . . . . 73.25 111.421 -176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HG3' ' CG2' ' A' ' 26' ' ' ILE . 33.1 mmtp -69.34 -33.92 73.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.257 -0.429 . . . . 71.129999999999995 110.944 -176.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 31' ' ' PHE . 72.3 t -65.47 -43.2 94.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 120.876 0.37 . . . . 72.219999999999999 110.4 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.5 p -75.1 -18.51 60.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.878 0.37 . . . . 73.409999999999997 110.898 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.8 t -67.69 -2.79 7.52 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.211 -0.45 . . . . 63.119999999999997 111.329 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.757 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.3 p -57.8 148.93 23.62 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.639 -0.255 . . . . 62.439999999999998 110.567 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.5 -84.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.437 -0.347 . . . . 71.310000000000002 110.32 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -162.07 135.92 6.5 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.237 -0.653 . . . . 73.540000000000006 109.237 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 65.68 9.43 5.93 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.684 0.615 . . . . 64.420000000000002 110.999 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.757 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.2 mm -76.48 115.97 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 73.340000000000003 110.552 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 102' ' ' PHE . 1.0 OUTLIER -74.7 110.8 9.29 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.121 -0.696 . . . . 74.120000000000005 109.121 175.265 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.515 HD11 ' HB3' ' A' ' 38' ' ' CYS . 27.9 mm -93.21 106.85 18.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.342 -0.844 . . . . 75.340000000000003 110.037 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.668 ' HB2' HG13 ' A' ' 76' ' ' ILE . 5.3 mp -92.38 149.63 21.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.945 -0.761 . . . . 73.409999999999997 108.945 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 58.5 t -132.23 110.99 17.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.906 -0.775 . . . . 53.109999999999999 108.906 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -94.31 159.95 14.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.259 0.552 . . . . 52.350000000000001 111.123 -173.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.113 -0.949 . . . . 71.540000000000006 109.004 165.37 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.403 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.2 ttt180 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.746 0.308 . . . . 75.299999999999997 111.051 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.632 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 13.0 m -74.45 -38.35 63.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.382 0.61 . . . . 54.149999999999999 110.563 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.529 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 mm? -61.03 -26.86 67.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.673 -0.694 . . . . 73.430000000000007 110.92 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 30.3 tt0 -56.52 -67.75 0.74 Allowed Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 119.333 -0.365 . . . . 73.140000000000001 110.238 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.477 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 27.8 Cg_endo -61.63 -39.41 54.33 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 121.484 1.456 . . . . 53.340000000000003 112.089 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.632 ' HG3' ' O ' ' A' ' 58' ' ' SER . 48.7 mt-30 -53.87 -52.7 59.62 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.74 -0.384 . . . . 70.349999999999994 111.433 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.91 -28.28 55.25 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.792 0.293 . . . . 53.420000000000002 111.792 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 93.2 mt-10 -65.37 -41.75 93.47 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.085 0.469 . . . . 74.530000000000001 109.828 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -67.34 -46.85 72.2 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.062 -0.517 . . . . 72.340000000000003 110.285 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' CD1' HD11 ' A' ' 116' ' ' ILE . 21.3 mt -62.85 -29.78 71.0 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.848 -0.341 . . . . 61.210000000000001 110.623 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.74 -51.34 67.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.433 -0.58 . . . . 73.510000000000005 109.433 175.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.492 ' HG2' ' SD ' ' A' ' 22' ' ' MET . 92.2 mt-30 -60.58 -32.2 71.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.837 -0.619 . . . . 72.549999999999997 111.062 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -77.16 -40.34 45.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 75.340000000000003 111.296 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -104.69 4.44 32.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.288 -0.415 . . . . 71.109999999999999 111.833 -174.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.8 t -53.01 -19.67 2.86 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.167 0.432 . . . . 71.109999999999999 112.167 -172.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -54.89 -41.91 71.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.093 -0.503 . . . . 75.239999999999995 110.187 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.473 ' HA ' HD13 ' A' ' 42' ' ' ILE . 52.3 m-80 -135.18 11.93 3.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.912 -0.586 . . . . 70.239999999999995 111.721 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.5 HG23 HD11 ' A' ' 127' ' ' ILE . 24.1 t -126.25 139.17 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 122.242 -0.286 . . . . 64.140000000000001 111.506 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -143.67 129.16 19.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.983 -0.747 . . . . 73.439999999999998 108.983 172.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' A' ' 45' ' ' LEU . 4.5 mp -105.63 138.28 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.08 0.466 . . . . 73.230000000000004 110.635 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 16.0 m-85 -127.42 165.06 20.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.277 -0.874 . . . . 74.420000000000002 108.963 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -161.81 165.01 28.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.344 -0.389 . . . . 74.549999999999997 110.149 173.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.4 tp -68.37 129.53 32.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 75.310000000000002 110.437 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 52.7 t30 -95.19 -15.98 22.88 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.13 -0.486 . . . . 62.200000000000003 110.554 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.4 mt -102.62 103.31 14.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.884 -0.598 . . . . 74.439999999999998 109.908 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.3 -18.46 63.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.012 0.434 . . . . 72.25 110.901 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.43 -14.11 60.43 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.816 -0.629 . . . . 72.439999999999998 111.006 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 28' ' ' ASP . 24.4 t-20 -102.2 119.52 38.93 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.906 0.384 . . . . 74.120000000000005 111.436 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -119.31 -3.51 10.51 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.543 -0.54 . . . . 73.409999999999997 109.543 169.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.2 m-20 -48.08 -49.66 30.88 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.482 -0.781 . . . . 61.299999999999997 111.457 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -54.97 -38.9 47.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 116.224 -0.443 . . . . 74.329999999999998 110.694 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -69.01 -42.75 76.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.221 -0.445 . . . . 53.130000000000003 109.866 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -61.2 -38.44 86.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.564 -0.744 . . . . 62.420000000000002 110.576 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 78.3 mm-40 -69.71 -49.81 49.77 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.079 -0.509 . . . . 75.329999999999998 111.298 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -89.49 -2.45 58.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.286 -0.416 . . . . 71.540000000000006 112.027 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.19 57.09 5.34 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.137 -0.554 . . . . 33.240000000000002 112.977 171.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.42 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 86.6 t -82.42 92.77 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.698 -0.482 . . . . 74.430000000000007 109.698 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.3 t -89.41 -34.12 16.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.775 -0.648 . . . . 75.310000000000002 110.617 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.66 143.83 28.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 43.329999999999998 110.149 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.742 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 50.2 mm -59.29 -52.64 72.97 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.494 -0.321 . . . . 74.439999999999998 110.691 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.742 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 58.2 Cg_endo -93.52 112.38 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.472 2.115 . . . . 73.120000000000005 111.145 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.437 ' C ' HD12 ' A' ' 99' ' ' ILE . 64.2 m -136.97 141.91 42.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.92 0.39 . . . . 73.340000000000003 111.247 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.569 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -123.44 119.19 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.606 -0.724 . . . . 71.310000000000002 109.939 174.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.482 HD23 ' HG3' ' A' ' 110' ' ' GLN . 91.3 mt -94.83 129.43 41.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.063 -0.717 . . . . 63.240000000000002 109.063 174.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 44.4 mtp -106.47 138.53 42.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.036 -0.357 . . . . 73.340000000000003 110.036 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.488 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 100.0 m-85 -143.63 165.44 27.62 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.467 -0.568 . . . . 73.140000000000001 109.467 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 40.0 ttmt -151.78 104.87 3.06 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 122.245 -0.284 . . . . 63.100000000000001 110.948 175.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.719 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 57.6 t30 47.68 56.07 7.6 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.368 0.604 . . . . 64.219999999999999 110.914 177.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.88 -16.78 3.11 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.441 -0.8 . . . . 54.340000000000003 113.791 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 63.2 tttp -80.88 143.43 32.71 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 117.082 0.441 . . . . 62.219999999999999 110.141 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -71.97 145.59 48.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.58 0.705 . . . . 71.519999999999996 111.076 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -146.39 167.75 22.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.587 -1.264 . . . . 70.329999999999998 107.587 -172.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.1 m -70.19 -177.79 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.419 0.628 . . . . 72.019999999999996 112.66 -164.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.482 ' HG3' HD23 ' A' ' 100' ' ' LEU . 54.7 tt0 -138.46 129.52 26.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 74.230000000000004 109.51 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.569 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.0 t -100.53 107.51 21.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.069 0.461 . . . . 50.240000000000002 110.231 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.3 mp -86.71 110.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.567 -0.742 . . . . 73.329999999999998 109.435 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.409 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 99.43 155.08 28.48 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.56 -0.616 . . . . 30.23 111.56 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.529 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -80.04 72.16 6.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.844 0.354 . . . . 43.439999999999998 110.95 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 119' ' ' ILE . 18.0 t70 -111.08 96.95 6.45 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.598 0.713 . . . . 74.109999999999999 110.505 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.444 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -61.59 -34.41 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.141 -0.936 . . . . 73.099999999999994 110.263 -173.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.1 p -63.13 -43.34 98.64 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.274 -0.421 . . . . 62.200000000000003 111.056 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.84 -43.85 78.57 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.715 -0.476 . . . . 75.409999999999997 109.715 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 115' ' ' ASP . 70.8 mt -56.05 -56.48 12.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-N 116.015 -0.539 . . . . 74.140000000000001 110.838 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.7 tt -65.52 -33.87 66.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.854 -0.612 . . . . 45.439999999999998 110.586 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.5 t -57.33 -51.93 67.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.229 -0.441 . . . . 61.229999999999997 110.111 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -60.66 -45.3 94.63 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.589 -0.278 . . . . 73.409999999999997 110.372 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 119' ' ' ILE . 72.7 mt -52.56 -56.04 8.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 116.107 -0.497 . . . . 71.299999999999997 111.182 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -68.21 -32.96 73.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.658 0.266 . . . . 74.239999999999995 110.632 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -61.75 -36.49 81.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.145 0.498 . . . . 72.129999999999995 110.228 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -85.4 -28.78 24.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 72.239999999999995 112.144 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.5 HD11 HG23 ' A' ' 74' ' ' VAL . 52.6 mt -103.74 -60.69 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.142 0.496 . . . . 72.409999999999997 112.232 -178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.383 -0.826 . . . . 65.439999999999998 110.921 -166.784 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.421 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 88.1 mmm . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 121.248 0.547 . . . . 54.299999999999997 110.483 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.449 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 13.0 mm -83.19 123.26 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.367 -0.833 . . . . 51.530000000000001 109.878 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.489 ' HG3' HG23 ' A' ' 26' ' ' ILE . 6.2 tp10 -74.27 160.24 31.38 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 123.165 0.29 . . . . 75.430000000000007 110.245 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 25.4 pt20 -133.85 115.89 15.0 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 110.026 -0.361 . . . . 65.129999999999995 110.026 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.542 HG21 ' HG3' ' A' ' 34' ' ' LYS . 21.5 pt -139.9 179.98 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.305 0.483 . . . . 63.420000000000002 112.305 -170.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.0 -157.14 9.9 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.392 -0.822 . . . . 70.420000000000002 111.293 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.401 ' HB3' ' OD1' ' A' ' 84' ' ' ASN . 12.4 t70 -68.21 -51.03 50.03 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.147 0.474 . . . . 64.140000000000001 111.24 -176.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 t -58.21 -43.84 87.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 55.210000000000001 110.356 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -83.12 -13.11 56.29 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.502 -0.317 . . . . 71.209999999999994 111.691 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.5 ' HA ' HD12 ' A' ' 26' ' ' ILE . 89.3 t80 -58.18 -57.7 11.69 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.961 -0.755 . . . . 74.340000000000003 108.961 175.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.61 -51.43 69.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 65.319999999999993 110.638 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -52.73 -57.42 10.18 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.307 0.379 . . . . 73.439999999999998 111.215 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HG3' HG21 ' A' ' 26' ' ' ILE . 34.6 mmtp -69.38 -37.02 77.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 62.140000000000001 111.59 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.38 -45.17 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 121.197 -0.201 . . . . 70.200000000000003 110.704 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.5 p -75.2 -24.7 57.81 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.881 -0.328 . . . . 63.32 111.243 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.7 t -70.04 -7.88 44.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.501 -0.318 . . . . 61.43 111.699 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.929 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 26.8 p -59.35 137.28 58.05 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.652 -0.499 . . . . 63.340000000000003 109.652 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -48.38 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.415 0.447 . . . . 72.409999999999997 111.142 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -161.98 145.37 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.449 -0.574 . . . . 72.450000000000003 109.449 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 48.22 13.14 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.084 0.954 . . . . 74.420000000000002 113.32 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.65 136.66 26.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.275 -0.268 . . . . 60.149999999999999 110.275 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -85.35 113.15 21.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.459 0.647 . . . . 70.200000000000003 109.301 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.1 mt -106.95 139.39 28.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.152 -0.931 . . . . 73.420000000000002 110.624 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.558 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -120.82 139.48 53.09 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.172 -1.047 . . . . 63.310000000000002 108.172 170.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 77' ' ' TYR . 97.1 t -127.26 104.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.192 -0.67 . . . . 71.409999999999997 109.192 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 3.2 p-10 -101.39 150.52 22.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.012 -0.54 . . . . 62.130000000000003 109.724 -177.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.426 -0.352 . . . . 72.120000000000005 110.328 177.406 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 . . . . . 0 N--CA 1.463 0.205 0 CA-C-O 120.792 0.329 . . . . 65.129999999999995 110.559 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.567 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 47.2 t -74.95 -36.27 62.1 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.518 0.675 . . . . 55.100000000000001 110.52 177.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.524 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 1.3 mm? -55.03 -44.6 74.8 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.475 -0.784 . . . . 74.140000000000001 112.059 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.05 -56.86 30.68 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 119.374 -0.346 . . . . 72.340000000000003 111.543 -176.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HG2' ' O ' ' A' ' 58' ' ' SER . 10.0 Cg_endo -54.14 -38.14 87.53 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.739 1.626 . . . . 61.119999999999997 111.748 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 58' ' ' SER . 36.8 mt-30 -61.94 -39.64 92.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.753 -0.379 . . . . 74.400000000000006 110.956 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 80.3 mt -67.33 -36.92 82.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.425 -0.352 . . . . 63.439999999999998 110.147 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 42.8 mt-10 -59.4 -47.85 83.89 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.491 -0.559 . . . . 71.219999999999999 109.491 174.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -55.31 -50.61 69.13 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.578 -0.737 . . . . 74.209999999999994 110.566 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.538 HD11 HD11 ' A' ' 116' ' ' ILE . 23.1 mt -65.43 -37.14 86.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 64.409999999999997 110.443 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.534 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.98 -31.83 72.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 65.409999999999997 110.742 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 54.7 mt-30 -76.81 -50.59 13.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.001 0.429 . . . . 65.230000000000004 110.541 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -64.11 -41.19 97.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.745 -0.661 . . . . 74.430000000000007 110.715 -175.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.401 ' HE2' HD22 ' A' ' 66' ' ' LEU . 95.5 m-85 -99.11 5.56 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 72.530000000000001 112.178 -174.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.3 t -52.73 -19.57 2.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.762 0.653 . . . . 55.130000000000003 112.762 -170.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.16 -33.7 75.98 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.839 0.352 . . . . 64.099999999999994 110.971 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -126.2 -4.5 6.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.317 -0.401 . . . . 65.25 112.072 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.63 138.69 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.956 0.407 . . . . 72.219999999999999 111.726 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -142.95 121.68 12.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.703 -0.68 . . . . 74.030000000000001 109.833 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.558 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.1 mt -111.55 144.49 19.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 120.939 0.4 . . . . 73.400000000000006 111.197 -177.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.487 ' CE1' ' HB3' ' A' ' 34' ' ' LYS . 96.3 m-85 -130.56 136.36 48.83 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.558 -0.746 . . . . 75.25 110.213 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HG3' ' CG2' ' A' ' 23' ' ' ILE . 29.4 mtpp -107.97 134.04 51.45 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.582 -0.525 . . . . 64.219999999999999 109.582 173.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.3 mt -73.42 104.65 2.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.805 -0.813 . . . . 71.340000000000003 108.805 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 23.9 t-20 -98.95 -39.75 8.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.172 -0.467 . . . . 72.329999999999998 111.685 -173.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.4 mm -79.64 105.24 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.492 -0.322 . . . . 62.119999999999997 110.899 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -24.74 64.06 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.795 -0.638 . . . . 75.230000000000004 111.986 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -71.4 -5.1 30.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.127 0.489 . . . . 54.340000000000003 110.621 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.401 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 24.0 m-80 -124.59 29.12 6.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 44.539999999999999 111.136 -176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -69.07 -7.34 34.92 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.352 -0.385 . . . . 64.25 110.916 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -47.11 -38.71 11.94 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.047 -0.524 . . . . 71.299999999999997 110.909 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -53.06 -41.67 42.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 115.703 -0.681 . . . . 34.509999999999998 110.894 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.0 -41.48 96.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.619 -0.719 . . . . 72.129999999999995 110.499 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.5 m -69.5 -38.04 77.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.738 -0.665 . . . . 75.439999999999998 110.454 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -58.5 -51.69 68.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.972 -0.558 . . . . 75.219999999999999 110.842 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -77.11 -25.69 52.44 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 121.013 -0.275 . . . . 74.319999999999993 111.201 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 51.84 9.35 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.572 -0.823 . . . . 71.049999999999997 111.045 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.413 HG23 HG21 ' A' ' 98' ' ' THR . 7.7 p -59.71 135.77 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.258 -0.471 . . . . 71.140000000000001 111.305 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -69.84 -38.12 76.41 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.883 -0.598 . . . . 73.0 111.913 -174.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.42 164.03 34.64 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.464 -0.148 . . . . 73.129999999999995 110.874 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.605 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 48.2 mm -61.41 -48.69 90.21 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.543 -0.299 . . . . 43.299999999999997 110.836 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 3.6 Cg_exo -80.13 101.49 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.978 1.785 . . . . 75.439999999999998 110.552 172.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.413 HG21 HG23 ' A' ' 93' ' ' VAL . 97.1 m -153.2 146.63 24.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.326 -0.397 . . . . 53.520000000000003 110.576 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.592 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -118.37 116.26 50.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.035 -0.53 . . . . 53.100000000000001 110.089 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.441 HD23 ' HG3' ' A' ' 110' ' ' GLN . 89.1 mt -94.91 123.43 38.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.21 -0.663 . . . . 61.420000000000002 109.21 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.405 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 51.4 mtp -92.77 147.97 22.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.144 -0.317 . . . . 73.019999999999996 110.144 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.2 m-85 -144.92 161.09 40.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.551 -0.537 . . . . 74.420000000000002 109.551 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 20.7 ttmm -148.5 105.01 3.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.629 0.252 . . . . 73.120000000000005 110.568 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.929 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 65.7 t30 57.02 39.72 29.13 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.32 0.581 . . . . 71.329999999999998 110.692 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.98 -16.05 23.72 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.944 -0.571 . . . . 61.0 112.768 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 62.1 tttp -75.96 148.93 37.78 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 110.132 -0.321 . . . . 71.430000000000007 110.132 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -65.1 157.25 29.07 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.411 0.624 . . . . 71.099999999999994 110.903 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.26 167.9 23.2 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.358 -1.349 . . . . 63.0 107.358 -167.583 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.408 ' H ' HD13 ' A' ' 108' ' ' LEU . 38.7 m -70.44 178.64 2.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.425 0.631 . . . . 54.140000000000001 112.369 -167.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.441 ' HG3' HD23 ' A' ' 100' ' ' LEU . 59.0 tt0 -134.25 130.39 37.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.734 -0.666 . . . . 63.100000000000001 110.621 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.592 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.4 t -101.1 107.31 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.044 -0.724 . . . . 73.439999999999998 109.044 173.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.8 mt -87.48 109.14 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.144 -0.48 . . . . 75.219999999999999 110.095 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.8 -147.75 16.42 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.395 -0.682 . . . . 62.219999999999999 111.395 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.524 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -132.21 96.26 3.84 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.413 -0.217 . . . . 74.299999999999997 110.413 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -139.56 103.48 4.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.213 0.53 . . . . 70.409999999999997 110.473 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -63.34 -28.32 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 64.099999999999994 110.143 -175.086 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.3 m -62.9 -53.45 53.88 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.974 -0.557 . . . . 60.020000000000003 110.224 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -60.8 -44.36 96.95 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.21 -0.45 . . . . 73.120000000000005 110.09 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.475 HD13 HD21 ' A' ' 63' ' ' LEU . 66.0 mt -55.45 -56.12 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.964 -0.562 . . . . 64.299999999999997 111.316 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.6 tp -64.21 -34.46 69.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.526 0.203 . . . . 61.409999999999997 110.717 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.4 m -58.14 -50.69 72.61 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.538 -0.301 . . . . 61.149999999999999 110.468 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.82 -38.12 85.83 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.593 -0.276 . . . . 74.319999999999993 111.472 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.6 mt -58.65 -56.01 19.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.962 0.41 . . . . 64.299999999999997 110.115 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.78 -39.11 83.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 63.43 110.365 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -60.29 -39.84 88.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.486 -0.779 . . . . 73.120000000000005 111.215 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -100.57 -2.4 33.01 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 112.173 0.434 . . . . 72.409999999999997 112.173 -174.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.0 mt -90.92 -55.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.671 -0.492 . . . . 53.32 109.671 168.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--O 1.251 1.149 0 CA-C-N 115.811 -0.631 . . . . 54.509999999999998 109.548 -179.841 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 C--O 1.24 0.555 0 N-CA-C 108.556 -0.905 . . . . 73.140000000000001 108.556 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.442 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 10.7 mm -75.89 99.78 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 114.995 -1.002 . . . . 73.150000000000006 108.788 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.03 161.57 24.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.231 -0.44 . . . . 73.430000000000007 110.786 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.677 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 4.3 pm0 -125.67 122.82 37.45 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.885 0.374 . . . . 73.049999999999997 110.24 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 31' ' ' PHE . 34.4 pt -139.09 -179.75 2.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 122.942 0.497 . . . . 73.430000000000007 110.834 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.504 ' HA3' ' ND2' ' A' ' 84' ' ' ASN . . . -129.45 -157.57 9.22 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.904 -0.589 . . . . 64.209999999999994 111.944 176.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.4 -56.7 7.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.952 0.406 . . . . 73.209999999999994 111.123 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.5 m -62.78 -19.3 63.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 64.310000000000002 111.358 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 21.2 mp0 -96.07 -22.11 17.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.51 -0.314 . . . . 74.030000000000001 110.89 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.588 ' HA ' HD12 ' A' ' 26' ' ' ILE . 93.1 t80 -56.36 -62.32 1.8 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.81 0.338 . . . . 73.439999999999998 111.409 -174.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -59.21 -46.8 87.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 74.430000000000007 110.366 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -54.3 -55.83 24.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.064 -0.971 . . . . 73.200000000000003 111.404 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -65.68 -41.43 92.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.057 -0.519 . . . . 73.349999999999994 111.51 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.54 HG22 HG21 ' A' ' 44' ' ' ILE . 91.1 t -70.04 -29.24 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.116 0.26 . . . . 64.109999999999999 111.646 -177.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.5 p -85.95 -31.11 22.28 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.936 0.398 . . . . 74.129999999999995 111.142 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -76.86 10.97 1.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.031 -0.531 . . . . 75.230000000000004 111.25 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.976 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 9.3 p -73.2 -0.18 13.57 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.864 0.32 . . . . 73.340000000000003 111.864 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 t30 70.87 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.173 0.589 . . . . 71.040000000000006 111.869 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -162.17 137.35 7.17 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.531 0.567 . . . . 74.420000000000002 112.531 -177.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 61.56 2.72 0.72 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 60.32 113.614 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.799 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.9 mm -79.91 114.69 21.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.928 -0.397 . . . . 75.519999999999996 109.928 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tt -79.33 115.99 19.3 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.854 -0.612 . . . . 74.310000000000002 109.662 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.54 HG21 HG22 ' A' ' 35' ' ' VAL . 15.6 mm -99.2 120.04 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.458 -0.792 . . . . 74.400000000000006 110.214 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.6 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.2 mp -107.48 113.75 27.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.959 -0.756 . . . . 74.010000000000005 108.959 174.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -104.82 104.91 17.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.862 0.363 . . . . 51.210000000000001 110.963 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.672 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 7.7 t70 -80.55 148.05 30.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.758 -0.656 . . . . 61.210000000000001 109.464 172.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 109.208 -0.664 . . . . 71.319999999999993 109.208 172.257 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.889 0.376 . . . . 75.420000000000002 110.449 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.539 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 11.5 t -75.26 -26.78 59.09 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.481 0.658 . . . . 65.209999999999994 110.551 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 114' ' ' ALA . 9.4 tp -64.22 -41.06 97.18 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.762 -0.653 . . . . 71.129999999999995 111.877 -171.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.502 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 49.2 mt-10 -55.92 -53.22 65.5 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 120.782 -0.367 . . . . 72.010000000000005 110.183 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 12.0 Cg_exo -52.65 -43.13 57.73 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.889 1.726 . . . . 63.229999999999997 112.255 170.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 58' ' ' SER . 35.3 mt-30 -65.72 -32.9 74.71 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.114 -0.635 . . . . 64.540000000000006 110.781 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.438 HD21 HD13 ' A' ' 119' ' ' ILE . 53.9 mt -70.11 -37.57 75.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.447 -0.797 . . . . 73.319999999999993 109.715 178.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.424 ' OE2' HG12 ' A' ' 23' ' ' ILE . 18.4 mm-40 -58.13 -46.37 85.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.352 -0.385 . . . . 73.0 109.973 171.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -55.87 -54.46 44.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.009 -0.542 . . . . 73.209999999999994 110.392 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.495 HD11 ' CD1' ' A' ' 116' ' ' ILE . 18.8 mt -63.55 -36.56 84.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.022 -0.535 . . . . 63.130000000000003 110.568 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.499 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.79 -33.26 75.27 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.784 -0.644 . . . . 65.319999999999993 110.629 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -78.33 -47.67 17.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 65.129999999999995 110.947 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -61.42 -38.94 88.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.079 -0.51 . . . . 74.150000000000006 110.873 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -104.88 5.76 33.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.42 -0.809 . . . . 72.340000000000003 112.269 -173.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.2 t -52.48 -23.26 5.87 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.811 1.041 . . . . 72.450000000000003 113.811 -166.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.95 -36.46 77.96 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.595 -0.442 . . . . 74.340000000000003 110.67 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -114.33 -4.73 12.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 64.140000000000001 111.676 -175.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.7 t -130.34 150.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.005 0.372 . . . . 73.230000000000004 112.005 -174.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -151.69 125.46 9.04 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.905 -0.589 . . . . 75.319999999999993 109.735 172.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.6 HG12 ' HB2' ' A' ' 45' ' ' LEU . 62.3 mt -101.54 142.56 15.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 120.889 0.376 . . . . 75.319999999999993 110.593 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -128.02 168.49 15.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.554 -0.748 . . . . 74.230000000000004 109.188 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 8.4 ptpp? -147.39 163.15 37.37 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.705 -0.48 . . . . 63.25 109.705 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mt -81.87 114.32 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.253 -0.647 . . . . 74.340000000000003 109.253 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.677 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 11.9 t30 -73.14 -36.79 66.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.927 -0.578 . . . . 74.040000000000006 112.272 -173.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.534 HG13 ' H ' ' A' ' 83' ' ' ASP . 9.2 tp -135.62 143.26 37.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.951 0.405 . . . . 73.209999999999994 111.281 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.46 -18.73 60.3 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.673 -0.694 . . . . 71.209999999999994 112.009 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.534 ' H ' HG13 ' A' ' 81' ' ' ILE . 8.3 m-20 -71.27 -22.64 61.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.313 0.578 . . . . 74.329999999999998 110.288 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.504 ' ND2' ' HA3' ' A' ' 27' ' ' GLY . 92.3 m-20 -96.88 20.9 10.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.778 -0.646 . . . . 74.329999999999998 110.534 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -71.63 -13.96 61.91 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.813 -0.631 . . . . 70.150000000000006 110.201 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -44.69 -42.41 7.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.471 -0.786 . . . . 54.210000000000001 111.742 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.4 t -53.17 -42.23 45.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.14 -0.482 . . . . 72.510000000000005 111.196 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.22 80.8 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.957 -0.565 . . . . 60.509999999999998 110.495 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.8 m -66.54 -35.46 80.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.711 -0.677 . . . . 64.109999999999999 110.992 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.49 -47.96 71.34 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.253 -0.431 . . . . 74.010000000000005 110.839 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -71.13 -24.12 62.21 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.206 -0.452 . . . . 64.209999999999994 110.984 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.67 39.44 7.65 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 121.071 -0.585 . . . . 73.019999999999996 112.77 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 95' ' ' ALA . 30.8 t -90.66 125.59 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.53 -0.544 . . . . 65.430000000000007 109.53 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.1 t -104.39 17.64 23.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.701 0.286 . . . . 75.310000000000002 111.362 -174.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.436 ' H ' HG12 ' A' ' 93' ' ' VAL . . . -126.88 139.8 52.81 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.221 -0.289 . . . . 71.420000000000002 110.221 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.553 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 2.2 mp -78.04 -56.45 1.05 Allowed Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.663 -0.244 . . . . 74.450000000000003 110.985 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 90.9 Cg_endo -79.87 78.67 3.61 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.716 1.611 . . . . 74.510000000000005 111.515 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.6 m -127.34 135.25 50.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.864 -0.607 . . . . 63.450000000000003 111.164 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 99' ' ' ILE . 2.8 mp -110.22 111.74 37.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.472 -0.786 . . . . 62.119999999999997 109.702 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.4 mp -88.64 141.27 28.65 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.318 -0.623 . . . . 70.030000000000001 109.318 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.54 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 36.2 mtp -110.18 140.46 44.27 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.854 -0.425 . . . . 65.129999999999995 109.854 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -146.66 144.49 29.52 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.569 -0.9 . . . . 72.299999999999997 108.569 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.509 ' HB2' HD22 ' A' ' 108' ' ' LEU . 38.2 ttpt -126.47 104.91 8.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.16 -0.616 . . . . 63.450000000000003 110.596 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.976 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.8 t-20 50.79 47.51 24.42 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.561 0.696 . . . . 74.010000000000005 110.809 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.26 -16.19 35.39 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.559 -0.746 . . . . 73.299999999999997 112.955 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -70.07 134.25 48.03 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.917 0.358 . . . . 61.520000000000003 110.475 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -61.42 144.32 54.32 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.044 0.84 . . . . 71.340000000000003 109.132 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.54 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.6 tp -158.73 168.43 26.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.944 -0.571 . . . . 43.109999999999999 109.636 -163.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 101' ' ' MET . 37.8 m -69.47 179.64 2.0 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.069 0.548 . . . . 64.319999999999993 111.845 -167.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.406 HE21 HD11 ' A' ' 112' ' ' ILE . 28.3 tt0 -144.44 124.76 13.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 72.329999999999998 110.057 -174.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.43 108.88 22.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.41 . . . . 73.109999999999999 110.227 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.3 mp -87.55 101.72 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.048 -0.524 . . . . 74.150000000000006 109.651 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.88 -176.76 20.79 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.154 -0.546 . . . . 31.300000000000001 112.816 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.531 ' HA ' HD22 ' A' ' 59' ' ' LEU . . . -92.86 76.82 4.82 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.834 0.453 . . . . 73.030000000000001 111.271 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -117.79 83.52 2.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.499 0.666 . . . . 73.209999999999994 109.458 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.539 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -59.14 -30.47 43.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.093 -0.958 . . . . 72.140000000000001 110.241 -174.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.6 m -58.66 -53.22 60.84 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.13 -0.487 . . . . 63.009999999999998 110.478 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -65.39 -41.25 93.9 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 116.48 -0.327 . . . . 74.129999999999995 110.359 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 123' ' ' ILE . 76.2 mt -55.72 -56.24 13.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.246 -0.434 . . . . 63.329999999999998 110.808 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.85 -34.33 69.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 116.443 -0.344 . . . . 75.530000000000001 110.418 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 t -58.7 -52.09 67.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.061 -0.518 . . . . 73.209999999999994 109.736 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -62.33 -40.36 96.09 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.343 -0.389 . . . . 72.010000000000005 111.108 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.467 HD12 HD13 ' A' ' 66' ' ' LEU . 64.9 mt -52.66 -55.76 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.769 0.319 . . . . 75.129999999999995 110.379 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -68.96 -29.82 68.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 75.299999999999997 110.777 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -68.34 -33.91 75.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 63.329999999999998 111.368 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.508 ' OD1' HD11 ' A' ' 108' ' ' LEU . 66.0 m-80 -98.49 -24.15 15.26 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.119 0.415 . . . . 62.240000000000002 112.119 -175.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 123' ' ' ILE . 61.6 mt -71.49 -59.5 3.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.951 0.405 . . . . 72.219999999999999 110.153 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.726 -0.67 . . . . 71.030000000000001 110.434 -177.713 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 91.4 mmm . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 121.12 0.486 . . . . 73.530000000000001 110.498 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.5 mm -83.37 105.86 13.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.651 -0.704 . . . . 75.129999999999995 109.131 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -78.25 161.48 27.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 62.350000000000001 109.994 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.688 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 10.1 pt20 -137.21 133.13 34.8 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.858 0.361 . . . . 74.140000000000001 110.924 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 32.6 pt -144.69 179.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.169 -0.469 . . . . 65.319999999999993 110.984 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.562 ' HA3' HD12 ' A' ' 81' ' ' ILE . . . -117.96 -165.54 13.53 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.131 -0.486 . . . . 72.430000000000007 112.02 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.426 ' H ' ' HB3' ' A' ' 84' ' ' ASN . 6.8 t70 -67.67 -51.28 51.57 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.693 0.397 . . . . 65.310000000000002 110.687 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 m -56.16 -24.79 43.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.879 -0.6 . . . . 74.239999999999995 110.754 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 42.6 mt-10 -95.07 -31.25 13.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.784 -0.644 . . . . 72.239999999999995 110.421 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.487 ' HA ' HD12 ' A' ' 26' ' ' ILE . 92.8 t80 -50.14 -61.91 1.88 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.968 -0.56 . . . . 64.319999999999993 111.843 -171.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 36' ' ' THR . 8.4 t70 -53.56 -56.44 17.05 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 123.382 0.426 . . . . 72.219999999999999 110.516 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 37' ' ' SER . 5.9 m-20 -54.09 -57.3 11.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 73.400000000000006 111.509 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 75.5 mmtt -56.43 -38.79 72.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.848 0.356 . . . . 73.310000000000002 110.33 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.495 ' HA ' HD12 ' A' ' 44' ' ' ILE . 3.9 t -66.79 -54.81 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.93 -0.577 . . . . 73.319999999999993 111.915 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 32' ' ' ASP . 9.4 t -76.51 -7.48 55.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.699 0.285 . . . . 73.0 111.039 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 22.6 t -74.58 -5.0 40.37 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.392 -0.367 . . . . 65.549999999999997 111.667 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.1 m -57.11 96.35 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 110.165 -0.309 . . . . 65.299999999999997 110.165 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -51.11 -44.63 61.33 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.502 0.501 . . . . 61.5 111.24 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -155.78 121.39 4.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.697 0.284 . . . . 75.329999999999998 110.981 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 41.89 24.9 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.547 1.314 . . . . 73.209999999999994 114.547 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.8 mm -70.09 100.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.475 -0.565 . . . . 62.130000000000003 109.475 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.78 114.88 6.74 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.239 0.542 . . . . 72.209999999999994 110.333 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 35' ' ' VAL . 34.9 mt -104.05 120.5 54.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.299 -0.864 . . . . 74.109999999999999 110.833 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.507 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.5 mp -105.13 110.87 23.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.11 -0.7 . . . . 45.229999999999997 109.11 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 61.1 t -95.55 110.16 23.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.525 -0.176 . . . . 73.019999999999996 110.525 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.439 ' CG ' ' HZ2' ' A' ' 78' ' ' LYS . 2.1 p-10 -91.08 129.65 37.06 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.291 0.567 . . . . 43.509999999999998 110.656 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 108.388 -0.967 . . . . 54.32 108.388 170.423 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.946 0.403 . . . . 70.409999999999997 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.622 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 46.0 t -74.89 -39.09 61.69 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.666 0.746 . . . . 62.420000000000002 110.583 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.523 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.3 mm? -52.88 -45.72 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.113 -0.949 . . . . 72.209999999999994 111.989 -175.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 32.3 mt-10 -59.01 -58.57 18.56 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 119.133 -0.46 . . . . 75.239999999999995 111.58 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.78 -40.53 84.4 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 121.81 1.673 . . . . 73.530000000000001 112.165 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.1 mt-30 -58.28 -46.49 85.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.145 0.497 . . . . 71.549999999999997 110.427 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 81.8 mt -69.65 -28.45 65.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.86 -0.609 . . . . 62.130000000000003 110.6 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 44.6 mt-10 -63.78 -44.22 94.01 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.575 -0.528 . . . . 73.239999999999995 109.575 175.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -63.32 -49.93 72.03 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.394 -0.366 . . . . 63.520000000000003 110.211 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.455 HD11 HD11 ' A' ' 116' ' ' ILE . 28.1 mt -60.56 -32.95 72.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.455 . . . . 63.329999999999998 110.465 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.28 -50.36 70.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.52 -0.548 . . . . 64.5 109.52 176.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.3 mt-30 -57.78 -39.16 76.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.249 0.547 . . . . 75.519999999999996 110.734 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -70.05 -45.39 67.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.259 -0.882 . . . . 71.120000000000005 111.249 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -104.58 5.02 33.49 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.874 -0.603 . . . . 65.319999999999993 112.373 -171.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.6 t -52.88 -19.85 2.86 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.223 0.824 . . . . 75.219999999999999 113.223 -169.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.12 -37.36 84.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.008 0.432 . . . . 54.310000000000002 110.63 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -124.0 -2.83 8.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.771 -0.649 . . . . 71.530000000000001 111.639 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -127.07 136.88 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.184 0.516 . . . . 54.240000000000002 112.209 -173.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 20.6 mmtt -146.1 127.23 14.69 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.345 -0.843 . . . . 62.350000000000001 109.538 173.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 76' ' ' ILE . 3.3 mp -99.23 137.91 25.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.692 -0.485 . . . . 73.140000000000001 109.692 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 71.8 m-85 -123.83 144.45 49.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.286 -0.415 . . . . 75.140000000000001 110.031 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.439 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 3.1 ttmp? -121.47 137.96 54.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.885 -0.598 . . . . 65.030000000000001 110.05 -177.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.475 HD11 ' HA ' ' A' ' 85' ' ' GLN . 12.4 tt -70.34 117.36 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.884 -0.413 . . . . 64.409999999999997 109.884 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.688 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 22.9 t-20 -113.9 -50.33 2.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.175 -0.466 . . . . 75.040000000000006 111.71 -173.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.562 HD12 ' HA3' ' A' ' 27' ' ' GLY . 52.1 mt -66.47 106.69 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 121.052 0.453 . . . . 73.239999999999995 110.861 -175.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -49.19 -40.87 34.98 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.961 -1.018 . . . . 71.25 112.907 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -71.38 -25.65 62.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.986 0.422 . . . . 53.439999999999998 110.9 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.447 ' N ' HD22 ' A' ' 84' ' ' ASN . 0.9 OUTLIER -90.43 30.63 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.876 -0.602 . . . . 74.430000000000007 110.927 -173.184 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.475 ' HA ' HD11 ' A' ' 79' ' ' ILE . 32.4 tt0 -70.5 -12.81 61.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.74 -0.664 . . . . 64.319999999999993 110.976 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.412 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 15.7 m-20 -49.81 -30.07 9.05 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.86 -0.609 . . . . 73.140000000000001 112.469 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -52.61 -39.3 29.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.101 0.476 . . . . 72.120000000000005 110.379 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.86 -49.24 75.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.813 -0.63 . . . . 72.510000000000005 110.267 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -61.29 -41.38 96.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.648 -0.705 . . . . 65.420000000000002 111.077 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.1 mm100 -70.78 -44.69 66.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.002 -0.545 . . . . 73.340000000000003 111.454 -174.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -87.44 -9.66 54.05 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.416 -0.356 . . . . 73.400000000000006 111.594 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.31 55.68 5.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.801 -0.714 . . . . 21.129999999999999 112.584 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.0 t -81.09 98.82 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.203 -0.666 . . . . 70.019999999999996 109.203 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t -60.38 -58.83 6.83 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.012 -0.54 . . . . 74.109999999999999 110.913 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.99 136.28 45.93 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.227 -0.657 . . . . 45.25 109.227 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.432 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 72.9 mt -51.8 -54.36 40.99 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 123.389 0.43 . . . . 73.530000000000001 111.874 -176.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 96' ' ' ILE . 41.6 Cg_endo -65.37 87.58 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.614 1.542 . . . . 61.43 111.866 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 112' ' ' ILE . 56.4 m -151.77 143.02 23.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.737 -0.665 . . . . 72.219999999999999 110.09 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 99' ' ' ILE . 2.5 mp -109.83 114.05 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.848 -0.426 . . . . 64.400000000000006 109.848 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.1 mp -95.83 124.91 40.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 109.756 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.42 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 61.8 mtp -93.25 143.72 25.99 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.682 -0.488 . . . . 73.230000000000004 109.682 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.465 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.0 m-85 -146.92 158.17 43.84 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.673 -0.491 . . . . 72.109999999999999 109.673 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -151.21 105.15 3.18 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.943 -0.303 . . . . 61.509999999999998 111.164 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 56.6 44.22 24.3 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.363 0.601 . . . . 74.430000000000007 110.381 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.5 -16.51 7.75 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.82 -0.627 . . . . 61.409999999999997 112.752 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 14.0 tmtt? -79.66 139.78 37.28 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.45 -0.574 . . . . 73.120000000000005 109.45 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -68.97 136.74 52.98 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 122.104 0.954 . . . . 72.329999999999998 112.302 -174.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -133.36 168.22 18.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.623 -1.626 . . . . 33.119999999999997 107.794 -175.161 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 m -70.27 -178.77 1.78 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.312 0.486 . . . . 40.009999999999998 112.312 -167.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -138.44 121.83 17.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.513 -0.312 . . . . 72.310000000000002 110.497 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.1 t -97.87 107.41 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.83 -0.433 . . . . 73.329999999999998 109.83 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.564 ' HA ' HG23 ' A' ' 98' ' ' THR . 64.7 mt -80.15 135.25 25.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.364 -0.38 . . . . 71.0 110.509 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.5 -137.64 15.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.995 -0.622 . . . . 72.030000000000001 111.846 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.523 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -144.6 76.76 1.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 74.120000000000005 110.375 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.447 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.3 t70 -117.3 103.36 10.08 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.128 -0.487 . . . . 61.450000000000003 109.991 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.482 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -63.34 -36.74 77.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 64.129999999999995 110.382 -174.001 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -63.49 -42.94 98.54 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.249 -0.432 . . . . 52.32 110.151 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -66.06 -41.16 91.17 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.363 -0.38 . . . . 54.240000000000002 110.198 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 115' ' ' ASP . 69.1 mt -59.81 -56.35 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.443 -0.344 . . . . 63.009999999999998 111.048 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.1 tt -62.73 -33.97 62.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 120.818 0.342 . . . . 62.039999999999999 110.339 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 t -55.75 -51.66 66.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.86 -0.609 . . . . 74.140000000000001 109.596 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -62.01 -40.86 97.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 71.219999999999999 110.891 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 119' ' ' ILE . 73.0 mt -56.04 -55.85 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.663 0.268 . . . . 71.319999999999993 110.934 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -71.67 -29.42 64.58 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.803 -0.359 . . . . 74.109999999999999 110.77 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -68.24 -39.96 82.15 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.031 0.443 . . . . 73.25 111.022 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -90.06 -24.84 21.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.919 -0.582 . . . . 73.0 111.29 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.7 mt -77.75 -54.15 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.757 0.313 . . . . 51.439999999999998 110.795 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.569 -0.729 . . . . 75.519999999999996 110.313 -176.471 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.435 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 94.0 mmm . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 120.888 0.375 . . . . 74.099999999999994 110.379 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.452 HG12 ' HG2' ' A' ' 64' ' ' GLU . 24.6 mm -87.55 119.69 35.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.785 -0.643 . . . . 55.539999999999999 109.471 177.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 154.0 18.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.97 0.414 . . . . 72.109999999999999 111.213 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -110.63 141.77 43.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.899 -0.591 . . . . 73.349999999999994 110.216 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.536 HG21 ' HG3' ' A' ' 34' ' ' LYS . 34.7 pt -140.31 161.26 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.902 0.382 . . . . 65.120000000000005 110.978 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.38 169.18 37.4 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.825 -0.625 . . . . 34.130000000000003 111.954 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.831 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 18.2 t70 -57.04 -42.43 80.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.116 0.484 . . . . 74.540000000000006 110.763 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.3 t -72.29 -16.19 61.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 65.129999999999995 110.924 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 11.1 mm-40 -83.16 -24.41 32.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 74.510000000000005 111.845 -176.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 35' ' ' VAL . 88.7 t80 -45.33 -61.94 1.46 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.559 0.577 . . . . 71.420000000000002 112.559 -170.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.91 -46.11 91.95 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.727 0.298 . . . . 72.310000000000002 110.653 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -48.37 -57.14 6.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 64.329999999999998 110.588 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 9.8 mmpt? -64.62 -49.64 70.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 44.329999999999998 110.11 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.556 HG12 ' HA2' ' A' ' 105' ' ' GLY . 95.5 t -62.18 -36.8 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.735 -0.666 . . . . 62.119999999999997 111.839 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -77.76 -47.03 19.97 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.838 0.31 . . . . 65.109999999999999 111.838 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.2 p -77.15 11.03 2.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.273 0.842 . . . . 60.329999999999998 113.273 -171.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.517 ' HB3' HD11 ' A' ' 44' ' ' ILE . 24.9 p -76.78 79.93 3.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.289 . . . . 62.329999999999998 111.686 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.9 t30 32.28 -94.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.147 0.979 . . . . 73.310000000000002 112.763 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -161.72 140.34 9.49 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.789 -0.449 . . . . 60.32 109.789 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 53.19 21.04 2.04 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.223 0.609 . . . . 73.209999999999994 112.474 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 103' ' ' LYS . 47.9 mm -75.68 128.84 37.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 120.784 0.326 . . . . 64.219999999999999 110.481 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -84.76 111.12 19.31 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.013 -0.736 . . . . 61.399999999999999 109.013 178.454 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.517 HD11 ' HB3' ' A' ' 38' ' ' CYS . 52.9 mt -106.84 129.12 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.971 -0.559 . . . . 73.439999999999998 110.932 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.544 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.9 mp -113.97 109.73 18.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.101 -0.703 . . . . 75.140000000000001 109.101 174.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 77' ' ' TYR . 48.7 t -101.54 104.84 16.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.951 -0.388 . . . . 72.420000000000002 109.951 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 17.8 t70 -85.26 146.6 26.98 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.068 0.461 . . . . 74.219999999999999 109.878 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.4 t80 . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 115.784 -0.644 . . . . 73.310000000000002 111.495 -173.439 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.565 ' HD3' ' N ' ' A' ' 58' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 111.74 0.274 . . . . 72.239999999999995 111.74 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.565 ' N ' ' HD3' ' A' ' 57' ' ' ARG . 20.2 m -75.87 -30.63 58.93 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.569 0.699 . . . . 70.25 110.935 173.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.525 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.5 mm? -66.2 -42.58 88.62 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.479 -0.782 . . . . 74.120000000000005 112.522 -173.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.647 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 3.0 mp0 -49.72 -57.52 11.97 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 118.697 0.681 . . . . 72.340000000000003 110.255 177.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.647 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 23.2 Cg_exo -55.43 -55.5 3.04 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.885 1.723 . . . . 65.120000000000005 112.327 175.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.5 mt-30 -51.33 -49.7 60.88 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.175 0.435 . . . . 71.219999999999999 112.175 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.73 -40.54 76.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.875 -0.602 . . . . 73.439999999999998 111.058 -173.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 32.4 mt-10 -64.05 -34.84 78.93 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.881 -0.328 . . . . 65.019999999999996 110.307 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -62.54 -54.99 31.62 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.176 0.513 . . . . 73.340000000000003 110.04 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.4 mt -62.08 -32.95 73.54 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.849 -0.614 . . . . 62.140000000000001 109.928 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -61.93 -40.74 96.56 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.993 -0.549 . . . . 62.399999999999999 109.933 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.0 mt-30 -64.28 -45.45 87.96 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.885 0.374 . . . . 74.430000000000007 110.66 177.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -65.89 -38.18 88.07 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.962 -0.563 . . . . 62.520000000000003 111.225 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -104.63 4.58 32.88 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 112.242 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.0 t -53.23 -19.91 3.59 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.07 0.767 . . . . 74.150000000000006 113.07 -169.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.66 -34.54 75.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 74.319999999999993 110.824 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -123.37 -20.41 5.63 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.796 -0.638 . . . . 72.25 111.612 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.14 128.25 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.946 0.403 . . . . 63.420000000000002 112.051 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.515 ' HB3' ' HZ2' ' A' ' 75' ' ' LYS . 2.2 mmmp? -131.69 138.22 48.6 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.99 -0.744 . . . . 61.310000000000002 108.99 173.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.544 HG12 ' HB2' ' A' ' 45' ' ' LEU . 60.6 mt -118.09 114.38 45.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.011 0.434 . . . . 74.540000000000006 110.655 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.503 ' HB2' HG22 ' A' ' 46' ' ' VAL . 56.7 m-85 -101.45 163.99 11.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 72.319999999999993 109.809 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 20.5 ttmm -139.16 138.09 36.64 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.869 0.366 . . . . 71.120000000000005 111.279 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.486 HD11 ' O ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -126.57 100.8 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.472 -0.936 . . . . 73.439999999999998 108.472 174.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -124.47 7.63 8.33 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.045 -0.525 . . . . 72.310000000000002 112.033 -172.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 57.5 mt -76.47 112.44 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.273 -0.269 . . . . 70.340000000000003 110.273 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.75 -31.19 70.53 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.839 0.352 . . . . 44.439999999999998 111.331 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.29 -23.29 61.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.161 0.505 . . . . 72.329999999999998 110.957 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.831 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 33.5 m-80 -123.92 91.94 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 55.049999999999997 110.509 -174.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -140.25 14.63 2.41 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.537 0.569 . . . . 61.350000000000001 112.537 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.67 -44.77 63.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.206 0.527 . . . . 74.340000000000003 110.043 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.59 -38.92 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.272 -0.877 . . . . 73.219999999999999 110.897 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.99 -41.06 91.58 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.213 0.53 . . . . 62.149999999999999 110.269 -175.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.1 m -72.25 -35.91 68.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.51 -0.768 . . . . 62.229999999999997 110.932 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -68.55 -45.96 70.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.473 -0.33 . . . . 74.099999999999994 111.841 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -86.86 -23.54 25.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.617 0.229 . . . . 62.5 111.617 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.49 80.38 1.51 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.717 -0.754 . . . . 72.120000000000005 113.062 173.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.4 t -99.63 138.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.271 -0.641 . . . . 61.219999999999999 109.271 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.4 m -141.49 18.29 2.21 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.997 0.369 . . . . 75.230000000000004 111.997 -174.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.87 152.53 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.652 -0.249 . . . . 51.229999999999997 110.444 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.685 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 60.1 mt -59.68 -50.03 88.93 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.416 -0.356 . . . . 51.240000000000002 110.526 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.685 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 73.1 Cg_endo -95.37 112.67 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.695 2.264 . . . . 72.439999999999998 111.061 169.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.426 HG23 HD13 ' A' ' 112' ' ' ILE . 54.8 m -145.82 118.68 8.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.005 -0.369 . . . . 55.310000000000002 110.005 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.534 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.5 mp -109.7 110.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.316 -0.402 . . . . 62.32 110.129 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.0 mp -90.21 123.31 33.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.767 -0.827 . . . . 75.530000000000001 108.767 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.441 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 45.2 mtp -101.0 145.43 28.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.851 -0.426 . . . . 74.400000000000006 109.851 -176.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.466 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 97.1 m-85 -148.22 160.81 42.56 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.354 -0.609 . . . . 74.549999999999997 109.354 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 39.3 ttpt -143.93 114.34 7.52 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.917 -0.313 . . . . 75.200000000000003 110.596 175.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.5 t30 62.19 25.68 15.38 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.536 0.684 . . . . 72.129999999999995 109.711 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.556 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 84.61 -14.41 47.13 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.699 -0.682 . . . . 73.040000000000006 111.965 -176.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -69.33 142.31 54.06 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.832 -0.433 . . . . 74.200000000000003 109.832 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -58.3 150.93 20.68 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 124.1 0.875 . . . . 64.219999999999999 111.097 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -162.36 168.74 21.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.909 -1.042 . . . . 74.010000000000005 108.995 -169.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -70.19 167.71 17.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.384 0.611 . . . . 63.149999999999999 112.356 -167.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -130.48 118.57 21.32 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.81 -0.632 . . . . 70.530000000000001 109.945 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.534 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.0 t -86.8 119.43 34.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 74.430000000000007 110.29 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 98' ' ' THR . 50.0 mm -100.13 102.47 13.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.222 -0.445 . . . . 74.340000000000003 110.2 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.482 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 107.46 166.25 21.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.267 -0.492 . . . . 34.229999999999997 112.217 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.525 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -80.79 72.2 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.863 0.363 . . . . 64.120000000000005 111.107 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 61.2 t0 -112.07 92.88 4.19 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.374 0.607 . . . . 64.019999999999996 110.185 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.494 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -59.22 -34.97 55.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.276 -0.875 . . . . 75.540000000000006 110.153 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.6 t -62.68 -46.21 89.2 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.077 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.473 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -65.29 -42.96 92.6 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.859 -0.61 . . . . 74.099999999999994 109.937 -179.316 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 123' ' ' ILE . 74.0 mt -57.22 -56.14 16.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 115.419 -0.81 . . . . 71.140000000000001 111.098 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.2 tt -65.4 -35.21 74.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 121.063 -0.255 . . . . 74.219999999999999 110.788 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 t -56.72 -52.05 66.47 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.103 -0.499 . . . . 75.319999999999993 110.027 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -70.46 -31.63 68.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 65.299999999999997 111.477 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 119' ' ' ILE . 62.0 mt -57.34 -56.52 14.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.686 -0.406 . . . . 70.549999999999997 110.229 176.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -69.8 -32.82 71.48 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.757 -0.377 . . . . 74.25 110.21 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -62.06 -49.67 75.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.137 -0.483 . . . . 64.430000000000007 111.153 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -86.98 -20.24 27.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 112.219 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.9 mt -78.62 -52.76 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.853 -0.339 . . . . 72.239999999999995 110.619 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.536 -0.745 . . . . 70.200000000000003 110.288 -177.392 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 80.1 mmm . . . . . 0 C--O 1.235 0.321 0 N-CA-C 108.227 -1.027 . . . . 62.109999999999999 108.227 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.581 HG21 ' NZ ' ' A' ' 78' ' ' LYS . 17.2 mm -54.99 107.79 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.642 -1.163 . . . . 53.130000000000003 109.222 174.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' HB3' ' CD1' ' A' ' 77' ' ' TYR . 35.9 tt0 -76.26 112.22 12.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.353 0.597 . . . . 64.319999999999993 110.62 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -70.16 127.22 32.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.043 -0.981 . . . . 72.239999999999995 110.873 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.52 HG21 ' HG3' ' A' ' 34' ' ' LYS . 44.3 pt -136.27 159.04 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.04 0.447 . . . . 71.129999999999995 111.274 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.96 176.29 30.58 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.973 -0.558 . . . . 74.120000000000005 112.232 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' CB ' ' HB3' ' A' ' 84' ' ' ASN . 16.9 t70 -55.29 -38.38 68.54 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.157 0.583 . . . . 61.5 111.346 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -84.48 -8.65 58.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 75.140000000000001 112.132 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -94.37 -12.94 26.92 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.267 0.469 . . . . 74.219999999999999 112.267 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.428 ' O ' HG23 ' A' ' 35' ' ' VAL . 31.1 m-85 -50.2 -61.79 1.96 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.29 0.478 . . . . 74.150000000000006 112.29 -175.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.08 -36.58 80.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.461 -0.336 . . . . 70.299999999999997 110.544 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.48 -57.3 13.26 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.699 0.761 . . . . 74.209999999999994 109.075 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.674 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 10.2 mmpt? -62.52 -39.17 92.67 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.363 -1.29 . . . . 62.310000000000002 111.01 -172.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 31' ' ' PHE . 96.7 t -66.34 -49.8 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.909 -0.587 . . . . 75.209999999999994 110.329 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -67.85 -17.93 64.65 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 111.711 0.263 . . . . 65.420000000000002 111.711 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -66.27 -8.88 27.62 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.962 0.356 . . . . 72.420000000000002 111.962 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.725 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.8 t -60.72 117.36 5.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.726 0.298 . . . . 71.439999999999998 110.823 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.65 -50.95 12.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 72.230000000000004 110.66 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -161.67 121.9 2.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.331 -0.395 . . . . 62.119999999999997 111.21 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 51.42 16.01 0.38 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.263 0.838 . . . . 50.520000000000003 113.263 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.724 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 44.5 mm -70.1 104.48 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.629 -0.508 . . . . 72.230000000000004 109.629 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.06 108.04 8.69 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.526 -0.761 . . . . 74.109999999999999 109.032 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.482 HG23 ' CE2' ' A' ' 77' ' ' TYR . 76.0 mt -100.31 113.58 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.965 -1.016 . . . . 72.239999999999995 110.814 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.0 mp -105.24 142.75 34.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.731 -0.668 . . . . 74.329999999999998 109.291 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 77' ' ' TYR . 57.6 t -129.96 109.44 17.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.391 -0.596 . . . . 75.140000000000001 109.391 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -90.54 143.83 26.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.072 0.463 . . . . 75.450000000000003 110.111 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.2 t80 . . . . . 0 C--N 1.322 -0.622 0 N-CA-C 108.954 -0.758 . . . . 70.140000000000001 108.954 177.582 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.434 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 53.9 ttt-85 . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.724 0.297 . . . . 70.030000000000001 111.095 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.575 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 15.2 m -65.11 -34.36 78.22 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.736 0.779 . . . . 72.340000000000003 110.905 -177.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.46 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.2 mm? -65.65 -24.14 66.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.364 -0.835 . . . . 64.239999999999995 111.623 -175.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.439 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 40.7 tt0 -62.69 -63.69 3.89 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 120.578 -0.449 . . . . 63.350000000000001 109.842 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.439 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 31.0 Cg_endo -63.44 -31.64 71.92 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.724 1.616 . . . . 53.130000000000003 112.541 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 58' ' ' SER . 28.0 mt-30 -66.52 -52.94 40.42 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.38 -0.528 . . . . 60.219999999999999 111.687 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.95 -35.26 80.1 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.176 -0.305 . . . . 74.219999999999999 110.176 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.498 ' OE1' HG12 ' A' ' 23' ' ' ILE . 5.2 mm-40 -59.92 -42.92 94.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.877 -0.601 . . . . 65.519999999999996 110.811 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -59.31 -55.14 38.54 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.334 0.588 . . . . 75.129999999999995 109.892 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.6 mt -59.47 -33.63 71.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.028 -0.987 . . . . 63.130000000000003 110.102 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.574 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.7 -44.73 92.8 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.82 -0.627 . . . . 64.019999999999996 110.105 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 51.8 mt-30 -63.82 -47.12 82.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.087 -0.506 . . . . 72.150000000000006 111.134 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -69.42 -41.37 76.44 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.216 -0.447 . . . . 61.229999999999997 111.614 -175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -102.72 5.72 39.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.641 0.608 . . . . 72.420000000000002 112.641 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.35 -19.42 2.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.189 0.811 . . . . 62.43 113.189 -169.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.88 -42.3 93.47 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.599 0.238 . . . . 70.430000000000007 110.771 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -128.03 -2.84 5.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.377 -0.374 . . . . 73.040000000000006 111.886 -175.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.9 t -112.36 131.94 62.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.923 0.392 . . . . 74.439999999999998 110.821 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -135.65 120.12 18.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.773 -0.649 . . . . 64.120000000000005 110.201 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.521 HD13 ' HB2' ' A' ' 67' ' ' ALA . 3.6 mp -106.32 137.34 37.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.65 -0.5 . . . . 74.299999999999997 109.65 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.541 ' CE1' ' HD3' ' A' ' 34' ' ' LYS . 76.0 m-85 -131.3 165.77 22.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 72.239999999999995 109.993 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' NZ ' HG21 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -158.16 166.72 31.73 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.158 0.504 . . . . 52.420000000000002 110.91 169.549 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 tp -73.0 147.51 9.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.077 -0.965 . . . . 61.240000000000002 112.211 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -108.05 -58.32 2.0 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.402 -0.817 . . . . 61.530000000000001 110.452 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.1 mt -70.58 105.43 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.992 0.425 . . . . 63.310000000000002 111.235 -173.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -56.3 -33.9 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.674 -0.694 . . . . 74.239999999999995 111.2 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -87.83 2.67 50.78 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.193 -0.458 . . . . 73.439999999999998 111.466 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.429 ' HB3' ' CB ' ' A' ' 28' ' ' ASP . 11.2 m120 -139.38 90.18 2.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.034 0.445 . . . . 73.319999999999993 110.263 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -117.94 13.59 14.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.486 -0.779 . . . . 73.340000000000003 109.418 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 32.7 t70 -49.52 -50.97 39.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.432 -0.804 . . . . 73.439999999999998 110.943 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.2 t -53.15 -37.75 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.655 -0.702 . . . . 73.049999999999997 110.871 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.38 -43.9 84.59 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.294 0.569 . . . . 74.439999999999998 109.828 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.2 m -66.65 -30.1 70.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.489 -0.778 . . . . 61.109999999999999 110.686 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 18.5 mm-40 -74.13 -41.65 61.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.893 -0.594 . . . . 73.140000000000001 111.089 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -74.51 -31.34 62.13 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 111.718 0.266 . . . . 74.439999999999998 111.718 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.53 43.58 0.26 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.286 -0.959 . . . . 73.450000000000003 113.781 172.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.2 t -90.55 107.38 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.569 -0.53 . . . . 64.019999999999996 109.569 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 t -135.2 21.15 3.44 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.203 0.525 . . . . 70.040000000000006 110.551 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.66 168.47 19.21 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.065 -0.516 . . . . 72.230000000000004 110.05 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.754 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 48.0 mm -67.86 -53.04 22.37 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.56 -0.291 . . . . 74.010000000000005 110.646 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.754 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 58.6 Cg_endo -102.75 107.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 123.1 2.533 . . . . 73.109999999999999 111.834 172.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.5 m -132.14 118.92 20.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.791 -0.186 . . . . 61.43 110.798 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.8 mp -110.48 115.25 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 110.262 -0.273 . . . . 74.329999999999998 110.262 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.59 137.3 32.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.399 -0.593 . . . . 60.240000000000002 109.399 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.409 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 51.6 mtp -115.92 143.48 45.37 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.817 0.28 . . . . 72.010000000000005 110.429 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -142.78 152.86 42.71 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.267 -0.642 . . . . 71.430000000000007 109.267 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -143.49 107.49 4.71 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.508 -0.477 . . . . 73.129999999999995 111.597 176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.725 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 10.5 t30 53.0 36.2 21.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.48 0.657 . . . . 74.319999999999993 111.584 174.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.41 -16.63 55.63 Favored Glycine 0 N--CA 1.454 -0.117 0 CA-C-N 115.759 -0.655 . . . . 63.130000000000003 112.644 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -81.6 145.17 30.75 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.363 -0.606 . . . . 73.120000000000005 109.363 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -61.86 160.5 11.95 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.516 0.674 . . . . 51.119999999999997 110.826 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.409 ' HB3' ' C ' ' A' ' 101' ' ' MET . 0.2 OUTLIER -162.28 167.36 24.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.364 -1.347 . . . . 74.450000000000003 107.364 -168.509 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.404 ' H ' HD13 ' A' ' 108' ' ' LEU . 73.1 m -70.96 178.29 3.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.958 0.885 . . . . 34.140000000000001 112.687 -165.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -140.84 118.44 11.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.854 -1.067 . . . . 73.150000000000006 108.912 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 42.5 t -93.81 107.12 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.171 0.51 . . . . 75.230000000000004 110.02 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.1 mt -92.72 107.31 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.623 -0.717 . . . . 74.140000000000001 109.471 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.615 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 110.97 158.44 15.49 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.46 -0.656 . . . . 52.520000000000003 111.46 -175.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.46 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -81.92 78.53 8.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.721 0.296 . . . . 64.109999999999999 110.844 -178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.413 ' O ' HG13 ' A' ' 119' ' ' ILE . 19.3 m-20 -117.1 80.96 1.56 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.079 0.466 . . . . 70.420000000000002 110.048 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.428 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -59.11 -32.09 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.773 -0.648 . . . . 72.430000000000007 109.799 -177.195 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.8 m -58.36 -50.0 75.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.91 -0.587 . . . . 41.039999999999999 110.39 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -69.45 -35.8 76.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.219 -0.446 . . . . 75.25 110.313 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 123' ' ' ILE . 76.4 mt -58.33 -56.39 16.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.188 -0.46 . . . . 72.040000000000006 110.513 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.31 -34.74 71.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.129 -0.487 . . . . 74.049999999999997 110.346 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.5 t -57.06 -49.72 74.98 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.153 -0.476 . . . . 72.150000000000006 109.787 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -62.31 -38.54 89.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.476 -0.329 . . . . 63.229999999999997 110.573 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 119' ' ' ILE . 58.3 mt -57.62 -56.5 15.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.672 0.272 . . . . 64.230000000000004 110.938 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -71.33 -25.16 62.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.761 0.315 . . . . 74.200000000000003 110.626 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.48 -44.11 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 73.150000000000006 111.132 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -93.0 -18.06 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 73.200000000000003 111.975 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.5 mt -76.78 -53.28 15.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 120.929 0.395 . . . . 74.310000000000002 110.054 173.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.377 -0.821 . . . . 75.420000000000002 110.392 -178.664 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.1 mmm . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.61 0.243 . . . . 74.209999999999994 110.664 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.521 HG12 ' OE2' ' A' ' 64' ' ' GLU . 12.9 mm -69.73 97.61 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 109.653 -0.499 . . . . 72.25 109.653 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.8 124.11 24.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 75.530000000000001 110.81 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -90.72 128.98 36.85 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.687 -0.486 . . . . 72.329999999999998 109.687 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 39.9 pt -141.77 179.85 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.12 -0.491 . . . . 61.539999999999999 110.735 -176.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.2 -177.74 15.15 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.643 -0.983 . . . . 75.439999999999998 110.643 171.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 13.3 t70 -52.73 -43.12 65.51 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.856 0.36 . . . . 75.439999999999998 110.973 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 p -63.17 -24.01 67.7 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.013 -0.54 . . . . 72.420000000000002 112.26 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 16.8 mp0 -96.99 -32.39 12.03 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.761 -0.199 . . . . 71.209999999999994 111.117 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.461 ' HA ' HD12 ' A' ' 26' ' ' ILE . 85.0 t80 -41.24 -61.8 0.96 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.002 0.742 . . . . 74.540000000000006 113.002 -166.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.4 -50.27 65.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.715 0.293 . . . . 75.409999999999997 111.116 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -60.36 -51.56 68.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.031 -0.531 . . . . 65.439999999999998 110.734 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.45 ' HG3' HG21 ' A' ' 26' ' ' ILE . 70.7 mmtt -59.45 -36.66 76.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.812 -0.631 . . . . 65.120000000000005 111.049 -176.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.3 -54.66 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.13 -0.487 . . . . 55.340000000000003 111.309 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.8 p -62.92 -25.65 68.43 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.564 0.221 . . . . 63.310000000000002 111.559 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.6 t -75.35 5.51 5.6 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.589 -0.278 . . . . 73.409999999999997 111.674 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 24.4 p -62.52 140.83 58.63 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.875 -0.417 . . . . 44.530000000000001 109.875 175.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -58.41 -83.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.556 -0.293 . . . . 61.310000000000002 110.837 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -161.95 152.54 17.44 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.082 -0.71 . . . . 73.5 109.082 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.9 p30 45.84 22.07 0.11 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.702 0.801 . . . . 75.140000000000001 112.685 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 mm -81.95 127.25 39.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 120.607 0.241 . . . . 75.310000000000002 110.427 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.9 tp -88.43 108.59 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.143 0.497 . . . . 63.520000000000003 110.041 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 38' ' ' CYS . 57.4 mt -101.33 114.36 40.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.652 -0.704 . . . . 72.5 110.366 178.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 mp -99.04 118.77 36.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.182 -0.673 . . . . 70.129999999999995 109.182 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 67.0 t -104.34 105.02 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 110.002 -0.37 . . . . 54.32 110.002 175.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.81 156.53 20.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.95 0.405 . . . . 74.400000000000006 110.526 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.3 t80 . . . . . 0 C--N 1.327 -0.401 0 N-CA-C 109.118 -0.697 . . . . 74.310000000000002 109.118 174.469 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' A' ' 57' ' ' ARG . 2.3 tmt_? . . . . . 0 C--O 1.223 -0.309 0 CA-C-O 120.487 0.184 . . . . 75.450000000000003 110.637 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.622 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 16.6 m -75.67 -57.12 4.07 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.484 0.659 . . . . 62.43 111.388 175.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.43 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.2 mm? -60.57 -42.55 96.86 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.498 -0.774 . . . . 74.530000000000001 112.625 -168.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.1 -59.18 12.52 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 117.917 0.326 . . . . 64.409999999999997 111.226 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.4 -33.24 58.83 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.678 1.585 . . . . 65.439999999999998 112.691 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.6 mt-30 -59.46 -45.85 90.44 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.021 -0.672 . . . . 75.310000000000002 110.7 173.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 84.5 mt -62.7 -43.74 98.02 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.155 -0.475 . . . . 63.109999999999999 110.33 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.587 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 25.7 mm-40 -53.63 -53.25 54.51 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.053 -0.521 . . . . 70.319999999999993 110.377 174.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -51.34 -52.9 41.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.989 -0.551 . . . . 62.530000000000001 110.709 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.0 -31.69 72.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 75.140000000000001 110.694 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.648 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -71.7 -25.15 61.97 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.267 -0.424 . . . . 75.010000000000005 110.725 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 89.3 mt-30 -85.21 -37.93 19.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.992 0.425 . . . . 61.200000000000003 110.493 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -74.41 -50.54 18.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 71.209999999999994 110.936 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -90.45 5.09 49.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.553 -0.749 . . . . 74.439999999999998 112.159 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.648 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.6 t -53.04 -24.34 9.57 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.639 0.607 . . . . 63.229999999999997 112.639 -172.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -59.35 -18.79 41.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.069 0.462 . . . . 74.010000000000005 110.859 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -133.44 -29.31 1.39 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.748 -0.66 . . . . 72.230000000000004 111.365 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.425 HG23 HD11 ' A' ' 127' ' ' ILE . 66.0 t -105.49 144.36 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 112.285 0.476 . . . . 75.150000000000006 112.285 -169.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 45.6 mmtm -142.53 140.04 31.65 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.689 -0.856 . . . . 74.439999999999998 108.689 170.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mt -117.06 138.3 48.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.012 0.434 . . . . 71.329999999999998 111.027 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 57.0 m-85 -131.29 162.62 29.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.374 -0.83 . . . . 70.349999999999994 109.072 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -157.03 136.18 11.93 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.897 0.38 . . . . 75.030000000000001 110.902 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.659 HG12 HG11 ' A' ' 87' ' ' VAL . 2.3 mp -71.09 100.2 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.221 -0.659 . . . . 51.530000000000001 109.221 177.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -103.7 -1.64 27.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.761 -0.654 . . . . 64.109999999999999 109.856 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.6 mm -95.93 96.72 5.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.789 -0.642 . . . . 63.43 110.405 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.79 -22.1 63.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.939 -0.573 . . . . 75.239999999999995 110.921 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.1 -23.57 62.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.113 0.482 . . . . 72.5 110.045 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 30.3 m-80 -111.53 77.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.226 -0.657 . . . . 73.450000000000003 109.226 176.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -100.34 -21.84 15.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.683 -0.689 . . . . 73.200000000000003 111.77 -170.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.558 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 4.4 m-20 -52.26 -34.55 46.71 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.703 0.631 . . . . 74.120000000000005 112.703 -174.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.659 HG11 HG12 ' A' ' 79' ' ' ILE . 14.7 p -53.36 -39.79 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.155 0.503 . . . . 75.150000000000006 110.543 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.42 -41.13 93.9 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.876 -0.602 . . . . 62.140000000000001 110.274 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 m -62.07 -40.66 96.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.553 -0.748 . . . . 62.340000000000003 109.824 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 30.0 mm-40 -64.67 -46.5 82.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.288 -0.869 . . . . 45.049999999999997 110.988 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.43 ' HH ' ' HE2' ' A' ' 31' ' ' PHE . 82.5 m-85 -80.77 -15.54 56.17 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 121.108 -0.237 . . . . 71.239999999999995 111.383 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.18 52.48 31.72 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.059 -0.591 . . . . 64.140000000000001 112.644 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.65 112.5 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.958 0.408 . . . . 71.109999999999999 110.36 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.5 t -90.24 -55.97 3.4 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.211 -0.45 . . . . 74.319999999999993 110.641 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.62 155.88 33.14 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.172 -0.467 . . . . 72.239999999999995 110.437 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.743 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 45.1 mm -69.68 -59.77 4.38 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.669 -0.241 . . . . 73.409999999999997 110.741 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.743 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 1.9 Cg_endo -80.28 74.57 5.48 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.048 1.832 . . . . 72.049999999999997 111.098 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.7 m -113.1 124.92 53.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 70.230000000000004 110.701 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -110.06 117.5 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.41 -0.359 . . . . 34.340000000000003 110.173 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.52 HD23 ' HG3' ' A' ' 110' ' ' GLN . 86.9 mt -88.35 122.98 32.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.907 -0.775 . . . . 73.230000000000004 108.907 174.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 56.9 mtp -96.93 143.66 27.6 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.931 -0.396 . . . . 72.349999999999994 109.931 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -141.38 144.93 34.78 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.283 -0.636 . . . . 64.120000000000005 109.283 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 22.3 tptm -129.68 104.38 7.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.194 -0.299 . . . . 74.140000000000001 110.194 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.591 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 65.8 t30 46.22 46.94 13.43 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.971 0.508 . . . . 75.25 111.934 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.13 -15.51 57.97 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.401 -0.428 . . . . 73.299999999999997 113.806 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 52.6 tttp -82.84 144.57 30.01 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.622 0.369 . . . . 74.540000000000006 110.894 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -68.97 142.25 54.73 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.021 0.439 . . . . 71.010000000000005 110.098 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.58 169.05 19.18 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.126 0.971 . . . . 75.420000000000002 108.907 -169.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.8 m -69.22 173.2 5.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.529 0.681 . . . . 75.340000000000003 112.539 -162.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.52 ' HG3' HD23 ' A' ' 100' ' ' LEU . 20.0 tt0 -125.9 122.42 35.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 65.140000000000001 109.673 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.555 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.4 t -92.73 110.36 22.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.971 -0.381 . . . . 74.329999999999998 109.971 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.5 mp -94.2 122.15 45.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.74 -0.467 . . . . 64.150000000000006 109.74 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.86 146.7 20.87 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 116.32 -0.4 . . . . 75.239999999999995 112.249 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.64 77.74 1.09 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.929 0.395 . . . . 72.230000000000004 110.203 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -125.2 97.06 5.07 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.366 0.603 . . . . 62.100000000000001 109.905 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -26.42 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.33 -0.85 . . . . 71.239999999999995 109.882 -174.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.7 t -63.4 -47.21 82.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 109.881 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -65.37 -43.97 89.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.272 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.508 ' O ' HG13 ' A' ' 123' ' ' ILE . 73.8 mt -55.79 -56.26 13.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.17 -0.468 . . . . 60.039999999999999 110.663 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.1 tt -64.31 -33.83 65.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.326 -0.397 . . . . 71.239999999999995 110.422 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.4 t -57.3 -52.36 65.66 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.203 -0.453 . . . . 70.400000000000006 110.071 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.2 -37.23 86.65 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.457 -0.338 . . . . 74.439999999999998 110.411 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 119' ' ' ILE . 65.7 mt -56.42 -56.39 13.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 120.716 0.293 . . . . 61.109999999999999 111.098 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -71.52 -27.54 63.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.991 -0.284 . . . . 74.319999999999993 110.441 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -65.76 -34.55 78.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.805 0.336 . . . . 75.450000000000003 110.505 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -79.14 -42.94 25.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.316 -0.402 . . . . 61.310000000000002 111.339 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 74' ' ' VAL . 56.6 mt -69.74 -46.06 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 65.319999999999993 110.738 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.426 -0.797 . . . . 74.230000000000004 109.815 -177.329 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.3 ptm . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.984 0.421 . . . . 75.230000000000004 109.884 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.51 129.43 35.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 51.130000000000003 109.906 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -83.4 150.31 26.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.335 -0.393 . . . . 73.25 110.146 -176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -119.71 130.14 54.86 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.966 0.413 . . . . 72.129999999999995 110.652 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.9 pt -138.81 177.01 5.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.795 -0.638 . . . . 74.349999999999994 110.3 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.88 -179.06 16.46 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.163 -0.542 . . . . 61.43 112.422 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.01 -47.24 71.68 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.301 0.64 . . . . 74.200000000000003 111.173 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.9 t -75.32 -20.45 59.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.821 -0.627 . . . . 23.34 111.711 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -91.61 -8.58 46.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.432 0.158 . . . . 74.329999999999998 110.961 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -53.67 -62.5 1.61 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 111.938 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -61.24 -47.68 84.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.979 0.419 . . . . 52.119999999999997 110.872 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -55.42 -55.3 33.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.591 -0.731 . . . . 71.340000000000003 111.411 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.27 -32.17 68.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.56 -0.291 . . . . 72.120000000000005 111.563 -174.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.93 -38.6 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.805 0.336 . . . . 64.319999999999993 110.882 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.0 p -82.58 -20.6 36.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.812 0.339 . . . . 61.340000000000003 110.994 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -71.67 5.66 2.35 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.21 -0.45 . . . . 41.210000000000001 112.101 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.77 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 25.5 p -56.95 142.38 41.86 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.154 -0.313 . . . . 61.119999999999997 110.154 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -58.93 -74.46 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.572 0.225 . . . . 72.25 110.53 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -153.12 122.0 6.49 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.874 -0.417 . . . . 43.450000000000003 109.874 175.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 55.48 21.82 4.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.512 0.56 . . . . 74.120000000000005 112.512 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.77 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.0 mm -74.69 113.45 13.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 110.121 -0.326 . . . . 74.0 110.121 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.04 113.68 9.33 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.036 -0.728 . . . . 43.25 109.036 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.438 HG23 ' CD1' ' A' ' 77' ' ' TYR . 47.8 mt -106.48 114.4 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.736 -0.665 . . . . 75.239999999999995 110.9 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.44 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -92.55 154.21 18.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.266 -0.642 . . . . 71.200000000000003 109.266 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 63.0 t -132.61 104.96 8.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.459 -0.571 . . . . 65.519999999999996 109.459 176.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.577 ' CG ' ' HZ2' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -94.48 161.73 14.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.171 -0.468 . . . . 65.209999999999994 110.459 -176.207 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.8 t80 . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.742 -0.663 . . . . 70.099999999999994 110.121 168.149 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.97 0.414 . . . . 75.430000000000007 110.309 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.667 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 31.5 t -74.89 -38.14 61.94 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.438 0.637 . . . . 63.210000000000001 109.944 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.543 HD13 ' HG ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -55.68 -28.32 54.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.299 -0.864 . . . . 65.409999999999997 110.487 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.587 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 41.2 mt-10 -59.19 -67.7 0.93 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.738 -0.21 . . . . 75.129999999999995 110.776 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.587 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 32.6 Cg_endo -62.62 -28.5 77.08 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 121.518 1.478 . . . . 41.130000000000003 111.972 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.0 mt-30 -62.35 -47.3 84.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.711 -0.396 . . . . 63.340000000000003 111.646 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.543 ' HG ' HD13 ' A' ' 59' ' ' LEU . 22.1 mt -66.92 -39.98 87.53 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.962 -0.295 . . . . 64.120000000000005 110.561 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -64.58 -31.13 72.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.455 -0.338 . . . . 75.200000000000003 110.357 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.6 -53.63 48.66 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.334 0.588 . . . . 74.340000000000003 109.589 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.438 HD11 ' CD1' ' A' ' 116' ' ' ILE . 19.5 mt -61.76 -31.13 71.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.339 -0.846 . . . . 71.409999999999997 110.128 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.73 -53.54 39.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.039 -0.528 . . . . 62.119999999999997 110.11 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -61.78 -34.44 75.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.299 -0.41 . . . . 74.519999999999996 111.202 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -75.87 -40.7 54.1 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.129 -0.487 . . . . 51.25 111.101 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -104.66 5.27 33.45 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.049 0.54 . . . . 75.340000000000003 112.359 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.1 t -53.3 -18.89 2.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.37 0.507 . . . . 74.129999999999995 112.37 -173.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.15 -43.45 82.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.822 0.344 . . . . 74.439999999999998 110.441 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -129.25 8.13 5.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.939 -0.573 . . . . 64.340000000000003 111.73 -175.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t -125.81 138.42 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.008 0.432 . . . . 74.099999999999994 111.774 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 24.4 tptp -141.6 120.0 12.33 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.713 -0.676 . . . . 72.420000000000002 109.217 174.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.44 HG12 ' HB2' ' A' ' 45' ' ' LEU . 55.6 mt -96.92 141.19 16.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 120.757 0.313 . . . . 74.129999999999995 110.855 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.438 ' CD1' HG23 ' A' ' 44' ' ' ILE . 30.6 m-85 -126.13 162.44 25.35 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.614 0.766 . . . . 71.340000000000003 109.784 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 4.4 ttmp? -135.62 125.65 26.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.543 -0.54 . . . . 75.140000000000001 109.543 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.3 pt -91.4 117.83 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.948 0.404 . . . . 73.140000000000001 111.023 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.97 93.3 5.06 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.462 0.649 . . . . 50.329999999999998 110.58 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.7 pt -54.92 -23.93 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.355 -0.839 . . . . 74.319999999999993 111.969 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -48.16 -40.94 25.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.729 0.411 . . . . 75.439999999999998 111.631 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.18 -33.75 67.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.924 0.392 . . . . 72.239999999999995 110.916 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 177.68 144.22 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.514 -0.921 . . . . 62.299999999999997 108.514 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -124.48 -0.92 8.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.806 0.298 . . . . 74.230000000000004 111.806 -168.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 1.2 m-20 -49.08 -48.74 43.97 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.161 -0.472 . . . . 73.310000000000002 111.829 -175.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.8 t -53.79 -38.35 35.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-O 120.909 0.385 . . . . 54.009999999999998 110.934 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.06 88.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.138 0.494 . . . . 55.409999999999997 110.064 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.1 m -68.75 -36.75 78.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.679 -0.692 . . . . 75.420000000000002 110.618 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.557 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 97.5 mt-30 -60.82 -57.78 11.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.274 -0.421 . . . . 74.400000000000006 110.61 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -75.01 -24.47 58.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 63.0 111.292 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.75 73.19 1.14 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.94 -0.648 . . . . 53.310000000000002 113.08 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.0 t -89.72 91.49 3.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.88 -0.785 . . . . 71.219999999999999 108.88 172.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.4 p -74.52 -47.9 30.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.648 -0.706 . . . . 53.210000000000001 111.779 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.16 164.57 11.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 62.329999999999998 110.506 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 49.2 mm -62.08 -55.45 40.67 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 123.184 0.302 . . . . 72.420000000000002 110.605 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 2.1 Cg_endo -81.0 104.44 1.55 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.968 1.779 . . . . 75.409999999999997 110.978 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.425 ' C ' HD12 ' A' ' 99' ' ' ILE . 69.9 m -139.15 138.5 37.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.812 0.339 . . . . 73.540000000000006 110.852 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.463 HG12 HD11 ' A' ' 63' ' ' LEU . 2.0 mp -120.34 114.59 44.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 115.829 -0.623 . . . . 62.229999999999997 110.26 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.9 mp -90.6 156.09 18.39 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.254 -0.647 . . . . 65.019999999999996 109.254 173.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.425 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . 48.8 mtp -126.27 139.5 53.27 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.965 -0.754 . . . . 73.129999999999995 108.965 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.45 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.3 m-85 -147.63 157.02 43.37 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.668 -0.493 . . . . 73.319999999999993 109.668 176.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 40.6 ttpt -151.1 109.41 3.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.491 -0.483 . . . . 74.030000000000001 111.595 175.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.703 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 66.2 t30 55.9 36.9 28.17 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.485 0.66 . . . . 73.450000000000003 111.24 174.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.66 -16.68 58.65 Favored Glycine 0 CA--C 1.518 0.275 0 CA-C-N 115.647 -0.706 . . . . 71.519999999999996 112.829 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 12.8 ttmt -74.33 135.21 42.53 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 116.813 0.306 . . . . 70.239999999999995 110.393 177.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -77.9 88.05 4.1 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.19 0.995 . . . . 73.109999999999999 110.751 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.475 HD11 ' CG ' ' A' ' 126' ' ' ASN . 0.3 OUTLIER -71.84 168.85 17.02 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.35 -1.75 . . . . 74.519999999999996 109.782 172.647 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.9 m -69.87 -177.61 1.34 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.277 0.631 . . . . 74.310000000000002 112.353 -166.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -142.38 121.41 12.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 110.214 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.45 115.81 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 70.200000000000003 110.135 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.1 mt -89.51 128.23 41.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.579 . . . . 63.310000000000002 110.38 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.17 -155.77 30.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.172 -0.537 . . . . 64.120000000000005 112.3 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -105.99 112.62 25.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.783 -0.451 . . . . 65.450000000000003 109.783 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 119' ' ' ILE . 5.4 t70 -154.05 82.58 1.14 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.376 0.608 . . . . 70.099999999999994 110.246 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.547 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -60.24 -29.53 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.356 -0.838 . . . . 74.010000000000005 110.67 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.9 t -66.39 -54.25 26.56 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.124 0.488 . . . . 75.299999999999997 110.086 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -57.77 -46.21 84.88 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.814 -0.63 . . . . 72.329999999999998 110.167 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.504 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.7 mt -56.47 -56.34 14.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.879 -0.601 . . . . 75.230000000000004 111.091 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -63.21 -34.18 65.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 120.56 0.219 . . . . 75.340000000000003 110.696 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 t -60.1 -52.15 66.59 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.369 -0.378 . . . . 54.229999999999997 110.063 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.3 -40.31 93.68 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.212 -0.449 . . . . 75.099999999999994 110.149 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.555 ' O ' HG13 ' A' ' 127' ' ' ILE . 53.2 mt -57.12 -56.33 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.859 -0.61 . . . . 64.010000000000005 111.273 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -69.82 -33.41 72.29 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 120.42 -0.512 . . . . 65.230000000000004 110.198 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -58.66 -36.26 73.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.12 -0.491 . . . . 62.439999999999998 110.362 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.475 ' CG ' HD11 ' A' ' 108' ' ' LEU . 39.2 m-80 -108.81 1.31 20.87 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.369 0.877 . . . . 50.310000000000002 113.369 -175.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 123' ' ' ILE . 46.6 mt -84.12 -52.95 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.378 -0.971 . . . . 74.340000000000003 108.378 166.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.408 -0.814 . . . . 74.109999999999999 109.688 175.035 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.884 0.374 . . . . 71.430000000000007 110.057 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.62 116.14 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 52.409999999999997 110.732 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -63.73 131.48 48.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.015 -0.539 . . . . 64.409999999999997 110.905 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -138.38 150.89 46.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.067 -0.515 . . . . 71.319999999999993 110.248 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -62.03 153.07 30.72 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.48 -0.327 . . . . 71.540000000000006 110.217 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -96.56 149.91 21.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.186 0.517 . . . . 73.209999999999994 111.417 -172.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.908 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 44.0 m80 -145.77 -179.27 6.58 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.127 -1.064 . . . . 75.5 108.127 172.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -162.73 145.75 10.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.887 0.312 . . . . 72.010000000000005 111.186 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.0 mmt -93.74 150.87 20.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 62.43 109.846 175.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.45 -64.24 4.57 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.464 -0.654 . . . . 73.209999999999994 111.464 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 t -156.17 133.91 11.06 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.76 -0.83 . . . . 73.010000000000005 108.76 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.4 tp -87.33 90.97 8.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.936 0.398 . . . . 62.109999999999999 111.194 -172.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -137.23 176.36 8.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.742 -0.663 . . . . 72.340000000000003 109.451 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.98 85.38 0.7 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.83 -0.804 . . . . 63.130000000000003 108.83 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -83.71 171.79 12.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.423 -0.808 . . . . 73.25 111.589 -174.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.5 m -90.84 26.15 2.17 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.904 0.859 . . . . 75.209999999999994 109.858 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -160.32 111.1 1.86 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.149 -0.932 . . . . 73.349999999999994 109.839 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.41 177.72 15.4 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 111.819 -0.512 . . . . 71.319999999999993 111.819 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -88.43 13.9 2.43 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.064 2.509 . . . . 62.399999999999999 112.46 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.02 -170.46 29.05 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.83 -0.508 . . . . 74.25 111.83 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 p -82.99 118.36 23.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.567 0.222 . . . . 74.409999999999997 110.822 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.8 mmt -78.13 -49.01 14.71 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.296 -0.631 . . . . 55.119999999999997 109.296 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 76' ' ' ILE . 3.6 mm -82.84 81.74 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.55 -0.908 . . . . 72.230000000000004 108.55 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 77' ' ' TYR . 7.4 tp10 -69.47 161.54 29.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.728 -0.669 . . . . 60.340000000000003 111.807 -170.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.404 ' H ' ' HG3' ' A' ' 25' ' ' GLN . 4.4 pp0? -96.75 138.69 33.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.01 -0.541 . . . . 74.349999999999994 110.901 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.7 pt -148.53 169.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.18 0.514 . . . . 71.420000000000002 111.158 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.15 -163.95 11.46 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 109.922 -1.271 . . . . 53.409999999999997 109.922 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -63.33 -39.64 95.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 117.56 0.68 . . . . 75.310000000000002 110.298 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -64.47 -38.35 90.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.576 -0.738 . . . . 72.140000000000001 111.706 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -83.89 -29.08 27.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.688 -0.233 . . . . 64.209999999999994 110.897 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -47.61 -61.64 1.83 Allowed 'General case' 0 C--O 1.238 0.471 0 O-C-N 123.482 0.489 . . . . 63.329999999999998 111.426 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -56.08 -45.1 79.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 75.150000000000006 110.928 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -58.46 -53.8 54.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.0 -0.545 . . . . 73.040000000000006 111.206 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -65.31 -38.72 91.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.066 -0.516 . . . . 70.209999999999994 111.117 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 44' ' ' ILE . 56.8 t -72.64 -42.01 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.302 0.482 . . . . 73.219999999999999 112.302 -176.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.2 p -85.96 -45.29 11.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.116 0.413 . . . . 55.030000000000001 112.116 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t -86.87 10.47 16.02 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.28 -0.418 . . . . 73.439999999999998 112.096 -172.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 7.5 p -71.29 81.49 0.74 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.88 0.371 . . . . 71.319999999999993 111.261 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 29.9 -93.89 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.776 1.231 . . . . 72.340000000000003 113.355 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -161.72 132.32 5.04 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.637 0.375 . . . . 74.409999999999997 110.526 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 54.98 14.69 0.98 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.544 0.572 . . . . 64.120000000000005 112.544 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.9 mm -74.45 115.55 15.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.857 0.36 . . . . 63.420000000000002 110.13 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 102' ' ' PHE . 42.2 tp -76.55 110.29 10.99 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.475 0.655 . . . . 73.120000000000005 110.72 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 23.6 mm -88.98 117.63 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.873 -1.058 . . . . 70.040000000000006 109.744 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.464 HD13 HG13 ' A' ' 74' ' ' VAL . 4.8 mp -106.68 127.85 53.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.439 -0.949 . . . . 52.509999999999998 108.439 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 57.6 t -110.97 104.39 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.273 -0.64 . . . . 74.019999999999996 109.273 175.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.02 114.37 28.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.744 -0.662 . . . . 73.040000000000006 110.141 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -76.82 133.28 39.42 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.3 -0.409 . . . . 72.319999999999993 110.03 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -116.51 168.04 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.839 -0.619 . . . . 72.099999999999994 111.165 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . . . -161.32 130.46 3.15 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.669 . . . . 72.030000000000001 109.77 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 50' ' ' ALA . 25.7 Cg_exo -63.75 -14.18 41.36 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.732 2.288 . . . . 65.540000000000006 111.816 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 31.6 t90 -118.14 80.6 1.54 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.563 -0.744 . . . . 72.209999999999994 109.446 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 41.2 t -164.97 119.06 1.28 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.688 -0.687 . . . . 75.129999999999995 110.074 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.03 -63.31 5.17 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 116.273 -0.421 . . . . 31.210000000000001 113.226 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.461 ' O ' HD23 ' A' ' 59' ' ' LEU . 40.8 Cg_exo -57.06 -47.91 20.66 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.567 2.178 . . . . 75.319999999999993 111.986 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 36.4 m -50.91 -33.62 25.01 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.865 -0.607 . . . . 74.200000000000003 111.74 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -65.06 -36.93 85.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 73.340000000000003 110.69 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.639 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 28.7 t -74.57 -30.53 61.75 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.652 0.739 . . . . 53.130000000000003 110.128 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.514 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 mm? -64.29 -20.73 66.27 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.76 -0.654 . . . . 62.149999999999999 110.872 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.518 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 54.5 mt-10 -54.92 -67.11 0.73 Allowed Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.767 -0.457 . . . . 64.540000000000006 109.767 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.908 ' HG3' ' HB2' ' A' ' 7' ' ' HIS . 53.6 Cg_endo -66.64 -37.27 22.28 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 121.735 1.623 . . . . 62.530000000000001 112.387 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.639 ' HG3' ' O ' ' A' ' 58' ' ' SER . 40.2 mt-30 -59.98 -55.9 28.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.355 -0.538 . . . . 74.510000000000005 111.062 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.58 -51.85 63.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.522 -0.308 . . . . 72.239999999999995 111.117 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.555 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 15.8 mm-40 -50.73 -45.63 58.78 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.86 0.362 . . . . 64.329999999999998 110.94 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -69.04 -47.63 64.89 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.387 -0.369 . . . . 74.040000000000006 111.252 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.545 HD11 HD11 ' A' ' 116' ' ' ILE . 16.9 mt -62.29 -31.34 71.92 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.632 -0.427 . . . . 71.310000000000002 110.455 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 71' ' ' THR . . . -66.55 -47.33 73.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.792 -0.447 . . . . 51.030000000000001 109.792 175.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 96.5 mt-30 -59.79 -30.59 69.0 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.101 0.477 . . . . 75.310000000000002 110.801 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.2 tp60 -76.33 -45.22 33.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.047 -0.524 . . . . 71.25 111.086 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -103.75 5.21 35.97 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.928 0.714 . . . . 72.439999999999998 112.928 -169.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.89 -19.41 2.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.705 0.402 . . . . 75.129999999999995 112.072 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -55.14 -40.48 70.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 74.209999999999994 110.708 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -127.58 -5.88 5.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.82 -0.627 . . . . 74.109999999999999 111.398 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.464 HG13 HD13 ' A' ' 45' ' ' LEU . 42.1 t -117.06 136.28 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.921 0.391 . . . . 71.239999999999995 111.485 -175.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -141.33 120.11 12.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.686 -0.688 . . . . 64.209999999999994 109.52 173.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.433 HG22 HG23 ' A' ' 23' ' ' ILE . 50.0 mt -99.55 143.02 14.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.367 -0.379 . . . . 63.409999999999997 109.994 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.465 ' CD1' ' HB3' ' A' ' 24' ' ' GLU . 96.8 m-85 -135.61 154.55 51.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.839 -0.618 . . . . 72.219999999999999 109.877 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -141.26 144.1 34.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.302 -0.629 . . . . 63.030000000000001 109.302 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 tt -77.03 135.43 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.303 -0.408 . . . . 71.120000000000005 110.317 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -107.25 -37.54 6.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.105 -0.498 . . . . 73.400000000000006 110.411 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 81' ' ' ILE . 2.8 mp -81.43 103.43 8.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.906 -0.588 . . . . 74.319999999999993 110.387 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.1 -25.22 61.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 63.32 111.806 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.23 -21.22 62.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.641 0.258 . . . . 75.439999999999998 111.187 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -102.3 12.88 35.97 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.594 -0.275 . . . . 72.099999999999994 111.511 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -69.8 -9.38 54.43 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.032 0.444 . . . . 74.319999999999993 110.094 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -54.46 -30.92 54.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.434 -0.803 . . . . 53.32 110.591 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -53.03 -38.82 30.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.754 -0.657 . . . . 71.340000000000003 110.409 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.445 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -57.3 -54.48 46.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.38 -0.827 . . . . 60.200000000000003 110.547 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -60.41 -39.33 87.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.624 -0.716 . . . . 73.439999999999998 110.769 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -64.37 -44.87 90.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.741 -0.663 . . . . 75.540000000000006 111.831 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -80.09 -22.69 41.92 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.664 -0.244 . . . . 74.120000000000005 111.358 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.61 48.6 0.73 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.873 -0.679 . . . . 74.25 113.178 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.445 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 88.5 t -94.61 111.44 25.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.934 -0.395 . . . . 73.219999999999999 109.934 176.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.2 t -110.32 19.74 18.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.286 -0.415 . . . . 65.409999999999997 111.082 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.78 149.42 30.5 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.069 -0.345 . . . . 73.200000000000003 110.069 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.657 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 62.6 mt -61.36 -54.93 48.22 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 123.011 0.195 . . . . 64.420000000000002 110.865 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 86.3 Cg_endo -86.68 98.2 0.52 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.781 1.654 . . . . 64.150000000000006 111.234 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 m -140.42 142.61 35.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.431 . . . . 75.409999999999997 110.327 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.646 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -113.25 117.99 56.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 73.230000000000004 110.268 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.405 HD23 ' HG3' ' A' ' 110' ' ' GLN . 98.7 mt -94.17 122.95 37.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.507 -0.923 . . . . 64.430000000000007 108.507 172.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.447 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 51.2 mtp -100.2 146.9 26.31 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.919 -0.4 . . . . 70.310000000000002 109.919 -177.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.562 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 98.6 m-85 -149.56 161.87 41.3 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.51 -0.552 . . . . 75.400000000000006 109.51 176.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -151.34 107.17 3.39 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.294 -0.254 . . . . 72.299999999999997 111.101 176.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.552 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 64.4 t30 55.42 35.9 26.0 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.282 0.563 . . . . 63.0 111.273 173.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.33 -16.33 56.25 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.08 -0.509 . . . . 71.219999999999999 112.756 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -79.95 143.82 33.85 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.546 -0.538 . . . . 71.209999999999994 109.546 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -67.91 162.57 23.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.263 0.554 . . . . 73.129999999999995 110.949 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.61 168.3 21.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.763 -1.108 . . . . 72.329999999999998 108.117 -164.029 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -70.27 179.75 2.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.592 0.711 . . . . 75.019999999999996 112.458 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.405 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.8 tt0 -139.73 118.91 12.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.403 -0.817 . . . . 73.349999999999994 109.446 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.646 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.0 t -97.54 113.18 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 74.540000000000006 110.552 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.0 mp -88.22 108.37 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.394 -0.595 . . . . 74.140000000000001 109.394 177.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.85 143.24 10.65 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.775 -0.53 . . . . 52.149999999999999 111.775 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.514 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -74.65 72.04 1.94 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.936 0.398 . . . . 54.32 110.155 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.415 ' O ' HG13 ' A' ' 119' ' ' ILE . 19.4 t70 -111.08 105.35 14.06 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.893 -0.594 . . . . 73.219999999999999 110.69 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.554 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -59.08 -31.98 46.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.301 -0.863 . . . . 61.130000000000003 110.209 -176.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 m -62.4 -55.79 24.52 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.349 -0.387 . . . . 71.129999999999995 110.931 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -63.57 -41.34 98.39 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.544 0.212 . . . . 63.310000000000002 110.461 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 123' ' ' ILE . 80.6 mt -56.21 -56.28 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.307 -0.406 . . . . 64.310000000000002 110.482 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.75 -33.9 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.481 -0.327 . . . . 54.049999999999997 110.662 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.7 m -57.84 -49.49 76.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.433 -0.349 . . . . 74.120000000000005 110.242 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -69.74 -36.44 75.83 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.464 -0.335 . . . . 72.299999999999997 110.924 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 119' ' ' ILE . 70.8 mt -56.08 -55.95 15.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 64.310000000000002 109.779 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -58.49 -42.47 87.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.546 -0.752 . . . . 71.239999999999995 110.495 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -60.59 -33.7 73.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.319 -0.855 . . . . 75.219999999999999 111.263 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.408 ' OD1' HD11 ' A' ' 108' ' ' LEU . 38.8 m-80 -102.42 -9.52 20.21 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.961 0.726 . . . . 72.549999999999997 112.961 -175.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.5 mt -89.75 -60.51 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.705 -0.398 . . . . 73.129999999999995 110.35 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.158 -0.925 . . . . 74.5 110.154 -178.069 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 tpt . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.766 -0.457 . . . . 71.430000000000007 109.766 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.83 155.01 16.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.34 -0.391 . . . . 52.409999999999997 111.107 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -144.64 103.82 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 64.409999999999997 110.072 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.476 ' HB3' ' OG ' ' A' ' 58' ' ' SER . 9.2 t60 -113.47 -75.73 0.59 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.218 -0.29 . . . . 71.319999999999993 110.218 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -147.03 -172.0 3.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 110.257 -0.275 . . . . 71.540000000000006 110.257 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -130.68 97.79 4.46 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.113 0.483 . . . . 73.209999999999994 112.001 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.432 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 11.9 m170 -106.52 -160.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.939 -1.134 . . . . 75.5 107.939 170.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -179.44 133.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.002 -0.37 . . . . 72.010000000000005 110.002 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.6 mmt -92.18 131.78 37.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.207 -0.451 . . . . 62.43 109.824 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.05 -47.86 43.48 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.315 -0.714 . . . . 73.209999999999994 111.315 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -172.12 157.61 4.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.82 -0.437 . . . . 73.010000000000005 109.82 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 21' ' ' SER . 31.9 tp -132.72 78.96 1.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.376 0.607 . . . . 62.109999999999999 109.994 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -103.88 -158.44 0.67 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.889 -1.051 . . . . 72.340000000000003 108.607 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.18 78.66 0.09 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.118 0.485 . . . . 63.130000000000003 109.859 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -79.57 138.67 37.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.745 -0.661 . . . . 73.25 110.321 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.8 m -77.72 73.9 4.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.168 0.509 . . . . 75.209999999999994 110.072 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -176.88 109.37 0.08 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.6 -0.727 . . . . 73.349999999999994 110.098 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.67 -124.75 37.11 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.338 -0.458 . . . . 71.319999999999993 112.827 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -83.69 -179.46 4.17 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.989 2.459 . . . . 62.399999999999999 112.251 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.2 -121.16 4.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.212 -0.518 . . . . 74.25 112.247 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.408 ' HA ' ' HG ' ' A' ' 12' ' ' LEU . 9.1 p -75.26 93.47 2.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 74.409999999999997 111.911 -176.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.527 ' HE3' ' HA ' ' A' ' 68' ' ' GLN . 13.5 mmt -64.85 -70.4 0.23 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.373 0.606 . . . . 55.119999999999997 109.418 170.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.428 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 8.3 mm -70.49 80.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.908 -1.042 . . . . 72.230000000000004 108.785 172.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 9.0 tp10 -66.51 157.01 33.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.247 -0.433 . . . . 60.340000000000003 111.211 -175.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -109.27 136.88 48.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.442 0.297 . . . . 74.349999999999994 110.718 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 31' ' ' PHE . 37.9 pt -147.38 176.26 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.001 0.429 . . . . 71.420000000000002 110.992 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.25 -167.27 11.9 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.915 -0.874 . . . . 53.409999999999997 110.915 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.22 -50.68 68.79 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.956 0.407 . . . . 75.310000000000002 111.425 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -68.94 -32.54 72.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.884 -0.598 . . . . 72.140000000000001 112.169 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -80.78 -22.43 40.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.823 -0.172 . . . . 64.209999999999994 110.783 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.464 ' HE1' HG21 ' A' ' 46' ' ' VAL . 91.9 t80 -51.88 -61.96 1.93 Allowed 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.52 0.513 . . . . 63.329999999999998 111.383 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -57.41 -47.17 82.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.099 -0.501 . . . . 75.150000000000006 110.653 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -56.15 -54.44 45.15 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.537 -0.756 . . . . 73.040000000000006 111.278 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -67.44 -33.03 74.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 70.209999999999994 111.343 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.549 HG22 HG21 ' A' ' 44' ' ' ILE . 65.5 t -72.03 -38.2 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.463 -0.335 . . . . 73.219999999999999 111.758 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -85.99 -41.82 14.54 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.024 0.44 . . . . 55.030000000000001 112.028 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 t -83.26 11.54 6.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.112 -0.494 . . . . 73.439999999999998 111.788 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 13.8 p -72.26 82.58 1.02 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.78 0.324 . . . . 71.319999999999993 111.85 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.0 t30 41.52 -93.65 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.367 -0.833 . . . . 72.340000000000003 112.462 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -162.04 121.94 2.47 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 110.412 -0.218 . . . . 74.409999999999997 110.412 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 48.0 m-80 55.36 18.96 2.8 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.779 0.659 . . . . 64.120000000000005 112.779 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.1 mm -71.96 133.62 31.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 120.893 0.378 . . . . 63.420000000000002 110.759 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 74' ' ' VAL . 31.2 tp -80.28 114.97 19.57 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.828 -0.624 . . . . 73.120000000000005 110.389 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.549 HG21 HG22 ' A' ' 35' ' ' VAL . 29.1 mm -95.27 118.9 42.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 70.040000000000006 110.396 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.541 HD13 HG13 ' A' ' 74' ' ' VAL . 5.5 mp -104.19 125.25 50.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.384 -0.969 . . . . 52.509999999999998 108.384 170.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.464 HG21 ' HE1' ' A' ' 31' ' ' PHE . 59.3 t -112.08 104.47 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.454 -0.573 . . . . 74.019999999999996 109.454 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.47 118.3 35.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.659 -0.701 . . . . 73.040000000000006 110.806 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -73.97 89.77 1.93 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.369 0.604 . . . . 72.319999999999993 109.652 174.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -65.27 150.03 48.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.983 -1.008 . . . . 72.099999999999994 111.336 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.79 116.88 5.83 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.757 -0.656 . . . . 72.030000000000001 109.549 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.41 -18.01 62.64 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.659 2.24 . . . . 65.540000000000006 111.972 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -115.43 86.38 2.45 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.716 -0.675 . . . . 72.209999999999994 109.208 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.2 t -169.09 105.04 0.39 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.757 -0.656 . . . . 75.129999999999995 110.306 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -54.15 -55.28 27.03 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.932 -0.576 . . . . 31.210000000000001 112.986 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.517 ' O ' HD23 ' A' ' 59' ' ' LEU . 52.3 Cg_exo -56.57 -50.61 11.29 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.566 2.177 . . . . 75.319999999999993 112.19 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 33.7 m -54.89 -33.81 62.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.293 -0.412 . . . . 74.200000000000003 111.077 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -62.09 -30.54 71.07 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.932 -0.576 . . . . 73.340000000000003 110.851 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.627 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 21.5 t -74.78 -35.93 62.53 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-O 122.007 0.908 . . . . 53.130000000000003 109.611 174.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.534 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.6 mm? -65.06 -26.2 68.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.775 -1.102 . . . . 62.149999999999999 110.763 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.508 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 46.2 mt-10 -53.52 -64.25 1.88 Allowed Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.681 -0.408 . . . . 64.540000000000006 109.998 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 46.2 Cg_endo -66.83 -39.17 15.33 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 121.699 1.599 . . . . 62.530000000000001 112.441 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 58' ' ' SER . 37.0 mt-30 -61.63 -46.2 90.83 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.107 -0.637 . . . . 74.510000000000005 111.236 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.49 -37.53 60.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.331 -0.395 . . . . 72.239999999999995 110.997 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 3.0 mm-40 -57.31 -38.3 73.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.025 0.44 . . . . 64.329999999999998 110.132 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.91 -55.08 25.31 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.839 -0.619 . . . . 74.040000000000006 110.221 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 116' ' ' ILE . 27.8 mt -60.94 -32.32 71.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.665 -0.698 . . . . 71.310000000000002 110.747 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.547 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.47 -53.71 26.49 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.154 -0.476 . . . . 51.030000000000001 109.937 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.527 ' HA ' ' HE3' ' A' ' 22' ' ' MET . 97.7 mt-30 -59.1 -36.15 74.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.415 . . . . 75.310000000000002 111.04 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -71.94 -52.16 18.56 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.979 0.418 . . . . 71.25 111.374 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -95.22 4.7 53.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.618 0.599 . . . . 72.439999999999998 112.618 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.2 t -52.89 -22.86 6.03 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.816 0.673 . . . . 75.129999999999995 112.816 -170.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.3 -31.84 73.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.747 0.308 . . . . 74.209999999999994 110.818 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -125.69 -0.26 7.42 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.377 -0.374 . . . . 74.109999999999999 110.891 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.541 HG13 HD13 ' A' ' 45' ' ' LEU . 36.6 t -127.94 136.16 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.958 0.408 . . . . 71.239999999999995 111.421 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 71' ' ' THR . 39.8 mmtm -141.89 131.45 23.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.934 -0.575 . . . . 64.209999999999994 109.604 172.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.7 mt -104.97 143.12 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 63.409999999999997 110.444 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -131.46 143.35 50.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.077 -0.51 . . . . 72.219999999999999 110.156 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 25.1 pttm -124.18 127.84 48.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.943 -0.571 . . . . 63.030000000000001 109.667 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.7 tt -80.09 107.18 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.157 0.503 . . . . 71.120000000000005 109.67 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -86.08 -31.96 21.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.234 -0.439 . . . . 73.400000000000006 111.084 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 81' ' ' ILE . 3.0 mp -81.56 85.83 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.32 0.581 . . . . 74.319999999999993 110.286 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -27.34 62.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.359 -0.837 . . . . 63.32 111.277 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.36 -21.97 61.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 75.439999999999998 111.064 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -113.44 41.22 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 72.099999999999994 110.172 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -80.63 22.5 0.58 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.858 -0.61 . . . . 74.319999999999993 111.149 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 37.3 t70 -54.03 -35.93 62.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.625 0.37 . . . . 53.32 110.714 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.3 t -52.74 -40.33 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.709 -0.678 . . . . 71.340000000000003 110.539 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.42 -54.32 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 60.200000000000003 110.51 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 m -62.88 -29.63 70.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 73.439999999999998 110.967 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 33.6 mm-40 -69.13 -56.04 8.87 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.343 -0.39 . . . . 75.540000000000006 111.174 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -75.0 -9.54 58.63 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.791 0.329 . . . . 74.120000000000005 111.231 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.81 45.4 7.77 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.031 -0.604 . . . . 74.25 112.498 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.0 103.58 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.543 -0.54 . . . . 73.219999999999999 109.543 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.7 t -86.37 -52.36 5.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.298 -0.41 . . . . 65.409999999999997 109.928 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.19 150.99 46.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.251 -0.431 . . . . 73.200000000000003 110.092 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.675 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 66.4 mt -72.97 -59.53 2.17 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 119.742 -0.171 . . . . 64.420000000000002 111.145 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 86.6 Cg_endo -82.74 63.62 8.0 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.952 1.768 . . . . 64.150000000000006 112.01 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.5 m -100.92 145.67 28.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.121 -0.49 . . . . 75.409999999999997 110.486 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.603 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -112.16 122.67 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 73.230000000000004 110.265 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.504 HD23 ' HG3' ' A' ' 110' ' ' GLN . 84.7 mt -93.2 123.12 36.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.906 -0.776 . . . . 64.430000000000007 108.906 173.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 109' ' ' SER . 42.0 mtp -98.29 143.22 29.0 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.778 -0.453 . . . . 70.310000000000002 109.778 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.626 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.5 m-85 -149.09 161.39 42.04 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.328 -0.619 . . . . 75.400000000000006 109.328 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -142.63 109.3 5.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.034 -0.266 . . . . 72.299999999999997 110.646 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.538 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 60.6 t30 57.03 29.01 15.74 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.353 0.596 . . . . 63.0 111.061 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.513 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 89.4 -2.72 83.42 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.235 -0.507 . . . . 71.219999999999999 112.92 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -91.7 146.79 23.48 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.784 -0.45 . . . . 71.209999999999994 109.784 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -60.84 154.62 21.56 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.277 0.561 . . . . 73.129999999999995 112.117 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.626 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.16 167.62 23.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.695 -1.138 . . . . 72.329999999999998 108.217 -169.537 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 101' ' ' MET . 5.2 m -70.99 171.48 10.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.744 0.783 . . . . 75.019999999999996 112.692 -170.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.504 ' HG3' HD23 ' A' ' 100' ' ' LEU . 26.8 tt0 -126.04 127.28 45.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.233 -0.894 . . . . 73.349999999999994 109.775 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.603 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 61.3 t -97.52 107.61 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.074 -0.343 . . . . 74.540000000000006 110.074 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 112' ' ' ILE . 2.9 mp -81.46 106.95 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 74.140000000000001 109.906 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.56 136.7 7.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.297 -0.477 . . . . 52.149999999999999 112.142 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.534 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -57.61 92.13 0.01 OUTLIER 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.929 0.395 . . . . 54.32 110.814 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.414 ' O ' HG13 ' A' ' 119' ' ' ILE . 12.4 t70 -127.22 99.33 5.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 73.219999999999999 109.963 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.514 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -59.07 -33.68 51.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.846 -0.616 . . . . 61.130000000000003 110.728 -174.389 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.8 m -61.06 -54.02 49.88 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.755 0.312 . . . . 71.129999999999995 110.487 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -63.71 -40.88 97.87 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.57 -0.286 . . . . 63.310000000000002 110.543 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.6 mt -58.76 -55.06 25.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.145 -0.48 . . . . 64.310000000000002 110.683 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.9 tt -63.33 -34.11 65.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 116.617 -0.265 . . . . 54.049999999999997 110.341 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.6 m -59.44 -45.69 90.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.668 0.27 . . . . 74.120000000000005 110.318 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -69.99 -38.05 75.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.625 -0.261 . . . . 72.299999999999997 111.186 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.0 mt -57.14 -53.72 39.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.956 0.408 . . . . 64.310000000000002 110.012 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -59.59 -39.58 84.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.755 -0.657 . . . . 71.239999999999995 109.988 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -63.65 -31.86 73.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.652 -0.703 . . . . 75.219999999999999 111.511 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -90.11 -30.12 17.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.184 0.438 . . . . 72.549999999999997 112.184 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.475 HD11 HG23 ' A' ' 74' ' ' VAL . 68.5 mt -86.31 -45.97 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.059 0.457 . . . . 73.129999999999995 110.577 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.455 -0.783 . . . . 74.5 109.65 -179.097 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.808 -0.441 . . . . 74.049999999999997 109.808 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.72 115.25 11.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.652 0.263 . . . . 70.409999999999997 111.021 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -78.03 60.56 2.41 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.45 0.643 . . . . 75.430000000000007 109.861 176.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -58.94 138.5 57.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.882 -1.054 . . . . 42.109999999999999 111.553 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -157.83 137.47 12.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.772 -0.649 . . . . 74.540000000000006 109.547 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -143.44 128.15 18.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.409 -0.589 . . . . 71.519999999999996 109.409 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -74.78 122.29 23.09 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.532 -0.544 . . . . 63.229999999999997 109.532 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -79.18 105.52 10.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 73.230000000000004 110.236 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.6 ttt -120.55 88.11 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.584 -0.735 . . . . 74.150000000000006 109.163 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.0 43.76 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.625 -0.59 . . . . 62.200000000000003 111.625 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.2 p -81.92 97.99 8.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.332 . . . . 74.439999999999998 110.206 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -157.68 111.96 2.61 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.223 -0.658 . . . . 62.520000000000003 109.223 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.81 177.4 7.98 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.153 -0.476 . . . . 71.420000000000002 110.465 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.84 167.18 21.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.139 -0.482 . . . . 72.219999999999999 110.505 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -138.19 144.1 40.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.407 -0.59 . . . . 65.209999999999994 109.407 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -149.71 -179.94 7.51 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.716 0.293 . . . . 63.310000000000002 110.855 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -126.21 167.44 15.43 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.335 -0.393 . . . . 73.239999999999995 111.012 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.55 177.71 52.58 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 116.093 -0.503 . . . . 43.329999999999998 113.092 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.69 -3.6 13.98 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.155 2.57 . . . . 63.0 112.482 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.17 -88.25 0.53 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 121.321 -0.466 . . . . 21.129999999999999 112.751 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 p -87.1 152.85 22.0 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.8 0.334 . . . . 74.019999999999996 111.241 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.438 ' HG3' ' CG ' ' A' ' 68' ' ' GLN . 93.9 mmm -90.55 -29.48 17.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.075 -0.511 . . . . 72.340000000000003 109.898 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.451 HG12 ' OE2' ' A' ' 64' ' ' GLU . 32.9 mm -67.83 99.38 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.587 -0.894 . . . . 71.0 108.587 174.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 16.2 tt0 -74.85 112.36 10.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.342 0.592 . . . . 75.230000000000004 109.936 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.454 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 8.5 tt0 -88.99 131.14 35.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.488 -0.778 . . . . 62.009999999999998 110.717 -170.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.546 HG21 ' HG3' ' A' ' 34' ' ' LYS . 47.6 pt -144.94 -179.85 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.756 0.312 . . . . 73.510000000000005 111.201 -175.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.64 -174.42 15.6 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.209 -0.451 . . . . 71.540000000000006 112.534 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' OD1' HG23 ' A' ' 87' ' ' VAL . 20.0 t70 -50.84 -57.01 9.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.502 0.721 . . . . 71.109999999999999 112.649 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -69.25 -27.13 65.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 71.5 110.919 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -74.21 -15.59 61.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 62.450000000000003 110.642 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . 90.0 t80 -52.56 -61.38 2.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.912 -0.586 . . . . 73.140000000000001 111.017 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -55.21 -53.43 56.1 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.433 -0.349 . . . . 60.100000000000001 111.167 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -53.34 -55.92 20.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.844 -0.616 . . . . 70.329999999999998 111.211 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.706 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 11.0 mmpt? -61.66 -45.61 93.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.864 -0.607 . . . . 71.230000000000004 111.33 -176.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.415 ' HA ' HD12 ' A' ' 44' ' ' ILE . 70.4 t -64.29 -40.66 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.448 -0.342 . . . . 74.329999999999998 111.347 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.1 p -78.26 -25.02 46.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.703 0.287 . . . . 72.0 111.009 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -61.78 -14.95 37.21 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.261 -0.427 . . . . 51.009999999999998 111.459 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.617 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 22.8 p -49.48 114.45 1.04 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 123.148 0.28 . . . . 73.230000000000004 110.798 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.8 -70.3 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 111.183 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -156.01 122.17 5.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.374 -0.375 . . . . 73.409999999999997 110.474 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 58.82 17.69 5.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.94 -0.573 . . . . 74.310000000000002 111.655 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.4 mm -74.74 97.96 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.661 -0.496 . . . . 74.530000000000001 109.661 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.81 111.47 9.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.708 -0.678 . . . . 64.439999999999998 109.499 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.426 HG23 ' CD1' ' A' ' 77' ' ' TYR . 58.3 mt -101.51 115.1 42.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.181 -0.918 . . . . 62.329999999999998 110.459 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.469 ' HB2' HG13 ' A' ' 76' ' ' ILE . 5.1 mp -103.07 106.41 16.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.817 -0.628 . . . . 72.099999999999994 109.619 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.81 105.0 16.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.731 -0.213 . . . . 73.519999999999996 110.47 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 20.8 t0 -83.16 151.44 25.7 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.142 0.496 . . . . 65.239999999999995 110.688 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -71.69 170.81 12.73 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.63 -0.713 . . . . 55.020000000000003 111.694 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -61.12 105.04 0.44 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.665 -0.698 . . . . 73.219999999999999 110.129 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -161.04 97.48 1.34 Allowed Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.731 -0.668 . . . . 75.439999999999998 109.669 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.37 -18.04 7.33 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.95 2.433 . . . . 72.239999999999995 111.947 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -166.74 137.36 3.24 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.912 -0.586 . . . . 61.32 109.816 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.46 156.28 8.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 72.230000000000004 110.141 175.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -43.21 -72.49 0.31 Allowed Glycine 0 C--N 1.335 0.502 0 O-C-N 123.683 0.614 . . . . 41.43 114.236 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.494 ' O ' HD23 ' A' ' 59' ' ' LEU . 41.8 Cg_endo -66.31 -22.07 53.51 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.412 2.075 . . . . 73.200000000000003 112.2 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 31.6 m -65.35 -19.06 65.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.027 -0.533 . . . . 71.340000000000003 111.216 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -54.05 -48.22 70.81 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.306 -0.406 . . . . 65.430000000000007 110.085 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.571 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 38.9 t -75.59 -44.0 45.34 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.527 0.68 . . . . 53.119999999999997 111.478 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -60.65 -45.59 93.53 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.852 0.686 . . . . 75.150000000000006 112.852 -171.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.52 -56.31 28.24 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 117.609 0.186 . . . . 74.239999999999995 111.171 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HG2' ' O ' ' A' ' 58' ' ' SER . 18.9 Cg_endo -60.25 -40.49 58.9 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.781 1.654 . . . . 74.340000000000003 112.087 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.571 ' HG3' ' O ' ' A' ' 58' ' ' SER . 34.9 mt-30 -58.31 -39.1 78.47 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.681 -0.408 . . . . 63.340000000000003 111.756 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 85.5 mt -68.43 -41.35 80.47 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.009 -0.367 . . . . 70.299999999999997 110.009 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 19.7 mm-40 -59.47 -41.14 89.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 73.510000000000005 110.415 174.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.579 ' NZ ' ' HB2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -60.56 -57.13 14.04 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.379 0.609 . . . . 63.229999999999997 110.329 178.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.45 -28.76 70.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.489 -0.778 . . . . 72.310000000000002 110.232 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.555 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.08 -50.6 65.5 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.123 -0.49 . . . . 61.240000000000002 109.869 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 91.4 mt-30 -59.77 -41.22 90.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.028 -0.533 . . . . 74.510000000000005 111.115 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -74.32 -54.87 6.77 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.011 0.434 . . . . 64.120000000000005 111.288 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -84.81 4.4 33.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.894 -0.594 . . . . 72.129999999999995 112.475 -172.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.7 t -52.97 -19.57 2.73 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 111.887 0.329 . . . . 63.509999999999998 111.887 -173.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -58.71 -38.92 79.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 52.229999999999997 110.585 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -134.89 10.95 3.63 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 111.407 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.567 HG23 HD11 ' A' ' 127' ' ' ILE . 31.8 t -128.83 142.14 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.22 0.533 . . . . 53.520000000000003 112.347 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 45.9 mmtt -143.6 119.97 10.93 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.194 -0.912 . . . . 72.129999999999995 109.762 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.55 HD13 ' HB2' ' A' ' 67' ' ' ALA . 3.6 mp -98.75 136.74 28.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 109.614 -0.513 . . . . 74.310000000000002 109.614 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 77.3 m-85 -124.31 164.52 19.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 72.200000000000003 109.912 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -153.4 132.58 12.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 74.319999999999993 109.638 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 64.9 mt -75.51 118.43 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.885 -0.413 . . . . 53.310000000000002 109.885 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 25' ' ' GLN . 4.2 p-10 -91.46 -40.34 11.46 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.801 0.334 . . . . 74.349999999999994 111.379 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 81' ' ' ILE . 13.4 tt -83.54 99.24 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.732 0.777 . . . . 71.140000000000001 110.971 -174.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -17.51 62.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.418 -0.81 . . . . 73.310000000000002 111.663 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -70.2 -27.05 64.19 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.572 -0.529 . . . . 74.310000000000002 109.572 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 16.0 m120 -128.13 86.9 2.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.885 -0.598 . . . . 75.340000000000003 109.894 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -138.41 27.94 2.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.728 -0.669 . . . . 65.049999999999997 109.495 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 33.8 t70 -56.76 -35.32 68.5 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.187 -0.915 . . . . 65.349999999999994 111.709 -172.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.469 HG23 ' OD1' ' A' ' 28' ' ' ASP . 90.2 t -52.53 -35.98 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.073 0.463 . . . . 73.540000000000006 110.489 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.68 71.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.941 -0.572 . . . . 65.340000000000003 110.497 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.8 m -59.67 -37.94 80.13 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.286 0.565 . . . . 74.129999999999995 110.492 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 19.8 mm-40 -64.5 -48.23 75.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.43 -0.804 . . . . 72.120000000000005 110.798 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -76.74 -18.3 58.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.56 -0.291 . . . . 73.010000000000005 111.155 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.32 36.51 8.11 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 121.365 -0.445 . . . . 71.230000000000004 112.922 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.86 117.99 39.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 122.411 0.284 . . . . 71.310000000000002 110.422 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.6 m -133.4 13.75 4.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.921 0.391 . . . . 75.230000000000004 110.776 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.19 136.23 39.45 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.549 -0.537 . . . . 73.109999999999999 109.549 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.725 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 49.3 mm -56.19 -54.91 47.55 Favored Pre-proline 0 CA--C 1.542 0.642 0 O-C-N 123.274 0.359 . . . . 71.239999999999995 111.679 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 94.5 Cg_endo -94.2 105.3 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.295 1.996 . . . . 61.25 111.322 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.522 HG23 HG13 ' A' ' 112' ' ' ILE . 27.9 m -148.53 118.24 7.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.284 -0.265 . . . . 71.219999999999999 110.284 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.455 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.1 mp -109.51 110.71 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.189 -0.46 . . . . 63.340000000000003 109.949 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.5 mp -92.46 123.3 35.67 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.176 -0.676 . . . . 72.430000000000007 109.176 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 53.3 mtp -98.73 142.31 30.43 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.854 -0.424 . . . . 63.399999999999999 109.854 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.567 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.8 m-85 -144.89 151.03 38.08 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.549 -0.537 . . . . 70.310000000000002 109.549 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -149.32 123.56 9.55 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.741 -0.384 . . . . 61.5 110.984 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.617 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.5 m-20 62.21 25.45 15.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.265 0.555 . . . . 71.319999999999993 110.325 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.71 -2.89 52.56 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.775 -0.648 . . . . 75.019999999999996 111.988 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -88.17 145.06 26.11 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.846 -0.428 . . . . 65.040000000000006 109.846 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.48 145.61 43.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 124.047 0.842 . . . . 74.450000000000003 110.903 -176.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -150.67 168.02 25.57 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.182 -1.414 . . . . 70.099999999999994 107.182 -170.188 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.3 m -70.29 177.89 3.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.19 0.519 . . . . 51.329999999999998 112.352 -165.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -142.49 119.38 11.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 44.310000000000002 110.057 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -100.63 107.42 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.248 -0.433 . . . . 72.530000000000001 110.112 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -96.16 121.6 46.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.304 -0.628 . . . . 71.319999999999993 109.304 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.87 162.5 32.26 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.794 -0.523 . . . . 41.409999999999997 111.794 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.66 89.93 2.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.753 0.311 . . . . 71.329999999999998 111.175 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.501 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 57.4 t0 -132.45 82.23 2.0 Allowed 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.681 0.753 . . . . 75.0 109.848 174.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.87 -29.04 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 114.993 -1.003 . . . . 74.450000000000003 110.021 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.4 m -60.82 -50.33 73.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.615 -0.513 . . . . 52.409999999999997 109.615 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -61.68 -46.3 90.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.648 -0.706 . . . . 53.539999999999999 110.183 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 123' ' ' ILE . 78.3 mt -55.57 -56.54 11.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.762 -0.654 . . . . 61.350000000000001 111.201 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -66.69 -34.7 71.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.374 -0.376 . . . . 53.310000000000002 110.629 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.3 t -59.3 -51.88 68.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.885 -0.413 . . . . 75.450000000000003 109.885 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -63.67 -36.01 82.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.435 -0.348 . . . . 75.049999999999997 111.232 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.1 mt -56.56 -56.28 14.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.05 0.452 . . . . 71.010000000000005 110.41 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -69.6 -29.06 66.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 61.329999999999998 110.682 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -65.88 -43.8 87.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 64.450000000000003 110.887 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.42 ' CG ' HD11 ' A' ' 108' ' ' LEU . 46.8 m-80 -93.41 -17.95 22.92 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.541 0.571 . . . . 55.140000000000001 112.541 -172.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.567 HD11 HG23 ' A' ' 74' ' ' VAL . 58.6 mt -78.27 -59.83 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 120.543 -0.463 . . . . 64.109999999999999 110.284 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.303 -0.856 . . . . 75.030000000000001 110.205 -176.459 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.885 0.374 . . . . 74.239999999999995 110.843 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.25 14.49 2.11 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.094 0.775 . . . . 52.119999999999997 113.094 172.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -102.49 111.04 23.18 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.827 0.346 . . . . 64.349999999999994 110.864 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -78.48 89.01 4.44 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.885 -0.783 . . . . 72.439999999999998 108.885 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -70.01 168.78 14.71 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.67 0.619 . . . . 62.020000000000003 112.67 -173.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -74.57 140.54 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.784 -1.098 . . . . 64.120000000000005 111.023 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -120.48 -53.43 2.11 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.493 0.183 . . . . 61.009999999999998 111.493 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -63.87 89.84 0.05 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.805 0.336 . . . . 75.310000000000002 110.916 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.8 ttt -104.37 78.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.596 -0.52 . . . . 73.140000000000001 109.596 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.91 95.26 1.95 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.631 -0.713 . . . . 34.509999999999998 111.905 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -99.64 147.3 25.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.993 0.425 . . . . 72.230000000000004 111.103 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.575 HD23 ' HB3' ' A' ' 85' ' ' GLN . 3.1 mm? -123.62 -167.85 1.69 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.854 -0.795 . . . . 74.120000000000005 108.854 174.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.99 111.31 8.47 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.873 0.368 . . . . 74.239999999999995 110.37 174.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -176.17 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.211 -0.449 . . . . 52.520000000000003 111.843 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -65.68 106.67 1.54 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.421 0.629 . . . . 74.510000000000005 110.942 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.2 p -109.09 123.01 48.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 74.230000000000004 109.967 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -88.84 -75.19 0.44 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.857 0.361 . . . . 60.520000000000003 111.021 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.05 -163.43 33.18 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 111.424 -0.67 . . . . 75.510000000000005 111.424 -174.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.1 -45.85 5.28 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.473 2.115 . . . . 74.439999999999998 111.482 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.12 29.96 63.27 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.623 -0.717 . . . . 75.019999999999996 112.565 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.3 m -77.39 -38.94 48.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.995 0.426 . . . . 63.25 110.058 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.495 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 95.4 mmm -122.41 -1.55 9.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.961 -0.563 . . . . 75.439999999999998 110.591 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -111.85 126.16 69.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.206 -0.452 . . . . 63.520000000000003 110.422 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -87.4 151.37 23.13 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.446 -0.343 . . . . 72.549999999999997 110.618 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -114.83 129.68 56.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.436 -0.347 . . . . 71.319999999999993 110.067 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 31' ' ' PHE . 45.7 pt -144.88 169.72 7.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.2 0.524 . . . . 75.430000000000007 111.751 -174.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.527 ' HA2' HD12 ' A' ' 79' ' ' ILE . . . -136.33 -173.71 13.06 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.298 -0.865 . . . . 64.329999999999998 111.274 174.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 7.3 t70 -45.16 -47.22 12.33 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.053 0.454 . . . . 72.099999999999994 111.353 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -62.61 -29.35 70.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.712 -0.676 . . . . 63.039999999999999 112.424 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -102.87 -17.77 15.38 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 122.395 -0.191 . . . . 53.329999999999998 111.435 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 26' ' ' ILE . 88.4 t80 -50.49 -62.01 1.85 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 112.439 0.533 . . . . 70.010000000000005 112.439 -169.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.637 ' O ' HG22 ' A' ' 36' ' ' THR . 10.6 m-20 -56.96 -55.46 34.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 41.149999999999999 110.537 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -54.63 -55.84 25.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.731 -0.668 . . . . 62.020000000000003 111.447 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HG3' HG21 ' A' ' 26' ' ' ILE . 63.7 mmtt -57.74 -40.82 80.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 71.239999999999995 111.386 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.88 -59.72 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.47 -0.332 . . . . 74.109999999999999 111.326 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 32' ' ' ASP . 9.0 t -81.38 -0.27 40.55 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.62 -0.263 . . . . 62.32 111.522 -173.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.6 t -61.74 -19.25 62.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.047 0.451 . . . . 64.099999999999994 109.978 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.817 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 21.3 p -55.8 137.19 50.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.655 -0.702 . . . . 63.009999999999998 110.648 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -74.46 -72.22 0.3 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.453 0.168 . . . . 71.109999999999999 110.701 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -136.2 121.91 19.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.559 0.219 . . . . 72.010000000000005 111.372 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 48.78 26.56 1.3 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.515 0.726 . . . . 73.340000000000003 112.895 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.776 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.7 mm -71.22 126.15 31.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 110.009 -0.367 . . . . 63.009999999999998 110.009 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.501 HD12 HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -75.63 107.49 7.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 72.030000000000001 109.641 -178.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 36.5 mm -92.64 133.3 34.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.225 -0.898 . . . . 74.230000000000004 109.887 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.501 HD11 HD12 ' A' ' 43' ' ' LEU . 4.1 mp -121.66 149.66 42.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.994 -0.743 . . . . 73.530000000000001 108.994 173.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 66.9 t -136.79 104.76 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.239 -0.652 . . . . 63.539999999999999 109.239 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -90.97 154.54 19.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.33 0.586 . . . . 44.140000000000001 110.499 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -131.4 111.69 12.05 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.345 -1.354 . . . . 74.430000000000007 107.345 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -120.84 141.78 50.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.241 0.543 . . . . 75.319999999999993 110.789 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.644 ' HB3' HG23 ' A' ' 96' ' ' ILE . . . -128.01 126.41 23.75 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.317 -0.856 . . . . 72.319999999999993 108.988 173.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.45 76.37 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.5 2.134 . . . . 73.109999999999999 111.927 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -163.94 27.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.704 0.764 . . . . 72.409999999999997 109.391 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 3.6 p -130.06 167.43 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.784 . . . . 74.120000000000005 110.521 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.95 -68.83 0.98 Allowed Glycine 0 CA--C 1.522 0.485 0 CA-C-N 116.205 -0.452 . . . . 72.420000000000002 112.853 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.404 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 58.9 Cg_exo -52.95 -23.04 20.03 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.251 2.634 . . . . 75.010000000000005 113.507 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 3.6 p -61.7 -25.47 67.44 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.67 -0.241 . . . . 24.449999999999999 110.976 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HD3' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.14 -50.27 67.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.021 0.439 . . . . 72.030000000000001 110.016 176.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.692 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.6 m -75.06 -39.62 60.81 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.255 0.55 . . . . 74.420000000000002 110.646 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.674 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 3.2 mm? -58.59 -37.83 76.66 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.673 0.62 . . . . 64.099999999999994 112.673 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 45.1 mt-10 -56.85 -61.02 7.72 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.057 0.389 . . . . 74.219999999999999 110.988 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 18.3 Cg_endo -60.2 -38.9 73.11 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.599 1.533 . . . . 72.0 111.942 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.692 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.6 mt-30 -61.45 -41.15 96.76 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.688 -0.405 . . . . 75.239999999999995 111.012 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 66.7 mt -65.92 -50.91 62.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 62.350000000000001 110.302 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 22.7 mt-10 -65.04 -27.57 68.89 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.68 -0.408 . . . . 74.099999999999994 110.88 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -72.59 -49.45 32.18 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.819 0.343 . . . . 72.109999999999999 110.442 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.01 -31.55 72.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.841 -0.429 . . . . 61.020000000000003 109.841 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.491 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.37 -48.2 80.82 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.939 -0.573 . . . . 62.520000000000003 109.711 174.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.495 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 96.0 mt-30 -57.52 -42.21 82.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.902 0.382 . . . . 74.25 110.981 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -69.16 -42.67 75.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.593 . . . . 73.420000000000002 111.443 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -105.15 5.96 32.71 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.131 0.789 . . . . 74.129999999999995 113.131 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.5 t -52.98 -19.91 3.0 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.977 1.103 . . . . 65.109999999999999 113.977 -168.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -73.42 -29.24 62.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.016 0.436 . . . . 64.200000000000003 110.685 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -115.97 -13.85 11.26 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.669 -0.696 . . . . 71.120000000000005 111.346 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.43 HG23 HD11 ' A' ' 127' ' ' ILE . 35.5 t -120.43 133.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.791 0.329 . . . . 65.239999999999995 111.677 -173.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -136.16 119.81 17.17 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.769 -0.651 . . . . 71.030000000000001 109.299 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.464 HG12 HD13 ' A' ' 45' ' ' LEU . 43.3 mt -104.82 137.19 35.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.162 0.506 . . . . 51.350000000000001 110.639 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.435 ' CE2' ' HB3' ' A' ' 34' ' ' LYS . 73.9 m-85 -125.9 169.19 12.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.607 -0.886 . . . . 74.25 108.607 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.519 ' HB3' ' HZ3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -139.72 129.93 25.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.898 0.38 . . . . 75.400000000000006 110.54 172.319 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.527 HD12 ' HA2' ' A' ' 27' ' ' GLY . 5.7 tp -79.87 78.7 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 109.252 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -112.54 -17.41 12.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.766 -0.652 . . . . 54.25 111.76 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.433 ' HB ' ' HA3' ' A' ' 27' ' ' GLY . 54.0 mt -64.46 92.44 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.464 0.65 . . . . 73.239999999999995 109.889 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 85' ' ' GLN . 10.3 pt-20 -54.72 -29.21 52.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.654 -1.157 . . . . 53.210000000000001 112.842 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.42 -19.25 62.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.394 0.616 . . . . 71.340000000000003 110.272 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 1.4 m120 -134.66 42.81 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.068 -0.969 . . . . 74.340000000000003 108.943 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.575 ' HB3' HD23 ' A' ' 12' ' ' LEU . 17.5 tp60 -71.95 -14.73 61.99 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.895 -1.048 . . . . 71.209999999999994 111.464 -176.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 34.6 t70 -46.14 -39.66 9.87 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.288 0.847 . . . . 71.340000000000003 113.288 -168.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 80.0 t -52.94 -40.96 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.903 0.383 . . . . 51.43 111.313 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.14 93.11 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.101 -0.499 . . . . 64.409999999999997 110.36 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 m -69.79 -33.73 72.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.681 -0.69 . . . . 72.140000000000001 110.622 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 45.0 mt-30 -65.43 -56.52 12.05 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 110.622 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -70.53 -25.22 63.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.158 -0.474 . . . . 75.0 110.938 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.23 60.89 1.1 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.889 -0.672 . . . . 62.350000000000001 113.222 173.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -82.4 94.79 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.669 -0.493 . . . . 54.5 109.669 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 t -107.12 -12.17 15.46 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.165 -0.47 . . . . 74.340000000000003 111.375 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.58 147.67 25.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.639 -0.255 . . . . 74.519999999999996 110.68 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.706 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 67.2 mt -57.32 -51.76 79.32 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.315 -0.402 . . . . 75.329999999999998 110.887 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.706 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 69.8 Cg_endo -102.5 100.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.942 2.428 . . . . 71.340000000000003 111.751 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.1 m -124.97 116.21 21.8 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.284 -0.26 . . . . 73.049999999999997 110.906 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.64 113.95 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.421 -0.354 . . . . 75.239999999999995 110.39 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.2 mp -92.05 143.18 26.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.257 -0.645 . . . . 50.409999999999997 109.257 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 109' ' ' SER . 47.1 mtp -113.97 146.22 40.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.892 0.377 . . . . 71.510000000000005 110.042 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.571 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.7 m-85 -145.73 160.03 42.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.371 -0.974 . . . . 51.109999999999999 108.371 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -149.8 117.47 6.2 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.494 -0.483 . . . . 74.129999999999995 110.863 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.817 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.0 t30 60.15 25.3 14.63 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.805 -0.634 . . . . 72.409999999999997 110.731 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.61 -14.66 63.42 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 116.121 -0.49 . . . . 44.409999999999997 112.445 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -83.38 152.75 24.89 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 122.51 0.324 . . . . 72.299999999999997 110.374 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -64.93 157.22 28.67 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.65 0.738 . . . . 63.439999999999998 111.206 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.32 168.78 21.69 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.965 -1.494 . . . . 71.120000000000005 106.965 -166.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 101' ' ' MET . 58.5 m -69.9 -177.67 1.36 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.066 0.46 . . . . 72.510000000000005 111.69 -167.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -148.83 120.15 7.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.031 -0.359 . . . . 54.340000000000003 110.031 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.4 t -93.62 107.48 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.999 -0.546 . . . . 64.510000000000005 110.106 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -88.82 102.07 12.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.109 -0.7 . . . . 74.099999999999994 109.109 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 117.49 162.79 12.66 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.618 -0.593 . . . . 71.329999999999998 111.618 -177.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.539 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -88.43 72.19 8.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.954 0.407 . . . . 72.510000000000005 110.224 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.38 94.46 4.98 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 116.025 -0.534 . . . . 73.219999999999999 110.113 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.405 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.37 -33.95 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 115.673 -0.694 . . . . 72.219999999999999 110.172 -175.184 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -59.61 -47.62 84.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.247 -0.433 . . . . 73.030000000000001 110.631 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -69.15 -42.02 76.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 71.129999999999995 110.269 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 123' ' ' ILE . 78.9 mt -55.54 -56.21 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.736 0.303 . . . . 72.129999999999995 110.897 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.1 tt -66.01 -33.9 66.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.784 0.326 . . . . 70.030000000000001 110.387 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.6 t -55.14 -52.32 63.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.044 -0.525 . . . . 64.519999999999996 110.477 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 18.6 mm-40 -72.18 -37.17 69.38 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.248 -0.433 . . . . 74.329999999999998 110.664 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 119' ' ' ILE . 49.3 mt -52.32 -56.12 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.898 0.38 . . . . 75.420000000000002 110.09 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.75 -43.66 92.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.159 -0.473 . . . . 64.209999999999994 110.196 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 8.3 t30 -58.12 -30.25 66.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.96 -0.564 . . . . 73.420000000000002 111.65 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -99.17 -29.27 12.94 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.645 0.609 . . . . 71.239999999999995 112.645 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 74' ' ' VAL . 66.3 mt -72.74 -48.83 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 117.947 0.339 . . . . 71.319999999999993 110.301 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.41 -0.805 . . . . 62.210000000000001 110.466 178.782 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.457 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.85 -0.426 . . . . 73.129999999999995 109.85 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.13 127.25 22.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 75.340000000000003 110.286 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -128.93 -48.09 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 75.239999999999995 110.602 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -151.32 119.44 6.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.494 -0.321 . . . . 74.319999999999993 110.171 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -91.04 154.6 19.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 74.430000000000007 110.712 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -76.06 130.64 38.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.724 -0.671 . . . . 71.319999999999993 111.095 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -138.2 125.5 21.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.957 -0.757 . . . . 64.120000000000005 108.957 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -85.46 126.25 33.66 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.848 -0.427 . . . . 72.230000000000004 109.848 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.2 ttm -72.59 93.62 1.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.822 -0.436 . . . . 70.340000000000003 109.822 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.94 179.74 28.98 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.733 -0.667 . . . . 72.319999999999993 111.655 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.404 ' HA ' ' OD2' ' A' ' 83' ' ' ASP . 72.5 m -146.57 121.02 9.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.913 -0.403 . . . . 62.43 109.913 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.8 mt -130.23 166.13 20.96 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.982 0.42 . . . . 60.310000000000002 111.155 -173.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.54 -177.66 6.63 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.856 -0.611 . . . . 75.099999999999994 109.862 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.38 -68.86 0.64 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.849 0.357 . . . . 44.32 110.565 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.67 141.84 47.54 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.486 -0.561 . . . . 74.299999999999997 109.486 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.461 ' HB ' ' OE1' ' A' ' 17' ' ' GLN . 5.7 m -63.74 -52.19 61.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.252 -0.431 . . . . 75.319999999999993 111.427 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.461 ' OE1' ' HB ' ' A' ' 16' ' ' THR . 4.2 pm0 -126.17 -169.06 1.95 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 71.299999999999997 110.842 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.53 168.22 19.64 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.899 -0.881 . . . . 61.509999999999998 110.899 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.87 13.41 1.0 Allowed 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.791 2.328 . . . . 75.230000000000004 112.995 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.69 35.2 66.86 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.405 -0.678 . . . . 74.150000000000006 111.405 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 p -65.4 151.64 45.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.3 -0.45 . . . . 51.039999999999999 111.497 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 79.9 mmm -57.04 -36.37 70.41 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.782 -0.821 . . . . 73.409999999999997 108.782 171.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 mm -59.75 108.81 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 114.725 -1.125 . . . . 71.120000000000005 109.046 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -73.08 154.14 40.54 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.874 0.369 . . . . 74.319999999999993 111.115 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -118.88 134.67 55.02 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.167 0.587 . . . . 73.510000000000005 110.309 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 31' ' ' PHE . 41.7 pt -150.09 179.63 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.348 0.594 . . . . 33.130000000000003 111.421 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 30' ' ' GLU . . . -131.67 -159.16 9.34 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.323 -0.853 . . . . 72.209999999999994 111.036 172.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 11.0 p-10 -65.96 -46.2 78.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.026 0.441 . . . . 55.43 110.916 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.3 m -65.71 -29.16 69.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.703 -0.68 . . . . 73.439999999999998 110.668 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.409 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 17.2 mm-40 -95.39 -10.18 30.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.963 -0.562 . . . . 74.209999999999994 111.118 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.536 ' HA ' HD12 ' A' ' 26' ' ' ILE . 88.1 t80 -61.77 -61.87 2.2 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.543 -0.54 . . . . 64.010000000000005 109.543 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -57.76 -47.6 82.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.915 -0.584 . . . . 52.229999999999997 110.058 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -51.22 -57.74 8.0 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.577 -0.738 . . . . 74.129999999999995 110.84 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -80.08 -26.18 39.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.972 -1.013 . . . . 63.210000000000001 111.683 -168.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.447 ' HA ' HD13 ' A' ' 44' ' ' ILE . 79.4 t -78.81 -39.37 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.735 -0.212 . . . . 62.299999999999997 111.401 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.5 p -84.89 -37.14 20.96 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.934 0.346 . . . . 60.210000000000001 111.934 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.5 t -69.06 -13.07 62.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.472 0.545 . . . . 64.230000000000004 112.472 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.903 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 28.4 p -57.13 142.0 44.13 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.166 -0.309 . . . . 71.140000000000001 110.166 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -61.65 -82.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.387 0.514 . . . . 43.409999999999997 112.387 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -160.46 143.41 13.33 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.641 -0.254 . . . . 72.109999999999999 110.492 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 61.3 8.2 2.01 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.654 0.596 . . . . 71.230000000000004 111.796 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 mm -73.24 102.52 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.193 0.521 . . . . 72.230000000000004 110.51 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.412 ' HB3' HG22 ' A' ' 74' ' ' VAL . 3.2 tm? -71.85 108.16 4.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.191 -0.913 . . . . 63.450000000000003 109.165 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 35' ' ' VAL . 70.3 mt -102.01 137.18 30.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.437 -0.801 . . . . 73.439999999999998 111.005 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.614 HD13 HG13 ' A' ' 76' ' ' ILE . 3.4 mp -118.14 148.94 41.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.924 -0.769 . . . . 71.530000000000001 108.924 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.5 t -130.59 104.82 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.535 -0.542 . . . . 74.349999999999994 109.535 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -88.11 126.63 35.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 75.510000000000005 110.599 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 100' ' ' LEU . 17.7 m-85 -89.85 133.14 34.9 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.116 -0.698 . . . . 74.450000000000003 109.116 169.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.418 ' HE1' ' HA ' ' A' ' 80' ' ' ASN . 88.6 m95 -56.31 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.32 0.581 . . . . 74.540000000000006 111.252 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 97' ' ' PRO . . . -78.21 141.99 62.98 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.132 -0.94 . . . . 41.520000000000003 111.297 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.67 115.36 2.39 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.923 1.749 . . . . 61.240000000000002 110.1 169.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -51.49 101.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.086 0.47 . . . . 75.329999999999998 111.433 -172.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 20.1 p -86.75 -174.69 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.604 -0.725 . . . . 75.140000000000001 110.777 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.45 -64.4 3.63 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.156 -0.475 . . . . 54.409999999999997 112.007 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.69 -28.71 57.97 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.783 2.322 . . . . 65.049999999999997 111.945 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 72.5 m -54.5 -25.76 27.47 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.638 -0.71 . . . . 61.219999999999999 111.612 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -53.37 -45.83 69.38 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.93 0.395 . . . . 71.299999999999997 110.545 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.5 m -75.72 -32.5 60.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.133 -0.485 . . . . 40.210000000000001 111.223 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 1.4 mm? -57.95 -45.5 86.55 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.518 0.933 . . . . 50.530000000000001 113.518 -164.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.521 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 7.9 mp0 -53.77 -60.47 7.14 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-N 118.734 0.697 . . . . 71.230000000000004 110.529 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.538 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 39.3 Cg_endo -67.31 -19.72 49.66 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.792 1.661 . . . . 71.510000000000005 112.548 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.492 ' NE2' HG21 ' A' ' 116' ' ' ILE . 3.4 mm100 -66.47 -52.78 42.52 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 110.263 -0.273 . . . . 72.310000000000002 110.263 174.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.486 HD21 HD13 ' A' ' 119' ' ' ILE . 97.2 mt -62.48 -40.9 98.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.474 -0.565 . . . . 73.319999999999993 109.474 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.6 mm-40 -58.17 -42.83 86.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.666 -0.697 . . . . 74.129999999999995 111.025 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.403 ' HB3' ' HZ3' ' A' ' 65' ' ' LYS . 7.1 ttpm? -63.91 -50.74 67.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.898 0.38 . . . . 71.319999999999993 110.244 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.5 mt -64.9 -32.42 74.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.953 -0.567 . . . . 61.450000000000003 110.248 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.477 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.6 -53.9 44.39 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.197 -0.456 . . . . 43.200000000000003 109.824 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 55.2 mt-30 -57.28 -38.94 74.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.014 -0.539 . . . . 73.439999999999998 111.019 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.49 -42.55 52.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.887 -0.597 . . . . 75.5 111.389 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -104.86 5.07 32.71 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.743 0.646 . . . . 71.200000000000003 112.743 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.8 t -52.88 -21.31 4.13 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.747 0.647 . . . . 60.100000000000001 112.747 -169.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.73 -39.13 90.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.822 0.344 . . . . 71.239999999999995 110.408 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -120.69 -1.86 9.96 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.77 -0.65 . . . . 74.519999999999996 111.575 -176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.542 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 43.0 t -128.44 131.58 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 112.054 0.391 . . . . 73.099999999999994 112.054 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HD2' ' O ' ' A' ' 74' ' ' VAL . 13.6 mptt -138.92 122.96 17.91 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.034 -0.53 . . . . 71.129999999999995 109.939 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.614 HG13 HD13 ' A' ' 45' ' ' LEU . 3.3 mp -99.21 146.12 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.7 -0.481 . . . . 72.109999999999999 109.7 176.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.407 ' CD1' HG23 ' A' ' 44' ' ' ILE . 97.5 m-85 -132.0 142.74 49.69 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.738 0.415 . . . . 74.230000000000004 110.318 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -111.22 132.42 54.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.861 0.465 . . . . 74.430000000000007 110.015 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -86.29 99.16 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.549 -0.908 . . . . 73.430000000000007 108.549 174.133 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.418 ' HA ' ' HE1' ' A' ' 49' ' ' TRP . 15.6 m120 -80.66 -48.36 12.73 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.539 0.57 . . . . 44.450000000000003 112.539 -171.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.535 ' HB ' ' OD1' ' A' ' 84' ' ' ASN . 49.7 mt -78.56 106.92 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 74.439999999999998 111.093 -173.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.79 -17.91 52.13 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.168 -0.469 . . . . 74.129999999999995 111.464 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.441 ' HB2' HG22 ' A' ' 81' ' ' ILE . 2.7 m-20 -70.02 -20.36 63.27 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.041 0.448 . . . . 71.299999999999997 109.827 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.535 ' OD1' ' HB ' ' A' ' 81' ' ' ILE . 10.3 m120 -84.17 41.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.786 -0.643 . . . . 65.230000000000004 109.723 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -55.07 -24.92 27.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.424 -0.807 . . . . 74.450000000000003 111.265 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -40.36 -55.94 2.11 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.55 -0.75 . . . . 71.099999999999994 112.119 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.08 -37.82 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.31 -0.404 . . . . 61.219999999999999 111.035 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.88 -54.79 16.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.066 0.46 . . . . 41.450000000000003 110.595 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 m -67.36 -35.89 80.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.753 -0.658 . . . . 40.240000000000002 111.141 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.405 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 14.0 mm-40 -75.27 -41.34 57.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.595 . . . . 74.040000000000006 111.537 -175.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -88.79 -12.13 42.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.796 0.331 . . . . 72.310000000000002 110.779 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.48 45.33 8.75 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.917 -0.659 . . . . 72.409999999999997 112.576 172.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.08 94.84 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.469 -0.567 . . . . 75.040000000000006 109.469 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.1 m -58.93 -39.24 80.99 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.751 -0.659 . . . . 73.209999999999994 112.047 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.18 144.83 51.15 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.16 -0.311 . . . . 74.340000000000003 110.16 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.474 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 59.9 mt -54.67 -49.67 90.01 Favored Pre-proline 0 CA--C 1.541 0.597 0 O-C-N 123.21 0.319 . . . . 62.009999999999998 111.792 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.517 ' HA ' ' HB2' ' A' ' 50' ' ' ALA . 56.5 Cg_endo -69.37 82.02 0.69 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 121.868 1.712 . . . . 75.430000000000007 112.125 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.6 m -146.54 142.64 28.23 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.231 0.538 . . . . 72.340000000000003 111.543 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 mp -115.71 120.65 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.268 -0.878 . . . . 74.530000000000001 109.369 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 48' ' ' PHE . 9.3 mp -97.43 135.13 39.75 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.895 -0.409 . . . . 72.430000000000007 109.895 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.505 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 42.0 mtp -101.87 146.8 27.32 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.077 -0.342 . . . . 73.140000000000001 110.077 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -148.04 158.47 44.08 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.398 -0.593 . . . . 72.310000000000002 109.398 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -141.89 106.73 4.9 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 120.729 -0.388 . . . . 71.409999999999997 111.371 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.903 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.4 t30 60.78 27.56 17.33 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.481 0.657 . . . . 65.450000000000003 110.579 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.84 -10.11 75.28 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.777 -0.647 . . . . 44.219999999999999 112.33 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -70.08 132.04 45.23 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 109.593 -0.521 . . . . 75.230000000000004 109.593 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -62.07 143.33 56.78 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 124.132 0.895 . . . . 64.310000000000002 109.348 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.505 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.7 tp -155.84 168.28 27.71 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.102 -0.703 . . . . 75.420000000000002 109.102 -164.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.1 m -69.8 171.92 8.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.42 0.629 . . . . 71.109999999999999 112.49 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -131.05 133.91 46.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.717 -0.674 . . . . 74.040000000000006 110.489 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.42 HG22 ' HG3' ' A' ' 118' ' ' LYS . 46.2 t -103.77 120.36 53.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.907 -0.588 . . . . 74.340000000000003 109.725 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.1 mp -97.79 125.05 51.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.664 -0.495 . . . . 72.239999999999995 109.664 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.25 -174.27 53.52 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.292 -0.48 . . . . 44.340000000000003 112.33 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -87.16 86.4 7.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.687 0.279 . . . . 61.409999999999997 110.436 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 119' ' ' ILE . 65.4 t0 -123.79 87.83 2.81 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.605 0.717 . . . . 75.030000000000001 109.776 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.492 HG21 ' NE2' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -65.56 -29.39 46.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.263 -0.88 . . . . 74.230000000000004 109.532 -176.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.9 t -61.86 -48.74 79.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.917 -0.583 . . . . 71.549999999999997 109.716 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HG3' HG22 ' A' ' 111' ' ' VAL . 58.4 tptt -63.22 -43.3 98.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.132 -0.486 . . . . 73.310000000000002 110.167 177.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.486 HD13 HD21 ' A' ' 63' ' ' LEU . 82.7 mt -56.62 -56.46 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.225 -0.443 . . . . 53.350000000000001 111.293 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.26 -34.13 68.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.662 0.267 . . . . 75.519999999999996 110.472 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.7 t -56.53 -51.56 68.09 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.109 -0.496 . . . . 73.209999999999994 109.868 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -65.64 -40.17 92.21 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.155 -0.475 . . . . 72.510000000000005 110.728 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 119' ' ' ILE . 64.8 mt -54.85 -55.9 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.657 0.265 . . . . 70.299999999999997 110.417 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -64.46 -36.93 85.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.6 -0.273 . . . . 73.439999999999998 110.321 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -67.11 -26.4 66.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.041 -0.527 . . . . 43.530000000000001 111.257 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -101.03 -13.74 18.11 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.878 0.325 . . . . 70.140000000000001 111.878 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 123' ' ' ILE . 54.5 mt -85.94 -54.48 8.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.722 0.296 . . . . 71.120000000000005 110.395 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.661 -0.685 . . . . 54.0 110.922 -177.328 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.514 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.183 -0.303 . . . . 52.210000000000001 110.183 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.6 87.85 0.22 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.247 -0.433 . . . . 44.549999999999997 111.792 -175.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -75.49 72.46 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.214 -1.032 . . . . 73.5 108.214 171.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -57.37 114.15 2.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.178 -0.919 . . . . 61.219999999999999 111.755 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -65.25 102.26 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.384 -0.825 . . . . 75.099999999999994 109.458 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -82.37 93.45 7.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.005 -0.543 . . . . 63.240000000000002 110.941 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -99.4 121.79 41.61 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.087 -0.506 . . . . 73.230000000000004 110.294 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -158.87 99.8 1.56 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.592 -0.522 . . . . 72.239999999999995 109.592 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.486 ' SD ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -113.86 143.22 45.04 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.964 -0.754 . . . . 62.520000000000003 108.964 178.821 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' O ' ' SD ' ' A' ' 9' ' ' MET . . . -98.85 160.83 20.2 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.175 -0.536 . . . . 34.549999999999997 112.817 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.0 p -91.99 -68.54 0.79 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.88 0.372 . . . . 75.150000000000006 110.016 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.651 HD23 ' H ' ' A' ' 12' ' ' LEU . 2.4 pt? -118.99 123.96 45.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.415 -0.587 . . . . 73.420000000000002 109.415 172.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -65.55 -57.96 6.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 75.209999999999994 110.75 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -169.86 160.4 8.48 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.391 -0.368 . . . . 62.310000000000002 110.881 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -136.52 160.0 40.09 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.35 -0.611 . . . . 65.129999999999995 109.35 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.7 p -121.72 -73.35 0.65 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.855 -0.157 . . . . 64.340000000000003 110.982 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 59.61 36.55 22.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.258 0.551 . . . . 74.120000000000005 110.084 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.78 172.1 46.61 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.527 -0.761 . . . . 72.340000000000003 113.603 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -90.88 -157.47 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.625 2.884 . . . . 61.039999999999999 112.795 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.0 56.75 4.59 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 114.839 0.696 . . . . 71.230000000000004 114.839 -170.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t 64.99 120.73 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.357 0.598 . . . . 44.219999999999999 112.553 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -75.64 -71.54 0.36 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.537 -0.756 . . . . 71.019999999999996 110.918 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -105.19 100.56 10.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 109.66 -0.496 . . . . 74.219999999999999 109.66 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 30.3 tt0 -93.62 112.11 23.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.938 0.399 . . . . 65.129999999999995 110.435 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -75.8 133.2 40.72 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.938 0.399 . . . . 73.409999999999997 110.889 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 39.6 pt -144.8 179.64 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.271 -0.422 . . . . 63.32 110.806 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.48 -176.09 15.59 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.969 -0.852 . . . . 54.119999999999997 110.969 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 84' ' ' ASN . 27.6 t70 -66.72 -28.63 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.014 0.435 . . . . 55.420000000000002 110.334 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.9 m -65.58 -34.86 79.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.779 -0.646 . . . . 75.140000000000001 110.718 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 2.3 mp0 -92.38 -22.24 19.78 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.575 -0.284 . . . . 73.150000000000006 110.824 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.622 ' HE1' HG21 ' A' ' 46' ' ' VAL . 70.4 t80 -46.77 -61.46 1.84 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.314 0.383 . . . . 73.519999999999996 111.932 -173.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -63.05 -40.91 99.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.444 -0.344 . . . . 53.329999999999998 110.497 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' SER . 36.9 m-80 -58.65 -41.68 86.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.796 -0.638 . . . . 63.219999999999999 110.678 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -72.04 -43.72 64.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.886 -0.597 . . . . 74.530000000000001 110.156 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 31' ' ' PHE . 91.0 t -62.6 -40.68 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.954 -0.566 . . . . 61.119999999999997 110.809 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.4 p -80.65 -25.61 38.2 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.148 0.425 . . . . 74.439999999999998 112.148 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 22.3 t -67.69 -14.23 62.77 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.92 0.341 . . . . 63.310000000000002 111.92 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.78 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 27.6 p -56.84 129.79 42.92 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.102 -0.332 . . . . 72.109999999999999 110.102 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.39 -71.38 0.14 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.675 0.274 . . . . 51.210000000000001 110.781 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -161.59 135.57 6.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.453 -0.34 . . . . 62.409999999999997 110.45 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.42 ' H ' ' HB2' ' A' ' 104' ' ' ASN . 96.0 m-20 61.37 2.31 0.63 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.957 0.725 . . . . 74.319999999999993 112.957 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.681 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.0 mm -62.29 130.7 27.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.895 0.378 . . . . 75.239999999999995 110.388 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER -93.01 112.85 24.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 72.420000000000002 109.612 -178.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 38' ' ' CYS . 73.7 mt -107.67 123.06 62.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.819 -0.628 . . . . 61.130000000000003 110.313 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.651 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -105.97 146.14 30.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.142 -0.688 . . . . 63.329999999999998 109.142 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.622 HG21 ' HE1' ' A' ' 31' ' ' PHE . 61.8 t -125.26 104.72 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.724 -0.473 . . . . 70.040000000000006 109.724 177.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -94.83 112.85 24.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.669 . . . . 63.32 109.768 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 17.1 m-85 -65.61 169.97 5.63 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.939 0.399 . . . . 64.25 111.099 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -94.54 130.99 40.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.064 -0.516 . . . . 73.5 110.536 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.88 101.14 31.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 73.5 110.117 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.04 -34.59 97.97 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.707 2.271 . . . . 63.32 111.981 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -153.77 129.59 10.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 72.329999999999998 109.89 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.6 t -173.74 125.12 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.351 -0.386 . . . . 43.43 110.253 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -65.48 -75.57 0.4 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 121.39 -0.433 . . . . 74.200000000000003 112.663 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.54 -28.46 45.49 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.165 2.577 . . . . 65.019999999999996 112.913 -175.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 70.9 m -57.25 -22.62 42.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 72.230000000000004 111.875 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 7.0 ptp85 -57.37 -36.82 71.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.525 0.202 . . . . 74.120000000000005 110.579 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.643 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 9.6 m -74.84 -40.47 61.01 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.773 0.797 . . . . 72.109999999999999 110.289 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.4 mm? -58.01 -38.67 76.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.22 -0.9 . . . . 73.409999999999997 111.415 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 55.2 mt-10 -54.64 -63.2 3.05 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 119.399 -0.334 . . . . 52.340000000000003 111.339 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.43 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 17.8 Cg_endo -60.24 -38.86 72.99 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 121.827 1.684 . . . . 73.129999999999995 112.118 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 58' ' ' SER . 46.4 mt-30 -57.73 -42.54 84.09 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.548 -0.461 . . . . 74.129999999999995 111.184 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.466 HD21 HD13 ' A' ' 119' ' ' ILE . 93.9 mt -68.97 -45.75 69.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.391 . . . . 54.310000000000002 110.467 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 44.7 mt-10 -56.84 -36.77 70.38 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.065 0.46 . . . . 74.310000000000002 109.904 176.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -66.89 -52.4 43.81 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.661 -0.699 . . . . 73.140000000000001 110.471 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 36.4 mt -59.75 -34.14 72.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.584 . . . . 64.409999999999997 109.891 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -60.64 -53.56 55.95 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.666 -0.697 . . . . 52.409999999999997 109.353 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 51.5 mt-30 -53.77 -42.13 67.91 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.235 -0.439 . . . . 75.310000000000002 110.961 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -65.88 -46.31 78.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.805 -0.634 . . . . 71.140000000000001 111.37 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -104.98 4.7 32.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.772 0.656 . . . . 73.010000000000005 112.772 -171.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.4 t -53.29 -20.59 4.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.232 1.197 . . . . 73.420000000000002 114.232 -168.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -73.12 -23.54 60.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.95 0.405 . . . . 73.340000000000003 110.835 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -118.83 -16.17 9.33 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.808 -0.633 . . . . 71.299999999999997 110.629 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.63 HG23 HD11 ' A' ' 127' ' ' ILE . 20.6 t -119.38 133.4 66.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.096 -0.502 . . . . 75.340000000000003 111.387 -173.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -131.76 119.85 21.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.511 -0.768 . . . . 73.349999999999994 109.239 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.651 HG12 ' HB2' ' A' ' 45' ' ' LEU . 71.7 mt -99.32 139.44 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.972 -0.381 . . . . 71.200000000000003 109.972 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 96.5 m-85 -129.82 151.47 50.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.951 -0.568 . . . . 75.540000000000006 110.032 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -134.14 109.93 9.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.041 0.448 . . . . 71.140000000000001 110.466 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.3 pp -78.56 70.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.733 0.778 . . . . 72.109999999999999 110.368 176.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.57 -13.0 60.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.385 -0.825 . . . . 75.140000000000001 111.077 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 60.4 mt -67.12 108.56 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 110.105 -0.331 . . . . 74.540000000000006 110.105 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -36.12 64.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.101 -0.5 . . . . 73.299999999999997 111.888 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.63 -22.22 61.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.542 . . . . 43.130000000000003 110.927 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.444 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.9 OUTLIER -102.62 23.12 12.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.945 -0.571 . . . . 60.509999999999998 111.539 -175.283 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.51 12.81 1.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.84 0.311 . . . . 72.209999999999994 111.84 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.592 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 30.4 t70 -53.11 -36.78 61.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.864 0.364 . . . . 73.109999999999999 110.637 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -52.75 -35.25 21.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.817 -0.629 . . . . 75.540000000000006 110.638 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.404 ' HB2' ' HE2' ' A' ' 48' ' ' PHE . . . -62.97 -50.23 71.59 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.903 -0.589 . . . . 52.200000000000003 110.335 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.1 m -66.7 -31.33 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.656 -0.702 . . . . 64.150000000000006 110.781 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 32.6 mm-40 -67.98 -53.85 22.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.21 -0.45 . . . . 63.200000000000003 110.928 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -91.71 -2.36 57.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.165 -0.47 . . . . 65.430000000000007 112.028 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.46 71.37 1.16 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.814 -0.708 . . . . 75.540000000000006 112.384 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' A' ' 48' ' ' PHE . 98.4 t -104.51 101.04 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 63.039999999999999 110.363 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.8 t -94.6 -35.22 12.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 61.210000000000001 109.904 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.94 146.07 37.78 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.924 -0.58 . . . . 70.450000000000003 110.783 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.684 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 65.2 mt -69.09 -54.54 11.79 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.481 -0.327 . . . . 64.230000000000004 110.937 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.684 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 5.1 Cg_endo -85.0 93.79 0.68 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.142 1.895 . . . . 61.509999999999998 110.943 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 90.7 m -127.65 132.6 49.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.042 0.449 . . . . 53.229999999999997 111.208 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.6 mp -115.78 122.65 69.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.629 -0.714 . . . . 73.030000000000001 109.829 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.487 HD23 ' HG3' ' A' ' 110' ' ' GLN . 90.6 mt -98.68 125.26 43.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.664 -0.495 . . . . 74.400000000000006 109.664 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.549 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 52.9 mtp -98.46 147.73 24.45 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.964 -0.384 . . . . 63.420000000000002 109.964 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.73 150.78 36.88 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.096 -0.705 . . . . 74.140000000000001 109.096 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.531 ' HB2' HD22 ' A' ' 108' ' ' LEU . 61.9 tttp -139.54 106.78 5.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 120.907 -0.317 . . . . 74.209999999999994 111.024 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.78 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.4 t30 59.08 30.9 20.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.698 0.761 . . . . 51.210000000000001 110.444 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.87 -13.99 61.48 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.639 -0.71 . . . . 70.040000000000006 112.25 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -70.37 138.07 51.06 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 110.038 -0.356 . . . . 63.409999999999997 110.038 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -56.86 152.73 12.12 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.231 0.957 . . . . 72.239999999999995 109.447 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.549 ' HB3' ' C ' ' A' ' 101' ' ' MET . 11.5 tp -162.82 168.79 20.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.512 -0.767 . . . . 75.420000000000002 109.893 -165.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.7 m -69.19 164.04 23.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.787 0.803 . . . . 73.329999999999998 112.411 -164.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.487 ' HG3' HD23 ' A' ' 100' ' ' LEU . 61.8 tt0 -127.65 124.14 37.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.11 -0.95 . . . . 74.120000000000005 109.593 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.8 t -97.66 111.89 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 70.030000000000001 110.234 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.491 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -97.52 109.99 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.805 -0.634 . . . . 73.310000000000002 109.801 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.08 -174.68 23.39 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.043 -0.598 . . . . 44.310000000000002 112.284 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.4 72.29 4.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.188 0.518 . . . . 31.199999999999999 110.808 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.418 ' O ' HG13 ' A' ' 119' ' ' ILE . 0.9 OUTLIER -110.79 77.79 1.07 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.91 -0.586 . . . . 72.420000000000002 109.915 177.288 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -34.72 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.627 -0.715 . . . . 51.340000000000003 110.024 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.1 t -63.52 -42.66 98.45 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.163 -0.471 . . . . 54.530000000000001 110.224 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -65.48 -41.38 93.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 72.349999999999994 109.991 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 123' ' ' ILE . 77.0 mt -59.18 -56.69 15.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.028 -0.533 . . . . 73.530000000000001 110.807 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.7 tt -62.9 -37.08 78.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 116.466 -0.334 . . . . 74.230000000000004 110.439 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.0 t -58.19 -51.9 67.8 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 116.289 -0.414 . . . . 74.549999999999997 110.128 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.87 -39.45 91.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.448 -0.342 . . . . 71.239999999999995 110.633 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 119' ' ' ILE . 74.4 mt -57.54 -56.51 14.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 121.109 -0.236 . . . . 62.219999999999999 111.159 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -71.07 -24.99 62.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.755 -0.378 . . . . 53.119999999999997 110.356 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -66.61 -38.55 87.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.163 0.506 . . . . 75.319999999999993 110.43 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -92.51 -12.79 31.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.291 -0.413 . . . . 65.530000000000001 111.922 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.63 HD11 HG23 ' A' ' 74' ' ' VAL . 62.4 mt -95.97 -60.47 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.769 0.318 . . . . 71.140000000000001 111.431 173.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.751 -0.642 . . . . 62.509999999999998 110.364 -174.913 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 110.026 -0.361 . . . . 63.420000000000002 110.026 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.8 97.39 7.12 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.174 -0.466 . . . . 61.210000000000001 110.69 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -113.29 51.1 0.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.472 0.653 . . . . 74.400000000000006 109.444 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -56.56 137.42 53.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.985 -1.007 . . . . 63.409999999999997 111.416 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -98.22 154.52 17.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.824 -0.626 . . . . 71.420000000000002 109.529 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -149.78 148.86 29.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.516 0.198 . . . . 74.120000000000005 110.548 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -108.77 169.76 8.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 61.329999999999998 109.763 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -147.42 86.03 1.6 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.667 -0.494 . . . . 71.140000000000001 109.667 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.0 ptm -143.36 136.38 27.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.571 -0.74 . . . . 54.530000000000001 109.885 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.21 152.29 7.94 Favored Glycine 0 C--O 1.234 0.153 0 C-N-CA 121.193 -0.527 . . . . 51.549999999999997 111.808 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.9 m -95.95 104.96 16.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.03 0.443 . . . . 72.540000000000006 110.078 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.2 mm? -78.09 95.41 4.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 110.895 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -143.36 122.43 12.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.914 -0.585 . . . . 74.420000000000002 109.681 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -137.39 74.69 1.49 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.17 0.51 . . . . 72.450000000000003 111.106 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -89.69 90.56 8.28 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.281 -0.637 . . . . 74.450000000000003 109.281 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.0 p -74.23 -2.01 23.01 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.445 -0.798 . . . . 62.530000000000001 112.97 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -115.64 135.71 53.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 74.310000000000002 110.657 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.06 156.37 28.09 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.358 -0.697 . . . . 74.430000000000007 111.358 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.09 -26.28 50.45 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.429 2.086 . . . . 72.239999999999995 111.979 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.84 -88.55 0.22 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.97 -0.559 . . . . 65.340000000000003 112.691 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.8 t -152.57 85.84 1.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.917 0.389 . . . . 55.509999999999998 110.137 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 85.5 mmm -91.13 -31.92 16.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.481 . . . . 54.229999999999997 110.265 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 78' ' ' LYS . 21.0 mm -81.09 123.17 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.026 -0.534 . . . . 73.319999999999993 109.561 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -88.99 126.16 35.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.923 0.392 . . . . 73.150000000000006 111.158 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.763 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 10.2 pt20 -82.76 130.94 35.2 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.402 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 31' ' ' PHE . 47.2 pt -141.83 168.17 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.294 0.568 . . . . 71.299999999999997 111.87 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.75 -170.0 12.64 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.188 -0.915 . . . . 22.140000000000001 111.093 173.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.58 -45.28 92.33 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.181 0.515 . . . . 73.400000000000006 110.991 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.8 m -57.38 -28.45 63.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.385 -0.825 . . . . 51.539999999999999 111.592 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.4 mp0 -106.52 -20.42 13.37 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.693 -0.231 . . . . 64.150000000000006 111.582 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.454 ' O ' HG23 ' A' ' 35' ' ' VAL . 91.2 t80 -52.0 -62.01 1.9 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 111.949 0.352 . . . . 74.329999999999998 111.949 -171.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.33 -44.31 79.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.265 -0.425 . . . . 64.120000000000005 110.252 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -59.59 -57.4 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.767 -0.651 . . . . 62.509999999999998 110.883 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 35.7 mmtp -59.31 -32.12 69.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.873 -0.603 . . . . 74.450000000000003 111.342 -174.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 31' ' ' PHE . 96.3 t -78.52 -44.76 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.874 0.324 . . . . 71.530000000000001 111.874 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.3 p -86.01 -14.99 42.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.609 0.596 . . . . 52.409999999999997 112.609 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.3 m -78.11 9.69 3.52 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.804 0.335 . . . . 73.310000000000002 111.605 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.915 ' SG ' ' HB ' ' A' ' 42' ' ' ILE . 41.6 t -67.36 169.1 9.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 75.430000000000007 110.208 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.456 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 45.0 t-20 -114.01 -62.47 1.59 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.951 -0.389 . . . . 74.140000000000001 109.951 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -162.38 138.59 7.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.483 -0.326 . . . . 72.329999999999998 111.368 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 60.15 1.71 0.37 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.092 1.145 . . . . 53.409999999999997 114.092 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.915 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 50.7 mm -79.73 107.03 11.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 118.325 0.511 . . . . 73.329999999999998 110.33 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.6 tp -75.47 129.39 37.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.648 -0.705 . . . . 70.319999999999993 110.274 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.5 mt -116.56 119.92 63.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.631 -0.713 . . . . 62.25 110.488 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.3 mp -108.13 143.57 36.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.908 -0.775 . . . . 64.200000000000003 108.908 175.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.426 HG22 ' HB2' ' A' ' 77' ' ' TYR . 64.3 t -130.0 110.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.719 -0.475 . . . . 74.420000000000002 109.719 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -88.96 143.01 27.16 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.043 0.449 . . . . 73.530000000000001 111.607 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -95.38 118.32 31.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.717 -0.674 . . . . 64.040000000000006 109.912 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.611 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 26.3 t90 -89.27 -55.69 3.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.177 -0.465 . . . . 72.430000000000007 111.915 -172.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 70.44 155.94 0.15 Allowed Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.645 0.591 . . . . 53.310000000000002 110.8 -175.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.8 -29.86 73.86 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.558 2.172 . . . . 72.140000000000001 111.874 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -139.35 106.26 5.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 73.129999999999995 109.805 175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 1.8 p -85.92 -66.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 73.129999999999995 110.767 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.11 -94.12 0.85 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.102 -0.57 . . . . 75.420000000000002 112.429 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 53' ' ' CYS . 31.2 Cg_endo -62.72 -5.37 7.19 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.893 2.395 . . . . 60.140000000000001 112.088 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.441 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 8.9 p -55.31 -20.76 12.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.469 -0.787 . . . . 71.430000000000007 111.495 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -53.72 -46.99 70.99 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.639 -0.255 . . . . 74.510000000000005 111.01 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.622 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.7 m -75.39 -43.49 49.88 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.606 0.717 . . . . 71.219999999999999 111.415 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.477 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.3 mm? -64.88 -33.8 76.88 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.53 -0.759 . . . . 74.319999999999993 112.093 -170.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 13.4 mm-40 -59.34 -59.96 12.12 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 121.043 -0.263 . . . . 70.439999999999998 110.567 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 18.5 Cg_endo -59.6 -42.17 49.72 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 121.829 1.686 . . . . 70.109999999999999 111.992 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.5 mt-30 -57.37 -46.46 83.37 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 120.599 -0.44 . . . . 52.450000000000003 111.422 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.75 -43.82 78.98 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.394 -0.367 . . . . 71.109999999999999 110.617 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HG2' HG12 ' A' ' 23' ' ' ILE . 36.0 mt-10 -63.48 -33.83 76.43 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.648 0.261 . . . . 55.219999999999999 110.509 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -63.18 -54.71 33.39 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.23 0.538 . . . . 74.5 110.146 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.499 HD13 HD13 ' A' ' 120' ' ' ILE . 22.4 mt -63.19 -34.06 76.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.772 -0.649 . . . . 73.239999999999995 110.132 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.516 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -61.58 -43.48 98.78 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.99 -0.55 . . . . 74.239999999999995 110.076 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 97.2 mt-30 -63.7 -48.34 77.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.932 0.396 . . . . 74.120000000000005 110.61 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.85 -43.29 99.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.868 -0.605 . . . . 74.0 111.12 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.91 5.72 33.11 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 112.995 0.739 . . . . 63.140000000000001 112.995 -169.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.6 t -52.87 -23.47 7.12 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.383 0.882 . . . . 71.129999999999995 113.383 -170.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.65 -18.77 60.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.84 0.352 . . . . 73.230000000000004 111.313 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.29 -6.65 4.29 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.964 -0.562 . . . . 63.149999999999999 111.191 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.563 HG23 HD11 ' A' ' 127' ' ' ILE . 39.6 t -128.97 138.42 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.048 0.452 . . . . 53.210000000000001 111.535 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -135.93 127.59 28.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.596 -0.729 . . . . 74.109999999999999 109.063 170.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.1 mt -113.42 114.52 47.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.943 0.401 . . . . 73.450000000000003 110.311 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.426 ' HB2' HG22 ' A' ' 46' ' ' VAL . 98.7 m-85 -93.71 167.32 11.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.747 -0.66 . . . . 73.530000000000001 109.868 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HE3' ' HB2' ' A' ' 49' ' ' TRP . 31.9 tttp -145.15 140.97 28.35 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.348 -0.612 . . . . 65.040000000000006 109.348 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.0 tt -64.01 108.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.215 0.531 . . . . 71.310000000000002 110.811 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.763 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 41.2 t30 -89.62 -52.94 4.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.733 -0.667 . . . . 74.239999999999995 110.32 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.4 mm -74.14 112.6 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.36 -0.836 . . . . 72.129999999999995 110.687 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -59.95 -30.11 68.86 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.551 0.691 . . . . 73.230000000000004 110.381 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.74 -22.65 61.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.512 -0.767 . . . . 62.5 110.497 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -88.95 45.37 1.29 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.454 0.645 . . . . 72.340000000000003 110.721 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.438 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 13.6 pt20 -88.94 -7.53 55.88 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.963 -0.754 . . . . 72.319999999999993 108.963 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 21.5 t70 -48.75 -51.42 29.06 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.252 -0.885 . . . . 50.439999999999998 110.599 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -54.57 -33.9 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.946 -0.57 . . . . 62.399999999999999 111.445 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -66.3 -41.52 89.62 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.427 -0.583 . . . . 72.0 109.427 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.7 m -70.46 -29.72 66.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.615 -0.72 . . . . 55.240000000000002 110.716 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 83.1 mm-40 -70.6 -48.9 52.82 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.224 -0.443 . . . . 63.210000000000001 111.179 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -82.91 -24.81 32.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.353 -0.385 . . . . 73.420000000000002 111.442 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.82 64.67 0.85 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.962 -0.637 . . . . 51.329999999999998 112.593 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.523 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 90.8 t -102.5 102.2 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.615 -0.513 . . . . 71.319999999999993 109.615 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -113.8 8.67 17.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 74.319999999999993 110.429 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.92 151.98 44.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.495 -0.558 . . . . 50.409999999999997 109.495 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.659 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 68.0 mt -63.37 -57.51 19.91 Favored Pre-proline 0 CA--C 1.538 0.493 0 O-C-N 123.077 0.236 . . . . 43.200000000000003 111.114 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 96.6 Cg_endo -86.62 100.78 0.57 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.757 1.638 . . . . 53.219999999999999 111.614 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.4 m -137.36 121.59 18.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.775 0.322 . . . . 73.299999999999997 110.576 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.0 mp -110.17 110.9 33.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.801 -0.636 . . . . 74.319999999999993 109.941 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -88.31 126.04 34.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.625 -0.509 . . . . 73.230000000000004 109.625 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.466 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 33.5 mtp -106.67 140.76 39.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.963 -0.384 . . . . 74.140000000000001 109.963 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -147.27 155.37 41.99 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.993 -0.743 . . . . 75.25 108.993 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -129.07 105.49 8.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.674 -0.41 . . . . 72.230000000000004 110.611 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.567 ' HA ' ' HB3' ' A' ' 38' ' ' CYS . 17.7 t-20 61.27 25.67 15.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.593 0.711 . . . . 64.329999999999998 110.566 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.24 -12.2 70.25 Favored Glycine 0 N--CA 1.454 -0.103 0 CA-C-N 115.831 -0.622 . . . . 62.539999999999999 112.071 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -75.08 139.21 42.65 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 110.02 -0.363 . . . . 65.209999999999994 110.02 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -58.62 145.96 37.83 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 124.405 1.066 . . . . 75.010000000000005 110.813 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 101' ' ' MET . 0.9 OUTLIER -162.34 168.92 21.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 72.319999999999993 109.52 -167.281 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.4 m -69.96 172.32 8.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.143 0.577 . . . . 62.520000000000003 111.927 -168.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.465 ' OE1' ' HG ' ' A' ' 100' ' ' LEU . 26.0 tt0 -142.03 118.48 10.9 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.995 -0.548 . . . . 72.019999999999996 109.613 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.85 107.19 17.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.409 -0.36 . . . . 74.329999999999998 110.064 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 65.0 mt -95.57 104.89 16.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.288 -0.415 . . . . 73.310000000000002 110.243 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.41 148.01 6.8 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.656 -0.578 . . . . 62.329999999999998 111.656 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.477 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -80.1 71.78 6.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.094 0.473 . . . . 52.450000000000003 109.958 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 119' ' ' ILE . 29.5 t70 -122.2 95.72 4.76 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.473 0.654 . . . . 72.209999999999994 109.812 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -62.42 -28.43 44.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.984 -1.007 . . . . 75.409999999999997 110.019 -174.025 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.9 m -62.34 -48.67 78.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.146 -0.479 . . . . 73.349999999999994 110.561 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -67.54 -37.65 83.03 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.725 0.298 . . . . 52.240000000000002 110.207 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 123' ' ' ILE . 75.2 mt -58.25 -56.33 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.217 -0.447 . . . . 64.510000000000005 110.904 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.499 HD13 HD13 ' A' ' 66' ' ' LEU . 7.9 tp -64.74 -34.46 70.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.773 0.321 . . . . 73.450000000000003 110.642 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.7 t -58.68 -45.02 90.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 54.310000000000002 110.125 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 48.8 mm-40 -70.86 -37.29 73.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.449 -0.341 . . . . 64.450000000000003 111.143 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 119' ' ' ILE . 68.6 mt -54.75 -55.9 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.124 0.488 . . . . 74.049999999999997 109.975 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -60.24 -41.91 94.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 74.349999999999994 110.642 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 33.3 t30 -58.26 -38.4 76.86 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.654 -0.703 . . . . 65.430000000000007 111.505 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -99.58 -11.99 20.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.227 0.454 . . . . 75.120000000000005 112.227 -174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.563 HD11 HG23 ' A' ' 74' ' ' VAL . 55.6 mt -92.82 -59.54 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 120.902 0.382 . . . . 70.340000000000003 111.075 173.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.592 -0.718 . . . . 51.329999999999998 110.276 -174.263 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.835 0.35 . . . . 54.549999999999997 110.32 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.96 123.44 28.33 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.087 -0.506 . . . . 51.530000000000001 110.546 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -113.21 -3.93 13.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.473 -0.33 . . . . 75.140000000000001 110.822 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -171.27 144.21 1.99 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.44 -0.345 . . . . 75.439999999999998 110.548 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -115.11 120.16 38.84 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.339 -0.615 . . . . 54.530000000000001 109.339 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -139.88 94.33 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.665 0.269 . . . . 72.109999999999999 111.046 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -159.54 165.41 32.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.52 . . . . 64.140000000000001 110.326 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -115.92 126.22 53.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.071 -0.513 . . . . 73.420000000000002 109.764 175.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptm -89.09 139.35 30.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.524 -0.547 . . . . 72.129999999999995 109.524 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.65 81.08 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.487 -0.645 . . . . 74.430000000000007 111.487 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 m -147.92 -34.68 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.497 0.189 . . . . 75.310000000000002 110.865 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp 70.37 -58.06 0.56 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.26 0.624 . . . . 54.200000000000003 110.239 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 66.38 105.66 0.04 OUTLIER 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.427 0.691 . . . . 71.349999999999994 111.355 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.423 ' HB3' ' CD1' ' A' ' 49' ' ' TRP . . . -82.41 96.26 7.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 34.310000000000002 109.849 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -56.61 110.1 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 74.439999999999998 110.383 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -59.67 92.83 0.02 OUTLIER 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.225 -0.443 . . . . 64.349999999999994 111.404 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -76.98 72.34 3.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.895 -0.593 . . . . 72.200000000000003 110.178 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.78 159.03 47.44 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 116.002 -0.545 . . . . 72.230000000000004 112.744 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.55 50.41 2.96 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.561 2.841 . . . . 74.329999999999998 111.526 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.94 61.29 0.38 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 108.66 -1.776 . . . . 71.310000000000002 108.66 -166.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.0 p -42.31 107.35 0.08 Allowed 'General case' 0 C--O 1.234 0.281 0 N-CA-C 113.314 0.857 . . . . 74.540000000000006 113.314 -166.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.1 mmm -74.63 -19.52 60.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.951 -0.759 . . . . 74.409999999999997 108.951 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mm -91.75 136.49 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.83 -1.077 . . . . 71.430000000000007 108.764 174.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.0 tp10 -112.8 144.07 42.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.725 0.298 . . . . 74.540000000000006 110.725 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -114.26 132.01 56.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.781 -0.451 . . . . 71.349999999999994 109.781 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 25.1 pt -140.27 178.27 3.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 120.867 0.365 . . . . 73.530000000000001 111.126 -177.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.59 172.95 25.48 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 115.89 -0.595 . . . . 52.030000000000001 111.869 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.68 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 10.5 t70 -52.24 -56.82 12.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.978 0.418 . . . . 72.349999999999994 111.504 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -64.21 -19.98 65.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.821 -0.627 . . . . 74.230000000000004 111.695 -174.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 37.5 mt-10 -78.08 -29.22 49.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.663 -0.244 . . . . 73.109999999999999 111.202 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -52.68 -49.39 65.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.731 0.301 . . . . 74.420000000000002 110.515 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.17 -55.85 26.59 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.969 -0.56 . . . . 60.439999999999998 109.916 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -53.27 -57.56 10.1 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.162 -0.927 . . . . 72.340000000000003 110.884 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 73.2 mmtt -64.07 -41.52 97.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.423 -1.262 . . . . 51.450000000000003 111.211 -169.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.56 -41.14 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.537 -0.301 . . . . 62.32 110.973 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 p -75.82 -19.28 59.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.784 0.326 . . . . 75.109999999999999 111.324 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -76.37 -14.57 60.08 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.434 -0.348 . . . . 75.140000000000001 110.717 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.756 ' SG ' HD11 ' A' ' 44' ' ' ILE . 66.6 m -70.93 101.16 2.1 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.879 0.371 . . . . 73.439999999999998 110.256 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -67.41 -47.93 68.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 72.230000000000004 112.371 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -153.82 133.27 12.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.092 0.472 . . . . 63.229999999999997 111.853 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 67.28 2.13 2.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.915 -1.039 . . . . 72.439999999999998 113.421 165.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.69 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 48.0 mm -80.63 97.16 3.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.367 0.603 . . . . 61.109999999999999 110.325 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 tt -80.77 113.13 18.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.33 -0.85 . . . . 72.319999999999993 108.944 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.756 HD11 ' SG ' ' A' ' 38' ' ' CYS . 47.3 mt -98.26 133.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.08 -0.509 . . . . 62.130000000000003 111.29 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.9 mp -114.56 124.88 52.99 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.57 -0.9 . . . . 63.240000000000002 108.57 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 92.4 t -106.37 110.02 30.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 110.205 -0.294 . . . . 73.120000000000005 110.205 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -99.71 131.92 45.38 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.236 0.541 . . . . 65.239999999999995 111.337 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -103.49 107.6 18.51 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.356 -0.979 . . . . 75.219999999999999 108.356 168.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 14' ' ' ALA . 14.8 t-105 -81.13 137.01 35.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.245 0.545 . . . . 74.420000000000002 110.572 -170.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 97' ' ' PRO . . . -76.92 129.22 79.41 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.781 -0.645 . . . . 64.239999999999995 111.356 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.95 -24.46 67.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.314 2.01 . . . . 73.519999999999996 110.412 172.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -87.95 88.54 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.446 -0.946 . . . . 74.239999999999995 108.446 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.1 t -76.96 144.2 38.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.24 0.543 . . . . 74.430000000000007 111.887 -171.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -154.63 -80.84 0.03 OUTLIER Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.345 -0.843 . . . . 72.150000000000006 111.185 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.71 16.56 1.56 Allowed 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.832 2.355 . . . . 71.140000000000001 112.428 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.1 m -54.96 -48.42 73.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.166 -0.47 . . . . 73.450000000000003 110.654 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -53.91 -36.28 62.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.934 -1.03 . . . . 74.510000000000005 111.174 -173.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.628 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 17.5 m -75.41 -59.13 2.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.03 -0.532 . . . . 75.439999999999998 111.558 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.55 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.5 mm? -64.06 -29.25 70.4 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.751 0.649 . . . . 73.540000000000006 112.751 -169.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.45 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 41.0 mt-10 -57.01 -63.9 3.13 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 120.56 -0.456 . . . . 51.549999999999997 110.454 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.45 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 38.0 Cg_endo -65.44 -36.86 32.69 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 121.761 1.641 . . . . 73.120000000000005 112.132 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 58' ' ' SER . 37.9 mt-30 -58.8 -48.9 79.66 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.537 -0.465 . . . . 74.040000000000006 111.234 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.422 HD21 HD13 ' A' ' 119' ' ' ILE . 80.0 mt -66.89 -46.59 74.43 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.922 -0.127 . . . . 70.019999999999996 110.699 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 30.9 mt-10 -63.41 -30.56 71.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.493 -0.483 . . . . 65.239999999999995 110.685 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -64.71 -57.17 9.72 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.186 0.517 . . . . 70.439999999999998 109.935 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 120' ' ' ILE . 37.7 mt -58.97 -34.81 72.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.489 -0.778 . . . . 72.409999999999997 109.597 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.65 -49.47 75.02 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.52 -0.764 . . . . 74.439999999999998 110.258 176.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.1 mt-30 -60.06 -35.87 76.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.784 0.326 . . . . 72.030000000000001 111.03 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -76.86 -41.93 42.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.012 -0.54 . . . . 61.219999999999999 111.393 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -105.06 4.95 32.08 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 113.132 0.79 . . . . 75.430000000000007 113.132 -171.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.5 t -53.14 -19.96 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.901 0.704 . . . . 75.319999999999993 112.901 -170.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -64.52 -33.71 76.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.046 0.451 . . . . 72.120000000000005 110.486 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -129.43 8.76 5.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.78 -0.645 . . . . 75.340000000000003 111.983 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.562 HG23 HD11 ' A' ' 127' ' ' ILE . 43.0 t -133.64 142.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.206 -0.309 . . . . 74.140000000000001 111.653 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.4 tppt? -151.69 133.77 15.1 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.053 -0.721 . . . . 73.209999999999994 109.053 175.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 76' ' ' ILE . 4.2 mp -108.17 136.67 42.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.718 0.294 . . . . 74.219999999999999 110.423 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 74.4 m-85 -128.39 158.18 38.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 62.439999999999998 109.935 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.735 ' HZ2' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -152.33 172.74 16.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.653 -0.499 . . . . 73.319999999999993 109.653 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.42 142.56 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.765 -0.457 . . . . 53.539999999999999 109.765 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -103.56 -9.67 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 74.129999999999995 110.834 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.537 HG13 ' H ' ' A' ' 83' ' ' ASP . 8.5 tp -153.88 118.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.345 0.593 . . . . 71.040000000000006 110.77 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -58.81 -18.38 31.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.565 -0.743 . . . . 73.319999999999993 111.924 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.537 ' H ' HG13 ' A' ' 81' ' ' ILE . 4.4 m-20 -71.09 -7.9 49.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.544 -0.298 . . . . 74.150000000000006 111.57 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.68 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 58.5 m-20 -125.63 78.53 1.74 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 74.430000000000007 110.441 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -114.3 10.37 17.15 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.483 -0.78 . . . . 72.239999999999995 110.088 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 2.8 m-20 -49.32 -45.98 46.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.506 -0.77 . . . . 72.519999999999996 109.991 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.0 p -55.02 -39.68 50.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.539 -0.755 . . . . 71.329999999999998 111.258 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.97 -33.25 74.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.31 0.576 . . . . 71.310000000000002 109.743 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.8 m -73.53 -32.31 64.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.21 -0.904 . . . . 74.409999999999997 110.142 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.8 mm-40 -70.86 -39.57 72.83 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 111.019 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -83.39 -23.73 32.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.539 0.209 . . . . 73.409999999999997 111.148 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.67 57.82 2.51 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.186 -0.53 . . . . 74.439999999999998 112.639 175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.02 124.0 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.504 0.192 . . . . 75.420000000000002 110.56 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.1 m -69.81 -62.52 1.35 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.142 -0.481 . . . . 64.510000000000005 111.879 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.81 161.87 17.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 63.229999999999997 110.253 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.495 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 47.5 mm -61.9 -54.62 49.1 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 123.224 0.328 . . . . 72.340000000000003 111.178 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.618 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 73.1 Cg_endo -74.74 80.6 2.32 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.809 1.673 . . . . 53.32 112.225 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.5 m -137.01 137.03 38.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 50.200000000000003 111.016 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 99' ' ' ILE . 2.7 mp -110.82 114.55 47.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.067 -0.515 . . . . 53.439999999999998 109.645 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 100' ' ' LEU . 7.2 mp -90.66 154.01 19.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.417 -0.586 . . . . 65.420000000000002 109.417 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.406 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 57.6 mtp -119.22 144.73 46.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.06 -0.348 . . . . 60.310000000000002 110.06 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.529 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.7 m-85 -149.13 149.76 31.57 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.171 -0.677 . . . . 54.219999999999999 109.171 176.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 ttpt -145.15 113.77 6.74 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.054 -0.658 . . . . 72.400000000000006 111.594 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 59.32 25.72 14.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.816 0.817 . . . . 62.219999999999999 110.663 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.24 -16.33 49.02 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.802 -0.635 . . . . 75.349999999999994 111.876 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 8.2 tmtm? -72.83 135.3 45.17 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.579 -0.897 . . . . 75.099999999999994 108.579 177.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 34.2 mmtp -65.87 145.84 55.46 Favored 'General case' 0 N--CA 1.46 0.038 0 CA-C-O 121.577 0.703 . . . . 73.200000000000003 111.37 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -145.38 167.81 22.01 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.66 -1.155 . . . . 73.409999999999997 108.979 -167.027 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.6 m -70.99 -177.65 1.7 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.539 0.685 . . . . 74.329999999999998 112.352 -169.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -141.32 121.0 13.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.684 -0.689 . . . . 72.129999999999995 109.77 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.7 t -95.89 116.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.208 -0.451 . . . . 74.239999999999995 110.0 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 112' ' ' ILE . 2.9 mp -91.62 115.63 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 75.310000000000002 109.974 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.46 169.68 41.91 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.12 -0.562 . . . . 74.099999999999994 112.575 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.55 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -83.33 76.02 9.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.447 0.299 . . . . 73.120000000000005 110.767 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.417 ' O ' HG13 ' A' ' 119' ' ' ILE . 23.6 t0 -115.1 95.89 5.42 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.483 0.659 . . . . 62.240000000000002 110.75 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -60.81 -28.19 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.091 -0.959 . . . . 73.340000000000003 110.089 -177.56 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.3 t -62.32 -53.81 49.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.943 0.401 . . . . 72.109999999999999 110.146 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -62.99 -41.43 99.57 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.308 -0.405 . . . . 71.049999999999997 110.23 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 123' ' ' ILE . 74.0 mt -55.45 -56.46 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.944 -0.571 . . . . 63.409999999999997 111.159 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.492 HD13 HD13 ' A' ' 66' ' ' LEU . 8.3 tp -65.58 -34.7 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.755 0.312 . . . . 72.430000000000007 110.651 -177.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 t -57.17 -52.18 66.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.125 -0.488 . . . . 33.520000000000003 110.35 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -72.04 -31.44 66.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.471 -0.331 . . . . 52.219999999999999 111.53 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 119' ' ' ILE . 49.5 mt -57.26 -55.71 19.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 120.62 -0.432 . . . . 54.340000000000003 110.006 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -68.53 -35.74 77.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.486 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -65.11 -34.95 79.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.861 -0.609 . . . . 64.430000000000007 111.335 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -101.16 -14.46 17.73 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.7 0.63 . . . . 61.240000000000002 112.7 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.562 HD11 HG23 ' A' ' 74' ' ' VAL . 58.9 mt -82.8 -48.5 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.549 -0.538 . . . . 73.030000000000001 109.549 171.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.316 -0.85 . . . . 62.409999999999997 109.455 178.313 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.859 0.361 . . . . 64.209999999999994 110.392 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.71 143.92 30.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.262 -0.426 . . . . 73.109999999999999 110.3 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -142.96 146.76 34.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 72.040000000000006 109.796 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -132.7 115.43 15.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 72.200000000000003 110.453 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -164.25 114.42 1.23 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.162 0.505 . . . . 71.239999999999995 109.913 172.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -158.28 90.36 1.03 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.718 . . . . 73.510000000000005 109.154 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -161.37 104.31 1.26 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.403 -0.817 . . . . 74.549999999999997 109.763 -172.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -153.37 132.51 12.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.541 -0.3 . . . . 74.430000000000007 110.713 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.5 tpp -157.64 111.21 2.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.149 -0.478 . . . . 63.219999999999999 109.871 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.44 77.24 0.21 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.306 -0.473 . . . . 34.420000000000002 112.152 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 t -168.3 107.08 0.5 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.942 0.401 . . . . 71.409999999999997 110.574 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.2 tp -171.73 81.76 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.104 0.478 . . . . 74.219999999999999 110.19 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -92.68 43.69 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 53.539999999999999 110.784 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.85 97.35 9.69 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.03 -0.532 . . . . 64.349999999999994 110.793 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -100.63 109.61 21.69 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.053 -0.521 . . . . 71.430000000000007 111.232 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.1 p -105.2 84.51 2.12 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.031 -0.531 . . . . 74.420000000000002 111.091 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.759 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 28.2 mt-30 -138.22 161.33 37.14 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.06 -0.518 . . . . 73.319999999999993 109.767 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.88 -172.38 24.46 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.474 -0.393 . . . . 74.219999999999999 113.357 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -89.89 -165.22 0.18 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.556 2.837 . . . . 72.239999999999995 112.751 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.19 49.2 0.01 OUTLIER Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.959 -0.638 . . . . 65.319999999999993 112.97 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 t 49.3 77.52 0.11 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.251 0.548 . . . . 74.209999999999994 110.996 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 95.1 mmm -117.0 -32.07 5.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.872 -0.604 . . . . 72.239999999999995 110.973 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.0 mm -62.74 116.89 3.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.394 -0.366 . . . . 75.150000000000006 110.183 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -86.37 151.27 23.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.299 -0.409 . . . . 74.239999999999995 110.12 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 14.1 pt20 -123.29 130.91 53.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 72.239999999999995 110.629 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.518 HG21 ' HG3' ' A' ' 34' ' ' LYS . 37.5 pt -139.38 174.1 9.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.056 -0.52 . . . . 61.130000000000003 110.309 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.22 160.35 19.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.205 -0.521 . . . . 52.299999999999997 112.131 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.726 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 13.8 t70 -53.68 -38.64 64.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.493 0.663 . . . . 71.040000000000006 110.72 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.2 m -76.52 1.63 16.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.315 -0.857 . . . . 71.120000000000005 111.788 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 35.5 mt-10 -113.45 -6.08 13.48 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.344 -0.222 . . . . 73.420000000000002 111.056 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.43 ' O ' HG23 ' A' ' 35' ' ' VAL . 89.2 t80 -50.21 -61.57 2.09 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.382 0.426 . . . . 72.310000000000002 111.501 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -56.98 -42.91 81.06 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 110.488 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -55.75 -57.06 13.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.671 -0.695 . . . . 70.200000000000003 110.461 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.5 mmtt -65.6 -37.08 85.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 64.239999999999995 111.061 -174.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.611 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 88.0 t -71.72 -29.18 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.716 0.293 . . . . 74.310000000000002 111.241 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.9 p -86.32 -21.0 27.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.891 0.377 . . . . 75.319999999999993 110.839 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -72.74 -9.5 58.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.046 -0.524 . . . . 63.25 111.266 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.823 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 26.0 p -82.32 77.71 9.07 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.38 -0.6 . . . . 63.350000000000001 109.38 175.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.52 -40.43 94.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.618 -0.719 . . . . 70.299999999999997 112.86 -173.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 42' ' ' ILE . 5.6 m-20 -135.9 121.23 19.18 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.098 0.407 . . . . 74.420000000000002 112.098 -173.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 55.85 2.22 0.07 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.776 1.398 . . . . 64.439999999999998 114.776 166.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.823 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 46.9 mm -80.86 109.49 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.328 0.513 . . . . 71.519999999999996 110.451 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.9 tt -82.52 115.9 21.72 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.171 -0.677 . . . . 73.25 109.171 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.52 HG21 HG22 ' A' ' 35' ' ' VAL . 32.7 mm -87.11 115.04 27.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.793 -0.64 . . . . 72.5 110.991 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.2 mp -102.47 148.1 25.93 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.5 -0.926 . . . . 71.200000000000003 108.5 171.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 60.5 t -133.35 106.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.617 -0.142 . . . . 73.420000000000002 110.617 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.52 143.13 26.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.987 0.423 . . . . 74.230000000000004 110.557 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -103.52 179.37 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.093 0.473 . . . . 61.43 111.562 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 30.6 m95 -77.91 167.4 21.56 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.64 -0.709 . . . . 74.450000000000003 111.263 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.07 93.36 1.66 Allowed Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.123 -0.49 . . . . 65.400000000000006 110.737 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.647 ' HD2' HG21 ' A' ' 96' ' ' ILE . 46.5 Cg_endo -68.96 -37.77 10.61 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.446 2.097 . . . . 51.229999999999997 111.307 175.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -141.86 140.63 32.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.433 -0.803 . . . . 74.140000000000001 109.199 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p 179.57 -55.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.744 -0.465 . . . . 64.319999999999993 109.744 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.16 -91.78 0.47 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 116.018 -0.537 . . . . 53.420000000000002 112.83 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.41 -16.45 18.2 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 123.376 2.717 . . . . 64.409999999999997 113.749 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 26.2 m -51.22 -30.66 18.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.346 0.258 . . . . 63.340000000000003 111.516 -176.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -55.74 -40.96 73.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.289 -0.414 . . . . 62.109999999999999 110.851 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.3 m -75.11 -35.17 61.76 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.212 0.53 . . . . 71.310000000000002 110.695 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.1 mm? -58.38 -42.85 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.716 -0.674 . . . . 71.319999999999993 111.629 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.449 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 37.6 mt-10 -54.89 -60.53 7.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.758 -0.163 . . . . 72.340000000000003 111.011 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.449 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 20.1 Cg_endo -61.7 -34.66 83.2 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.688 1.592 . . . . 73.340000000000003 112.211 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 58' ' ' SER . 14.9 mt-30 -63.9 -38.24 90.36 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.702 -0.399 . . . . 70.140000000000001 110.83 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 75.4 mt -68.62 -42.6 77.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.764 -0.458 . . . . 51.219999999999999 109.764 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -67.79 -26.79 66.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 54.030000000000001 110.71 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.759 ' HG3' ' HB2' ' A' ' 17' ' ' GLN . 33.4 ttpt -65.71 -56.78 10.24 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.725 0.774 . . . . 72.519999999999996 109.957 175.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.499 HD22 HD13 ' A' ' 120' ' ' ILE . 37.6 mt -59.13 -32.91 70.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.936 -1.029 . . . . 75.310000000000002 109.534 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.527 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.5 -51.27 66.28 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.692 -0.686 . . . . 71.230000000000004 109.562 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -55.89 -48.6 75.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.651 -0.704 . . . . 70.239999999999995 111.781 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -73.85 -39.68 63.83 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.44 -0.504 . . . . 73.329999999999998 111.169 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -101.04 4.93 42.77 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 113.021 0.748 . . . . 74.450000000000003 113.021 -171.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.9 t -53.25 -19.18 2.91 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.519 0.563 . . . . 74.200000000000003 112.519 -171.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -69.23 -34.68 75.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.656 0.265 . . . . 74.219999999999999 110.717 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.26 3.61 8.51 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.246 -0.434 . . . . 72.400000000000006 111.624 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.6 t -130.94 136.77 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.794 0.33 . . . . 74.430000000000007 111.368 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -138.36 131.28 29.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 70.319999999999993 109.624 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.405 HG12 ' HB2' ' A' ' 45' ' ' LEU . 50.0 mt -112.01 135.55 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.572 -0.529 . . . . 74.120000000000005 109.572 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 95.7 m-85 -129.26 147.93 51.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 73.319999999999993 110.469 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -133.99 145.14 49.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.061 -0.518 . . . . 71.5 109.849 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.436 HG21 ' O ' ' A' ' 84' ' ' ASN . 52.0 mt -70.21 112.52 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.958 -0.756 . . . . 74.150000000000006 108.958 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 66.9 t30 -75.31 -12.85 60.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.984 -0.553 . . . . 62.340000000000003 112.371 -170.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 83' ' ' ASP . 56.9 mt -130.89 119.97 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.683 0.277 . . . . 74.140000000000001 110.665 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -18.78 65.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.096 -0.502 . . . . 61.020000000000003 111.796 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.548 ' H ' HG22 ' A' ' 81' ' ' ILE . 24.8 t70 -71.37 -18.64 62.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.41 0.624 . . . . 60.450000000000003 109.833 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.726 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 92.2 m-20 -103.9 121.66 43.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.223 -0.898 . . . . 75.450000000000003 108.758 175.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -163.27 15.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.959 0.725 . . . . 63.329999999999998 112.959 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.548 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 1.8 m-20 -54.96 -42.46 72.39 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.061 -0.348 . . . . 64.409999999999997 110.061 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.402 HG23 ' OD2' ' A' ' 28' ' ' ASP . 77.4 t -53.15 -38.96 31.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.822 -0.627 . . . . 54.25 110.532 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.46 77.52 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.347 0.594 . . . . 72.450000000000003 110.003 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.6 m -67.32 -37.49 83.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.022 -0.99 . . . . 73.420000000000002 110.564 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 93.5 mt-30 -69.97 -53.47 17.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.827 -0.624 . . . . 74.140000000000001 111.061 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.42 -13.0 55.79 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.023 -0.535 . . . . 74.430000000000007 111.696 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.53 78.97 0.79 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.88 -0.676 . . . . 64.040000000000006 112.849 171.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.9 t -75.54 93.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.316 0.579 . . . . 73.120000000000005 109.797 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.7 m -71.76 -59.4 2.77 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.363 -0.835 . . . . 73.120000000000005 110.925 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.5 152.85 21.88 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.5 -0.556 . . . . 65.430000000000007 109.5 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.691 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 43.0 mm -55.35 -54.27 52.79 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 123.18 0.3 . . . . 52.439999999999998 111.087 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.691 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 19.8 Cg_endo -89.32 99.74 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.256 1.971 . . . . 73.25 111.318 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.3 m -118.62 146.49 44.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.136 -0.484 . . . . 74.329999999999998 110.567 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 3.5 mp -123.16 116.17 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.599 -0.728 . . . . 55.32 109.913 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 64.6 mt -90.24 143.05 27.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.301 -0.629 . . . . 73.439999999999998 109.301 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.407 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 48.0 mtp -117.48 136.28 53.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.985 -0.376 . . . . 72.439999999999998 109.985 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 95.3 m-85 -148.96 160.39 43.34 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.451 -0.944 . . . . 72.209999999999994 108.451 174.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -153.82 111.25 3.47 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.846 -0.742 . . . . 73.409999999999997 112.315 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.465 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 56.9 t30 55.57 37.59 29.08 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.721 0.772 . . . . 65.319999999999993 110.978 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.76 -16.35 50.93 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.411 -0.813 . . . . 64.129999999999995 112.575 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -77.72 138.84 39.26 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.669 0.271 . . . . 61.25 110.633 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -62.41 139.92 58.56 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.339 -0.846 . . . . 74.129999999999995 110.619 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -144.14 167.67 21.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.975 -1.12 . . . . 74.030000000000001 107.975 -174.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.1 m -70.75 -179.72 2.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.612 0.72 . . . . 74.439999999999998 112.759 -165.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.445 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.1 tt0 -142.26 118.71 10.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.718 -0.674 . . . . 64.5 110.013 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 49.7 t -100.02 107.72 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.459 . . . . 65.510000000000005 110.272 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -94.31 104.46 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.601 -0.518 . . . . 73.230000000000004 109.601 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.76 177.99 23.82 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.714 -0.555 . . . . 52.140000000000001 111.714 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.22 80.85 7.57 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.992 0.425 . . . . 70.230000000000004 110.936 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.425 ' O ' HG13 ' A' ' 119' ' ' ILE . 21.6 m-20 -117.51 73.7 0.89 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.031 -0.531 . . . . 63.350000000000001 110.146 175.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.407 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.39 -33.03 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.551 -0.537 . . . . 51.329999999999998 109.551 -177.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.5 t -59.0 -46.21 88.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.879 -0.6 . . . . 74.219999999999999 110.192 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -70.06 -36.37 74.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.095 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 123' ' ' ILE . 81.3 mt -58.78 -56.25 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 72.040000000000006 110.591 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.499 HD13 HD22 ' A' ' 66' ' ' LEU . 6.9 tp -64.68 -38.06 81.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.638 -0.256 . . . . 41.140000000000001 110.401 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.8 t -57.04 -48.5 78.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.248 -0.433 . . . . 62.200000000000003 109.951 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 65.6 mm-40 -69.6 -36.76 76.5 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.458 -0.337 . . . . 72.030000000000001 111.507 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 119' ' ' ILE . 56.3 mt -57.12 -56.19 16.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.241 0.543 . . . . 71.120000000000005 109.767 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -64.16 -35.81 82.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.652 -0.704 . . . . 70.329999999999998 110.468 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 23.6 t30 -65.28 -39.12 92.18 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.935 -0.575 . . . . 71.319999999999993 111.468 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -103.28 -5.2 23.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.571 0.582 . . . . 71.120000000000005 112.571 -172.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.8 mt -91.94 -54.05 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.895 -0.322 . . . . 71.219999999999999 110.698 170.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.477 -0.773 . . . . 64.540000000000006 110.71 -176.587 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.881 -0.415 . . . . 64.239999999999995 109.881 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.62 76.95 9.93 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.717 -0.475 . . . . 73.219999999999999 109.717 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -83.18 105.27 14.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.673 -0.694 . . . . 73.310000000000002 111.114 -174.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 65.45 71.79 0.43 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.856 -0.611 . . . . 73.230000000000004 110.898 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -143.23 107.25 4.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.474 -0.785 . . . . 70.040000000000006 109.619 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -156.5 142.95 18.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.905 -0.406 . . . . 71.430000000000007 109.905 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -79.12 148.46 32.36 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.854 0.359 . . . . 74.25 110.752 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -103.88 166.2 10.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.044 -0.526 . . . . 74.310000000000002 111.369 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -87.02 176.42 7.64 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.545 -0.752 . . . . 63.350000000000001 110.349 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.73 168.71 25.16 Favored Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 111.666 -0.573 . . . . 44.210000000000001 111.666 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.8 m -123.71 121.71 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.912 0.356 . . . . 64.430000000000007 110.291 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -139.66 96.77 3.13 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.051 -0.722 . . . . 61.350000000000001 109.051 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -98.21 116.46 30.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.138 -0.483 . . . . 65.040000000000006 110.079 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.15 129.2 37.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.407 -0.36 . . . . 73.25 110.541 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -72.56 100.08 2.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.394 . . . . 64.150000000000006 110.273 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 p -82.64 141.71 32.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.988 -0.551 . . . . 74.510000000000005 110.311 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -82.58 126.55 32.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.006 0.432 . . . . 73.120000000000005 111.509 -174.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.53 123.44 7.53 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.771 -0.932 . . . . 74.230000000000004 110.771 172.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.66 166.31 23.88 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.497 2.132 . . . . 60.43 112.634 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.94 159.19 14.07 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.835 -0.62 . . . . 44.299999999999997 111.713 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.3 m -62.54 121.11 12.49 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.144 0.497 . . . . 61.219999999999999 111.904 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 91.3 mmm -93.78 -30.71 14.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.6 -0.727 . . . . 73.109999999999999 110.164 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.487 HG21 ' HE3' ' A' ' 78' ' ' LYS . 28.1 mm -58.28 107.48 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.029 -0.532 . . . . 71.319999999999993 110.036 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.552 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 9.4 tp10 -75.0 141.1 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 60.140000000000001 110.173 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.464 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . 78.1 mt-30 -109.09 122.51 47.42 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.316 -0.253 . . . . 65.239999999999995 110.316 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 47.3 pt -145.06 179.96 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.901 0.381 . . . . 70.019999999999996 111.468 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -125.82 -165.83 12.14 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.632 -0.713 . . . . 63.439999999999998 111.424 175.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' H ' ' HB3' ' A' ' 84' ' ' ASN . 27.2 t70 -69.37 -45.91 68.21 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.957 0.378 . . . . 54.109999999999999 110.966 -177.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.0 t -59.55 -29.74 68.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.92 -0.582 . . . . 75.420000000000002 109.906 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 12.0 mm-40 -85.98 -31.89 21.82 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.006 -0.543 . . . . 71.209999999999994 110.725 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.435 ' HA ' HD12 ' A' ' 26' ' ' ILE . 85.1 t80 -47.92 -61.62 1.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.359 0.503 . . . . 74.310000000000002 112.359 -171.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.84 -43.5 98.19 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.604 0.24 . . . . 64.5 110.412 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -57.65 -53.98 52.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.181 -0.463 . . . . 75.319999999999993 110.418 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HG3' HG21 ' A' ' 26' ' ' ILE . 75.7 mmtt -60.71 -41.52 95.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.752 -0.658 . . . . 63.109999999999999 111.063 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 31' ' ' PHE . 98.3 t -67.74 -53.07 33.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 61.310000000000002 110.687 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.7 p -65.46 -18.68 65.5 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.497 -0.32 . . . . 63.43 111.761 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -77.02 3.35 12.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.632 -0.258 . . . . 63.530000000000001 111.259 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.53 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 25.0 p -62.46 113.39 2.91 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.928 -0.397 . . . . 75.319999999999993 109.928 175.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -52.84 -64.16 0.91 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.348 -0.387 . . . . 74.519999999999996 111.357 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -156.36 121.63 4.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 75.209999999999994 110.614 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 48.2 m-80 49.96 24.66 1.4 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.945 0.72 . . . . 73.209999999999994 112.945 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.4 mm -73.61 127.59 35.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 110.323 -0.251 . . . . 54.399999999999999 110.323 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 28.0 tp -85.79 107.78 17.79 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.722 0.772 . . . . 71.519999999999996 110.444 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.442 HG23 ' CD1' ' A' ' 77' ' ' TYR . 72.7 mt -108.44 113.47 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.112 -0.949 . . . . 62.109999999999999 110.205 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.8 mp -97.06 152.63 18.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.192 -0.669 . . . . 70.120000000000005 109.192 177.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 77' ' ' TYR . 58.5 t -138.08 118.53 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 110.034 -0.358 . . . . 72.109999999999999 110.034 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -95.35 154.59 17.12 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.082 0.468 . . . . 74.340000000000003 110.618 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -126.3 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.716 -0.674 . . . . 72.230000000000004 110.354 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.491 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 20.6 m0 -57.94 -44.12 86.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.37 -0.377 . . . . 75.140000000000001 111.225 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.56 ' HB1' ' HD2' ' A' ' 51' ' ' PRO . . . 66.93 165.98 0.12 Allowed Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.178 -0.464 . . . . 71.040000000000006 111.018 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.56 ' HD2' ' HB1' ' A' ' 50' ' ' ALA . 18.5 Cg_endo -59.38 -32.06 95.95 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.087 1.858 . . . . 74.519999999999996 111.854 176.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -96.25 89.69 5.2 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.072 -0.714 . . . . 73.439999999999998 109.072 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 49' ' ' TRP . 2.5 p -132.46 -67.61 0.64 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.475 -0.33 . . . . 54.140000000000001 111.823 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.56 -94.38 1.03 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.189 -0.529 . . . . 43.450000000000003 112.568 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.78 -16.36 8.35 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.217 2.611 . . . . 72.040000000000006 112.411 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 19.0 p -50.7 -27.73 7.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.424 -0.807 . . . . 65.150000000000006 111.322 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -54.14 -43.45 70.54 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.174 -0.466 . . . . 65.439999999999998 111.307 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 22.7 t -75.96 -46.44 29.69 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.8 0.81 . . . . 64.140000000000001 110.983 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.69 -34.02 75.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.155 -0.93 . . . . 74.019999999999996 112.402 -171.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' HG2' ' CZ3' ' A' ' 49' ' ' TRP . 38.7 mt-10 -60.27 -62.46 5.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.406 -0.518 . . . . 71.349999999999994 110.227 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 19.6 Cg_endo -58.75 -38.87 86.71 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.727 1.618 . . . . 55.539999999999999 112.258 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 58' ' ' SER . 37.3 mt-30 -57.44 -55.65 32.04 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.834 -0.346 . . . . 70.109999999999999 111.179 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.475 HD11 HD13 ' A' ' 119' ' ' ILE . 30.2 mt -71.98 -25.29 61.79 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.723 -0.217 . . . . 64.530000000000001 111.313 -176.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.449 ' OE1' HG12 ' A' ' 23' ' ' ILE . 4.5 mm-40 -62.26 -44.98 95.31 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.216 0.531 . . . . 71.409999999999997 109.837 172.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -62.36 -50.64 70.79 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.531 -0.759 . . . . 53.520000000000003 109.909 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.2 mt -62.9 -32.02 73.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.63 . . . . 72.239999999999995 110.776 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.82 -53.75 45.84 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.726 -0.472 . . . . 64.420000000000002 109.726 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -58.94 -35.64 73.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.959 -0.564 . . . . 74.140000000000001 110.84 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -65.72 -49.29 69.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 63.310000000000002 110.825 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.91 5.18 32.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.625 -0.716 . . . . 72.209999999999994 112.716 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 8.9 t -53.18 -19.88 3.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.787 0.662 . . . . 62.210000000000001 112.787 -171.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.05 -29.86 65.72 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.291 -0.256 . . . . 72.129999999999995 111.424 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -131.13 -10.63 3.74 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.466 -0.334 . . . . 73.5 111.336 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 71' ' ' THR . 40.9 t -116.96 134.65 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.823 0.344 . . . . 65.129999999999995 111.835 -172.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HE2' ' HB2' ' A' ' 24' ' ' GLU . 21.1 tptm -143.59 127.12 16.92 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.128 -0.487 . . . . 63.240000000000002 109.802 173.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.2 mp -99.69 141.05 17.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.953 -0.388 . . . . 75.209999999999994 109.953 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.487 ' HB2' HG22 ' A' ' 46' ' ' VAL . 62.9 m-85 -123.67 150.31 44.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 73.420000000000002 109.444 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HE3' HG21 ' A' ' 23' ' ' ILE . 39.9 ttmt -129.2 122.14 29.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.672 -0.492 . . . . 74.519999999999996 109.672 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.403 HD13 HG13 ' A' ' 26' ' ' ILE . 42.5 mm -78.91 73.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.772 -0.825 . . . . 53.109999999999999 108.772 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 25' ' ' GLN . 3.4 p-10 -72.46 -30.4 64.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.525 -0.761 . . . . 55.329999999999998 110.367 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.4 mt -62.68 100.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.989 -0.551 . . . . 74.019999999999996 109.929 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.493 ' HA ' ' HG3' ' A' ' 85' ' ' GLN . 10.5 pt-20 -56.51 -27.94 58.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.744 -0.662 . . . . 74.430000000000007 111.191 -177.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -71.58 -24.52 61.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.758 -0.656 . . . . 74.450000000000003 110.006 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.429 ' HB3' ' H ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -104.08 15.76 27.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.307 -0.86 . . . . 75.219999999999999 111.315 -175.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.493 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 92.9 mt-30 -71.32 1.42 6.22 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.636 0.255 . . . . 72.019999999999996 111.085 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -46.53 -37.96 8.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.977 -0.556 . . . . 71.230000000000004 110.361 172.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.7 t -52.7 -43.28 43.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.562 -0.744 . . . . 74.219999999999999 110.502 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.8 -53.35 58.47 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.642 -0.708 . . . . 74.349999999999994 110.273 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.4 m -59.13 -34.81 72.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.62 . . . . 71.150000000000006 110.985 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.06 -56.66 13.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.218 -0.446 . . . . 60.149999999999999 111.163 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -72.3 -15.68 61.89 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.58 0.228 . . . . 55.420000000000002 111.148 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.9 40.01 5.67 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.234 -0.508 . . . . 73.019999999999996 112.724 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.64 93.9 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.111 0.482 . . . . 71.420000000000002 110.562 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.9 t -90.65 -37.14 13.96 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.637 -0.71 . . . . 64.209999999999994 109.536 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.21 136.28 33.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.035 -0.728 . . . . 73.439999999999998 109.035 174.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.637 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 50.8 mm -58.87 -58.84 16.38 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 111.411 0.152 . . . . 63.229999999999997 111.411 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.637 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 83.3 Cg_endo -80.77 72.3 6.6 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.797 1.665 . . . . 73.400000000000006 112.262 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.1 m -102.96 133.07 48.69 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.963 0.411 . . . . 62.43 110.796 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.63 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -116.52 121.0 66.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.537 -0.756 . . . . 73.230000000000004 109.846 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 110' ' ' GLN . 88.7 mt -98.14 123.48 42.22 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.775 -0.454 . . . . 73.329999999999998 109.775 175.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 59.9 mtp -96.06 139.95 31.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.375 -0.602 . . . . 55.409999999999997 109.375 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -138.6 147.69 43.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.904 -0.776 . . . . 72.209999999999994 108.904 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 126' ' ' ASN . 29.0 ttpp -147.47 121.36 9.34 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.306 -0.558 . . . . 70.329999999999998 111.225 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 6.0 t30 61.17 25.69 15.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.542 -0.754 . . . . 62.140000000000001 110.24 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.46 6.87 86.95 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.727 -0.669 . . . . 33.450000000000003 112.127 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -101.38 150.34 23.12 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 120.701 0.286 . . . . 61.039999999999999 110.61 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -56.49 128.47 36.28 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.076 -0.966 . . . . 73.209999999999994 111.489 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.92 168.54 18.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.869 -1.514 . . . . 74.439999999999998 106.932 -177.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.7 m -69.53 157.16 37.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.795 0.807 . . . . 71.230000000000004 112.72 -158.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.485 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.8 tt0 -114.4 118.41 33.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.136 -0.938 . . . . 70.200000000000003 109.851 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.63 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 44.6 t -96.95 107.17 19.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.185 -0.461 . . . . 72.219999999999999 110.097 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.6 mp -92.35 105.12 16.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.366 -0.605 . . . . 73.25 109.366 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 105.06 158.55 23.27 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.575 -0.61 . . . . 63.32 111.575 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.45 83.54 3.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.79 0.328 . . . . 61.229999999999997 110.679 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 33.8 t70 -121.51 90.12 3.25 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.703 0.763 . . . . 71.129999999999995 110.262 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -59.02 -30.63 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 114.795 -1.093 . . . . 43.399999999999999 109.425 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.8 t -56.32 -53.36 58.17 Favored 'General case' 0 CA--C 1.526 0.045 0 CA-C-N 116.13 -0.486 . . . . 64.329999999999998 110.159 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -60.59 -48.03 83.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.144 -0.48 . . . . 72.239999999999995 109.941 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 123' ' ' ILE . 65.5 mt -56.69 -56.31 14.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.719 -0.673 . . . . 75.129999999999995 111.128 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 116' ' ' ILE . 13.7 tt -64.33 -35.7 74.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.767 0.317 . . . . 71.420000000000002 110.247 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.4 t -55.82 -52.32 64.42 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.797 -0.638 . . . . 53.140000000000001 110.278 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 24.7 mm-40 -74.54 -30.0 61.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.911 -0.586 . . . . 73.439999999999998 111.301 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.3 mt -58.42 -56.03 18.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.961 0.41 . . . . 74.409999999999997 110.064 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -71.33 -29.26 64.8 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.94 -0.304 . . . . 75.420000000000002 110.223 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.478 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 19.7 t30 -61.11 -44.38 97.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.103 -0.499 . . . . 73.340000000000003 110.971 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.55 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 32.1 m-80 -84.93 -27.1 26.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 62.210000000000001 112.137 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.4 mt -73.71 -48.7 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 120.915 0.388 . . . . 75.420000000000002 110.479 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.808 -0.615 . . . . 41.43 110.125 -179.783 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.7 mmm . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.975 0.417 . . . . 52.520000000000003 110.227 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.1 -167.09 2.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.759 -0.655 . . . . 72.239999999999995 109.528 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -136.63 172.18 13.4 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.716 -0.476 . . . . 75.129999999999995 109.716 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -124.34 141.81 51.78 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.865 -0.152 . . . . 64.299999999999997 110.637 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.1 p-80 -75.52 125.91 29.95 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.699 -0.852 . . . . 55.43 108.699 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -97.65 -41.13 8.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.571 0.212 . . . . 73.329999999999998 111.571 -175.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.9 138.35 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.617 0.573 . . . . 74.349999999999994 110.379 -174.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.596 ' HB3' HG21 ' A' ' 112' ' ' ILE . 41.0 t-80 -139.72 -95.15 0.16 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.043 -0.354 . . . . 73.040000000000006 110.043 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.0 ttm 177.15 154.01 0.24 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.531 -0.544 . . . . 72.430000000000007 109.531 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.27 62.93 0.02 OUTLIER Glycine 0 C--O 1.234 0.137 0 N-CA-C 111.343 -0.703 . . . . 55.520000000000003 111.343 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.6 m -93.17 120.45 33.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.847 0.356 . . . . 75.129999999999995 110.666 -176.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.9 tp -137.08 113.05 9.67 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.259 -0.645 . . . . 54.020000000000003 109.259 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -76.62 75.97 3.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.744 0.307 . . . . 71.319999999999993 110.656 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -162.95 93.41 0.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.608 . . . . 71.140000000000001 109.434 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -91.84 154.68 18.74 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.978 -0.555 . . . . 61.43 111.166 -174.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.5 t -153.52 -179.0 7.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.598 -0.728 . . . . 75.209999999999994 109.728 174.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.14 -40.5 0.47 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.137 -0.69 . . . . 72.450000000000003 109.137 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.78 -139.15 44.87 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.571 -0.74 . . . . 61.549999999999997 112.528 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.39 -77.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.777 2.318 . . . . 54.32 110.857 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.25 36.11 81.31 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.384 -0.436 . . . . 73.140000000000001 112.926 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.8 t -68.67 -31.73 71.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.211 0.529 . . . . 72.430000000000007 110.251 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 92.0 mmm -93.23 4.25 54.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.826 -0.624 . . . . 50.299999999999997 110.428 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.499 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 26.7 mm -119.34 104.69 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.756 -0.657 . . . . 72.439999999999998 109.826 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.34 160.49 18.78 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.336 -0.393 . . . . 61.340000000000003 111.054 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.404 ' HA ' ' H ' ' A' ' 78' ' ' LYS . 26.6 tt0 -137.72 133.81 34.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.01 -0.367 . . . . 71.129999999999995 110.01 172.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.543 HG21 ' HG3' ' A' ' 34' ' ' LYS . 32.0 pt -138.86 179.95 2.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 122.53 0.332 . . . . 64.329999999999998 111.211 -174.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.06 176.85 22.96 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.055 -0.521 . . . . 71.010000000000005 112.965 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 12.4 t70 -51.86 -56.62 12.91 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.366 0.666 . . . . 41.439999999999998 111.737 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -62.81 -27.57 69.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 74.129999999999995 111.481 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -79.55 -23.36 42.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.806 0.298 . . . . 72.549999999999997 111.806 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 35' ' ' VAL . 92.4 t80 -47.68 -61.7 1.81 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.278 0.361 . . . . 71.0 111.85 -174.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.573 ' O ' HG22 ' A' ' 36' ' ' THR . 10.0 m-20 -54.63 -53.59 52.79 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.246 0.546 . . . . 54.149999999999999 110.504 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -55.92 -57.41 12.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.076 -0.965 . . . . 72.439999999999998 111.378 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.2 mmtt -58.51 -35.39 72.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 74.319999999999993 111.055 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 31' ' ' PHE . 40.6 t -64.98 -56.58 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.298 -0.41 . . . . 52.310000000000002 111.336 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 32' ' ' ASP . 7.9 t -86.08 -0.29 55.25 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.145 0.424 . . . . 63.229999999999997 112.145 -175.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.2 t -71.14 -5.93 35.46 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.892 0.377 . . . . 72.150000000000006 111.131 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.867 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 8.5 p -66.14 158.08 29.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.946 -0.57 . . . . 72.519999999999996 111.747 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.58 -79.65 0.11 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.903 -0.59 . . . . 63.310000000000002 110.61 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -161.82 148.67 14.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.216 -0.447 . . . . 73.430000000000007 109.981 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.0 t30 63.46 2.28 1.16 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.115 0.566 . . . . 71.319999999999993 111.34 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 42.6 mm -74.93 108.32 6.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 120.88 0.372 . . . . 61.240000000000002 110.276 -178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.498 ' CD2' ' HA ' ' A' ' 123' ' ' ILE . 30.9 tp -80.28 109.05 14.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.627 -0.715 . . . . 73.040000000000006 110.024 174.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 36.9 mt -102.7 116.69 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.501 -0.772 . . . . 64.310000000000002 110.376 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.55 ' HB2' HG13 ' A' ' 76' ' ' ILE . 3.4 mp -99.99 153.04 19.51 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.623 -0.881 . . . . 63.210000000000001 108.623 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 77' ' ' TYR . 60.8 t -135.36 104.35 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.311 -0.255 . . . . 72.430000000000007 110.311 175.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.87 96.78 10.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.901 -1.148 . . . . 72.540000000000006 107.901 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -54.5 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.375 0.509 . . . . 73.299999999999997 112.375 -171.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.42 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 73.1 m95 -108.61 129.11 55.32 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.87 -0.419 . . . . 74.040000000000006 109.87 -177.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 109.74 40.04 Favored Pre-proline 0 C--O 1.234 0.272 0 CA-C-N 116.466 -0.334 . . . . 72.140000000000001 110.767 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 49' ' ' TRP . 67.5 Cg_endo -90.44 156.41 4.46 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.896 2.397 . . . . 42.240000000000002 112.089 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -97.41 119.32 35.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.047 -0.723 . . . . 74.150000000000006 109.047 176.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.491 ' H ' ' HB2' ' A' ' 56' ' ' CYS . 13.1 p -158.35 174.16 15.56 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 110.355 -0.239 . . . . 71.200000000000003 110.355 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.623 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -56.32 -62.86 5.87 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.057 -0.52 . . . . 75.129999999999995 112.566 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.415 ' O ' HD23 ' A' ' 59' ' ' LEU . 50.6 Cg_exo -55.74 -34.49 91.02 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.407 2.071 . . . . 74.519999999999996 112.152 176.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.491 ' HB2' ' H ' ' A' ' 53' ' ' CYS . 77.5 m -56.08 -49.91 72.51 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.099 -0.5 . . . . 72.200000000000003 111.773 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.623 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -60.7 -26.42 67.13 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.766 0.317 . . . . 73.239999999999995 110.716 -176.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 46.8 t -75.6 -49.36 18.75 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.752 0.787 . . . . 73.409999999999997 110.494 172.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 55' ' ' PRO . 3.5 mm? -58.89 -43.13 90.92 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.198 -0.91 . . . . 73.010000000000005 112.3 -173.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 40.6 mt-10 -52.82 -60.39 6.71 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 117.807 0.276 . . . . 72.120000000000005 111.074 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 29.9 Cg_endo -64.14 -35.11 54.65 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.616 1.544 . . . . 75.310000000000002 112.254 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 58' ' ' SER . 20.2 mt-30 -61.26 -42.44 98.64 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.418 -0.513 . . . . 74.230000000000004 111.1 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.43 -42.99 67.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 73.310000000000002 110.321 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 28.1 mt-10 -63.69 -36.45 83.9 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.855 -0.338 . . . . 74.099999999999994 110.415 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -57.05 -57.16 13.76 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.464 0.65 . . . . 75.099999999999994 109.819 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 62' ' ' GLN . 36.6 mt -61.52 -36.55 80.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.05 -0.977 . . . . 63.240000000000002 109.909 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.56 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.05 -27.97 67.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 33.530000000000001 110.93 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.1 mt-30 -77.01 -48.34 18.2 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.851 0.358 . . . . 65.200000000000003 110.955 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -72.63 -37.75 67.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.183 0.516 . . . . 64.239999999999995 110.668 -176.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -97.61 5.85 48.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.765 -0.652 . . . . 72.140000000000001 111.891 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -52.74 -19.94 2.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.778 0.659 . . . . 72.519999999999996 112.778 -172.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.64 -31.2 70.18 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.274 -0.266 . . . . 74.120000000000005 110.794 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.431 ' HA ' HD13 ' A' ' 42' ' ' ILE . 91.6 m-20 -131.75 1.61 4.02 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.048 -0.524 . . . . 64.530000000000001 112.098 -174.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.526 HG23 HD11 ' A' ' 127' ' ' ILE . 72.5 t -131.76 134.03 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 122.257 -0.277 . . . . 74.129999999999995 111.527 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 26.8 mmtp -147.08 136.62 22.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 110.095 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.55 HG13 ' HB2' ' A' ' 45' ' ' LEU . 4.1 mp -115.83 146.65 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.664 -0.244 . . . . 73.450000000000003 110.636 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.502 ' HB2' HG22 ' A' ' 46' ' ' VAL . 40.4 m-85 -124.53 164.55 19.55 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.038 0.535 . . . . 75.140000000000001 110.516 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 23' ' ' ILE . 33.6 mtmm -143.61 178.82 7.52 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.816 0.446 . . . . 73.340000000000003 110.091 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.4 tt -151.76 158.6 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.839 -0.43 . . . . 72.230000000000004 109.839 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -142.57 -3.26 1.03 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.528 0.204 . . . . 73.439999999999998 111.511 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 40.4 mt -84.52 110.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 74.519999999999996 110.668 -174.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -49.48 -55.4 13.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.66 -0.7 . . . . 72.209999999999994 111.851 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.62 6.72 5.44 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.358 -0.383 . . . . 70.010000000000005 111.876 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.596 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.9 OUTLIER -107.3 22.13 16.46 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.057 0.456 . . . . 74.319999999999993 109.902 176.249 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -81.12 -10.85 59.59 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.003 -0.544 . . . . 64.439999999999998 111.498 -176.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -45.27 -56.96 4.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.709 0.29 . . . . 71.200000000000003 111.219 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.445 ' O ' ' HD1' ' A' ' 91' ' ' TYR . 7.5 p -53.1 -34.19 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.862 -0.608 . . . . 70.129999999999995 111.036 -178.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -67.75 -50.67 55.98 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.085 0.469 . . . . 70.109999999999999 109.967 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.2 m -60.42 -29.62 69.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.598 -0.728 . . . . 65.150000000000006 110.529 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.67 -55.89 8.76 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.867 -0.606 . . . . 52.43 111.32 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.445 ' HD1' ' O ' ' A' ' 87' ' ' VAL . 85.6 m-85 -77.22 -9.84 59.04 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.707 0.262 . . . . 72.099999999999994 111.707 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.29 53.61 1.14 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.801 -0.714 . . . . 72.409999999999997 113.391 170.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.496 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 80.6 t -93.92 111.84 25.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.993 -0.373 . . . . 52.149999999999999 109.993 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 m -121.97 25.17 9.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.362 0.601 . . . . 73.109999999999999 110.065 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.38 154.69 36.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.376 -0.829 . . . . 51.240000000000002 109.661 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.601 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 46.4 mm -67.71 -56.05 12.82 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.758 -0.46 . . . . 51.329999999999998 109.758 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.601 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 90.0 Cg_endo -82.09 67.67 8.08 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.007 1.804 . . . . 62.210000000000001 111.813 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.426 HG21 HG22 ' A' ' 93' ' ' VAL . 67.5 m -105.43 121.36 43.75 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.876 -0.602 . . . . 55.219999999999999 110.456 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.535 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.3 mp -110.27 112.68 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.558 -0.746 . . . . 51.32 110.102 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.449 HD23 ' HG3' ' A' ' 110' ' ' GLN . 36.9 mt -90.23 131.22 36.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.441 -0.577 . . . . 64.019999999999996 109.441 173.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.517 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 38.7 mtp -110.23 138.99 45.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.493 -0.558 . . . . 72.349999999999994 109.493 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -144.03 144.54 31.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.531 -0.544 . . . . 72.129999999999995 109.531 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HD3' ' HB3' ' A' ' 126' ' ' ASN . 39.6 ttpt -118.8 104.93 11.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.85 -0.34 . . . . 62.049999999999997 110.578 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.867 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 60.6 t30 59.25 30.55 20.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.594 0.711 . . . . 64.219999999999999 110.353 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.8 -16.4 60.36 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.887 -0.597 . . . . 73.420000000000002 112.083 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -73.34 142.72 47.07 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 110.133 -0.321 . . . . 63.219999999999999 110.133 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -63.68 145.77 55.09 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.529 -0.76 . . . . 71.150000000000006 111.181 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.517 ' HB3' ' O ' ' A' ' 101' ' ' MET . 1.3 tp -162.14 169.88 20.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.374 -0.83 . . . . 73.400000000000006 110.563 -164.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.6 m -69.63 167.93 15.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.039 0.935 . . . . 74.510000000000005 113.044 -163.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.449 ' HG3' HD23 ' A' ' 100' ' ' LEU . 57.2 tt0 -126.61 118.66 25.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.674 -1.148 . . . . 71.430000000000007 109.418 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 23.0 t -96.03 107.23 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.565 -0.531 . . . . 72.530000000000001 109.565 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.596 HG21 ' HB3' ' A' ' 8' ' ' HIS . 3.8 mp -96.68 101.69 12.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.592 -0.521 . . . . 64.329999999999998 109.592 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.1 167.29 18.82 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.613 -0.595 . . . . 73.140000000000001 111.613 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.67 86.3 7.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.799 -0.236 . . . . 60.25 111.102 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -124.79 86.65 2.59 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 121.82 0.819 . . . . 63.43 109.717 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -62.63 -27.64 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 114.887 -1.052 . . . . 54.0 110.048 -174.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -63.42 -47.83 80.31 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.34 -0.391 . . . . 62.119999999999997 110.145 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.538 ' HE2' ' HG2' ' A' ' 122' ' ' GLU . 10.6 tptm -69.38 -39.64 77.91 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.152 -0.314 . . . . 75.319999999999993 110.152 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.3 mt -55.39 -56.23 12.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.07 0.462 . . . . 71.549999999999997 110.624 177.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 116' ' ' ILE . 13.5 tt -65.98 -33.81 66.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 116.027 -0.533 . . . . 75.400000000000006 110.569 -178.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.1 t -54.95 -51.85 64.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.03 -0.532 . . . . 44.310000000000002 109.673 176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.538 ' HG2' ' HE2' ' A' ' 118' ' ' LYS . 60.2 mm-40 -63.25 -40.11 96.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.034 -0.53 . . . . 74.219999999999999 110.494 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.498 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 63.9 mt -52.04 -56.43 6.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.719 0.295 . . . . 72.530000000000001 110.889 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 128' ' ' ASN . 2.0 p-10 -71.88 -25.39 61.92 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 120.536 -0.466 . . . . 63.299999999999997 110.709 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 34.3 t30 -63.21 -33.93 76.55 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.06 0.457 . . . . 72.310000000000002 110.85 177.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.474 ' HB3' ' HD3' ' A' ' 103' ' ' LYS . 38.6 m-80 -94.55 -37.05 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.01 -0.541 . . . . 75.129999999999995 111.874 -176.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.526 HD11 HG23 ' A' ' 74' ' ' VAL . 66.7 mt -72.14 -48.98 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 64.140000000000001 110.862 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 124' ' ' ASN . 6.2 m-20 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.533 -0.746 . . . . 63.130000000000003 110.27 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.54 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 120.611 0.243 . . . . 74.349999999999994 110.495 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.04 96.95 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 41.520000000000003 110.248 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -130.19 92.13 3.23 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.753 -0.462 . . . . 64.430000000000007 109.753 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -129.7 83.47 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.245 0.545 . . . . 72.439999999999998 109.946 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -147.78 86.89 1.6 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.353 -0.839 . . . . 73.019999999999996 109.953 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -157.98 130.06 7.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.456 . . . . 75.519999999999996 110.712 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -139.01 161.26 37.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.755 -0.657 . . . . 70.310000000000002 109.245 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -93.92 90.94 6.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.443 -0.577 . . . . 74.219999999999999 109.443 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.4 ptm -139.28 101.46 4.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.882 -0.599 . . . . 65.310000000000002 110.38 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.75 53.0 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.019 -0.832 . . . . 70.209999999999994 111.019 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.5 t -107.29 151.53 25.35 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.072 0.463 . . . . 62.240000000000002 110.568 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 pp -158.76 161.59 37.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.737 -0.665 . . . . 72.230000000000004 109.761 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -104.98 -58.1 1.93 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.449 -0.574 . . . . 72.25 109.449 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.81 143.18 32.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 75.140000000000001 110.66 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -100.69 34.36 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 63.539999999999999 110.537 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.4 p -58.84 97.29 0.03 OUTLIER 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.093 0.473 . . . . 72.540000000000006 111.252 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -150.27 171.51 16.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.365 -0.834 . . . . 75.430000000000007 109.962 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.43 126.02 5.32 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.165 -0.541 . . . . 34.299999999999997 111.99 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.67 155.51 27.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.628 2.218 . . . . 61.310000000000002 112.119 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.62 36.08 1.09 Allowed Glycine 0 C--O 1.235 0.208 0 N-CA-C 111.614 -0.594 . . . . 60.0 111.614 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -81.5 168.79 17.89 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.911 0.484 . . . . 53.310000000000002 110.922 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 93.7 mmm -67.42 -29.17 68.58 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.451 -0.574 . . . . 71.319999999999993 109.451 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -73.71 115.79 15.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.678 -0.86 . . . . 73.239999999999995 108.678 171.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -74.38 146.47 42.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.99 0.424 . . . . 74.120000000000005 111.516 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.54 118.86 37.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.602 -0.727 . . . . 74.239999999999995 109.348 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.464 HG21 ' HG3' ' A' ' 34' ' ' LYS . 46.9 pt -144.58 175.12 3.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 120.826 0.346 . . . . 73.019999999999996 110.924 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.12 175.17 15.59 Favored Glycine 0 CA--C 1.521 0.406 0 CA-C-N 115.912 -0.585 . . . . 74.340000000000003 112.418 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.49 ' OD2' HG23 ' A' ' 87' ' ' VAL . 13.5 t70 -51.78 -45.86 63.95 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.466 0.706 . . . . 75.340000000000003 111.623 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 t -66.27 -28.57 68.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.150000000000006 110.806 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 43.0 mt-10 -80.97 -13.33 58.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 61.100000000000001 111.352 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.575 ' O ' HG23 ' A' ' 35' ' ' VAL . 87.2 t80 -51.43 -61.88 1.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.13 0.269 . . . . 73.310000000000002 111.14 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.18 -48.2 81.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.17 0.51 . . . . 70.209999999999994 110.76 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -60.81 -53.32 58.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.522 -0.763 . . . . 70.319999999999993 111.487 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HG3' HG21 ' A' ' 26' ' ' ILE . 35.0 mmtp -67.28 -31.82 72.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.102 -0.499 . . . . 74.219999999999999 111.293 -175.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 44' ' ' ILE . 74.5 t -66.3 -45.49 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.899 0.38 . . . . 65.010000000000005 109.979 174.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.5 p -75.11 -16.15 60.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.314 -0.403 . . . . 73.409999999999997 111.22 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -75.6 0.16 18.43 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.286 -0.415 . . . . 75.349999999999994 111.205 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.754 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.2 p -56.68 122.1 11.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.698 -0.228 . . . . 72.120000000000005 110.633 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -56.07 -76.17 0.03 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.332 -0.394 . . . . 71.150000000000006 110.889 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -161.98 145.31 12.0 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.358 -0.608 . . . . 72.329999999999998 109.358 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.4 p30 45.0 27.47 0.29 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.001 0.813 . . . . 71.129999999999995 111.727 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 47.0 mm -87.84 123.79 40.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.984 -0.553 . . . . 73.420000000000002 110.221 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -89.97 110.34 21.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.575 -0.738 . . . . 71.349999999999994 109.101 178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.602 HG21 HG22 ' A' ' 35' ' ' VAL . 22.8 mm -89.07 109.11 19.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.59 -0.732 . . . . 54.130000000000003 110.384 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.521 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.5 mp -99.04 146.97 25.5 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.541 -0.911 . . . . 71.209999999999994 108.541 172.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 70.1 t -139.13 113.15 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.348 -0.242 . . . . 75.540000000000006 110.348 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' OD2' ' HB3' ' A' ' 78' ' ' LYS . 1.6 p30 -91.69 137.55 32.27 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.716 -0.475 . . . . 52.219999999999999 109.716 176.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.62 ' HE2' ' HG ' ' A' ' 100' ' ' LEU . 79.5 m-85 -93.08 106.94 18.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.352 -0.385 . . . . 74.510000000000005 111.991 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.428 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 63.2 t-105 49.33 51.15 16.85 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.349 -0.841 . . . . 71.439999999999998 111.76 170.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.5 91.1 3.75 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.287 -0.415 . . . . 73.409999999999997 109.996 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 52' ' ' TRP . 89.7 Cg_endo -84.76 -31.64 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.674 2.249 . . . . 63.229999999999997 111.794 175.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.469 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 49.2 p-90 170.33 155.18 0.06 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.868 0.867 . . . . 62.409999999999997 109.24 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.531 ' N ' ' HB2' ' A' ' 56' ' ' CYS . 3.7 p -171.99 -177.03 1.81 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.691 -0.855 . . . . 60.43 108.691 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -48.84 -69.47 0.99 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.415 -0.422 . . . . 64.200000000000003 112.561 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.44 ' O ' HD23 ' A' ' 59' ' ' LEU . 30.4 Cg_endo -65.15 -43.61 11.04 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.206 1.937 . . . . 60.140000000000001 112.04 175.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.531 ' HB2' ' N ' ' A' ' 53' ' ' CYS . 13.0 m -51.3 -30.06 16.91 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.967 0.413 . . . . 64.049999999999997 111.195 -176.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 57' ' ' ARG . 43.3 ttt-85 -54.02 -58.22 8.14 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.621 -0.718 . . . . 53.409999999999997 110.853 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 33.0 t -75.75 -40.06 56.06 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.504 0.669 . . . . 55.119999999999997 111.084 174.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.523 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.8 mm? -57.51 -49.74 75.32 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.252 -0.885 . . . . 70.439999999999998 112.918 -171.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.51 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 49.9 mt-10 -56.39 -53.95 58.51 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 117.914 0.324 . . . . 71.439999999999998 111.147 -176.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 31.2 Cg_exo -50.29 -50.98 11.91 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.944 1.763 . . . . 63.450000000000003 111.74 172.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 58' ' ' SER . 45.2 mt-30 -54.35 -41.98 69.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.141 -0.481 . . . . 74.540000000000006 111.798 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 75.0 mt -68.36 -38.92 81.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.48 -0.327 . . . . 72.519999999999996 110.42 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 37.7 mt-10 -68.06 -29.59 68.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.145 -0.479 . . . . 63.32 110.26 177.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -64.91 -54.04 37.08 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.131 -0.692 . . . . 74.519999999999996 109.131 176.178 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.07 -32.78 73.35 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.306 -0.861 . . . . 53.340000000000003 110.068 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.531 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.54 -50.73 70.21 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.946 -0.57 . . . . 70.140000000000001 109.781 177.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.5 mt-30 -54.63 -47.99 72.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.174 0.511 . . . . 74.310000000000002 110.245 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -63.92 -45.21 90.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.408 -0.815 . . . . 41.420000000000002 111.767 -178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -104.98 4.26 31.53 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 113.239 0.829 . . . . 74.150000000000006 113.239 -170.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 14.0 t -53.33 -24.89 13.08 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.791 0.663 . . . . 54.439999999999998 112.791 -171.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.455 ' HG3' ' OD1' ' A' ' 73' ' ' ASN . 5.6 pt-20 -64.15 -25.41 68.07 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.005 0.431 . . . . 71.450000000000003 111.135 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.455 ' OD1' ' HG3' ' A' ' 72' ' ' GLU . 5.2 m120 -127.95 -0.76 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.334 -0.394 . . . . 74.329999999999998 111.257 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.461 HG23 HD11 ' A' ' 127' ' ' ILE . 25.8 t -130.51 139.12 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.043 0.449 . . . . 72.219999999999999 112.161 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -145.26 119.73 9.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 73.340000000000003 109.801 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.521 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.7 mp -98.68 140.06 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.181 -0.674 . . . . 54.32 109.181 174.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 73.7 m-85 -125.95 149.01 49.08 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.107 -0.701 . . . . 72.5 109.107 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HB3' ' OD2' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -133.47 135.06 44.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.885 -0.413 . . . . 72.530000000000001 109.885 176.365 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.0 mt -76.9 91.78 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.203 -0.665 . . . . 64.129999999999995 109.203 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -82.16 -18.5 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.917 -0.583 . . . . 65.099999999999994 110.477 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.1 mm -69.53 89.2 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.367 0.603 . . . . 70.230000000000004 109.882 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -48.98 -35.95 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.876 -1.057 . . . . 65.230000000000004 111.549 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.79 -22.76 60.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.327 -0.851 . . . . 74.140000000000001 112.313 -173.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -131.06 108.51 9.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.699 0.285 . . . . 71.349999999999994 110.826 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.99 32.36 1.02 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.839 -0.619 . . . . 72.409999999999997 110.416 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -52.37 -37.27 55.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.558 -0.746 . . . . 64.230000000000004 111.141 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.49 HG23 ' OD2' ' A' ' 28' ' ' ASP . 97.7 t -52.8 -36.28 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.757 -0.656 . . . . 73.439999999999998 111.17 -178.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.49 -54.91 24.99 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.064 0.459 . . . . 74.219999999999999 110.952 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.7 m -63.2 -40.94 98.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.802 -0.636 . . . . 70.319999999999993 110.903 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -67.77 -51.33 50.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.257 -0.429 . . . . 65.150000000000006 111.758 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -70.87 -29.13 65.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.777 -0.192 . . . . 65.129999999999995 111.286 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.09 57.14 0.57 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.653 -0.784 . . . . 72.329999999999998 112.657 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -92.66 99.63 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.937 0.399 . . . . 73.219999999999999 109.989 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -79.9 -50.65 10.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.848 -0.614 . . . . 72.150000000000006 110.543 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.13 136.33 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.596 -0.52 . . . . 33.340000000000003 109.596 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.649 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 62.3 mt -51.96 -55.38 31.18 Favored Pre-proline 0 CA--C 1.54 0.559 0 O-C-N 123.21 0.319 . . . . 72.540000000000006 111.56 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.649 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 4.4 Cg_exo -73.61 82.36 1.69 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.94 1.76 . . . . 62.32 111.852 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.0 m -122.6 138.89 54.44 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.132 -0.485 . . . . 72.329999999999998 110.03 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.9 mp -119.56 118.81 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.014 -0.539 . . . . 74.219999999999999 110.235 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HG ' ' HE2' ' A' ' 48' ' ' PHE . 49.4 mt -88.53 141.85 28.19 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.646 -0.502 . . . . 64.109999999999999 109.646 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.586 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 52.6 mtp -114.08 144.92 42.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.204 -0.665 . . . . 73.430000000000007 109.204 175.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.466 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 97.2 m-85 -146.64 160.22 42.47 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.777 -0.823 . . . . 72.430000000000007 108.777 174.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -148.15 109.52 4.37 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 120.077 -0.649 . . . . 73.310000000000002 111.789 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.754 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.9 m-20 56.47 31.79 19.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.012 0.434 . . . . 74.310000000000002 111.178 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.55 -15.22 61.96 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.108 -0.568 . . . . 51.130000000000003 112.657 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -67.94 132.67 47.76 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 109.645 -0.502 . . . . 75.230000000000004 109.645 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.6 147.49 45.5 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 124.045 0.841 . . . . 75.049999999999997 108.943 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.586 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.2 tp -156.48 168.44 27.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.093 -0.706 . . . . 63.340000000000003 109.093 -164.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.3 m -69.65 172.31 7.64 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.493 0.717 . . . . 74.319999999999993 112.512 -164.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.51 ' HG3' HD23 ' A' ' 100' ' ' LEU . 23.2 tt0 -131.01 131.81 44.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.23 -0.895 . . . . 72.450000000000003 109.91 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.79 111.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.915 -0.402 . . . . 73.219999999999999 109.915 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.2 mp -85.95 113.54 24.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.245 -0.65 . . . . 65.129999999999995 109.245 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.31 142.81 7.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.983 -0.627 . . . . 75.420000000000002 111.763 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.523 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -72.07 87.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.701 0.286 . . . . 72.030000000000001 110.765 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 119' ' ' ILE . 14.3 t70 -119.53 111.01 17.56 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.23 -0.441 . . . . 74.109999999999999 110.35 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -33.54 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.716 -0.675 . . . . 73.310000000000002 110.549 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -64.82 -53.25 49.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.984 0.421 . . . . 65.209999999999994 110.355 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -60.79 -45.6 93.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.162 -0.472 . . . . 73.519999999999996 110.331 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 115' ' ' ASP . 81.8 mt -58.66 -56.15 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.026 -0.534 . . . . 72.219999999999999 110.972 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -61.2 -36.32 71.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 120.772 0.32 . . . . 62.340000000000003 110.549 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.6 t -59.63 -52.05 67.19 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.117 -0.492 . . . . 61.520000000000003 110.015 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -62.56 -40.58 97.29 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.32 -0.4 . . . . 74.150000000000006 110.691 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 127' ' ' ILE . 57.3 mt -55.36 -56.11 13.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.288 -0.415 . . . . 64.299999999999997 110.644 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -66.1 -33.18 75.19 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.028 0.442 . . . . 72.510000000000005 110.343 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -69.36 -28.45 66.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 43.149999999999999 111.547 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.536 ' OD1' HD11 ' A' ' 108' ' ' LEU . 65.1 m-80 -107.86 -8.91 15.85 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.789 0.663 . . . . 71.019999999999996 112.789 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.461 HD11 HG23 ' A' ' 74' ' ' VAL . 61.3 mt -85.93 -51.58 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.883 -0.414 . . . . 63.32 109.883 170.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.25 1.097 0 CA-C-N 115.824 -0.626 . . . . 53.210000000000001 109.956 -178.741 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.7 mmm . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.543 0.211 . . . . 70.409999999999997 110.657 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.66 -169.68 2.68 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.55 -0.296 . . . . 63.399999999999999 110.997 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.3 m170 70.89 10.24 6.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.14 0.576 . . . . 70.420000000000002 111.929 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -84.29 53.99 2.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.695 0.759 . . . . 64.340000000000003 109.978 177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -55.0 105.94 0.19 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.79 -1.095 . . . . 70.200000000000003 111.752 -177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -83.83 -49.27 9.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.517 0.675 . . . . 73.329999999999998 109.203 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -123.7 103.78 8.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.188 -0.915 . . . . 72.109999999999999 109.104 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -97.65 -177.28 3.74 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.175 -0.466 . . . . 71.310000000000002 110.992 -173.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.5 ttm -151.48 158.16 43.28 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.927 -0.398 . . . . 72.450000000000003 109.927 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.83 121.24 3.89 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 111.424 -0.67 . . . . 34.299999999999997 111.424 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.7 m -68.71 151.47 46.63 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.6 0.238 . . . . 71.109999999999999 111.114 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.685 ' HG ' HD13 ' A' ' 120' ' ' ILE . 6.3 mp -68.66 87.87 0.34 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.469 -0.332 . . . . 74.319999999999993 110.46 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -90.15 78.74 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 54.210000000000001 111.021 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.28 66.35 4.71 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.354 -0.61 . . . . 72.310000000000002 109.354 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -82.24 -177.05 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.355 -0.839 . . . . 72.319999999999993 111.801 -172.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.0 p -77.54 -172.79 2.68 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.681 -0.69 . . . . 64.140000000000001 110.89 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -70.1 89.51 0.63 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.039 0.447 . . . . 72.209999999999994 110.55 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.53 123.82 6.6 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.675 -0.97 . . . . 51.409999999999997 110.675 174.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.29 137.12 25.36 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.513 2.142 . . . . 73.549999999999997 112.952 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.06 45.93 0.42 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.562 -1.015 . . . . 41.039999999999999 110.562 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.1 m -59.73 88.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.401 0.62 . . . . 75.409999999999997 112.306 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.492 ' SD ' ' HG2' ' A' ' 68' ' ' GLN . 19.2 ptm -124.11 16.77 9.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.1 -0.955 . . . . 70.230000000000004 109.137 173.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -80.44 107.07 12.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.024 -0.989 . . . . 71.409999999999997 109.704 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -62.82 152.52 35.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.258 0.552 . . . . 72.200000000000003 111.762 -172.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 10.1 pt20 -124.67 125.56 44.3 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.613 -0.721 . . . . 72.450000000000003 109.528 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 31' ' ' PHE . 25.6 pt -135.7 158.11 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.697 0.284 . . . . 73.420000000000002 111.409 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.52 -179.93 52.34 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.202 -0.454 . . . . 74.349999999999994 112.442 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HB2' ' ND2' ' A' ' 84' ' ' ASN . 18.3 t70 -58.9 -56.3 24.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.098 0.475 . . . . 72.310000000000002 111.341 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.0 m -69.76 -15.61 63.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 65.310000000000002 111.344 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -84.7 -10.99 56.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 111.4 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 26' ' ' ILE . 79.5 t80 -55.28 -62.47 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.664 0.246 . . . . 64.409999999999997 111.664 -173.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.95 -45.32 95.18 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.902 0.382 . . . . 72.120000000000005 110.925 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.27 -49.82 76.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.749 -0.66 . . . . 73.25 111.421 -176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HG3' ' CG2' ' A' ' 26' ' ' ILE . 33.1 mmtp -69.34 -33.92 73.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.257 -0.429 . . . . 71.129999999999995 110.944 -176.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 31' ' ' PHE . 72.3 t -65.47 -43.2 94.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 120.876 0.37 . . . . 72.219999999999999 110.4 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.5 p -75.1 -18.51 60.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.878 0.37 . . . . 73.409999999999997 110.898 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.8 t -67.69 -2.79 7.52 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.211 -0.45 . . . . 63.119999999999997 111.329 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.757 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.3 p -57.8 148.93 23.62 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.639 -0.255 . . . . 62.439999999999998 110.567 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.5 -84.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.437 -0.347 . . . . 71.310000000000002 110.32 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -162.07 135.92 6.5 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.237 -0.653 . . . . 73.540000000000006 109.237 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 65.68 9.43 5.93 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.684 0.615 . . . . 64.420000000000002 110.999 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.757 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.2 mm -76.48 115.97 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 73.340000000000003 110.552 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 102' ' ' PHE . 1.0 OUTLIER -74.7 110.8 9.29 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.121 -0.696 . . . . 74.120000000000005 109.121 175.265 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.515 HD11 ' HB3' ' A' ' 38' ' ' CYS . 27.9 mm -93.21 106.85 18.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.342 -0.844 . . . . 75.340000000000003 110.037 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.668 ' HB2' HG13 ' A' ' 76' ' ' ILE . 5.3 mp -92.38 149.63 21.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.945 -0.761 . . . . 73.409999999999997 108.945 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 58.5 t -132.23 110.99 17.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.906 -0.775 . . . . 53.109999999999999 108.906 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -94.31 159.95 14.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.259 0.552 . . . . 52.350000000000001 111.123 -173.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -128.54 83.27 2.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.113 -0.949 . . . . 71.540000000000006 109.004 165.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.478 ' CH2' HD12 ' A' ' 63' ' ' LEU . 5.5 m95 -51.37 -35.66 39.64 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.124 -0.489 . . . . 62.310000000000002 110.883 177.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 66.01 112.51 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 115.219 -0.9 . . . . 63.100000000000001 110.201 -175.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.79 -23.5 11.65 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.926 2.417 . . . . 52.409999999999997 112.811 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -127.06 88.59 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.53 . . . . 74.010000000000005 109.866 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.3 t -147.39 158.38 43.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.081 -0.509 . . . . 73.140000000000001 110.202 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.51 -77.34 1.37 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.437 -0.411 . . . . 65.430000000000007 112.701 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.47 -24.61 75.57 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.008 2.472 . . . . 73.329999999999998 112.538 -175.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 97' ' ' PRO . 57.5 m -55.58 -27.38 48.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 110.647 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.403 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.2 ttt180 -55.28 -45.02 76.17 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.94 -0.573 . . . . 75.299999999999997 111.051 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.632 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 13.0 m -74.45 -38.35 63.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.382 0.61 . . . . 54.149999999999999 110.563 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.529 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 mm? -61.03 -26.86 67.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.673 -0.694 . . . . 73.430000000000007 110.92 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 30.3 tt0 -56.52 -67.75 0.74 Allowed Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 119.333 -0.365 . . . . 73.140000000000001 110.238 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.477 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 27.8 Cg_endo -61.63 -39.41 54.33 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 121.484 1.456 . . . . 53.340000000000003 112.089 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.632 ' HG3' ' O ' ' A' ' 58' ' ' SER . 48.7 mt-30 -53.87 -52.7 59.62 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.74 -0.384 . . . . 70.349999999999994 111.433 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.478 HD12 ' CH2' ' A' ' 49' ' ' TRP . 53.7 mt -76.91 -28.28 55.25 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.792 0.293 . . . . 53.420000000000002 111.792 -175.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 93.2 mt-10 -65.37 -41.75 93.47 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.085 0.469 . . . . 74.530000000000001 109.828 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -67.34 -46.85 72.2 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.062 -0.517 . . . . 72.340000000000003 110.285 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' CD1' HD11 ' A' ' 116' ' ' ILE . 21.3 mt -62.85 -29.78 71.0 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.848 -0.341 . . . . 61.210000000000001 110.623 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.74 -51.34 67.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.433 -0.58 . . . . 73.510000000000005 109.433 175.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.492 ' HG2' ' SD ' ' A' ' 22' ' ' MET . 92.2 mt-30 -60.58 -32.2 71.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.837 -0.619 . . . . 72.549999999999997 111.062 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -77.16 -40.34 45.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 75.340000000000003 111.296 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -104.69 4.44 32.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.288 -0.415 . . . . 71.109999999999999 111.833 -174.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.8 t -53.01 -19.67 2.86 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.167 0.432 . . . . 71.109999999999999 112.167 -172.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -54.89 -41.91 71.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.093 -0.503 . . . . 75.239999999999995 110.187 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.473 ' HA ' HD13 ' A' ' 42' ' ' ILE . 52.3 m-80 -135.18 11.93 3.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.912 -0.586 . . . . 70.239999999999995 111.721 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.5 HG23 HD11 ' A' ' 127' ' ' ILE . 24.1 t -126.25 139.17 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 122.242 -0.286 . . . . 64.140000000000001 111.506 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -143.67 129.16 19.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.983 -0.747 . . . . 73.439999999999998 108.983 172.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' A' ' 45' ' ' LEU . 4.5 mp -105.63 138.28 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.08 0.466 . . . . 73.230000000000004 110.635 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 16.0 m-85 -127.42 165.06 20.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.277 -0.874 . . . . 74.420000000000002 108.963 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -161.81 165.01 28.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.344 -0.389 . . . . 74.549999999999997 110.149 173.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.4 tp -68.37 129.53 32.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 75.310000000000002 110.437 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 52.7 t30 -95.19 -15.98 22.88 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.13 -0.486 . . . . 62.200000000000003 110.554 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.4 mt -102.62 103.31 14.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.884 -0.598 . . . . 74.439999999999998 109.908 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.3 -18.46 63.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.012 0.434 . . . . 72.25 110.901 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.43 -14.11 60.43 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.816 -0.629 . . . . 72.439999999999998 111.006 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 28' ' ' ASP . 24.4 t-20 -102.2 119.52 38.93 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.906 0.384 . . . . 74.120000000000005 111.436 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -119.31 -3.51 10.51 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.543 -0.54 . . . . 73.409999999999997 109.543 169.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.2 m-20 -48.08 -49.66 30.88 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.482 -0.781 . . . . 61.299999999999997 111.457 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -54.97 -38.9 47.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 116.224 -0.443 . . . . 74.329999999999998 110.694 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -69.01 -42.75 76.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.221 -0.445 . . . . 53.130000000000003 109.866 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -61.2 -38.44 86.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.564 -0.744 . . . . 62.420000000000002 110.576 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 78.3 mm-40 -69.71 -49.81 49.77 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.079 -0.509 . . . . 75.329999999999998 111.298 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -89.49 -2.45 58.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.286 -0.416 . . . . 71.540000000000006 112.027 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.19 57.09 5.34 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.137 -0.554 . . . . 33.240000000000002 112.977 171.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.42 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 86.6 t -82.42 92.77 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.698 -0.482 . . . . 74.430000000000007 109.698 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.3 t -89.41 -34.12 16.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.775 -0.648 . . . . 75.310000000000002 110.617 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.66 143.83 28.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 43.329999999999998 110.149 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.742 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 50.2 mm -59.29 -52.64 72.97 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.494 -0.321 . . . . 74.439999999999998 110.691 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.742 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 58.2 Cg_endo -93.52 112.38 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.472 2.115 . . . . 73.120000000000005 111.145 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.437 ' C ' HD12 ' A' ' 99' ' ' ILE . 64.2 m -136.97 141.91 42.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.92 0.39 . . . . 73.340000000000003 111.247 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.569 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -123.44 119.19 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.606 -0.724 . . . . 71.310000000000002 109.939 174.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.482 HD23 ' HG3' ' A' ' 110' ' ' GLN . 91.3 mt -94.83 129.43 41.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.063 -0.717 . . . . 63.240000000000002 109.063 174.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 44.4 mtp -106.47 138.53 42.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.036 -0.357 . . . . 73.340000000000003 110.036 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.488 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 100.0 m-85 -143.63 165.44 27.62 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.467 -0.568 . . . . 73.140000000000001 109.467 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 40.0 ttmt -151.78 104.87 3.06 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 122.245 -0.284 . . . . 63.100000000000001 110.948 175.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.719 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 57.6 t30 47.68 56.07 7.6 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.368 0.604 . . . . 64.219999999999999 110.914 177.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.88 -16.78 3.11 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.441 -0.8 . . . . 54.340000000000003 113.791 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 63.2 tttp -80.88 143.43 32.71 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 117.082 0.441 . . . . 62.219999999999999 110.141 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -71.97 145.59 48.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.58 0.705 . . . . 71.519999999999996 111.076 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -146.39 167.75 22.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.587 -1.264 . . . . 70.329999999999998 107.587 -172.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.1 m -70.19 -177.79 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.419 0.628 . . . . 72.019999999999996 112.66 -164.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.482 ' HG3' HD23 ' A' ' 100' ' ' LEU . 54.7 tt0 -138.46 129.52 26.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 74.230000000000004 109.51 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.569 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.0 t -100.53 107.51 21.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.069 0.461 . . . . 50.240000000000002 110.231 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.3 mp -86.71 110.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.567 -0.742 . . . . 73.329999999999998 109.435 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.409 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 99.43 155.08 28.48 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.56 -0.616 . . . . 30.23 111.56 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.529 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -80.04 72.16 6.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.844 0.354 . . . . 43.439999999999998 110.95 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 119' ' ' ILE . 18.0 t70 -111.08 96.95 6.45 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.598 0.713 . . . . 74.109999999999999 110.505 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.444 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -61.59 -34.41 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.141 -0.936 . . . . 73.099999999999994 110.263 -173.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.1 p -63.13 -43.34 98.64 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.274 -0.421 . . . . 62.200000000000003 111.056 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.84 -43.85 78.57 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.715 -0.476 . . . . 75.409999999999997 109.715 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 115' ' ' ASP . 70.8 mt -56.05 -56.48 12.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-N 116.015 -0.539 . . . . 74.140000000000001 110.838 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.685 HD13 ' HG ' ' A' ' 12' ' ' LEU . 15.7 tt -65.52 -33.87 66.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.854 -0.612 . . . . 45.439999999999998 110.586 -176.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.5 t -57.33 -51.93 67.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.229 -0.441 . . . . 61.229999999999997 110.111 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -60.66 -45.3 94.63 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.589 -0.278 . . . . 73.409999999999997 110.372 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 119' ' ' ILE . 72.7 mt -52.56 -56.04 8.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 116.107 -0.497 . . . . 71.299999999999997 111.182 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -68.21 -32.96 73.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.658 0.266 . . . . 74.239999999999995 110.632 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -61.75 -36.49 81.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.145 0.498 . . . . 72.129999999999995 110.228 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -85.4 -28.78 24.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 72.239999999999995 112.144 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.5 HD11 HG23 ' A' ' 74' ' ' VAL . 52.6 mt -103.74 -60.69 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.142 0.496 . . . . 72.409999999999997 112.232 -178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.383 -0.826 . . . . 65.439999999999998 110.921 -166.784 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 tpp . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 121.001 0.429 . . . . 63.420000000000002 110.451 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.61 135.69 43.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 61.229999999999997 110.671 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -156.21 145.88 21.0 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.284 -1.006 . . . . 74.129999999999995 108.284 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -83.63 164.68 19.56 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.094 -0.335 . . . . 70.530000000000001 110.094 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -121.98 34.99 5.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.23 -1.026 . . . . 74.019999999999996 108.23 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -101.74 91.77 4.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.894 -1.503 . . . . 73.329999999999998 109.754 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -75.24 111.33 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 71.310000000000002 109.937 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -93.73 111.82 23.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.488 -0.778 . . . . 73.099999999999994 110.228 -173.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -136.48 158.52 44.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.967 0.413 . . . . 72.349999999999994 110.969 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.12 116.24 0.39 Allowed Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.023 -0.831 . . . . 62.399999999999999 111.023 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -124.83 159.82 30.16 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.84 0.352 . . . . 73.409999999999997 110.836 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.626 ' H ' ' NE2' ' A' ' 85' ' ' GLN . 97.8 mt -131.0 -67.38 0.71 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.946 -0.57 . . . . 64.530000000000001 109.93 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -120.31 154.24 35.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.25 -0.432 . . . . 71.109999999999999 109.918 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.08 129.04 36.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.2 -0.296 . . . . 15.35 110.2 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.498 ' HG3' ' HB3' ' A' ' 82' ' ' GLU . 23.7 mt-30 -99.16 158.33 15.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.573 -0.285 . . . . 72.200000000000003 110.769 -177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 p -83.58 -77.97 0.24 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.176 -0.466 . . . . 74.239999999999995 111.885 -176.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -174.44 -177.5 1.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.837 0.351 . . . . 71.129999999999995 110.429 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.27 161.04 20.66 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.263 -0.735 . . . . 62.43 111.263 171.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.05 -10.48 19.55 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.518 2.145 . . . . 70.010000000000005 112.333 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.87 68.91 1.47 Allowed Glycine 0 C--N 1.334 0.425 0 N-CA-C 111.109 -0.797 . . . . 75.150000000000006 111.109 -176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -142.51 -167.19 2.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.46 0.172 . . . . 72.329999999999998 110.689 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.421 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 88.1 mmm -59.73 -16.88 30.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.248 0.547 . . . . 54.299999999999997 110.483 173.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.449 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 13.0 mm -83.19 123.26 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.367 -0.833 . . . . 51.530000000000001 109.878 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.489 ' HG3' HG23 ' A' ' 26' ' ' ILE . 6.2 tp10 -74.27 160.24 31.38 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 123.165 0.29 . . . . 75.430000000000007 110.245 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 25.4 pt20 -133.85 115.89 15.0 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 110.026 -0.361 . . . . 65.129999999999995 110.026 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.542 HG21 ' HG3' ' A' ' 34' ' ' LYS . 21.5 pt -139.9 179.98 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.305 0.483 . . . . 63.420000000000002 112.305 -170.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.0 -157.14 9.9 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.392 -0.822 . . . . 70.420000000000002 111.293 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.401 ' HB3' ' OD1' ' A' ' 84' ' ' ASN . 12.4 t70 -68.21 -51.03 50.03 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.147 0.474 . . . . 64.140000000000001 111.24 -176.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 t -58.21 -43.84 87.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 55.210000000000001 110.356 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -83.12 -13.11 56.29 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.502 -0.317 . . . . 71.209999999999994 111.691 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.5 ' HA ' HD12 ' A' ' 26' ' ' ILE . 89.3 t80 -58.18 -57.7 11.69 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.961 -0.755 . . . . 74.340000000000003 108.961 175.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.61 -51.43 69.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 65.319999999999993 110.638 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -52.73 -57.42 10.18 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.307 0.379 . . . . 73.439999999999998 111.215 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HG3' HG21 ' A' ' 26' ' ' ILE . 34.6 mmtp -69.38 -37.02 77.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 62.140000000000001 111.59 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.38 -45.17 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 121.197 -0.201 . . . . 70.200000000000003 110.704 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.5 p -75.2 -24.7 57.81 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.881 -0.328 . . . . 63.32 111.243 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.7 t -70.04 -7.88 44.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.501 -0.318 . . . . 61.43 111.699 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.929 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 26.8 p -59.35 137.28 58.05 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.652 -0.499 . . . . 63.340000000000003 109.652 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -48.38 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.415 0.447 . . . . 72.409999999999997 111.142 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -161.98 145.37 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.449 -0.574 . . . . 72.450000000000003 109.449 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 48.22 13.14 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.084 0.954 . . . . 74.420000000000002 113.32 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.65 136.66 26.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.275 -0.268 . . . . 60.149999999999999 110.275 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -85.35 113.15 21.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.459 0.647 . . . . 70.200000000000003 109.301 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.1 mt -106.95 139.39 28.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.152 -0.931 . . . . 73.420000000000002 110.624 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.558 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -120.82 139.48 53.09 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.172 -1.047 . . . . 63.310000000000002 108.172 170.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 77' ' ' TYR . 97.1 t -127.26 104.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.192 -0.67 . . . . 71.409999999999997 109.192 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 3.2 p-10 -101.39 150.52 22.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.012 -0.54 . . . . 62.130000000000003 109.724 -177.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -85.22 157.39 20.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.426 -0.352 . . . . 72.120000000000005 110.328 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -51.35 -37.98 50.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.121 -0.49 . . . . 75.329999999999998 111.866 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 68.17 144.09 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 123.842 0.714 . . . . 73.409999999999997 111.622 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -90.81 -167.58 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.773 2.316 . . . . 65.230000000000004 111.888 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -60.52 97.7 0.06 Allowed 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.533 -0.543 . . . . 74.230000000000004 109.533 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 11.5 t -132.69 127.52 34.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.881 -0.6 . . . . 64.230000000000004 111.016 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.54 -67.8 2.01 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.909 -0.587 . . . . 61.119999999999997 113.327 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -56.6 -38.49 95.4 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.45 2.1 . . . . 73.519999999999996 111.574 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.604 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 21.7 m -61.76 -32.12 72.35 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.905 -0.589 . . . . 60.439999999999998 110.804 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.57 -47.46 73.25 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.975 -0.557 . . . . 65.129999999999995 110.559 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.567 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 47.2 t -74.95 -36.27 62.1 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.518 0.675 . . . . 55.100000000000001 110.52 177.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 1.3 mm? -55.03 -44.6 74.8 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.475 -0.784 . . . . 74.140000000000001 112.059 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.05 -56.86 30.68 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 119.374 -0.346 . . . . 72.340000000000003 111.543 -176.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HG2' ' O ' ' A' ' 58' ' ' SER . 10.0 Cg_endo -54.14 -38.14 87.53 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.739 1.626 . . . . 61.119999999999997 111.748 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 58' ' ' SER . 36.8 mt-30 -61.94 -39.64 92.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.753 -0.379 . . . . 74.400000000000006 110.956 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 80.3 mt -67.33 -36.92 82.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.425 -0.352 . . . . 63.439999999999998 110.147 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 42.8 mt-10 -59.4 -47.85 83.89 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.491 -0.559 . . . . 71.219999999999999 109.491 174.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -55.31 -50.61 69.13 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.578 -0.737 . . . . 74.209999999999994 110.566 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.538 HD11 HD11 ' A' ' 116' ' ' ILE . 23.1 mt -65.43 -37.14 86.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 64.409999999999997 110.443 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.534 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.98 -31.83 72.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 65.409999999999997 110.742 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 54.7 mt-30 -76.81 -50.59 13.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.001 0.429 . . . . 65.230000000000004 110.541 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -64.11 -41.19 97.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.745 -0.661 . . . . 74.430000000000007 110.715 -175.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.401 ' HE2' HD22 ' A' ' 66' ' ' LEU . 95.5 m-85 -99.11 5.56 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 72.530000000000001 112.178 -174.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.3 t -52.73 -19.57 2.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.762 0.653 . . . . 55.130000000000003 112.762 -170.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.16 -33.7 75.98 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.839 0.352 . . . . 64.099999999999994 110.971 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -126.2 -4.5 6.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.317 -0.401 . . . . 65.25 112.072 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.63 138.69 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.956 0.407 . . . . 72.219999999999999 111.726 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -142.95 121.68 12.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.703 -0.68 . . . . 74.030000000000001 109.833 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.558 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.1 mt -111.55 144.49 19.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 120.939 0.4 . . . . 73.400000000000006 111.197 -177.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.487 ' CE1' ' HB3' ' A' ' 34' ' ' LYS . 96.3 m-85 -130.56 136.36 48.83 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.558 -0.746 . . . . 75.25 110.213 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HG3' ' CG2' ' A' ' 23' ' ' ILE . 29.4 mtpp -107.97 134.04 51.45 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.582 -0.525 . . . . 64.219999999999999 109.582 173.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.3 mt -73.42 104.65 2.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.805 -0.813 . . . . 71.340000000000003 108.805 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 23.9 t-20 -98.95 -39.75 8.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.172 -0.467 . . . . 72.329999999999998 111.685 -173.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.4 mm -79.64 105.24 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.492 -0.322 . . . . 62.119999999999997 110.899 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.498 ' HB3' ' HG3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -59.61 -24.74 64.06 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.795 -0.638 . . . . 75.230000000000004 111.986 -178.536 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -71.4 -5.1 30.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.127 0.489 . . . . 54.340000000000003 110.621 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.401 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 24.0 m-80 -124.59 29.12 6.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 44.539999999999999 111.136 -176.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.626 ' NE2' ' H ' ' A' ' 12' ' ' LEU . 40.3 mt-30 -69.07 -7.34 34.92 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.352 -0.385 . . . . 64.25 110.916 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -47.11 -38.71 11.94 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.047 -0.524 . . . . 71.299999999999997 110.909 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -53.06 -41.67 42.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 115.703 -0.681 . . . . 34.509999999999998 110.894 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.0 -41.48 96.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.619 -0.719 . . . . 72.129999999999995 110.499 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.5 m -69.5 -38.04 77.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.738 -0.665 . . . . 75.439999999999998 110.454 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -58.5 -51.69 68.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.972 -0.558 . . . . 75.219999999999999 110.842 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -77.11 -25.69 52.44 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 121.013 -0.275 . . . . 74.319999999999993 111.201 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 51.84 9.35 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.572 -0.823 . . . . 71.049999999999997 111.045 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.413 HG23 HG21 ' A' ' 98' ' ' THR . 7.7 p -59.71 135.77 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.258 -0.471 . . . . 71.140000000000001 111.305 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -69.84 -38.12 76.41 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.883 -0.598 . . . . 73.0 111.913 -174.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.42 164.03 34.64 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.464 -0.148 . . . . 73.129999999999995 110.874 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.605 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 48.2 mm -61.41 -48.69 90.21 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.543 -0.299 . . . . 43.299999999999997 110.836 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 3.6 Cg_exo -80.13 101.49 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.978 1.785 . . . . 75.439999999999998 110.552 172.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.413 HG21 HG23 ' A' ' 93' ' ' VAL . 97.1 m -153.2 146.63 24.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.326 -0.397 . . . . 53.520000000000003 110.576 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.592 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -118.37 116.26 50.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.035 -0.53 . . . . 53.100000000000001 110.089 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.441 HD23 ' HG3' ' A' ' 110' ' ' GLN . 89.1 mt -94.91 123.43 38.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.21 -0.663 . . . . 61.420000000000002 109.21 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.405 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 51.4 mtp -92.77 147.97 22.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.144 -0.317 . . . . 73.019999999999996 110.144 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.2 m-85 -144.92 161.09 40.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.551 -0.537 . . . . 74.420000000000002 109.551 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 20.7 ttmm -148.5 105.01 3.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.629 0.252 . . . . 73.120000000000005 110.568 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.929 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 65.7 t30 57.02 39.72 29.13 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.32 0.581 . . . . 71.329999999999998 110.692 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.98 -16.05 23.72 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.944 -0.571 . . . . 61.0 112.768 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 62.1 tttp -75.96 148.93 37.78 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 110.132 -0.321 . . . . 71.430000000000007 110.132 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -65.1 157.25 29.07 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.411 0.624 . . . . 71.099999999999994 110.903 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.26 167.9 23.2 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.358 -1.349 . . . . 63.0 107.358 -167.583 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.408 ' H ' HD13 ' A' ' 108' ' ' LEU . 38.7 m -70.44 178.64 2.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.425 0.631 . . . . 54.140000000000001 112.369 -167.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.441 ' HG3' HD23 ' A' ' 100' ' ' LEU . 59.0 tt0 -134.25 130.39 37.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.734 -0.666 . . . . 63.100000000000001 110.621 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.592 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.4 t -101.1 107.31 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.044 -0.724 . . . . 73.439999999999998 109.044 173.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.8 mt -87.48 109.14 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.144 -0.48 . . . . 75.219999999999999 110.095 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.8 -147.75 16.42 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.395 -0.682 . . . . 62.219999999999999 111.395 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.524 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -132.21 96.26 3.84 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.413 -0.217 . . . . 74.299999999999997 110.413 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -139.56 103.48 4.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.213 0.53 . . . . 70.409999999999997 110.473 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -63.34 -28.32 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 64.099999999999994 110.143 -175.086 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.3 m -62.9 -53.45 53.88 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.974 -0.557 . . . . 60.020000000000003 110.224 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -60.8 -44.36 96.95 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.21 -0.45 . . . . 73.120000000000005 110.09 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.475 HD13 HD21 ' A' ' 63' ' ' LEU . 66.0 mt -55.45 -56.12 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.964 -0.562 . . . . 64.299999999999997 111.316 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.6 tp -64.21 -34.46 69.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.526 0.203 . . . . 61.409999999999997 110.717 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.4 m -58.14 -50.69 72.61 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.538 -0.301 . . . . 61.149999999999999 110.468 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.82 -38.12 85.83 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.593 -0.276 . . . . 74.319999999999993 111.472 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.6 mt -58.65 -56.01 19.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.962 0.41 . . . . 64.299999999999997 110.115 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.78 -39.11 83.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 63.43 110.365 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -60.29 -39.84 88.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.486 -0.779 . . . . 73.120000000000005 111.215 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -100.57 -2.4 33.01 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 112.173 0.434 . . . . 72.409999999999997 112.173 -174.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.0 mt -90.92 -55.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.671 -0.492 . . . . 53.32 109.671 168.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--O 1.251 1.149 0 CA-C-N 115.811 -0.631 . . . . 54.509999999999998 109.548 -179.841 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.467 ' SD ' ' HB2' ' A' ' 3' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.874 -0.417 . . . . 71.140000000000001 109.874 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.68 79.91 1.53 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.142 0.496 . . . . 71.530000000000001 110.486 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.467 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 12.3 t-80 -103.97 101.7 11.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.516 -0.766 . . . . 74.519999999999996 110.643 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -67.94 142.56 55.98 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.545 -0.298 . . . . 72.230000000000004 110.273 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -120.14 75.29 1.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.709 0.29 . . . . 64.530000000000001 110.292 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.23 149.78 0.16 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.399 0.68 . . . . 65.340000000000003 109.3 177.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -157.49 163.76 38.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.861 0.362 . . . . 73.099999999999994 110.782 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -128.02 163.97 23.38 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.279 -0.637 . . . . 74.150000000000006 109.279 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.8 tpt -134.08 131.0 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.807 0.337 . . . . 74.310000000000002 110.102 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.9 112.34 3.57 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.063 -0.517 . . . . 62.020000000000003 112.175 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -92.2 98.97 11.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.661 0.267 . . . . 74.140000000000001 110.554 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.78 133.25 53.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.071 0.462 . . . . 74.239999999999995 110.609 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -102.02 -178.63 3.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.63 -0.714 . . . . 74.209999999999994 109.413 176.042 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.14 111.21 5.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.899 0.381 . . . . 63.219999999999999 111.66 -176.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -92.85 108.04 19.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.252 -0.647 . . . . 52.43 109.252 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.0 p -122.24 145.74 47.93 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.969 0.414 . . . . 74.450000000000003 111.423 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -133.23 172.83 12.15 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.807 -0.633 . . . . 74.25 109.583 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.87 162.45 28.32 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.921 -0.657 . . . . 62.43 112.726 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.92 -168.95 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.941 2.427 . . . . 71.450000000000003 111.965 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.99 144.43 7.2 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.198 -0.525 . . . . 61.149999999999999 112.203 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 t 76.83 14.59 2.08 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.412 0.685 . . . . 64.519999999999996 111.621 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 90.7 mmm -80.02 -36.24 36.14 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.556 -0.905 . . . . 73.140000000000001 108.556 172.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.442 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 10.7 mm -75.89 99.78 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 114.995 -1.002 . . . . 73.150000000000006 108.788 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.03 161.57 24.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.231 -0.44 . . . . 73.430000000000007 110.786 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.677 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 4.3 pm0 -125.67 122.82 37.45 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.885 0.374 . . . . 73.049999999999997 110.24 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 31' ' ' PHE . 34.4 pt -139.09 -179.75 2.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 122.942 0.497 . . . . 73.430000000000007 110.834 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.504 ' HA3' ' ND2' ' A' ' 84' ' ' ASN . . . -129.45 -157.57 9.22 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.904 -0.589 . . . . 64.209999999999994 111.944 176.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.4 -56.7 7.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.952 0.406 . . . . 73.209999999999994 111.123 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.5 m -62.78 -19.3 63.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 64.310000000000002 111.358 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 21.2 mp0 -96.07 -22.11 17.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.51 -0.314 . . . . 74.030000000000001 110.89 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.588 ' HA ' HD12 ' A' ' 26' ' ' ILE . 93.1 t80 -56.36 -62.32 1.8 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.81 0.338 . . . . 73.439999999999998 111.409 -174.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -59.21 -46.8 87.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 74.430000000000007 110.366 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -54.3 -55.83 24.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.064 -0.971 . . . . 73.200000000000003 111.404 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -65.68 -41.43 92.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.057 -0.519 . . . . 73.349999999999994 111.51 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.54 HG22 HG21 ' A' ' 44' ' ' ILE . 91.1 t -70.04 -29.24 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.116 0.26 . . . . 64.109999999999999 111.646 -177.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.5 p -85.95 -31.11 22.28 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.936 0.398 . . . . 74.129999999999995 111.142 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -76.86 10.97 1.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.031 -0.531 . . . . 75.230000000000004 111.25 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.976 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 9.3 p -73.2 -0.18 13.57 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.864 0.32 . . . . 73.340000000000003 111.864 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 t30 70.87 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.173 0.589 . . . . 71.040000000000006 111.869 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -162.17 137.35 7.17 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.531 0.567 . . . . 74.420000000000002 112.531 -177.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 61.56 2.72 0.72 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 60.32 113.614 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.799 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.9 mm -79.91 114.69 21.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.928 -0.397 . . . . 75.519999999999996 109.928 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tt -79.33 115.99 19.3 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.854 -0.612 . . . . 74.310000000000002 109.662 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.54 HG21 HG22 ' A' ' 35' ' ' VAL . 15.6 mm -99.2 120.04 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.458 -0.792 . . . . 74.400000000000006 110.214 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.6 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.2 mp -107.48 113.75 27.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.959 -0.756 . . . . 74.010000000000005 108.959 174.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -104.82 104.91 17.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.862 0.363 . . . . 51.210000000000001 110.963 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.672 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 7.7 t70 -80.55 148.05 30.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.758 -0.656 . . . . 61.210000000000001 109.464 172.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -74.24 -74.55 0.19 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.208 -0.664 . . . . 71.319999999999993 109.208 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.523 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 36.9 p90 179.54 138.7 0.11 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.384 -0.826 . . . . 74.340000000000003 109.06 174.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.06 100.7 9.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.544 -0.298 . . . . 73.019999999999996 110.224 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 49' ' ' TRP . 72.2 Cg_endo -92.26 -95.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.936 2.424 . . . . 64.239999999999995 112.277 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -104.72 112.1 25.06 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.623 -0.51 . . . . 62.409999999999997 109.623 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 56' ' ' CYS . 21.1 t -172.37 167.05 5.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.327 -175.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.468 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -76.48 -95.94 0.17 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.917 -0.659 . . . . 31.210000000000001 112.171 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.19 -17.4 56.55 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.836 2.357 . . . . 72.120000000000005 112.478 -175.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 55.9 m -57.63 -34.95 69.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 74.109999999999999 111.206 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -64.44 -36.98 85.92 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.889 0.376 . . . . 75.420000000000002 110.449 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.539 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 11.5 t -75.26 -26.78 59.09 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.481 0.658 . . . . 65.209999999999994 110.551 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 114' ' ' ALA . 9.4 tp -64.22 -41.06 97.18 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.762 -0.653 . . . . 71.129999999999995 111.877 -171.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.502 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 49.2 mt-10 -55.92 -53.22 65.5 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 120.782 -0.367 . . . . 72.010000000000005 110.183 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 12.0 Cg_exo -52.65 -43.13 57.73 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.889 1.726 . . . . 63.229999999999997 112.255 170.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 58' ' ' SER . 35.3 mt-30 -65.72 -32.9 74.71 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.114 -0.635 . . . . 64.540000000000006 110.781 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.438 HD21 HD13 ' A' ' 119' ' ' ILE . 53.9 mt -70.11 -37.57 75.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.447 -0.797 . . . . 73.319999999999993 109.715 178.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' OE2' HG12 ' A' ' 23' ' ' ILE . 18.4 mm-40 -58.13 -46.37 85.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.352 -0.385 . . . . 73.0 109.973 171.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -55.87 -54.46 44.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.009 -0.542 . . . . 73.209999999999994 110.392 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.495 HD11 ' CD1' ' A' ' 116' ' ' ILE . 18.8 mt -63.55 -36.56 84.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.022 -0.535 . . . . 63.130000000000003 110.568 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.499 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.79 -33.26 75.27 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.784 -0.644 . . . . 65.319999999999993 110.629 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -78.33 -47.67 17.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 65.129999999999995 110.947 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -61.42 -38.94 88.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.079 -0.51 . . . . 74.150000000000006 110.873 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -104.88 5.76 33.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.42 -0.809 . . . . 72.340000000000003 112.269 -173.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.2 t -52.48 -23.26 5.87 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.811 1.041 . . . . 72.450000000000003 113.811 -166.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.95 -36.46 77.96 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.595 -0.442 . . . . 74.340000000000003 110.67 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -114.33 -4.73 12.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 64.140000000000001 111.676 -175.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.7 t -130.34 150.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.005 0.372 . . . . 73.230000000000004 112.005 -174.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -151.69 125.46 9.04 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.905 -0.589 . . . . 75.319999999999993 109.735 172.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.6 HG12 ' HB2' ' A' ' 45' ' ' LEU . 62.3 mt -101.54 142.56 15.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 120.889 0.376 . . . . 75.319999999999993 110.593 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -128.02 168.49 15.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.554 -0.748 . . . . 74.230000000000004 109.188 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 8.4 ptpp? -147.39 163.15 37.37 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.705 -0.48 . . . . 63.25 109.705 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mt -81.87 114.32 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.253 -0.647 . . . . 74.340000000000003 109.253 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.677 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 11.9 t30 -73.14 -36.79 66.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.927 -0.578 . . . . 74.040000000000006 112.272 -173.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.534 HG13 ' H ' ' A' ' 83' ' ' ASP . 9.2 tp -135.62 143.26 37.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.951 0.405 . . . . 73.209999999999994 111.281 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.46 -18.73 60.3 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.673 -0.694 . . . . 71.209999999999994 112.009 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.534 ' H ' HG13 ' A' ' 81' ' ' ILE . 8.3 m-20 -71.27 -22.64 61.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.313 0.578 . . . . 74.329999999999998 110.288 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.504 ' ND2' ' HA3' ' A' ' 27' ' ' GLY . 92.3 m-20 -96.88 20.9 10.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.778 -0.646 . . . . 74.329999999999998 110.534 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -71.63 -13.96 61.91 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.813 -0.631 . . . . 70.150000000000006 110.201 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -44.69 -42.41 7.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.471 -0.786 . . . . 54.210000000000001 111.742 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.4 t -53.17 -42.23 45.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.14 -0.482 . . . . 72.510000000000005 111.196 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.22 80.8 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.957 -0.565 . . . . 60.509999999999998 110.495 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.8 m -66.54 -35.46 80.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.711 -0.677 . . . . 64.109999999999999 110.992 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.49 -47.96 71.34 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.253 -0.431 . . . . 74.010000000000005 110.839 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -71.13 -24.12 62.21 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.206 -0.452 . . . . 64.209999999999994 110.984 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.67 39.44 7.65 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 121.071 -0.585 . . . . 73.019999999999996 112.77 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 95' ' ' ALA . 30.8 t -90.66 125.59 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.53 -0.544 . . . . 65.430000000000007 109.53 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.1 t -104.39 17.64 23.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.701 0.286 . . . . 75.310000000000002 111.362 -174.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.436 ' H ' HG12 ' A' ' 93' ' ' VAL . . . -126.88 139.8 52.81 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.221 -0.289 . . . . 71.420000000000002 110.221 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.553 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 2.2 mp -78.04 -56.45 1.05 Allowed Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.663 -0.244 . . . . 74.450000000000003 110.985 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 90.9 Cg_endo -79.87 78.67 3.61 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.716 1.611 . . . . 74.510000000000005 111.515 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.6 m -127.34 135.25 50.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.864 -0.607 . . . . 63.450000000000003 111.164 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 99' ' ' ILE . 2.8 mp -110.22 111.74 37.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.472 -0.786 . . . . 62.119999999999997 109.702 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.4 mp -88.64 141.27 28.65 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.318 -0.623 . . . . 70.030000000000001 109.318 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.54 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 36.2 mtp -110.18 140.46 44.27 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.854 -0.425 . . . . 65.129999999999995 109.854 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -146.66 144.49 29.52 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.569 -0.9 . . . . 72.299999999999997 108.569 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.509 ' HB2' HD22 ' A' ' 108' ' ' LEU . 38.2 ttpt -126.47 104.91 8.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.16 -0.616 . . . . 63.450000000000003 110.596 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.976 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 2.8 t-20 50.79 47.51 24.42 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.561 0.696 . . . . 74.010000000000005 110.809 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.26 -16.19 35.39 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.559 -0.746 . . . . 73.299999999999997 112.955 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -70.07 134.25 48.03 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.917 0.358 . . . . 61.520000000000003 110.475 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -61.42 144.32 54.32 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.044 0.84 . . . . 71.340000000000003 109.132 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.54 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.6 tp -158.73 168.43 26.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.944 -0.571 . . . . 43.109999999999999 109.636 -163.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 101' ' ' MET . 37.8 m -69.47 179.64 2.0 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.069 0.548 . . . . 64.319999999999993 111.845 -167.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.406 HE21 HD11 ' A' ' 112' ' ' ILE . 28.3 tt0 -144.44 124.76 13.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 72.329999999999998 110.057 -174.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.43 108.88 22.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.41 . . . . 73.109999999999999 110.227 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.3 mp -87.55 101.72 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.048 -0.524 . . . . 74.150000000000006 109.651 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.88 -176.76 20.79 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.154 -0.546 . . . . 31.300000000000001 112.816 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.531 ' HA ' HD22 ' A' ' 59' ' ' LEU . . . -92.86 76.82 4.82 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.834 0.453 . . . . 73.030000000000001 111.271 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -117.79 83.52 2.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.499 0.666 . . . . 73.209999999999994 109.458 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.539 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -59.14 -30.47 43.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.093 -0.958 . . . . 72.140000000000001 110.241 -174.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.6 m -58.66 -53.22 60.84 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.13 -0.487 . . . . 63.009999999999998 110.478 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -65.39 -41.25 93.9 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 116.48 -0.327 . . . . 74.129999999999995 110.359 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 123' ' ' ILE . 76.2 mt -55.72 -56.24 13.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.246 -0.434 . . . . 63.329999999999998 110.808 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.85 -34.33 69.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 116.443 -0.344 . . . . 75.530000000000001 110.418 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 t -58.7 -52.09 67.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.061 -0.518 . . . . 73.209999999999994 109.736 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -62.33 -40.36 96.09 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.343 -0.389 . . . . 72.010000000000005 111.108 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.467 HD12 HD13 ' A' ' 66' ' ' LEU . 64.9 mt -52.66 -55.76 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.769 0.319 . . . . 75.129999999999995 110.379 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -68.96 -29.82 68.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 75.299999999999997 110.777 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -68.34 -33.91 75.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 63.329999999999998 111.368 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.508 ' OD1' HD11 ' A' ' 108' ' ' LEU . 66.0 m-80 -98.49 -24.15 15.26 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.119 0.415 . . . . 62.240000000000002 112.119 -175.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 123' ' ' ILE . 61.6 mt -71.49 -59.5 3.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.951 0.405 . . . . 72.219999999999999 110.153 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.726 -0.67 . . . . 71.030000000000001 110.434 -177.713 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.88 -0.415 . . . . 73.329999999999998 109.88 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.75 124.0 23.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 61.420000000000002 111.247 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -122.06 99.39 6.41 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.034 -0.728 . . . . 73.400000000000006 109.034 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -101.34 152.73 20.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 73.0 111.531 -174.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -133.54 129.69 37.43 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.264 -0.643 . . . . 53.399999999999999 109.264 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -140.28 161.84 36.71 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.975 0.417 . . . . 63.530000000000001 111.464 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -157.46 172.51 18.44 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.422 -0.808 . . . . 74.230000000000004 109.19 175.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -117.46 92.58 3.88 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.258 0.551 . . . . 73.530000000000001 110.661 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptm 176.13 174.3 0.33 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.085 -0.961 . . . . 72.209999999999994 109.028 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.61 48.27 0.92 Allowed Glycine 0 C--O 1.237 0.311 0 C-N-CA 120.702 -0.761 . . . . 41.450000000000003 112.326 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 t -172.15 123.07 0.49 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.185 0.516 . . . . 64.329999999999998 112.309 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.404 ' HG ' ' N ' ' A' ' 13' ' ' GLU . 1.3 pt? -154.52 -50.26 0.09 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.692 -0.685 . . . . 71.0 109.618 167.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' N ' ' HG ' ' A' ' 12' ' ' LEU . 40.0 tt0 173.22 110.61 0.01 OUTLIER 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.844 0.458 . . . . 72.340000000000003 110.738 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . . . -154.28 138.17 16.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 71.420000000000002 109.98 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -68.67 132.0 46.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.414 -0.357 . . . . 74.049999999999997 110.054 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.6 p -60.4 94.11 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.009 -0.541 . . . . 74.310000000000002 112.408 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 62.61 -169.7 0.18 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.334 -0.848 . . . . 74.239999999999995 112.513 169.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.89 -88.86 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 110.644 -0.982 . . . . 60.219999999999999 110.644 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.73 -171.22 0.94 Allowed 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.87 2.38 . . . . 75.310000000000002 111.46 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.7 63.41 0.01 OUTLIER Glycine 0 C--N 1.33 0.222 0 N-CA-C 111.421 -0.672 . . . . 65.439999999999998 111.421 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -134.53 -138.0 0.17 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.885 -0.413 . . . . 74.540000000000006 109.885 -172.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 91.4 mmm -56.55 -24.79 49.39 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.12 0.486 . . . . 73.530000000000001 110.498 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.5 mm -83.37 105.86 13.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.651 -0.704 . . . . 75.129999999999995 109.131 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -78.25 161.48 27.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 62.350000000000001 109.994 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.688 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 10.1 pt20 -137.21 133.13 34.8 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.858 0.361 . . . . 74.140000000000001 110.924 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 32.6 pt -144.69 179.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.169 -0.469 . . . . 65.319999999999993 110.984 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.562 ' HA3' HD12 ' A' ' 81' ' ' ILE . . . -117.96 -165.54 13.53 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.131 -0.486 . . . . 72.430000000000007 112.02 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.426 ' H ' ' HB3' ' A' ' 84' ' ' ASN . 6.8 t70 -67.67 -51.28 51.57 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.693 0.397 . . . . 65.310000000000002 110.687 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 m -56.16 -24.79 43.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.879 -0.6 . . . . 74.239999999999995 110.754 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 42.6 mt-10 -95.07 -31.25 13.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.784 -0.644 . . . . 72.239999999999995 110.421 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.487 ' HA ' HD12 ' A' ' 26' ' ' ILE . 92.8 t80 -50.14 -61.91 1.88 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.968 -0.56 . . . . 64.319999999999993 111.843 -171.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 36' ' ' THR . 8.4 t70 -53.56 -56.44 17.05 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 123.382 0.426 . . . . 72.219999999999999 110.516 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 37' ' ' SER . 5.9 m-20 -54.09 -57.3 11.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 73.400000000000006 111.509 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 75.5 mmtt -56.43 -38.79 72.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.848 0.356 . . . . 73.310000000000002 110.33 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.495 ' HA ' HD12 ' A' ' 44' ' ' ILE . 3.9 t -66.79 -54.81 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.93 -0.577 . . . . 73.319999999999993 111.915 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 32' ' ' ASP . 9.4 t -76.51 -7.48 55.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.699 0.285 . . . . 73.0 111.039 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 22.6 t -74.58 -5.0 40.37 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.392 -0.367 . . . . 65.549999999999997 111.667 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.1 m -57.11 96.35 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 110.165 -0.309 . . . . 65.299999999999997 110.165 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -51.11 -44.63 61.33 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.502 0.501 . . . . 61.5 111.24 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -155.78 121.39 4.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.697 0.284 . . . . 75.329999999999998 110.981 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 41.89 24.9 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.547 1.314 . . . . 73.209999999999994 114.547 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.8 mm -70.09 100.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.475 -0.565 . . . . 62.130000000000003 109.475 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.78 114.88 6.74 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.239 0.542 . . . . 72.209999999999994 110.333 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 35' ' ' VAL . 34.9 mt -104.05 120.5 54.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.299 -0.864 . . . . 74.109999999999999 110.833 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.507 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.5 mp -105.13 110.87 23.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.11 -0.7 . . . . 45.229999999999997 109.11 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 61.1 t -95.55 110.16 23.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.525 -0.176 . . . . 73.019999999999996 110.525 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.439 ' CG ' ' HZ2' ' A' ' 78' ' ' LYS . 2.1 p-10 -91.08 129.65 37.06 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.291 0.567 . . . . 43.509999999999998 110.656 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -96.34 85.0 3.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.388 -0.967 . . . . 54.32 108.388 170.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.46 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 3.7 p-90 -63.73 147.76 50.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.965 -1.016 . . . . 72.129999999999995 112.092 -175.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.34 118.88 28.69 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.326 -0.852 . . . . 53.439999999999998 109.165 172.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.23 162.01 35.08 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.128 1.885 . . . . 74.230000000000004 111.516 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.7 m95 65.17 12.35 7.92 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.74 0.416 . . . . 72.340000000000003 111.246 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.0 t -87.19 138.2 31.69 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.343 -0.39 . . . . 40.439999999999998 110.92 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.69 -68.4 1.56 Allowed Glycine 0 CA--C 1.524 0.617 0 CA-C-N 116.113 -0.494 . . . . 73.129999999999995 112.823 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.92 -39.26 82.78 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.619 2.213 . . . . 60.340000000000003 112.386 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.9 m -54.05 -32.92 56.0 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.239 -0.437 . . . . 74.319999999999993 110.712 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -56.26 -46.4 79.67 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.428 -0.805 . . . . 70.409999999999997 110.908 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.622 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 46.0 t -74.89 -39.09 61.69 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.666 0.746 . . . . 62.420000000000002 110.583 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.523 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.3 mm? -52.88 -45.72 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.113 -0.949 . . . . 72.209999999999994 111.989 -175.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 32.3 mt-10 -59.01 -58.57 18.56 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 119.133 -0.46 . . . . 75.239999999999995 111.58 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.78 -40.53 84.4 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 121.81 1.673 . . . . 73.530000000000001 112.165 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.1 mt-30 -58.28 -46.49 85.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.145 0.497 . . . . 71.549999999999997 110.427 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 81.8 mt -69.65 -28.45 65.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.86 -0.609 . . . . 62.130000000000003 110.6 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 44.6 mt-10 -63.78 -44.22 94.01 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.575 -0.528 . . . . 73.239999999999995 109.575 175.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -63.32 -49.93 72.03 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.394 -0.366 . . . . 63.520000000000003 110.211 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.455 HD11 HD11 ' A' ' 116' ' ' ILE . 28.1 mt -60.56 -32.95 72.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.455 . . . . 63.329999999999998 110.465 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.28 -50.36 70.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.52 -0.548 . . . . 64.5 109.52 176.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.3 mt-30 -57.78 -39.16 76.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.249 0.547 . . . . 75.519999999999996 110.734 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -70.05 -45.39 67.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.259 -0.882 . . . . 71.120000000000005 111.249 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -104.58 5.02 33.49 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.874 -0.603 . . . . 65.319999999999993 112.373 -171.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.6 t -52.88 -19.85 2.86 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.223 0.824 . . . . 75.219999999999999 113.223 -169.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.12 -37.36 84.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.008 0.432 . . . . 54.310000000000002 110.63 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -124.0 -2.83 8.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.771 -0.649 . . . . 71.530000000000001 111.639 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -127.07 136.88 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.184 0.516 . . . . 54.240000000000002 112.209 -173.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 20.6 mmtt -146.1 127.23 14.69 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.345 -0.843 . . . . 62.350000000000001 109.538 173.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 76' ' ' ILE . 3.3 mp -99.23 137.91 25.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.692 -0.485 . . . . 73.140000000000001 109.692 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 71.8 m-85 -123.83 144.45 49.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.286 -0.415 . . . . 75.140000000000001 110.031 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' A' ' 49' ' ' TRP . 3.1 ttmp? -121.47 137.96 54.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.885 -0.598 . . . . 65.030000000000001 110.05 -177.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.475 HD11 ' HA ' ' A' ' 85' ' ' GLN . 12.4 tt -70.34 117.36 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.884 -0.413 . . . . 64.409999999999997 109.884 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.688 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 22.9 t-20 -113.9 -50.33 2.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.175 -0.466 . . . . 75.040000000000006 111.71 -173.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.562 HD12 ' HA3' ' A' ' 27' ' ' GLY . 52.1 mt -66.47 106.69 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 121.052 0.453 . . . . 73.239999999999995 110.861 -175.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 10.9 pt-20 -49.19 -40.87 34.98 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.961 -1.018 . . . . 71.25 112.907 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -71.38 -25.65 62.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.986 0.422 . . . . 53.439999999999998 110.9 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.447 ' N ' HD22 ' A' ' 84' ' ' ASN . 0.9 OUTLIER -90.43 30.63 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.876 -0.602 . . . . 74.430000000000007 110.927 -173.184 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.475 ' HA ' HD11 ' A' ' 79' ' ' ILE . 32.4 tt0 -70.5 -12.81 61.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.74 -0.664 . . . . 64.319999999999993 110.976 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.412 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 15.7 m-20 -49.81 -30.07 9.05 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.86 -0.609 . . . . 73.140000000000001 112.469 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -52.61 -39.3 29.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.101 0.476 . . . . 72.120000000000005 110.379 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.86 -49.24 75.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.813 -0.63 . . . . 72.510000000000005 110.267 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -61.29 -41.38 96.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.648 -0.705 . . . . 65.420000000000002 111.077 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.1 mm100 -70.78 -44.69 66.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.002 -0.545 . . . . 73.340000000000003 111.454 -174.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -87.44 -9.66 54.05 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.416 -0.356 . . . . 73.400000000000006 111.594 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.31 55.68 5.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.801 -0.714 . . . . 21.129999999999999 112.584 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.0 t -81.09 98.82 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.203 -0.666 . . . . 70.019999999999996 109.203 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t -60.38 -58.83 6.83 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.012 -0.54 . . . . 74.109999999999999 110.913 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.99 136.28 45.93 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.227 -0.657 . . . . 45.25 109.227 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.432 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 72.9 mt -51.8 -54.36 40.99 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 123.389 0.43 . . . . 73.530000000000001 111.874 -176.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 96' ' ' ILE . 41.6 Cg_endo -65.37 87.58 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.614 1.542 . . . . 61.43 111.866 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 112' ' ' ILE . 56.4 m -151.77 143.02 23.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.737 -0.665 . . . . 72.219999999999999 110.09 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 99' ' ' ILE . 2.5 mp -109.83 114.05 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.848 -0.426 . . . . 64.400000000000006 109.848 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.1 mp -95.83 124.91 40.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 109.756 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.42 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 61.8 mtp -93.25 143.72 25.99 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.682 -0.488 . . . . 73.230000000000004 109.682 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.465 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.0 m-85 -146.92 158.17 43.84 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.673 -0.491 . . . . 72.109999999999999 109.673 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -151.21 105.15 3.18 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.943 -0.303 . . . . 61.509999999999998 111.164 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 56.6 44.22 24.3 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.363 0.601 . . . . 74.430000000000007 110.381 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.5 -16.51 7.75 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.82 -0.627 . . . . 61.409999999999997 112.752 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 14.0 tmtt? -79.66 139.78 37.28 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.45 -0.574 . . . . 73.120000000000005 109.45 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -68.97 136.74 52.98 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 122.104 0.954 . . . . 72.329999999999998 112.302 -174.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -133.36 168.22 18.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.623 -1.626 . . . . 33.119999999999997 107.794 -175.161 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 m -70.27 -178.77 1.78 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.312 0.486 . . . . 40.009999999999998 112.312 -167.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -138.44 121.83 17.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.513 -0.312 . . . . 72.310000000000002 110.497 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.1 t -97.87 107.41 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.83 -0.433 . . . . 73.329999999999998 109.83 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.564 ' HA ' HG23 ' A' ' 98' ' ' THR . 64.7 mt -80.15 135.25 25.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.364 -0.38 . . . . 71.0 110.509 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.5 -137.64 15.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.995 -0.622 . . . . 72.030000000000001 111.846 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.523 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -144.6 76.76 1.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 74.120000000000005 110.375 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.447 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.3 t70 -117.3 103.36 10.08 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.128 -0.487 . . . . 61.450000000000003 109.991 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.482 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -63.34 -36.74 77.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 64.129999999999995 110.382 -174.001 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -63.49 -42.94 98.54 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.249 -0.432 . . . . 52.32 110.151 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -66.06 -41.16 91.17 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.363 -0.38 . . . . 54.240000000000002 110.198 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 115' ' ' ASP . 69.1 mt -59.81 -56.35 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.443 -0.344 . . . . 63.009999999999998 111.048 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.1 tt -62.73 -33.97 62.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 120.818 0.342 . . . . 62.039999999999999 110.339 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 t -55.75 -51.66 66.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.86 -0.609 . . . . 74.140000000000001 109.596 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -62.01 -40.86 97.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 71.219999999999999 110.891 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 119' ' ' ILE . 73.0 mt -56.04 -55.85 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.663 0.268 . . . . 71.319999999999993 110.934 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -71.67 -29.42 64.58 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.803 -0.359 . . . . 74.109999999999999 110.77 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -68.24 -39.96 82.15 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.031 0.443 . . . . 73.25 111.022 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -90.06 -24.84 21.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.919 -0.582 . . . . 73.0 111.29 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.7 mt -77.75 -54.15 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.757 0.313 . . . . 51.439999999999998 110.795 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.569 -0.729 . . . . 75.519999999999996 110.313 -176.471 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.794 0.33 . . . . 72.129999999999995 110.665 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.48 110.67 1.75 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.717 0.636 . . . . 72.409999999999997 112.717 -170.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -106.34 36.97 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.761 -1.2 . . . . 74.519999999999996 107.761 167.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -67.26 -26.12 66.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.412 -1.267 . . . . 64.140000000000001 112.332 -169.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -71.61 96.87 1.61 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.51 0.672 . . . . 70.420000000000002 109.972 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -96.41 142.72 28.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.789 -0.642 . . . . 75.420000000000002 110.159 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -72.44 102.1 3.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 74.209999999999994 109.942 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -72.63 105.51 4.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.864 -0.607 . . . . 71.150000000000006 110.282 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.8 ptm -71.83 -26.85 62.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 71.439999999999998 109.917 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.83 -176.02 46.64 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.484 -0.78 . . . . 70.420000000000002 112.615 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 t -132.08 124.16 28.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.08 0.467 . . . . 73.209999999999994 110.289 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.0 mm? -97.94 91.55 5.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.581 -0.525 . . . . 73.239999999999995 109.581 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -89.56 95.05 10.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.534 . . . . 63.130000000000003 110.348 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -151.87 79.08 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.34 . . . . 64.409999999999997 111.345 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 25.5 pt20 -84.76 78.19 9.92 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.782 -0.822 . . . . 74.120000000000005 108.782 172.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.6 p -69.66 92.45 0.66 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.206 -0.906 . . . . 55.439999999999998 111.431 -175.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -132.98 152.08 51.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.629 -0.714 . . . . 64.239999999999995 109.588 175.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.84 -171.55 32.86 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 116.037 -0.529 . . . . 52.310000000000002 112.254 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.94 19.11 0.92 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.907 2.405 . . . . 65.219999999999999 112.716 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.64 -58.91 7.73 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.116 -0.793 . . . . 42.420000000000002 111.116 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.7 t 63.0 23.54 14.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.85 0.46 . . . . 52.140000000000001 111.397 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.435 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 94.0 mmm -78.66 -27.51 45.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.888 0.375 . . . . 74.099999999999994 110.379 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.452 HG12 ' HG2' ' A' ' 64' ' ' GLU . 24.6 mm -87.55 119.69 35.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.785 -0.643 . . . . 55.539999999999999 109.471 177.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 154.0 18.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.97 0.414 . . . . 72.109999999999999 111.213 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -110.63 141.77 43.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.899 -0.591 . . . . 73.349999999999994 110.216 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.536 HG21 ' HG3' ' A' ' 34' ' ' LYS . 34.7 pt -140.31 161.26 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.902 0.382 . . . . 65.120000000000005 110.978 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.38 169.18 37.4 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.825 -0.625 . . . . 34.130000000000003 111.954 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.831 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 18.2 t70 -57.04 -42.43 80.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.116 0.484 . . . . 74.540000000000006 110.763 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.3 t -72.29 -16.19 61.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 65.129999999999995 110.924 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 11.1 mm-40 -83.16 -24.41 32.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 74.510000000000005 111.845 -176.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 35' ' ' VAL . 88.7 t80 -45.33 -61.94 1.46 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.559 0.577 . . . . 71.420000000000002 112.559 -170.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.91 -46.11 91.95 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.727 0.298 . . . . 72.310000000000002 110.653 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -48.37 -57.14 6.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 64.329999999999998 110.588 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 9.8 mmpt? -64.62 -49.64 70.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 44.329999999999998 110.11 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.556 HG12 ' HA2' ' A' ' 105' ' ' GLY . 95.5 t -62.18 -36.8 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.735 -0.666 . . . . 62.119999999999997 111.839 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -77.76 -47.03 19.97 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.838 0.31 . . . . 65.109999999999999 111.838 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.2 p -77.15 11.03 2.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.273 0.842 . . . . 60.329999999999998 113.273 -171.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.517 ' HB3' HD11 ' A' ' 44' ' ' ILE . 24.9 p -76.78 79.93 3.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.289 . . . . 62.329999999999998 111.686 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.9 t30 32.28 -94.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.147 0.979 . . . . 73.310000000000002 112.763 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -161.72 140.34 9.49 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.789 -0.449 . . . . 60.32 109.789 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 53.19 21.04 2.04 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.223 0.609 . . . . 73.209999999999994 112.474 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 103' ' ' LYS . 47.9 mm -75.68 128.84 37.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 120.784 0.326 . . . . 64.219999999999999 110.481 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -84.76 111.12 19.31 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.013 -0.736 . . . . 61.399999999999999 109.013 178.454 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.517 HD11 ' HB3' ' A' ' 38' ' ' CYS . 52.9 mt -106.84 129.12 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.971 -0.559 . . . . 73.439999999999998 110.932 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.544 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.9 mp -113.97 109.73 18.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.101 -0.703 . . . . 75.140000000000001 109.101 174.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 77' ' ' TYR . 48.7 t -101.54 104.84 16.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.951 -0.388 . . . . 72.420000000000002 109.951 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 17.8 t70 -85.26 146.6 26.98 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.068 0.461 . . . . 74.219999999999999 109.878 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.488 ' CD2' ' HB2' ' A' ' 49' ' ' TRP . 43.4 t80 -81.21 -100.07 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.784 -0.644 . . . . 73.310000000000002 111.495 -173.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.488 ' HB2' ' CD2' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -97.73 -83.72 0.39 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.699 0.285 . . . . 74.010000000000005 110.765 -168.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.561 ' N ' ' HD3' ' A' ' 51' ' ' PRO . . . 60.13 36.9 0.27 Allowed Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 114.462 1.282 . . . . 74.530000000000001 114.462 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 50' ' ' ALA . 45.0 Cg_endo -97.44 -5.06 1.18 Allowed 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 122.215 1.943 . . . . 72.329999999999998 111.373 174.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -141.47 83.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.174 -1.047 . . . . 73.219999999999999 108.174 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.0 t -152.14 151.41 31.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.523 -0.762 . . . . 50.119999999999997 110.467 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -86.42 -73.86 1.28 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.285 -0.483 . . . . 71.349999999999994 112.598 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.75 -22.02 69.61 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.898 2.398 . . . . 74.439999999999998 112.86 -173.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 79.6 m -56.16 -27.3 53.77 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.27 0.471 . . . . 74.019999999999996 112.27 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.565 ' HD3' ' N ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -53.95 -33.9 58.16 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.74 0.274 . . . . 72.239999999999995 111.74 -178.282 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.565 ' N ' ' HD3' ' A' ' 57' ' ' ARG . 20.2 m -75.87 -30.63 58.93 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.569 0.699 . . . . 70.25 110.935 173.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.525 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.5 mm? -66.2 -42.58 88.62 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.479 -0.782 . . . . 74.120000000000005 112.522 -173.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.647 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 3.0 mp0 -49.72 -57.52 11.97 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 118.697 0.681 . . . . 72.340000000000003 110.255 177.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.647 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 23.2 Cg_exo -55.43 -55.5 3.04 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.885 1.723 . . . . 65.120000000000005 112.327 175.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.5 mt-30 -51.33 -49.7 60.88 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.175 0.435 . . . . 71.219999999999999 112.175 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.73 -40.54 76.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.875 -0.602 . . . . 73.439999999999998 111.058 -173.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 32.4 mt-10 -64.05 -34.84 78.93 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.881 -0.328 . . . . 65.019999999999996 110.307 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -62.54 -54.99 31.62 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.176 0.513 . . . . 73.340000000000003 110.04 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.4 mt -62.08 -32.95 73.54 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.849 -0.614 . . . . 62.140000000000001 109.928 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -61.93 -40.74 96.56 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.993 -0.549 . . . . 62.399999999999999 109.933 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.0 mt-30 -64.28 -45.45 87.96 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.885 0.374 . . . . 74.430000000000007 110.66 177.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -65.89 -38.18 88.07 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.962 -0.563 . . . . 62.520000000000003 111.225 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -104.63 4.58 32.88 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 112.242 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.0 t -53.23 -19.91 3.59 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.07 0.767 . . . . 74.150000000000006 113.07 -169.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.66 -34.54 75.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 74.319999999999993 110.824 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -123.37 -20.41 5.63 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.796 -0.638 . . . . 72.25 111.612 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.14 128.25 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.946 0.403 . . . . 63.420000000000002 112.051 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.515 ' HB3' ' HZ2' ' A' ' 75' ' ' LYS . 2.2 mmmp? -131.69 138.22 48.6 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.99 -0.744 . . . . 61.310000000000002 108.99 173.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.544 HG12 ' HB2' ' A' ' 45' ' ' LEU . 60.6 mt -118.09 114.38 45.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.011 0.434 . . . . 74.540000000000006 110.655 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.503 ' HB2' HG22 ' A' ' 46' ' ' VAL . 56.7 m-85 -101.45 163.99 11.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 72.319999999999993 109.809 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 20.5 ttmm -139.16 138.09 36.64 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.869 0.366 . . . . 71.120000000000005 111.279 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.486 HD11 ' O ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -126.57 100.8 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.472 -0.936 . . . . 73.439999999999998 108.472 174.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -124.47 7.63 8.33 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.045 -0.525 . . . . 72.310000000000002 112.033 -172.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 57.5 mt -76.47 112.44 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.273 -0.269 . . . . 70.340000000000003 110.273 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.75 -31.19 70.53 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.839 0.352 . . . . 44.439999999999998 111.331 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.29 -23.29 61.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.161 0.505 . . . . 72.329999999999998 110.957 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.831 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 33.5 m-80 -123.92 91.94 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 55.049999999999997 110.509 -174.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -140.25 14.63 2.41 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.537 0.569 . . . . 61.350000000000001 112.537 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.67 -44.77 63.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.206 0.527 . . . . 74.340000000000003 110.043 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.59 -38.92 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.272 -0.877 . . . . 73.219999999999999 110.897 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.99 -41.06 91.58 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.213 0.53 . . . . 62.149999999999999 110.269 -175.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.1 m -72.25 -35.91 68.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.51 -0.768 . . . . 62.229999999999997 110.932 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -68.55 -45.96 70.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.473 -0.33 . . . . 74.099999999999994 111.841 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -86.86 -23.54 25.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.617 0.229 . . . . 62.5 111.617 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.49 80.38 1.51 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.717 -0.754 . . . . 72.120000000000005 113.062 173.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.4 t -99.63 138.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.271 -0.641 . . . . 61.219999999999999 109.271 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.4 m -141.49 18.29 2.21 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.997 0.369 . . . . 75.230000000000004 111.997 -174.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.87 152.53 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.652 -0.249 . . . . 51.229999999999997 110.444 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.685 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 60.1 mt -59.68 -50.03 88.93 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.416 -0.356 . . . . 51.240000000000002 110.526 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.685 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 73.1 Cg_endo -95.37 112.67 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.695 2.264 . . . . 72.439999999999998 111.061 169.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.426 HG23 HD13 ' A' ' 112' ' ' ILE . 54.8 m -145.82 118.68 8.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.005 -0.369 . . . . 55.310000000000002 110.005 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.534 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.5 mp -109.7 110.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.316 -0.402 . . . . 62.32 110.129 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.0 mp -90.21 123.31 33.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.767 -0.827 . . . . 75.530000000000001 108.767 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.441 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 45.2 mtp -101.0 145.43 28.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.851 -0.426 . . . . 74.400000000000006 109.851 -176.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.466 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 97.1 m-85 -148.22 160.81 42.56 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.354 -0.609 . . . . 74.549999999999997 109.354 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 39.3 ttpt -143.93 114.34 7.52 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.917 -0.313 . . . . 75.200000000000003 110.596 175.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.5 t30 62.19 25.68 15.38 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.536 0.684 . . . . 72.129999999999995 109.711 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.556 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 84.61 -14.41 47.13 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.699 -0.682 . . . . 73.040000000000006 111.965 -176.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -69.33 142.31 54.06 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.832 -0.433 . . . . 74.200000000000003 109.832 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -58.3 150.93 20.68 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 124.1 0.875 . . . . 64.219999999999999 111.097 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -162.36 168.74 21.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.909 -1.042 . . . . 74.010000000000005 108.995 -169.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -70.19 167.71 17.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.384 0.611 . . . . 63.149999999999999 112.356 -167.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -130.48 118.57 21.32 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.81 -0.632 . . . . 70.530000000000001 109.945 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.534 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.0 t -86.8 119.43 34.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 74.430000000000007 110.29 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 98' ' ' THR . 50.0 mm -100.13 102.47 13.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.222 -0.445 . . . . 74.340000000000003 110.2 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.482 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 107.46 166.25 21.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.267 -0.492 . . . . 34.229999999999997 112.217 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.525 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -80.79 72.2 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.863 0.363 . . . . 64.120000000000005 111.107 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 61.2 t0 -112.07 92.88 4.19 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.374 0.607 . . . . 64.019999999999996 110.185 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.494 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -59.22 -34.97 55.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.276 -0.875 . . . . 75.540000000000006 110.153 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.6 t -62.68 -46.21 89.2 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.077 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.473 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -65.29 -42.96 92.6 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.859 -0.61 . . . . 74.099999999999994 109.937 -179.316 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 123' ' ' ILE . 74.0 mt -57.22 -56.14 16.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 115.419 -0.81 . . . . 71.140000000000001 111.098 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.2 tt -65.4 -35.21 74.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 121.063 -0.255 . . . . 74.219999999999999 110.788 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 t -56.72 -52.05 66.47 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.103 -0.499 . . . . 75.319999999999993 110.027 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -70.46 -31.63 68.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 65.299999999999997 111.477 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 119' ' ' ILE . 62.0 mt -57.34 -56.52 14.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.686 -0.406 . . . . 70.549999999999997 110.229 176.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -69.8 -32.82 71.48 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.757 -0.377 . . . . 74.25 110.21 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -62.06 -49.67 75.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.137 -0.483 . . . . 64.430000000000007 111.153 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -86.98 -20.24 27.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 112.219 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.9 mt -78.62 -52.76 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.853 -0.339 . . . . 72.239999999999995 110.619 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.536 -0.745 . . . . 70.200000000000003 110.288 -177.392 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 110.085 -0.339 . . . . 62.219999999999999 110.085 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.96 139.41 49.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.223 -0.444 . . . . 73.219999999999999 110.136 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -86.82 91.12 8.54 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.494 -0.928 . . . . 74.129999999999995 108.494 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -47.97 -43.62 29.68 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.422 -0.808 . . . . 73.010000000000005 112.563 -167.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -137.98 144.73 41.29 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.607 -0.516 . . . . 74.109999999999999 109.607 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -54.68 -53.9 48.8 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.695 0.622 . . . . 74.230000000000004 111.702 -172.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 56.85 36.48 27.79 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.508 0.671 . . . . 71.230000000000004 110.233 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -113.51 77.05 1.02 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.048 -0.978 . . . . 72.209999999999994 110.402 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -107.48 93.86 4.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.762 0.792 . . . . 72.430000000000007 110.362 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.34 -60.82 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 109.918 -1.273 . . . . 65.530000000000001 109.918 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.42 HG23 ' HD2' ' A' ' 78' ' ' LYS . 89.2 m -75.02 81.79 2.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.355 -0.609 . . . . 74.109999999999999 109.355 169.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.8 127.01 33.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.756 -0.657 . . . . 71.5 110.062 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.54 ' HB3' ' NE2' ' A' ' 17' ' ' GLN . 38.8 mt-10 -65.88 99.23 0.46 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.68 -0.859 . . . . 75.310000000000002 108.68 175.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.079 0.77 . . . . 71.209999999999994 113.079 -167.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -134.69 93.4 3.03 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.071 0.462 . . . . 64.140000000000001 111.58 -167.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m 62.36 64.61 0.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.325 -0.852 . . . . 63.240000000000002 111.528 173.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.546 ' HB2' ' HG3' ' A' ' 64' ' ' GLU . 8.1 pm0 -72.1 -32.06 66.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.565 -0.743 . . . . 53.310000000000002 109.696 175.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 136.66 -121.81 2.47 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.542 -0.754 . . . . 65.219999999999999 111.672 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -79.47 -21.99 8.39 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.876 2.384 . . . . 61.229999999999997 112.63 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.32 141.5 3.62 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 110.404 -1.078 . . . . 74.450000000000003 110.404 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 p -46.53 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.096 0.776 . . . . 73.420000000000002 113.096 -172.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 80.1 mmm -69.88 -32.64 71.09 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.227 -1.027 . . . . 62.109999999999999 108.227 165.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.581 HG21 ' NZ ' ' A' ' 78' ' ' LYS . 17.2 mm -54.99 107.79 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.642 -1.163 . . . . 53.130000000000003 109.222 174.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.48 ' HB3' ' CD1' ' A' ' 77' ' ' TYR . 35.9 tt0 -76.26 112.22 12.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.353 0.597 . . . . 64.319999999999993 110.62 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -70.16 127.22 32.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.043 -0.981 . . . . 72.239999999999995 110.873 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.52 HG21 ' HG3' ' A' ' 34' ' ' LYS . 44.3 pt -136.27 159.04 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.04 0.447 . . . . 71.129999999999995 111.274 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.96 176.29 30.58 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.973 -0.558 . . . . 74.120000000000005 112.232 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' CB ' ' HB3' ' A' ' 84' ' ' ASN . 16.9 t70 -55.29 -38.38 68.54 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.157 0.583 . . . . 61.5 111.346 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -84.48 -8.65 58.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 75.140000000000001 112.132 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -94.37 -12.94 26.92 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.267 0.469 . . . . 74.219999999999999 112.267 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.428 ' O ' HG23 ' A' ' 35' ' ' VAL . 31.1 m-85 -50.2 -61.79 1.96 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.29 0.478 . . . . 74.150000000000006 112.29 -175.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.08 -36.58 80.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.461 -0.336 . . . . 70.299999999999997 110.544 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.48 -57.3 13.26 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.699 0.761 . . . . 74.209999999999994 109.075 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.674 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 10.2 mmpt? -62.52 -39.17 92.67 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.363 -1.29 . . . . 62.310000000000002 111.01 -172.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 31' ' ' PHE . 96.7 t -66.34 -49.8 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.909 -0.587 . . . . 75.209999999999994 110.329 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -67.85 -17.93 64.65 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 111.711 0.263 . . . . 65.420000000000002 111.711 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -66.27 -8.88 27.62 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.962 0.356 . . . . 72.420000000000002 111.962 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.725 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.8 t -60.72 117.36 5.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.726 0.298 . . . . 71.439999999999998 110.823 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.65 -50.95 12.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 72.230000000000004 110.66 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -161.67 121.9 2.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.331 -0.395 . . . . 62.119999999999997 111.21 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 51.42 16.01 0.38 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.263 0.838 . . . . 50.520000000000003 113.263 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.724 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 44.5 mm -70.1 104.48 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.629 -0.508 . . . . 72.230000000000004 109.629 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.06 108.04 8.69 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.526 -0.761 . . . . 74.109999999999999 109.032 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.482 HG23 ' CE2' ' A' ' 77' ' ' TYR . 76.0 mt -100.31 113.58 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.965 -1.016 . . . . 72.239999999999995 110.814 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.0 mp -105.24 142.75 34.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.731 -0.668 . . . . 74.329999999999998 109.291 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 77' ' ' TYR . 57.6 t -129.96 109.44 17.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.391 -0.596 . . . . 75.140000000000001 109.391 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -90.54 143.83 26.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.072 0.463 . . . . 75.450000000000003 110.111 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -134.66 105.45 6.49 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.954 -0.758 . . . . 70.140000000000001 108.954 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -116.1 128.09 55.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.922 -0.399 . . . . 73.530000000000001 109.922 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.694 ' HB3' HG23 ' A' ' 96' ' ' ILE . . . -74.67 140.78 75.2 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.609 -0.515 . . . . 64.329999999999998 109.609 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.95 -24.95 11.38 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.843 2.362 . . . . 64.450000000000003 112.852 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -92.73 80.41 4.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 71.010000000000005 109.586 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 42.6 t -153.59 164.59 37.99 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.115 -0.493 . . . . 61.439999999999998 110.507 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -119.43 -66.15 0.29 Allowed Glycine 0 CA--C 1.522 0.484 0 CA-C-N 115.813 -0.63 . . . . 53.100000000000001 112.144 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.86 -28.4 48.37 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.902 2.401 . . . . 51.32 112.632 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -53.58 -27.54 27.09 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.871 -0.604 . . . . 64.120000000000005 111.529 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.434 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 53.9 ttt-85 -56.17 -50.23 71.78 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.313 -0.403 . . . . 70.030000000000001 111.095 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.575 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 15.2 m -65.11 -34.36 78.22 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.736 0.779 . . . . 72.340000000000003 110.905 -177.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.46 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.2 mm? -65.65 -24.14 66.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.364 -0.835 . . . . 64.239999999999995 111.623 -175.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.439 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 40.7 tt0 -62.69 -63.69 3.89 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 120.578 -0.449 . . . . 63.350000000000001 109.842 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.439 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 31.0 Cg_endo -63.44 -31.64 71.92 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.724 1.616 . . . . 53.130000000000003 112.541 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 58' ' ' SER . 28.0 mt-30 -66.52 -52.94 40.42 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.38 -0.528 . . . . 60.219999999999999 111.687 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.95 -35.26 80.1 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.176 -0.305 . . . . 74.219999999999999 110.176 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.546 ' HG3' ' HB2' ' A' ' 17' ' ' GLN . 5.2 mm-40 -59.92 -42.92 94.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.877 -0.601 . . . . 65.519999999999996 110.811 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -59.31 -55.14 38.54 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.334 0.588 . . . . 75.129999999999995 109.892 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.6 mt -59.47 -33.63 71.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.028 -0.987 . . . . 63.130000000000003 110.102 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.574 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.7 -44.73 92.8 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.82 -0.627 . . . . 64.019999999999996 110.105 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 48.0 mt-30 -63.82 -47.12 82.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.087 -0.506 . . . . 72.150000000000006 111.134 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -69.42 -41.37 76.44 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.216 -0.447 . . . . 61.229999999999997 111.614 -175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -102.72 5.72 39.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.641 0.608 . . . . 72.420000000000002 112.641 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.35 -19.42 2.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.189 0.811 . . . . 62.43 113.189 -169.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.88 -42.3 93.47 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.599 0.238 . . . . 70.430000000000007 110.771 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -128.03 -2.84 5.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.377 -0.374 . . . . 73.040000000000006 111.886 -175.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.9 t -112.36 131.94 62.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.923 0.392 . . . . 74.439999999999998 110.821 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -135.65 120.12 18.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.773 -0.649 . . . . 64.120000000000005 110.201 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.521 HD13 ' HB2' ' A' ' 67' ' ' ALA . 3.6 mp -106.32 137.34 37.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.65 -0.5 . . . . 74.299999999999997 109.65 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.541 ' CE1' ' HD3' ' A' ' 34' ' ' LYS . 76.0 m-85 -131.3 165.77 22.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 72.239999999999995 109.993 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' NZ ' HG21 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -158.16 166.72 31.73 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.158 0.504 . . . . 52.420000000000002 110.91 169.549 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 tp -73.0 147.51 9.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.077 -0.965 . . . . 61.240000000000002 112.211 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.504 ' C ' HD22 ' A' ' 80' ' ' ASN . 0.2 OUTLIER -108.05 -58.32 2.0 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.402 -0.817 . . . . 61.530000000000001 110.452 175.527 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.1 mt -70.58 105.43 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.992 0.425 . . . . 63.310000000000002 111.235 -173.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -56.3 -33.9 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.674 -0.694 . . . . 74.239999999999995 111.2 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -87.83 2.67 50.78 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.193 -0.458 . . . . 73.439999999999998 111.466 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.429 ' HB3' ' CB ' ' A' ' 28' ' ' ASP . 11.2 m120 -139.38 90.18 2.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.034 0.445 . . . . 73.319999999999993 110.263 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -117.94 13.59 14.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.486 -0.779 . . . . 73.340000000000003 109.418 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 32.7 t70 -49.52 -50.97 39.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.432 -0.804 . . . . 73.439999999999998 110.943 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.2 t -53.15 -37.75 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.655 -0.702 . . . . 73.049999999999997 110.871 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.38 -43.9 84.59 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.294 0.569 . . . . 74.439999999999998 109.828 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.2 m -66.65 -30.1 70.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.489 -0.778 . . . . 61.109999999999999 110.686 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 18.5 mm-40 -74.13 -41.65 61.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.893 -0.594 . . . . 73.140000000000001 111.089 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -74.51 -31.34 62.13 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 111.718 0.266 . . . . 74.439999999999998 111.718 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.53 43.58 0.26 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.286 -0.959 . . . . 73.450000000000003 113.781 172.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.2 t -90.55 107.38 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.569 -0.53 . . . . 64.019999999999996 109.569 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 t -135.2 21.15 3.44 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.203 0.525 . . . . 70.040000000000006 110.551 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.66 168.47 19.21 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.065 -0.516 . . . . 72.230000000000004 110.05 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.754 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 48.0 mm -67.86 -53.04 22.37 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.56 -0.291 . . . . 74.010000000000005 110.646 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.754 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 58.6 Cg_endo -102.75 107.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 123.1 2.533 . . . . 73.109999999999999 111.834 172.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.5 m -132.14 118.92 20.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.791 -0.186 . . . . 61.43 110.798 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.8 mp -110.48 115.25 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 110.262 -0.273 . . . . 74.329999999999998 110.262 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.59 137.3 32.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.399 -0.593 . . . . 60.240000000000002 109.399 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.409 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 51.6 mtp -115.92 143.48 45.37 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.817 0.28 . . . . 72.010000000000005 110.429 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -142.78 152.86 42.71 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.267 -0.642 . . . . 71.430000000000007 109.267 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -143.49 107.49 4.71 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.508 -0.477 . . . . 73.129999999999995 111.597 176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.725 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 10.5 t30 53.0 36.2 21.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.48 0.657 . . . . 74.319999999999993 111.584 174.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.41 -16.63 55.63 Favored Glycine 0 N--CA 1.454 -0.117 0 CA-C-N 115.759 -0.655 . . . . 63.130000000000003 112.644 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -81.6 145.17 30.75 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.363 -0.606 . . . . 73.120000000000005 109.363 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -61.86 160.5 11.95 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.516 0.674 . . . . 51.119999999999997 110.826 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.409 ' HB3' ' C ' ' A' ' 101' ' ' MET . 0.2 OUTLIER -162.28 167.36 24.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.364 -1.347 . . . . 74.450000000000003 107.364 -168.509 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.404 ' H ' HD13 ' A' ' 108' ' ' LEU . 73.1 m -70.96 178.29 3.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.958 0.885 . . . . 34.140000000000001 112.687 -165.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -140.84 118.44 11.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.854 -1.067 . . . . 73.150000000000006 108.912 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 42.5 t -93.81 107.12 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.171 0.51 . . . . 75.230000000000004 110.02 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.1 mt -92.72 107.31 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.623 -0.717 . . . . 74.140000000000001 109.471 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.615 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 110.97 158.44 15.49 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.46 -0.656 . . . . 52.520000000000003 111.46 -175.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.46 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -81.92 78.53 8.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.721 0.296 . . . . 64.109999999999999 110.844 -178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.413 ' O ' HG13 ' A' ' 119' ' ' ILE . 19.3 m-20 -117.1 80.96 1.56 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.079 0.466 . . . . 70.420000000000002 110.048 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.428 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -59.11 -32.09 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.773 -0.648 . . . . 72.430000000000007 109.799 -177.195 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.8 m -58.36 -50.0 75.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.91 -0.587 . . . . 41.039999999999999 110.39 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -69.45 -35.8 76.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.219 -0.446 . . . . 75.25 110.313 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 123' ' ' ILE . 76.4 mt -58.33 -56.39 16.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.188 -0.46 . . . . 72.040000000000006 110.513 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.31 -34.74 71.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.129 -0.487 . . . . 74.049999999999997 110.346 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.5 t -57.06 -49.72 74.98 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.153 -0.476 . . . . 72.150000000000006 109.787 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -62.31 -38.54 89.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.476 -0.329 . . . . 63.229999999999997 110.573 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 119' ' ' ILE . 58.3 mt -57.62 -56.5 15.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.672 0.272 . . . . 64.230000000000004 110.938 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -71.33 -25.16 62.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.761 0.315 . . . . 74.200000000000003 110.626 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.48 -44.11 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 73.150000000000006 111.132 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -93.0 -18.06 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 73.200000000000003 111.975 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.5 mt -76.78 -53.28 15.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 120.929 0.395 . . . . 74.310000000000002 110.054 173.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.377 -0.821 . . . . 75.420000000000002 110.392 -178.664 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.498 0.19 . . . . 71.219999999999999 110.739 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.47 96.15 0.02 OUTLIER 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.931 0.396 . . . . 62.530000000000001 111.023 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -64.82 103.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.82 -0.627 . . . . 72.450000000000003 109.929 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -137.76 90.01 2.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 110.606 -176.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -138.67 28.53 2.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.109 0.48 . . . . 74.209999999999994 110.269 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -65.53 88.7 0.09 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.019 -0.734 . . . . 75.409999999999997 109.019 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -139.16 125.19 19.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.953 -0.567 . . . . 63.310000000000002 111.626 -170.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -170.39 116.51 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.125 -0.694 . . . . 63.140000000000001 109.125 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.433 ' C ' ' SD ' ' A' ' 9' ' ' MET . 1.1 tmt? -150.1 140.04 21.92 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.385 -0.228 . . . . 74.5 110.385 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.36 -55.35 4.63 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.313 -0.47 . . . . 74.540000000000006 112.154 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 t -72.51 145.08 47.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.987 0.422 . . . . 54.039999999999999 110.569 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 12' ' ' LEU . 1.5 pt? -133.81 113.62 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 72.519999999999996 109.936 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -84.94 60.32 6.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.575 0.702 . . . . 74.319999999999993 109.706 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.98 87.53 3.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.45 -0.795 . . . . 74.5 110.7 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -167.58 147.39 5.11 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.796 -0.638 . . . . 75.120000000000005 110.565 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -173.13 143.32 1.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.488 -0.778 . . . . 74.329999999999998 108.922 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -83.76 87.88 7.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.511 -0.552 . . . . 70.319999999999993 109.511 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.14 -175.21 25.74 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.165 -0.925 . . . . 65.230000000000004 111.119 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.63 -20.88 52.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.322 2.014 . . . . 31.32 111.725 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.6 -120.44 0.92 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.509 -0.636 . . . . 34.240000000000002 111.509 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -167.2 107.66 0.61 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.805 -0.442 . . . . 73.219999999999999 109.805 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.1 mmm -88.11 -36.01 17.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.244 -0.435 . . . . 74.209999999999994 110.664 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.521 HG12 ' OE2' ' A' ' 64' ' ' GLU . 12.9 mm -69.73 97.61 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 109.653 -0.499 . . . . 72.25 109.653 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.8 124.11 24.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 75.530000000000001 110.81 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -90.72 128.98 36.85 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.687 -0.486 . . . . 72.329999999999998 109.687 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 39.9 pt -141.77 179.85 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.12 -0.491 . . . . 61.539999999999999 110.735 -176.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.2 -177.74 15.15 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.643 -0.983 . . . . 75.439999999999998 110.643 171.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 13.3 t70 -52.73 -43.12 65.51 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.856 0.36 . . . . 75.439999999999998 110.973 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 p -63.17 -24.01 67.7 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.013 -0.54 . . . . 72.420000000000002 112.26 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 16.8 mp0 -96.99 -32.39 12.03 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.761 -0.199 . . . . 71.209999999999994 111.117 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.461 ' HA ' HD12 ' A' ' 26' ' ' ILE . 85.0 t80 -41.24 -61.8 0.96 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.002 0.742 . . . . 74.540000000000006 113.002 -166.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.4 -50.27 65.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.715 0.293 . . . . 75.409999999999997 111.116 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -60.36 -51.56 68.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.031 -0.531 . . . . 65.439999999999998 110.734 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.45 ' HG3' HG21 ' A' ' 26' ' ' ILE . 70.7 mmtt -59.45 -36.66 76.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.812 -0.631 . . . . 65.120000000000005 111.049 -176.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.3 -54.66 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.13 -0.487 . . . . 55.340000000000003 111.309 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.8 p -62.92 -25.65 68.43 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.564 0.221 . . . . 63.310000000000002 111.559 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.6 t -75.35 5.51 5.6 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.589 -0.278 . . . . 73.409999999999997 111.674 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 24.4 p -62.52 140.83 58.63 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.875 -0.417 . . . . 44.530000000000001 109.875 175.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -58.41 -83.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.556 -0.293 . . . . 61.310000000000002 110.837 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -161.95 152.54 17.44 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.082 -0.71 . . . . 73.5 109.082 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.9 p30 45.84 22.07 0.11 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.702 0.801 . . . . 75.140000000000001 112.685 -177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 mm -81.95 127.25 39.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 120.607 0.241 . . . . 75.310000000000002 110.427 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.9 tp -88.43 108.59 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.143 0.497 . . . . 63.520000000000003 110.041 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 38' ' ' CYS . 57.4 mt -101.33 114.36 40.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.652 -0.704 . . . . 72.5 110.366 178.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 mp -99.04 118.77 36.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.182 -0.673 . . . . 70.129999999999995 109.182 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 67.0 t -104.34 105.02 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 110.002 -0.37 . . . . 54.32 110.002 175.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.81 156.53 20.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.95 0.405 . . . . 74.400000000000006 110.526 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -109.61 75.24 0.93 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.118 -0.697 . . . . 74.310000000000002 109.118 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.503 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 62.1 t90 -48.29 -45.52 34.94 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.323 -0.853 . . . . 71.329999999999998 111.154 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 66.55 151.81 0.12 Allowed Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 115.618 -0.719 . . . . 54.439999999999998 112.144 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.1 -24.7 27.8 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.184 1.923 . . . . 62.219999999999999 111.883 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -85.56 79.83 9.26 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.427 0.632 . . . . 75.540000000000006 109.353 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 35.6 t -85.05 149.9 25.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.159 -0.928 . . . . 65.409999999999997 111.874 -174.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -147.19 -88.0 0.07 OUTLIER Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.278 -0.874 . . . . 42.439999999999998 111.473 177.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.14 17.8 1.41 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.917 2.412 . . . . 74.450000000000003 112.7 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.77 -30.24 69.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.225 -0.443 . . . . 72.150000000000006 111.164 -175.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' A' ' 57' ' ' ARG . 2.3 tmt_? -54.2 -41.68 68.9 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.105 -0.498 . . . . 75.450000000000003 110.637 -174.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.622 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 16.6 m -75.67 -57.12 4.07 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.484 0.659 . . . . 62.43 111.388 175.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.43 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.2 mm? -60.57 -42.55 96.86 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.498 -0.774 . . . . 74.530000000000001 112.625 -168.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.1 -59.18 12.52 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 117.917 0.326 . . . . 64.409999999999997 111.226 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.4 -33.24 58.83 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.678 1.585 . . . . 65.439999999999998 112.691 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.6 mt-30 -59.46 -45.85 90.44 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.021 -0.672 . . . . 75.310000000000002 110.7 173.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 84.5 mt -62.7 -43.74 98.02 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.155 -0.475 . . . . 63.109999999999999 110.33 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.587 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 25.7 mm-40 -53.63 -53.25 54.51 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.053 -0.521 . . . . 70.319999999999993 110.377 174.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -51.34 -52.9 41.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.989 -0.551 . . . . 62.530000000000001 110.709 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.0 -31.69 72.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 75.140000000000001 110.694 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.648 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -71.7 -25.15 61.97 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.267 -0.424 . . . . 75.010000000000005 110.725 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 89.3 mt-30 -85.21 -37.93 19.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.992 0.425 . . . . 61.200000000000003 110.493 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -74.41 -50.54 18.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 71.209999999999994 110.936 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -90.45 5.09 49.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.553 -0.749 . . . . 74.439999999999998 112.159 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.648 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.6 t -53.04 -24.34 9.57 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.639 0.607 . . . . 63.229999999999997 112.639 -172.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -59.35 -18.79 41.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.069 0.462 . . . . 74.010000000000005 110.859 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -133.44 -29.31 1.39 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.748 -0.66 . . . . 72.230000000000004 111.365 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.425 HG23 HD11 ' A' ' 127' ' ' ILE . 66.0 t -105.49 144.36 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 112.285 0.476 . . . . 75.150000000000006 112.285 -169.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 45.6 mmtm -142.53 140.04 31.65 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.689 -0.856 . . . . 74.439999999999998 108.689 170.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mt -117.06 138.3 48.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.012 0.434 . . . . 71.329999999999998 111.027 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 57.0 m-85 -131.29 162.62 29.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.374 -0.83 . . . . 70.349999999999994 109.072 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 17.6 pttp -157.03 136.18 11.93 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.897 0.38 . . . . 75.030000000000001 110.902 173.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.659 HG12 HG11 ' A' ' 87' ' ' VAL . 2.3 mp -71.09 100.2 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.221 -0.659 . . . . 51.530000000000001 109.221 177.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -103.7 -1.64 27.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.761 -0.654 . . . . 64.109999999999999 109.856 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.6 mm -95.93 96.72 5.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.789 -0.642 . . . . 63.43 110.405 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.79 -22.1 63.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.939 -0.573 . . . . 75.239999999999995 110.921 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.1 -23.57 62.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.113 0.482 . . . . 72.5 110.045 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 30.3 m-80 -111.53 77.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.226 -0.657 . . . . 73.450000000000003 109.226 176.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -100.34 -21.84 15.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.683 -0.689 . . . . 73.200000000000003 111.77 -170.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.558 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 4.4 m-20 -52.26 -34.55 46.71 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.703 0.631 . . . . 74.120000000000005 112.703 -174.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.659 HG11 HG12 ' A' ' 79' ' ' ILE . 14.7 p -53.36 -39.79 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.155 0.503 . . . . 75.150000000000006 110.543 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.42 -41.13 93.9 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.876 -0.602 . . . . 62.140000000000001 110.274 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 m -62.07 -40.66 96.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.553 -0.748 . . . . 62.340000000000003 109.824 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 30.0 mm-40 -64.67 -46.5 82.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.288 -0.869 . . . . 45.049999999999997 110.988 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.43 ' HH ' ' HE2' ' A' ' 31' ' ' PHE . 82.5 m-85 -80.77 -15.54 56.17 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 121.108 -0.237 . . . . 71.239999999999995 111.383 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.18 52.48 31.72 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.059 -0.591 . . . . 64.140000000000001 112.644 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.65 112.5 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.958 0.408 . . . . 71.109999999999999 110.36 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.5 t -90.24 -55.97 3.4 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.211 -0.45 . . . . 74.319999999999993 110.641 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.62 155.88 33.14 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.172 -0.467 . . . . 72.239999999999995 110.437 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.743 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 45.1 mm -69.68 -59.77 4.38 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.669 -0.241 . . . . 73.409999999999997 110.741 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.743 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 1.9 Cg_endo -80.28 74.57 5.48 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.048 1.832 . . . . 72.049999999999997 111.098 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.7 m -113.1 124.92 53.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 70.230000000000004 110.701 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -110.06 117.5 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.41 -0.359 . . . . 34.340000000000003 110.173 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.52 HD23 ' HG3' ' A' ' 110' ' ' GLN . 86.9 mt -88.35 122.98 32.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.907 -0.775 . . . . 73.230000000000004 108.907 174.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 56.9 mtp -96.93 143.66 27.6 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.931 -0.396 . . . . 72.349999999999994 109.931 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -141.38 144.93 34.78 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.283 -0.636 . . . . 64.120000000000005 109.283 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 22.3 tptm -129.68 104.38 7.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.194 -0.299 . . . . 74.140000000000001 110.194 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.591 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 65.8 t30 46.22 46.94 13.43 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.971 0.508 . . . . 75.25 111.934 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.13 -15.51 57.97 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.401 -0.428 . . . . 73.299999999999997 113.806 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 52.6 tttp -82.84 144.57 30.01 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.622 0.369 . . . . 74.540000000000006 110.894 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -68.97 142.25 54.73 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.021 0.439 . . . . 71.010000000000005 110.098 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.58 169.05 19.18 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.126 0.971 . . . . 75.420000000000002 108.907 -169.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.8 m -69.22 173.2 5.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.529 0.681 . . . . 75.340000000000003 112.539 -162.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.52 ' HG3' HD23 ' A' ' 100' ' ' LEU . 20.0 tt0 -125.9 122.42 35.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 65.140000000000001 109.673 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.555 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.4 t -92.73 110.36 22.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.971 -0.381 . . . . 74.329999999999998 109.971 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.5 mp -94.2 122.15 45.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.74 -0.467 . . . . 64.150000000000006 109.74 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.86 146.7 20.87 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 116.32 -0.4 . . . . 75.239999999999995 112.249 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.64 77.74 1.09 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.929 0.395 . . . . 72.230000000000004 110.203 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -125.2 97.06 5.07 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.366 0.603 . . . . 62.100000000000001 109.905 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -26.42 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.33 -0.85 . . . . 71.239999999999995 109.882 -174.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.7 t -63.4 -47.21 82.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 109.881 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -65.37 -43.97 89.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.272 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.508 ' O ' HG13 ' A' ' 123' ' ' ILE . 73.8 mt -55.79 -56.26 13.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.17 -0.468 . . . . 60.039999999999999 110.663 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.1 tt -64.31 -33.83 65.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.326 -0.397 . . . . 71.239999999999995 110.422 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.4 t -57.3 -52.36 65.66 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.203 -0.453 . . . . 70.400000000000006 110.071 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.2 -37.23 86.65 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.457 -0.338 . . . . 74.439999999999998 110.411 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 119' ' ' ILE . 65.7 mt -56.42 -56.39 13.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 120.716 0.293 . . . . 61.109999999999999 111.098 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -71.52 -27.54 63.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.991 -0.284 . . . . 74.319999999999993 110.441 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -65.76 -34.55 78.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.805 0.336 . . . . 75.450000000000003 110.505 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -79.14 -42.94 25.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.316 -0.402 . . . . 61.310000000000002 111.339 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 74' ' ' VAL . 56.6 mt -69.74 -46.06 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 65.319999999999993 110.738 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.426 -0.797 . . . . 74.230000000000004 109.815 -177.329 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.4 tpp . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.659 -0.497 . . . . 72.200000000000003 109.659 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.6 103.66 15.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.883 0.373 . . . . 71.420000000000002 111.691 -173.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -92.14 12.98 20.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.125 -0.489 . . . . 70.200000000000003 110.147 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -89.03 -70.35 0.66 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.098 -0.501 . . . . 64.530000000000001 109.888 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -155.19 152.99 30.04 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.984 -0.747 . . . . 74.420000000000002 108.984 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -105.5 174.58 5.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.743 0.306 . . . . 73.219999999999999 111.036 -173.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -117.83 108.38 15.28 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.17 -0.468 . . . . 73.310000000000002 110.551 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -88.4 114.81 25.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.001 -0.37 . . . . 73.540000000000006 110.001 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 mmt -65.63 157.91 28.69 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.166 -0.47 . . . . 74.310000000000002 111.095 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.44 -66.86 0.01 OUTLIER Glycine 0 C--N 1.331 0.266 0 CA-C-N 115.913 -0.585 . . . . 70.019999999999996 111.929 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.0 t -74.39 173.89 9.66 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 110.228 -0.286 . . . . 72.450000000000003 110.228 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.4 tp -160.28 -79.44 0.05 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.812 -0.176 . . . . 61.409999999999997 111.276 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.414 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 7.5 tp10 -172.64 158.76 4.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.887 0.375 . . . . 71.019999999999996 111.758 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.36 -154.57 0.41 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.291 0.637 . . . . 63.350000000000001 110.728 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -130.8 82.5 2.06 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.559 0.578 . . . . 71.450000000000003 112.559 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.2 p 47.38 -167.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.077 1.14 . . . . 44.32 114.077 167.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.462 ' HG3' ' HD3' ' A' ' 65' ' ' LYS . 0.6 OUTLIER 178.85 -55.84 0.01 OUTLIER 'General case' 0 C--N 1.344 0.33 0 CA-C-N 115.752 -0.658 . . . . 71.450000000000003 110.464 172.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.548 ' H ' ' HB2' ' A' ' 61' ' ' PRO . . . 167.85 120.26 0.52 Allowed Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.904 -0.665 . . . . 62.32 112.401 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -87.22 165.46 8.28 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.989 2.459 . . . . 62.149999999999999 111.937 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.7 0.79 0.15 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.736 -0.745 . . . . 40.299999999999997 113.674 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.3 p 49.07 59.12 4.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.429 0.633 . . . . 74.200000000000003 110.971 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.3 ptm -114.82 2.19 14.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.556 -0.747 . . . . 75.230000000000004 109.884 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.51 129.43 35.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 51.130000000000003 109.906 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -83.4 150.31 26.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.335 -0.393 . . . . 73.25 110.146 -176.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -119.71 130.14 54.86 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.966 0.413 . . . . 72.129999999999995 110.652 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.9 pt -138.81 177.01 5.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.795 -0.638 . . . . 74.349999999999994 110.3 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.88 -179.06 16.46 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.163 -0.542 . . . . 61.43 112.422 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.01 -47.24 71.68 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.301 0.64 . . . . 74.200000000000003 111.173 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.9 t -75.32 -20.45 59.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.821 -0.627 . . . . 23.34 111.711 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -91.61 -8.58 46.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.432 0.158 . . . . 74.329999999999998 110.961 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -53.67 -62.5 1.61 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 111.938 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -61.24 -47.68 84.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.979 0.419 . . . . 52.119999999999997 110.872 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -55.42 -55.3 33.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.591 -0.731 . . . . 71.340000000000003 111.411 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.27 -32.17 68.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.56 -0.291 . . . . 72.120000000000005 111.563 -174.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.93 -38.6 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.805 0.336 . . . . 64.319999999999993 110.882 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.0 p -82.58 -20.6 36.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.812 0.339 . . . . 61.340000000000003 110.994 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -71.67 5.66 2.35 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.21 -0.45 . . . . 41.210000000000001 112.101 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.77 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 25.5 p -56.95 142.38 41.86 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.154 -0.313 . . . . 61.119999999999997 110.154 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -58.93 -74.46 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.572 0.225 . . . . 72.25 110.53 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -153.12 122.0 6.49 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.874 -0.417 . . . . 43.450000000000003 109.874 175.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 55.48 21.82 4.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.512 0.56 . . . . 74.120000000000005 112.512 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.77 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.0 mm -74.69 113.45 13.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 110.121 -0.326 . . . . 74.0 110.121 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.04 113.68 9.33 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.036 -0.728 . . . . 43.25 109.036 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.438 HG23 ' CD1' ' A' ' 77' ' ' TYR . 47.8 mt -106.48 114.4 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.736 -0.665 . . . . 75.239999999999995 110.9 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.44 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -92.55 154.21 18.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.266 -0.642 . . . . 71.200000000000003 109.266 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 63.0 t -132.61 104.96 8.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.459 -0.571 . . . . 65.519999999999996 109.459 176.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.477 ' CG ' ' HZ2' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -94.48 161.73 14.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.171 -0.468 . . . . 65.209999999999994 110.459 -176.207 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -143.83 87.77 1.94 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.742 -0.663 . . . . 70.099999999999994 110.121 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.628 ' HZ3' HD12 ' A' ' 63' ' ' LEU . 1.6 p90 -105.8 169.8 8.27 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.132 -0.486 . . . . 72.049999999999997 109.748 171.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.52 153.21 17.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.483 -0.326 . . . . 54.310000000000002 110.721 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.33 -14.47 29.91 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.871 2.381 . . . . 74.109999999999999 112.359 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -86.79 17.23 4.14 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.034 -0.53 . . . . 71.230000000000004 110.444 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.1 t -124.01 150.82 44.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.668 -0.696 . . . . 74.120000000000005 109.964 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.62 -75.29 1.17 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 121.377 -0.439 . . . . 71.439999999999998 113.704 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.96 -42.69 42.44 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.615 2.21 . . . . 71.109999999999999 112.291 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 19.3 p -60.02 -10.71 4.52 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.734 -0.666 . . . . 50.219999999999999 111.518 -172.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -54.62 -34.18 61.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.97 0.414 . . . . 75.430000000000007 110.309 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.667 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 31.5 t -74.89 -38.14 61.94 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.438 0.637 . . . . 63.210000000000001 109.944 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.543 HD13 ' HG ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -55.68 -28.32 54.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.299 -0.864 . . . . 65.409999999999997 110.487 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.587 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 41.2 mt-10 -59.19 -67.7 0.93 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.738 -0.21 . . . . 75.129999999999995 110.776 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.587 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 32.6 Cg_endo -62.62 -28.5 77.08 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 121.518 1.478 . . . . 41.130000000000003 111.972 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.0 mt-30 -62.35 -47.3 84.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.711 -0.396 . . . . 63.340000000000003 111.646 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.628 HD12 ' HZ3' ' A' ' 49' ' ' TRP . 22.1 mt -66.92 -39.98 87.53 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.962 -0.295 . . . . 64.120000000000005 110.561 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -64.58 -31.13 72.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.455 -0.338 . . . . 75.200000000000003 110.357 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.462 ' HD3' ' HG3' ' A' ' 17' ' ' GLN . 35.3 ttpt -63.6 -53.63 48.66 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.334 0.588 . . . . 74.340000000000003 109.589 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.438 HD11 ' CD1' ' A' ' 116' ' ' ILE . 19.5 mt -61.76 -31.13 71.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.339 -0.846 . . . . 71.409999999999997 110.128 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.73 -53.54 39.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.039 -0.528 . . . . 62.119999999999997 110.11 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -61.78 -34.44 75.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.299 -0.41 . . . . 74.519999999999996 111.202 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -75.87 -40.7 54.1 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.129 -0.487 . . . . 51.25 111.101 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -104.66 5.27 33.45 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.049 0.54 . . . . 75.340000000000003 112.359 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.1 t -53.3 -18.89 2.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.37 0.507 . . . . 74.129999999999995 112.37 -173.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.15 -43.45 82.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.822 0.344 . . . . 74.439999999999998 110.441 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -129.25 8.13 5.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.939 -0.573 . . . . 64.340000000000003 111.73 -175.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t -125.81 138.42 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.008 0.432 . . . . 74.099999999999994 111.774 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 24.4 tptp -141.6 120.0 12.33 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.713 -0.676 . . . . 72.420000000000002 109.217 174.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.44 HG12 ' HB2' ' A' ' 45' ' ' LEU . 55.6 mt -96.92 141.19 16.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 120.757 0.313 . . . . 74.129999999999995 110.855 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.438 ' CD1' HG23 ' A' ' 44' ' ' ILE . 30.6 m-85 -126.13 162.44 25.35 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.614 0.766 . . . . 71.340000000000003 109.784 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 4.4 ttmp? -135.62 125.65 26.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.543 -0.54 . . . . 75.140000000000001 109.543 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.3 pt -91.4 117.83 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.948 0.404 . . . . 73.140000000000001 111.023 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.97 93.3 5.06 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.462 0.649 . . . . 50.329999999999998 110.58 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 41.7 pt -54.92 -23.93 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.355 -0.839 . . . . 74.319999999999993 111.969 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -48.16 -40.94 25.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.729 0.411 . . . . 75.439999999999998 111.631 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.18 -33.75 67.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.924 0.392 . . . . 72.239999999999995 110.916 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 177.68 144.22 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.514 -0.921 . . . . 62.299999999999997 108.514 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -124.48 -0.92 8.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.806 0.298 . . . . 74.230000000000004 111.806 -168.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 1.2 m-20 -49.08 -48.74 43.97 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.161 -0.472 . . . . 73.310000000000002 111.829 -175.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.8 t -53.79 -38.35 35.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-O 120.909 0.385 . . . . 54.009999999999998 110.934 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.06 88.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.138 0.494 . . . . 55.409999999999997 110.064 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.1 m -68.75 -36.75 78.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.679 -0.692 . . . . 75.420000000000002 110.618 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.557 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 97.5 mt-30 -60.82 -57.78 11.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.274 -0.421 . . . . 74.400000000000006 110.61 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -75.01 -24.47 58.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 63.0 111.292 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.75 73.19 1.14 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.94 -0.648 . . . . 53.310000000000002 113.08 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.0 t -89.72 91.49 3.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.88 -0.785 . . . . 71.219999999999999 108.88 172.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.4 p -74.52 -47.9 30.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.648 -0.706 . . . . 53.210000000000001 111.779 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.16 164.57 11.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 62.329999999999998 110.506 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 49.2 mm -62.08 -55.45 40.67 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 123.184 0.302 . . . . 72.420000000000002 110.605 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 2.1 Cg_endo -81.0 104.44 1.55 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.968 1.779 . . . . 75.409999999999997 110.978 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.425 ' C ' HD12 ' A' ' 99' ' ' ILE . 69.9 m -139.15 138.5 37.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.812 0.339 . . . . 73.540000000000006 110.852 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.463 HG12 HD11 ' A' ' 63' ' ' LEU . 2.0 mp -120.34 114.59 44.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 115.829 -0.623 . . . . 62.229999999999997 110.26 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.9 mp -90.6 156.09 18.39 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.254 -0.647 . . . . 65.019999999999996 109.254 173.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.425 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . 48.8 mtp -126.27 139.5 53.27 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.965 -0.754 . . . . 73.129999999999995 108.965 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.45 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.3 m-85 -147.63 157.02 43.37 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.668 -0.493 . . . . 73.319999999999993 109.668 176.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 40.6 ttpt -151.1 109.41 3.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.491 -0.483 . . . . 74.030000000000001 111.595 175.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.703 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 66.2 t30 55.9 36.9 28.17 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.485 0.66 . . . . 73.450000000000003 111.24 174.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.66 -16.68 58.65 Favored Glycine 0 CA--C 1.518 0.275 0 CA-C-N 115.647 -0.706 . . . . 71.519999999999996 112.829 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 12.8 ttmt -74.33 135.21 42.53 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 116.813 0.306 . . . . 70.239999999999995 110.393 177.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -77.9 88.05 4.1 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.19 0.995 . . . . 73.109999999999999 110.751 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.475 HD11 ' CG ' ' A' ' 126' ' ' ASN . 0.3 OUTLIER -71.84 168.85 17.02 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.35 -1.75 . . . . 74.519999999999996 109.782 172.647 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.9 m -69.87 -177.61 1.34 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.277 0.631 . . . . 74.310000000000002 112.353 -166.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -142.38 121.41 12.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 110.214 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.45 115.81 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 70.200000000000003 110.135 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.1 mt -89.51 128.23 41.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.579 . . . . 63.310000000000002 110.38 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.17 -155.77 30.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.172 -0.537 . . . . 64.120000000000005 112.3 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -105.99 112.62 25.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.783 -0.451 . . . . 65.450000000000003 109.783 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 119' ' ' ILE . 5.4 t70 -154.05 82.58 1.14 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.376 0.608 . . . . 70.099999999999994 110.246 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.547 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -60.24 -29.53 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.356 -0.838 . . . . 74.010000000000005 110.67 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.9 t -66.39 -54.25 26.56 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.124 0.488 . . . . 75.299999999999997 110.086 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -57.77 -46.21 84.88 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.814 -0.63 . . . . 72.329999999999998 110.167 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.504 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.7 mt -56.47 -56.34 14.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.879 -0.601 . . . . 75.230000000000004 111.091 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -63.21 -34.18 65.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 120.56 0.219 . . . . 75.340000000000003 110.696 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 t -60.1 -52.15 66.59 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.369 -0.378 . . . . 54.229999999999997 110.063 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.3 -40.31 93.68 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.212 -0.449 . . . . 75.099999999999994 110.149 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.555 ' O ' HG13 ' A' ' 127' ' ' ILE . 53.2 mt -57.12 -56.33 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.859 -0.61 . . . . 64.010000000000005 111.273 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -69.82 -33.41 72.29 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 120.42 -0.512 . . . . 65.230000000000004 110.198 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -58.66 -36.26 73.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.12 -0.491 . . . . 62.439999999999998 110.362 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.475 ' CG ' HD11 ' A' ' 108' ' ' LEU . 39.2 m-80 -108.81 1.31 20.87 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.369 0.877 . . . . 50.310000000000002 113.369 -175.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 123' ' ' ILE . 46.6 mt -84.12 -52.95 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.378 -0.971 . . . . 74.340000000000003 108.378 166.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.408 -0.814 . . . . 74.109999999999999 109.688 175.035 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 C--O 1.233 0.199 0 N-CA-C 109.296 -0.631 . . . . 55.119999999999997 109.296 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 76' ' ' ILE . 3.6 mm -82.84 81.74 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.55 -0.908 . . . . 72.230000000000004 108.55 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 77' ' ' TYR . 7.4 tp10 -69.47 161.54 29.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.728 -0.669 . . . . 60.340000000000003 111.807 -170.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.404 ' H ' ' HG3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -96.75 138.69 33.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.01 -0.541 . . . . 74.349999999999994 110.901 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.7 pt -148.53 169.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.18 0.514 . . . . 71.420000000000002 111.158 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.15 -163.95 11.46 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 109.922 -1.271 . . . . 53.409999999999997 109.922 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -63.33 -39.64 95.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 117.56 0.68 . . . . 75.310000000000002 110.298 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -64.47 -38.35 90.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.576 -0.738 . . . . 72.140000000000001 111.706 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -83.89 -29.08 27.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.688 -0.233 . . . . 64.209999999999994 110.897 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -47.61 -61.64 1.83 Allowed 'General case' 0 C--O 1.238 0.471 0 O-C-N 123.482 0.489 . . . . 63.329999999999998 111.426 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -56.08 -45.1 79.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 75.150000000000006 110.928 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -58.46 -53.8 54.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.0 -0.545 . . . . 73.040000000000006 111.206 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -65.31 -38.72 91.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.066 -0.516 . . . . 70.209999999999994 111.117 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 44' ' ' ILE . 56.8 t -72.64 -42.01 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.302 0.482 . . . . 73.219999999999999 112.302 -176.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.2 p -85.96 -45.29 11.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.116 0.413 . . . . 55.030000000000001 112.116 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t -86.87 10.47 16.02 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.28 -0.418 . . . . 73.439999999999998 112.096 -172.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 7.5 p -71.29 81.49 0.74 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.88 0.371 . . . . 71.319999999999993 111.261 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 29.9 -93.89 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.776 1.231 . . . . 72.340000000000003 113.355 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -161.72 132.32 5.04 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.637 0.375 . . . . 74.409999999999997 110.526 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 54.98 14.69 0.98 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.544 0.572 . . . . 64.120000000000005 112.544 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.9 mm -74.45 115.55 15.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.857 0.36 . . . . 63.420000000000002 110.13 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 102' ' ' PHE . 42.2 tp -76.55 110.29 10.99 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.475 0.655 . . . . 73.120000000000005 110.72 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 23.6 mm -88.98 117.63 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.873 -1.058 . . . . 70.040000000000006 109.744 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.464 HD13 HG13 ' A' ' 74' ' ' VAL . 4.8 mp -106.68 127.85 53.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.439 -0.949 . . . . 52.509999999999998 108.439 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 57.6 t -110.97 104.39 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.273 -0.64 . . . . 74.019999999999996 109.273 175.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.02 114.37 28.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.744 -0.662 . . . . 73.040000000000006 110.141 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 . . . . . 0 C--O 1.234 0.261 0 CA-C-N 116.3 -0.409 . . . . 72.319999999999993 110.03 177.233 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 121.076 0.465 . . . . 73.340000000000003 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.639 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 28.7 t -74.57 -30.53 61.75 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.652 0.739 . . . . 53.130000000000003 110.128 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.514 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 mm? -64.29 -20.73 66.27 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.76 -0.654 . . . . 62.149999999999999 110.872 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.518 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 54.5 mt-10 -54.92 -67.11 0.73 Allowed Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.767 -0.457 . . . . 64.540000000000006 109.767 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.518 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 53.6 Cg_endo -66.64 -37.27 22.28 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 121.735 1.623 . . . . 62.530000000000001 112.387 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.639 ' HG3' ' O ' ' A' ' 58' ' ' SER . 40.2 mt-30 -59.98 -55.9 28.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.355 -0.538 . . . . 74.510000000000005 111.062 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.58 -51.85 63.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.522 -0.308 . . . . 72.239999999999995 111.117 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.555 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 15.8 mm-40 -50.73 -45.63 58.78 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.86 0.362 . . . . 64.329999999999998 110.94 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -69.04 -47.63 64.89 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.387 -0.369 . . . . 74.040000000000006 111.252 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.545 HD11 HD11 ' A' ' 116' ' ' ILE . 16.9 mt -62.29 -31.34 71.92 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.632 -0.427 . . . . 71.310000000000002 110.455 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 71' ' ' THR . . . -66.55 -47.33 73.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.792 -0.447 . . . . 51.030000000000001 109.792 175.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 96.5 mt-30 -59.79 -30.59 69.0 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.101 0.477 . . . . 75.310000000000002 110.801 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -76.33 -45.22 33.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.047 -0.524 . . . . 71.25 111.086 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -103.75 5.21 35.97 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.928 0.714 . . . . 72.439999999999998 112.928 -169.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.89 -19.41 2.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.705 0.402 . . . . 75.129999999999995 112.072 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -55.14 -40.48 70.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 74.209999999999994 110.708 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -127.58 -5.88 5.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.82 -0.627 . . . . 74.109999999999999 111.398 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.464 HG13 HD13 ' A' ' 45' ' ' LEU . 42.1 t -117.06 136.28 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.921 0.391 . . . . 71.239999999999995 111.485 -175.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -141.33 120.11 12.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.686 -0.688 . . . . 64.209999999999994 109.52 173.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.433 HG22 HG23 ' A' ' 23' ' ' ILE . 50.0 mt -99.55 143.02 14.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.367 -0.379 . . . . 63.409999999999997 109.994 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.465 ' CD1' ' HB3' ' A' ' 24' ' ' GLU . 96.8 m-85 -135.61 154.55 51.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.839 -0.618 . . . . 72.219999999999999 109.877 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -141.26 144.1 34.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.302 -0.629 . . . . 63.030000000000001 109.302 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 tt -77.03 135.43 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.303 -0.408 . . . . 71.120000000000005 110.317 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -107.25 -37.54 6.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.105 -0.498 . . . . 73.400000000000006 110.411 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 81' ' ' ILE . 2.8 mp -81.43 103.43 8.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.906 -0.588 . . . . 74.319999999999993 110.387 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.1 -25.22 61.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 63.32 111.806 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.23 -21.22 62.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.641 0.258 . . . . 75.439999999999998 111.187 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -102.3 12.88 35.97 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.594 -0.275 . . . . 72.099999999999994 111.511 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -69.8 -9.38 54.43 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.032 0.444 . . . . 74.319999999999993 110.094 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -54.46 -30.92 54.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.434 -0.803 . . . . 53.32 110.591 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -53.03 -38.82 30.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.754 -0.657 . . . . 71.340000000000003 110.409 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.445 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -57.3 -54.48 46.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.38 -0.827 . . . . 60.200000000000003 110.547 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -60.41 -39.33 87.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.624 -0.716 . . . . 73.439999999999998 110.769 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -64.37 -44.87 90.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.741 -0.663 . . . . 75.540000000000006 111.831 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -80.09 -22.69 41.92 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.664 -0.244 . . . . 74.120000000000005 111.358 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.61 48.6 0.73 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.873 -0.679 . . . . 74.25 113.178 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.445 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 88.5 t -94.61 111.44 25.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.934 -0.395 . . . . 73.219999999999999 109.934 176.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.2 t -110.32 19.74 18.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.286 -0.415 . . . . 65.409999999999997 111.082 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.78 149.42 30.5 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.069 -0.345 . . . . 73.200000000000003 110.069 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.657 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 62.6 mt -61.36 -54.93 48.22 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 123.011 0.195 . . . . 64.420000000000002 110.865 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 86.3 Cg_endo -86.68 98.2 0.52 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.781 1.654 . . . . 64.150000000000006 111.234 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 m -140.42 142.61 35.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.431 . . . . 75.409999999999997 110.327 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.646 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -113.25 117.99 56.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 73.230000000000004 110.268 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.405 HD23 ' HG3' ' A' ' 110' ' ' GLN . 98.7 mt -94.17 122.95 37.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.507 -0.923 . . . . 64.430000000000007 108.507 172.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.447 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 51.2 mtp -100.2 146.9 26.31 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.919 -0.4 . . . . 70.310000000000002 109.919 -177.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.562 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 98.6 m-85 -149.56 161.87 41.3 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.51 -0.552 . . . . 75.400000000000006 109.51 176.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -151.34 107.17 3.39 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.294 -0.254 . . . . 72.299999999999997 111.101 176.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.552 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 3.1 t-20 55.42 35.9 26.0 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.282 0.563 . . . . 63.0 111.273 173.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.33 -16.33 56.25 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.08 -0.509 . . . . 71.219999999999999 112.756 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -79.95 143.82 33.85 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.546 -0.538 . . . . 71.209999999999994 109.546 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -67.91 162.57 23.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.263 0.554 . . . . 73.129999999999995 110.949 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.61 168.3 21.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.763 -1.108 . . . . 72.329999999999998 108.117 -164.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -70.27 179.75 2.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.592 0.711 . . . . 75.019999999999996 112.458 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.405 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.8 tt0 -139.73 118.91 12.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.403 -0.817 . . . . 73.349999999999994 109.446 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.646 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.0 t -97.54 113.18 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 74.540000000000006 110.552 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.0 mp -88.22 108.37 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.394 -0.595 . . . . 74.140000000000001 109.394 177.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.85 143.24 10.65 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.775 -0.53 . . . . 52.149999999999999 111.775 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.514 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -74.65 72.04 1.94 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.936 0.398 . . . . 54.32 110.155 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.415 ' O ' HG13 ' A' ' 119' ' ' ILE . 19.4 t70 -111.08 105.35 14.06 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.893 -0.594 . . . . 73.219999999999999 110.69 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.554 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -59.08 -31.98 46.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.301 -0.863 . . . . 61.130000000000003 110.209 -176.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 m -62.4 -55.79 24.52 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.349 -0.387 . . . . 71.129999999999995 110.931 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -63.57 -41.34 98.39 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.544 0.212 . . . . 63.310000000000002 110.461 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 123' ' ' ILE . 80.6 mt -56.21 -56.28 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.307 -0.406 . . . . 64.310000000000002 110.482 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.75 -33.9 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.481 -0.327 . . . . 54.049999999999997 110.662 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.7 m -57.84 -49.49 76.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.433 -0.349 . . . . 74.120000000000005 110.242 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -69.74 -36.44 75.83 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.464 -0.335 . . . . 72.299999999999997 110.924 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 119' ' ' ILE . 70.8 mt -56.08 -55.95 15.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 64.310000000000002 109.779 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -58.49 -42.47 87.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.546 -0.752 . . . . 71.239999999999995 110.495 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -60.59 -33.7 73.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.319 -0.855 . . . . 75.219999999999999 111.263 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.408 ' OD1' HD11 ' A' ' 108' ' ' LEU . 38.8 m-80 -102.42 -9.52 20.21 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.961 0.726 . . . . 72.549999999999997 112.961 -175.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.5 mt -89.75 -60.51 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.705 -0.398 . . . . 73.129999999999995 110.35 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.158 -0.925 . . . . 74.5 110.154 -178.069 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 13.5 mmt . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.373 0.606 . . . . 55.119999999999997 109.418 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.428 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 8.3 mm -70.49 80.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.908 -1.042 . . . . 72.230000000000004 108.785 172.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 9.0 tp10 -66.51 157.01 33.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.247 -0.433 . . . . 60.340000000000003 111.211 -175.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.27 136.88 48.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.442 0.297 . . . . 74.349999999999994 110.718 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 31' ' ' PHE . 37.9 pt -147.38 176.26 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.001 0.429 . . . . 71.420000000000002 110.992 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.25 -167.27 11.9 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.915 -0.874 . . . . 53.409999999999997 110.915 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.22 -50.68 68.79 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.956 0.407 . . . . 75.310000000000002 111.425 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -68.94 -32.54 72.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.884 -0.598 . . . . 72.140000000000001 112.169 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -80.78 -22.43 40.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.823 -0.172 . . . . 64.209999999999994 110.783 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.464 ' HE1' HG21 ' A' ' 46' ' ' VAL . 91.9 t80 -51.88 -61.96 1.93 Allowed 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.52 0.513 . . . . 63.329999999999998 111.383 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -57.41 -47.17 82.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.099 -0.501 . . . . 75.150000000000006 110.653 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -56.15 -54.44 45.15 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.537 -0.756 . . . . 73.040000000000006 111.278 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -67.44 -33.03 74.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 70.209999999999994 111.343 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.549 HG22 HG21 ' A' ' 44' ' ' ILE . 65.5 t -72.03 -38.2 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.463 -0.335 . . . . 73.219999999999999 111.758 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -85.99 -41.82 14.54 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.024 0.44 . . . . 55.030000000000001 112.028 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 t -83.26 11.54 6.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.112 -0.494 . . . . 73.439999999999998 111.788 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 13.8 p -72.26 82.58 1.02 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.78 0.324 . . . . 71.319999999999993 111.85 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.0 t30 41.52 -93.65 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.367 -0.833 . . . . 72.340000000000003 112.462 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -162.04 121.94 2.47 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 110.412 -0.218 . . . . 74.409999999999997 110.412 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 48.0 m-80 55.36 18.96 2.8 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.779 0.659 . . . . 64.120000000000005 112.779 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.1 mm -71.96 133.62 31.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 120.893 0.378 . . . . 63.420000000000002 110.759 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 74' ' ' VAL . 31.2 tp -80.28 114.97 19.57 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.828 -0.624 . . . . 73.120000000000005 110.389 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.549 HG21 HG22 ' A' ' 35' ' ' VAL . 29.1 mm -95.27 118.9 42.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 70.040000000000006 110.396 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.541 HD13 HG13 ' A' ' 74' ' ' VAL . 5.5 mp -104.19 125.25 50.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.384 -0.969 . . . . 52.509999999999998 108.384 170.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.464 HG21 ' HE1' ' A' ' 31' ' ' PHE . 59.3 t -112.08 104.47 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.454 -0.573 . . . . 74.019999999999996 109.454 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.47 118.3 35.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.659 -0.701 . . . . 73.040000000000006 110.806 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 121.369 0.604 . . . . 72.319999999999993 109.652 174.275 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 121.22 0.533 . . . . 73.340000000000003 110.851 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.627 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 21.5 t -74.78 -35.93 62.53 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-O 122.007 0.908 . . . . 53.130000000000003 109.611 174.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.534 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.6 mm? -65.06 -26.2 68.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.775 -1.102 . . . . 62.149999999999999 110.763 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.508 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 46.2 mt-10 -53.52 -64.25 1.88 Allowed Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.681 -0.408 . . . . 64.540000000000006 109.998 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.508 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 46.2 Cg_endo -66.83 -39.17 15.33 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 121.699 1.599 . . . . 62.530000000000001 112.441 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 58' ' ' SER . 37.0 mt-30 -61.63 -46.2 90.83 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.107 -0.637 . . . . 74.510000000000005 111.236 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.49 -37.53 60.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.331 -0.395 . . . . 72.239999999999995 110.997 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 3.0 mm-40 -57.31 -38.3 73.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.025 0.44 . . . . 64.329999999999998 110.132 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.91 -55.08 25.31 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.839 -0.619 . . . . 74.040000000000006 110.221 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 116' ' ' ILE . 27.8 mt -60.94 -32.32 71.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.665 -0.698 . . . . 71.310000000000002 110.747 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.547 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.47 -53.71 26.49 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.154 -0.476 . . . . 51.030000000000001 109.937 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.7 mt-30 -59.1 -36.15 74.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.415 . . . . 75.310000000000002 111.04 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.94 -52.16 18.56 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.979 0.418 . . . . 71.25 111.374 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -95.22 4.7 53.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.618 0.599 . . . . 72.439999999999998 112.618 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.2 t -52.89 -22.86 6.03 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.816 0.673 . . . . 75.129999999999995 112.816 -170.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.3 -31.84 73.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.747 0.308 . . . . 74.209999999999994 110.818 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -125.69 -0.26 7.42 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.377 -0.374 . . . . 74.109999999999999 110.891 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.541 HG13 HD13 ' A' ' 45' ' ' LEU . 36.6 t -127.94 136.16 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.958 0.408 . . . . 71.239999999999995 111.421 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 71' ' ' THR . 39.8 mmtm -141.89 131.45 23.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.934 -0.575 . . . . 64.209999999999994 109.604 172.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.7 mt -104.97 143.12 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 63.409999999999997 110.444 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -131.46 143.35 50.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.077 -0.51 . . . . 72.219999999999999 110.156 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 25.1 pttm -124.18 127.84 48.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.943 -0.571 . . . . 63.030000000000001 109.667 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.7 tt -80.09 107.18 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.157 0.503 . . . . 71.120000000000005 109.67 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -86.08 -31.96 21.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.234 -0.439 . . . . 73.400000000000006 111.084 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 81' ' ' ILE . 3.0 mp -81.56 85.83 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.32 0.581 . . . . 74.319999999999993 110.286 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -27.34 62.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.359 -0.837 . . . . 63.32 111.277 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.36 -21.97 61.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 75.439999999999998 111.064 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -113.44 41.22 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 72.099999999999994 110.172 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -80.63 22.5 0.58 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.858 -0.61 . . . . 74.319999999999993 111.149 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 37.3 t70 -54.03 -35.93 62.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.625 0.37 . . . . 53.32 110.714 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.3 t -52.74 -40.33 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.709 -0.678 . . . . 71.340000000000003 110.539 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.42 -54.32 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 60.200000000000003 110.51 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 m -62.88 -29.63 70.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 73.439999999999998 110.967 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 33.6 mm-40 -69.13 -56.04 8.87 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.343 -0.39 . . . . 75.540000000000006 111.174 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -75.0 -9.54 58.63 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.791 0.329 . . . . 74.120000000000005 111.231 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.81 45.4 7.77 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.031 -0.604 . . . . 74.25 112.498 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.0 103.58 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.543 -0.54 . . . . 73.219999999999999 109.543 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.7 t -86.37 -52.36 5.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.298 -0.41 . . . . 65.409999999999997 109.928 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.19 150.99 46.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.251 -0.431 . . . . 73.200000000000003 110.092 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.675 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 66.4 mt -72.97 -59.53 2.17 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 119.742 -0.171 . . . . 64.420000000000002 111.145 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 86.6 Cg_endo -82.74 63.62 8.0 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.952 1.768 . . . . 64.150000000000006 112.01 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.5 m -100.92 145.67 28.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.121 -0.49 . . . . 75.409999999999997 110.486 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.603 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -112.16 122.67 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 73.230000000000004 110.265 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.504 HD23 ' HG3' ' A' ' 110' ' ' GLN . 84.7 mt -93.2 123.12 36.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.906 -0.776 . . . . 64.430000000000007 108.906 173.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 109' ' ' SER . 42.0 mtp -98.29 143.22 29.0 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.778 -0.453 . . . . 70.310000000000002 109.778 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.626 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.5 m-85 -149.09 161.39 42.04 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.328 -0.619 . . . . 75.400000000000006 109.328 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -142.63 109.3 5.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.034 -0.266 . . . . 72.299999999999997 110.646 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.538 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 60.6 t30 57.03 29.01 15.74 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.353 0.596 . . . . 63.0 111.061 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.513 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 89.4 -2.72 83.42 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.235 -0.507 . . . . 71.219999999999999 112.92 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -91.7 146.79 23.48 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.784 -0.45 . . . . 71.209999999999994 109.784 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -60.84 154.62 21.56 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.277 0.561 . . . . 73.129999999999995 112.117 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.626 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.16 167.62 23.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.695 -1.138 . . . . 72.329999999999998 108.217 -169.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 101' ' ' MET . 5.2 m -70.99 171.48 10.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.744 0.783 . . . . 75.019999999999996 112.692 -170.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.504 ' HG3' HD23 ' A' ' 100' ' ' LEU . 26.8 tt0 -126.04 127.28 45.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.233 -0.894 . . . . 73.349999999999994 109.775 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.603 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 61.3 t -97.52 107.61 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.074 -0.343 . . . . 74.540000000000006 110.074 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 112' ' ' ILE . 2.9 mp -81.46 106.95 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 74.140000000000001 109.906 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.56 136.7 7.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.297 -0.477 . . . . 52.149999999999999 112.142 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.534 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -57.61 92.13 0.01 OUTLIER 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.929 0.395 . . . . 54.32 110.814 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.414 ' O ' HG13 ' A' ' 119' ' ' ILE . 12.4 t70 -127.22 99.33 5.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 73.219999999999999 109.963 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.514 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -59.07 -33.68 51.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.846 -0.616 . . . . 61.130000000000003 110.728 -174.389 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.8 m -61.06 -54.02 49.88 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.755 0.312 . . . . 71.129999999999995 110.487 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -63.71 -40.88 97.87 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.57 -0.286 . . . . 63.310000000000002 110.543 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.6 mt -58.76 -55.06 25.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.145 -0.48 . . . . 64.310000000000002 110.683 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.9 tt -63.33 -34.11 65.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 116.617 -0.265 . . . . 54.049999999999997 110.341 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.6 m -59.44 -45.69 90.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.668 0.27 . . . . 74.120000000000005 110.318 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -69.99 -38.05 75.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.625 -0.261 . . . . 72.299999999999997 111.186 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.0 mt -57.14 -53.72 39.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.956 0.408 . . . . 64.310000000000002 110.012 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -59.59 -39.58 84.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.755 -0.657 . . . . 71.239999999999995 109.988 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -63.65 -31.86 73.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.652 -0.703 . . . . 75.219999999999999 111.511 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -90.11 -30.12 17.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.184 0.438 . . . . 72.549999999999997 112.184 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.475 HD11 HG23 ' A' ' 74' ' ' VAL . 68.5 mt -86.31 -45.97 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.059 0.457 . . . . 73.129999999999995 110.577 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.46 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.455 -0.783 . . . . 74.5 109.65 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.438 ' HG3' ' CG ' ' A' ' 68' ' ' GLN . 93.9 mmm . . . . . 0 C--O 1.233 0.236 0 N-CA-C 109.898 -0.408 . . . . 72.340000000000003 109.898 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.451 HG12 ' OE2' ' A' ' 64' ' ' GLU . 32.9 mm -67.83 99.38 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.587 -0.894 . . . . 71.0 108.587 174.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 16.2 tt0 -74.85 112.36 10.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.342 0.592 . . . . 75.230000000000004 109.936 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.454 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 8.5 tt0 -88.99 131.14 35.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.488 -0.778 . . . . 62.009999999999998 110.717 -170.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.546 HG21 ' HG3' ' A' ' 34' ' ' LYS . 47.6 pt -144.94 -179.85 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.756 0.312 . . . . 73.510000000000005 111.201 -175.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.64 -174.42 15.6 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.209 -0.451 . . . . 71.540000000000006 112.534 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' OD1' HG23 ' A' ' 87' ' ' VAL . 20.0 t70 -50.84 -57.01 9.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.502 0.721 . . . . 71.109999999999999 112.649 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -69.25 -27.13 65.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 71.5 110.919 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -74.21 -15.59 61.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 62.450000000000003 110.642 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . 90.0 t80 -52.56 -61.38 2.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.912 -0.586 . . . . 73.140000000000001 111.017 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -55.21 -53.43 56.1 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.433 -0.349 . . . . 60.100000000000001 111.167 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -53.34 -55.92 20.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.844 -0.616 . . . . 70.329999999999998 111.211 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.706 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 11.0 mmpt? -61.66 -45.61 93.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.864 -0.607 . . . . 71.230000000000004 111.33 -176.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.415 ' HA ' HD12 ' A' ' 44' ' ' ILE . 70.4 t -64.29 -40.66 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.448 -0.342 . . . . 74.329999999999998 111.347 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.1 p -78.26 -25.02 46.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.703 0.287 . . . . 72.0 111.009 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -61.78 -14.95 37.21 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.261 -0.427 . . . . 51.009999999999998 111.459 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.617 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 22.8 p -49.48 114.45 1.04 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 123.148 0.28 . . . . 73.230000000000004 110.798 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.8 -70.3 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 111.183 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -156.01 122.17 5.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.374 -0.375 . . . . 73.409999999999997 110.474 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 58.82 17.69 5.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.94 -0.573 . . . . 74.310000000000002 111.655 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.4 mm -74.74 97.96 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.661 -0.496 . . . . 74.530000000000001 109.661 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.81 111.47 9.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.708 -0.678 . . . . 64.439999999999998 109.499 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.426 HG23 ' CD1' ' A' ' 77' ' ' TYR . 58.3 mt -101.51 115.1 42.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.181 -0.918 . . . . 62.329999999999998 110.459 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.469 ' HB2' HG13 ' A' ' 76' ' ' ILE . 5.1 mp -103.07 106.41 16.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.817 -0.628 . . . . 72.099999999999994 109.619 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.81 105.0 16.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.731 -0.213 . . . . 73.519999999999996 110.47 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 20.8 t0 -83.16 151.44 25.7 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.142 0.496 . . . . 65.239999999999995 110.688 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.0 t80 . . . . . 0 C--O 1.24 0.586 0 CA-C-N 115.63 -0.713 . . . . 55.020000000000003 111.694 -174.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 110.085 -0.339 . . . . 65.430000000000007 110.085 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.571 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 38.9 t -75.59 -44.0 45.34 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.527 0.68 . . . . 53.119999999999997 111.478 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.3 mm? -60.65 -45.59 93.53 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.852 0.686 . . . . 75.150000000000006 112.852 -171.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.52 -56.31 28.24 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 117.609 0.186 . . . . 74.239999999999995 111.171 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HG2' ' O ' ' A' ' 58' ' ' SER . 18.9 Cg_endo -60.25 -40.49 58.9 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.781 1.654 . . . . 74.340000000000003 112.087 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.571 ' HG3' ' O ' ' A' ' 58' ' ' SER . 36.8 mt-30 -58.31 -39.1 78.47 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.681 -0.408 . . . . 63.340000000000003 111.756 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 85.5 mt -68.43 -41.35 80.47 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.009 -0.367 . . . . 70.299999999999997 110.009 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 19.7 mm-40 -59.47 -41.14 89.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 73.510000000000005 110.415 174.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.579 ' NZ ' ' HB2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -60.56 -57.13 14.04 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.379 0.609 . . . . 63.229999999999997 110.329 178.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.45 -28.76 70.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.489 -0.778 . . . . 72.310000000000002 110.232 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.555 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.08 -50.6 65.5 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.123 -0.49 . . . . 61.240000000000002 109.869 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 91.4 mt-30 -59.77 -41.22 90.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.028 -0.533 . . . . 74.510000000000005 111.115 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -74.32 -54.87 6.77 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.011 0.434 . . . . 64.120000000000005 111.288 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -84.81 4.4 33.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.894 -0.594 . . . . 72.129999999999995 112.475 -172.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.7 t -52.97 -19.57 2.73 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 111.887 0.329 . . . . 63.509999999999998 111.887 -173.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -58.71 -38.92 79.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 52.229999999999997 110.585 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -134.89 10.95 3.63 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 111.407 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.567 HG23 HD11 ' A' ' 127' ' ' ILE . 31.8 t -128.83 142.14 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.22 0.533 . . . . 53.520000000000003 112.347 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 45.9 mmtt -143.6 119.97 10.93 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.194 -0.912 . . . . 72.129999999999995 109.762 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.55 HD13 ' HB2' ' A' ' 67' ' ' ALA . 3.6 mp -98.75 136.74 28.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 109.614 -0.513 . . . . 74.310000000000002 109.614 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 77.3 m-85 -124.31 164.52 19.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 72.200000000000003 109.912 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -153.4 132.58 12.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 74.319999999999993 109.638 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 64.9 mt -75.51 118.43 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.885 -0.413 . . . . 53.310000000000002 109.885 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 25' ' ' GLN . 4.2 p-10 -91.46 -40.34 11.46 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.801 0.334 . . . . 74.349999999999994 111.379 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 81' ' ' ILE . 13.4 tt -83.54 99.24 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.732 0.777 . . . . 71.140000000000001 110.971 -174.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -17.51 62.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.418 -0.81 . . . . 73.310000000000002 111.663 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -70.2 -27.05 64.19 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.572 -0.529 . . . . 74.310000000000002 109.572 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 16.0 m120 -128.13 86.9 2.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.885 -0.598 . . . . 75.340000000000003 109.894 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -138.41 27.94 2.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.728 -0.669 . . . . 65.049999999999997 109.495 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 33.8 t70 -56.76 -35.32 68.5 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.187 -0.915 . . . . 65.349999999999994 111.709 -172.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.469 HG23 ' OD1' ' A' ' 28' ' ' ASP . 90.2 t -52.53 -35.98 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.073 0.463 . . . . 73.540000000000006 110.489 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.68 71.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.941 -0.572 . . . . 65.340000000000003 110.497 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.8 m -59.67 -37.94 80.13 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.286 0.565 . . . . 74.129999999999995 110.492 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 19.8 mm-40 -64.5 -48.23 75.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.43 -0.804 . . . . 72.120000000000005 110.798 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -76.74 -18.3 58.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.56 -0.291 . . . . 73.010000000000005 111.155 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.32 36.51 8.11 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 121.365 -0.445 . . . . 71.230000000000004 112.922 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.86 117.99 39.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 122.411 0.284 . . . . 71.310000000000002 110.422 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.6 m -133.4 13.75 4.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.921 0.391 . . . . 75.230000000000004 110.776 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.19 136.23 39.45 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.549 -0.537 . . . . 73.109999999999999 109.549 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.725 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 49.3 mm -56.19 -54.91 47.55 Favored Pre-proline 0 CA--C 1.542 0.642 0 O-C-N 123.274 0.359 . . . . 71.239999999999995 111.679 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 94.5 Cg_endo -94.2 105.3 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.295 1.996 . . . . 61.25 111.322 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.522 HG23 HG13 ' A' ' 112' ' ' ILE . 27.9 m -148.53 118.24 7.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.284 -0.265 . . . . 71.219999999999999 110.284 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.455 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.1 mp -109.51 110.71 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.189 -0.46 . . . . 63.340000000000003 109.949 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.5 mp -92.46 123.3 35.67 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.176 -0.676 . . . . 72.430000000000007 109.176 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 53.3 mtp -98.73 142.31 30.43 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.854 -0.424 . . . . 63.399999999999999 109.854 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.567 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.8 m-85 -144.89 151.03 38.08 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.549 -0.537 . . . . 70.310000000000002 109.549 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -149.32 123.56 9.55 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.741 -0.384 . . . . 61.5 110.984 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.617 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.5 m-20 62.21 25.45 15.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.265 0.555 . . . . 71.319999999999993 110.325 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.71 -2.89 52.56 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.775 -0.648 . . . . 75.019999999999996 111.988 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -88.17 145.06 26.11 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.846 -0.428 . . . . 65.040000000000006 109.846 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.48 145.61 43.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 124.047 0.842 . . . . 74.450000000000003 110.903 -176.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -150.67 168.02 25.57 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.182 -1.414 . . . . 70.099999999999994 107.182 -170.188 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.3 m -70.29 177.89 3.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.19 0.519 . . . . 51.329999999999998 112.352 -165.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -142.49 119.38 11.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 44.310000000000002 110.057 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -100.63 107.42 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.248 -0.433 . . . . 72.530000000000001 110.112 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -96.16 121.6 46.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.304 -0.628 . . . . 71.319999999999993 109.304 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.87 162.5 32.26 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.794 -0.523 . . . . 41.409999999999997 111.794 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.66 89.93 2.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.753 0.311 . . . . 71.329999999999998 111.175 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.501 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 57.4 t0 -132.45 82.23 2.0 Allowed 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.681 0.753 . . . . 75.0 109.848 174.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.87 -29.04 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 114.993 -1.003 . . . . 74.450000000000003 110.021 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.4 m -60.82 -50.33 73.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.615 -0.513 . . . . 52.409999999999997 109.615 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -61.68 -46.3 90.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.648 -0.706 . . . . 53.539999999999999 110.183 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 123' ' ' ILE . 78.3 mt -55.57 -56.54 11.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.762 -0.654 . . . . 61.350000000000001 111.201 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -66.69 -34.7 71.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.374 -0.376 . . . . 53.310000000000002 110.629 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.3 t -59.3 -51.88 68.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.885 -0.413 . . . . 75.450000000000003 109.885 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -63.67 -36.01 82.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.435 -0.348 . . . . 75.049999999999997 111.232 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.1 mt -56.56 -56.28 14.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.05 0.452 . . . . 71.010000000000005 110.41 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -69.6 -29.06 66.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 61.329999999999998 110.682 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -65.88 -43.8 87.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 64.450000000000003 110.887 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.42 ' CG ' HD11 ' A' ' 108' ' ' LEU . 46.8 m-80 -93.41 -17.95 22.92 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.541 0.571 . . . . 55.140000000000001 112.541 -172.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.567 HD11 HG23 ' A' ' 74' ' ' VAL . 58.6 mt -78.27 -59.83 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 120.543 -0.463 . . . . 64.109999999999999 110.284 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.303 -0.856 . . . . 75.030000000000001 110.205 -176.459 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.495 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 95.4 mmm . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.735 0.302 . . . . 75.439999999999998 110.591 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -111.85 126.16 69.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.206 -0.452 . . . . 63.520000000000003 110.422 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -87.4 151.37 23.13 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.446 -0.343 . . . . 72.549999999999997 110.618 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -114.83 129.68 56.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.436 -0.347 . . . . 71.319999999999993 110.067 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 31' ' ' PHE . 45.7 pt -144.88 169.72 7.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.2 0.524 . . . . 75.430000000000007 111.751 -174.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.527 ' HA2' HD12 ' A' ' 79' ' ' ILE . . . -136.33 -173.71 13.06 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.298 -0.865 . . . . 64.329999999999998 111.274 174.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 7.3 t70 -45.16 -47.22 12.33 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.053 0.454 . . . . 72.099999999999994 111.353 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -62.61 -29.35 70.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.712 -0.676 . . . . 63.039999999999999 112.424 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -102.87 -17.77 15.38 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 122.395 -0.191 . . . . 53.329999999999998 111.435 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 26' ' ' ILE . 88.4 t80 -50.49 -62.01 1.85 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 112.439 0.533 . . . . 70.010000000000005 112.439 -169.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.637 ' O ' HG22 ' A' ' 36' ' ' THR . 10.6 m-20 -56.96 -55.46 34.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 41.149999999999999 110.537 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -54.63 -55.84 25.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.731 -0.668 . . . . 62.020000000000003 111.447 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HG3' HG21 ' A' ' 26' ' ' ILE . 63.7 mmtt -57.74 -40.82 80.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 71.239999999999995 111.386 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.88 -59.72 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.47 -0.332 . . . . 74.109999999999999 111.326 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 32' ' ' ASP . 9.0 t -81.38 -0.27 40.55 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.62 -0.263 . . . . 62.32 111.522 -173.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.6 t -61.74 -19.25 62.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.047 0.451 . . . . 64.099999999999994 109.978 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.817 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 21.3 p -55.8 137.19 50.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.655 -0.702 . . . . 63.009999999999998 110.648 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -74.46 -72.22 0.3 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.453 0.168 . . . . 71.109999999999999 110.701 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -136.2 121.91 19.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.559 0.219 . . . . 72.010000000000005 111.372 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 48.78 26.56 1.3 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.515 0.726 . . . . 73.340000000000003 112.895 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.776 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.7 mm -71.22 126.15 31.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 110.009 -0.367 . . . . 63.009999999999998 110.009 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.501 HD12 HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -75.63 107.49 7.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 72.030000000000001 109.641 -178.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 36.5 mm -92.64 133.3 34.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.225 -0.898 . . . . 74.230000000000004 109.887 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.501 HD11 HD12 ' A' ' 43' ' ' LEU . 4.1 mp -121.66 149.66 42.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.994 -0.743 . . . . 73.530000000000001 108.994 173.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 66.9 t -136.79 104.76 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.239 -0.652 . . . . 63.539999999999999 109.239 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -90.97 154.54 19.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.33 0.586 . . . . 44.140000000000001 110.499 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.0 t80 . . . . . 0 C--N 1.318 -0.782 0 N-CA-C 107.345 -1.354 . . . . 74.430000000000007 107.345 169.225 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HD3' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.101 0 CA-C-O 121.021 0.439 . . . . 72.030000000000001 110.016 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.692 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.6 m -75.06 -39.62 60.81 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.255 0.55 . . . . 74.420000000000002 110.646 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.2 mm? -58.59 -37.83 76.66 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.673 0.62 . . . . 64.099999999999994 112.673 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 45.1 mt-10 -56.85 -61.02 7.72 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.057 0.389 . . . . 74.219999999999999 110.988 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 18.3 Cg_endo -60.2 -38.9 73.11 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.599 1.533 . . . . 72.0 111.942 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.692 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.6 mt-30 -61.45 -41.15 96.76 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.688 -0.405 . . . . 75.239999999999995 111.012 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 66.7 mt -65.92 -50.91 62.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 62.350000000000001 110.302 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 22.7 mt-10 -65.04 -27.57 68.89 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.68 -0.408 . . . . 74.099999999999994 110.88 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -72.59 -49.45 32.18 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.819 0.343 . . . . 72.109999999999999 110.442 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.01 -31.55 72.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.841 -0.429 . . . . 61.020000000000003 109.841 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.491 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.37 -48.2 80.82 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.939 -0.573 . . . . 62.520000000000003 109.711 174.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.495 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 96.0 mt-30 -57.52 -42.21 82.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.902 0.382 . . . . 74.25 110.981 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -69.16 -42.67 75.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.593 . . . . 73.420000000000002 111.443 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -105.15 5.96 32.71 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.131 0.789 . . . . 74.129999999999995 113.131 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.5 t -52.98 -19.91 3.0 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.977 1.103 . . . . 65.109999999999999 113.977 -168.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -73.42 -29.24 62.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.016 0.436 . . . . 64.200000000000003 110.685 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -115.97 -13.85 11.26 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.669 -0.696 . . . . 71.120000000000005 111.346 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.43 HG23 HD11 ' A' ' 127' ' ' ILE . 35.5 t -120.43 133.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.791 0.329 . . . . 65.239999999999995 111.677 -173.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -136.16 119.81 17.17 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.769 -0.651 . . . . 71.030000000000001 109.299 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.464 HG12 HD13 ' A' ' 45' ' ' LEU . 43.3 mt -104.82 137.19 35.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.162 0.506 . . . . 51.350000000000001 110.639 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.435 ' CE2' ' HB3' ' A' ' 34' ' ' LYS . 73.9 m-85 -125.9 169.19 12.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.607 -0.886 . . . . 74.25 108.607 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.519 ' HB3' ' HZ3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -139.72 129.93 25.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.898 0.38 . . . . 75.400000000000006 110.54 172.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.527 HD12 ' HA2' ' A' ' 27' ' ' GLY . 5.7 tp -79.87 78.7 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 109.252 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -112.54 -17.41 12.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.766 -0.652 . . . . 54.25 111.76 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.433 ' HB ' ' HA3' ' A' ' 27' ' ' GLY . 54.0 mt -64.46 92.44 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.464 0.65 . . . . 73.239999999999995 109.889 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 85' ' ' GLN . 10.3 pt-20 -54.72 -29.21 52.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.654 -1.157 . . . . 53.210000000000001 112.842 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.42 -19.25 62.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.394 0.616 . . . . 71.340000000000003 110.272 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 30.0 m-20 -134.66 42.81 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.068 -0.969 . . . . 74.340000000000003 108.943 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 82' ' ' GLU . 17.5 tp60 -71.95 -14.73 61.99 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.895 -1.048 . . . . 71.209999999999994 111.464 -176.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 34.6 t70 -46.14 -39.66 9.87 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.288 0.847 . . . . 71.340000000000003 113.288 -168.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 80.0 t -52.94 -40.96 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.903 0.383 . . . . 51.43 111.313 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.14 93.11 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.101 -0.499 . . . . 64.409999999999997 110.36 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 m -69.79 -33.73 72.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.681 -0.69 . . . . 72.140000000000001 110.622 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 45.0 mt-30 -65.43 -56.52 12.05 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 110.622 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -70.53 -25.22 63.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.158 -0.474 . . . . 75.0 110.938 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.23 60.89 1.1 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.889 -0.672 . . . . 62.350000000000001 113.222 173.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -82.4 94.79 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.669 -0.493 . . . . 54.5 109.669 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 t -107.12 -12.17 15.46 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.165 -0.47 . . . . 74.340000000000003 111.375 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.58 147.67 25.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.639 -0.255 . . . . 74.519999999999996 110.68 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.706 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 67.2 mt -57.32 -51.76 79.32 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.315 -0.402 . . . . 75.329999999999998 110.887 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.706 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 69.8 Cg_endo -102.5 100.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.942 2.428 . . . . 71.340000000000003 111.751 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.1 m -124.97 116.21 21.8 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.284 -0.26 . . . . 73.049999999999997 110.906 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.64 113.95 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.421 -0.354 . . . . 75.239999999999995 110.39 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.2 mp -92.05 143.18 26.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.257 -0.645 . . . . 50.409999999999997 109.257 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 109' ' ' SER . 47.1 mtp -113.97 146.22 40.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.892 0.377 . . . . 71.510000000000005 110.042 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.571 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.7 m-85 -145.73 160.03 42.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.371 -0.974 . . . . 51.109999999999999 108.371 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -149.8 117.47 6.2 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.494 -0.483 . . . . 74.129999999999995 110.863 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.817 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.0 t30 60.15 25.3 14.63 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.805 -0.634 . . . . 72.409999999999997 110.731 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.61 -14.66 63.42 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 116.121 -0.49 . . . . 44.409999999999997 112.445 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -83.38 152.75 24.89 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 122.51 0.324 . . . . 72.299999999999997 110.374 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -64.93 157.22 28.67 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.65 0.738 . . . . 63.439999999999998 111.206 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.32 168.78 21.69 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.965 -1.494 . . . . 71.120000000000005 106.965 -166.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 101' ' ' MET . 58.5 m -69.9 -177.67 1.36 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.066 0.46 . . . . 72.510000000000005 111.69 -167.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -148.83 120.15 7.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.031 -0.359 . . . . 54.340000000000003 110.031 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.4 t -93.62 107.48 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.999 -0.546 . . . . 64.510000000000005 110.106 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -88.82 102.07 12.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.109 -0.7 . . . . 74.099999999999994 109.109 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 117.49 162.79 12.66 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.618 -0.593 . . . . 71.329999999999998 111.618 -177.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.539 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -88.43 72.19 8.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.954 0.407 . . . . 72.510000000000005 110.224 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.38 94.46 4.98 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 116.025 -0.534 . . . . 73.219999999999999 110.113 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.405 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.37 -33.95 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 115.673 -0.694 . . . . 72.219999999999999 110.172 -175.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -59.61 -47.62 84.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.247 -0.433 . . . . 73.030000000000001 110.631 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -69.15 -42.02 76.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 71.129999999999995 110.269 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 123' ' ' ILE . 78.9 mt -55.54 -56.21 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.736 0.303 . . . . 72.129999999999995 110.897 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.1 tt -66.01 -33.9 66.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.784 0.326 . . . . 70.030000000000001 110.387 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.6 t -55.14 -52.32 63.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.044 -0.525 . . . . 64.519999999999996 110.477 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 18.6 mm-40 -72.18 -37.17 69.38 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.248 -0.433 . . . . 74.329999999999998 110.664 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 119' ' ' ILE . 49.3 mt -52.32 -56.12 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.898 0.38 . . . . 75.420000000000002 110.09 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.75 -43.66 92.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.159 -0.473 . . . . 64.209999999999994 110.196 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 8.3 t30 -58.12 -30.25 66.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.96 -0.564 . . . . 73.420000000000002 111.65 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -99.17 -29.27 12.94 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.645 0.609 . . . . 71.239999999999995 112.645 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 74' ' ' VAL . 66.3 mt -72.74 -48.83 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 117.947 0.339 . . . . 71.319999999999993 110.301 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.4 p30 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.41 -0.805 . . . . 62.210000000000001 110.466 178.782 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 79.9 mmm . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 108.782 -0.821 . . . . 73.409999999999997 108.782 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 mm -59.75 108.81 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 114.725 -1.125 . . . . 71.120000000000005 109.046 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -73.08 154.14 40.54 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.874 0.369 . . . . 74.319999999999993 111.115 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -118.88 134.67 55.02 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.167 0.587 . . . . 73.510000000000005 110.309 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 31' ' ' PHE . 41.7 pt -150.09 179.63 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.348 0.594 . . . . 33.130000000000003 111.421 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 30' ' ' GLU . . . -131.67 -159.16 9.34 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.323 -0.853 . . . . 72.209999999999994 111.036 172.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 11.0 p-10 -65.96 -46.2 78.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.026 0.441 . . . . 55.43 110.916 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.3 m -65.71 -29.16 69.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.703 -0.68 . . . . 73.439999999999998 110.668 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.409 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 17.2 mm-40 -95.39 -10.18 30.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.963 -0.562 . . . . 74.209999999999994 111.118 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.536 ' HA ' HD12 ' A' ' 26' ' ' ILE . 88.1 t80 -61.77 -61.87 2.2 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.543 -0.54 . . . . 64.010000000000005 109.543 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -57.76 -47.6 82.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.915 -0.584 . . . . 52.229999999999997 110.058 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -51.22 -57.74 8.0 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.577 -0.738 . . . . 74.129999999999995 110.84 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -80.08 -26.18 39.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.972 -1.013 . . . . 63.210000000000001 111.683 -168.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.447 ' HA ' HD13 ' A' ' 44' ' ' ILE . 79.4 t -78.81 -39.37 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.735 -0.212 . . . . 62.299999999999997 111.401 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.5 p -84.89 -37.14 20.96 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.934 0.346 . . . . 60.210000000000001 111.934 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.5 t -69.06 -13.07 62.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.472 0.545 . . . . 64.230000000000004 112.472 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.903 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 28.4 p -57.13 142.0 44.13 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.166 -0.309 . . . . 71.140000000000001 110.166 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -61.65 -82.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.387 0.514 . . . . 43.409999999999997 112.387 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -160.46 143.41 13.33 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.641 -0.254 . . . . 72.109999999999999 110.492 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 61.3 8.2 2.01 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.654 0.596 . . . . 71.230000000000004 111.796 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 mm -73.24 102.52 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.193 0.521 . . . . 72.230000000000004 110.51 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.412 ' HB3' HG22 ' A' ' 74' ' ' VAL . 3.2 tm? -71.85 108.16 4.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.191 -0.913 . . . . 63.450000000000003 109.165 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 35' ' ' VAL . 70.3 mt -102.01 137.18 30.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.437 -0.801 . . . . 73.439999999999998 111.005 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.614 HD13 HG13 ' A' ' 76' ' ' ILE . 3.4 mp -118.14 148.94 41.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.924 -0.769 . . . . 71.530000000000001 108.924 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.5 t -130.59 104.82 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.535 -0.542 . . . . 74.349999999999994 109.535 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -88.11 126.63 35.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 75.510000000000005 110.599 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 100' ' ' LEU . 17.7 m-85 . . . . . 0 C--N 1.33 -0.245 0 N-CA-C 109.116 -0.698 . . . . 74.450000000000003 109.116 169.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.93 0.395 . . . . 71.299999999999997 110.545 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.5 m -75.72 -32.5 60.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.133 -0.485 . . . . 40.210000000000001 111.223 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 62' ' ' GLN . 1.4 mm? -57.95 -45.5 86.55 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.518 0.933 . . . . 50.530000000000001 113.518 -164.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.521 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 7.9 mp0 -53.77 -60.47 7.14 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-N 118.734 0.697 . . . . 71.230000000000004 110.529 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.538 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 39.3 Cg_endo -67.31 -19.72 49.66 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.792 1.661 . . . . 71.510000000000005 112.548 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.492 ' NE2' HG21 ' A' ' 116' ' ' ILE . 3.4 mm100 -66.47 -52.78 42.52 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 110.263 -0.273 . . . . 72.310000000000002 110.263 174.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.486 HD21 HD13 ' A' ' 119' ' ' ILE . 97.2 mt -62.48 -40.9 98.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.474 -0.565 . . . . 73.319999999999993 109.474 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.6 mm-40 -58.17 -42.83 86.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.666 -0.697 . . . . 74.129999999999995 111.025 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.403 ' HB3' ' HZ3' ' A' ' 65' ' ' LYS . 7.1 ttpm? -63.91 -50.74 67.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.898 0.38 . . . . 71.319999999999993 110.244 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.5 mt -64.9 -32.42 74.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.953 -0.567 . . . . 61.450000000000003 110.248 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.477 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.6 -53.9 44.39 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.197 -0.456 . . . . 43.200000000000003 109.824 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 55.2 mt-30 -57.28 -38.94 74.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.014 -0.539 . . . . 73.439999999999998 111.019 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.49 -42.55 52.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.887 -0.597 . . . . 75.5 111.389 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -104.86 5.07 32.71 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.743 0.646 . . . . 71.200000000000003 112.743 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.8 t -52.88 -21.31 4.13 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.747 0.647 . . . . 60.100000000000001 112.747 -169.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.73 -39.13 90.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.822 0.344 . . . . 71.239999999999995 110.408 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -120.69 -1.86 9.96 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.77 -0.65 . . . . 74.519999999999996 111.575 -176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.542 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 43.0 t -128.44 131.58 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 112.054 0.391 . . . . 73.099999999999994 112.054 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HD2' ' O ' ' A' ' 74' ' ' VAL . 13.6 mptt -138.92 122.96 17.91 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.034 -0.53 . . . . 71.129999999999995 109.939 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.614 HG13 HD13 ' A' ' 45' ' ' LEU . 3.3 mp -99.21 146.12 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.7 -0.481 . . . . 72.109999999999999 109.7 176.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.407 ' CD1' HG23 ' A' ' 44' ' ' ILE . 97.5 m-85 -132.0 142.74 49.69 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.738 0.415 . . . . 74.230000000000004 110.318 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -111.22 132.42 54.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.861 0.465 . . . . 74.430000000000007 110.015 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -86.29 99.16 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.549 -0.908 . . . . 73.430000000000007 108.549 174.133 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -80.66 -48.36 12.73 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.539 0.57 . . . . 44.450000000000003 112.539 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.535 ' HB ' ' OD1' ' A' ' 84' ' ' ASN . 49.7 mt -78.56 106.92 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 74.439999999999998 111.093 -173.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.79 -17.91 52.13 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.168 -0.469 . . . . 74.129999999999995 111.464 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.441 ' HB2' HG22 ' A' ' 81' ' ' ILE . 2.7 m-20 -70.02 -20.36 63.27 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.041 0.448 . . . . 71.299999999999997 109.827 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.535 ' OD1' ' HB ' ' A' ' 81' ' ' ILE . 10.3 m120 -84.17 41.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.786 -0.643 . . . . 65.230000000000004 109.723 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -55.07 -24.92 27.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.424 -0.807 . . . . 74.450000000000003 111.265 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -40.36 -55.94 2.11 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.55 -0.75 . . . . 71.099999999999994 112.119 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.08 -37.82 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.31 -0.404 . . . . 61.219999999999999 111.035 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.88 -54.79 16.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.066 0.46 . . . . 41.450000000000003 110.595 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 m -67.36 -35.89 80.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.753 -0.658 . . . . 40.240000000000002 111.141 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.405 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 14.0 mm-40 -75.27 -41.34 57.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.595 . . . . 74.040000000000006 111.537 -175.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -88.79 -12.13 42.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.796 0.331 . . . . 72.310000000000002 110.779 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.48 45.33 8.75 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.917 -0.659 . . . . 72.409999999999997 112.576 172.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.08 94.84 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.469 -0.567 . . . . 75.040000000000006 109.469 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.1 m -58.93 -39.24 80.99 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.751 -0.659 . . . . 73.209999999999994 112.047 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.18 144.83 51.15 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.16 -0.311 . . . . 74.340000000000003 110.16 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.474 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 59.9 mt -54.67 -49.67 90.01 Favored Pre-proline 0 CA--C 1.541 0.597 0 O-C-N 123.21 0.319 . . . . 62.009999999999998 111.792 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 96' ' ' ILE . 56.5 Cg_endo -69.37 82.02 0.69 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 121.868 1.712 . . . . 75.430000000000007 112.125 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.6 m -146.54 142.64 28.23 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.231 0.538 . . . . 72.340000000000003 111.543 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 mp -115.71 120.65 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.268 -0.878 . . . . 74.530000000000001 109.369 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 48' ' ' PHE . 9.3 mp -97.43 135.13 39.75 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.895 -0.409 . . . . 72.430000000000007 109.895 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.505 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 42.0 mtp -101.87 146.8 27.32 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.077 -0.342 . . . . 73.140000000000001 110.077 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -148.04 158.47 44.08 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.398 -0.593 . . . . 72.310000000000002 109.398 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -141.89 106.73 4.9 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 120.729 -0.388 . . . . 71.409999999999997 111.371 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.903 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.6 t-20 60.78 27.56 17.33 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.481 0.657 . . . . 65.450000000000003 110.579 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.84 -10.11 75.28 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.777 -0.647 . . . . 44.219999999999999 112.33 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -70.08 132.04 45.23 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 109.593 -0.521 . . . . 75.230000000000004 109.593 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -62.07 143.33 56.78 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 124.132 0.895 . . . . 64.310000000000002 109.348 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.505 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.7 tp -155.84 168.28 27.71 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.102 -0.703 . . . . 75.420000000000002 109.102 -164.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.1 m -69.8 171.92 8.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.42 0.629 . . . . 71.109999999999999 112.49 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -131.05 133.91 46.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.717 -0.674 . . . . 74.040000000000006 110.489 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.42 HG22 ' HG3' ' A' ' 118' ' ' LYS . 46.2 t -103.77 120.36 53.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.907 -0.588 . . . . 74.340000000000003 109.725 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.1 mp -97.79 125.05 51.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.664 -0.495 . . . . 72.239999999999995 109.664 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.25 -174.27 53.52 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.292 -0.48 . . . . 44.340000000000003 112.33 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -87.16 86.4 7.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.687 0.279 . . . . 61.409999999999997 110.436 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 119' ' ' ILE . 65.4 t0 -123.79 87.83 2.81 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.605 0.717 . . . . 75.030000000000001 109.776 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.492 HG21 ' NE2' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -65.56 -29.39 46.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.263 -0.88 . . . . 74.230000000000004 109.532 -176.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.9 t -61.86 -48.74 79.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.917 -0.583 . . . . 71.549999999999997 109.716 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HG3' HG22 ' A' ' 111' ' ' VAL . 58.4 tptt -63.22 -43.3 98.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.132 -0.486 . . . . 73.310000000000002 110.167 177.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.486 HD13 HD21 ' A' ' 63' ' ' LEU . 82.7 mt -56.62 -56.46 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.225 -0.443 . . . . 53.350000000000001 111.293 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.26 -34.13 68.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.662 0.267 . . . . 75.519999999999996 110.472 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.7 t -56.53 -51.56 68.09 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.109 -0.496 . . . . 73.209999999999994 109.868 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -65.64 -40.17 92.21 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.155 -0.475 . . . . 72.510000000000005 110.728 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 119' ' ' ILE . 64.8 mt -54.85 -55.9 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.657 0.265 . . . . 70.299999999999997 110.417 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -64.46 -36.93 85.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.6 -0.273 . . . . 73.439999999999998 110.321 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -67.11 -26.4 66.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.041 -0.527 . . . . 43.530000000000001 111.257 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -101.03 -13.74 18.11 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.878 0.325 . . . . 70.140000000000001 111.878 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 123' ' ' ILE . 54.5 mt -85.94 -54.48 8.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.722 0.296 . . . . 71.120000000000005 110.395 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.661 -0.685 . . . . 54.0 110.922 -177.328 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.779 0.324 . . . . 71.019999999999996 110.918 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -105.19 100.56 10.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 109.66 -0.496 . . . . 74.219999999999999 109.66 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 30.3 tt0 -93.62 112.11 23.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.938 0.399 . . . . 65.129999999999995 110.435 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 133.2 40.72 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.938 0.399 . . . . 73.409999999999997 110.889 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 39.6 pt -144.8 179.64 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.271 -0.422 . . . . 63.32 110.806 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.48 -176.09 15.59 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.969 -0.852 . . . . 54.119999999999997 110.969 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 84' ' ' ASN . 27.6 t70 -66.72 -28.63 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.014 0.435 . . . . 55.420000000000002 110.334 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.9 m -65.58 -34.86 79.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.779 -0.646 . . . . 75.140000000000001 110.718 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 2.3 mp0 -92.38 -22.24 19.78 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.575 -0.284 . . . . 73.150000000000006 110.824 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.622 ' HE1' HG21 ' A' ' 46' ' ' VAL . 70.4 t80 -46.77 -61.46 1.84 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.314 0.383 . . . . 73.519999999999996 111.932 -173.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -63.05 -40.91 99.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.444 -0.344 . . . . 53.329999999999998 110.497 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' SER . 36.9 m-80 -58.65 -41.68 86.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.796 -0.638 . . . . 63.219999999999999 110.678 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -72.04 -43.72 64.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.886 -0.597 . . . . 74.530000000000001 110.156 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 31' ' ' PHE . 91.0 t -62.6 -40.68 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.954 -0.566 . . . . 61.119999999999997 110.809 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.4 p -80.65 -25.61 38.2 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.148 0.425 . . . . 74.439999999999998 112.148 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 22.3 t -67.69 -14.23 62.77 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.92 0.341 . . . . 63.310000000000002 111.92 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.78 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 27.6 p -56.84 129.79 42.92 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.102 -0.332 . . . . 72.109999999999999 110.102 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.39 -71.38 0.14 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.675 0.274 . . . . 51.210000000000001 110.781 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -161.59 135.57 6.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.453 -0.34 . . . . 62.409999999999997 110.45 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.42 ' H ' ' HB2' ' A' ' 104' ' ' ASN . 96.0 m-20 61.37 2.31 0.63 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.957 0.725 . . . . 74.319999999999993 112.957 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.681 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.0 mm -62.29 130.7 27.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.895 0.378 . . . . 75.239999999999995 110.388 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER -93.01 112.85 24.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 72.420000000000002 109.612 -178.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 38' ' ' CYS . 73.7 mt -107.67 123.06 62.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.819 -0.628 . . . . 61.130000000000003 110.313 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.651 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -105.97 146.14 30.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.142 -0.688 . . . . 63.329999999999998 109.142 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.622 HG21 ' HE1' ' A' ' 31' ' ' PHE . 61.8 t -125.26 104.72 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.724 -0.473 . . . . 70.040000000000006 109.724 177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -94.83 112.85 24.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.669 . . . . 63.32 109.768 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 17.1 m-85 . . . . . 0 C--O 1.236 0.375 0 CA-C-O 120.939 0.399 . . . . 64.25 111.099 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.0 ptp85 . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 120.525 0.202 . . . . 74.120000000000005 110.579 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.643 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 9.6 m -74.84 -40.47 61.01 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.773 0.797 . . . . 72.109999999999999 110.289 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.4 mm? -58.01 -38.67 76.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.22 -0.9 . . . . 73.409999999999997 111.415 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 55.2 mt-10 -54.64 -63.2 3.05 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 119.399 -0.334 . . . . 52.340000000000003 111.339 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.43 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 17.8 Cg_endo -60.24 -38.86 72.99 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 121.827 1.684 . . . . 73.129999999999995 112.118 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.4 mt-30 -57.73 -42.54 84.09 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.548 -0.461 . . . . 74.129999999999995 111.184 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.466 HD21 HD13 ' A' ' 119' ' ' ILE . 93.9 mt -68.97 -45.75 69.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.391 . . . . 54.310000000000002 110.467 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 44.7 mt-10 -56.84 -36.77 70.38 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.065 0.46 . . . . 74.310000000000002 109.904 176.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -66.89 -52.4 43.81 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.661 -0.699 . . . . 73.140000000000001 110.471 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 36.4 mt -59.75 -34.14 72.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.584 . . . . 64.409999999999997 109.891 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -60.64 -53.56 55.95 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.666 -0.697 . . . . 52.409999999999997 109.353 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 51.5 mt-30 -53.77 -42.13 67.91 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.235 -0.439 . . . . 75.310000000000002 110.961 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -65.88 -46.31 78.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.805 -0.634 . . . . 71.140000000000001 111.37 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -104.98 4.7 32.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.772 0.656 . . . . 73.010000000000005 112.772 -171.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.4 t -53.29 -20.59 4.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.232 1.197 . . . . 73.420000000000002 114.232 -168.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -73.12 -23.54 60.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.95 0.405 . . . . 73.340000000000003 110.835 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -118.83 -16.17 9.33 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.808 -0.633 . . . . 71.299999999999997 110.629 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.63 HG23 HD11 ' A' ' 127' ' ' ILE . 20.6 t -119.38 133.4 66.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.096 -0.502 . . . . 75.340000000000003 111.387 -173.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -131.76 119.85 21.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.511 -0.768 . . . . 73.349999999999994 109.239 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.651 HG12 ' HB2' ' A' ' 45' ' ' LEU . 71.7 mt -99.32 139.44 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.972 -0.381 . . . . 71.200000000000003 109.972 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 96.5 m-85 -129.82 151.47 50.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.951 -0.568 . . . . 75.540000000000006 110.032 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -134.14 109.93 9.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.041 0.448 . . . . 71.140000000000001 110.466 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.3 pp -78.56 70.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.733 0.778 . . . . 72.109999999999999 110.368 176.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.57 -13.0 60.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.385 -0.825 . . . . 75.140000000000001 111.077 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 60.4 mt -67.12 108.56 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 110.105 -0.331 . . . . 74.540000000000006 110.105 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -36.12 64.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.101 -0.5 . . . . 73.299999999999997 111.888 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.63 -22.22 61.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.542 . . . . 43.130000000000003 110.927 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.444 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.9 OUTLIER -102.62 23.12 12.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.945 -0.571 . . . . 60.509999999999998 111.539 -175.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -76.51 12.81 1.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.84 0.311 . . . . 72.209999999999994 111.84 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.592 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 30.4 t70 -53.11 -36.78 61.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.864 0.364 . . . . 73.109999999999999 110.637 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -52.75 -35.25 21.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.817 -0.629 . . . . 75.540000000000006 110.638 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.404 ' HB2' ' HE2' ' A' ' 48' ' ' PHE . . . -62.97 -50.23 71.59 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.903 -0.589 . . . . 52.200000000000003 110.335 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.1 m -66.7 -31.33 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.656 -0.702 . . . . 64.150000000000006 110.781 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 32.6 mm-40 -67.98 -53.85 22.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.21 -0.45 . . . . 63.200000000000003 110.928 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -91.71 -2.36 57.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.165 -0.47 . . . . 65.430000000000007 112.028 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.46 71.37 1.16 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.814 -0.708 . . . . 75.540000000000006 112.384 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' A' ' 48' ' ' PHE . 98.4 t -104.51 101.04 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 63.039999999999999 110.363 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.8 t -94.6 -35.22 12.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 61.210000000000001 109.904 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.94 146.07 37.78 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.924 -0.58 . . . . 70.450000000000003 110.783 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.684 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 65.2 mt -69.09 -54.54 11.79 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.481 -0.327 . . . . 64.230000000000004 110.937 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.684 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 5.1 Cg_endo -85.0 93.79 0.68 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.142 1.895 . . . . 61.509999999999998 110.943 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 90.7 m -127.65 132.6 49.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.042 0.449 . . . . 53.229999999999997 111.208 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.6 mp -115.78 122.65 69.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.629 -0.714 . . . . 73.030000000000001 109.829 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.487 HD23 ' HG3' ' A' ' 110' ' ' GLN . 90.6 mt -98.68 125.26 43.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.664 -0.495 . . . . 74.400000000000006 109.664 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.549 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 52.9 mtp -98.46 147.73 24.45 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.964 -0.384 . . . . 63.420000000000002 109.964 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.73 150.78 36.88 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.096 -0.705 . . . . 74.140000000000001 109.096 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.531 ' HB2' HD22 ' A' ' 108' ' ' LEU . 61.9 tttp -139.54 106.78 5.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 120.907 -0.317 . . . . 74.209999999999994 111.024 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.78 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.4 t30 59.08 30.9 20.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.698 0.761 . . . . 51.210000000000001 110.444 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.87 -13.99 61.48 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.639 -0.71 . . . . 70.040000000000006 112.25 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -70.37 138.07 51.06 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 110.038 -0.356 . . . . 63.409999999999997 110.038 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -56.86 152.73 12.12 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.231 0.957 . . . . 72.239999999999995 109.447 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.549 ' HB3' ' C ' ' A' ' 101' ' ' MET . 11.5 tp -162.82 168.79 20.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.512 -0.767 . . . . 75.420000000000002 109.893 -165.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.7 m -69.19 164.04 23.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.787 0.803 . . . . 73.329999999999998 112.411 -164.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.487 ' HG3' HD23 ' A' ' 100' ' ' LEU . 61.8 tt0 -127.65 124.14 37.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.11 -0.95 . . . . 74.120000000000005 109.593 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.8 t -97.66 111.89 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 70.030000000000001 110.234 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.491 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -97.52 109.99 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.805 -0.634 . . . . 73.310000000000002 109.801 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.08 -174.68 23.39 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.043 -0.598 . . . . 44.310000000000002 112.284 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.4 72.29 4.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.188 0.518 . . . . 31.199999999999999 110.808 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.418 ' O ' HG13 ' A' ' 119' ' ' ILE . 0.9 OUTLIER -110.79 77.79 1.07 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.91 -0.586 . . . . 72.420000000000002 109.915 177.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -34.72 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.627 -0.715 . . . . 51.340000000000003 110.024 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.1 t -63.52 -42.66 98.45 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.163 -0.471 . . . . 54.530000000000001 110.224 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -65.48 -41.38 93.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 72.349999999999994 109.991 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 123' ' ' ILE . 77.0 mt -59.18 -56.69 15.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.028 -0.533 . . . . 73.530000000000001 110.807 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.7 tt -62.9 -37.08 78.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 116.466 -0.334 . . . . 74.230000000000004 110.439 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.0 t -58.19 -51.9 67.8 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 116.289 -0.414 . . . . 74.549999999999997 110.128 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.87 -39.45 91.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.448 -0.342 . . . . 71.239999999999995 110.633 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 119' ' ' ILE . 74.4 mt -57.54 -56.51 14.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 121.109 -0.236 . . . . 62.219999999999999 111.159 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -71.07 -24.99 62.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.755 -0.378 . . . . 53.119999999999997 110.356 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -66.61 -38.55 87.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.163 0.506 . . . . 75.319999999999993 110.43 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -92.51 -12.79 31.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.291 -0.413 . . . . 65.530000000000001 111.922 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.63 HD11 HG23 ' A' ' 74' ' ' VAL . 62.4 mt -95.97 -60.47 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.769 0.318 . . . . 71.140000000000001 111.431 173.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.525 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.751 -0.642 . . . . 62.509999999999998 110.364 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 85.5 mmm . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.843 0.354 . . . . 54.229999999999997 110.265 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 78' ' ' LYS . 21.0 mm -81.09 123.17 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.026 -0.534 . . . . 73.319999999999993 109.561 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -88.99 126.16 35.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.923 0.392 . . . . 73.150000000000006 111.158 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.763 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 10.2 pt20 -82.76 130.94 35.2 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.402 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 31' ' ' PHE . 47.2 pt -141.83 168.17 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.294 0.568 . . . . 71.299999999999997 111.87 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.75 -170.0 12.64 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.188 -0.915 . . . . 22.140000000000001 111.093 173.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.58 -45.28 92.33 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.181 0.515 . . . . 73.400000000000006 110.991 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.8 m -57.38 -28.45 63.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.385 -0.825 . . . . 51.539999999999999 111.592 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.4 mp0 -106.52 -20.42 13.37 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.693 -0.231 . . . . 64.150000000000006 111.582 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.454 ' O ' HG23 ' A' ' 35' ' ' VAL . 91.2 t80 -52.0 -62.01 1.9 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 111.949 0.352 . . . . 74.329999999999998 111.949 -171.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.33 -44.31 79.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.265 -0.425 . . . . 64.120000000000005 110.252 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -59.59 -57.4 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.767 -0.651 . . . . 62.509999999999998 110.883 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 35.7 mmtp -59.31 -32.12 69.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.873 -0.603 . . . . 74.450000000000003 111.342 -174.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 31' ' ' PHE . 96.3 t -78.52 -44.76 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.874 0.324 . . . . 71.530000000000001 111.874 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.3 p -86.01 -14.99 42.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.609 0.596 . . . . 52.409999999999997 112.609 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.3 m -78.11 9.69 3.52 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.804 0.335 . . . . 73.310000000000002 111.605 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.915 ' SG ' ' HB ' ' A' ' 42' ' ' ILE . 41.6 t -67.36 169.1 9.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 75.430000000000007 110.208 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.456 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 45.0 t-20 -114.01 -62.47 1.59 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.951 -0.389 . . . . 74.140000000000001 109.951 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -162.38 138.59 7.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.483 -0.326 . . . . 72.329999999999998 111.368 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 60.15 1.71 0.37 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.092 1.145 . . . . 53.409999999999997 114.092 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.915 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 50.7 mm -79.73 107.03 11.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 118.325 0.511 . . . . 73.329999999999998 110.33 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.6 tp -75.47 129.39 37.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.648 -0.705 . . . . 70.319999999999993 110.274 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.5 mt -116.56 119.92 63.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.631 -0.713 . . . . 62.25 110.488 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.3 mp -108.13 143.57 36.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.908 -0.775 . . . . 64.200000000000003 108.908 175.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.426 HG22 ' HB2' ' A' ' 77' ' ' TYR . 64.3 t -130.0 110.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.719 -0.475 . . . . 74.420000000000002 109.719 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -88.96 143.01 27.16 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.043 0.449 . . . . 73.530000000000001 111.607 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.0 t80 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 115.717 -0.674 . . . . 64.040000000000006 109.912 176.076 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.5 0.19 . . . . 74.510000000000005 111.01 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.622 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.7 m -75.39 -43.49 49.88 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.606 0.717 . . . . 71.219999999999999 111.415 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.477 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.3 mm? -64.88 -33.8 76.88 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.53 -0.759 . . . . 74.319999999999993 112.093 -170.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.402 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 13.4 mm-40 -59.34 -59.96 12.12 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 121.043 -0.263 . . . . 70.439999999999998 110.567 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 18.5 Cg_endo -59.6 -42.17 49.72 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 121.829 1.686 . . . . 70.109999999999999 111.992 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.5 mt-30 -57.37 -46.46 83.37 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 120.599 -0.44 . . . . 52.450000000000003 111.422 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.75 -43.82 78.98 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.394 -0.367 . . . . 71.109999999999999 110.617 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HG2' HG12 ' A' ' 23' ' ' ILE . 36.0 mt-10 -63.48 -33.83 76.43 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.648 0.261 . . . . 55.219999999999999 110.509 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -63.18 -54.71 33.39 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.23 0.538 . . . . 74.5 110.146 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.499 HD13 HD13 ' A' ' 120' ' ' ILE . 22.4 mt -63.19 -34.06 76.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.772 -0.649 . . . . 73.239999999999995 110.132 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.516 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -61.58 -43.48 98.78 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.99 -0.55 . . . . 74.239999999999995 110.076 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 97.2 mt-30 -63.7 -48.34 77.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.932 0.396 . . . . 74.120000000000005 110.61 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.85 -43.29 99.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.868 -0.605 . . . . 74.0 111.12 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.91 5.72 33.11 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 112.995 0.739 . . . . 63.140000000000001 112.995 -169.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.6 t -52.87 -23.47 7.12 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.383 0.882 . . . . 71.129999999999995 113.383 -170.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.65 -18.77 60.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.84 0.352 . . . . 73.230000000000004 111.313 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.29 -6.65 4.29 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.964 -0.562 . . . . 63.149999999999999 111.191 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.563 HG23 HD11 ' A' ' 127' ' ' ILE . 39.6 t -128.97 138.42 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.048 0.452 . . . . 53.210000000000001 111.535 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -135.93 127.59 28.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.596 -0.729 . . . . 74.109999999999999 109.063 170.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.1 mt -113.42 114.52 47.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.943 0.401 . . . . 73.450000000000003 110.311 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.426 ' HB2' HG22 ' A' ' 46' ' ' VAL . 98.7 m-85 -93.71 167.32 11.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.747 -0.66 . . . . 73.530000000000001 109.868 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.548 ' HB2' HG22 ' A' ' 23' ' ' ILE . 31.9 tttp -145.15 140.97 28.35 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.348 -0.612 . . . . 65.040000000000006 109.348 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.0 tt -64.01 108.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.215 0.531 . . . . 71.310000000000002 110.811 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.763 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 41.2 t30 -89.62 -52.94 4.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.733 -0.667 . . . . 74.239999999999995 110.32 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.4 mm -74.14 112.6 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.36 -0.836 . . . . 72.129999999999995 110.687 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -59.95 -30.11 68.86 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.551 0.691 . . . . 73.230000000000004 110.381 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.74 -22.65 61.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.512 -0.767 . . . . 62.5 110.497 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -88.95 45.37 1.29 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.454 0.645 . . . . 72.340000000000003 110.721 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.438 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 3.0 pt20 -88.94 -7.53 55.88 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.963 -0.754 . . . . 72.319999999999993 108.963 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 21.5 t70 -48.75 -51.42 29.06 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.252 -0.885 . . . . 50.439999999999998 110.599 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -54.57 -33.9 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.946 -0.57 . . . . 62.399999999999999 111.445 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -66.3 -41.52 89.62 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.427 -0.583 . . . . 72.0 109.427 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.7 m -70.46 -29.72 66.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.615 -0.72 . . . . 55.240000000000002 110.716 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 83.1 mm-40 -70.6 -48.9 52.82 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.224 -0.443 . . . . 63.210000000000001 111.179 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -82.91 -24.81 32.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.353 -0.385 . . . . 73.420000000000002 111.442 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.82 64.67 0.85 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.962 -0.637 . . . . 51.329999999999998 112.593 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.523 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 90.8 t -102.5 102.2 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.615 -0.513 . . . . 71.319999999999993 109.615 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -113.8 8.67 17.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 74.319999999999993 110.429 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.92 151.98 44.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.495 -0.558 . . . . 50.409999999999997 109.495 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.659 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 68.0 mt -63.37 -57.51 19.91 Favored Pre-proline 0 CA--C 1.538 0.493 0 O-C-N 123.077 0.236 . . . . 43.200000000000003 111.114 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 96.6 Cg_endo -86.62 100.78 0.57 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.757 1.638 . . . . 53.219999999999999 111.614 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.4 m -137.36 121.59 18.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.775 0.322 . . . . 73.299999999999997 110.576 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.0 mp -110.17 110.9 33.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.801 -0.636 . . . . 74.319999999999993 109.941 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -88.31 126.04 34.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.625 -0.509 . . . . 73.230000000000004 109.625 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.466 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 33.5 mtp -106.67 140.76 39.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.963 -0.384 . . . . 74.140000000000001 109.963 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -147.27 155.37 41.99 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.993 -0.743 . . . . 75.25 108.993 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -129.07 105.49 8.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.674 -0.41 . . . . 72.230000000000004 110.611 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.567 ' HA ' ' HB3' ' A' ' 38' ' ' CYS . 8.9 t30 61.27 25.67 15.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.593 0.711 . . . . 64.329999999999998 110.566 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.24 -12.2 70.25 Favored Glycine 0 N--CA 1.454 -0.103 0 CA-C-N 115.831 -0.622 . . . . 62.539999999999999 112.071 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -75.08 139.21 42.65 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 110.02 -0.363 . . . . 65.209999999999994 110.02 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -58.62 145.96 37.83 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 124.405 1.066 . . . . 75.010000000000005 110.813 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 101' ' ' MET . 0.9 OUTLIER -162.34 168.92 21.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 72.319999999999993 109.52 -167.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.4 m -69.96 172.32 8.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.143 0.577 . . . . 62.520000000000003 111.927 -168.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.465 ' OE1' ' HG ' ' A' ' 100' ' ' LEU . 26.0 tt0 -142.03 118.48 10.9 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.995 -0.548 . . . . 72.019999999999996 109.613 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.85 107.19 17.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.409 -0.36 . . . . 74.329999999999998 110.064 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 65.0 mt -95.57 104.89 16.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.288 -0.415 . . . . 73.310000000000002 110.243 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.41 148.01 6.8 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.656 -0.578 . . . . 62.329999999999998 111.656 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.477 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -80.1 71.78 6.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.094 0.473 . . . . 52.450000000000003 109.958 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 119' ' ' ILE . 29.5 t70 -122.2 95.72 4.76 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.473 0.654 . . . . 72.209999999999994 109.812 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -62.42 -28.43 44.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.984 -1.007 . . . . 75.409999999999997 110.019 -174.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.9 m -62.34 -48.67 78.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.146 -0.479 . . . . 73.349999999999994 110.561 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -67.54 -37.65 83.03 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.725 0.298 . . . . 52.240000000000002 110.207 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 123' ' ' ILE . 75.2 mt -58.25 -56.33 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.217 -0.447 . . . . 64.510000000000005 110.904 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.499 HD13 HD13 ' A' ' 66' ' ' LEU . 7.9 tp -64.74 -34.46 70.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.773 0.321 . . . . 73.450000000000003 110.642 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.7 t -58.68 -45.02 90.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 54.310000000000002 110.125 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 48.8 mm-40 -70.86 -37.29 73.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.449 -0.341 . . . . 64.450000000000003 111.143 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 119' ' ' ILE . 68.6 mt -54.75 -55.9 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.124 0.488 . . . . 74.049999999999997 109.975 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -60.24 -41.91 94.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 74.349999999999994 110.642 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 33.3 t30 -58.26 -38.4 76.86 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.654 -0.703 . . . . 65.430000000000007 111.505 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -99.58 -11.99 20.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.227 0.454 . . . . 75.120000000000005 112.227 -174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.563 HD11 HG23 ' A' ' 74' ' ' VAL . 55.6 mt -92.82 -59.54 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 120.902 0.382 . . . . 70.340000000000003 111.075 173.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.592 -0.718 . . . . 51.329999999999998 110.276 -174.263 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.1 mmm . . . . . 0 C--O 1.232 0.157 0 N-CA-C 108.951 -0.759 . . . . 74.409999999999997 108.951 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mm -91.75 136.49 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.83 -1.077 . . . . 71.430000000000007 108.764 174.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.0 tp10 -112.8 144.07 42.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.725 0.298 . . . . 74.540000000000006 110.725 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -114.26 132.01 56.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.781 -0.451 . . . . 71.349999999999994 109.781 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 25.1 pt -140.27 178.27 3.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 120.867 0.365 . . . . 73.530000000000001 111.126 -177.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.59 172.95 25.48 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 115.89 -0.595 . . . . 52.030000000000001 111.869 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.68 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 10.5 t70 -52.24 -56.82 12.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.978 0.418 . . . . 72.349999999999994 111.504 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -64.21 -19.98 65.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.821 -0.627 . . . . 74.230000000000004 111.695 -174.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 37.5 mt-10 -78.08 -29.22 49.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.663 -0.244 . . . . 73.109999999999999 111.202 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -52.68 -49.39 65.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.731 0.301 . . . . 74.420000000000002 110.515 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.17 -55.85 26.59 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.969 -0.56 . . . . 60.439999999999998 109.916 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -53.27 -57.56 10.1 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.162 -0.927 . . . . 72.340000000000003 110.884 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 73.2 mmtt -64.07 -41.52 97.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.423 -1.262 . . . . 51.450000000000003 111.211 -169.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.56 -41.14 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.537 -0.301 . . . . 62.32 110.973 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 p -75.82 -19.28 59.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.784 0.326 . . . . 75.109999999999999 111.324 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -76.37 -14.57 60.08 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.434 -0.348 . . . . 75.140000000000001 110.717 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.756 ' SG ' HD11 ' A' ' 44' ' ' ILE . 66.6 m -70.93 101.16 2.1 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.879 0.371 . . . . 73.439999999999998 110.256 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -67.41 -47.93 68.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 72.230000000000004 112.371 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -153.82 133.27 12.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.092 0.472 . . . . 63.229999999999997 111.853 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 67.28 2.13 2.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.915 -1.039 . . . . 72.439999999999998 113.421 165.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.69 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 48.0 mm -80.63 97.16 3.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.367 0.603 . . . . 61.109999999999999 110.325 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 tt -80.77 113.13 18.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.33 -0.85 . . . . 72.319999999999993 108.944 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.756 HD11 ' SG ' ' A' ' 38' ' ' CYS . 47.3 mt -98.26 133.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.08 -0.509 . . . . 62.130000000000003 111.29 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.9 mp -114.56 124.88 52.99 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.57 -0.9 . . . . 63.240000000000002 108.57 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 92.4 t -106.37 110.02 30.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 110.205 -0.294 . . . . 73.120000000000005 110.205 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -99.71 131.92 45.38 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.236 0.541 . . . . 65.239999999999995 111.337 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 . . . . . 0 C--N 1.326 -0.454 0 N-CA-C 108.356 -0.979 . . . . 75.219999999999999 108.356 168.038 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.821 0.343 . . . . 74.510000000000005 111.174 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.628 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 17.5 m -75.41 -59.13 2.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.03 -0.532 . . . . 75.439999999999998 111.558 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.55 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.5 mm? -64.06 -29.25 70.4 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.751 0.649 . . . . 73.540000000000006 112.751 -169.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.45 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 41.0 mt-10 -57.01 -63.9 3.13 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 120.56 -0.456 . . . . 51.549999999999997 110.454 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.45 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 38.0 Cg_endo -65.44 -36.86 32.69 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 121.761 1.641 . . . . 73.120000000000005 112.132 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 58' ' ' SER . 37.9 mt-30 -58.8 -48.9 79.66 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.537 -0.465 . . . . 74.040000000000006 111.234 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.422 HD21 HD13 ' A' ' 119' ' ' ILE . 80.0 mt -66.89 -46.59 74.43 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.922 -0.127 . . . . 70.019999999999996 110.699 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 30.9 mt-10 -63.41 -30.56 71.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.493 -0.483 . . . . 65.239999999999995 110.685 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -64.71 -57.17 9.72 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.186 0.517 . . . . 70.439999999999998 109.935 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 120' ' ' ILE . 37.7 mt -58.97 -34.81 72.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.489 -0.778 . . . . 72.409999999999997 109.597 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.65 -49.47 75.02 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.52 -0.764 . . . . 74.439999999999998 110.258 176.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.1 mt-30 -60.06 -35.87 76.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.784 0.326 . . . . 72.030000000000001 111.03 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.86 -41.93 42.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.012 -0.54 . . . . 61.219999999999999 111.393 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -105.06 4.95 32.08 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 113.132 0.79 . . . . 75.430000000000007 113.132 -171.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.5 t -53.14 -19.96 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.901 0.704 . . . . 75.319999999999993 112.901 -170.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -64.52 -33.71 76.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.046 0.451 . . . . 72.120000000000005 110.486 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -129.43 8.76 5.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.78 -0.645 . . . . 75.340000000000003 111.983 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.562 HG23 HD11 ' A' ' 127' ' ' ILE . 43.0 t -133.64 142.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.206 -0.309 . . . . 74.140000000000001 111.653 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.4 tppt? -151.69 133.77 15.1 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.053 -0.721 . . . . 73.209999999999994 109.053 175.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 76' ' ' ILE . 4.2 mp -108.17 136.67 42.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.718 0.294 . . . . 74.219999999999999 110.423 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 74.4 m-85 -128.39 158.18 38.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 62.439999999999998 109.935 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.432 ' NZ ' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -152.33 172.74 16.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.653 -0.499 . . . . 73.319999999999993 109.653 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.42 142.56 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.765 -0.457 . . . . 53.539999999999999 109.765 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -103.56 -9.67 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 74.129999999999995 110.834 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.537 HG13 ' H ' ' A' ' 83' ' ' ASP . 8.5 tp -153.88 118.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.345 0.593 . . . . 71.040000000000006 110.77 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -58.81 -18.38 31.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.565 -0.743 . . . . 73.319999999999993 111.924 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.537 ' H ' HG13 ' A' ' 81' ' ' ILE . 4.4 m-20 -71.09 -7.9 49.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.544 -0.298 . . . . 74.150000000000006 111.57 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.68 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 3.9 m120 -125.63 78.53 1.74 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 74.430000000000007 110.441 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -114.3 10.37 17.15 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.483 -0.78 . . . . 72.239999999999995 110.088 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 2.8 m-20 -49.32 -45.98 46.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.506 -0.77 . . . . 72.519999999999996 109.991 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.0 p -55.02 -39.68 50.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.539 -0.755 . . . . 71.329999999999998 111.258 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.97 -33.25 74.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.31 0.576 . . . . 71.310000000000002 109.743 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.8 m -73.53 -32.31 64.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.21 -0.904 . . . . 74.409999999999997 110.142 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.8 mm-40 -70.86 -39.57 72.83 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 111.019 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -83.39 -23.73 32.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.539 0.209 . . . . 73.409999999999997 111.148 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.67 57.82 2.51 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.186 -0.53 . . . . 74.439999999999998 112.639 175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.02 124.0 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.504 0.192 . . . . 75.420000000000002 110.56 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.1 m -69.81 -62.52 1.35 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.142 -0.481 . . . . 64.510000000000005 111.879 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.81 161.87 17.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 63.229999999999997 110.253 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.495 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 47.5 mm -61.9 -54.62 49.1 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 123.224 0.328 . . . . 72.340000000000003 111.178 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.495 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 73.1 Cg_endo -74.74 80.6 2.32 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.809 1.673 . . . . 53.32 112.225 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.5 m -137.01 137.03 38.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 50.200000000000003 111.016 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 99' ' ' ILE . 2.7 mp -110.82 114.55 47.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.067 -0.515 . . . . 53.439999999999998 109.645 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 100' ' ' LEU . 7.2 mp -90.66 154.01 19.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.417 -0.586 . . . . 65.420000000000002 109.417 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.406 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 57.6 mtp -119.22 144.73 46.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.06 -0.348 . . . . 60.310000000000002 110.06 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.529 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.7 m-85 -149.13 149.76 31.57 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.171 -0.677 . . . . 54.219999999999999 109.171 176.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 ttpt -145.15 113.77 6.74 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.054 -0.658 . . . . 72.400000000000006 111.594 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 59.32 25.72 14.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.816 0.817 . . . . 62.219999999999999 110.663 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.24 -16.33 49.02 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.802 -0.635 . . . . 75.349999999999994 111.876 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 8.2 tmtm? -72.83 135.3 45.17 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.579 -0.897 . . . . 75.099999999999994 108.579 177.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 34.2 mmtp -65.87 145.84 55.46 Favored 'General case' 0 N--CA 1.46 0.038 0 CA-C-O 121.577 0.703 . . . . 73.200000000000003 111.37 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -145.38 167.81 22.01 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.66 -1.155 . . . . 73.409999999999997 108.979 -167.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.6 m -70.99 -177.65 1.7 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.539 0.685 . . . . 74.329999999999998 112.352 -169.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -141.32 121.0 13.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.684 -0.689 . . . . 72.129999999999995 109.77 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.7 t -95.89 116.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.208 -0.451 . . . . 74.239999999999995 110.0 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 112' ' ' ILE . 2.9 mp -91.62 115.63 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 75.310000000000002 109.974 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.46 169.68 41.91 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.12 -0.562 . . . . 74.099999999999994 112.575 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.55 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -83.33 76.02 9.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.447 0.299 . . . . 73.120000000000005 110.767 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.417 ' O ' HG13 ' A' ' 119' ' ' ILE . 23.6 t0 -115.1 95.89 5.42 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.483 0.659 . . . . 62.240000000000002 110.75 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -60.81 -28.19 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.091 -0.959 . . . . 73.340000000000003 110.089 -177.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.3 t -62.32 -53.81 49.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.943 0.401 . . . . 72.109999999999999 110.146 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -62.99 -41.43 99.57 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.308 -0.405 . . . . 71.049999999999997 110.23 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 123' ' ' ILE . 74.0 mt -55.45 -56.46 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.944 -0.571 . . . . 63.409999999999997 111.159 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.492 HD13 HD13 ' A' ' 66' ' ' LEU . 8.3 tp -65.58 -34.7 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.755 0.312 . . . . 72.430000000000007 110.651 -177.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 t -57.17 -52.18 66.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.125 -0.488 . . . . 33.520000000000003 110.35 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -72.04 -31.44 66.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.471 -0.331 . . . . 52.219999999999999 111.53 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 119' ' ' ILE . 49.5 mt -57.26 -55.71 19.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 120.62 -0.432 . . . . 54.340000000000003 110.006 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -68.53 -35.74 77.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.486 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -65.11 -34.95 79.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.861 -0.609 . . . . 64.430000000000007 111.335 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -101.16 -14.46 17.73 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.7 0.63 . . . . 61.240000000000002 112.7 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.562 HD11 HG23 ' A' ' 74' ' ' VAL . 58.9 mt -82.8 -48.5 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.549 -0.538 . . . . 73.030000000000001 109.549 171.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.316 -0.85 . . . . 62.409999999999997 109.455 178.313 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 95.1 mmm . . . . . 0 C--O 1.235 0.312 0 CA-C-O 120.441 0.162 . . . . 72.239999999999995 110.973 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.0 mm -62.74 116.89 3.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.394 -0.366 . . . . 75.150000000000006 110.183 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -86.37 151.27 23.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.299 -0.409 . . . . 74.239999999999995 110.12 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 14.1 pt20 -123.29 130.91 53.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 72.239999999999995 110.629 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.518 HG21 ' HG3' ' A' ' 34' ' ' LYS . 37.5 pt -139.38 174.1 9.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.056 -0.52 . . . . 61.130000000000003 110.309 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.22 160.35 19.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.205 -0.521 . . . . 52.299999999999997 112.131 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.726 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 13.8 t70 -53.68 -38.64 64.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.493 0.663 . . . . 71.040000000000006 110.72 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.2 m -76.52 1.63 16.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.315 -0.857 . . . . 71.120000000000005 111.788 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 35.5 mt-10 -113.45 -6.08 13.48 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.344 -0.222 . . . . 73.420000000000002 111.056 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.43 ' O ' HG23 ' A' ' 35' ' ' VAL . 89.2 t80 -50.21 -61.57 2.09 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.382 0.426 . . . . 72.310000000000002 111.501 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -56.98 -42.91 81.06 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 110.488 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -55.75 -57.06 13.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.671 -0.695 . . . . 70.200000000000003 110.461 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.5 mmtt -65.6 -37.08 85.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 64.239999999999995 111.061 -174.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.611 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 88.0 t -71.72 -29.18 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.716 0.293 . . . . 74.310000000000002 111.241 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.9 p -86.32 -21.0 27.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.891 0.377 . . . . 75.319999999999993 110.839 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -72.74 -9.5 58.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.046 -0.524 . . . . 63.25 111.266 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.823 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 26.0 p -82.32 77.71 9.07 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.38 -0.6 . . . . 63.350000000000001 109.38 175.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.52 -40.43 94.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.618 -0.719 . . . . 70.299999999999997 112.86 -173.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 42' ' ' ILE . 5.6 m-20 -135.9 121.23 19.18 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.098 0.407 . . . . 74.420000000000002 112.098 -173.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 55.85 2.22 0.07 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.776 1.398 . . . . 64.439999999999998 114.776 166.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.823 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 46.9 mm -80.86 109.49 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.328 0.513 . . . . 71.519999999999996 110.451 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.9 tt -82.52 115.9 21.72 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.171 -0.677 . . . . 73.25 109.171 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.52 HG21 HG22 ' A' ' 35' ' ' VAL . 32.7 mm -87.11 115.04 27.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.793 -0.64 . . . . 72.5 110.991 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.2 mp -102.47 148.1 25.93 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.5 -0.926 . . . . 71.200000000000003 108.5 171.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 60.5 t -133.35 106.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.617 -0.142 . . . . 73.420000000000002 110.617 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.52 143.13 26.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.987 0.423 . . . . 74.230000000000004 110.557 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.093 0.473 . . . . 61.43 111.562 176.373 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 120.551 0.215 . . . . 62.109999999999999 110.851 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.3 m -75.11 -35.17 61.76 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.212 0.53 . . . . 71.310000000000002 110.695 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.1 mm? -58.38 -42.85 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.716 -0.674 . . . . 71.319999999999993 111.629 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.449 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 37.6 mt-10 -54.89 -60.53 7.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.758 -0.163 . . . . 72.340000000000003 111.011 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.449 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 20.1 Cg_endo -61.7 -34.66 83.2 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.688 1.592 . . . . 73.340000000000003 112.211 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 58' ' ' SER . 14.9 mt-30 -63.9 -38.24 90.36 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.702 -0.399 . . . . 70.140000000000001 110.83 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 75.4 mt -68.62 -42.6 77.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.764 -0.458 . . . . 51.219999999999999 109.764 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -67.79 -26.79 66.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 54.030000000000001 110.71 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 62' ' ' GLN . 33.4 ttpt -65.71 -56.78 10.24 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.725 0.774 . . . . 72.519999999999996 109.957 175.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.499 HD22 HD13 ' A' ' 120' ' ' ILE . 37.6 mt -59.13 -32.91 70.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.936 -1.029 . . . . 75.310000000000002 109.534 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.527 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.5 -51.27 66.28 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.692 -0.686 . . . . 71.230000000000004 109.562 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -55.89 -48.6 75.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.651 -0.704 . . . . 70.239999999999995 111.781 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -73.85 -39.68 63.83 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.44 -0.504 . . . . 73.329999999999998 111.169 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -101.04 4.93 42.77 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 113.021 0.748 . . . . 74.450000000000003 113.021 -171.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.9 t -53.25 -19.18 2.91 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.519 0.563 . . . . 74.200000000000003 112.519 -171.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -69.23 -34.68 75.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.656 0.265 . . . . 74.219999999999999 110.717 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.26 3.61 8.51 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.246 -0.434 . . . . 72.400000000000006 111.624 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.6 t -130.94 136.77 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.794 0.33 . . . . 74.430000000000007 111.368 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -138.36 131.28 29.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 70.319999999999993 109.624 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.405 HG12 ' HB2' ' A' ' 45' ' ' LEU . 50.0 mt -112.01 135.55 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.572 -0.529 . . . . 74.120000000000005 109.572 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 95.7 m-85 -129.26 147.93 51.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 73.319999999999993 110.469 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -133.99 145.14 49.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.061 -0.518 . . . . 71.5 109.849 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.436 HG21 ' O ' ' A' ' 84' ' ' ASN . 52.0 mt -70.21 112.52 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.958 -0.756 . . . . 74.150000000000006 108.958 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 66.9 t30 -75.31 -12.85 60.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.984 -0.553 . . . . 62.340000000000003 112.371 -170.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 83' ' ' ASP . 56.9 mt -130.89 119.97 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.683 0.277 . . . . 74.140000000000001 110.665 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -18.78 65.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.096 -0.502 . . . . 61.020000000000003 111.796 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.548 ' H ' HG22 ' A' ' 81' ' ' ILE . 24.8 t70 -71.37 -18.64 62.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.41 0.624 . . . . 60.450000000000003 109.833 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.726 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 16.6 m120 -103.9 121.66 43.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.223 -0.898 . . . . 75.450000000000003 108.758 175.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -163.27 15.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.959 0.725 . . . . 63.329999999999998 112.959 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.548 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 1.8 m-20 -54.96 -42.46 72.39 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.061 -0.348 . . . . 64.409999999999997 110.061 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.402 HG23 ' OD2' ' A' ' 28' ' ' ASP . 77.4 t -53.15 -38.96 31.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.822 -0.627 . . . . 54.25 110.532 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.46 77.52 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.347 0.594 . . . . 72.450000000000003 110.003 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.6 m -67.32 -37.49 83.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.022 -0.99 . . . . 73.420000000000002 110.564 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 93.5 mt-30 -69.97 -53.47 17.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.827 -0.624 . . . . 74.140000000000001 111.061 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.42 -13.0 55.79 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.023 -0.535 . . . . 74.430000000000007 111.696 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.53 78.97 0.79 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.88 -0.676 . . . . 64.040000000000006 112.849 171.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.9 t -75.54 93.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.316 0.579 . . . . 73.120000000000005 109.797 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.7 m -71.76 -59.4 2.77 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.363 -0.835 . . . . 73.120000000000005 110.925 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.5 152.85 21.88 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.5 -0.556 . . . . 65.430000000000007 109.5 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.691 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 43.0 mm -55.35 -54.27 52.79 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 123.18 0.3 . . . . 52.439999999999998 111.087 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.691 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 19.8 Cg_endo -89.32 99.74 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.256 1.971 . . . . 73.25 111.318 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.3 m -118.62 146.49 44.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.136 -0.484 . . . . 74.329999999999998 110.567 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 3.5 mp -123.16 116.17 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.599 -0.728 . . . . 55.32 109.913 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 64.6 mt -90.24 143.05 27.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.301 -0.629 . . . . 73.439999999999998 109.301 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.407 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 48.0 mtp -117.48 136.28 53.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.985 -0.376 . . . . 72.439999999999998 109.985 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 95.3 m-85 -148.96 160.39 43.34 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.451 -0.944 . . . . 72.209999999999994 108.451 174.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -153.82 111.25 3.47 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.846 -0.742 . . . . 73.409999999999997 112.315 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.465 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 56.9 t30 55.57 37.59 29.08 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.721 0.772 . . . . 65.319999999999993 110.978 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.76 -16.35 50.93 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.411 -0.813 . . . . 64.129999999999995 112.575 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -77.72 138.84 39.26 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.669 0.271 . . . . 61.25 110.633 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -62.41 139.92 58.56 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.339 -0.846 . . . . 74.129999999999995 110.619 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -144.14 167.67 21.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.975 -1.12 . . . . 74.030000000000001 107.975 -174.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.1 m -70.75 -179.72 2.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.612 0.72 . . . . 74.439999999999998 112.759 -165.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.445 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.1 tt0 -142.26 118.71 10.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.718 -0.674 . . . . 64.5 110.013 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 49.7 t -100.02 107.72 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.459 . . . . 65.510000000000005 110.272 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -94.31 104.46 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.601 -0.518 . . . . 73.230000000000004 109.601 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.76 177.99 23.82 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.714 -0.555 . . . . 52.140000000000001 111.714 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.22 80.85 7.57 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.992 0.425 . . . . 70.230000000000004 110.936 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.425 ' O ' HG13 ' A' ' 119' ' ' ILE . 21.6 m-20 -117.51 73.7 0.89 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.031 -0.531 . . . . 63.350000000000001 110.146 175.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.407 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.39 -33.03 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.551 -0.537 . . . . 51.329999999999998 109.551 -177.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.5 t -59.0 -46.21 88.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.879 -0.6 . . . . 74.219999999999999 110.192 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -70.06 -36.37 74.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.095 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 123' ' ' ILE . 81.3 mt -58.78 -56.25 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 72.040000000000006 110.591 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.499 HD13 HD22 ' A' ' 66' ' ' LEU . 6.9 tp -64.68 -38.06 81.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.638 -0.256 . . . . 41.140000000000001 110.401 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.8 t -57.04 -48.5 78.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.248 -0.433 . . . . 62.200000000000003 109.951 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 65.6 mm-40 -69.6 -36.76 76.5 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.458 -0.337 . . . . 72.030000000000001 111.507 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 119' ' ' ILE . 56.3 mt -57.12 -56.19 16.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.241 0.543 . . . . 71.120000000000005 109.767 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -64.16 -35.81 82.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.652 -0.704 . . . . 70.329999999999998 110.468 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 23.6 t30 -65.28 -39.12 92.18 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.935 -0.575 . . . . 71.319999999999993 111.468 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -103.28 -5.2 23.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.571 0.582 . . . . 71.120000000000005 112.571 -172.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.445 HG22 ' ND2' ' A' ' 128' ' ' ASN . 55.8 mt -91.94 -54.05 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.895 -0.322 . . . . 71.219999999999999 110.698 170.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.445 ' ND2' HG22 ' A' ' 127' ' ' ILE . 13.2 m120 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.477 -0.773 . . . . 64.540000000000006 110.71 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 91.3 mmm . . . . . 0 C--O 1.234 0.248 0 N-CA-C 110.164 -0.31 . . . . 73.109999999999999 110.164 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.487 HG21 ' HE3' ' A' ' 78' ' ' LYS . 28.1 mm -58.28 107.48 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.029 -0.532 . . . . 71.319999999999993 110.036 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.552 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 9.4 tp10 -75.0 141.1 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 60.140000000000001 110.173 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.464 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . 78.1 mt-30 -109.09 122.51 47.42 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.316 -0.253 . . . . 65.239999999999995 110.316 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 47.3 pt -145.06 179.96 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.901 0.381 . . . . 70.019999999999996 111.468 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -125.82 -165.83 12.14 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.632 -0.713 . . . . 63.439999999999998 111.424 175.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' H ' ' HB3' ' A' ' 84' ' ' ASN . 27.2 t70 -69.37 -45.91 68.21 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.957 0.378 . . . . 54.109999999999999 110.966 -177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.0 t -59.55 -29.74 68.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.92 -0.582 . . . . 75.420000000000002 109.906 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 12.0 mm-40 -85.98 -31.89 21.82 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.006 -0.543 . . . . 71.209999999999994 110.725 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.435 ' HA ' HD12 ' A' ' 26' ' ' ILE . 85.1 t80 -47.92 -61.62 1.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.359 0.503 . . . . 74.310000000000002 112.359 -171.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.84 -43.5 98.19 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.604 0.24 . . . . 64.5 110.412 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -57.65 -53.98 52.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.181 -0.463 . . . . 75.319999999999993 110.418 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HG3' HG21 ' A' ' 26' ' ' ILE . 75.7 mmtt -60.71 -41.52 95.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.752 -0.658 . . . . 63.109999999999999 111.063 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 31' ' ' PHE . 98.3 t -67.74 -53.07 33.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 61.310000000000002 110.687 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.7 p -65.46 -18.68 65.5 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.497 -0.32 . . . . 63.43 111.761 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -77.02 3.35 12.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.632 -0.258 . . . . 63.530000000000001 111.259 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.53 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 25.0 p -62.46 113.39 2.91 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.928 -0.397 . . . . 75.319999999999993 109.928 175.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -52.84 -64.16 0.91 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.348 -0.387 . . . . 74.519999999999996 111.357 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -156.36 121.63 4.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 75.209999999999994 110.614 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 48.2 m-80 49.96 24.66 1.4 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.945 0.72 . . . . 73.209999999999994 112.945 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.4 mm -73.61 127.59 35.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 110.323 -0.251 . . . . 54.399999999999999 110.323 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 28.0 tp -85.79 107.78 17.79 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.722 0.772 . . . . 71.519999999999996 110.444 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.442 HG23 ' CD1' ' A' ' 77' ' ' TYR . 72.7 mt -108.44 113.47 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.112 -0.949 . . . . 62.109999999999999 110.205 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.8 mp -97.06 152.63 18.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.192 -0.669 . . . . 70.120000000000005 109.192 177.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 77' ' ' TYR . 58.5 t -138.08 118.53 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 110.034 -0.358 . . . . 72.109999999999999 110.034 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -95.35 154.59 17.12 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.082 0.468 . . . . 74.340000000000003 110.618 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 115.716 -0.674 . . . . 72.230000000000004 110.354 173.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 N--CA 1.464 0.241 0 N-CA-C 111.307 0.114 . . . . 65.439999999999998 111.307 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 22.7 t -75.96 -46.44 29.69 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.8 0.81 . . . . 64.140000000000001 110.983 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.69 -34.02 75.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.155 -0.93 . . . . 74.019999999999996 112.402 -171.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 38.7 mt-10 -60.27 -62.46 5.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.406 -0.518 . . . . 71.349999999999994 110.227 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 19.6 Cg_endo -58.75 -38.87 86.71 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.727 1.618 . . . . 55.539999999999999 112.258 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.1 mt-30 -57.44 -55.65 32.04 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.834 -0.346 . . . . 70.109999999999999 111.179 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.475 HD11 HD13 ' A' ' 119' ' ' ILE . 30.2 mt -71.98 -25.29 61.79 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.723 -0.217 . . . . 64.530000000000001 111.313 -176.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.449 ' OE1' HG12 ' A' ' 23' ' ' ILE . 4.5 mm-40 -62.26 -44.98 95.31 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.216 0.531 . . . . 71.409999999999997 109.837 172.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -62.36 -50.64 70.79 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.531 -0.759 . . . . 53.520000000000003 109.909 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.2 mt -62.9 -32.02 73.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.63 . . . . 72.239999999999995 110.776 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.82 -53.75 45.84 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.726 -0.472 . . . . 64.420000000000002 109.726 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -58.94 -35.64 73.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.959 -0.564 . . . . 74.140000000000001 110.84 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -65.72 -49.29 69.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 63.310000000000002 110.825 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.91 5.18 32.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.625 -0.716 . . . . 72.209999999999994 112.716 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 8.9 t -53.18 -19.88 3.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.787 0.662 . . . . 62.210000000000001 112.787 -171.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.05 -29.86 65.72 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.291 -0.256 . . . . 72.129999999999995 111.424 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -131.13 -10.63 3.74 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.466 -0.334 . . . . 73.5 111.336 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 71' ' ' THR . 40.9 t -116.96 134.65 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.823 0.344 . . . . 65.129999999999995 111.835 -172.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HE2' ' HB2' ' A' ' 24' ' ' GLU . 21.1 tptm -143.59 127.12 16.92 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.128 -0.487 . . . . 63.240000000000002 109.802 173.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.2 mp -99.69 141.05 17.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.953 -0.388 . . . . 75.209999999999994 109.953 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.487 ' HB2' HG22 ' A' ' 46' ' ' VAL . 62.9 m-85 -123.67 150.31 44.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 73.420000000000002 109.444 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HE3' HG21 ' A' ' 23' ' ' ILE . 39.9 ttmt -129.2 122.14 29.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.672 -0.492 . . . . 74.519999999999996 109.672 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.403 HD13 HG13 ' A' ' 26' ' ' ILE . 42.5 mm -78.91 73.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.772 -0.825 . . . . 53.109999999999999 108.772 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 25' ' ' GLN . 3.4 p-10 -72.46 -30.4 64.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.525 -0.761 . . . . 55.329999999999998 110.367 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.4 mt -62.68 100.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.989 -0.551 . . . . 74.019999999999996 109.929 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.493 ' HA ' ' HG3' ' A' ' 85' ' ' GLN . 10.5 pt-20 -56.51 -27.94 58.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.744 -0.662 . . . . 74.430000000000007 111.191 -177.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -71.58 -24.52 61.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.758 -0.656 . . . . 74.450000000000003 110.006 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.429 ' HB3' ' H ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -104.08 15.76 27.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.307 -0.86 . . . . 75.219999999999999 111.315 -175.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.493 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 92.9 mt-30 -71.32 1.42 6.22 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.636 0.255 . . . . 72.019999999999996 111.085 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -46.53 -37.96 8.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.977 -0.556 . . . . 71.230000000000004 110.361 172.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.7 t -52.7 -43.28 43.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.562 -0.744 . . . . 74.219999999999999 110.502 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.8 -53.35 58.47 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.642 -0.708 . . . . 74.349999999999994 110.273 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.4 m -59.13 -34.81 72.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.62 . . . . 71.150000000000006 110.985 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.06 -56.66 13.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.218 -0.446 . . . . 60.149999999999999 111.163 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -72.3 -15.68 61.89 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.58 0.228 . . . . 55.420000000000002 111.148 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.9 40.01 5.67 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.234 -0.508 . . . . 73.019999999999996 112.724 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.64 93.9 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.111 0.482 . . . . 71.420000000000002 110.562 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.9 t -90.65 -37.14 13.96 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.637 -0.71 . . . . 64.209999999999994 109.536 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.21 136.28 33.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.035 -0.728 . . . . 73.439999999999998 109.035 174.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.637 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 50.8 mm -58.87 -58.84 16.38 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 111.411 0.152 . . . . 63.229999999999997 111.411 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.637 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 83.3 Cg_endo -80.77 72.3 6.6 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.797 1.665 . . . . 73.400000000000006 112.262 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.1 m -102.96 133.07 48.69 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.963 0.411 . . . . 62.43 110.796 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.63 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -116.52 121.0 66.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.537 -0.756 . . . . 73.230000000000004 109.846 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 110' ' ' GLN . 88.7 mt -98.14 123.48 42.22 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.775 -0.454 . . . . 73.329999999999998 109.775 175.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 59.9 mtp -96.06 139.95 31.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.375 -0.602 . . . . 55.409999999999997 109.375 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -138.6 147.69 43.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.904 -0.776 . . . . 72.209999999999994 108.904 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 126' ' ' ASN . 29.0 ttpp -147.47 121.36 9.34 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.306 -0.558 . . . . 70.329999999999998 111.225 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 6.0 t30 61.17 25.69 15.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.542 -0.754 . . . . 62.140000000000001 110.24 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.46 6.87 86.95 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.727 -0.669 . . . . 33.450000000000003 112.127 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -101.38 150.34 23.12 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 120.701 0.286 . . . . 61.039999999999999 110.61 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -56.49 128.47 36.28 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.076 -0.966 . . . . 73.209999999999994 111.489 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.92 168.54 18.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.869 -1.514 . . . . 74.439999999999998 106.932 -177.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.7 m -69.53 157.16 37.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.795 0.807 . . . . 71.230000000000004 112.72 -158.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.485 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.8 tt0 -114.4 118.41 33.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.136 -0.938 . . . . 70.200000000000003 109.851 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.63 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 44.6 t -96.95 107.17 19.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.185 -0.461 . . . . 72.219999999999999 110.097 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.6 mp -92.35 105.12 16.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.366 -0.605 . . . . 73.25 109.366 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 105.06 158.55 23.27 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.575 -0.61 . . . . 63.32 111.575 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.45 83.54 3.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.79 0.328 . . . . 61.229999999999997 110.679 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 33.8 t70 -121.51 90.12 3.25 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.703 0.763 . . . . 71.129999999999995 110.262 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -59.02 -30.63 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 114.795 -1.093 . . . . 43.399999999999999 109.425 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.8 t -56.32 -53.36 58.17 Favored 'General case' 0 CA--C 1.526 0.045 0 CA-C-N 116.13 -0.486 . . . . 64.329999999999998 110.159 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -60.59 -48.03 83.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.144 -0.48 . . . . 72.239999999999995 109.941 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 123' ' ' ILE . 65.5 mt -56.69 -56.31 14.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.719 -0.673 . . . . 75.129999999999995 111.128 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 116' ' ' ILE . 13.7 tt -64.33 -35.7 74.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.767 0.317 . . . . 71.420000000000002 110.247 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.4 t -55.82 -52.32 64.42 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.797 -0.638 . . . . 53.140000000000001 110.278 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 24.7 mm-40 -74.54 -30.0 61.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.911 -0.586 . . . . 73.439999999999998 111.301 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.3 mt -58.42 -56.03 18.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.961 0.41 . . . . 74.409999999999997 110.064 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -71.33 -29.26 64.8 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.94 -0.304 . . . . 75.420000000000002 110.223 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.478 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 19.7 t30 -61.11 -44.38 97.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.103 -0.499 . . . . 73.340000000000003 110.971 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.55 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 32.1 m-80 -84.93 -27.1 26.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 62.210000000000001 112.137 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.4 mt -73.71 -48.7 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 120.915 0.388 . . . . 75.420000000000002 110.479 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.808 -0.615 . . . . 41.43 110.125 -179.783 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 92.0 mmm . . . . . 0 C--O 1.232 0.179 0 CA-C-O 121.103 0.477 . . . . 50.299999999999997 110.428 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.499 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 26.7 mm -119.34 104.69 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.756 -0.657 . . . . 72.439999999999998 109.826 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.34 160.49 18.78 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.336 -0.393 . . . . 61.340000000000003 111.054 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.404 ' HA ' ' H ' ' A' ' 78' ' ' LYS . 26.6 tt0 -137.72 133.81 34.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.01 -0.367 . . . . 71.129999999999995 110.01 172.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.543 HG21 ' HG3' ' A' ' 34' ' ' LYS . 32.0 pt -138.86 179.95 2.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 122.53 0.332 . . . . 64.329999999999998 111.211 -174.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.06 176.85 22.96 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.055 -0.521 . . . . 71.010000000000005 112.965 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 12.4 t70 -51.86 -56.62 12.91 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.366 0.666 . . . . 41.439999999999998 111.737 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -62.81 -27.57 69.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 74.129999999999995 111.481 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -79.55 -23.36 42.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.806 0.298 . . . . 72.549999999999997 111.806 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 35' ' ' VAL . 92.4 t80 -47.68 -61.7 1.81 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.278 0.361 . . . . 71.0 111.85 -174.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.573 ' O ' HG22 ' A' ' 36' ' ' THR . 10.0 m-20 -54.63 -53.59 52.79 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.246 0.546 . . . . 54.149999999999999 110.504 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -55.92 -57.41 12.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.076 -0.965 . . . . 72.439999999999998 111.378 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.2 mmtt -58.51 -35.39 72.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 74.319999999999993 111.055 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 31' ' ' PHE . 40.6 t -64.98 -56.58 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.298 -0.41 . . . . 52.310000000000002 111.336 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 32' ' ' ASP . 7.9 t -86.08 -0.29 55.25 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.145 0.424 . . . . 63.229999999999997 112.145 -175.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.2 t -71.14 -5.93 35.46 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.892 0.377 . . . . 72.150000000000006 111.131 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.867 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 8.5 p -66.14 158.08 29.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.946 -0.57 . . . . 72.519999999999996 111.747 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.58 -79.65 0.11 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.903 -0.59 . . . . 63.310000000000002 110.61 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -161.82 148.67 14.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.216 -0.447 . . . . 73.430000000000007 109.981 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 63.46 2.28 1.16 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.115 0.566 . . . . 71.319999999999993 111.34 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 42.6 mm -74.93 108.32 6.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 120.88 0.372 . . . . 61.240000000000002 110.276 -178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.498 ' CD2' ' HA ' ' A' ' 123' ' ' ILE . 30.9 tp -80.28 109.05 14.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.627 -0.715 . . . . 73.040000000000006 110.024 174.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 36.9 mt -102.7 116.69 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.501 -0.772 . . . . 64.310000000000002 110.376 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.55 ' HB2' HG13 ' A' ' 76' ' ' ILE . 3.4 mp -99.99 153.04 19.51 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.623 -0.881 . . . . 63.210000000000001 108.623 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 77' ' ' TYR . 60.8 t -135.36 104.35 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.311 -0.255 . . . . 72.430000000000007 110.311 175.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.87 96.78 10.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.901 -1.148 . . . . 72.540000000000006 107.901 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 112.375 0.509 . . . . 73.299999999999997 112.375 -171.222 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 120.766 0.317 . . . . 73.239999999999995 110.716 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 46.8 t -75.6 -49.36 18.75 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.752 0.787 . . . . 73.409999999999997 110.494 172.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.89 -43.13 90.92 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.198 -0.91 . . . . 73.010000000000005 112.3 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 40.6 mt-10 -52.82 -60.39 6.71 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 117.807 0.276 . . . . 72.120000000000005 111.074 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 29.9 Cg_endo -64.14 -35.11 54.65 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.616 1.544 . . . . 75.310000000000002 112.254 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 58' ' ' SER . 26.7 mt-30 -61.26 -42.44 98.64 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.418 -0.513 . . . . 74.230000000000004 111.1 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.43 -42.99 67.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 73.310000000000002 110.321 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 28.1 mt-10 -63.69 -36.45 83.9 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.855 -0.338 . . . . 74.099999999999994 110.415 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -57.05 -57.16 13.76 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.464 0.65 . . . . 75.099999999999994 109.819 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 62' ' ' GLN . 36.6 mt -61.52 -36.55 80.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.05 -0.977 . . . . 63.240000000000002 109.909 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.56 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.05 -27.97 67.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 33.530000000000001 110.93 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.1 mt-30 -77.01 -48.34 18.2 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.851 0.358 . . . . 65.200000000000003 110.955 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -72.63 -37.75 67.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.183 0.516 . . . . 64.239999999999995 110.668 -176.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -97.61 5.85 48.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.765 -0.652 . . . . 72.140000000000001 111.891 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -52.74 -19.94 2.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.778 0.659 . . . . 72.519999999999996 112.778 -172.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.64 -31.2 70.18 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.274 -0.266 . . . . 74.120000000000005 110.794 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.431 ' HA ' HD13 ' A' ' 42' ' ' ILE . 91.6 m-20 -131.75 1.61 4.02 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.048 -0.524 . . . . 64.530000000000001 112.098 -174.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.526 HG23 HD11 ' A' ' 127' ' ' ILE . 72.5 t -131.76 134.03 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 122.257 -0.277 . . . . 74.129999999999995 111.527 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 26.8 mmtp -147.08 136.62 22.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 110.095 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.55 HG13 ' HB2' ' A' ' 45' ' ' LEU . 4.1 mp -115.83 146.65 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.664 -0.244 . . . . 73.450000000000003 110.636 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.502 ' HB2' HG22 ' A' ' 46' ' ' VAL . 40.4 m-85 -124.53 164.55 19.55 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.038 0.535 . . . . 75.140000000000001 110.516 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 23' ' ' ILE . 33.6 mtmm -143.61 178.82 7.52 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.816 0.446 . . . . 73.340000000000003 110.091 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.4 tt -151.76 158.6 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.839 -0.43 . . . . 72.230000000000004 109.839 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -142.57 -3.26 1.03 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.528 0.204 . . . . 73.439999999999998 111.511 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 40.4 mt -84.52 110.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 74.519999999999996 110.668 -174.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -49.48 -55.4 13.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.66 -0.7 . . . . 72.209999999999994 111.851 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.62 6.72 5.44 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.358 -0.383 . . . . 70.010000000000005 111.876 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.596 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.9 OUTLIER -107.3 22.13 16.46 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.057 0.456 . . . . 74.319999999999993 109.902 176.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -81.12 -10.85 59.59 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.003 -0.544 . . . . 64.439999999999998 111.498 -176.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -45.27 -56.96 4.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.709 0.29 . . . . 71.200000000000003 111.219 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.445 ' O ' ' HD1' ' A' ' 91' ' ' TYR . 7.5 p -53.1 -34.19 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.862 -0.608 . . . . 70.129999999999995 111.036 -178.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -67.75 -50.67 55.98 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.085 0.469 . . . . 70.109999999999999 109.967 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.2 m -60.42 -29.62 69.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.598 -0.728 . . . . 65.150000000000006 110.529 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.67 -55.89 8.76 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.867 -0.606 . . . . 52.43 111.32 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.445 ' HD1' ' O ' ' A' ' 87' ' ' VAL . 85.6 m-85 -77.22 -9.84 59.04 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.707 0.262 . . . . 72.099999999999994 111.707 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.29 53.61 1.14 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.801 -0.714 . . . . 72.409999999999997 113.391 170.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.496 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 80.6 t -93.92 111.84 25.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.993 -0.373 . . . . 52.149999999999999 109.993 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 m -121.97 25.17 9.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.362 0.601 . . . . 73.109999999999999 110.065 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.38 154.69 36.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.376 -0.829 . . . . 51.240000000000002 109.661 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.601 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 46.4 mm -67.71 -56.05 12.82 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.758 -0.46 . . . . 51.329999999999998 109.758 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.601 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 90.0 Cg_endo -82.09 67.67 8.08 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.007 1.804 . . . . 62.210000000000001 111.813 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.426 HG21 HG22 ' A' ' 93' ' ' VAL . 67.5 m -105.43 121.36 43.75 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.876 -0.602 . . . . 55.219999999999999 110.456 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.535 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.3 mp -110.27 112.68 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.558 -0.746 . . . . 51.32 110.102 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.449 HD23 ' HG3' ' A' ' 110' ' ' GLN . 36.9 mt -90.23 131.22 36.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.441 -0.577 . . . . 64.019999999999996 109.441 173.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.517 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 38.7 mtp -110.23 138.99 45.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.493 -0.558 . . . . 72.349999999999994 109.493 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -144.03 144.54 31.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.531 -0.544 . . . . 72.129999999999995 109.531 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HD3' ' HB3' ' A' ' 126' ' ' ASN . 39.6 ttpt -118.8 104.93 11.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.85 -0.34 . . . . 62.049999999999997 110.578 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.867 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 60.6 t30 59.25 30.55 20.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.594 0.711 . . . . 64.219999999999999 110.353 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.8 -16.4 60.36 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.887 -0.597 . . . . 73.420000000000002 112.083 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -73.34 142.72 47.07 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 110.133 -0.321 . . . . 63.219999999999999 110.133 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -63.68 145.77 55.09 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.529 -0.76 . . . . 71.150000000000006 111.181 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.517 ' HB3' ' O ' ' A' ' 101' ' ' MET . 1.3 tp -162.14 169.88 20.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.374 -0.83 . . . . 73.400000000000006 110.563 -164.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.6 m -69.63 167.93 15.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.039 0.935 . . . . 74.510000000000005 113.044 -163.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.449 ' HG3' HD23 ' A' ' 100' ' ' LEU . 57.2 tt0 -126.61 118.66 25.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.674 -1.148 . . . . 71.430000000000007 109.418 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 23.0 t -96.03 107.23 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.565 -0.531 . . . . 72.530000000000001 109.565 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.8 mp -96.68 101.69 12.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.592 -0.521 . . . . 64.329999999999998 109.592 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.1 167.29 18.82 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.613 -0.595 . . . . 73.140000000000001 111.613 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.67 86.3 7.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.799 -0.236 . . . . 60.25 111.102 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -124.79 86.65 2.59 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 121.82 0.819 . . . . 63.43 109.717 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -62.63 -27.64 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 114.887 -1.052 . . . . 54.0 110.048 -174.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -63.42 -47.83 80.31 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.34 -0.391 . . . . 62.119999999999997 110.145 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.538 ' HE2' ' HG2' ' A' ' 122' ' ' GLU . 10.6 tptm -69.38 -39.64 77.91 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.152 -0.314 . . . . 75.319999999999993 110.152 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.3 mt -55.39 -56.23 12.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.07 0.462 . . . . 71.549999999999997 110.624 177.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 116' ' ' ILE . 13.5 tt -65.98 -33.81 66.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 116.027 -0.533 . . . . 75.400000000000006 110.569 -178.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.1 t -54.95 -51.85 64.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.03 -0.532 . . . . 44.310000000000002 109.673 176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.538 ' HG2' ' HE2' ' A' ' 118' ' ' LYS . 60.2 mm-40 -63.25 -40.11 96.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.034 -0.53 . . . . 74.219999999999999 110.494 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.498 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 63.9 mt -52.04 -56.43 6.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.719 0.295 . . . . 72.530000000000001 110.889 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 128' ' ' ASN . 10.2 p30 -71.88 -25.39 61.92 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 120.536 -0.466 . . . . 63.299999999999997 110.709 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 34.3 t30 -63.21 -33.93 76.55 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.06 0.457 . . . . 72.310000000000002 110.85 177.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.474 ' HB3' ' HD3' ' A' ' 103' ' ' LYS . 38.6 m-80 -94.55 -37.05 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.01 -0.541 . . . . 75.129999999999995 111.874 -176.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.526 HD11 HG23 ' A' ' 74' ' ' VAL . 66.7 mt -72.14 -48.98 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 64.140000000000001 110.862 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.513 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.533 -0.746 . . . . 63.130000000000003 110.27 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 93.7 mmm . . . . . 0 C--O 1.234 0.255 0 N-CA-C 109.451 -0.574 . . . . 71.319999999999993 109.451 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -73.71 115.79 15.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.678 -0.86 . . . . 73.239999999999995 108.678 171.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -74.38 146.47 42.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.99 0.424 . . . . 74.120000000000005 111.516 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.54 118.86 37.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.602 -0.727 . . . . 74.239999999999995 109.348 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.464 HG21 ' HG3' ' A' ' 34' ' ' LYS . 46.9 pt -144.58 175.12 3.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 120.826 0.346 . . . . 73.019999999999996 110.924 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.12 175.17 15.59 Favored Glycine 0 CA--C 1.521 0.406 0 CA-C-N 115.912 -0.585 . . . . 74.340000000000003 112.418 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.49 ' OD2' HG23 ' A' ' 87' ' ' VAL . 13.5 t70 -51.78 -45.86 63.95 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.466 0.706 . . . . 75.340000000000003 111.623 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 t -66.27 -28.57 68.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.150000000000006 110.806 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 43.0 mt-10 -80.97 -13.33 58.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 61.100000000000001 111.352 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.575 ' O ' HG23 ' A' ' 35' ' ' VAL . 87.2 t80 -51.43 -61.88 1.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.13 0.269 . . . . 73.310000000000002 111.14 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.18 -48.2 81.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.17 0.51 . . . . 70.209999999999994 110.76 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -60.81 -53.32 58.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.522 -0.763 . . . . 70.319999999999993 111.487 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HG3' HG21 ' A' ' 26' ' ' ILE . 35.0 mmtp -67.28 -31.82 72.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.102 -0.499 . . . . 74.219999999999999 111.293 -175.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 44' ' ' ILE . 74.5 t -66.3 -45.49 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.899 0.38 . . . . 65.010000000000005 109.979 174.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.5 p -75.11 -16.15 60.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.314 -0.403 . . . . 73.409999999999997 111.22 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -75.6 0.16 18.43 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.286 -0.415 . . . . 75.349999999999994 111.205 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.754 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.2 p -56.68 122.1 11.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.698 -0.228 . . . . 72.120000000000005 110.633 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -56.07 -76.17 0.03 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.332 -0.394 . . . . 71.150000000000006 110.889 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -161.98 145.31 12.0 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.358 -0.608 . . . . 72.329999999999998 109.358 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 45.0 27.47 0.29 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.001 0.813 . . . . 71.129999999999995 111.727 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 47.0 mm -87.84 123.79 40.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.984 -0.553 . . . . 73.420000000000002 110.221 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -89.97 110.34 21.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.575 -0.738 . . . . 71.349999999999994 109.101 178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.602 HG21 HG22 ' A' ' 35' ' ' VAL . 22.8 mm -89.07 109.11 19.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.59 -0.732 . . . . 54.130000000000003 110.384 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.521 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.5 mp -99.04 146.97 25.5 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.541 -0.911 . . . . 71.209999999999994 108.541 172.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 70.1 t -139.13 113.15 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.348 -0.242 . . . . 75.540000000000006 110.348 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' OD2' ' HB3' ' A' ' 78' ' ' LYS . 1.6 p30 -91.69 137.55 32.27 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.716 -0.475 . . . . 52.219999999999999 109.716 176.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.62 ' HE2' ' HG ' ' A' ' 100' ' ' LEU . 79.5 m-85 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.352 -0.385 . . . . 74.510000000000005 111.991 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 57' ' ' ARG . 43.3 ttt-85 . . . . . 0 CA--C 1.534 0.34 0 CA-C-O 120.575 0.226 . . . . 53.409999999999997 110.853 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 33.0 t -75.75 -40.06 56.06 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.504 0.669 . . . . 55.119999999999997 111.084 174.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.523 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.8 mm? -57.51 -49.74 75.32 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.252 -0.885 . . . . 70.439999999999998 112.918 -171.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.51 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 49.9 mt-10 -56.39 -53.95 58.51 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 117.914 0.324 . . . . 71.439999999999998 111.147 -176.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 31.2 Cg_exo -50.29 -50.98 11.91 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.944 1.763 . . . . 63.450000000000003 111.74 172.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.0 mt-30 -54.35 -41.98 69.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.141 -0.481 . . . . 74.540000000000006 111.798 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 75.0 mt -68.36 -38.92 81.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.48 -0.327 . . . . 72.519999999999996 110.42 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 37.7 mt-10 -68.06 -29.59 68.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.145 -0.479 . . . . 63.32 110.26 177.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -64.91 -54.04 37.08 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.131 -0.692 . . . . 74.519999999999996 109.131 176.178 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.07 -32.78 73.35 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.306 -0.861 . . . . 53.340000000000003 110.068 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.531 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.54 -50.73 70.21 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.946 -0.57 . . . . 70.140000000000001 109.781 177.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.5 mt-30 -54.63 -47.99 72.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.174 0.511 . . . . 74.310000000000002 110.245 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -63.92 -45.21 90.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.408 -0.815 . . . . 41.420000000000002 111.767 -178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -104.98 4.26 31.53 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 113.239 0.829 . . . . 74.150000000000006 113.239 -170.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 14.0 t -53.33 -24.89 13.08 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.791 0.663 . . . . 54.439999999999998 112.791 -171.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.592 ' HG3' ' ND2' ' A' ' 73' ' ' ASN . 5.6 pt-20 -64.15 -25.41 68.07 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.005 0.431 . . . . 71.450000000000003 111.135 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.592 ' ND2' ' HG3' ' A' ' 72' ' ' GLU . 5.5 m-80 -127.95 -0.76 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.334 -0.394 . . . . 74.329999999999998 111.257 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.461 HG23 HD11 ' A' ' 127' ' ' ILE . 25.8 t -130.51 139.12 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.043 0.449 . . . . 72.219999999999999 112.161 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -145.26 119.73 9.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 73.340000000000003 109.801 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.521 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.7 mp -98.68 140.06 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.181 -0.674 . . . . 54.32 109.181 174.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 73.7 m-85 -125.95 149.01 49.08 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.107 -0.701 . . . . 72.5 109.107 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HB3' ' OD2' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -133.47 135.06 44.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.885 -0.413 . . . . 72.530000000000001 109.885 176.365 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.0 mt -76.9 91.78 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.203 -0.665 . . . . 64.129999999999995 109.203 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -82.16 -18.5 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.917 -0.583 . . . . 65.099999999999994 110.477 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.1 mm -69.53 89.2 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.367 0.603 . . . . 70.230000000000004 109.882 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -48.98 -35.95 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.876 -1.057 . . . . 65.230000000000004 111.549 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.79 -22.76 60.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.327 -0.851 . . . . 74.140000000000001 112.313 -173.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -131.06 108.51 9.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.699 0.285 . . . . 71.349999999999994 110.826 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.99 32.36 1.02 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.839 -0.619 . . . . 72.409999999999997 110.416 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -52.37 -37.27 55.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.558 -0.746 . . . . 64.230000000000004 111.141 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.49 HG23 ' OD2' ' A' ' 28' ' ' ASP . 97.7 t -52.8 -36.28 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.757 -0.656 . . . . 73.439999999999998 111.17 -178.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.49 -54.91 24.99 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.064 0.459 . . . . 74.219999999999999 110.952 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.7 m -63.2 -40.94 98.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.802 -0.636 . . . . 70.319999999999993 110.903 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -67.77 -51.33 50.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.257 -0.429 . . . . 65.150000000000006 111.758 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -70.87 -29.13 65.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.777 -0.192 . . . . 65.129999999999995 111.286 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.09 57.14 0.57 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.653 -0.784 . . . . 72.329999999999998 112.657 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -92.66 99.63 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.937 0.399 . . . . 73.219999999999999 109.989 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -79.9 -50.65 10.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.848 -0.614 . . . . 72.150000000000006 110.543 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.13 136.33 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.596 -0.52 . . . . 33.340000000000003 109.596 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.649 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 62.3 mt -51.96 -55.38 31.18 Favored Pre-proline 0 CA--C 1.54 0.559 0 O-C-N 123.21 0.319 . . . . 72.540000000000006 111.56 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.649 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 4.4 Cg_exo -73.61 82.36 1.69 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.94 1.76 . . . . 62.32 111.852 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.0 m -122.6 138.89 54.44 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.132 -0.485 . . . . 72.329999999999998 110.03 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.9 mp -119.56 118.81 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.014 -0.539 . . . . 74.219999999999999 110.235 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HG ' ' HE2' ' A' ' 48' ' ' PHE . 49.4 mt -88.53 141.85 28.19 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.646 -0.502 . . . . 64.109999999999999 109.646 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.586 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 52.6 mtp -114.08 144.92 42.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.204 -0.665 . . . . 73.430000000000007 109.204 175.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.466 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 97.2 m-85 -146.64 160.22 42.47 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.777 -0.823 . . . . 72.430000000000007 108.777 174.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -148.15 109.52 4.37 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 120.077 -0.649 . . . . 73.310000000000002 111.789 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.754 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.9 m-20 56.47 31.79 19.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.012 0.434 . . . . 74.310000000000002 111.178 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.55 -15.22 61.96 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.108 -0.568 . . . . 51.130000000000003 112.657 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -67.94 132.67 47.76 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 109.645 -0.502 . . . . 75.230000000000004 109.645 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.6 147.49 45.5 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 124.045 0.841 . . . . 75.049999999999997 108.943 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.586 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.2 tp -156.48 168.44 27.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.093 -0.706 . . . . 63.340000000000003 109.093 -164.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.3 m -69.65 172.31 7.64 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.493 0.717 . . . . 74.319999999999993 112.512 -164.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.51 ' HG3' HD23 ' A' ' 100' ' ' LEU . 23.2 tt0 -131.01 131.81 44.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.23 -0.895 . . . . 72.450000000000003 109.91 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.79 111.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.915 -0.402 . . . . 73.219999999999999 109.915 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.2 mp -85.95 113.54 24.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.245 -0.65 . . . . 65.129999999999995 109.245 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.31 142.81 7.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.983 -0.627 . . . . 75.420000000000002 111.763 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.523 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -72.07 87.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.701 0.286 . . . . 72.030000000000001 110.765 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 119' ' ' ILE . 14.3 t70 -119.53 111.01 17.56 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.23 -0.441 . . . . 74.109999999999999 110.35 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -33.54 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.716 -0.675 . . . . 73.310000000000002 110.549 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -64.82 -53.25 49.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.984 0.421 . . . . 65.209999999999994 110.355 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -60.79 -45.6 93.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.162 -0.472 . . . . 73.519999999999996 110.331 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 115' ' ' ASP . 81.8 mt -58.66 -56.15 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.026 -0.534 . . . . 72.219999999999999 110.972 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -61.2 -36.32 71.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 120.772 0.32 . . . . 62.340000000000003 110.549 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.6 t -59.63 -52.05 67.19 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.117 -0.492 . . . . 61.520000000000003 110.015 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -62.56 -40.58 97.29 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.32 -0.4 . . . . 74.150000000000006 110.691 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 127' ' ' ILE . 57.3 mt -55.36 -56.11 13.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.288 -0.415 . . . . 64.299999999999997 110.644 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -66.1 -33.18 75.19 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.028 0.442 . . . . 72.510000000000005 110.343 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -69.36 -28.45 66.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 43.149999999999999 111.547 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.536 ' OD1' HD11 ' A' ' 108' ' ' LEU . 65.1 m-80 -107.86 -8.91 15.85 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.789 0.663 . . . . 71.019999999999996 112.789 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.461 HD11 HG23 ' A' ' 74' ' ' VAL . 61.3 mt -85.93 -51.58 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.883 -0.414 . . . . 63.32 109.883 170.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.54 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-N 115.824 -0.626 . . . . 53.210000000000001 109.956 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.492 ' SD ' ' HG2' ' A' ' 68' ' ' GLN . 19.2 ptm . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 121.573 0.702 . . . . 70.230000000000004 109.137 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -80.44 107.07 12.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.024 -0.989 . . . . 71.409999999999997 109.704 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -62.82 152.52 35.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.258 0.552 . . . . 72.200000000000003 111.762 -172.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 3.6 pt20 -124.67 125.56 44.3 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.613 -0.721 . . . . 72.450000000000003 109.528 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 31' ' ' PHE . 25.6 pt -135.7 158.11 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.697 0.284 . . . . 73.420000000000002 111.409 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.52 -179.93 52.34 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.202 -0.454 . . . . 74.349999999999994 112.442 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HB2' ' ND2' ' A' ' 84' ' ' ASN . 18.3 t70 -58.9 -56.3 24.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.098 0.475 . . . . 72.310000000000002 111.341 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.0 m -69.76 -15.61 63.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 65.310000000000002 111.344 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -84.7 -10.99 56.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 111.4 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 26' ' ' ILE . 79.5 t80 -55.28 -62.47 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.664 0.246 . . . . 64.409999999999997 111.664 -173.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.95 -45.32 95.18 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.902 0.382 . . . . 72.120000000000005 110.925 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.27 -49.82 76.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.749 -0.66 . . . . 73.25 111.421 -176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HG3' ' CG2' ' A' ' 26' ' ' ILE . 33.1 mmtp -69.34 -33.92 73.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.257 -0.429 . . . . 71.129999999999995 110.944 -176.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 31' ' ' PHE . 72.3 t -65.47 -43.2 94.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 120.876 0.37 . . . . 72.219999999999999 110.4 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.5 p -75.1 -18.51 60.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.878 0.37 . . . . 73.409999999999997 110.898 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.8 t -67.69 -2.79 7.52 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.211 -0.45 . . . . 63.119999999999997 111.329 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.757 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.3 p -57.8 148.93 23.62 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.639 -0.255 . . . . 62.439999999999998 110.567 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.5 -84.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.437 -0.347 . . . . 71.310000000000002 110.32 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -162.07 135.92 6.5 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.237 -0.653 . . . . 73.540000000000006 109.237 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 m120 65.68 9.43 5.93 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.684 0.615 . . . . 64.420000000000002 110.999 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.757 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.2 mm -76.48 115.97 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 73.340000000000003 110.552 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 102' ' ' PHE . 1.0 OUTLIER -74.7 110.8 9.29 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.121 -0.696 . . . . 74.120000000000005 109.121 175.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.515 HD11 ' HB3' ' A' ' 38' ' ' CYS . 27.9 mm -93.21 106.85 18.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.342 -0.844 . . . . 75.340000000000003 110.037 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.668 ' HB2' HG13 ' A' ' 76' ' ' ILE . 5.3 mp -92.38 149.63 21.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.945 -0.761 . . . . 73.409999999999997 108.945 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 58.5 t -132.23 110.99 17.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.906 -0.775 . . . . 53.109999999999999 108.906 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -94.31 159.95 14.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.259 0.552 . . . . 52.350000000000001 111.123 -173.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.113 -0.949 . . . . 71.540000000000006 109.004 165.37 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.403 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.2 ttt180 . . . . . 0 CA--C 1.53 0.198 0 CA-C-O 120.746 0.308 . . . . 75.299999999999997 111.051 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.632 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 13.0 m -74.45 -38.35 63.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.382 0.61 . . . . 54.149999999999999 110.563 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.529 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 mm? -61.03 -26.86 67.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.673 -0.694 . . . . 73.430000000000007 110.92 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 30.3 tt0 -56.52 -67.75 0.74 Allowed Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 119.333 -0.365 . . . . 73.140000000000001 110.238 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.477 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 27.8 Cg_endo -61.63 -39.41 54.33 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 121.484 1.456 . . . . 53.340000000000003 112.089 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.632 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.7 mt-30 -53.87 -52.7 59.62 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.74 -0.384 . . . . 70.349999999999994 111.433 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.91 -28.28 55.25 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.792 0.293 . . . . 53.420000000000002 111.792 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 93.2 mt-10 -65.37 -41.75 93.47 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.085 0.469 . . . . 74.530000000000001 109.828 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -67.34 -46.85 72.2 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.062 -0.517 . . . . 72.340000000000003 110.285 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' CD1' HD11 ' A' ' 116' ' ' ILE . 21.3 mt -62.85 -29.78 71.0 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.848 -0.341 . . . . 61.210000000000001 110.623 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.74 -51.34 67.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.433 -0.58 . . . . 73.510000000000005 109.433 175.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.492 ' HG2' ' SD ' ' A' ' 22' ' ' MET . 92.2 mt-30 -60.58 -32.2 71.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.837 -0.619 . . . . 72.549999999999997 111.062 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -77.16 -40.34 45.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 75.340000000000003 111.296 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -104.69 4.44 32.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.288 -0.415 . . . . 71.109999999999999 111.833 -174.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.8 t -53.01 -19.67 2.86 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.167 0.432 . . . . 71.109999999999999 112.167 -172.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -54.89 -41.91 71.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.093 -0.503 . . . . 75.239999999999995 110.187 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.473 ' HA ' HD13 ' A' ' 42' ' ' ILE . 52.3 m-80 -135.18 11.93 3.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.912 -0.586 . . . . 70.239999999999995 111.721 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.5 HG23 HD11 ' A' ' 127' ' ' ILE . 24.1 t -126.25 139.17 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 122.242 -0.286 . . . . 64.140000000000001 111.506 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -143.67 129.16 19.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.983 -0.747 . . . . 73.439999999999998 108.983 172.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' A' ' 45' ' ' LEU . 4.5 mp -105.63 138.28 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.08 0.466 . . . . 73.230000000000004 110.635 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 16.0 m-85 -127.42 165.06 20.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.277 -0.874 . . . . 74.420000000000002 108.963 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -161.81 165.01 28.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.344 -0.389 . . . . 74.549999999999997 110.149 173.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.4 tp -68.37 129.53 32.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 75.310000000000002 110.437 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 3.0 t-20 -95.19 -15.98 22.88 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.13 -0.486 . . . . 62.200000000000003 110.554 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.4 mt -102.62 103.31 14.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.884 -0.598 . . . . 74.439999999999998 109.908 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.3 -18.46 63.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.012 0.434 . . . . 72.25 110.901 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.43 -14.11 60.43 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.816 -0.629 . . . . 72.439999999999998 111.006 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 28' ' ' ASP . 24.4 t-20 -102.2 119.52 38.93 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.906 0.384 . . . . 74.120000000000005 111.436 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -119.31 -3.51 10.51 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.543 -0.54 . . . . 73.409999999999997 109.543 169.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.2 m-20 -48.08 -49.66 30.88 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.482 -0.781 . . . . 61.299999999999997 111.457 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -54.97 -38.9 47.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 116.224 -0.443 . . . . 74.329999999999998 110.694 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -69.01 -42.75 76.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.221 -0.445 . . . . 53.130000000000003 109.866 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -61.2 -38.44 86.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.564 -0.744 . . . . 62.420000000000002 110.576 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 78.3 mm-40 -69.71 -49.81 49.77 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.079 -0.509 . . . . 75.329999999999998 111.298 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -89.49 -2.45 58.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.286 -0.416 . . . . 71.540000000000006 112.027 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.19 57.09 5.34 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.137 -0.554 . . . . 33.240000000000002 112.977 171.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.42 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 86.6 t -82.42 92.77 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.698 -0.482 . . . . 74.430000000000007 109.698 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.3 t -89.41 -34.12 16.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.775 -0.648 . . . . 75.310000000000002 110.617 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.66 143.83 28.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 43.329999999999998 110.149 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.742 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 50.2 mm -59.29 -52.64 72.97 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.494 -0.321 . . . . 74.439999999999998 110.691 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.742 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 58.2 Cg_endo -93.52 112.38 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.472 2.115 . . . . 73.120000000000005 111.145 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.437 ' C ' HD12 ' A' ' 99' ' ' ILE . 64.2 m -136.97 141.91 42.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.92 0.39 . . . . 73.340000000000003 111.247 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.569 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -123.44 119.19 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.606 -0.724 . . . . 71.310000000000002 109.939 174.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.482 HD23 ' HG3' ' A' ' 110' ' ' GLN . 91.3 mt -94.83 129.43 41.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.063 -0.717 . . . . 63.240000000000002 109.063 174.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 44.4 mtp -106.47 138.53 42.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.036 -0.357 . . . . 73.340000000000003 110.036 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.488 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 100.0 m-85 -143.63 165.44 27.62 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.467 -0.568 . . . . 73.140000000000001 109.467 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 40.0 ttmt -151.78 104.87 3.06 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 122.245 -0.284 . . . . 63.100000000000001 110.948 175.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.719 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 57.6 t30 47.68 56.07 7.6 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.368 0.604 . . . . 64.219999999999999 110.914 177.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.88 -16.78 3.11 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.441 -0.8 . . . . 54.340000000000003 113.791 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 63.2 tttp -80.88 143.43 32.71 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 117.082 0.441 . . . . 62.219999999999999 110.141 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -71.97 145.59 48.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.58 0.705 . . . . 71.519999999999996 111.076 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -146.39 167.75 22.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.587 -1.264 . . . . 70.329999999999998 107.587 -172.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.1 m -70.19 -177.79 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.419 0.628 . . . . 72.019999999999996 112.66 -164.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.482 ' HG3' HD23 ' A' ' 100' ' ' LEU . 54.7 tt0 -138.46 129.52 26.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 74.230000000000004 109.51 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.569 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.0 t -100.53 107.51 21.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.069 0.461 . . . . 50.240000000000002 110.231 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.3 mp -86.71 110.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.567 -0.742 . . . . 73.329999999999998 109.435 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.409 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 99.43 155.08 28.48 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.56 -0.616 . . . . 30.23 111.56 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.529 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -80.04 72.16 6.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.844 0.354 . . . . 43.439999999999998 110.95 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 119' ' ' ILE . 18.0 t70 -111.08 96.95 6.45 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.598 0.713 . . . . 74.109999999999999 110.505 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.444 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -61.59 -34.41 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.141 -0.936 . . . . 73.099999999999994 110.263 -173.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.1 p -63.13 -43.34 98.64 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.274 -0.421 . . . . 62.200000000000003 111.056 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.84 -43.85 78.57 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.715 -0.476 . . . . 75.409999999999997 109.715 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 115' ' ' ASP . 70.8 mt -56.05 -56.48 12.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-N 116.015 -0.539 . . . . 74.140000000000001 110.838 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.7 tt -65.52 -33.87 66.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.854 -0.612 . . . . 45.439999999999998 110.586 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.5 t -57.33 -51.93 67.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.229 -0.441 . . . . 61.229999999999997 110.111 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -60.66 -45.3 94.63 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.589 -0.278 . . . . 73.409999999999997 110.372 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 119' ' ' ILE . 72.7 mt -52.56 -56.04 8.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 116.107 -0.497 . . . . 71.299999999999997 111.182 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -68.21 -32.96 73.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.658 0.266 . . . . 74.239999999999995 110.632 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -61.75 -36.49 81.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.145 0.498 . . . . 72.129999999999995 110.228 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -85.4 -28.78 24.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 72.239999999999995 112.144 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.5 HD11 HG23 ' A' ' 74' ' ' VAL . 52.6 mt -103.74 -60.69 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.142 0.496 . . . . 72.409999999999997 112.232 -178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.383 -0.826 . . . . 65.439999999999998 110.921 -166.784 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.421 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 88.1 mmm . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 121.248 0.547 . . . . 54.299999999999997 110.483 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.449 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 13.0 mm -83.19 123.26 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.367 -0.833 . . . . 51.530000000000001 109.878 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.489 ' HG3' HG23 ' A' ' 26' ' ' ILE . 6.2 tp10 -74.27 160.24 31.38 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 123.165 0.29 . . . . 75.430000000000007 110.245 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 25.4 pt20 -133.85 115.89 15.0 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 110.026 -0.361 . . . . 65.129999999999995 110.026 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.542 HG21 ' HG3' ' A' ' 34' ' ' LYS . 21.5 pt -139.9 179.98 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.305 0.483 . . . . 63.420000000000002 112.305 -170.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.0 -157.14 9.9 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.392 -0.822 . . . . 70.420000000000002 111.293 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.401 ' HB3' ' OD1' ' A' ' 84' ' ' ASN . 12.4 t70 -68.21 -51.03 50.03 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.147 0.474 . . . . 64.140000000000001 111.24 -176.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 t -58.21 -43.84 87.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 55.210000000000001 110.356 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -83.12 -13.11 56.29 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.502 -0.317 . . . . 71.209999999999994 111.691 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.5 ' HA ' HD12 ' A' ' 26' ' ' ILE . 89.3 t80 -58.18 -57.7 11.69 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.961 -0.755 . . . . 74.340000000000003 108.961 175.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.61 -51.43 69.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 65.319999999999993 110.638 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -52.73 -57.42 10.18 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.307 0.379 . . . . 73.439999999999998 111.215 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HG3' HG21 ' A' ' 26' ' ' ILE . 34.6 mmtp -69.38 -37.02 77.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 62.140000000000001 111.59 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.38 -45.17 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 121.197 -0.201 . . . . 70.200000000000003 110.704 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.5 p -75.2 -24.7 57.81 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.881 -0.328 . . . . 63.32 111.243 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.7 t -70.04 -7.88 44.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.501 -0.318 . . . . 61.43 111.699 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.929 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 26.8 p -59.35 137.28 58.05 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.652 -0.499 . . . . 63.340000000000003 109.652 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -48.38 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.415 0.447 . . . . 72.409999999999997 111.142 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -161.98 145.37 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.449 -0.574 . . . . 72.450000000000003 109.449 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 48.22 13.14 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.084 0.954 . . . . 74.420000000000002 113.32 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.65 136.66 26.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.275 -0.268 . . . . 60.149999999999999 110.275 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -85.35 113.15 21.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.459 0.647 . . . . 70.200000000000003 109.301 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.1 mt -106.95 139.39 28.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.152 -0.931 . . . . 73.420000000000002 110.624 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.558 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -120.82 139.48 53.09 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.172 -1.047 . . . . 63.310000000000002 108.172 170.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 77' ' ' TYR . 97.1 t -127.26 104.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.192 -0.67 . . . . 71.409999999999997 109.192 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 3.2 p-10 -101.39 150.52 22.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.012 -0.54 . . . . 62.130000000000003 109.724 -177.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.426 -0.352 . . . . 72.120000000000005 110.328 177.406 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 . . . . . 0 N--CA 1.463 0.205 0 CA-C-O 120.792 0.329 . . . . 65.129999999999995 110.559 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.567 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 47.2 t -74.95 -36.27 62.1 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.518 0.675 . . . . 55.100000000000001 110.52 177.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.524 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 1.3 mm? -55.03 -44.6 74.8 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.475 -0.784 . . . . 74.140000000000001 112.059 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.05 -56.86 30.68 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 119.374 -0.346 . . . . 72.340000000000003 111.543 -176.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HG2' ' O ' ' A' ' 58' ' ' SER . 10.0 Cg_endo -54.14 -38.14 87.53 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.739 1.626 . . . . 61.119999999999997 111.748 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 58' ' ' SER . 36.8 mt-30 -61.94 -39.64 92.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.753 -0.379 . . . . 74.400000000000006 110.956 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 80.3 mt -67.33 -36.92 82.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.425 -0.352 . . . . 63.439999999999998 110.147 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 42.8 mt-10 -59.4 -47.85 83.89 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.491 -0.559 . . . . 71.219999999999999 109.491 174.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -55.31 -50.61 69.13 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.578 -0.737 . . . . 74.209999999999994 110.566 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.538 HD11 HD11 ' A' ' 116' ' ' ILE . 23.1 mt -65.43 -37.14 86.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 64.409999999999997 110.443 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.534 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.98 -31.83 72.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 65.409999999999997 110.742 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 54.7 mt-30 -76.81 -50.59 13.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.001 0.429 . . . . 65.230000000000004 110.541 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -64.11 -41.19 97.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.745 -0.661 . . . . 74.430000000000007 110.715 -175.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.401 ' HE2' HD22 ' A' ' 66' ' ' LEU . 95.5 m-85 -99.11 5.56 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 72.530000000000001 112.178 -174.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.3 t -52.73 -19.57 2.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.762 0.653 . . . . 55.130000000000003 112.762 -170.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.16 -33.7 75.98 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.839 0.352 . . . . 64.099999999999994 110.971 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -126.2 -4.5 6.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.317 -0.401 . . . . 65.25 112.072 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.63 138.69 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.956 0.407 . . . . 72.219999999999999 111.726 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -142.95 121.68 12.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.703 -0.68 . . . . 74.030000000000001 109.833 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.558 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.1 mt -111.55 144.49 19.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 120.939 0.4 . . . . 73.400000000000006 111.197 -177.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.487 ' CE1' ' HB3' ' A' ' 34' ' ' LYS . 96.3 m-85 -130.56 136.36 48.83 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.558 -0.746 . . . . 75.25 110.213 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HG3' ' CG2' ' A' ' 23' ' ' ILE . 29.4 mtpp -107.97 134.04 51.45 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.582 -0.525 . . . . 64.219999999999999 109.582 173.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.3 mt -73.42 104.65 2.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.805 -0.813 . . . . 71.340000000000003 108.805 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 23.9 t-20 -98.95 -39.75 8.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.172 -0.467 . . . . 72.329999999999998 111.685 -173.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.4 mm -79.64 105.24 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.492 -0.322 . . . . 62.119999999999997 110.899 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -24.74 64.06 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.795 -0.638 . . . . 75.230000000000004 111.986 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -71.4 -5.1 30.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.127 0.489 . . . . 54.340000000000003 110.621 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.401 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 24.0 m-80 -124.59 29.12 6.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 44.539999999999999 111.136 -176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -69.07 -7.34 34.92 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.352 -0.385 . . . . 64.25 110.916 177.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -47.11 -38.71 11.94 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.047 -0.524 . . . . 71.299999999999997 110.909 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -53.06 -41.67 42.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 115.703 -0.681 . . . . 34.509999999999998 110.894 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.0 -41.48 96.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.619 -0.719 . . . . 72.129999999999995 110.499 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.5 m -69.5 -38.04 77.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.738 -0.665 . . . . 75.439999999999998 110.454 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -58.5 -51.69 68.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.972 -0.558 . . . . 75.219999999999999 110.842 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -77.11 -25.69 52.44 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 121.013 -0.275 . . . . 74.319999999999993 111.201 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 51.84 9.35 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.572 -0.823 . . . . 71.049999999999997 111.045 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.413 HG23 HG21 ' A' ' 98' ' ' THR . 7.7 p -59.71 135.77 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.258 -0.471 . . . . 71.140000000000001 111.305 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -69.84 -38.12 76.41 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.883 -0.598 . . . . 73.0 111.913 -174.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.42 164.03 34.64 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.464 -0.148 . . . . 73.129999999999995 110.874 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.605 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 48.2 mm -61.41 -48.69 90.21 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.543 -0.299 . . . . 43.299999999999997 110.836 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 3.6 Cg_exo -80.13 101.49 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.978 1.785 . . . . 75.439999999999998 110.552 172.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.413 HG21 HG23 ' A' ' 93' ' ' VAL . 97.1 m -153.2 146.63 24.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.326 -0.397 . . . . 53.520000000000003 110.576 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.592 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -118.37 116.26 50.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.035 -0.53 . . . . 53.100000000000001 110.089 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.441 HD23 ' HG3' ' A' ' 110' ' ' GLN . 89.1 mt -94.91 123.43 38.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.21 -0.663 . . . . 61.420000000000002 109.21 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.405 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 51.4 mtp -92.77 147.97 22.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.144 -0.317 . . . . 73.019999999999996 110.144 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.2 m-85 -144.92 161.09 40.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.551 -0.537 . . . . 74.420000000000002 109.551 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 20.7 ttmm -148.5 105.01 3.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.629 0.252 . . . . 73.120000000000005 110.568 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.929 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 65.7 t30 57.02 39.72 29.13 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.32 0.581 . . . . 71.329999999999998 110.692 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.98 -16.05 23.72 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.944 -0.571 . . . . 61.0 112.768 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 62.1 tttp -75.96 148.93 37.78 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 110.132 -0.321 . . . . 71.430000000000007 110.132 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -65.1 157.25 29.07 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.411 0.624 . . . . 71.099999999999994 110.903 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.26 167.9 23.2 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.358 -1.349 . . . . 63.0 107.358 -167.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.408 ' H ' HD13 ' A' ' 108' ' ' LEU . 38.7 m -70.44 178.64 2.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.425 0.631 . . . . 54.140000000000001 112.369 -167.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.441 ' HG3' HD23 ' A' ' 100' ' ' LEU . 59.0 tt0 -134.25 130.39 37.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.734 -0.666 . . . . 63.100000000000001 110.621 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.592 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.4 t -101.1 107.31 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.044 -0.724 . . . . 73.439999999999998 109.044 173.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.8 mt -87.48 109.14 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.144 -0.48 . . . . 75.219999999999999 110.095 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.8 -147.75 16.42 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.395 -0.682 . . . . 62.219999999999999 111.395 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.524 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -132.21 96.26 3.84 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.413 -0.217 . . . . 74.299999999999997 110.413 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -139.56 103.48 4.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.213 0.53 . . . . 70.409999999999997 110.473 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -63.34 -28.32 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 64.099999999999994 110.143 -175.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.3 m -62.9 -53.45 53.88 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.974 -0.557 . . . . 60.020000000000003 110.224 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -60.8 -44.36 96.95 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.21 -0.45 . . . . 73.120000000000005 110.09 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.475 HD13 HD21 ' A' ' 63' ' ' LEU . 66.0 mt -55.45 -56.12 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.964 -0.562 . . . . 64.299999999999997 111.316 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.6 tp -64.21 -34.46 69.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.526 0.203 . . . . 61.409999999999997 110.717 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.4 m -58.14 -50.69 72.61 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.538 -0.301 . . . . 61.149999999999999 110.468 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.82 -38.12 85.83 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.593 -0.276 . . . . 74.319999999999993 111.472 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.6 mt -58.65 -56.01 19.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.962 0.41 . . . . 64.299999999999997 110.115 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.78 -39.11 83.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 63.43 110.365 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -60.29 -39.84 88.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.486 -0.779 . . . . 73.120000000000005 111.215 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -100.57 -2.4 33.01 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 112.173 0.434 . . . . 72.409999999999997 112.173 -174.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.0 mt -90.92 -55.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.671 -0.492 . . . . 53.32 109.671 168.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--O 1.251 1.149 0 CA-C-N 115.811 -0.631 . . . . 54.509999999999998 109.548 -179.841 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 C--O 1.24 0.555 0 N-CA-C 108.556 -0.905 . . . . 73.140000000000001 108.556 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.442 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 10.7 mm -75.89 99.78 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 114.995 -1.002 . . . . 73.150000000000006 108.788 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.03 161.57 24.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.231 -0.44 . . . . 73.430000000000007 110.786 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.677 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 4.3 pm0 -125.67 122.82 37.45 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.885 0.374 . . . . 73.049999999999997 110.24 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 31' ' ' PHE . 34.4 pt -139.09 -179.75 2.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 122.942 0.497 . . . . 73.430000000000007 110.834 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.504 ' HA3' ' ND2' ' A' ' 84' ' ' ASN . . . -129.45 -157.57 9.22 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.904 -0.589 . . . . 64.209999999999994 111.944 176.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.4 -56.7 7.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.952 0.406 . . . . 73.209999999999994 111.123 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.5 m -62.78 -19.3 63.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 64.310000000000002 111.358 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 21.2 mp0 -96.07 -22.11 17.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.51 -0.314 . . . . 74.030000000000001 110.89 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.588 ' HA ' HD12 ' A' ' 26' ' ' ILE . 93.1 t80 -56.36 -62.32 1.8 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.81 0.338 . . . . 73.439999999999998 111.409 -174.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -59.21 -46.8 87.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 74.430000000000007 110.366 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -54.3 -55.83 24.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.064 -0.971 . . . . 73.200000000000003 111.404 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -65.68 -41.43 92.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.057 -0.519 . . . . 73.349999999999994 111.51 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.54 HG22 HG21 ' A' ' 44' ' ' ILE . 91.1 t -70.04 -29.24 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.116 0.26 . . . . 64.109999999999999 111.646 -177.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.5 p -85.95 -31.11 22.28 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.936 0.398 . . . . 74.129999999999995 111.142 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -76.86 10.97 1.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.031 -0.531 . . . . 75.230000000000004 111.25 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.976 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 9.3 p -73.2 -0.18 13.57 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.864 0.32 . . . . 73.340000000000003 111.864 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 t30 70.87 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.173 0.589 . . . . 71.040000000000006 111.869 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -162.17 137.35 7.17 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.531 0.567 . . . . 74.420000000000002 112.531 -177.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 61.56 2.72 0.72 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 60.32 113.614 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.799 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.9 mm -79.91 114.69 21.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.928 -0.397 . . . . 75.519999999999996 109.928 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tt -79.33 115.99 19.3 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.854 -0.612 . . . . 74.310000000000002 109.662 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.54 HG21 HG22 ' A' ' 35' ' ' VAL . 15.6 mm -99.2 120.04 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.458 -0.792 . . . . 74.400000000000006 110.214 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.6 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.2 mp -107.48 113.75 27.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.959 -0.756 . . . . 74.010000000000005 108.959 174.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -104.82 104.91 17.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.862 0.363 . . . . 51.210000000000001 110.963 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.672 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 7.7 t70 -80.55 148.05 30.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.758 -0.656 . . . . 61.210000000000001 109.464 172.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 109.208 -0.664 . . . . 71.319999999999993 109.208 172.257 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.889 0.376 . . . . 75.420000000000002 110.449 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.539 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 11.5 t -75.26 -26.78 59.09 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.481 0.658 . . . . 65.209999999999994 110.551 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 114' ' ' ALA . 9.4 tp -64.22 -41.06 97.18 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.762 -0.653 . . . . 71.129999999999995 111.877 -171.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.502 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 49.2 mt-10 -55.92 -53.22 65.5 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 120.782 -0.367 . . . . 72.010000000000005 110.183 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 12.0 Cg_exo -52.65 -43.13 57.73 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.889 1.726 . . . . 63.229999999999997 112.255 170.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 58' ' ' SER . 35.3 mt-30 -65.72 -32.9 74.71 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.114 -0.635 . . . . 64.540000000000006 110.781 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.438 HD21 HD13 ' A' ' 119' ' ' ILE . 53.9 mt -70.11 -37.57 75.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.447 -0.797 . . . . 73.319999999999993 109.715 178.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.424 ' OE2' HG12 ' A' ' 23' ' ' ILE . 18.4 mm-40 -58.13 -46.37 85.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.352 -0.385 . . . . 73.0 109.973 171.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -55.87 -54.46 44.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.009 -0.542 . . . . 73.209999999999994 110.392 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.495 HD11 ' CD1' ' A' ' 116' ' ' ILE . 18.8 mt -63.55 -36.56 84.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.022 -0.535 . . . . 63.130000000000003 110.568 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.499 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.79 -33.26 75.27 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.784 -0.644 . . . . 65.319999999999993 110.629 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -78.33 -47.67 17.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 65.129999999999995 110.947 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -61.42 -38.94 88.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.079 -0.51 . . . . 74.150000000000006 110.873 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -104.88 5.76 33.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.42 -0.809 . . . . 72.340000000000003 112.269 -173.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.2 t -52.48 -23.26 5.87 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.811 1.041 . . . . 72.450000000000003 113.811 -166.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.95 -36.46 77.96 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.595 -0.442 . . . . 74.340000000000003 110.67 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -114.33 -4.73 12.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 64.140000000000001 111.676 -175.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.7 t -130.34 150.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.005 0.372 . . . . 73.230000000000004 112.005 -174.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -151.69 125.46 9.04 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.905 -0.589 . . . . 75.319999999999993 109.735 172.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.6 HG12 ' HB2' ' A' ' 45' ' ' LEU . 62.3 mt -101.54 142.56 15.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 120.889 0.376 . . . . 75.319999999999993 110.593 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -128.02 168.49 15.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.554 -0.748 . . . . 74.230000000000004 109.188 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 8.4 ptpp? -147.39 163.15 37.37 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.705 -0.48 . . . . 63.25 109.705 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mt -81.87 114.32 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.253 -0.647 . . . . 74.340000000000003 109.253 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.677 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 11.9 t30 -73.14 -36.79 66.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.927 -0.578 . . . . 74.040000000000006 112.272 -173.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.534 HG13 ' H ' ' A' ' 83' ' ' ASP . 9.2 tp -135.62 143.26 37.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.951 0.405 . . . . 73.209999999999994 111.281 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.46 -18.73 60.3 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.673 -0.694 . . . . 71.209999999999994 112.009 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.534 ' H ' HG13 ' A' ' 81' ' ' ILE . 8.3 m-20 -71.27 -22.64 61.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.313 0.578 . . . . 74.329999999999998 110.288 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.504 ' ND2' ' HA3' ' A' ' 27' ' ' GLY . 92.3 m-20 -96.88 20.9 10.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.778 -0.646 . . . . 74.329999999999998 110.534 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.63 -13.96 61.91 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.813 -0.631 . . . . 70.150000000000006 110.201 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -44.69 -42.41 7.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.471 -0.786 . . . . 54.210000000000001 111.742 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.4 t -53.17 -42.23 45.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.14 -0.482 . . . . 72.510000000000005 111.196 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.22 80.8 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.957 -0.565 . . . . 60.509999999999998 110.495 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.8 m -66.54 -35.46 80.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.711 -0.677 . . . . 64.109999999999999 110.992 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.49 -47.96 71.34 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.253 -0.431 . . . . 74.010000000000005 110.839 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -71.13 -24.12 62.21 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.206 -0.452 . . . . 64.209999999999994 110.984 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.67 39.44 7.65 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 121.071 -0.585 . . . . 73.019999999999996 112.77 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 95' ' ' ALA . 30.8 t -90.66 125.59 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.53 -0.544 . . . . 65.430000000000007 109.53 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.1 t -104.39 17.64 23.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.701 0.286 . . . . 75.310000000000002 111.362 -174.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.436 ' H ' HG12 ' A' ' 93' ' ' VAL . . . -126.88 139.8 52.81 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.221 -0.289 . . . . 71.420000000000002 110.221 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.553 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 2.2 mp -78.04 -56.45 1.05 Allowed Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.663 -0.244 . . . . 74.450000000000003 110.985 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 90.9 Cg_endo -79.87 78.67 3.61 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.716 1.611 . . . . 74.510000000000005 111.515 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.6 m -127.34 135.25 50.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.864 -0.607 . . . . 63.450000000000003 111.164 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 99' ' ' ILE . 2.8 mp -110.22 111.74 37.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.472 -0.786 . . . . 62.119999999999997 109.702 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.4 mp -88.64 141.27 28.65 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.318 -0.623 . . . . 70.030000000000001 109.318 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.54 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 36.2 mtp -110.18 140.46 44.27 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.854 -0.425 . . . . 65.129999999999995 109.854 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -146.66 144.49 29.52 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.569 -0.9 . . . . 72.299999999999997 108.569 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.509 ' HB2' HD22 ' A' ' 108' ' ' LEU . 38.2 ttpt -126.47 104.91 8.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.16 -0.616 . . . . 63.450000000000003 110.596 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.976 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.8 t30 50.79 47.51 24.42 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.561 0.696 . . . . 74.010000000000005 110.809 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.26 -16.19 35.39 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.559 -0.746 . . . . 73.299999999999997 112.955 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -70.07 134.25 48.03 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.917 0.358 . . . . 61.520000000000003 110.475 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -61.42 144.32 54.32 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.044 0.84 . . . . 71.340000000000003 109.132 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.54 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.6 tp -158.73 168.43 26.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.944 -0.571 . . . . 43.109999999999999 109.636 -163.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 101' ' ' MET . 37.8 m -69.47 179.64 2.0 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.069 0.548 . . . . 64.319999999999993 111.845 -167.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.406 HE21 HD11 ' A' ' 112' ' ' ILE . 28.3 tt0 -144.44 124.76 13.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 72.329999999999998 110.057 -174.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.43 108.88 22.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.41 . . . . 73.109999999999999 110.227 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.3 mp -87.55 101.72 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.048 -0.524 . . . . 74.150000000000006 109.651 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.88 -176.76 20.79 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.154 -0.546 . . . . 31.300000000000001 112.816 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.531 ' HA ' HD22 ' A' ' 59' ' ' LEU . . . -92.86 76.82 4.82 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.834 0.453 . . . . 73.030000000000001 111.271 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -117.79 83.52 2.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.499 0.666 . . . . 73.209999999999994 109.458 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.539 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -59.14 -30.47 43.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.093 -0.958 . . . . 72.140000000000001 110.241 -174.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.6 m -58.66 -53.22 60.84 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.13 -0.487 . . . . 63.009999999999998 110.478 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -65.39 -41.25 93.9 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 116.48 -0.327 . . . . 74.129999999999995 110.359 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 123' ' ' ILE . 76.2 mt -55.72 -56.24 13.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.246 -0.434 . . . . 63.329999999999998 110.808 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.85 -34.33 69.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 116.443 -0.344 . . . . 75.530000000000001 110.418 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 t -58.7 -52.09 67.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.061 -0.518 . . . . 73.209999999999994 109.736 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -62.33 -40.36 96.09 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.343 -0.389 . . . . 72.010000000000005 111.108 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.467 HD12 HD13 ' A' ' 66' ' ' LEU . 64.9 mt -52.66 -55.76 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.769 0.319 . . . . 75.129999999999995 110.379 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -68.96 -29.82 68.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 75.299999999999997 110.777 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -68.34 -33.91 75.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 63.329999999999998 111.368 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.508 ' OD1' HD11 ' A' ' 108' ' ' LEU . 66.0 m-80 -98.49 -24.15 15.26 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.119 0.415 . . . . 62.240000000000002 112.119 -175.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 123' ' ' ILE . 61.6 mt -71.49 -59.5 3.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.951 0.405 . . . . 72.219999999999999 110.153 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.726 -0.67 . . . . 71.030000000000001 110.434 -177.713 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 91.4 mmm . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 121.12 0.486 . . . . 73.530000000000001 110.498 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.5 mm -83.37 105.86 13.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.651 -0.704 . . . . 75.129999999999995 109.131 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -78.25 161.48 27.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 62.350000000000001 109.994 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.688 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 10.1 pt20 -137.21 133.13 34.8 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.858 0.361 . . . . 74.140000000000001 110.924 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 32.6 pt -144.69 179.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.169 -0.469 . . . . 65.319999999999993 110.984 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.562 ' HA3' HD12 ' A' ' 81' ' ' ILE . . . -117.96 -165.54 13.53 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.131 -0.486 . . . . 72.430000000000007 112.02 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.426 ' H ' ' HB3' ' A' ' 84' ' ' ASN . 6.8 t70 -67.67 -51.28 51.57 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.693 0.397 . . . . 65.310000000000002 110.687 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 m -56.16 -24.79 43.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.879 -0.6 . . . . 74.239999999999995 110.754 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 42.6 mt-10 -95.07 -31.25 13.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.784 -0.644 . . . . 72.239999999999995 110.421 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.487 ' HA ' HD12 ' A' ' 26' ' ' ILE . 92.8 t80 -50.14 -61.91 1.88 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.968 -0.56 . . . . 64.319999999999993 111.843 -171.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 36' ' ' THR . 8.4 t70 -53.56 -56.44 17.05 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 123.382 0.426 . . . . 72.219999999999999 110.516 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 37' ' ' SER . 0.9 OUTLIER -54.09 -57.3 11.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 73.400000000000006 111.509 -176.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 75.5 mmtt -56.43 -38.79 72.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.848 0.356 . . . . 73.310000000000002 110.33 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.495 ' HA ' HD12 ' A' ' 44' ' ' ILE . 3.9 t -66.79 -54.81 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.93 -0.577 . . . . 73.319999999999993 111.915 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 32' ' ' ASP . 9.4 t -76.51 -7.48 55.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.699 0.285 . . . . 73.0 111.039 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 22.6 t -74.58 -5.0 40.37 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.392 -0.367 . . . . 65.549999999999997 111.667 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.1 m -57.11 96.35 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 110.165 -0.309 . . . . 65.299999999999997 110.165 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -51.11 -44.63 61.33 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.502 0.501 . . . . 61.5 111.24 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -155.78 121.39 4.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.697 0.284 . . . . 75.329999999999998 110.981 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 41.89 24.9 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.547 1.314 . . . . 73.209999999999994 114.547 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.8 mm -70.09 100.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.475 -0.565 . . . . 62.130000000000003 109.475 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.78 114.88 6.74 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.239 0.542 . . . . 72.209999999999994 110.333 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 35' ' ' VAL . 34.9 mt -104.05 120.5 54.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.299 -0.864 . . . . 74.109999999999999 110.833 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.507 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.5 mp -105.13 110.87 23.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.11 -0.7 . . . . 45.229999999999997 109.11 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 61.1 t -95.55 110.16 23.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.525 -0.176 . . . . 73.019999999999996 110.525 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.439 ' CG ' ' HZ2' ' A' ' 78' ' ' LYS . 2.1 p-10 -91.08 129.65 37.06 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.291 0.567 . . . . 43.509999999999998 110.656 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 108.388 -0.967 . . . . 54.32 108.388 170.423 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 120.946 0.403 . . . . 70.409999999999997 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.622 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 46.0 t -74.89 -39.09 61.69 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.666 0.746 . . . . 62.420000000000002 110.583 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.523 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.3 mm? -52.88 -45.72 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.113 -0.949 . . . . 72.209999999999994 111.989 -175.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 32.3 mt-10 -59.01 -58.57 18.56 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 119.133 -0.46 . . . . 75.239999999999995 111.58 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.78 -40.53 84.4 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 121.81 1.673 . . . . 73.530000000000001 112.165 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.3 mt-30 -58.28 -46.49 85.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.145 0.497 . . . . 71.549999999999997 110.427 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 81.8 mt -69.65 -28.45 65.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.86 -0.609 . . . . 62.130000000000003 110.6 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 44.6 mt-10 -63.78 -44.22 94.01 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.575 -0.528 . . . . 73.239999999999995 109.575 175.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -63.32 -49.93 72.03 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.394 -0.366 . . . . 63.520000000000003 110.211 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.455 HD11 HD11 ' A' ' 116' ' ' ILE . 28.1 mt -60.56 -32.95 72.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.455 . . . . 63.329999999999998 110.465 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.28 -50.36 70.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.52 -0.548 . . . . 64.5 109.52 176.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.3 mt-30 -57.78 -39.16 76.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.249 0.547 . . . . 75.519999999999996 110.734 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -70.05 -45.39 67.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.259 -0.882 . . . . 71.120000000000005 111.249 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -104.58 5.02 33.49 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.874 -0.603 . . . . 65.319999999999993 112.373 -171.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.6 t -52.88 -19.85 2.86 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.223 0.824 . . . . 75.219999999999999 113.223 -169.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.12 -37.36 84.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.008 0.432 . . . . 54.310000000000002 110.63 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -124.0 -2.83 8.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.771 -0.649 . . . . 71.530000000000001 111.639 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -127.07 136.88 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.184 0.516 . . . . 54.240000000000002 112.209 -173.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 20.6 mmtt -146.1 127.23 14.69 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.345 -0.843 . . . . 62.350000000000001 109.538 173.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 76' ' ' ILE . 3.3 mp -99.23 137.91 25.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.692 -0.485 . . . . 73.140000000000001 109.692 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 71.8 m-85 -123.83 144.45 49.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.286 -0.415 . . . . 75.140000000000001 110.031 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.439 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 3.1 ttmp? -121.47 137.96 54.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.885 -0.598 . . . . 65.030000000000001 110.05 -177.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.475 HD11 ' HA ' ' A' ' 85' ' ' GLN . 12.4 tt -70.34 117.36 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.884 -0.413 . . . . 64.409999999999997 109.884 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.688 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 22.9 t-20 -113.9 -50.33 2.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.175 -0.466 . . . . 75.040000000000006 111.71 -173.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.562 HD12 ' HA3' ' A' ' 27' ' ' GLY . 52.1 mt -66.47 106.69 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 121.052 0.453 . . . . 73.239999999999995 110.861 -175.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -49.19 -40.87 34.98 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.961 -1.018 . . . . 71.25 112.907 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -71.38 -25.65 62.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.986 0.422 . . . . 53.439999999999998 110.9 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.447 ' N ' HD22 ' A' ' 84' ' ' ASN . 0.9 OUTLIER -90.43 30.63 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.876 -0.602 . . . . 74.430000000000007 110.927 -173.184 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.475 ' HA ' HD11 ' A' ' 79' ' ' ILE . 32.4 tt0 -70.5 -12.81 61.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.74 -0.664 . . . . 64.319999999999993 110.976 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.412 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 15.7 m-20 -49.81 -30.07 9.05 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.86 -0.609 . . . . 73.140000000000001 112.469 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -52.61 -39.3 29.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.101 0.476 . . . . 72.120000000000005 110.379 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.86 -49.24 75.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.813 -0.63 . . . . 72.510000000000005 110.267 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -61.29 -41.38 96.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.648 -0.705 . . . . 65.420000000000002 111.077 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.1 mm100 -70.78 -44.69 66.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.002 -0.545 . . . . 73.340000000000003 111.454 -174.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -87.44 -9.66 54.05 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.416 -0.356 . . . . 73.400000000000006 111.594 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.31 55.68 5.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.801 -0.714 . . . . 21.129999999999999 112.584 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.0 t -81.09 98.82 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.203 -0.666 . . . . 70.019999999999996 109.203 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t -60.38 -58.83 6.83 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.012 -0.54 . . . . 74.109999999999999 110.913 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.99 136.28 45.93 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.227 -0.657 . . . . 45.25 109.227 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.432 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 72.9 mt -51.8 -54.36 40.99 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 123.389 0.43 . . . . 73.530000000000001 111.874 -176.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 96' ' ' ILE . 41.6 Cg_endo -65.37 87.58 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.614 1.542 . . . . 61.43 111.866 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 112' ' ' ILE . 56.4 m -151.77 143.02 23.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.737 -0.665 . . . . 72.219999999999999 110.09 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 99' ' ' ILE . 2.5 mp -109.83 114.05 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.848 -0.426 . . . . 64.400000000000006 109.848 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.1 mp -95.83 124.91 40.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 109.756 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.42 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 61.8 mtp -93.25 143.72 25.99 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.682 -0.488 . . . . 73.230000000000004 109.682 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.465 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.0 m-85 -146.92 158.17 43.84 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.673 -0.491 . . . . 72.109999999999999 109.673 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -151.21 105.15 3.18 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.943 -0.303 . . . . 61.509999999999998 111.164 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 56.6 44.22 24.3 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.363 0.601 . . . . 74.430000000000007 110.381 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.5 -16.51 7.75 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.82 -0.627 . . . . 61.409999999999997 112.752 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 14.0 tmtt? -79.66 139.78 37.28 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.45 -0.574 . . . . 73.120000000000005 109.45 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -68.97 136.74 52.98 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 122.104 0.954 . . . . 72.329999999999998 112.302 -174.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -133.36 168.22 18.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.623 -1.626 . . . . 33.119999999999997 107.794 -175.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 m -70.27 -178.77 1.78 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.312 0.486 . . . . 40.009999999999998 112.312 -167.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -138.44 121.83 17.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.513 -0.312 . . . . 72.310000000000002 110.497 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.1 t -97.87 107.41 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.83 -0.433 . . . . 73.329999999999998 109.83 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.564 ' HA ' HG23 ' A' ' 98' ' ' THR . 64.7 mt -80.15 135.25 25.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.364 -0.38 . . . . 71.0 110.509 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.5 -137.64 15.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.995 -0.622 . . . . 72.030000000000001 111.846 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.523 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -144.6 76.76 1.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 74.120000000000005 110.375 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.447 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.3 t70 -117.3 103.36 10.08 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.128 -0.487 . . . . 61.450000000000003 109.991 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.482 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -63.34 -36.74 77.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 64.129999999999995 110.382 -174.001 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -63.49 -42.94 98.54 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.249 -0.432 . . . . 52.32 110.151 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -66.06 -41.16 91.17 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.363 -0.38 . . . . 54.240000000000002 110.198 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 115' ' ' ASP . 69.1 mt -59.81 -56.35 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.443 -0.344 . . . . 63.009999999999998 111.048 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.1 tt -62.73 -33.97 62.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 120.818 0.342 . . . . 62.039999999999999 110.339 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 t -55.75 -51.66 66.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.86 -0.609 . . . . 74.140000000000001 109.596 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -62.01 -40.86 97.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 71.219999999999999 110.891 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 119' ' ' ILE . 73.0 mt -56.04 -55.85 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.663 0.268 . . . . 71.319999999999993 110.934 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -71.67 -29.42 64.58 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.803 -0.359 . . . . 74.109999999999999 110.77 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -68.24 -39.96 82.15 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.031 0.443 . . . . 73.25 111.022 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -90.06 -24.84 21.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.919 -0.582 . . . . 73.0 111.29 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.7 mt -77.75 -54.15 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.757 0.313 . . . . 51.439999999999998 110.795 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.569 -0.729 . . . . 75.519999999999996 110.313 -176.471 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.435 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 94.0 mmm . . . . . 0 N--CA 1.462 0.153 0 CA-C-O 120.888 0.375 . . . . 74.099999999999994 110.379 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.452 HG12 ' HG2' ' A' ' 64' ' ' GLU . 24.6 mm -87.55 119.69 35.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.785 -0.643 . . . . 55.539999999999999 109.471 177.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 154.0 18.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.97 0.414 . . . . 72.109999999999999 111.213 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -110.63 141.77 43.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.899 -0.591 . . . . 73.349999999999994 110.216 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.536 HG21 ' HG3' ' A' ' 34' ' ' LYS . 34.7 pt -140.31 161.26 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.902 0.382 . . . . 65.120000000000005 110.978 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.38 169.18 37.4 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.825 -0.625 . . . . 34.130000000000003 111.954 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.831 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 18.2 t70 -57.04 -42.43 80.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.116 0.484 . . . . 74.540000000000006 110.763 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.3 t -72.29 -16.19 61.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 65.129999999999995 110.924 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 11.1 mm-40 -83.16 -24.41 32.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 74.510000000000005 111.845 -176.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 35' ' ' VAL . 88.7 t80 -45.33 -61.94 1.46 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.559 0.577 . . . . 71.420000000000002 112.559 -170.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.91 -46.11 91.95 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.727 0.298 . . . . 72.310000000000002 110.653 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -48.37 -57.14 6.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 64.329999999999998 110.588 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 9.8 mmpt? -64.62 -49.64 70.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 44.329999999999998 110.11 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.556 HG12 ' HA2' ' A' ' 105' ' ' GLY . 95.5 t -62.18 -36.8 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.735 -0.666 . . . . 62.119999999999997 111.839 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -77.76 -47.03 19.97 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.838 0.31 . . . . 65.109999999999999 111.838 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.2 p -77.15 11.03 2.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.273 0.842 . . . . 60.329999999999998 113.273 -171.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.517 ' HB3' HD11 ' A' ' 44' ' ' ILE . 24.9 p -76.78 79.93 3.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.289 . . . . 62.329999999999998 111.686 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.9 t30 32.28 -94.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.147 0.979 . . . . 73.310000000000002 112.763 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -161.72 140.34 9.49 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.789 -0.449 . . . . 60.32 109.789 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 53.19 21.04 2.04 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.223 0.609 . . . . 73.209999999999994 112.474 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 103' ' ' LYS . 47.9 mm -75.68 128.84 37.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 120.784 0.326 . . . . 64.219999999999999 110.481 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -84.76 111.12 19.31 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.013 -0.736 . . . . 61.399999999999999 109.013 178.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.517 HD11 ' HB3' ' A' ' 38' ' ' CYS . 52.9 mt -106.84 129.12 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.971 -0.559 . . . . 73.439999999999998 110.932 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.544 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.9 mp -113.97 109.73 18.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.101 -0.703 . . . . 75.140000000000001 109.101 174.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 77' ' ' TYR . 48.7 t -101.54 104.84 16.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.951 -0.388 . . . . 72.420000000000002 109.951 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 17.8 t70 -85.26 146.6 26.98 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.068 0.461 . . . . 74.219999999999999 109.878 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.4 t80 . . . . . 0 C--N 1.321 -0.637 0 CA-C-N 115.784 -0.644 . . . . 73.310000000000002 111.495 -173.439 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.565 ' HD3' ' N ' ' A' ' 58' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 111.74 0.274 . . . . 72.239999999999995 111.74 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.565 ' N ' ' HD3' ' A' ' 57' ' ' ARG . 20.2 m -75.87 -30.63 58.93 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.569 0.699 . . . . 70.25 110.935 173.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.525 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.5 mm? -66.2 -42.58 88.62 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.479 -0.782 . . . . 74.120000000000005 112.522 -173.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.647 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 3.0 mp0 -49.72 -57.52 11.97 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 118.697 0.681 . . . . 72.340000000000003 110.255 177.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.647 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 23.2 Cg_exo -55.43 -55.5 3.04 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.885 1.723 . . . . 65.120000000000005 112.327 175.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.5 mt-30 -51.33 -49.7 60.88 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.175 0.435 . . . . 71.219999999999999 112.175 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.73 -40.54 76.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.875 -0.602 . . . . 73.439999999999998 111.058 -173.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 32.4 mt-10 -64.05 -34.84 78.93 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.881 -0.328 . . . . 65.019999999999996 110.307 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -62.54 -54.99 31.62 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.176 0.513 . . . . 73.340000000000003 110.04 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.4 mt -62.08 -32.95 73.54 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.849 -0.614 . . . . 62.140000000000001 109.928 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -61.93 -40.74 96.56 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.993 -0.549 . . . . 62.399999999999999 109.933 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.0 mt-30 -64.28 -45.45 87.96 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.885 0.374 . . . . 74.430000000000007 110.66 177.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -65.89 -38.18 88.07 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.962 -0.563 . . . . 62.520000000000003 111.225 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -104.63 4.58 32.88 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 112.242 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.0 t -53.23 -19.91 3.59 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.07 0.767 . . . . 74.150000000000006 113.07 -169.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.66 -34.54 75.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 74.319999999999993 110.824 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -123.37 -20.41 5.63 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.796 -0.638 . . . . 72.25 111.612 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.14 128.25 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.946 0.403 . . . . 63.420000000000002 112.051 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.515 ' HB3' ' HZ2' ' A' ' 75' ' ' LYS . 2.2 mmmp? -131.69 138.22 48.6 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.99 -0.744 . . . . 61.310000000000002 108.99 173.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.544 HG12 ' HB2' ' A' ' 45' ' ' LEU . 60.6 mt -118.09 114.38 45.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.011 0.434 . . . . 74.540000000000006 110.655 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.503 ' HB2' HG22 ' A' ' 46' ' ' VAL . 56.7 m-85 -101.45 163.99 11.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 72.319999999999993 109.809 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 20.5 ttmm -139.16 138.09 36.64 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.869 0.366 . . . . 71.120000000000005 111.279 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.486 HD11 ' O ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -126.57 100.8 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.472 -0.936 . . . . 73.439999999999998 108.472 174.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -124.47 7.63 8.33 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.045 -0.525 . . . . 72.310000000000002 112.033 -172.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 57.5 mt -76.47 112.44 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.273 -0.269 . . . . 70.340000000000003 110.273 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.75 -31.19 70.53 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.839 0.352 . . . . 44.439999999999998 111.331 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.29 -23.29 61.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.161 0.505 . . . . 72.329999999999998 110.957 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.831 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 33.5 m-80 -123.92 91.94 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 55.049999999999997 110.509 -174.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -140.25 14.63 2.41 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.537 0.569 . . . . 61.350000000000001 112.537 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.67 -44.77 63.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.206 0.527 . . . . 74.340000000000003 110.043 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.59 -38.92 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.272 -0.877 . . . . 73.219999999999999 110.897 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.99 -41.06 91.58 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.213 0.53 . . . . 62.149999999999999 110.269 -175.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.1 m -72.25 -35.91 68.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.51 -0.768 . . . . 62.229999999999997 110.932 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -68.55 -45.96 70.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.473 -0.33 . . . . 74.099999999999994 111.841 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -86.86 -23.54 25.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.617 0.229 . . . . 62.5 111.617 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.49 80.38 1.51 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.717 -0.754 . . . . 72.120000000000005 113.062 173.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.4 t -99.63 138.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.271 -0.641 . . . . 61.219999999999999 109.271 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.4 m -141.49 18.29 2.21 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.997 0.369 . . . . 75.230000000000004 111.997 -174.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.87 152.53 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.652 -0.249 . . . . 51.229999999999997 110.444 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.685 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 60.1 mt -59.68 -50.03 88.93 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.416 -0.356 . . . . 51.240000000000002 110.526 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.685 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 73.1 Cg_endo -95.37 112.67 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.695 2.264 . . . . 72.439999999999998 111.061 169.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.426 HG23 HD13 ' A' ' 112' ' ' ILE . 54.8 m -145.82 118.68 8.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.005 -0.369 . . . . 55.310000000000002 110.005 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.534 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.5 mp -109.7 110.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.316 -0.402 . . . . 62.32 110.129 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.0 mp -90.21 123.31 33.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.767 -0.827 . . . . 75.530000000000001 108.767 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.441 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 45.2 mtp -101.0 145.43 28.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.851 -0.426 . . . . 74.400000000000006 109.851 -176.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.466 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 97.1 m-85 -148.22 160.81 42.56 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.354 -0.609 . . . . 74.549999999999997 109.354 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 39.3 ttpt -143.93 114.34 7.52 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.917 -0.313 . . . . 75.200000000000003 110.596 175.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.5 t30 62.19 25.68 15.38 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.536 0.684 . . . . 72.129999999999995 109.711 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.556 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 84.61 -14.41 47.13 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.699 -0.682 . . . . 73.040000000000006 111.965 -176.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -69.33 142.31 54.06 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.832 -0.433 . . . . 74.200000000000003 109.832 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -58.3 150.93 20.68 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 124.1 0.875 . . . . 64.219999999999999 111.097 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -162.36 168.74 21.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.909 -1.042 . . . . 74.010000000000005 108.995 -169.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -70.19 167.71 17.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.384 0.611 . . . . 63.149999999999999 112.356 -167.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -130.48 118.57 21.32 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.81 -0.632 . . . . 70.530000000000001 109.945 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.534 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.0 t -86.8 119.43 34.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 74.430000000000007 110.29 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 98' ' ' THR . 50.0 mm -100.13 102.47 13.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.222 -0.445 . . . . 74.340000000000003 110.2 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.482 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 107.46 166.25 21.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.267 -0.492 . . . . 34.229999999999997 112.217 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.525 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -80.79 72.2 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.863 0.363 . . . . 64.120000000000005 111.107 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 61.2 t0 -112.07 92.88 4.19 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.374 0.607 . . . . 64.019999999999996 110.185 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.494 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -59.22 -34.97 55.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.276 -0.875 . . . . 75.540000000000006 110.153 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.6 t -62.68 -46.21 89.2 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.077 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.473 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -65.29 -42.96 92.6 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.859 -0.61 . . . . 74.099999999999994 109.937 -179.316 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 123' ' ' ILE . 74.0 mt -57.22 -56.14 16.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 115.419 -0.81 . . . . 71.140000000000001 111.098 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.2 tt -65.4 -35.21 74.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 121.063 -0.255 . . . . 74.219999999999999 110.788 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 t -56.72 -52.05 66.47 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.103 -0.499 . . . . 75.319999999999993 110.027 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -70.46 -31.63 68.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 65.299999999999997 111.477 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 119' ' ' ILE . 62.0 mt -57.34 -56.52 14.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.686 -0.406 . . . . 70.549999999999997 110.229 176.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -69.8 -32.82 71.48 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.757 -0.377 . . . . 74.25 110.21 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -62.06 -49.67 75.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.137 -0.483 . . . . 64.430000000000007 111.153 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -86.98 -20.24 27.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 112.219 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.9 mt -78.62 -52.76 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.853 -0.339 . . . . 72.239999999999995 110.619 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.536 -0.745 . . . . 70.200000000000003 110.288 -177.392 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 80.1 mmm . . . . . 0 C--O 1.235 0.321 0 N-CA-C 108.227 -1.027 . . . . 62.109999999999999 108.227 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.581 HG21 ' NZ ' ' A' ' 78' ' ' LYS . 17.2 mm -54.99 107.79 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.642 -1.163 . . . . 53.130000000000003 109.222 174.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' HB3' ' CD1' ' A' ' 77' ' ' TYR . 35.9 tt0 -76.26 112.22 12.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.353 0.597 . . . . 64.319999999999993 110.62 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -70.16 127.22 32.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.043 -0.981 . . . . 72.239999999999995 110.873 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.52 HG21 ' HG3' ' A' ' 34' ' ' LYS . 44.3 pt -136.27 159.04 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.04 0.447 . . . . 71.129999999999995 111.274 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.96 176.29 30.58 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.973 -0.558 . . . . 74.120000000000005 112.232 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' CB ' ' HB3' ' A' ' 84' ' ' ASN . 16.9 t70 -55.29 -38.38 68.54 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.157 0.583 . . . . 61.5 111.346 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -84.48 -8.65 58.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 75.140000000000001 112.132 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -94.37 -12.94 26.92 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.267 0.469 . . . . 74.219999999999999 112.267 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.428 ' O ' HG23 ' A' ' 35' ' ' VAL . 31.1 m-85 -50.2 -61.79 1.96 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.29 0.478 . . . . 74.150000000000006 112.29 -175.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.08 -36.58 80.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.461 -0.336 . . . . 70.299999999999997 110.544 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.48 -57.3 13.26 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.699 0.761 . . . . 74.209999999999994 109.075 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.674 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 10.2 mmpt? -62.52 -39.17 92.67 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.363 -1.29 . . . . 62.310000000000002 111.01 -172.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 31' ' ' PHE . 96.7 t -66.34 -49.8 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.909 -0.587 . . . . 75.209999999999994 110.329 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -67.85 -17.93 64.65 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 111.711 0.263 . . . . 65.420000000000002 111.711 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -66.27 -8.88 27.62 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.962 0.356 . . . . 72.420000000000002 111.962 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.725 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.8 t -60.72 117.36 5.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.726 0.298 . . . . 71.439999999999998 110.823 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.65 -50.95 12.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 72.230000000000004 110.66 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -161.67 121.9 2.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.331 -0.395 . . . . 62.119999999999997 111.21 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 51.42 16.01 0.38 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.263 0.838 . . . . 50.520000000000003 113.263 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.724 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 44.5 mm -70.1 104.48 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.629 -0.508 . . . . 72.230000000000004 109.629 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.06 108.04 8.69 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.526 -0.761 . . . . 74.109999999999999 109.032 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.482 HG23 ' CE2' ' A' ' 77' ' ' TYR . 76.0 mt -100.31 113.58 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.965 -1.016 . . . . 72.239999999999995 110.814 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.0 mp -105.24 142.75 34.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.731 -0.668 . . . . 74.329999999999998 109.291 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 77' ' ' TYR . 57.6 t -129.96 109.44 17.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.391 -0.596 . . . . 75.140000000000001 109.391 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -90.54 143.83 26.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.072 0.463 . . . . 75.450000000000003 110.111 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.2 t80 . . . . . 0 C--N 1.322 -0.622 0 N-CA-C 108.954 -0.758 . . . . 70.140000000000001 108.954 177.582 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.434 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 53.9 ttt-85 . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.724 0.297 . . . . 70.030000000000001 111.095 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.575 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 15.2 m -65.11 -34.36 78.22 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.736 0.779 . . . . 72.340000000000003 110.905 -177.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.46 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.2 mm? -65.65 -24.14 66.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.364 -0.835 . . . . 64.239999999999995 111.623 -175.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.439 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 40.7 tt0 -62.69 -63.69 3.89 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 120.578 -0.449 . . . . 63.350000000000001 109.842 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.439 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 31.0 Cg_endo -63.44 -31.64 71.92 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.724 1.616 . . . . 53.130000000000003 112.541 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 58' ' ' SER . 28.0 mt-30 -66.52 -52.94 40.42 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.38 -0.528 . . . . 60.219999999999999 111.687 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.95 -35.26 80.1 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.176 -0.305 . . . . 74.219999999999999 110.176 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.498 ' OE1' HG12 ' A' ' 23' ' ' ILE . 5.2 mm-40 -59.92 -42.92 94.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.877 -0.601 . . . . 65.519999999999996 110.811 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -59.31 -55.14 38.54 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.334 0.588 . . . . 75.129999999999995 109.892 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.6 mt -59.47 -33.63 71.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.028 -0.987 . . . . 63.130000000000003 110.102 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.574 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.7 -44.73 92.8 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.82 -0.627 . . . . 64.019999999999996 110.105 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 51.8 mt-30 -63.82 -47.12 82.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.087 -0.506 . . . . 72.150000000000006 111.134 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -69.42 -41.37 76.44 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.216 -0.447 . . . . 61.229999999999997 111.614 -175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -102.72 5.72 39.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.641 0.608 . . . . 72.420000000000002 112.641 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.35 -19.42 2.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.189 0.811 . . . . 62.43 113.189 -169.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.88 -42.3 93.47 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.599 0.238 . . . . 70.430000000000007 110.771 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -128.03 -2.84 5.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.377 -0.374 . . . . 73.040000000000006 111.886 -175.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.9 t -112.36 131.94 62.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.923 0.392 . . . . 74.439999999999998 110.821 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -135.65 120.12 18.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.773 -0.649 . . . . 64.120000000000005 110.201 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.521 HD13 ' HB2' ' A' ' 67' ' ' ALA . 3.6 mp -106.32 137.34 37.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.65 -0.5 . . . . 74.299999999999997 109.65 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.541 ' CE1' ' HD3' ' A' ' 34' ' ' LYS . 76.0 m-85 -131.3 165.77 22.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 72.239999999999995 109.993 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.581 ' NZ ' HG21 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -158.16 166.72 31.73 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.158 0.504 . . . . 52.420000000000002 110.91 169.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 tp -73.0 147.51 9.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.077 -0.965 . . . . 61.240000000000002 112.211 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.504 ' C ' HD22 ' A' ' 80' ' ' ASN . 0.2 OUTLIER -108.05 -58.32 2.0 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.402 -0.817 . . . . 61.530000000000001 110.452 175.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.1 mt -70.58 105.43 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.992 0.425 . . . . 63.310000000000002 111.235 -173.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -56.3 -33.9 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.674 -0.694 . . . . 74.239999999999995 111.2 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -87.83 2.67 50.78 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.193 -0.458 . . . . 73.439999999999998 111.466 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.429 ' HB3' ' CB ' ' A' ' 28' ' ' ASP . 11.2 m120 -139.38 90.18 2.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.034 0.445 . . . . 73.319999999999993 110.263 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -117.94 13.59 14.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.486 -0.779 . . . . 73.340000000000003 109.418 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 32.7 t70 -49.52 -50.97 39.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.432 -0.804 . . . . 73.439999999999998 110.943 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.2 t -53.15 -37.75 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.655 -0.702 . . . . 73.049999999999997 110.871 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.38 -43.9 84.59 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.294 0.569 . . . . 74.439999999999998 109.828 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.2 m -66.65 -30.1 70.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.489 -0.778 . . . . 61.109999999999999 110.686 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 18.5 mm-40 -74.13 -41.65 61.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.893 -0.594 . . . . 73.140000000000001 111.089 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -74.51 -31.34 62.13 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 111.718 0.266 . . . . 74.439999999999998 111.718 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.53 43.58 0.26 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.286 -0.959 . . . . 73.450000000000003 113.781 172.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.2 t -90.55 107.38 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.569 -0.53 . . . . 64.019999999999996 109.569 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 t -135.2 21.15 3.44 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.203 0.525 . . . . 70.040000000000006 110.551 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.66 168.47 19.21 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.065 -0.516 . . . . 72.230000000000004 110.05 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.754 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 48.0 mm -67.86 -53.04 22.37 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.56 -0.291 . . . . 74.010000000000005 110.646 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.754 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 58.6 Cg_endo -102.75 107.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 123.1 2.533 . . . . 73.109999999999999 111.834 172.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.5 m -132.14 118.92 20.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.791 -0.186 . . . . 61.43 110.798 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.8 mp -110.48 115.25 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 110.262 -0.273 . . . . 74.329999999999998 110.262 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.59 137.3 32.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.399 -0.593 . . . . 60.240000000000002 109.399 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.409 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 51.6 mtp -115.92 143.48 45.37 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.817 0.28 . . . . 72.010000000000005 110.429 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -142.78 152.86 42.71 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.267 -0.642 . . . . 71.430000000000007 109.267 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -143.49 107.49 4.71 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.508 -0.477 . . . . 73.129999999999995 111.597 176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.725 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 10.5 t30 53.0 36.2 21.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.48 0.657 . . . . 74.319999999999993 111.584 174.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.41 -16.63 55.63 Favored Glycine 0 N--CA 1.454 -0.117 0 CA-C-N 115.759 -0.655 . . . . 63.130000000000003 112.644 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -81.6 145.17 30.75 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.363 -0.606 . . . . 73.120000000000005 109.363 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -61.86 160.5 11.95 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.516 0.674 . . . . 51.119999999999997 110.826 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.409 ' HB3' ' C ' ' A' ' 101' ' ' MET . 0.2 OUTLIER -162.28 167.36 24.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.364 -1.347 . . . . 74.450000000000003 107.364 -168.509 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.404 ' H ' HD13 ' A' ' 108' ' ' LEU . 73.1 m -70.96 178.29 3.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.958 0.885 . . . . 34.140000000000001 112.687 -165.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -140.84 118.44 11.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.854 -1.067 . . . . 73.150000000000006 108.912 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 42.5 t -93.81 107.12 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.171 0.51 . . . . 75.230000000000004 110.02 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.1 mt -92.72 107.31 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.623 -0.717 . . . . 74.140000000000001 109.471 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.615 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 110.97 158.44 15.49 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.46 -0.656 . . . . 52.520000000000003 111.46 -175.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.46 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -81.92 78.53 8.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.721 0.296 . . . . 64.109999999999999 110.844 -178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.413 ' O ' HG13 ' A' ' 119' ' ' ILE . 19.3 m-20 -117.1 80.96 1.56 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.079 0.466 . . . . 70.420000000000002 110.048 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.428 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -59.11 -32.09 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.773 -0.648 . . . . 72.430000000000007 109.799 -177.195 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.8 m -58.36 -50.0 75.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.91 -0.587 . . . . 41.039999999999999 110.39 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -69.45 -35.8 76.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.219 -0.446 . . . . 75.25 110.313 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 123' ' ' ILE . 76.4 mt -58.33 -56.39 16.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.188 -0.46 . . . . 72.040000000000006 110.513 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.31 -34.74 71.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.129 -0.487 . . . . 74.049999999999997 110.346 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.5 t -57.06 -49.72 74.98 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.153 -0.476 . . . . 72.150000000000006 109.787 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -62.31 -38.54 89.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.476 -0.329 . . . . 63.229999999999997 110.573 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 119' ' ' ILE . 58.3 mt -57.62 -56.5 15.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.672 0.272 . . . . 64.230000000000004 110.938 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -71.33 -25.16 62.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.761 0.315 . . . . 74.200000000000003 110.626 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.48 -44.11 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 73.150000000000006 111.132 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -93.0 -18.06 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 73.200000000000003 111.975 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.5 mt -76.78 -53.28 15.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 120.929 0.395 . . . . 74.310000000000002 110.054 173.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.1 m120 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.377 -0.821 . . . . 75.420000000000002 110.392 -178.664 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.1 mmm . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.61 0.243 . . . . 74.209999999999994 110.664 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.521 HG12 ' OE2' ' A' ' 64' ' ' GLU . 12.9 mm -69.73 97.61 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 109.653 -0.499 . . . . 72.25 109.653 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.8 124.11 24.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 75.530000000000001 110.81 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.576 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -90.72 128.98 36.85 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.687 -0.486 . . . . 72.329999999999998 109.687 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 39.9 pt -141.77 179.85 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.12 -0.491 . . . . 61.539999999999999 110.735 -176.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.2 -177.74 15.15 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.643 -0.983 . . . . 75.439999999999998 110.643 171.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 13.3 t70 -52.73 -43.12 65.51 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.856 0.36 . . . . 75.439999999999998 110.973 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 p -63.17 -24.01 67.7 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.013 -0.54 . . . . 72.420000000000002 112.26 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 16.8 mp0 -96.99 -32.39 12.03 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.761 -0.199 . . . . 71.209999999999994 111.117 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.461 ' HA ' HD12 ' A' ' 26' ' ' ILE . 85.0 t80 -41.24 -61.8 0.96 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.002 0.742 . . . . 74.540000000000006 113.002 -166.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.4 -50.27 65.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.715 0.293 . . . . 75.409999999999997 111.116 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 33' ' ' ASN . 0.9 OUTLIER -60.36 -51.56 68.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.031 -0.531 . . . . 65.439999999999998 110.734 -177.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.45 ' HG3' HG21 ' A' ' 26' ' ' ILE . 70.7 mmtt -59.45 -36.66 76.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.812 -0.631 . . . . 65.120000000000005 111.049 -176.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.3 -54.66 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.13 -0.487 . . . . 55.340000000000003 111.309 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.8 p -62.92 -25.65 68.43 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.564 0.221 . . . . 63.310000000000002 111.559 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.6 t -75.35 5.51 5.6 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.589 -0.278 . . . . 73.409999999999997 111.674 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 24.4 p -62.52 140.83 58.63 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.875 -0.417 . . . . 44.530000000000001 109.875 175.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -58.41 -83.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.556 -0.293 . . . . 61.310000000000002 110.837 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -161.95 152.54 17.44 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.082 -0.71 . . . . 73.5 109.082 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.448 HD22 ' ND2' ' A' ' 73' ' ' ASN . 2.1 p-10 45.84 22.07 0.11 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.702 0.801 . . . . 75.140000000000001 112.685 -177.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 mm -81.95 127.25 39.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 120.607 0.241 . . . . 75.310000000000002 110.427 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.9 tp -88.43 108.59 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.143 0.497 . . . . 63.520000000000003 110.041 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 38' ' ' CYS . 57.4 mt -101.33 114.36 40.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.652 -0.704 . . . . 72.5 110.366 178.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 mp -99.04 118.77 36.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.182 -0.673 . . . . 70.129999999999995 109.182 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 67.0 t -104.34 105.02 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 110.002 -0.37 . . . . 54.32 110.002 175.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.81 156.53 20.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.95 0.405 . . . . 74.400000000000006 110.526 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.3 t80 . . . . . 0 C--N 1.327 -0.401 0 N-CA-C 109.118 -0.697 . . . . 74.310000000000002 109.118 174.469 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' A' ' 57' ' ' ARG . 2.3 tmt_? . . . . . 0 C--O 1.223 -0.309 0 CA-C-O 120.487 0.184 . . . . 75.450000000000003 110.637 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.622 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 16.6 m -75.67 -57.12 4.07 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.484 0.659 . . . . 62.43 111.388 175.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.43 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.2 mm? -60.57 -42.55 96.86 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.498 -0.774 . . . . 74.530000000000001 112.625 -168.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.1 -59.18 12.52 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 117.917 0.326 . . . . 64.409999999999997 111.226 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.4 -33.24 58.83 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.678 1.585 . . . . 65.439999999999998 112.691 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.6 mt-30 -59.46 -45.85 90.44 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.021 -0.672 . . . . 75.310000000000002 110.7 173.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 84.5 mt -62.7 -43.74 98.02 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.155 -0.475 . . . . 63.109999999999999 110.33 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.587 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 25.7 mm-40 -53.63 -53.25 54.51 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.053 -0.521 . . . . 70.319999999999993 110.377 174.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -51.34 -52.9 41.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.989 -0.551 . . . . 62.530000000000001 110.709 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.0 -31.69 72.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 75.140000000000001 110.694 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.648 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -71.7 -25.15 61.97 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.267 -0.424 . . . . 75.010000000000005 110.725 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 89.3 mt-30 -85.21 -37.93 19.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.992 0.425 . . . . 61.200000000000003 110.493 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -74.41 -50.54 18.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 71.209999999999994 110.936 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -90.45 5.09 49.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.553 -0.749 . . . . 74.439999999999998 112.159 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.648 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.6 t -53.04 -24.34 9.57 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.639 0.607 . . . . 63.229999999999997 112.639 -172.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -59.35 -18.79 41.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.069 0.462 . . . . 74.010000000000005 110.859 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.448 ' ND2' HD22 ' A' ' 41' ' ' ASN . 26.4 t-20 -133.44 -29.31 1.39 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.748 -0.66 . . . . 72.230000000000004 111.365 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.425 HG23 HD11 ' A' ' 127' ' ' ILE . 66.0 t -105.49 144.36 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 112.285 0.476 . . . . 75.150000000000006 112.285 -169.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 45.6 mmtm -142.53 140.04 31.65 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.689 -0.856 . . . . 74.439999999999998 108.689 170.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mt -117.06 138.3 48.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.012 0.434 . . . . 71.329999999999998 111.027 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 57.0 m-85 -131.29 162.62 29.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.374 -0.83 . . . . 70.349999999999994 109.072 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -157.03 136.18 11.93 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.897 0.38 . . . . 75.030000000000001 110.902 173.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.659 HG12 HG11 ' A' ' 87' ' ' VAL . 2.3 mp -71.09 100.2 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.221 -0.659 . . . . 51.530000000000001 109.221 177.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -103.7 -1.64 27.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.761 -0.654 . . . . 64.109999999999999 109.856 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.6 mm -95.93 96.72 5.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.789 -0.642 . . . . 63.43 110.405 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.79 -22.1 63.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.939 -0.573 . . . . 75.239999999999995 110.921 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.1 -23.57 62.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.113 0.482 . . . . 72.5 110.045 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 30.3 m-80 -111.53 77.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.226 -0.657 . . . . 73.450000000000003 109.226 176.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -100.34 -21.84 15.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.683 -0.689 . . . . 73.200000000000003 111.77 -170.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.558 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 4.4 m-20 -52.26 -34.55 46.71 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.703 0.631 . . . . 74.120000000000005 112.703 -174.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.659 HG11 HG12 ' A' ' 79' ' ' ILE . 14.7 p -53.36 -39.79 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.155 0.503 . . . . 75.150000000000006 110.543 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.42 -41.13 93.9 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.876 -0.602 . . . . 62.140000000000001 110.274 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 m -62.07 -40.66 96.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.553 -0.748 . . . . 62.340000000000003 109.824 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 30.0 mm-40 -64.67 -46.5 82.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.288 -0.869 . . . . 45.049999999999997 110.988 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.43 ' HH ' ' HE2' ' A' ' 31' ' ' PHE . 82.5 m-85 -80.77 -15.54 56.17 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 121.108 -0.237 . . . . 71.239999999999995 111.383 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.18 52.48 31.72 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.059 -0.591 . . . . 64.140000000000001 112.644 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.65 112.5 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.958 0.408 . . . . 71.109999999999999 110.36 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.5 t -90.24 -55.97 3.4 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.211 -0.45 . . . . 74.319999999999993 110.641 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.62 155.88 33.14 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.172 -0.467 . . . . 72.239999999999995 110.437 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.743 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 45.1 mm -69.68 -59.77 4.38 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.669 -0.241 . . . . 73.409999999999997 110.741 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.743 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 1.9 Cg_endo -80.28 74.57 5.48 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.048 1.832 . . . . 72.049999999999997 111.098 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.7 m -113.1 124.92 53.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 70.230000000000004 110.701 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -110.06 117.5 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.41 -0.359 . . . . 34.340000000000003 110.173 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.52 HD23 ' HG3' ' A' ' 110' ' ' GLN . 86.9 mt -88.35 122.98 32.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.907 -0.775 . . . . 73.230000000000004 108.907 174.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 56.9 mtp -96.93 143.66 27.6 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.931 -0.396 . . . . 72.349999999999994 109.931 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -141.38 144.93 34.78 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.283 -0.636 . . . . 64.120000000000005 109.283 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 22.3 tptm -129.68 104.38 7.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.194 -0.299 . . . . 74.140000000000001 110.194 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.591 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 65.8 t30 46.22 46.94 13.43 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.971 0.508 . . . . 75.25 111.934 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.13 -15.51 57.97 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.401 -0.428 . . . . 73.299999999999997 113.806 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 52.6 tttp -82.84 144.57 30.01 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.622 0.369 . . . . 74.540000000000006 110.894 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -68.97 142.25 54.73 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.021 0.439 . . . . 71.010000000000005 110.098 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.58 169.05 19.18 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.126 0.971 . . . . 75.420000000000002 108.907 -169.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.8 m -69.22 173.2 5.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.529 0.681 . . . . 75.340000000000003 112.539 -162.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.52 ' HG3' HD23 ' A' ' 100' ' ' LEU . 20.0 tt0 -125.9 122.42 35.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 65.140000000000001 109.673 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.555 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.4 t -92.73 110.36 22.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.971 -0.381 . . . . 74.329999999999998 109.971 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.5 mp -94.2 122.15 45.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.74 -0.467 . . . . 64.150000000000006 109.74 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.86 146.7 20.87 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 116.32 -0.4 . . . . 75.239999999999995 112.249 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.64 77.74 1.09 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.929 0.395 . . . . 72.230000000000004 110.203 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -125.2 97.06 5.07 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.366 0.603 . . . . 62.100000000000001 109.905 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -26.42 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.33 -0.85 . . . . 71.239999999999995 109.882 -174.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.7 t -63.4 -47.21 82.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 109.881 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -65.37 -43.97 89.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.272 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.508 ' O ' HG13 ' A' ' 123' ' ' ILE . 73.8 mt -55.79 -56.26 13.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.17 -0.468 . . . . 60.039999999999999 110.663 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.1 tt -64.31 -33.83 65.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.326 -0.397 . . . . 71.239999999999995 110.422 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.4 t -57.3 -52.36 65.66 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.203 -0.453 . . . . 70.400000000000006 110.071 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.2 -37.23 86.65 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.457 -0.338 . . . . 74.439999999999998 110.411 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 119' ' ' ILE . 65.7 mt -56.42 -56.39 13.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 120.716 0.293 . . . . 61.109999999999999 111.098 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -71.52 -27.54 63.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.991 -0.284 . . . . 74.319999999999993 110.441 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -65.76 -34.55 78.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.805 0.336 . . . . 75.450000000000003 110.505 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -79.14 -42.94 25.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.316 -0.402 . . . . 61.310000000000002 111.339 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 74' ' ' VAL . 56.6 mt -69.74 -46.06 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 65.319999999999993 110.738 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.426 -0.797 . . . . 74.230000000000004 109.815 -177.329 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.3 ptm . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.984 0.421 . . . . 75.230000000000004 109.884 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.51 129.43 35.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 51.130000000000003 109.906 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -83.4 150.31 26.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.335 -0.393 . . . . 73.25 110.146 -176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -119.71 130.14 54.86 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.966 0.413 . . . . 72.129999999999995 110.652 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.9 pt -138.81 177.01 5.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.795 -0.638 . . . . 74.349999999999994 110.3 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.88 -179.06 16.46 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.163 -0.542 . . . . 61.43 112.422 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.01 -47.24 71.68 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.301 0.64 . . . . 74.200000000000003 111.173 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.9 t -75.32 -20.45 59.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.821 -0.627 . . . . 23.34 111.711 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -91.61 -8.58 46.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.432 0.158 . . . . 74.329999999999998 110.961 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -53.67 -62.5 1.61 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 111.938 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -61.24 -47.68 84.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.979 0.419 . . . . 52.119999999999997 110.872 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -55.42 -55.3 33.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.591 -0.731 . . . . 71.340000000000003 111.411 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.27 -32.17 68.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.56 -0.291 . . . . 72.120000000000005 111.563 -174.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.93 -38.6 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.805 0.336 . . . . 64.319999999999993 110.882 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.0 p -82.58 -20.6 36.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.812 0.339 . . . . 61.340000000000003 110.994 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -71.67 5.66 2.35 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.21 -0.45 . . . . 41.210000000000001 112.101 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.77 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 25.5 p -56.95 142.38 41.86 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.154 -0.313 . . . . 61.119999999999997 110.154 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -58.93 -74.46 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.572 0.225 . . . . 72.25 110.53 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -153.12 122.0 6.49 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.874 -0.417 . . . . 43.450000000000003 109.874 175.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 55.48 21.82 4.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.512 0.56 . . . . 74.120000000000005 112.512 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.77 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.0 mm -74.69 113.45 13.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 110.121 -0.326 . . . . 74.0 110.121 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.04 113.68 9.33 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.036 -0.728 . . . . 43.25 109.036 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.438 HG23 ' CD1' ' A' ' 77' ' ' TYR . 47.8 mt -106.48 114.4 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.736 -0.665 . . . . 75.239999999999995 110.9 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.44 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -92.55 154.21 18.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.266 -0.642 . . . . 71.200000000000003 109.266 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 63.0 t -132.61 104.96 8.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.459 -0.571 . . . . 65.519999999999996 109.459 176.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.577 ' CG ' ' HZ2' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -94.48 161.73 14.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.171 -0.468 . . . . 65.209999999999994 110.459 -176.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.8 t80 . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 115.742 -0.663 . . . . 70.099999999999994 110.121 168.149 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 120.97 0.414 . . . . 75.430000000000007 110.309 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.667 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 31.5 t -74.89 -38.14 61.94 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.438 0.637 . . . . 63.210000000000001 109.944 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.543 HD13 ' HG ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -55.68 -28.32 54.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.299 -0.864 . . . . 65.409999999999997 110.487 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.587 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 41.2 mt-10 -59.19 -67.7 0.93 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.738 -0.21 . . . . 75.129999999999995 110.776 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.587 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 32.6 Cg_endo -62.62 -28.5 77.08 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 121.518 1.478 . . . . 41.130000000000003 111.972 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.0 mt-30 -62.35 -47.3 84.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.711 -0.396 . . . . 63.340000000000003 111.646 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.543 ' HG ' HD13 ' A' ' 59' ' ' LEU . 22.1 mt -66.92 -39.98 87.53 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.962 -0.295 . . . . 64.120000000000005 110.561 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -64.58 -31.13 72.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.455 -0.338 . . . . 75.200000000000003 110.357 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.6 -53.63 48.66 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.334 0.588 . . . . 74.340000000000003 109.589 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.438 HD11 ' CD1' ' A' ' 116' ' ' ILE . 19.5 mt -61.76 -31.13 71.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.339 -0.846 . . . . 71.409999999999997 110.128 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.73 -53.54 39.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.039 -0.528 . . . . 62.119999999999997 110.11 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -61.78 -34.44 75.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.299 -0.41 . . . . 74.519999999999996 111.202 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -75.87 -40.7 54.1 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.129 -0.487 . . . . 51.25 111.101 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -104.66 5.27 33.45 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.049 0.54 . . . . 75.340000000000003 112.359 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.1 t -53.3 -18.89 2.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.37 0.507 . . . . 74.129999999999995 112.37 -173.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.15 -43.45 82.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.822 0.344 . . . . 74.439999999999998 110.441 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -129.25 8.13 5.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.939 -0.573 . . . . 64.340000000000003 111.73 -175.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t -125.81 138.42 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.008 0.432 . . . . 74.099999999999994 111.774 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 24.4 tptp -141.6 120.0 12.33 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.713 -0.676 . . . . 72.420000000000002 109.217 174.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.44 HG12 ' HB2' ' A' ' 45' ' ' LEU . 55.6 mt -96.92 141.19 16.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 120.757 0.313 . . . . 74.129999999999995 110.855 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.438 ' CD1' HG23 ' A' ' 44' ' ' ILE . 30.6 m-85 -126.13 162.44 25.35 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.614 0.766 . . . . 71.340000000000003 109.784 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 4.4 ttmp? -135.62 125.65 26.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.543 -0.54 . . . . 75.140000000000001 109.543 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.3 pt -91.4 117.83 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.948 0.404 . . . . 73.140000000000001 111.023 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.97 93.3 5.06 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.462 0.649 . . . . 50.329999999999998 110.58 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.447 HD12 ' NE2' ' A' ' 85' ' ' GLN . 41.7 pt -54.92 -23.93 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.355 -0.839 . . . . 74.319999999999993 111.969 -177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -48.16 -40.94 25.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.729 0.411 . . . . 75.439999999999998 111.631 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.18 -33.75 67.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.924 0.392 . . . . 72.239999999999995 110.916 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 177.68 144.22 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.514 -0.921 . . . . 62.299999999999997 108.514 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.482 HE21 ' HB2' ' A' ' 85' ' ' GLN . 5.7 tt0 -124.48 -0.92 8.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.806 0.298 . . . . 74.230000000000004 111.806 -168.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 1.2 m-20 -49.08 -48.74 43.97 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.161 -0.472 . . . . 73.310000000000002 111.829 -175.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.8 t -53.79 -38.35 35.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-O 120.909 0.385 . . . . 54.009999999999998 110.934 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.06 88.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.138 0.494 . . . . 55.409999999999997 110.064 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.1 m -68.75 -36.75 78.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.679 -0.692 . . . . 75.420000000000002 110.618 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.557 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 97.5 mt-30 -60.82 -57.78 11.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.274 -0.421 . . . . 74.400000000000006 110.61 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -75.01 -24.47 58.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 63.0 111.292 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.75 73.19 1.14 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.94 -0.648 . . . . 53.310000000000002 113.08 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.0 t -89.72 91.49 3.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.88 -0.785 . . . . 71.219999999999999 108.88 172.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.4 p -74.52 -47.9 30.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.648 -0.706 . . . . 53.210000000000001 111.779 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.16 164.57 11.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 62.329999999999998 110.506 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 49.2 mm -62.08 -55.45 40.67 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 123.184 0.302 . . . . 72.420000000000002 110.605 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 2.1 Cg_endo -81.0 104.44 1.55 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.968 1.779 . . . . 75.409999999999997 110.978 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.425 ' C ' HD12 ' A' ' 99' ' ' ILE . 69.9 m -139.15 138.5 37.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.812 0.339 . . . . 73.540000000000006 110.852 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.463 HG12 HD11 ' A' ' 63' ' ' LEU . 2.0 mp -120.34 114.59 44.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 115.829 -0.623 . . . . 62.229999999999997 110.26 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.9 mp -90.6 156.09 18.39 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.254 -0.647 . . . . 65.019999999999996 109.254 173.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.425 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . 48.8 mtp -126.27 139.5 53.27 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.965 -0.754 . . . . 73.129999999999995 108.965 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.45 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.3 m-85 -147.63 157.02 43.37 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.668 -0.493 . . . . 73.319999999999993 109.668 176.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 40.6 ttpt -151.1 109.41 3.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.491 -0.483 . . . . 74.030000000000001 111.595 175.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.703 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 66.2 t30 55.9 36.9 28.17 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.485 0.66 . . . . 73.450000000000003 111.24 174.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.66 -16.68 58.65 Favored Glycine 0 CA--C 1.518 0.275 0 CA-C-N 115.647 -0.706 . . . . 71.519999999999996 112.829 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 12.8 ttmt -74.33 135.21 42.53 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 116.813 0.306 . . . . 70.239999999999995 110.393 177.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -77.9 88.05 4.1 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.19 0.995 . . . . 73.109999999999999 110.751 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.475 HD11 ' CG ' ' A' ' 126' ' ' ASN . 0.3 OUTLIER -71.84 168.85 17.02 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.35 -1.75 . . . . 74.519999999999996 109.782 172.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.9 m -69.87 -177.61 1.34 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.277 0.631 . . . . 74.310000000000002 112.353 -166.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -142.38 121.41 12.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 110.214 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.45 115.81 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 70.200000000000003 110.135 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.1 mt -89.51 128.23 41.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.579 . . . . 63.310000000000002 110.38 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.17 -155.77 30.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.172 -0.537 . . . . 64.120000000000005 112.3 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -105.99 112.62 25.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.783 -0.451 . . . . 65.450000000000003 109.783 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 119' ' ' ILE . 5.4 t70 -154.05 82.58 1.14 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.376 0.608 . . . . 70.099999999999994 110.246 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.547 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -60.24 -29.53 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.356 -0.838 . . . . 74.010000000000005 110.67 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.9 t -66.39 -54.25 26.56 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.124 0.488 . . . . 75.299999999999997 110.086 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -57.77 -46.21 84.88 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.814 -0.63 . . . . 72.329999999999998 110.167 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.504 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.7 mt -56.47 -56.34 14.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.879 -0.601 . . . . 75.230000000000004 111.091 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -63.21 -34.18 65.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 120.56 0.219 . . . . 75.340000000000003 110.696 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 t -60.1 -52.15 66.59 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.369 -0.378 . . . . 54.229999999999997 110.063 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.3 -40.31 93.68 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.212 -0.449 . . . . 75.099999999999994 110.149 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.555 ' O ' HG13 ' A' ' 127' ' ' ILE . 53.2 mt -57.12 -56.33 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.859 -0.61 . . . . 64.010000000000005 111.273 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.82 -33.41 72.29 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 120.42 -0.512 . . . . 65.230000000000004 110.198 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -58.66 -36.26 73.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.12 -0.491 . . . . 62.439999999999998 110.362 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.475 ' CG ' HD11 ' A' ' 108' ' ' LEU . 39.2 m-80 -108.81 1.31 20.87 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.369 0.877 . . . . 50.310000000000002 113.369 -175.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 123' ' ' ILE . 46.6 mt -84.12 -52.95 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.378 -0.971 . . . . 74.340000000000003 108.378 166.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.417 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.408 -0.814 . . . . 74.109999999999999 109.688 175.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.884 0.374 . . . . 71.430000000000007 110.057 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.62 116.14 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.145 -0.48 . . . . 52.409999999999997 110.732 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -63.73 131.48 48.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.015 -0.539 . . . . 64.409999999999997 110.905 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -138.38 150.89 46.99 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.067 -0.515 . . . . 71.319999999999993 110.248 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -62.03 153.07 30.72 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.48 -0.327 . . . . 71.540000000000006 110.217 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 50.6 m170 -96.56 149.91 21.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.186 0.517 . . . . 73.209999999999994 111.417 -172.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.908 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 44.0 m80 -145.77 -179.27 6.58 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.127 -1.064 . . . . 75.5 108.127 172.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -162.73 145.75 10.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.887 0.312 . . . . 72.010000000000005 111.186 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.0 mmt -93.74 150.87 20.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 62.43 109.846 175.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.45 -64.24 4.57 Favored Glycine 0 C--N 1.335 0.486 0 N-CA-C 111.464 -0.654 . . . . 73.209999999999994 111.464 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.9 t -156.17 133.91 11.06 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.76 -0.83 . . . . 73.010000000000005 108.76 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 34.4 tp -87.33 90.97 8.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.936 0.398 . . . . 62.109999999999999 111.194 -172.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -137.23 176.36 8.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.742 -0.663 . . . . 72.340000000000003 109.451 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.98 85.38 0.7 Allowed 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.83 -0.804 . . . . 63.130000000000003 108.83 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -83.71 171.79 12.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.423 -0.808 . . . . 73.25 111.589 -174.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.5 m -90.84 26.15 2.17 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.904 0.859 . . . . 75.209999999999994 109.858 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -160.32 111.1 1.86 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.149 -0.932 . . . . 73.349999999999994 109.839 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.41 177.72 15.4 Favored Glycine 0 CA--C 1.519 0.308 0 N-CA-C 111.819 -0.512 . . . . 71.319999999999993 111.819 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -88.43 13.9 2.43 Favored 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.064 2.509 . . . . 62.399999999999999 112.46 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.02 -170.46 29.05 Favored Glycine 0 N--CA 1.452 -0.281 0 N-CA-C 111.83 -0.508 . . . . 74.25 111.83 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 p -82.99 118.36 23.45 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.567 0.222 . . . . 74.409999999999997 110.822 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.8 mmt -78.13 -49.01 14.71 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.296 -0.631 . . . . 55.119999999999997 109.296 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 76' ' ' ILE . 3.6 mm -82.84 81.74 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 108.55 -0.908 . . . . 72.230000000000004 108.55 176.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 77' ' ' TYR . 7.4 tp10 -69.47 161.54 29.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.728 -0.669 . . . . 60.340000000000003 111.807 -170.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.404 ' H ' ' HG3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -96.75 138.69 33.93 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.01 -0.541 . . . . 74.349999999999994 110.901 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.7 pt -148.53 169.0 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.18 0.514 . . . . 71.420000000000002 111.158 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.15 -163.95 11.46 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 109.922 -1.271 . . . . 53.409999999999997 109.922 169.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -63.33 -39.64 95.1 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 117.56 0.68 . . . . 75.310000000000002 110.298 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 p -64.47 -38.35 90.7 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.576 -0.738 . . . . 72.140000000000001 111.706 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -83.89 -29.08 27.49 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.688 -0.233 . . . . 64.209999999999994 110.897 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -47.61 -61.64 1.83 Allowed 'General case' 0 C--O 1.238 0.471 0 O-C-N 123.482 0.489 . . . . 63.329999999999998 111.426 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -56.08 -45.1 79.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 75.150000000000006 110.928 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -58.46 -53.8 54.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.0 -0.545 . . . . 73.040000000000006 111.206 -178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -65.31 -38.72 91.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.066 -0.516 . . . . 70.209999999999994 111.117 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.533 ' HA ' HG13 ' A' ' 44' ' ' ILE . 56.8 t -72.64 -42.01 62.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.302 0.482 . . . . 73.219999999999999 112.302 -176.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.2 p -85.96 -45.29 11.62 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.116 0.413 . . . . 55.030000000000001 112.116 -175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t -86.87 10.47 16.02 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.28 -0.418 . . . . 73.439999999999998 112.096 -172.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 7.5 p -71.29 81.49 0.74 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.88 0.371 . . . . 71.319999999999993 111.261 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 29.9 -93.89 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.776 1.231 . . . . 72.340000000000003 113.355 177.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -161.72 132.32 5.04 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.637 0.375 . . . . 74.409999999999997 110.526 -175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 54.98 14.69 0.98 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.544 0.572 . . . . 64.120000000000005 112.544 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.9 mm -74.45 115.55 15.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.857 0.36 . . . . 63.420000000000002 110.13 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 102' ' ' PHE . 42.2 tp -76.55 110.29 10.99 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.475 0.655 . . . . 73.120000000000005 110.72 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 23.6 mm -88.98 117.63 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.873 -1.058 . . . . 70.040000000000006 109.744 175.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.464 HD13 HG13 ' A' ' 74' ' ' VAL . 4.8 mp -106.68 127.85 53.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.439 -0.949 . . . . 52.509999999999998 108.439 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 57.6 t -110.97 104.39 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.273 -0.64 . . . . 74.019999999999996 109.273 175.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.02 114.37 28.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.744 -0.662 . . . . 73.040000000000006 110.141 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -76.82 133.28 39.42 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.3 -0.409 . . . . 72.319999999999993 110.03 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -116.51 168.04 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.839 -0.619 . . . . 72.099999999999994 111.165 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . . . -161.32 130.46 3.15 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.669 . . . . 72.030000000000001 109.77 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 50' ' ' ALA . 25.7 Cg_exo -63.75 -14.18 41.36 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.732 2.288 . . . . 65.540000000000006 111.816 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 31.6 t90 -118.14 80.6 1.54 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.563 -0.744 . . . . 72.209999999999994 109.446 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 41.2 t -164.97 119.06 1.28 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.688 -0.687 . . . . 75.129999999999995 110.074 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.03 -63.31 5.17 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 116.273 -0.421 . . . . 31.210000000000001 113.226 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.461 ' O ' HD23 ' A' ' 59' ' ' LEU . 40.8 Cg_exo -57.06 -47.91 20.66 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.567 2.178 . . . . 75.319999999999993 111.986 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 36.4 m -50.91 -33.62 25.01 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.865 -0.607 . . . . 74.200000000000003 111.74 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -65.06 -36.93 85.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.511 . . . . 73.340000000000003 110.69 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.639 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 28.7 t -74.57 -30.53 61.75 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-O 121.652 0.739 . . . . 53.130000000000003 110.128 176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.514 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 mm? -64.29 -20.73 66.27 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.76 -0.654 . . . . 62.149999999999999 110.872 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.518 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 54.5 mt-10 -54.92 -67.11 0.73 Allowed Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.767 -0.457 . . . . 64.540000000000006 109.767 174.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.908 ' HG3' ' HB2' ' A' ' 7' ' ' HIS . 53.6 Cg_endo -66.64 -37.27 22.28 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 121.735 1.623 . . . . 62.530000000000001 112.387 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.639 ' HG3' ' O ' ' A' ' 58' ' ' SER . 40.2 mt-30 -59.98 -55.9 28.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 120.355 -0.538 . . . . 74.510000000000005 111.062 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.58 -51.85 63.52 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.522 -0.308 . . . . 72.239999999999995 111.117 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.555 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 15.8 mm-40 -50.73 -45.63 58.78 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.86 0.362 . . . . 64.329999999999998 110.94 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -69.04 -47.63 64.89 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.387 -0.369 . . . . 74.040000000000006 111.252 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.545 HD11 HD11 ' A' ' 116' ' ' ILE . 16.9 mt -62.29 -31.34 71.92 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 120.632 -0.427 . . . . 71.310000000000002 110.455 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 71' ' ' THR . . . -66.55 -47.33 73.18 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.792 -0.447 . . . . 51.030000000000001 109.792 175.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 96.5 mt-30 -59.79 -30.59 69.0 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.101 0.477 . . . . 75.310000000000002 110.801 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -76.33 -45.22 33.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.047 -0.524 . . . . 71.25 111.086 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -103.75 5.21 35.97 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.928 0.714 . . . . 72.439999999999998 112.928 -169.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.89 -19.41 2.53 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.705 0.402 . . . . 75.129999999999995 112.072 -172.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -55.14 -40.48 70.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.079 0.466 . . . . 74.209999999999994 110.708 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -127.58 -5.88 5.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.82 -0.627 . . . . 74.109999999999999 111.398 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.464 HG13 HD13 ' A' ' 45' ' ' LEU . 42.1 t -117.06 136.28 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.921 0.391 . . . . 71.239999999999995 111.485 -175.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -141.33 120.11 12.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.686 -0.688 . . . . 64.209999999999994 109.52 173.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.433 HG22 HG23 ' A' ' 23' ' ' ILE . 50.0 mt -99.55 143.02 14.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.367 -0.379 . . . . 63.409999999999997 109.994 -178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.465 ' CD1' ' HB3' ' A' ' 24' ' ' GLU . 96.8 m-85 -135.61 154.55 51.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.839 -0.618 . . . . 72.219999999999999 109.877 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -141.26 144.1 34.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.302 -0.629 . . . . 63.030000000000001 109.302 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.2 tt -77.03 135.43 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.303 -0.408 . . . . 71.120000000000005 110.317 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -107.25 -37.54 6.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.105 -0.498 . . . . 73.400000000000006 110.411 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.532 ' N ' HD12 ' A' ' 81' ' ' ILE . 2.8 mp -81.43 103.43 8.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.906 -0.588 . . . . 74.319999999999993 110.387 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.1 -25.22 61.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 63.32 111.806 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.23 -21.22 62.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.641 0.258 . . . . 75.439999999999998 111.187 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -102.3 12.88 35.97 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.594 -0.275 . . . . 72.099999999999994 111.511 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -69.8 -9.38 54.43 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.032 0.444 . . . . 74.319999999999993 110.094 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -54.46 -30.92 54.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.434 -0.803 . . . . 53.32 110.591 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -53.03 -38.82 30.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.754 -0.657 . . . . 71.340000000000003 110.409 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.445 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -57.3 -54.48 46.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.38 -0.827 . . . . 60.200000000000003 110.547 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.7 m -60.41 -39.33 87.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.624 -0.716 . . . . 73.439999999999998 110.769 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -64.37 -44.87 90.02 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.741 -0.663 . . . . 75.540000000000006 111.831 -177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -80.09 -22.69 41.92 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.664 -0.244 . . . . 74.120000000000005 111.358 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 110.61 48.6 0.73 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.873 -0.679 . . . . 74.25 113.178 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.445 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 88.5 t -94.61 111.44 25.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.934 -0.395 . . . . 73.219999999999999 109.934 176.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.2 t -110.32 19.74 18.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.286 -0.415 . . . . 65.409999999999997 111.082 -175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.78 149.42 30.5 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 110.069 -0.345 . . . . 73.200000000000003 110.069 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.657 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 62.6 mt -61.36 -54.93 48.22 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 123.011 0.195 . . . . 64.420000000000002 110.865 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 86.3 Cg_endo -86.68 98.2 0.52 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.781 1.654 . . . . 64.150000000000006 111.234 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 m -140.42 142.61 35.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.431 . . . . 75.409999999999997 110.327 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.646 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -113.25 117.99 56.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.243 -0.435 . . . . 73.230000000000004 110.268 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.405 HD23 ' HG3' ' A' ' 110' ' ' GLN . 98.7 mt -94.17 122.95 37.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.507 -0.923 . . . . 64.430000000000007 108.507 172.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.447 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 51.2 mtp -100.2 146.9 26.31 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.919 -0.4 . . . . 70.310000000000002 109.919 -177.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.562 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 98.6 m-85 -149.56 161.87 41.3 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.51 -0.552 . . . . 75.400000000000006 109.51 176.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -151.34 107.17 3.39 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 122.294 -0.254 . . . . 72.299999999999997 111.101 176.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.552 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 3.1 t-20 55.42 35.9 26.0 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.282 0.563 . . . . 63.0 111.273 173.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.33 -16.33 56.25 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 116.08 -0.509 . . . . 71.219999999999999 112.756 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -79.95 143.82 33.85 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.546 -0.538 . . . . 71.209999999999994 109.546 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -67.91 162.57 23.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.263 0.554 . . . . 73.129999999999995 110.949 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.61 168.3 21.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.763 -1.108 . . . . 72.329999999999998 108.117 -164.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -70.27 179.75 2.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.592 0.711 . . . . 75.019999999999996 112.458 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.405 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.8 tt0 -139.73 118.91 12.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.403 -0.817 . . . . 73.349999999999994 109.446 -177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.646 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.0 t -97.54 113.18 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 74.540000000000006 110.552 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.0 mp -88.22 108.37 18.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 109.394 -0.595 . . . . 74.140000000000001 109.394 177.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.85 143.24 10.65 Favored Glycine 0 N--CA 1.452 -0.283 0 N-CA-C 111.775 -0.53 . . . . 52.149999999999999 111.775 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.514 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -74.65 72.04 1.94 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.936 0.398 . . . . 54.32 110.155 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.415 ' O ' HG13 ' A' ' 119' ' ' ILE . 19.4 t70 -111.08 105.35 14.06 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.893 -0.594 . . . . 73.219999999999999 110.69 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.554 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -59.08 -31.98 46.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.301 -0.863 . . . . 61.130000000000003 110.209 -176.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 24.4 m -62.4 -55.79 24.52 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.349 -0.387 . . . . 71.129999999999995 110.931 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -63.57 -41.34 98.39 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.544 0.212 . . . . 63.310000000000002 110.461 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 123' ' ' ILE . 80.6 mt -56.21 -56.28 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.307 -0.406 . . . . 64.310000000000002 110.482 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.5 tt -63.75 -33.9 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.481 -0.327 . . . . 54.049999999999997 110.662 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 67.7 m -57.84 -49.49 76.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.433 -0.349 . . . . 74.120000000000005 110.242 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -69.74 -36.44 75.83 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.464 -0.335 . . . . 72.299999999999997 110.924 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 119' ' ' ILE . 70.8 mt -56.08 -55.95 15.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 64.310000000000002 109.779 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -58.49 -42.47 87.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.546 -0.752 . . . . 71.239999999999995 110.495 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -60.59 -33.7 73.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.319 -0.855 . . . . 75.219999999999999 111.263 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.408 ' OD1' HD11 ' A' ' 108' ' ' LEU . 38.8 m-80 -102.42 -9.52 20.21 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.961 0.726 . . . . 72.549999999999997 112.961 -175.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.5 mt -89.75 -60.51 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 120.705 -0.398 . . . . 73.129999999999995 110.35 173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.158 -0.925 . . . . 74.5 110.154 -178.069 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 tpt . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 109.766 -0.457 . . . . 71.430000000000007 109.766 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.83 155.01 16.93 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.34 -0.391 . . . . 52.409999999999997 111.107 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -144.64 103.82 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 64.409999999999997 110.072 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.476 ' HB3' ' OG ' ' A' ' 58' ' ' SER . 9.2 t60 -113.47 -75.73 0.59 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.218 -0.29 . . . . 71.319999999999993 110.218 -178.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -147.03 -172.0 3.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 110.257 -0.275 . . . . 71.540000000000006 110.257 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -130.68 97.79 4.46 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.113 0.483 . . . . 73.209999999999994 112.001 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.432 ' HB2' ' HG3' ' A' ' 61' ' ' PRO . 11.9 m170 -106.52 -160.79 0.76 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.939 -1.134 . . . . 75.5 107.939 170.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -179.44 133.47 0.11 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.002 -0.37 . . . . 72.010000000000005 110.002 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.6 mmt -92.18 131.78 37.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.207 -0.451 . . . . 62.43 109.824 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.05 -47.86 43.48 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 111.315 -0.714 . . . . 73.209999999999994 111.315 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -172.12 157.61 4.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.82 -0.437 . . . . 73.010000000000005 109.82 177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 21' ' ' SER . 31.9 tp -132.72 78.96 1.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.376 0.607 . . . . 62.109999999999999 109.994 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -103.88 -158.44 0.67 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.889 -1.051 . . . . 72.340000000000003 108.607 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.18 78.66 0.09 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.118 0.485 . . . . 63.130000000000003 109.859 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 -79.57 138.67 37.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.745 -0.661 . . . . 73.25 110.321 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.8 m -77.72 73.9 4.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.168 0.509 . . . . 75.209999999999994 110.072 177.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -176.88 109.37 0.08 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.6 -0.727 . . . . 73.349999999999994 110.098 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.67 -124.75 37.11 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 121.338 -0.458 . . . . 71.319999999999993 112.827 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -83.69 -179.46 4.17 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.989 2.459 . . . . 62.399999999999999 112.251 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.2 -121.16 4.31 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.212 -0.518 . . . . 74.25 112.247 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.408 ' HA ' ' HG ' ' A' ' 12' ' ' LEU . 9.1 p -75.26 93.47 2.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.934 0.397 . . . . 74.409999999999997 111.911 -176.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.527 ' HE3' ' HA ' ' A' ' 68' ' ' GLN . 13.5 mmt -64.85 -70.4 0.23 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.373 0.606 . . . . 55.119999999999997 109.418 170.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.428 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 8.3 mm -70.49 80.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.908 -1.042 . . . . 72.230000000000004 108.785 172.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 9.0 tp10 -66.51 157.01 33.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.247 -0.433 . . . . 60.340000000000003 111.211 -175.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.27 136.88 48.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.442 0.297 . . . . 74.349999999999994 110.718 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 31' ' ' PHE . 37.9 pt -147.38 176.26 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.001 0.429 . . . . 71.420000000000002 110.992 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.25 -167.27 11.9 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.915 -0.874 . . . . 53.409999999999997 110.915 172.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -55.22 -50.68 68.79 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.956 0.407 . . . . 75.310000000000002 111.425 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 p -68.94 -32.54 72.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.884 -0.598 . . . . 72.140000000000001 112.169 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -80.78 -22.43 40.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.823 -0.172 . . . . 64.209999999999994 110.783 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.464 ' HE1' HG21 ' A' ' 46' ' ' VAL . 91.9 t80 -51.88 -61.96 1.93 Allowed 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.52 0.513 . . . . 63.329999999999998 111.383 -175.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -57.41 -47.17 82.45 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.099 -0.501 . . . . 75.150000000000006 110.653 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -56.15 -54.44 45.15 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.537 -0.756 . . . . 73.040000000000006 111.278 -178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -67.44 -33.03 74.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 70.209999999999994 111.343 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.549 HG22 HG21 ' A' ' 44' ' ' ILE . 65.5 t -72.03 -38.2 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.463 -0.335 . . . . 73.219999999999999 111.758 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -85.99 -41.82 14.54 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.024 0.44 . . . . 55.030000000000001 112.028 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 t -83.26 11.54 6.49 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.112 -0.494 . . . . 73.439999999999998 111.788 -172.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.538 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 13.8 p -72.26 82.58 1.02 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.78 0.324 . . . . 71.319999999999993 111.85 -177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.0 t30 41.52 -93.65 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.367 -0.833 . . . . 72.340000000000003 112.462 177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -162.04 121.94 2.47 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 110.412 -0.218 . . . . 74.409999999999997 110.412 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 48.0 m-80 55.36 18.96 2.8 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.779 0.659 . . . . 64.120000000000005 112.779 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.1 mm -71.96 133.62 31.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 120.893 0.378 . . . . 63.420000000000002 110.759 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 74' ' ' VAL . 31.2 tp -80.28 114.97 19.57 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.828 -0.624 . . . . 73.120000000000005 110.389 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.549 HG21 HG22 ' A' ' 35' ' ' VAL . 29.1 mm -95.27 118.9 42.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.354 -0.839 . . . . 70.040000000000006 110.396 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.541 HD13 HG13 ' A' ' 74' ' ' VAL . 5.5 mp -104.19 125.25 50.33 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.384 -0.969 . . . . 52.509999999999998 108.384 170.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.464 HG21 ' HE1' ' A' ' 31' ' ' PHE . 59.3 t -112.08 104.47 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.454 -0.573 . . . . 74.019999999999996 109.454 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.47 118.3 35.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.659 -0.701 . . . . 73.040000000000006 110.806 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -73.97 89.77 1.93 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.369 0.604 . . . . 72.319999999999993 109.652 174.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -65.27 150.03 48.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.983 -1.008 . . . . 72.099999999999994 111.336 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.79 116.88 5.83 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.757 -0.656 . . . . 72.030000000000001 109.549 178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.41 -18.01 62.64 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.659 2.24 . . . . 65.540000000000006 111.972 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -115.43 86.38 2.45 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.716 -0.675 . . . . 72.209999999999994 109.208 176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 48.2 t -169.09 105.04 0.39 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.757 -0.656 . . . . 75.129999999999995 110.306 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -54.15 -55.28 27.03 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.932 -0.576 . . . . 31.210000000000001 112.986 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.517 ' O ' HD23 ' A' ' 59' ' ' LEU . 52.3 Cg_exo -56.57 -50.61 11.29 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.566 2.177 . . . . 75.319999999999993 112.19 177.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 33.7 m -54.89 -33.81 62.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.293 -0.412 . . . . 74.200000000000003 111.077 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -62.09 -30.54 71.07 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.932 -0.576 . . . . 73.340000000000003 110.851 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.627 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 21.5 t -74.78 -35.93 62.53 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-O 122.007 0.908 . . . . 53.130000000000003 109.611 174.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.534 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.6 mm? -65.06 -26.2 68.14 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.775 -1.102 . . . . 62.149999999999999 110.763 -179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.508 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 46.2 mt-10 -53.52 -64.25 1.88 Allowed Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.681 -0.408 . . . . 64.540000000000006 109.998 176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 46.2 Cg_endo -66.83 -39.17 15.33 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 121.699 1.599 . . . . 62.530000000000001 112.441 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 58' ' ' SER . 37.0 mt-30 -61.63 -46.2 90.83 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.107 -0.637 . . . . 74.510000000000005 111.236 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.4 mt -75.49 -37.53 60.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.331 -0.395 . . . . 72.239999999999995 110.997 -176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 3.0 mm-40 -57.31 -38.3 73.8 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.025 0.44 . . . . 64.329999999999998 110.132 172.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.0 tttm -63.91 -55.08 25.31 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.839 -0.619 . . . . 74.040000000000006 110.221 177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.463 HD11 HD11 ' A' ' 116' ' ' ILE . 27.8 mt -60.94 -32.32 71.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.665 -0.698 . . . . 71.310000000000002 110.747 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.547 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.47 -53.71 26.49 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-N 116.154 -0.476 . . . . 51.030000000000001 109.937 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.527 ' HA ' ' HE3' ' A' ' 22' ' ' MET . 97.7 mt-30 -59.1 -36.15 74.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.288 -0.415 . . . . 75.310000000000002 111.04 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.94 -52.16 18.56 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.979 0.418 . . . . 71.25 111.374 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -95.22 4.7 53.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.618 0.599 . . . . 72.439999999999998 112.618 -170.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.2 t -52.89 -22.86 6.03 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.816 0.673 . . . . 75.129999999999995 112.816 -170.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.3 -31.84 73.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.747 0.308 . . . . 74.209999999999994 110.818 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -125.69 -0.26 7.42 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.377 -0.374 . . . . 74.109999999999999 110.891 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.541 HG13 HD13 ' A' ' 45' ' ' LEU . 36.6 t -127.94 136.16 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.958 0.408 . . . . 71.239999999999995 111.421 -177.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.409 ' NZ ' ' O ' ' A' ' 71' ' ' THR . 39.8 mmtm -141.89 131.45 23.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.934 -0.575 . . . . 64.209999999999994 109.604 172.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 57.7 mt -104.97 143.12 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 63.409999999999997 110.444 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -131.46 143.35 50.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.077 -0.51 . . . . 72.219999999999999 110.156 -177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 24' ' ' GLU . 25.1 pttm -124.18 127.84 48.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.943 -0.571 . . . . 63.030000000000001 109.667 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.7 tt -80.09 107.18 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.157 0.503 . . . . 71.120000000000005 109.67 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -86.08 -31.96 21.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.234 -0.439 . . . . 73.400000000000006 111.084 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.546 ' N ' HD12 ' A' ' 81' ' ' ILE . 3.0 mp -81.56 85.83 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.32 0.581 . . . . 74.319999999999993 110.286 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.32 -27.34 62.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.359 -0.837 . . . . 63.32 111.277 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.36 -21.97 61.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.05 -0.523 . . . . 75.439999999999998 111.064 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -113.44 41.22 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.242 0.544 . . . . 72.099999999999994 110.172 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -80.63 22.5 0.58 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.858 -0.61 . . . . 74.319999999999993 111.149 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 37.3 t70 -54.03 -35.93 62.49 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.625 0.37 . . . . 53.32 110.714 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.3 t -52.74 -40.33 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.709 -0.678 . . . . 71.340000000000003 110.539 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.42 -54.32 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 60.200000000000003 110.51 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.3 m -62.88 -29.63 70.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.59 . . . . 73.439999999999998 110.967 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 33.6 mm-40 -69.13 -56.04 8.87 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.343 -0.39 . . . . 75.540000000000006 111.174 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -75.0 -9.54 58.63 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.791 0.329 . . . . 74.120000000000005 111.231 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.81 45.4 7.77 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.031 -0.604 . . . . 74.25 112.498 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 87.9 t -77.0 103.58 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.543 -0.54 . . . . 73.219999999999999 109.543 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.7 t -86.37 -52.36 5.66 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.298 -0.41 . . . . 65.409999999999997 109.928 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.19 150.99 46.88 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.251 -0.431 . . . . 73.200000000000003 110.092 177.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.675 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 66.4 mt -72.97 -59.53 2.17 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 119.742 -0.171 . . . . 64.420000000000002 111.145 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.675 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 86.6 Cg_endo -82.74 63.62 8.0 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.952 1.768 . . . . 64.150000000000006 112.01 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.5 m -100.92 145.67 28.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.121 -0.49 . . . . 75.409999999999997 110.486 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.603 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -112.16 122.67 66.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 73.230000000000004 110.265 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.504 HD23 ' HG3' ' A' ' 110' ' ' GLN . 84.7 mt -93.2 123.12 36.25 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.906 -0.776 . . . . 64.430000000000007 108.906 173.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.419 ' HB2' ' O ' ' A' ' 109' ' ' SER . 42.0 mtp -98.29 143.22 29.0 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.778 -0.453 . . . . 70.310000000000002 109.778 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.626 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.5 m-85 -149.09 161.39 42.04 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.328 -0.619 . . . . 75.400000000000006 109.328 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -142.63 109.3 5.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 121.034 -0.266 . . . . 72.299999999999997 110.646 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.538 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 60.6 t30 57.03 29.01 15.74 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.353 0.596 . . . . 63.0 111.061 176.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.513 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 89.4 -2.72 83.42 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.235 -0.507 . . . . 71.219999999999999 112.92 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.6 ttpp -91.7 146.79 23.48 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.784 -0.45 . . . . 71.209999999999994 109.784 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -60.84 154.62 21.56 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 121.277 0.561 . . . . 73.129999999999995 112.117 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.626 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.16 167.62 23.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.695 -1.138 . . . . 72.329999999999998 108.217 -169.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 101' ' ' MET . 5.2 m -70.99 171.48 10.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.744 0.783 . . . . 75.019999999999996 112.692 -170.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.504 ' HG3' HD23 ' A' ' 100' ' ' LEU . 26.8 tt0 -126.04 127.28 45.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.233 -0.894 . . . . 73.349999999999994 109.775 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.603 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 61.3 t -97.52 107.61 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.074 -0.343 . . . . 74.540000000000006 110.074 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 112' ' ' ILE . 2.9 mp -81.46 106.95 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 74.140000000000001 109.906 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.56 136.7 7.65 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.297 -0.477 . . . . 52.149999999999999 112.142 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.534 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -57.61 92.13 0.01 OUTLIER 'General case' 0 C--O 1.237 0.44 0 CA-C-O 120.929 0.395 . . . . 54.32 110.814 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.414 ' O ' HG13 ' A' ' 119' ' ' ILE . 12.4 t70 -127.22 99.33 5.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.291 -0.413 . . . . 73.219999999999999 109.963 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.514 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -59.07 -33.68 51.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.846 -0.616 . . . . 61.130000000000003 110.728 -174.389 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.8 m -61.06 -54.02 49.88 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.755 0.312 . . . . 71.129999999999995 110.487 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -63.71 -40.88 97.87 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.57 -0.286 . . . . 63.310000000000002 110.543 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.6 mt -58.76 -55.06 25.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.145 -0.48 . . . . 64.310000000000002 110.683 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.9 tt -63.33 -34.11 65.19 Favored 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 116.617 -0.265 . . . . 54.049999999999997 110.341 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.6 m -59.44 -45.69 90.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.668 0.27 . . . . 74.120000000000005 110.318 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -69.99 -38.05 75.9 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.625 -0.261 . . . . 72.299999999999997 111.186 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.0 mt -57.14 -53.72 39.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.956 0.408 . . . . 64.310000000000002 110.012 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -59.59 -39.58 84.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.755 -0.657 . . . . 71.239999999999995 109.988 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -63.65 -31.86 73.16 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.652 -0.703 . . . . 75.219999999999999 111.511 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -90.11 -30.12 17.88 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.184 0.438 . . . . 72.549999999999997 112.184 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.475 HD11 HG23 ' A' ' 74' ' ' VAL . 68.5 mt -86.31 -45.97 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.059 0.457 . . . . 73.129999999999995 110.577 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.46 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.455 -0.783 . . . . 74.5 109.65 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.2 mmm . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.808 -0.441 . . . . 74.049999999999997 109.808 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.72 115.25 11.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.652 0.263 . . . . 70.409999999999997 111.021 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -78.03 60.56 2.41 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.45 0.643 . . . . 75.430000000000007 109.861 176.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.94 138.5 57.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.882 -1.054 . . . . 42.109999999999999 111.553 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -157.83 137.47 12.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.772 -0.649 . . . . 74.540000000000006 109.547 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -143.44 128.15 18.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.409 -0.589 . . . . 71.519999999999996 109.409 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -74.78 122.29 23.09 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.532 -0.544 . . . . 63.229999999999997 109.532 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -79.18 105.52 10.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.965 0.412 . . . . 73.230000000000004 110.236 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.6 ttt -120.55 88.11 2.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.584 -0.735 . . . . 74.150000000000006 109.163 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.0 43.76 0.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.625 -0.59 . . . . 62.200000000000003 111.625 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.2 p -81.92 97.99 8.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.798 0.332 . . . . 74.439999999999998 110.206 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -157.68 111.96 2.61 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.223 -0.658 . . . . 62.520000000000003 109.223 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.81 177.4 7.98 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.153 -0.476 . . . . 71.420000000000002 110.465 -177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.84 167.18 21.66 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.139 -0.482 . . . . 72.219999999999999 110.505 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -138.19 144.1 40.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.407 -0.59 . . . . 65.209999999999994 109.407 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -149.71 -179.94 7.51 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.716 0.293 . . . . 63.310000000000002 110.855 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -126.21 167.44 15.43 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.335 -0.393 . . . . 73.239999999999995 111.012 -176.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -83.55 177.71 52.58 Favored Glycine 0 CA--C 1.52 0.388 0 CA-C-N 116.093 -0.503 . . . . 43.329999999999998 113.092 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.69 -3.6 13.98 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.155 2.57 . . . . 63.0 112.482 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.17 -88.25 0.53 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 121.321 -0.466 . . . . 21.129999999999999 112.751 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 p -87.1 152.85 22.0 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.8 0.334 . . . . 74.019999999999996 111.241 -176.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.438 ' HG3' ' CG ' ' A' ' 68' ' ' GLN . 93.9 mmm -90.55 -29.48 17.83 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.075 -0.511 . . . . 72.340000000000003 109.898 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.451 HG12 ' OE2' ' A' ' 64' ' ' GLU . 32.9 mm -67.83 99.38 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.587 -0.894 . . . . 71.0 108.587 174.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 16.2 tt0 -74.85 112.36 10.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.342 0.592 . . . . 75.230000000000004 109.936 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.454 ' CG ' ' HB3' ' A' ' 80' ' ' ASN . 8.5 tt0 -88.99 131.14 35.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.488 -0.778 . . . . 62.009999999999998 110.717 -170.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.546 HG21 ' HG3' ' A' ' 34' ' ' LYS . 47.6 pt -144.94 -179.85 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.756 0.312 . . . . 73.510000000000005 111.201 -175.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.64 -174.42 15.6 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.209 -0.451 . . . . 71.540000000000006 112.534 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' OD1' HG23 ' A' ' 87' ' ' VAL . 20.0 t70 -50.84 -57.01 9.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.502 0.721 . . . . 71.109999999999999 112.649 -176.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.6 t -69.25 -27.13 65.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.004 0.431 . . . . 71.5 110.919 -173.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -74.21 -15.59 61.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 62.450000000000003 110.642 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.401 ' O ' HG23 ' A' ' 35' ' ' VAL . 90.0 t80 -52.56 -61.38 2.32 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.912 -0.586 . . . . 73.140000000000001 111.017 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -55.21 -53.43 56.1 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.433 -0.349 . . . . 60.100000000000001 111.167 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -53.34 -55.92 20.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.844 -0.616 . . . . 70.329999999999998 111.211 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.706 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 11.0 mmpt? -61.66 -45.61 93.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.864 -0.607 . . . . 71.230000000000004 111.33 -176.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.415 ' HA ' HD12 ' A' ' 44' ' ' ILE . 70.4 t -64.29 -40.66 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.448 -0.342 . . . . 74.329999999999998 111.347 -177.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 74.1 p -78.26 -25.02 46.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.703 0.287 . . . . 72.0 111.009 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.7 t -61.78 -14.95 37.21 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.261 -0.427 . . . . 51.009999999999998 111.459 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.617 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 22.8 p -49.48 114.45 1.04 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 123.148 0.28 . . . . 73.230000000000004 110.798 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.8 -70.3 0.19 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.164 -0.471 . . . . 74.430000000000007 111.183 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -156.01 122.17 5.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.374 -0.375 . . . . 73.409999999999997 110.474 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.1 m-80 58.82 17.69 5.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.94 -0.573 . . . . 74.310000000000002 111.655 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.4 mm -74.74 97.96 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.661 -0.496 . . . . 74.530000000000001 109.661 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.81 111.47 9.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.708 -0.678 . . . . 64.439999999999998 109.499 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.426 HG23 ' CD1' ' A' ' 77' ' ' TYR . 58.3 mt -101.51 115.1 42.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.181 -0.918 . . . . 62.329999999999998 110.459 -178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.469 ' HB2' HG13 ' A' ' 76' ' ' ILE . 5.1 mp -103.07 106.41 16.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.817 -0.628 . . . . 72.099999999999994 109.619 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.5 t -96.81 105.0 16.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.731 -0.213 . . . . 73.519999999999996 110.47 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 20.8 t0 -83.16 151.44 25.7 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.142 0.496 . . . . 65.239999999999995 110.688 177.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -71.69 170.81 12.73 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.63 -0.713 . . . . 55.020000000000003 111.694 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 72.6 t90 -61.12 105.04 0.44 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.665 -0.698 . . . . 73.219999999999999 110.129 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -161.04 97.48 1.34 Allowed Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.731 -0.668 . . . . 75.439999999999998 109.669 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.37 -18.04 7.33 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.95 2.433 . . . . 72.239999999999995 111.947 177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -166.74 137.36 3.24 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.912 -0.586 . . . . 61.32 109.816 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -168.46 156.28 8.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 72.230000000000004 110.141 175.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -43.21 -72.49 0.31 Allowed Glycine 0 C--N 1.335 0.502 0 O-C-N 123.683 0.614 . . . . 41.43 114.236 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.494 ' O ' HD23 ' A' ' 59' ' ' LEU . 41.8 Cg_endo -66.31 -22.07 53.51 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.412 2.075 . . . . 73.200000000000003 112.2 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 31.6 m -65.35 -19.06 65.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.027 -0.533 . . . . 71.340000000000003 111.216 -177.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -54.05 -48.22 70.81 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.306 -0.406 . . . . 65.430000000000007 110.085 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.571 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 38.9 t -75.59 -44.0 45.34 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.527 0.68 . . . . 53.119999999999997 111.478 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.3 mm? -60.65 -45.59 93.53 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.852 0.686 . . . . 75.150000000000006 112.852 -171.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.52 -56.31 28.24 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 117.609 0.186 . . . . 74.239999999999995 111.171 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HG2' ' O ' ' A' ' 58' ' ' SER . 18.9 Cg_endo -60.25 -40.49 58.9 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.781 1.654 . . . . 74.340000000000003 112.087 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.571 ' HG3' ' O ' ' A' ' 58' ' ' SER . 36.8 mt-30 -58.31 -39.1 78.47 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.681 -0.408 . . . . 63.340000000000003 111.756 176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 85.5 mt -68.43 -41.35 80.47 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.009 -0.367 . . . . 70.299999999999997 110.009 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 19.7 mm-40 -59.47 -41.14 89.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.894 -0.594 . . . . 73.510000000000005 110.415 174.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.579 ' NZ ' ' HB2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -60.56 -57.13 14.04 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.379 0.609 . . . . 63.229999999999997 110.329 178.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.45 -28.76 70.19 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.489 -0.778 . . . . 72.310000000000002 110.232 -177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.555 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.08 -50.6 65.5 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 116.123 -0.49 . . . . 61.240000000000002 109.869 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.491 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 91.4 mt-30 -59.77 -41.22 90.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.028 -0.533 . . . . 74.510000000000005 111.115 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -74.32 -54.87 6.77 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.011 0.434 . . . . 64.120000000000005 111.288 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -84.81 4.4 33.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.894 -0.594 . . . . 72.129999999999995 112.475 -172.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.7 t -52.97 -19.57 2.73 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 111.887 0.329 . . . . 63.509999999999998 111.887 -173.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -58.71 -38.92 79.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 52.229999999999997 110.585 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -134.89 10.95 3.63 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 111.407 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.567 HG23 HD11 ' A' ' 127' ' ' ILE . 31.8 t -128.83 142.14 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-O 121.22 0.533 . . . . 53.520000000000003 112.347 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 45.9 mmtt -143.6 119.97 10.93 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.194 -0.912 . . . . 72.129999999999995 109.762 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.55 HD13 ' HB2' ' A' ' 67' ' ' ALA . 3.6 mp -98.75 136.74 28.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 109.614 -0.513 . . . . 74.310000000000002 109.614 175.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 77.3 m-85 -124.31 164.52 19.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.875 -0.602 . . . . 72.200000000000003 109.912 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -153.4 132.58 12.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.995 -0.548 . . . . 74.319999999999993 109.638 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.514 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 64.9 mt -75.51 118.43 21.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.885 -0.413 . . . . 53.310000000000002 109.885 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' HB3' ' CG ' ' A' ' 25' ' ' GLN . 4.2 p-10 -91.46 -40.34 11.46 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.801 0.334 . . . . 74.349999999999994 111.379 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 81' ' ' ILE . 13.4 tt -83.54 99.24 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.732 0.777 . . . . 71.140000000000001 110.971 -174.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -17.51 62.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.418 -0.81 . . . . 73.310000000000002 111.663 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -70.2 -27.05 64.19 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.572 -0.529 . . . . 74.310000000000002 109.572 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 16.0 m120 -128.13 86.9 2.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.885 -0.598 . . . . 75.340000000000003 109.894 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -138.41 27.94 2.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.728 -0.669 . . . . 65.049999999999997 109.495 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 33.8 t70 -56.76 -35.32 68.5 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.187 -0.915 . . . . 65.349999999999994 111.709 -172.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.469 HG23 ' OD1' ' A' ' 28' ' ' ASP . 90.2 t -52.53 -35.98 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-O 121.073 0.463 . . . . 73.540000000000006 110.489 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.68 71.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.941 -0.572 . . . . 65.340000000000003 110.497 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.8 m -59.67 -37.94 80.13 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.286 0.565 . . . . 74.129999999999995 110.492 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 19.8 mm-40 -64.5 -48.23 75.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.43 -0.804 . . . . 72.120000000000005 110.798 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -76.74 -18.3 58.56 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.56 -0.291 . . . . 73.010000000000005 111.155 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.32 36.51 8.11 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 121.365 -0.445 . . . . 71.230000000000004 112.922 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.86 117.99 39.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 122.411 0.284 . . . . 71.310000000000002 110.422 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.6 m -133.4 13.75 4.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.921 0.391 . . . . 75.230000000000004 110.776 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.19 136.23 39.45 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.549 -0.537 . . . . 73.109999999999999 109.549 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.725 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 49.3 mm -56.19 -54.91 47.55 Favored Pre-proline 0 CA--C 1.542 0.642 0 O-C-N 123.274 0.359 . . . . 71.239999999999995 111.679 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 94.5 Cg_endo -94.2 105.3 0.14 Allowed 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.295 1.996 . . . . 61.25 111.322 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.522 HG23 HG13 ' A' ' 112' ' ' ILE . 27.9 m -148.53 118.24 7.06 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.284 -0.265 . . . . 71.219999999999999 110.284 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.455 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.1 mp -109.51 110.71 33.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.189 -0.46 . . . . 63.340000000000003 109.949 -177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.461 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.5 mp -92.46 123.3 35.67 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.176 -0.676 . . . . 72.430000000000007 109.176 175.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 53.3 mtp -98.73 142.31 30.43 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.854 -0.424 . . . . 63.399999999999999 109.854 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.567 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.8 m-85 -144.89 151.03 38.08 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 109.549 -0.537 . . . . 70.310000000000002 109.549 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -149.32 123.56 9.55 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.741 -0.384 . . . . 61.5 110.984 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.617 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.5 m-20 62.21 25.45 15.22 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.265 0.555 . . . . 71.319999999999993 110.325 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.71 -2.89 52.56 Favored Glycine 0 CA--C 1.519 0.334 0 CA-C-N 115.775 -0.648 . . . . 75.019999999999996 111.988 -174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -88.17 145.06 26.11 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 109.846 -0.428 . . . . 65.040000000000006 109.846 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.48 145.61 43.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 124.047 0.842 . . . . 74.450000000000003 110.903 -176.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -150.67 168.02 25.57 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.182 -1.414 . . . . 70.099999999999994 107.182 -170.188 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.3 m -70.29 177.89 3.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.19 0.519 . . . . 51.329999999999998 112.352 -165.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -142.49 119.38 11.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 44.310000000000002 110.057 -176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.2 t -100.63 107.42 21.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.248 -0.433 . . . . 72.530000000000001 110.112 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -96.16 121.6 46.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.304 -0.628 . . . . 71.319999999999993 109.304 177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.87 162.5 32.26 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.794 -0.523 . . . . 41.409999999999997 111.794 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.66 89.93 2.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.753 0.311 . . . . 71.329999999999998 111.175 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.501 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 57.4 t0 -132.45 82.23 2.0 Allowed 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.681 0.753 . . . . 75.0 109.848 174.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.87 -29.04 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 114.993 -1.003 . . . . 74.450000000000003 110.021 -177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.4 m -60.82 -50.33 73.88 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.615 -0.513 . . . . 52.409999999999997 109.615 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -61.68 -46.3 90.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.648 -0.706 . . . . 53.539999999999999 110.183 179.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 123' ' ' ILE . 78.3 mt -55.57 -56.54 11.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 115.762 -0.654 . . . . 61.350000000000001 111.201 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -66.69 -34.7 71.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.374 -0.376 . . . . 53.310000000000002 110.629 -175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.3 t -59.3 -51.88 68.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.885 -0.413 . . . . 75.450000000000003 109.885 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -63.67 -36.01 82.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.435 -0.348 . . . . 75.049999999999997 111.232 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.1 mt -56.56 -56.28 14.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.05 0.452 . . . . 71.010000000000005 110.41 176.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -69.6 -29.06 66.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.48 . . . . 61.329999999999998 110.682 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -65.88 -43.8 87.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.804 -0.635 . . . . 64.450000000000003 110.887 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.42 ' CG ' HD11 ' A' ' 108' ' ' LEU . 46.8 m-80 -93.41 -17.95 22.92 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.541 0.571 . . . . 55.140000000000001 112.541 -172.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.567 HD11 HG23 ' A' ' 74' ' ' VAL . 58.6 mt -78.27 -59.83 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 120.543 -0.463 . . . . 64.109999999999999 110.284 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.303 -0.856 . . . . 75.030000000000001 110.205 -176.459 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.885 0.374 . . . . 74.239999999999995 110.843 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.25 14.49 2.11 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.094 0.775 . . . . 52.119999999999997 113.094 172.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -102.49 111.04 23.18 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.827 0.346 . . . . 64.349999999999994 110.864 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -78.48 89.01 4.44 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.885 -0.783 . . . . 72.439999999999998 108.885 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -70.01 168.78 14.71 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.67 0.619 . . . . 62.020000000000003 112.67 -173.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -74.57 140.54 44.47 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.784 -1.098 . . . . 64.120000000000005 111.023 -172.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -120.48 -53.43 2.11 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.493 0.183 . . . . 61.009999999999998 111.493 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -63.87 89.84 0.05 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.805 0.336 . . . . 75.310000000000002 110.916 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.8 ttt -104.37 78.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.596 -0.52 . . . . 73.140000000000001 109.596 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.91 95.26 1.95 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.631 -0.713 . . . . 34.509999999999998 111.905 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -99.64 147.3 25.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.993 0.425 . . . . 72.230000000000004 111.103 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.575 HD23 ' HB3' ' A' ' 85' ' ' GLN . 3.1 mm? -123.62 -167.85 1.69 Allowed 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.854 -0.795 . . . . 74.120000000000005 108.854 174.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.99 111.31 8.47 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.873 0.368 . . . . 74.239999999999995 110.37 174.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -176.17 21.46 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.211 -0.449 . . . . 52.520000000000003 111.843 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -65.68 106.67 1.54 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.421 0.629 . . . . 74.510000000000005 110.942 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.2 p -109.09 123.01 48.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 74.230000000000004 109.967 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -88.84 -75.19 0.44 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.857 0.361 . . . . 60.520000000000003 111.021 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.05 -163.43 33.18 Favored Glycine 0 CA--C 1.519 0.292 0 N-CA-C 111.424 -0.67 . . . . 75.510000000000005 111.424 -174.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.1 -45.85 5.28 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.473 2.115 . . . . 74.439999999999998 111.482 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.12 29.96 63.27 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.623 -0.717 . . . . 75.019999999999996 112.565 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.3 m -77.39 -38.94 48.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.995 0.426 . . . . 63.25 110.058 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.495 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 95.4 mmm -122.41 -1.55 9.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.961 -0.563 . . . . 75.439999999999998 110.591 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -111.85 126.16 69.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.206 -0.452 . . . . 63.520000000000003 110.422 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -87.4 151.37 23.13 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.446 -0.343 . . . . 72.549999999999997 110.618 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -114.83 129.68 56.74 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.436 -0.347 . . . . 71.319999999999993 110.067 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 31' ' ' PHE . 45.7 pt -144.88 169.72 7.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.2 0.524 . . . . 75.430000000000007 111.751 -174.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.527 ' HA2' HD12 ' A' ' 79' ' ' ILE . . . -136.33 -173.71 13.06 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.298 -0.865 . . . . 64.329999999999998 111.274 174.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 7.3 t70 -45.16 -47.22 12.33 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.053 0.454 . . . . 72.099999999999994 111.353 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -62.61 -29.35 70.54 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.712 -0.676 . . . . 63.039999999999999 112.424 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.4 mp0 -102.87 -17.77 15.38 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 122.395 -0.191 . . . . 53.329999999999998 111.435 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 26' ' ' ILE . 88.4 t80 -50.49 -62.01 1.85 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 112.439 0.533 . . . . 70.010000000000005 112.439 -169.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.637 ' O ' HG22 ' A' ' 36' ' ' THR . 10.6 m-20 -56.96 -55.46 34.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.357 -0.383 . . . . 41.149999999999999 110.537 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -54.63 -55.84 25.31 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.731 -0.668 . . . . 62.020000000000003 111.447 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HG3' HG21 ' A' ' 26' ' ' ILE . 63.7 mmtt -57.74 -40.82 80.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 71.239999999999995 111.386 -177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.88 -59.72 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.47 -0.332 . . . . 74.109999999999999 111.326 178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.637 HG22 ' O ' ' A' ' 32' ' ' ASP . 9.0 t -81.38 -0.27 40.55 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.62 -0.263 . . . . 62.32 111.522 -173.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.6 t -61.74 -19.25 62.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.047 0.451 . . . . 64.099999999999994 109.978 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.817 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 21.3 p -55.8 137.19 50.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.655 -0.702 . . . . 63.009999999999998 110.648 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -74.46 -72.22 0.3 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.453 0.168 . . . . 71.109999999999999 110.701 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -136.2 121.91 19.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.559 0.219 . . . . 72.010000000000005 111.372 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 48.78 26.56 1.3 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.515 0.726 . . . . 73.340000000000003 112.895 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.776 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.7 mm -71.22 126.15 31.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 110.009 -0.367 . . . . 63.009999999999998 110.009 177.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.501 HD12 HD11 ' A' ' 45' ' ' LEU . 0.6 OUTLIER -75.63 107.49 7.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.789 -0.641 . . . . 72.030000000000001 109.641 -178.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 102' ' ' PHE . 36.5 mm -92.64 133.3 34.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.225 -0.898 . . . . 74.230000000000004 109.887 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.501 HD11 HD12 ' A' ' 43' ' ' LEU . 4.1 mp -121.66 149.66 42.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.994 -0.743 . . . . 73.530000000000001 108.994 173.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 66.9 t -136.79 104.76 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.239 -0.652 . . . . 63.539999999999999 109.239 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -90.97 154.54 19.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.33 0.586 . . . . 44.140000000000001 110.499 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -131.4 111.69 12.05 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.345 -1.354 . . . . 74.430000000000007 107.345 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -120.84 141.78 50.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.241 0.543 . . . . 75.319999999999993 110.789 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.644 ' HB3' HG23 ' A' ' 96' ' ' ILE . . . -128.01 126.41 23.75 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.317 -0.856 . . . . 72.319999999999993 108.988 173.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.45 76.37 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.5 2.134 . . . . 73.109999999999999 111.927 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 42.0 t-105 -163.94 27.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.704 0.764 . . . . 72.409999999999997 109.391 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 3.6 p -130.06 167.43 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.784 . . . . 74.120000000000005 110.521 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -96.95 -68.83 0.98 Allowed Glycine 0 CA--C 1.522 0.485 0 CA-C-N 116.205 -0.452 . . . . 72.420000000000002 112.853 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.404 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 58.9 Cg_exo -52.95 -23.04 20.03 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.251 2.634 . . . . 75.010000000000005 113.507 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.674 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 3.6 p -61.7 -25.47 67.44 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.67 -0.241 . . . . 24.449999999999999 110.976 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HD3' ' C ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -54.14 -50.27 67.31 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.021 0.439 . . . . 72.030000000000001 110.016 176.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.692 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.6 m -75.06 -39.62 60.81 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.255 0.55 . . . . 74.420000000000002 110.646 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.674 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 3.2 mm? -58.59 -37.83 76.66 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.673 0.62 . . . . 64.099999999999994 112.673 -174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 45.1 mt-10 -56.85 -61.02 7.72 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.057 0.389 . . . . 74.219999999999999 110.988 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 18.3 Cg_endo -60.2 -38.9 73.11 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.599 1.533 . . . . 72.0 111.942 177.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.692 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.6 mt-30 -61.45 -41.15 96.76 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.688 -0.405 . . . . 75.239999999999995 111.012 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 66.7 mt -65.92 -50.91 62.74 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 62.350000000000001 110.302 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 22.7 mt-10 -65.04 -27.57 68.89 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.68 -0.408 . . . . 74.099999999999994 110.88 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -72.59 -49.45 32.18 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.819 0.343 . . . . 72.109999999999999 110.442 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.01 -31.55 72.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.841 -0.429 . . . . 61.020000000000003 109.841 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.491 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.37 -48.2 80.82 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.939 -0.573 . . . . 62.520000000000003 109.711 174.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.495 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 96.0 mt-30 -57.52 -42.21 82.4 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.902 0.382 . . . . 74.25 110.981 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -69.16 -42.67 75.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.593 . . . . 73.420000000000002 111.443 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -105.15 5.96 32.71 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.131 0.789 . . . . 74.129999999999995 113.131 -172.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.5 t -52.98 -19.91 3.0 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.977 1.103 . . . . 65.109999999999999 113.977 -168.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -73.42 -29.24 62.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.016 0.436 . . . . 64.200000000000003 110.685 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -115.97 -13.85 11.26 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.669 -0.696 . . . . 71.120000000000005 111.346 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.43 HG23 HD11 ' A' ' 127' ' ' ILE . 35.5 t -120.43 133.96 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.791 0.329 . . . . 65.239999999999995 111.677 -173.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -136.16 119.81 17.17 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.769 -0.651 . . . . 71.030000000000001 109.299 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.464 HG12 HD13 ' A' ' 45' ' ' LEU . 43.3 mt -104.82 137.19 35.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.162 0.506 . . . . 51.350000000000001 110.639 -178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.435 ' CE2' ' HB3' ' A' ' 34' ' ' LYS . 73.9 m-85 -125.9 169.19 12.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.607 -0.886 . . . . 74.25 108.607 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.519 ' HB3' ' HZ3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -139.72 129.93 25.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.898 0.38 . . . . 75.400000000000006 110.54 172.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.527 HD12 ' HA2' ' A' ' 27' ' ' GLY . 5.7 tp -79.87 78.7 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 109.252 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -112.54 -17.41 12.65 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.766 -0.652 . . . . 54.25 111.76 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.433 ' HB ' ' HA3' ' A' ' 27' ' ' GLY . 54.0 mt -64.46 92.44 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.464 0.65 . . . . 73.239999999999995 109.889 177.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 85' ' ' GLN . 10.3 pt-20 -54.72 -29.21 52.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.654 -1.157 . . . . 53.210000000000001 112.842 -176.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.42 -19.25 62.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.394 0.616 . . . . 71.340000000000003 110.272 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 30.0 m-20 -134.66 42.81 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.068 -0.969 . . . . 74.340000000000003 108.943 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.575 ' HB3' HD23 ' A' ' 12' ' ' LEU . 17.5 tp60 -71.95 -14.73 61.99 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.895 -1.048 . . . . 71.209999999999994 111.464 -176.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 34.6 t70 -46.14 -39.66 9.87 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.288 0.847 . . . . 71.340000000000003 113.288 -168.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 80.0 t -52.94 -40.96 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.903 0.383 . . . . 51.43 111.313 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.14 93.11 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.101 -0.499 . . . . 64.409999999999997 110.36 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 m -69.79 -33.73 72.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.681 -0.69 . . . . 72.140000000000001 110.622 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 45.0 mt-30 -65.43 -56.52 12.05 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 110.622 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -70.53 -25.22 63.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.158 -0.474 . . . . 75.0 110.938 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.23 60.89 1.1 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.889 -0.672 . . . . 62.350000000000001 113.222 173.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 94.4 t -82.4 94.79 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.669 -0.493 . . . . 54.5 109.669 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.1 t -107.12 -12.17 15.46 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.165 -0.47 . . . . 74.340000000000003 111.375 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.58 147.67 25.1 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.639 -0.255 . . . . 74.519999999999996 110.68 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.706 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 67.2 mt -57.32 -51.76 79.32 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.315 -0.402 . . . . 75.329999999999998 110.887 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.706 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 69.8 Cg_endo -102.5 100.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.942 2.428 . . . . 71.340000000000003 111.751 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.1 m -124.97 116.21 21.8 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 122.284 -0.26 . . . . 73.049999999999997 110.906 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.2 mp -110.64 113.95 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.421 -0.354 . . . . 75.239999999999995 110.39 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.2 mp -92.05 143.18 26.72 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.257 -0.645 . . . . 50.409999999999997 109.257 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.414 ' HB2' ' O ' ' A' ' 109' ' ' SER . 47.1 mtp -113.97 146.22 40.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.892 0.377 . . . . 71.510000000000005 110.042 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.571 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.7 m-85 -145.73 160.03 42.32 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.371 -0.974 . . . . 51.109999999999999 108.371 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -149.8 117.47 6.2 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.494 -0.483 . . . . 74.129999999999995 110.863 175.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.817 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.0 t30 60.15 25.3 14.63 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.805 -0.634 . . . . 72.409999999999997 110.731 177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.61 -14.66 63.42 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 116.121 -0.49 . . . . 44.409999999999997 112.445 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -83.38 152.75 24.89 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 122.51 0.324 . . . . 72.299999999999997 110.374 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -64.93 157.22 28.67 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.65 0.738 . . . . 63.439999999999998 111.206 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.32 168.78 21.69 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.965 -1.494 . . . . 71.120000000000005 106.965 -166.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 101' ' ' MET . 58.5 m -69.9 -177.67 1.36 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.066 0.46 . . . . 72.510000000000005 111.69 -167.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -148.83 120.15 7.86 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.031 -0.359 . . . . 54.340000000000003 110.031 -174.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 42.4 t -93.62 107.48 19.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.999 -0.546 . . . . 64.510000000000005 110.106 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -88.82 102.07 12.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.109 -0.7 . . . . 74.099999999999994 109.109 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.533 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 117.49 162.79 12.66 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 111.618 -0.593 . . . . 71.329999999999998 111.618 -177.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.539 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -88.43 72.19 8.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.954 0.407 . . . . 72.510000000000005 110.224 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.38 94.46 4.98 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 116.025 -0.534 . . . . 73.219999999999999 110.113 -178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.405 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.37 -33.95 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 115.673 -0.694 . . . . 72.219999999999999 110.172 -175.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.9 m -59.61 -47.62 84.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.247 -0.433 . . . . 73.030000000000001 110.631 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -69.15 -42.02 76.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 71.129999999999995 110.269 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 123' ' ' ILE . 78.9 mt -55.54 -56.21 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 120.736 0.303 . . . . 72.129999999999995 110.897 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.1 tt -66.01 -33.9 66.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.784 0.326 . . . . 70.030000000000001 110.387 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.6 t -55.14 -52.32 63.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.044 -0.525 . . . . 64.519999999999996 110.477 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 18.6 mm-40 -72.18 -37.17 69.38 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.248 -0.433 . . . . 74.329999999999998 110.664 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 119' ' ' ILE . 49.3 mt -52.32 -56.12 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.898 0.38 . . . . 75.420000000000002 110.09 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.75 -43.66 92.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.159 -0.473 . . . . 64.209999999999994 110.196 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 8.3 t30 -58.12 -30.25 66.16 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.96 -0.564 . . . . 73.420000000000002 111.65 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -99.17 -29.27 12.94 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.645 0.609 . . . . 71.239999999999995 112.645 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 74' ' ' VAL . 66.3 mt -72.74 -48.83 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 117.947 0.339 . . . . 71.319999999999993 110.301 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.4 p30 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.41 -0.805 . . . . 62.210000000000001 110.466 178.782 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.457 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.85 -0.426 . . . . 73.129999999999995 109.85 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.13 127.25 22.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.303 -0.408 . . . . 75.340000000000003 110.286 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -128.93 -48.09 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 75.239999999999995 110.602 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -151.32 119.44 6.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.494 -0.321 . . . . 74.319999999999993 110.171 178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -91.04 154.6 19.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 74.430000000000007 110.712 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -76.06 130.64 38.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.724 -0.671 . . . . 71.319999999999993 111.095 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -138.2 125.5 21.74 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.957 -0.757 . . . . 64.120000000000005 108.957 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -85.46 126.25 33.66 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.848 -0.427 . . . . 72.230000000000004 109.848 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.2 ttm -72.59 93.62 1.62 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.822 -0.436 . . . . 70.340000000000003 109.822 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.94 179.74 28.98 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.733 -0.667 . . . . 72.319999999999993 111.655 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.404 ' HA ' ' OD2' ' A' ' 83' ' ' ASP . 72.5 m -146.57 121.02 9.67 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.913 -0.403 . . . . 62.43 109.913 178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.8 mt -130.23 166.13 20.96 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.982 0.42 . . . . 60.310000000000002 111.155 -173.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.54 -177.66 6.63 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.856 -0.611 . . . . 75.099999999999994 109.862 176.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.38 -68.86 0.64 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.849 0.357 . . . . 44.32 110.565 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -115.67 141.84 47.54 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.486 -0.561 . . . . 74.299999999999997 109.486 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.461 ' HB ' ' OE1' ' A' ' 17' ' ' GLN . 5.7 m -63.74 -52.19 61.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.252 -0.431 . . . . 75.319999999999993 111.427 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.461 ' OE1' ' HB ' ' A' ' 16' ' ' THR . 4.2 pm0 -126.17 -169.06 1.95 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.205 -0.452 . . . . 71.299999999999997 110.842 -174.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.53 168.22 19.64 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.899 -0.881 . . . . 61.509999999999998 110.899 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.87 13.41 1.0 Allowed 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.791 2.328 . . . . 75.230000000000004 112.995 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.69 35.2 66.86 Favored Glycine 0 C--N 1.333 0.389 0 N-CA-C 111.405 -0.678 . . . . 74.150000000000006 111.405 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 p -65.4 151.64 45.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.3 -0.45 . . . . 51.039999999999999 111.497 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 79.9 mmm -57.04 -36.37 70.41 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 108.782 -0.821 . . . . 73.409999999999997 108.782 171.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 mm -59.75 108.81 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 114.725 -1.125 . . . . 71.120000000000005 109.046 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -73.08 154.14 40.54 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.874 0.369 . . . . 74.319999999999993 111.115 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -118.88 134.67 55.02 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.167 0.587 . . . . 73.510000000000005 110.309 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 31' ' ' PHE . 41.7 pt -150.09 179.63 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.348 0.594 . . . . 33.130000000000003 111.421 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 30' ' ' GLU . . . -131.67 -159.16 9.34 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-N 115.323 -0.853 . . . . 72.209999999999994 111.036 172.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 11.0 p-10 -65.96 -46.2 78.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.026 0.441 . . . . 55.43 110.916 -178.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.3 m -65.71 -29.16 69.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.703 -0.68 . . . . 73.439999999999998 110.668 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.409 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 17.2 mm-40 -95.39 -10.18 30.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.963 -0.562 . . . . 74.209999999999994 111.118 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.536 ' HA ' HD12 ' A' ' 26' ' ' ILE . 88.1 t80 -61.77 -61.87 2.2 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.543 -0.54 . . . . 64.010000000000005 109.543 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -57.76 -47.6 82.03 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.915 -0.584 . . . . 52.229999999999997 110.058 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -51.22 -57.74 8.0 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.577 -0.738 . . . . 74.129999999999995 110.84 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -80.08 -26.18 39.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.972 -1.013 . . . . 63.210000000000001 111.683 -168.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.447 ' HA ' HD13 ' A' ' 44' ' ' ILE . 79.4 t -78.81 -39.37 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.735 -0.212 . . . . 62.299999999999997 111.401 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 80.5 p -84.89 -37.14 20.96 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.934 0.346 . . . . 60.210000000000001 111.934 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.5 t -69.06 -13.07 62.23 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.472 0.545 . . . . 64.230000000000004 112.472 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.903 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 28.4 p -57.13 142.0 44.13 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.166 -0.309 . . . . 71.140000000000001 110.166 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -61.65 -82.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.387 0.514 . . . . 43.409999999999997 112.387 -171.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -160.46 143.41 13.33 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.641 -0.254 . . . . 72.109999999999999 110.492 -174.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 61.3 8.2 2.01 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.654 0.596 . . . . 71.230000000000004 111.796 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.8 mm -73.24 102.52 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.193 0.521 . . . . 72.230000000000004 110.51 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.412 ' HB3' HG22 ' A' ' 74' ' ' VAL . 3.2 tm? -71.85 108.16 4.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.191 -0.913 . . . . 63.450000000000003 109.165 175.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 35' ' ' VAL . 70.3 mt -102.01 137.18 30.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.437 -0.801 . . . . 73.439999999999998 111.005 -176.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.614 HD13 HG13 ' A' ' 76' ' ' ILE . 3.4 mp -118.14 148.94 41.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.924 -0.769 . . . . 71.530000000000001 108.924 173.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 75.5 t -130.59 104.82 10.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.535 -0.542 . . . . 74.349999999999994 109.535 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -88.11 126.63 35.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.898 -0.592 . . . . 75.510000000000005 110.599 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.419 ' CE1' HD13 ' A' ' 100' ' ' LEU . 17.7 m-85 -89.85 133.14 34.9 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.116 -0.698 . . . . 74.450000000000003 109.116 169.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.418 ' HE1' ' HA ' ' A' ' 80' ' ' ASN . 88.6 m95 -56.31 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.32 0.581 . . . . 74.540000000000006 111.252 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 97' ' ' PRO . . . -78.21 141.99 62.98 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.132 -0.94 . . . . 41.520000000000003 111.297 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.67 115.36 2.39 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 121.923 1.749 . . . . 61.240000000000002 110.1 169.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -51.49 101.57 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.086 0.47 . . . . 75.329999999999998 111.433 -172.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 20.1 p -86.75 -174.69 5.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.604 -0.725 . . . . 75.140000000000001 110.777 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.45 -64.4 3.63 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 116.156 -0.475 . . . . 54.409999999999997 112.007 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.69 -28.71 57.97 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.783 2.322 . . . . 65.049999999999997 111.945 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 72.5 m -54.5 -25.76 27.47 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.638 -0.71 . . . . 61.219999999999999 111.612 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -53.37 -45.83 69.38 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.93 0.395 . . . . 71.299999999999997 110.545 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.5 m -75.72 -32.5 60.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.133 -0.485 . . . . 40.210000000000001 111.223 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.579 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 1.4 mm? -57.95 -45.5 86.55 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.518 0.933 . . . . 50.530000000000001 113.518 -164.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.521 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 7.9 mp0 -53.77 -60.47 7.14 Favored Pre-proline 0 N--CA 1.474 0.726 0 CA-C-N 118.734 0.697 . . . . 71.230000000000004 110.529 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.538 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 39.3 Cg_endo -67.31 -19.72 49.66 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.792 1.661 . . . . 71.510000000000005 112.548 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.492 ' NE2' HG21 ' A' ' 116' ' ' ILE . 3.4 mm100 -66.47 -52.78 42.52 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 110.263 -0.273 . . . . 72.310000000000002 110.263 174.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.486 HD21 HD13 ' A' ' 119' ' ' ILE . 97.2 mt -62.48 -40.9 98.16 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.474 -0.565 . . . . 73.319999999999993 109.474 177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.6 mm-40 -58.17 -42.83 86.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.666 -0.697 . . . . 74.129999999999995 111.025 174.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.403 ' HB3' ' HZ3' ' A' ' 65' ' ' LYS . 7.1 ttpm? -63.91 -50.74 67.55 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.898 0.38 . . . . 71.319999999999993 110.244 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.5 mt -64.9 -32.42 74.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.953 -0.567 . . . . 61.450000000000003 110.248 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.477 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.6 -53.9 44.39 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-N 116.197 -0.456 . . . . 43.200000000000003 109.824 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 55.2 mt-30 -57.28 -38.94 74.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.014 -0.539 . . . . 73.439999999999998 111.019 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -75.49 -42.55 52.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.887 -0.597 . . . . 75.5 111.389 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -104.86 5.07 32.71 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.743 0.646 . . . . 71.200000000000003 112.743 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.8 t -52.88 -21.31 4.13 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.747 0.647 . . . . 60.100000000000001 112.747 -169.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.73 -39.13 90.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.822 0.344 . . . . 71.239999999999995 110.408 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -120.69 -1.86 9.96 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.77 -0.65 . . . . 74.519999999999996 111.575 -176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.542 ' O ' ' HD2' ' A' ' 75' ' ' LYS . 43.0 t -128.44 131.58 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 112.054 0.391 . . . . 73.099999999999994 112.054 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.542 ' HD2' ' O ' ' A' ' 74' ' ' VAL . 13.6 mptt -138.92 122.96 17.91 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.034 -0.53 . . . . 71.129999999999995 109.939 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.614 HG13 HD13 ' A' ' 45' ' ' LEU . 3.3 mp -99.21 146.12 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.7 -0.481 . . . . 72.109999999999999 109.7 176.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.407 ' CD1' HG23 ' A' ' 44' ' ' ILE . 97.5 m-85 -132.0 142.74 49.69 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.738 0.415 . . . . 74.230000000000004 110.318 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -111.22 132.42 54.35 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 122.861 0.465 . . . . 74.430000000000007 110.015 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -86.29 99.16 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.549 -0.908 . . . . 73.430000000000007 108.549 174.133 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.418 ' HA ' ' HE1' ' A' ' 49' ' ' TRP . 15.6 m120 -80.66 -48.36 12.73 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.539 0.57 . . . . 44.450000000000003 112.539 -171.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.535 ' HB ' ' OD1' ' A' ' 84' ' ' ASN . 49.7 mt -78.56 106.92 10.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 74.439999999999998 111.093 -173.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.79 -17.91 52.13 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.168 -0.469 . . . . 74.129999999999995 111.464 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.441 ' HB2' HG22 ' A' ' 81' ' ' ILE . 2.7 m-20 -70.02 -20.36 63.27 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.041 0.448 . . . . 71.299999999999997 109.827 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.535 ' OD1' ' HB ' ' A' ' 81' ' ' ILE . 10.3 m120 -84.17 41.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.786 -0.643 . . . . 65.230000000000004 109.723 177.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -55.07 -24.92 27.66 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.424 -0.807 . . . . 74.450000000000003 111.265 -176.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -40.36 -55.94 2.11 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.55 -0.75 . . . . 71.099999999999994 112.119 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.5 t -53.08 -37.82 28.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.31 -0.404 . . . . 61.219999999999999 111.035 -174.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.88 -54.79 16.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.066 0.46 . . . . 41.450000000000003 110.595 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.3 m -67.36 -35.89 80.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.753 -0.658 . . . . 40.240000000000002 111.141 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.405 ' HA ' ' OE1' ' A' ' 90' ' ' GLN . 14.0 mm-40 -75.27 -41.34 57.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.892 -0.595 . . . . 74.040000000000006 111.537 -175.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -88.79 -12.13 42.94 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.796 0.331 . . . . 72.310000000000002 110.779 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.48 45.33 8.75 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.917 -0.659 . . . . 72.409999999999997 112.576 172.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.08 94.84 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.469 -0.567 . . . . 75.040000000000006 109.469 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.1 m -58.93 -39.24 80.99 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.751 -0.659 . . . . 73.209999999999994 112.047 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -128.18 144.83 51.15 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.16 -0.311 . . . . 74.340000000000003 110.16 -177.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.474 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 59.9 mt -54.67 -49.67 90.01 Favored Pre-proline 0 CA--C 1.541 0.597 0 O-C-N 123.21 0.319 . . . . 62.009999999999998 111.792 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.517 ' HA ' ' HB2' ' A' ' 50' ' ' ALA . 56.5 Cg_endo -69.37 82.02 0.69 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 121.868 1.712 . . . . 75.430000000000007 112.125 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 38.6 m -146.54 142.64 28.23 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.231 0.538 . . . . 72.340000000000003 111.543 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 mp -115.71 120.65 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.268 -0.878 . . . . 74.530000000000001 109.369 175.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 48' ' ' PHE . 9.3 mp -97.43 135.13 39.75 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.895 -0.409 . . . . 72.430000000000007 109.895 178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.505 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 42.0 mtp -101.87 146.8 27.32 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.077 -0.342 . . . . 73.140000000000001 110.077 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -148.04 158.47 44.08 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.398 -0.593 . . . . 72.310000000000002 109.398 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -141.89 106.73 4.9 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 120.729 -0.388 . . . . 71.409999999999997 111.371 174.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.903 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.6 t-20 60.78 27.56 17.33 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.481 0.657 . . . . 65.450000000000003 110.579 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.84 -10.11 75.28 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.777 -0.647 . . . . 44.219999999999999 112.33 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -70.08 132.04 45.23 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 109.593 -0.521 . . . . 75.230000000000004 109.593 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -62.07 143.33 56.78 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 124.132 0.895 . . . . 64.310000000000002 109.348 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.505 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.7 tp -155.84 168.28 27.71 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.102 -0.703 . . . . 75.420000000000002 109.102 -164.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.1 m -69.8 171.92 8.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.42 0.629 . . . . 71.109999999999999 112.49 -166.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -131.05 133.91 46.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.717 -0.674 . . . . 74.040000000000006 110.489 -174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.42 HG22 ' HG3' ' A' ' 118' ' ' LYS . 46.2 t -103.77 120.36 53.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.907 -0.588 . . . . 74.340000000000003 109.725 176.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.51 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.1 mp -97.79 125.05 51.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.664 -0.495 . . . . 72.239999999999995 109.664 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.25 -174.27 53.52 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.292 -0.48 . . . . 44.340000000000003 112.33 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -87.16 86.4 7.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.687 0.279 . . . . 61.409999999999997 110.436 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 119' ' ' ILE . 65.4 t0 -123.79 87.83 2.81 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.605 0.717 . . . . 75.030000000000001 109.776 175.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.492 HG21 ' NE2' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -65.56 -29.39 46.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.263 -0.88 . . . . 74.230000000000004 109.532 -176.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.9 t -61.86 -48.74 79.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.917 -0.583 . . . . 71.549999999999997 109.716 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HG3' HG22 ' A' ' 111' ' ' VAL . 58.4 tptt -63.22 -43.3 98.49 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.132 -0.486 . . . . 73.310000000000002 110.167 177.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.486 HD13 HD21 ' A' ' 63' ' ' LEU . 82.7 mt -56.62 -56.46 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.225 -0.443 . . . . 53.350000000000001 111.293 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.26 -34.13 68.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.662 0.267 . . . . 75.519999999999996 110.472 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.7 t -56.53 -51.56 68.09 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.109 -0.496 . . . . 73.209999999999994 109.868 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -65.64 -40.17 92.21 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.155 -0.475 . . . . 72.510000000000005 110.728 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 119' ' ' ILE . 64.8 mt -54.85 -55.9 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.657 0.265 . . . . 70.299999999999997 110.417 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -64.46 -36.93 85.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.6 -0.273 . . . . 73.439999999999998 110.321 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -67.11 -26.4 66.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.041 -0.527 . . . . 43.530000000000001 111.257 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -101.03 -13.74 18.11 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 111.878 0.325 . . . . 70.140000000000001 111.878 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 123' ' ' ILE . 54.5 mt -85.94 -54.48 8.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.722 0.296 . . . . 71.120000000000005 110.395 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.661 -0.685 . . . . 54.0 110.922 -177.328 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.514 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.183 -0.303 . . . . 52.210000000000001 110.183 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.6 87.85 0.22 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.247 -0.433 . . . . 44.549999999999997 111.792 -175.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -75.49 72.46 2.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.214 -1.032 . . . . 73.5 108.214 171.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -57.37 114.15 2.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.178 -0.919 . . . . 61.219999999999999 111.755 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -65.25 102.26 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.384 -0.825 . . . . 75.099999999999994 109.458 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -82.37 93.45 7.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.005 -0.543 . . . . 63.240000000000002 110.941 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -99.4 121.79 41.61 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.087 -0.506 . . . . 73.230000000000004 110.294 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -158.87 99.8 1.56 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.592 -0.522 . . . . 72.239999999999995 109.592 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.486 ' SD ' ' O ' ' A' ' 10' ' ' GLY . 0.0 OUTLIER -113.86 143.22 45.04 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.964 -0.754 . . . . 62.520000000000003 108.964 178.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' O ' ' SD ' ' A' ' 9' ' ' MET . . . -98.85 160.83 20.2 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 121.175 -0.536 . . . . 34.549999999999997 112.817 -174.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.0 p -91.99 -68.54 0.79 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.88 0.372 . . . . 75.150000000000006 110.016 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.651 HD23 ' H ' ' A' ' 12' ' ' LEU . 2.4 pt? -118.99 123.96 45.82 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.415 -0.587 . . . . 73.420000000000002 109.415 172.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -65.55 -57.96 6.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 75.209999999999994 110.75 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -169.86 160.4 8.48 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.391 -0.368 . . . . 62.310000000000002 110.881 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -136.52 160.0 40.09 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 109.35 -0.611 . . . . 65.129999999999995 109.35 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.7 p -121.72 -73.35 0.65 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.855 -0.157 . . . . 64.340000000000003 110.982 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 59.61 36.55 22.65 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.258 0.551 . . . . 74.120000000000005 110.084 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.78 172.1 46.61 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.527 -0.761 . . . . 72.340000000000003 113.603 -174.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -90.88 -157.47 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.625 2.884 . . . . 61.039999999999999 112.795 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.0 56.75 4.59 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 114.839 0.696 . . . . 71.230000000000004 114.839 -170.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t 64.99 120.73 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.357 0.598 . . . . 44.219999999999999 112.553 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -75.64 -71.54 0.36 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.537 -0.756 . . . . 71.019999999999996 110.918 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -105.19 100.56 10.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 109.66 -0.496 . . . . 74.219999999999999 109.66 -177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 30.3 tt0 -93.62 112.11 23.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.938 0.399 . . . . 65.129999999999995 110.435 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.8 133.2 40.72 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.938 0.399 . . . . 73.409999999999997 110.889 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.537 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 39.6 pt -144.8 179.64 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.271 -0.422 . . . . 63.32 110.806 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.48 -176.09 15.59 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.969 -0.852 . . . . 54.119999999999997 110.969 172.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' H ' ' HB3' ' A' ' 84' ' ' ASN . 27.6 t70 -66.72 -28.63 68.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.014 0.435 . . . . 55.420000000000002 110.334 -178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.9 m -65.58 -34.86 79.22 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.779 -0.646 . . . . 75.140000000000001 110.718 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 2.3 mp0 -92.38 -22.24 19.78 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.575 -0.284 . . . . 73.150000000000006 110.824 177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.622 ' HE1' HG21 ' A' ' 46' ' ' VAL . 70.4 t80 -46.77 -61.46 1.84 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.314 0.383 . . . . 73.519999999999996 111.932 -173.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -63.05 -40.91 99.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.444 -0.344 . . . . 53.329999999999998 110.497 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' SER . 36.9 m-80 -58.65 -41.68 86.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.796 -0.638 . . . . 63.219999999999999 110.678 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -72.04 -43.72 64.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.886 -0.597 . . . . 74.530000000000001 110.156 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 31' ' ' PHE . 91.0 t -62.6 -40.68 89.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 115.954 -0.566 . . . . 61.119999999999997 110.809 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.4 p -80.65 -25.61 38.2 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.148 0.425 . . . . 74.439999999999998 112.148 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 22.3 t -67.69 -14.23 62.77 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.92 0.341 . . . . 63.310000000000002 111.92 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.78 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 27.6 p -56.84 129.79 42.92 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.102 -0.332 . . . . 72.109999999999999 110.102 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -60.39 -71.38 0.14 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.675 0.274 . . . . 51.210000000000001 110.781 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -161.59 135.57 6.76 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.453 -0.34 . . . . 62.409999999999997 110.45 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.42 ' H ' ' HB2' ' A' ' 104' ' ' ASN . 96.0 m-20 61.37 2.31 0.63 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.957 0.725 . . . . 74.319999999999993 112.957 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.681 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.0 mm -62.29 130.7 27.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.895 0.378 . . . . 75.239999999999995 110.388 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 1.0 OUTLIER -93.01 112.85 24.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 72.420000000000002 109.612 -178.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.469 HD11 ' HB3' ' A' ' 38' ' ' CYS . 73.7 mt -107.67 123.06 62.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.819 -0.628 . . . . 61.130000000000003 110.313 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.651 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -105.97 146.14 30.43 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.142 -0.688 . . . . 63.329999999999998 109.142 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.622 HG21 ' HE1' ' A' ' 31' ' ' PHE . 61.8 t -125.26 104.72 13.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.724 -0.473 . . . . 70.040000000000006 109.724 177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -94.83 112.85 24.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.729 -0.669 . . . . 63.32 109.768 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 17.1 m-85 -65.61 169.97 5.63 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.939 0.399 . . . . 64.25 111.099 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -94.54 130.99 40.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.064 -0.516 . . . . 73.5 110.536 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.88 101.14 31.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 73.5 110.117 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -57.04 -34.59 97.97 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.707 2.271 . . . . 63.32 111.981 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 69.1 t90 -153.77 129.59 10.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 72.329999999999998 109.89 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 40.6 t -173.74 125.12 0.37 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.351 -0.386 . . . . 43.43 110.253 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . -65.48 -75.57 0.4 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 121.39 -0.433 . . . . 74.200000000000003 112.663 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -53.54 -28.46 45.49 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.165 2.577 . . . . 65.019999999999996 112.913 -175.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 70.9 m -57.25 -22.62 42.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 72.230000000000004 111.875 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 54' ' ' GLY . 7.0 ptp85 -57.37 -36.82 71.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.525 0.202 . . . . 74.120000000000005 110.579 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.643 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 9.6 m -74.84 -40.47 61.01 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.773 0.797 . . . . 72.109999999999999 110.289 177.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.4 mm? -58.01 -38.67 76.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.22 -0.9 . . . . 73.409999999999997 111.415 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 55.2 mt-10 -54.64 -63.2 3.05 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 119.399 -0.334 . . . . 52.340000000000003 111.339 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.43 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 17.8 Cg_endo -60.24 -38.86 72.99 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 121.827 1.684 . . . . 73.129999999999995 112.118 178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.4 mt-30 -57.73 -42.54 84.09 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.548 -0.461 . . . . 74.129999999999995 111.184 177.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.466 HD21 HD13 ' A' ' 119' ' ' ILE . 93.9 mt -68.97 -45.75 69.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.391 . . . . 54.310000000000002 110.467 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 44.7 mt-10 -56.84 -36.77 70.38 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.065 0.46 . . . . 74.310000000000002 109.904 176.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.6 tttp -66.89 -52.4 43.81 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.661 -0.699 . . . . 73.140000000000001 110.471 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 36.4 mt -59.75 -34.14 72.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.914 -0.584 . . . . 64.409999999999997 109.891 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.473 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -60.64 -53.56 55.95 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 115.666 -0.697 . . . . 52.409999999999997 109.353 176.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 51.5 mt-30 -53.77 -42.13 67.91 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.235 -0.439 . . . . 75.310000000000002 110.961 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -65.88 -46.31 78.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.805 -0.634 . . . . 71.140000000000001 111.37 -177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -104.98 4.7 32.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.772 0.656 . . . . 73.010000000000005 112.772 -171.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.4 t -53.29 -20.59 4.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.232 1.197 . . . . 73.420000000000002 114.232 -168.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -73.12 -23.54 60.51 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.95 0.405 . . . . 73.340000000000003 110.835 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -118.83 -16.17 9.33 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.808 -0.633 . . . . 71.299999999999997 110.629 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.63 HG23 HD11 ' A' ' 127' ' ' ILE . 20.6 t -119.38 133.4 66.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.096 -0.502 . . . . 75.340000000000003 111.387 -173.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -131.76 119.85 21.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.511 -0.768 . . . . 73.349999999999994 109.239 173.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.651 HG12 ' HB2' ' A' ' 45' ' ' LEU . 71.7 mt -99.32 139.44 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.972 -0.381 . . . . 71.200000000000003 109.972 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.423 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 96.5 m-85 -129.82 151.47 50.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.951 -0.568 . . . . 75.540000000000006 110.032 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -134.14 109.93 9.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.041 0.448 . . . . 71.140000000000001 110.466 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 26' ' ' ILE . 1.3 pp -78.56 70.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.733 0.778 . . . . 72.109999999999999 110.368 176.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.57 -13.0 60.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.385 -0.825 . . . . 75.140000000000001 111.077 -173.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 60.4 mt -67.12 108.56 1.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 110.105 -0.331 . . . . 74.540000000000006 110.105 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.63 -36.12 64.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.101 -0.5 . . . . 73.299999999999997 111.888 -175.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -71.63 -22.22 61.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.237 0.542 . . . . 43.130000000000003 110.927 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.444 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.9 OUTLIER -102.62 23.12 12.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.945 -0.571 . . . . 60.509999999999998 111.539 -175.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -76.51 12.81 1.13 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.84 0.311 . . . . 72.209999999999994 111.84 178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.592 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 30.4 t70 -53.11 -36.78 61.13 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.864 0.364 . . . . 73.109999999999999 110.637 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.3 t -52.75 -35.25 21.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.817 -0.629 . . . . 75.540000000000006 110.638 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.404 ' HB2' ' HE2' ' A' ' 48' ' ' PHE . . . -62.97 -50.23 71.59 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.903 -0.589 . . . . 52.200000000000003 110.335 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.1 m -66.7 -31.33 71.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.656 -0.702 . . . . 64.150000000000006 110.781 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 32.6 mm-40 -67.98 -53.85 22.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.21 -0.45 . . . . 63.200000000000003 110.928 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -91.71 -2.36 57.03 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.165 -0.47 . . . . 65.430000000000007 112.028 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.46 71.37 1.16 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.814 -0.708 . . . . 75.540000000000006 112.384 173.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.468 HG21 ' CZ ' ' A' ' 48' ' ' PHE . 98.4 t -104.51 101.04 11.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 63.039999999999999 110.363 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.8 t -94.6 -35.22 12.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 61.210000000000001 109.904 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.94 146.07 37.78 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.924 -0.58 . . . . 70.450000000000003 110.783 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.684 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 65.2 mt -69.09 -54.54 11.79 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 116.481 -0.327 . . . . 64.230000000000004 110.937 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.684 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 5.1 Cg_endo -85.0 93.79 0.68 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.142 1.895 . . . . 61.509999999999998 110.943 177.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 90.7 m -127.65 132.6 49.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.042 0.449 . . . . 53.229999999999997 111.208 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.6 mp -115.78 122.65 69.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.629 -0.714 . . . . 73.030000000000001 109.829 176.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.487 HD23 ' HG3' ' A' ' 110' ' ' GLN . 90.6 mt -98.68 125.26 43.92 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.664 -0.495 . . . . 74.400000000000006 109.664 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.549 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 52.9 mtp -98.46 147.73 24.45 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.964 -0.384 . . . . 63.420000000000002 109.964 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.73 150.78 36.88 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.096 -0.705 . . . . 74.140000000000001 109.096 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.531 ' HB2' HD22 ' A' ' 108' ' ' LEU . 61.9 tttp -139.54 106.78 5.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 120.907 -0.317 . . . . 74.209999999999994 111.024 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.78 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.4 t30 59.08 30.9 20.81 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.698 0.761 . . . . 51.210000000000001 110.444 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.87 -13.99 61.48 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.639 -0.71 . . . . 70.040000000000006 112.25 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -70.37 138.07 51.06 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 110.038 -0.356 . . . . 63.409999999999997 110.038 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -56.86 152.73 12.12 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.231 0.957 . . . . 72.239999999999995 109.447 173.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.549 ' HB3' ' C ' ' A' ' 101' ' ' MET . 11.5 tp -162.82 168.79 20.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.512 -0.767 . . . . 75.420000000000002 109.893 -165.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.7 m -69.19 164.04 23.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.787 0.803 . . . . 73.329999999999998 112.411 -164.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.487 ' HG3' HD23 ' A' ' 100' ' ' LEU . 61.8 tt0 -127.65 124.14 37.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.11 -0.95 . . . . 74.120000000000005 109.593 -174.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.8 t -97.66 111.89 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.872 0.368 . . . . 70.030000000000001 110.234 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.491 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -97.52 109.99 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.805 -0.634 . . . . 73.310000000000002 109.801 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.08 -174.68 23.39 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.043 -0.598 . . . . 44.310000000000002 112.284 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -93.4 72.29 4.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.188 0.518 . . . . 31.199999999999999 110.808 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.418 ' O ' HG13 ' A' ' 119' ' ' ILE . 0.9 OUTLIER -110.79 77.79 1.07 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.91 -0.586 . . . . 72.420000000000002 109.915 177.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -34.72 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 115.627 -0.715 . . . . 51.340000000000003 110.024 -176.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.1 t -63.52 -42.66 98.45 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.163 -0.471 . . . . 54.530000000000001 110.224 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -65.48 -41.38 93.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 72.349999999999994 109.991 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 123' ' ' ILE . 77.0 mt -59.18 -56.69 15.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 116.028 -0.533 . . . . 73.530000000000001 110.807 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.7 tt -62.9 -37.08 78.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 116.466 -0.334 . . . . 74.230000000000004 110.439 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.0 t -58.19 -51.9 67.8 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 116.289 -0.414 . . . . 74.549999999999997 110.128 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -61.87 -39.45 91.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.448 -0.342 . . . . 71.239999999999995 110.633 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 119' ' ' ILE . 74.4 mt -57.54 -56.51 14.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 121.109 -0.236 . . . . 62.219999999999999 111.159 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -71.07 -24.99 62.43 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.755 -0.378 . . . . 53.119999999999997 110.356 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -66.61 -38.55 87.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.163 0.506 . . . . 75.319999999999993 110.43 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -92.51 -12.79 31.02 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.291 -0.413 . . . . 65.530000000000001 111.922 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.63 HD11 HG23 ' A' ' 74' ' ' VAL . 62.4 mt -95.97 -60.47 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.769 0.318 . . . . 71.140000000000001 111.431 173.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.525 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.751 -0.642 . . . . 62.509999999999998 110.364 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 110.026 -0.361 . . . . 63.420000000000002 110.026 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.8 97.39 7.12 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.174 -0.466 . . . . 61.210000000000001 110.69 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -113.29 51.1 0.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.472 0.653 . . . . 74.400000000000006 109.444 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -56.56 137.42 53.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.985 -1.007 . . . . 63.409999999999997 111.416 -178.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -98.22 154.52 17.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.824 -0.626 . . . . 71.420000000000002 109.529 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -149.78 148.86 29.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.516 0.198 . . . . 74.120000000000005 110.548 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -108.77 169.76 8.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 61.329999999999998 109.763 176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -147.42 86.03 1.6 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.667 -0.494 . . . . 71.140000000000001 109.667 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.0 ptm -143.36 136.38 27.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.571 -0.74 . . . . 54.530000000000001 109.885 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.21 152.29 7.94 Favored Glycine 0 C--O 1.234 0.153 0 C-N-CA 121.193 -0.527 . . . . 51.549999999999997 111.808 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.9 m -95.95 104.96 16.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.03 0.443 . . . . 72.540000000000006 110.078 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.408 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.2 mm? -78.09 95.41 4.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 110.895 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -143.36 122.43 12.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.914 -0.585 . . . . 74.420000000000002 109.681 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -137.39 74.69 1.49 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.17 0.51 . . . . 72.450000000000003 111.106 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -89.69 90.56 8.28 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.281 -0.637 . . . . 74.450000000000003 109.281 175.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.0 p -74.23 -2.01 23.01 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.445 -0.798 . . . . 62.530000000000001 112.97 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -115.64 135.71 53.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.339 . . . . 74.310000000000002 110.657 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.06 156.37 28.09 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.358 -0.697 . . . . 74.430000000000007 111.358 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.09 -26.28 50.45 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.429 2.086 . . . . 72.239999999999995 111.979 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 68.84 -88.55 0.22 Allowed Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.97 -0.559 . . . . 65.340000000000003 112.691 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.8 t -152.57 85.84 1.26 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.917 0.389 . . . . 55.509999999999998 110.137 -178.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.43 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 85.5 mmm -91.13 -31.92 16.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.481 . . . . 54.229999999999997 110.265 176.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.548 HG22 ' HB2' ' A' ' 78' ' ' LYS . 21.0 mm -81.09 123.17 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 116.026 -0.534 . . . . 73.319999999999993 109.561 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -88.99 126.16 35.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.923 0.392 . . . . 73.150000000000006 111.158 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.763 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 10.2 pt20 -82.76 130.94 35.2 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.208 -0.451 . . . . 74.019999999999996 110.402 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 31' ' ' PHE . 47.2 pt -141.83 168.17 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.294 0.568 . . . . 71.299999999999997 111.87 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.75 -170.0 12.64 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.188 -0.915 . . . . 22.140000000000001 111.093 173.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.58 -45.28 92.33 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.181 0.515 . . . . 73.400000000000006 110.991 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.8 m -57.38 -28.45 63.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.385 -0.825 . . . . 51.539999999999999 111.592 -176.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.4 mp0 -106.52 -20.42 13.37 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.693 -0.231 . . . . 64.150000000000006 111.582 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.454 ' O ' HG23 ' A' ' 35' ' ' VAL . 91.2 t80 -52.0 -62.01 1.9 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 111.949 0.352 . . . . 74.329999999999998 111.949 -171.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.33 -44.31 79.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.265 -0.425 . . . . 64.120000000000005 110.252 -177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -59.59 -57.4 13.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.767 -0.651 . . . . 62.509999999999998 110.883 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 35.7 mmtp -59.31 -32.12 69.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.873 -0.603 . . . . 74.450000000000003 111.342 -174.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 31' ' ' PHE . 96.3 t -78.52 -44.76 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 111.874 0.324 . . . . 71.530000000000001 111.874 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.3 p -86.01 -14.99 42.85 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.609 0.596 . . . . 52.409999999999997 112.609 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.3 m -78.11 9.69 3.52 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.804 0.335 . . . . 73.310000000000002 111.605 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.915 ' SG ' ' HB ' ' A' ' 42' ' ' ILE . 41.6 t -67.36 169.1 9.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 75.430000000000007 110.208 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.456 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 45.0 t-20 -114.01 -62.47 1.59 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.951 -0.389 . . . . 74.140000000000001 109.951 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -162.38 138.59 7.6 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.483 -0.326 . . . . 72.329999999999998 111.368 -175.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 60.15 1.71 0.37 Allowed 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.092 1.145 . . . . 53.409999999999997 114.092 172.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.915 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 50.7 mm -79.73 107.03 11.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-N 118.325 0.511 . . . . 73.329999999999998 110.33 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.6 tp -75.47 129.39 37.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.648 -0.705 . . . . 70.319999999999993 110.274 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.5 mt -116.56 119.92 63.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.631 -0.713 . . . . 62.25 110.488 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.3 mp -108.13 143.57 36.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.908 -0.775 . . . . 64.200000000000003 108.908 175.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.426 HG22 ' HB2' ' A' ' 77' ' ' TYR . 64.3 t -130.0 110.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.719 -0.475 . . . . 74.420000000000002 109.719 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -88.96 143.01 27.16 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.043 0.449 . . . . 73.530000000000001 111.607 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -95.38 118.32 31.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.717 -0.674 . . . . 64.040000000000006 109.912 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.611 ' HB2' ' HE3' ' A' ' 78' ' ' LYS . 26.3 t90 -89.27 -55.69 3.57 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.177 -0.465 . . . . 72.430000000000007 111.915 -172.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 70.44 155.94 0.15 Allowed Pre-proline 0 N--CA 1.47 0.534 0 O-C-N 123.645 0.591 . . . . 53.310000000000002 110.8 -175.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.8 -29.86 73.86 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.558 2.172 . . . . 72.140000000000001 111.874 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -139.35 106.26 5.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 73.129999999999995 109.805 175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 55' ' ' PRO . 1.8 p -85.92 -66.36 0.91 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.016 -0.538 . . . . 73.129999999999995 110.767 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 108.11 -94.12 0.85 Allowed Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.102 -0.57 . . . . 75.420000000000002 112.429 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 53' ' ' CYS . 31.2 Cg_endo -62.72 -5.37 7.19 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.893 2.395 . . . . 60.140000000000001 112.088 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.441 ' O ' ' HG2' ' A' ' 60' ' ' GLU . 8.9 p -55.31 -20.76 12.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.469 -0.787 . . . . 71.430000000000007 111.495 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.2 tpp180 -53.72 -46.99 70.99 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.639 -0.255 . . . . 74.510000000000005 111.01 -176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.622 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.7 m -75.39 -43.49 49.88 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.606 0.717 . . . . 71.219999999999999 111.415 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.477 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.3 mm? -64.88 -33.8 76.88 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.53 -0.759 . . . . 74.319999999999993 112.093 -170.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 13.4 mm-40 -59.34 -59.96 12.12 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 121.043 -0.263 . . . . 70.439999999999998 110.567 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 18.5 Cg_endo -59.6 -42.17 49.72 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 121.829 1.686 . . . . 70.109999999999999 111.992 177.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.5 mt-30 -57.37 -46.46 83.37 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 120.599 -0.44 . . . . 52.450000000000003 111.422 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.75 -43.82 78.98 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.394 -0.367 . . . . 71.109999999999999 110.617 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HG2' HG12 ' A' ' 23' ' ' ILE . 36.0 mt-10 -63.48 -33.83 76.43 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.648 0.261 . . . . 55.219999999999999 110.509 178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -63.18 -54.71 33.39 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.23 0.538 . . . . 74.5 110.146 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.499 HD13 HD13 ' A' ' 120' ' ' ILE . 22.4 mt -63.19 -34.06 76.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.772 -0.649 . . . . 73.239999999999995 110.132 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.516 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -61.58 -43.48 98.78 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.99 -0.55 . . . . 74.239999999999995 110.076 177.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.43 ' HG3' ' HG3' ' A' ' 22' ' ' MET . 97.2 mt-30 -63.7 -48.34 77.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.932 0.396 . . . . 74.120000000000005 110.61 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -61.85 -43.29 99.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.868 -0.605 . . . . 74.0 111.12 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.91 5.72 33.11 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 112.995 0.739 . . . . 63.140000000000001 112.995 -169.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.6 t -52.87 -23.47 7.12 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.383 0.882 . . . . 71.129999999999995 113.383 -170.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -73.65 -18.77 60.99 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.84 0.352 . . . . 73.230000000000004 111.313 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -130.29 -6.65 4.29 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.964 -0.562 . . . . 63.149999999999999 111.191 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.563 HG23 HD11 ' A' ' 127' ' ' ILE . 39.6 t -128.97 138.42 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 121.048 0.452 . . . . 53.210000000000001 111.535 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -135.93 127.59 28.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.596 -0.729 . . . . 74.109999999999999 109.063 170.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.1 mt -113.42 114.52 47.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.943 0.401 . . . . 73.450000000000003 110.311 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.426 ' HB2' HG22 ' A' ' 46' ' ' VAL . 98.7 m-85 -93.71 167.32 11.73 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.747 -0.66 . . . . 73.530000000000001 109.868 175.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.611 ' HE3' ' HB2' ' A' ' 49' ' ' TRP . 31.9 tttp -145.15 140.97 28.35 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.348 -0.612 . . . . 65.040000000000006 109.348 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.0 tt -64.01 108.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.215 0.531 . . . . 71.310000000000002 110.811 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.763 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 41.2 t30 -89.62 -52.94 4.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.733 -0.667 . . . . 74.239999999999995 110.32 178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.4 mm -74.14 112.6 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.36 -0.836 . . . . 72.129999999999995 110.687 -177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -59.95 -30.11 68.86 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.551 0.691 . . . . 73.230000000000004 110.381 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.74 -22.65 61.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.512 -0.767 . . . . 62.5 110.497 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -88.95 45.37 1.29 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.454 0.645 . . . . 72.340000000000003 110.721 -177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.438 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 3.0 pt20 -88.94 -7.53 55.88 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.963 -0.754 . . . . 72.319999999999993 108.963 171.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 21.5 t70 -48.75 -51.42 29.06 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.252 -0.885 . . . . 50.439999999999998 110.599 177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.5 m -54.57 -33.9 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.689 0 CA-C-N 115.946 -0.57 . . . . 62.399999999999999 111.445 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -66.3 -41.52 89.62 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.427 -0.583 . . . . 72.0 109.427 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.7 m -70.46 -29.72 66.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.615 -0.72 . . . . 55.240000000000002 110.716 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 83.1 mm-40 -70.6 -48.9 52.82 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.224 -0.443 . . . . 63.210000000000001 111.179 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -82.91 -24.81 32.94 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.353 -0.385 . . . . 73.420000000000002 111.442 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.82 64.67 0.85 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.962 -0.637 . . . . 51.329999999999998 112.593 176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.523 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 90.8 t -102.5 102.2 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.615 -0.513 . . . . 71.319999999999993 109.615 175.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -113.8 8.67 17.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.968 -0.56 . . . . 74.319999999999993 110.429 -178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -124.92 151.98 44.7 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.495 -0.558 . . . . 50.409999999999997 109.495 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.659 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 68.0 mt -63.37 -57.51 19.91 Favored Pre-proline 0 CA--C 1.538 0.493 0 O-C-N 123.077 0.236 . . . . 43.200000000000003 111.114 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.659 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 96.6 Cg_endo -86.62 100.78 0.57 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.757 1.638 . . . . 53.219999999999999 111.614 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.4 m -137.36 121.59 18.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.775 0.322 . . . . 73.299999999999997 110.576 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.446 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.0 mp -110.17 110.9 33.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.801 -0.636 . . . . 74.319999999999993 109.941 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.482 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.7 mp -88.31 126.04 34.98 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.625 -0.509 . . . . 73.230000000000004 109.625 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.466 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 33.5 mtp -106.67 140.76 39.02 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.963 -0.384 . . . . 74.140000000000001 109.963 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -147.27 155.37 41.99 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.993 -0.743 . . . . 75.25 108.993 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -129.07 105.49 8.22 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 120.674 -0.41 . . . . 72.230000000000004 110.611 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.567 ' HA ' ' HB3' ' A' ' 38' ' ' CYS . 8.9 t30 61.27 25.67 15.62 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.593 0.711 . . . . 64.329999999999998 110.566 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.24 -12.2 70.25 Favored Glycine 0 N--CA 1.454 -0.103 0 CA-C-N 115.831 -0.622 . . . . 62.539999999999999 112.071 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -75.08 139.21 42.65 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 110.02 -0.363 . . . . 65.209999999999994 110.02 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -58.62 145.96 37.83 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 124.405 1.066 . . . . 75.010000000000005 110.813 -176.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 101' ' ' MET . 0.9 OUTLIER -162.34 168.92 21.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 72.319999999999993 109.52 -167.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.4 m -69.96 172.32 8.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.143 0.577 . . . . 62.520000000000003 111.927 -168.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.465 ' OE1' ' HG ' ' A' ' 100' ' ' LEU . 26.0 tt0 -142.03 118.48 10.9 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.995 -0.548 . . . . 72.019999999999996 109.613 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -87.85 107.19 17.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.409 -0.36 . . . . 74.329999999999998 110.064 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 65.0 mt -95.57 104.89 16.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.288 -0.415 . . . . 73.310000000000002 110.243 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.41 148.01 6.8 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.656 -0.578 . . . . 62.329999999999998 111.656 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.477 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -80.1 71.78 6.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.094 0.473 . . . . 52.450000000000003 109.958 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.411 ' O ' HG13 ' A' ' 119' ' ' ILE . 29.5 t70 -122.2 95.72 4.76 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.473 0.654 . . . . 72.209999999999994 109.812 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.436 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -62.42 -28.43 44.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.984 -1.007 . . . . 75.409999999999997 110.019 -174.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.9 m -62.34 -48.67 78.8 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.146 -0.479 . . . . 73.349999999999994 110.561 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -67.54 -37.65 83.03 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.725 0.298 . . . . 52.240000000000002 110.207 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 123' ' ' ILE . 75.2 mt -58.25 -56.33 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.217 -0.447 . . . . 64.510000000000005 110.904 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.499 HD13 HD13 ' A' ' 66' ' ' LEU . 7.9 tp -64.74 -34.46 70.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.773 0.321 . . . . 73.450000000000003 110.642 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.7 t -58.68 -45.02 90.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 54.310000000000002 110.125 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 48.8 mm-40 -70.86 -37.29 73.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.449 -0.341 . . . . 64.450000000000003 111.143 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 119' ' ' ILE . 68.6 mt -54.75 -55.9 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 121.124 0.488 . . . . 74.049999999999997 109.975 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -60.24 -41.91 94.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.845 -0.616 . . . . 74.349999999999994 110.642 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 33.3 t30 -58.26 -38.4 76.86 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.654 -0.703 . . . . 65.430000000000007 111.505 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -99.58 -11.99 20.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.227 0.454 . . . . 75.120000000000005 112.227 -174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.563 HD11 HG23 ' A' ' 74' ' ' VAL . 55.6 mt -92.82 -59.54 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-O 120.902 0.382 . . . . 70.340000000000003 111.075 173.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.592 -0.718 . . . . 51.329999999999998 110.276 -174.263 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 120.835 0.35 . . . . 54.549999999999997 110.32 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.96 123.44 28.33 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.087 -0.506 . . . . 51.530000000000001 110.546 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.9 t60 -113.21 -3.93 13.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.473 -0.33 . . . . 75.140000000000001 110.822 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -171.27 144.21 1.99 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.44 -0.345 . . . . 75.439999999999998 110.548 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.6 m-70 -115.11 120.16 38.84 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.339 -0.615 . . . . 54.530000000000001 109.339 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -139.88 94.33 2.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.665 0.269 . . . . 72.109999999999999 111.046 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -159.54 165.41 32.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.52 . . . . 64.140000000000001 110.326 176.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -115.92 126.22 53.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.071 -0.513 . . . . 73.420000000000002 109.764 175.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptm -89.09 139.35 30.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.524 -0.547 . . . . 72.129999999999995 109.524 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.65 81.08 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.487 -0.645 . . . . 74.430000000000007 111.487 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 m -147.92 -34.68 0.23 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.497 0.189 . . . . 75.310000000000002 110.865 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.2 tp 70.37 -58.06 0.56 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.26 0.624 . . . . 54.200000000000003 110.239 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 66.38 105.66 0.04 OUTLIER 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.427 0.691 . . . . 71.349999999999994 111.355 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.423 ' HB3' ' CD1' ' A' ' 49' ' ' TRP . . . -82.41 96.26 7.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.879 -0.6 . . . . 34.310000000000002 109.849 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -56.61 110.1 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 74.439999999999998 110.383 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -59.67 92.83 0.02 OUTLIER 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.225 -0.443 . . . . 64.349999999999994 111.404 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -76.98 72.34 3.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.895 -0.593 . . . . 72.200000000000003 110.178 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.78 159.03 47.44 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 116.002 -0.545 . . . . 72.230000000000004 112.744 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.55 50.41 2.96 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.561 2.841 . . . . 74.329999999999998 111.526 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.94 61.29 0.38 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 108.66 -1.776 . . . . 71.310000000000002 108.66 -166.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.0 p -42.31 107.35 0.08 Allowed 'General case' 0 C--O 1.234 0.281 0 N-CA-C 113.314 0.857 . . . . 74.540000000000006 113.314 -166.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.1 mmm -74.63 -19.52 60.26 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.951 -0.759 . . . . 74.409999999999997 108.951 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mm -91.75 136.49 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 114.83 -1.077 . . . . 71.430000000000007 108.764 174.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.0 tp10 -112.8 144.07 42.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.725 0.298 . . . . 74.540000000000006 110.725 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -114.26 132.01 56.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.781 -0.451 . . . . 71.349999999999994 109.781 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 25.1 pt -140.27 178.27 3.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-O 120.867 0.365 . . . . 73.530000000000001 111.126 -177.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.59 172.95 25.48 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 115.89 -0.595 . . . . 52.030000000000001 111.869 177.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.68 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 10.5 t70 -52.24 -56.82 12.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.978 0.418 . . . . 72.349999999999994 111.504 -175.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -64.21 -19.98 65.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.821 -0.627 . . . . 74.230000000000004 111.695 -174.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 37.5 mt-10 -78.08 -29.22 49.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.663 -0.244 . . . . 73.109999999999999 111.202 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -52.68 -49.39 65.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.731 0.301 . . . . 74.420000000000002 110.515 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -55.17 -55.85 26.59 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.969 -0.56 . . . . 60.439999999999998 109.916 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -53.27 -57.56 10.1 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.162 -0.927 . . . . 72.340000000000003 110.884 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 73.2 mmtt -64.07 -41.52 97.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.423 -1.262 . . . . 51.450000000000003 111.211 -169.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.56 -41.14 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.537 -0.301 . . . . 62.32 110.973 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.9 p -75.82 -19.28 59.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.784 0.326 . . . . 75.109999999999999 111.324 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -76.37 -14.57 60.08 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.434 -0.348 . . . . 75.140000000000001 110.717 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.756 ' SG ' HD11 ' A' ' 44' ' ' ILE . 66.6 m -70.93 101.16 2.1 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.879 0.371 . . . . 73.439999999999998 110.256 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -67.41 -47.93 68.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 72.230000000000004 112.371 -172.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -153.82 133.27 12.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.092 0.472 . . . . 63.229999999999997 111.853 -177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 67.28 2.13 2.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.915 -1.039 . . . . 72.439999999999998 113.421 165.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.69 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 48.0 mm -80.63 97.16 3.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.367 0.603 . . . . 61.109999999999999 110.325 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 tt -80.77 113.13 18.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.33 -0.85 . . . . 72.319999999999993 108.944 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.756 HD11 ' SG ' ' A' ' 38' ' ' CYS . 47.3 mt -98.26 133.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.08 -0.509 . . . . 62.130000000000003 111.29 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.9 mp -114.56 124.88 52.99 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.57 -0.9 . . . . 63.240000000000002 108.57 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 92.4 t -106.37 110.02 30.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 110.205 -0.294 . . . . 73.120000000000005 110.205 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -99.71 131.92 45.38 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.236 0.541 . . . . 65.239999999999995 111.337 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -103.49 107.6 18.51 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.356 -0.979 . . . . 75.219999999999999 108.356 168.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.423 ' CD1' ' HB3' ' A' ' 14' ' ' ALA . 14.8 t-105 -81.13 137.01 35.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.245 0.545 . . . . 74.420000000000002 110.572 -170.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 97' ' ' PRO . . . -76.92 129.22 79.41 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.781 -0.645 . . . . 64.239999999999995 111.356 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.95 -24.46 67.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.314 2.01 . . . . 73.519999999999996 110.412 172.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 18.7 m95 -87.95 88.54 7.68 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.446 -0.946 . . . . 74.239999999999995 108.446 174.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.1 t -76.96 144.2 38.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.24 0.543 . . . . 74.430000000000007 111.887 -171.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -154.63 -80.84 0.03 OUTLIER Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.345 -0.843 . . . . 72.150000000000006 111.185 177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.71 16.56 1.56 Allowed 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.832 2.355 . . . . 71.140000000000001 112.428 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 4.1 m -54.96 -48.42 73.22 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.166 -0.47 . . . . 73.450000000000003 110.654 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -53.91 -36.28 62.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.934 -1.03 . . . . 74.510000000000005 111.174 -173.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.628 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 17.5 m -75.41 -59.13 2.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.03 -0.532 . . . . 75.439999999999998 111.558 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.55 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.5 mm? -64.06 -29.25 70.4 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.751 0.649 . . . . 73.540000000000006 112.751 -169.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.45 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 41.0 mt-10 -57.01 -63.9 3.13 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 120.56 -0.456 . . . . 51.549999999999997 110.454 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.45 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 38.0 Cg_endo -65.44 -36.86 32.69 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 121.761 1.641 . . . . 73.120000000000005 112.132 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 58' ' ' SER . 37.9 mt-30 -58.8 -48.9 79.66 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 120.537 -0.465 . . . . 74.040000000000006 111.234 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.422 HD21 HD13 ' A' ' 119' ' ' ILE . 80.0 mt -66.89 -46.59 74.43 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.922 -0.127 . . . . 70.019999999999996 110.699 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 30.9 mt-10 -63.41 -30.56 71.67 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.493 -0.483 . . . . 65.239999999999995 110.685 178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -64.71 -57.17 9.72 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.186 0.517 . . . . 70.439999999999998 109.935 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.492 HD13 HD13 ' A' ' 120' ' ' ILE . 37.7 mt -58.97 -34.81 72.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.489 -0.778 . . . . 72.409999999999997 109.597 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.49 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.65 -49.47 75.02 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.52 -0.764 . . . . 74.439999999999998 110.258 176.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 99.1 mt-30 -60.06 -35.87 76.09 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.784 0.326 . . . . 72.030000000000001 111.03 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.86 -41.93 42.04 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.012 -0.54 . . . . 61.219999999999999 111.393 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -105.06 4.95 32.08 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 113.132 0.79 . . . . 75.430000000000007 113.132 -171.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.5 t -53.14 -19.96 3.4 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.901 0.704 . . . . 75.319999999999993 112.901 -170.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -64.52 -33.71 76.53 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.046 0.451 . . . . 72.120000000000005 110.486 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -129.43 8.76 5.49 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.78 -0.645 . . . . 75.340000000000003 111.983 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.562 HG23 HD11 ' A' ' 127' ' ' ILE . 43.0 t -133.64 142.9 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 122.206 -0.309 . . . . 74.140000000000001 111.653 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 2.4 tppt? -151.69 133.77 15.1 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.053 -0.721 . . . . 73.209999999999994 109.053 175.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 76' ' ' ILE . 4.2 mp -108.17 136.67 42.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.718 0.294 . . . . 74.219999999999999 110.423 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 74.4 m-85 -128.39 158.18 38.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.964 -0.562 . . . . 62.439999999999998 109.935 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.735 ' HZ2' ' HB2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -152.33 172.74 16.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.653 -0.499 . . . . 73.319999999999993 109.653 178.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.42 142.56 13.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.765 -0.457 . . . . 53.539999999999999 109.765 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -103.56 -9.67 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 74.129999999999995 110.834 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.537 HG13 ' H ' ' A' ' 83' ' ' ASP . 8.5 tp -153.88 118.72 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.345 0.593 . . . . 71.040000000000006 110.77 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -58.81 -18.38 31.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.565 -0.743 . . . . 73.319999999999993 111.924 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.537 ' H ' HG13 ' A' ' 81' ' ' ILE . 4.4 m-20 -71.09 -7.9 49.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.544 -0.298 . . . . 74.150000000000006 111.57 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.68 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 3.9 m120 -125.63 78.53 1.74 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 74.430000000000007 110.441 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -114.3 10.37 17.15 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.483 -0.78 . . . . 72.239999999999995 110.088 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 2.8 m-20 -49.32 -45.98 46.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.506 -0.77 . . . . 72.519999999999996 109.991 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.0 p -55.02 -39.68 50.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 115.539 -0.755 . . . . 71.329999999999998 111.258 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -67.97 -33.25 74.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.31 0.576 . . . . 71.310000000000002 109.743 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.8 m -73.53 -32.31 64.15 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.21 -0.904 . . . . 74.409999999999997 110.142 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 15.8 mm-40 -70.86 -39.57 72.83 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 111.019 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -83.39 -23.73 32.28 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.539 0.209 . . . . 73.409999999999997 111.148 177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.67 57.82 2.51 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.186 -0.53 . . . . 74.439999999999998 112.639 175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.02 124.0 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.504 0.192 . . . . 75.420000000000002 110.56 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.1 m -69.81 -62.52 1.35 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.142 -0.481 . . . . 64.510000000000005 111.879 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.81 161.87 17.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 63.229999999999997 110.253 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.495 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 47.5 mm -61.9 -54.62 49.1 Favored Pre-proline 0 CA--C 1.54 0.571 0 O-C-N 123.224 0.328 . . . . 72.340000000000003 111.178 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.618 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 73.1 Cg_endo -74.74 80.6 2.32 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.809 1.673 . . . . 53.32 112.225 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.5 m -137.01 137.03 38.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.254 -0.43 . . . . 50.200000000000003 111.016 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 99' ' ' ILE . 2.7 mp -110.82 114.55 47.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.067 -0.515 . . . . 53.439999999999998 109.645 176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 100' ' ' LEU . 7.2 mp -90.66 154.01 19.88 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.417 -0.586 . . . . 65.420000000000002 109.417 176.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.406 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 57.6 mtp -119.22 144.73 46.57 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.06 -0.348 . . . . 60.310000000000002 110.06 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.529 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 94.7 m-85 -149.13 149.76 31.57 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.171 -0.677 . . . . 54.219999999999999 109.171 176.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 40.9 ttpt -145.15 113.77 6.74 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 120.054 -0.658 . . . . 72.400000000000006 111.594 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 59.32 25.72 14.43 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.816 0.817 . . . . 62.219999999999999 110.663 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.24 -16.33 49.02 Favored Glycine 0 CA--C 1.519 0.306 0 CA-C-N 115.802 -0.635 . . . . 75.349999999999994 111.876 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 8.2 tmtm? -72.83 135.3 45.17 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.579 -0.897 . . . . 75.099999999999994 108.579 177.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 34.2 mmtp -65.87 145.84 55.46 Favored 'General case' 0 N--CA 1.46 0.038 0 CA-C-O 121.577 0.703 . . . . 73.200000000000003 111.37 -174.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -145.38 167.81 22.01 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.66 -1.155 . . . . 73.409999999999997 108.979 -167.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.6 m -70.99 -177.65 1.7 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.539 0.685 . . . . 74.329999999999998 112.352 -169.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -141.32 121.0 13.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.684 -0.689 . . . . 72.129999999999995 109.77 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.7 t -95.89 116.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.208 -0.451 . . . . 74.239999999999995 110.0 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 112' ' ' ILE . 2.9 mp -91.62 115.63 31.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.294 -0.412 . . . . 75.310000000000002 109.974 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.46 169.68 41.91 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.12 -0.562 . . . . 74.099999999999994 112.575 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.55 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -83.33 76.02 9.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 122.447 0.299 . . . . 73.120000000000005 110.767 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.417 ' O ' HG13 ' A' ' 119' ' ' ILE . 23.6 t0 -115.1 95.89 5.42 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.483 0.659 . . . . 62.240000000000002 110.75 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.471 HD11 HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -60.81 -28.19 42.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.091 -0.959 . . . . 73.340000000000003 110.089 -177.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 21.3 t -62.32 -53.81 49.74 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.943 0.401 . . . . 72.109999999999999 110.146 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -62.99 -41.43 99.57 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.308 -0.405 . . . . 71.049999999999997 110.23 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.467 ' O ' HG13 ' A' ' 123' ' ' ILE . 74.0 mt -55.45 -56.46 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 115.944 -0.571 . . . . 63.409999999999997 111.159 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.492 HD13 HD13 ' A' ' 66' ' ' LEU . 8.3 tp -65.58 -34.7 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.755 0.312 . . . . 72.430000000000007 110.651 -177.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.8 t -57.17 -52.18 66.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.125 -0.488 . . . . 33.520000000000003 110.35 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -72.04 -31.44 66.17 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.471 -0.331 . . . . 52.219999999999999 111.53 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 119' ' ' ILE . 49.5 mt -57.26 -55.71 19.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 120.62 -0.432 . . . . 54.340000000000003 110.006 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -68.53 -35.74 77.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.199 -0.455 . . . . 74.030000000000001 110.486 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -65.11 -34.95 79.61 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.861 -0.609 . . . . 64.430000000000007 111.335 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -101.16 -14.46 17.73 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.7 0.63 . . . . 61.240000000000002 112.7 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.562 HD11 HG23 ' A' ' 74' ' ' VAL . 58.9 mt -82.8 -48.5 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 N-CA-C 109.549 -0.538 . . . . 73.030000000000001 109.549 171.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.316 -0.85 . . . . 62.409999999999997 109.455 178.313 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.859 0.361 . . . . 64.209999999999994 110.392 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.71 143.92 30.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.262 -0.426 . . . . 73.109999999999999 110.3 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -142.96 146.76 34.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 72.040000000000006 109.796 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -132.7 115.43 15.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.183 -0.462 . . . . 72.200000000000003 110.453 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -164.25 114.42 1.23 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.162 0.505 . . . . 71.239999999999995 109.913 172.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -158.28 90.36 1.03 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.619 -0.718 . . . . 73.510000000000005 109.154 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -161.37 104.31 1.26 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.403 -0.817 . . . . 74.549999999999997 109.763 -172.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -153.37 132.51 12.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.541 -0.3 . . . . 74.430000000000007 110.713 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.5 tpp -157.64 111.21 2.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.149 -0.478 . . . . 63.219999999999999 109.871 176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.44 77.24 0.21 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.306 -0.473 . . . . 34.420000000000002 112.152 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.2 t -168.3 107.08 0.5 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.942 0.401 . . . . 71.409999999999997 110.574 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 42.2 tp -171.73 81.76 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.104 0.478 . . . . 74.219999999999999 110.19 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -92.68 43.69 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 53.539999999999999 110.784 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.85 97.35 9.69 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.03 -0.532 . . . . 64.349999999999994 110.793 -179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -100.63 109.61 21.69 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.053 -0.521 . . . . 71.430000000000007 111.232 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.1 p -105.2 84.51 2.12 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.031 -0.531 . . . . 74.420000000000002 111.091 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.759 ' HB2' ' HG3' ' A' ' 65' ' ' LYS . 77.6 mt-30 -138.22 161.33 37.14 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.06 -0.518 . . . . 73.319999999999993 109.767 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.88 -172.38 24.46 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 121.474 -0.393 . . . . 74.219999999999999 113.357 -175.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -89.89 -165.22 0.18 Allowed 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 123.556 2.837 . . . . 72.239999999999995 112.751 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.19 49.2 0.01 OUTLIER Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.959 -0.638 . . . . 65.319999999999993 112.97 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 t 49.3 77.52 0.11 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.251 0.548 . . . . 74.209999999999994 110.996 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 95.1 mmm -117.0 -32.07 5.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.872 -0.604 . . . . 72.239999999999995 110.973 -177.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.0 mm -62.74 116.89 3.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 116.394 -0.366 . . . . 75.150000000000006 110.183 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -86.37 151.27 23.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.299 -0.409 . . . . 74.239999999999995 110.12 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 14.1 pt20 -123.29 130.91 53.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.338 . . . . 72.239999999999995 110.629 -177.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.518 HG21 ' HG3' ' A' ' 34' ' ' LYS . 37.5 pt -139.38 174.1 9.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.056 -0.52 . . . . 61.130000000000003 110.309 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.22 160.35 19.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.205 -0.521 . . . . 52.299999999999997 112.131 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.726 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 13.8 t70 -53.68 -38.64 64.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.493 0.663 . . . . 71.040000000000006 110.72 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.2 m -76.52 1.63 16.09 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.315 -0.857 . . . . 71.120000000000005 111.788 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.418 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 35.5 mt-10 -113.45 -6.08 13.48 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.344 -0.222 . . . . 73.420000000000002 111.056 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.43 ' O ' HG23 ' A' ' 35' ' ' VAL . 89.2 t80 -50.21 -61.57 2.09 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.382 0.426 . . . . 72.310000000000002 111.501 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -56.98 -42.91 81.06 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 110.488 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -55.75 -57.06 13.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.671 -0.695 . . . . 70.200000000000003 110.461 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HG3' HG21 ' A' ' 26' ' ' ILE . 72.5 mmtt -65.6 -37.08 85.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 64.239999999999995 111.061 -174.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.611 ' O ' ' SG ' ' A' ' 38' ' ' CYS . 88.0 t -71.72 -29.18 33.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.716 0.293 . . . . 74.310000000000002 111.241 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.9 p -86.32 -21.0 27.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.891 0.377 . . . . 75.319999999999993 110.839 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -72.74 -9.5 58.71 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.046 -0.524 . . . . 63.25 111.266 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.823 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 26.0 p -82.32 77.71 9.07 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.38 -0.6 . . . . 63.350000000000001 109.38 175.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -61.52 -40.43 94.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.618 -0.719 . . . . 70.299999999999997 112.86 -173.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 42' ' ' ILE . 5.6 m-20 -135.9 121.23 19.18 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.098 0.407 . . . . 74.420000000000002 112.098 -173.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 55.85 2.22 0.07 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.776 1.398 . . . . 64.439999999999998 114.776 166.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.823 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 46.9 mm -80.86 109.49 15.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.328 0.513 . . . . 71.519999999999996 110.451 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.9 tt -82.52 115.9 21.72 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.171 -0.677 . . . . 73.25 109.171 177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.52 HG21 HG22 ' A' ' 35' ' ' VAL . 32.7 mm -87.11 115.04 27.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.793 -0.64 . . . . 72.5 110.991 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 45' ' ' LEU . 6.2 mp -102.47 148.1 25.93 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.5 -0.926 . . . . 71.200000000000003 108.5 171.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 60.5 t -133.35 106.57 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 110.617 -0.142 . . . . 73.420000000000002 110.617 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -94.52 143.13 26.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.987 0.423 . . . . 74.230000000000004 110.557 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -103.52 179.37 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.093 0.473 . . . . 61.43 111.562 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 30.6 m95 -77.91 167.4 21.56 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.64 -0.709 . . . . 74.450000000000003 111.263 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.07 93.36 1.66 Allowed Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.123 -0.49 . . . . 65.400000000000006 110.737 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.647 ' HD2' HG21 ' A' ' 96' ' ' ILE . 46.5 Cg_endo -68.96 -37.77 10.61 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.446 2.097 . . . . 51.229999999999997 111.307 175.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -141.86 140.63 32.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.433 -0.803 . . . . 74.140000000000001 109.199 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 14.3 p 179.57 -55.43 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.744 -0.465 . . . . 64.319999999999993 109.744 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.16 -91.78 0.47 Allowed Glycine 0 CA--C 1.522 0.525 0 CA-C-N 116.018 -0.537 . . . . 53.420000000000002 112.83 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.41 -16.45 18.2 Favored 'Trans proline' 0 N--CA 1.479 0.638 0 C-N-CA 123.376 2.717 . . . . 64.409999999999997 113.749 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 26.2 m -51.22 -30.66 18.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.346 0.258 . . . . 63.340000000000003 111.516 -176.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -55.74 -40.96 73.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.289 -0.414 . . . . 62.109999999999999 110.851 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 19.3 m -75.11 -35.17 61.76 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.212 0.53 . . . . 71.310000000000002 110.695 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 4.1 mm? -58.38 -42.85 87.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.716 -0.674 . . . . 71.319999999999993 111.629 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.449 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 37.6 mt-10 -54.89 -60.53 7.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 119.758 -0.163 . . . . 72.340000000000003 111.011 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.449 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 20.1 Cg_endo -61.7 -34.66 83.2 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 121.688 1.592 . . . . 73.340000000000003 112.211 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 58' ' ' SER . 14.9 mt-30 -63.9 -38.24 90.36 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.702 -0.399 . . . . 70.140000000000001 110.83 177.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 75.4 mt -68.62 -42.6 77.87 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.764 -0.458 . . . . 51.219999999999999 109.764 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -67.79 -26.79 66.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 54.030000000000001 110.71 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.759 ' HG3' ' HB2' ' A' ' 17' ' ' GLN . 33.4 ttpt -65.71 -56.78 10.24 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.725 0.774 . . . . 72.519999999999996 109.957 175.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.499 HD22 HD13 ' A' ' 120' ' ' ILE . 37.6 mt -59.13 -32.91 70.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.936 -1.029 . . . . 75.310000000000002 109.534 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.527 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.5 -51.27 66.28 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.692 -0.686 . . . . 71.230000000000004 109.562 176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -55.89 -48.6 75.31 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.651 -0.704 . . . . 70.239999999999995 111.781 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -73.85 -39.68 63.83 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.44 -0.504 . . . . 73.329999999999998 111.169 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -101.04 4.93 42.77 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 113.021 0.748 . . . . 74.450000000000003 113.021 -171.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.9 t -53.25 -19.18 2.91 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.519 0.563 . . . . 74.200000000000003 112.519 -171.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -69.23 -34.68 75.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.656 0.265 . . . . 74.219999999999999 110.717 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -124.26 3.61 8.51 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.246 -0.434 . . . . 72.400000000000006 111.624 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.6 t -130.94 136.77 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.794 0.33 . . . . 74.430000000000007 111.368 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -138.36 131.28 29.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.732 -0.667 . . . . 70.319999999999993 109.624 174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.405 HG12 ' HB2' ' A' ' 45' ' ' LEU . 50.0 mt -112.01 135.55 50.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.572 -0.529 . . . . 74.120000000000005 109.572 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 95.7 m-85 -129.26 147.93 51.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.111 -0.495 . . . . 73.319999999999993 110.469 -176.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -133.99 145.14 49.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.061 -0.518 . . . . 71.5 109.849 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.436 HG21 ' O ' ' A' ' 84' ' ' ASN . 52.0 mt -70.21 112.52 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 108.958 -0.756 . . . . 74.150000000000006 108.958 175.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 66.9 t30 -75.31 -12.85 60.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.984 -0.553 . . . . 62.340000000000003 112.371 -170.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.548 HG22 ' H ' ' A' ' 83' ' ' ASP . 56.9 mt -130.89 119.97 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 120.683 0.277 . . . . 74.140000000000001 110.665 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -18.78 65.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.096 -0.502 . . . . 61.020000000000003 111.796 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.548 ' H ' HG22 ' A' ' 81' ' ' ILE . 24.8 t70 -71.37 -18.64 62.36 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.41 0.624 . . . . 60.450000000000003 109.833 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.726 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 16.6 m120 -103.9 121.66 43.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.223 -0.898 . . . . 75.450000000000003 108.758 175.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -163.27 15.0 0.07 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.959 0.725 . . . . 63.329999999999998 112.959 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.548 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 1.8 m-20 -54.96 -42.46 72.39 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.061 -0.348 . . . . 64.409999999999997 110.061 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.402 HG23 ' OD2' ' A' ' 28' ' ' ASP . 77.4 t -53.15 -38.96 31.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.822 -0.627 . . . . 54.25 110.532 175.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.46 77.52 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.347 0.594 . . . . 72.450000000000003 110.003 -177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.6 m -67.32 -37.49 83.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.022 -0.99 . . . . 73.420000000000002 110.564 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 93.5 mt-30 -69.97 -53.47 17.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.827 -0.624 . . . . 74.140000000000001 111.061 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -83.42 -13.0 55.79 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.023 -0.535 . . . . 74.430000000000007 111.696 -174.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.53 78.97 0.79 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.88 -0.676 . . . . 64.040000000000006 112.849 171.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.9 t -75.54 93.09 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.316 0.579 . . . . 73.120000000000005 109.797 174.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.7 m -71.76 -59.4 2.77 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.363 -0.835 . . . . 73.120000000000005 110.925 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.5 152.85 21.88 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.5 -0.556 . . . . 65.430000000000007 109.5 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.691 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 43.0 mm -55.35 -54.27 52.79 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 123.18 0.3 . . . . 52.439999999999998 111.087 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.691 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 19.8 Cg_endo -89.32 99.74 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.256 1.971 . . . . 73.25 111.318 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.3 m -118.62 146.49 44.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.136 -0.484 . . . . 74.329999999999998 110.567 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 3.5 mp -123.16 116.17 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.599 -0.728 . . . . 55.32 109.913 177.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 64.6 mt -90.24 143.05 27.12 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.301 -0.629 . . . . 73.439999999999998 109.301 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.407 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 48.0 mtp -117.48 136.28 53.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.985 -0.376 . . . . 72.439999999999998 109.985 174.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 95.3 m-85 -148.96 160.39 43.34 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.451 -0.944 . . . . 72.209999999999994 108.451 174.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -153.82 111.25 3.47 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 119.846 -0.742 . . . . 73.409999999999997 112.315 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.465 ' N ' ' SG ' ' A' ' 38' ' ' CYS . 56.9 t30 55.57 37.59 29.08 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.721 0.772 . . . . 65.319999999999993 110.978 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.76 -16.35 50.93 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.411 -0.813 . . . . 64.129999999999995 112.575 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -77.72 138.84 39.26 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.669 0.271 . . . . 61.25 110.633 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -62.41 139.92 58.56 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.339 -0.846 . . . . 74.129999999999995 110.619 176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -144.14 167.67 21.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.975 -1.12 . . . . 74.030000000000001 107.975 -174.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 69.1 m -70.75 -179.72 2.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.612 0.72 . . . . 74.439999999999998 112.759 -165.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.445 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.1 tt0 -142.26 118.71 10.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.718 -0.674 . . . . 64.5 110.013 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 49.7 t -100.02 107.72 21.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.459 . . . . 65.510000000000005 110.272 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.4 mp -94.31 104.46 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.601 -0.518 . . . . 73.230000000000004 109.601 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.76 177.99 23.82 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.714 -0.555 . . . . 52.140000000000001 111.714 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.22 80.85 7.57 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.992 0.425 . . . . 70.230000000000004 110.936 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.425 ' O ' HG13 ' A' ' 119' ' ' ILE . 21.6 m-20 -117.51 73.7 0.89 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.031 -0.531 . . . . 63.350000000000001 110.146 175.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.407 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -61.39 -33.03 54.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.551 -0.537 . . . . 51.329999999999998 109.551 -177.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.5 t -59.0 -46.21 88.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.879 -0.6 . . . . 74.219999999999999 110.192 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -70.06 -36.37 74.93 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.095 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.437 ' O ' HG13 ' A' ' 123' ' ' ILE . 81.3 mt -58.78 -56.25 17.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 72.040000000000006 110.591 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.499 HD13 HD22 ' A' ' 66' ' ' LEU . 6.9 tp -64.68 -38.06 81.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 116.638 -0.256 . . . . 41.140000000000001 110.401 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.8 t -57.04 -48.5 78.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.248 -0.433 . . . . 62.200000000000003 109.951 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 65.6 mm-40 -69.6 -36.76 76.5 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 116.458 -0.337 . . . . 72.030000000000001 111.507 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 119' ' ' ILE . 56.3 mt -57.12 -56.19 16.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.241 0.543 . . . . 71.120000000000005 109.767 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -64.16 -35.81 82.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.652 -0.704 . . . . 70.329999999999998 110.468 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 23.6 t30 -65.28 -39.12 92.18 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.935 -0.575 . . . . 71.319999999999993 111.468 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 -103.28 -5.2 23.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.571 0.582 . . . . 71.120000000000005 112.571 -172.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.445 HG22 ' ND2' ' A' ' 128' ' ' ASN . 55.8 mt -91.94 -54.05 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 120.895 -0.322 . . . . 71.219999999999999 110.698 170.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.445 ' ND2' HG22 ' A' ' 127' ' ' ILE . 13.2 m120 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.477 -0.773 . . . . 64.540000000000006 110.71 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.881 -0.415 . . . . 64.239999999999995 109.881 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.62 76.95 9.93 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.717 -0.475 . . . . 73.219999999999999 109.717 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -83.18 105.27 14.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.673 -0.694 . . . . 73.310000000000002 111.114 -174.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 65.45 71.79 0.43 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.856 -0.611 . . . . 73.230000000000004 110.898 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -143.23 107.25 4.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.474 -0.785 . . . . 70.040000000000006 109.619 176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -156.5 142.95 18.39 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.905 -0.406 . . . . 71.430000000000007 109.905 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -79.12 148.46 32.36 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.854 0.359 . . . . 74.25 110.752 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -103.88 166.2 10.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.044 -0.526 . . . . 74.310000000000002 111.369 -174.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -87.02 176.42 7.64 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.545 -0.752 . . . . 63.350000000000001 110.349 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.73 168.71 25.16 Favored Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 111.666 -0.573 . . . . 44.210000000000001 111.666 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.8 m -123.71 121.71 36.2 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.912 0.356 . . . . 64.430000000000007 110.291 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -139.66 96.77 3.13 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.051 -0.722 . . . . 61.350000000000001 109.051 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -98.21 116.46 30.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.138 -0.483 . . . . 65.040000000000006 110.079 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.15 129.2 37.91 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.407 -0.36 . . . . 73.25 110.541 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -72.56 100.08 2.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.394 . . . . 64.150000000000006 110.273 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.9 p -82.64 141.71 32.29 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.988 -0.551 . . . . 74.510000000000005 110.311 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -82.58 126.55 32.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.006 0.432 . . . . 73.120000000000005 111.509 -174.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -94.53 123.44 7.53 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 110.771 -0.932 . . . . 74.230000000000004 110.771 172.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.66 166.31 23.88 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.497 2.132 . . . . 60.43 112.634 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -109.94 159.19 14.07 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.835 -0.62 . . . . 44.299999999999997 111.713 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.3 m -62.54 121.11 12.49 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.144 0.497 . . . . 61.219999999999999 111.904 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 91.3 mmm -93.78 -30.71 14.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.6 -0.727 . . . . 73.109999999999999 110.164 176.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.487 HG21 ' HE3' ' A' ' 78' ' ' LYS . 28.1 mm -58.28 107.48 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 116.029 -0.532 . . . . 71.319999999999993 110.036 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.552 ' HB2' ' HE2' ' A' ' 75' ' ' LYS . 9.4 tp10 -75.0 141.1 43.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.123 -0.49 . . . . 60.140000000000001 110.173 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.464 ' HB3' ' OD1' ' A' ' 80' ' ' ASN . 78.1 mt-30 -109.09 122.51 47.42 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 110.316 -0.253 . . . . 65.239999999999995 110.316 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 47.3 pt -145.06 179.96 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.901 0.381 . . . . 70.019999999999996 111.468 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -125.82 -165.83 12.14 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.632 -0.713 . . . . 63.439999999999998 111.424 175.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' H ' ' HB3' ' A' ' 84' ' ' ASN . 27.2 t70 -69.37 -45.91 68.21 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.957 0.378 . . . . 54.109999999999999 110.966 -177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.0 t -59.55 -29.74 68.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.92 -0.582 . . . . 75.420000000000002 109.906 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 12.0 mm-40 -85.98 -31.89 21.82 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-N 116.006 -0.543 . . . . 71.209999999999994 110.725 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.435 ' HA ' HD12 ' A' ' 26' ' ' ILE . 85.1 t80 -47.92 -61.62 1.87 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.359 0.503 . . . . 74.310000000000002 112.359 -171.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.84 -43.5 98.19 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-O 120.604 0.24 . . . . 64.5 110.412 -176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -57.65 -53.98 52.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.181 -0.463 . . . . 75.319999999999993 110.418 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HG3' HG21 ' A' ' 26' ' ' ILE . 75.7 mmtt -60.71 -41.52 95.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.752 -0.658 . . . . 63.109999999999999 111.063 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 31' ' ' PHE . 98.3 t -67.74 -53.07 33.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.494 -0.321 . . . . 61.310000000000002 110.687 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.7 p -65.46 -18.68 65.5 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.497 -0.32 . . . . 63.43 111.761 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -77.02 3.35 12.52 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.632 -0.258 . . . . 63.530000000000001 111.259 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.53 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 25.0 p -62.46 113.39 2.91 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.928 -0.397 . . . . 75.319999999999993 109.928 175.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -52.84 -64.16 0.91 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.348 -0.387 . . . . 74.519999999999996 111.357 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -156.36 121.63 4.74 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.526 -0.306 . . . . 75.209999999999994 110.614 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 48.2 m-80 49.96 24.66 1.4 Allowed 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.945 0.72 . . . . 73.209999999999994 112.945 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 50.4 mm -73.61 127.59 35.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 110.323 -0.251 . . . . 54.399999999999999 110.323 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 28.0 tp -85.79 107.78 17.79 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.722 0.772 . . . . 71.519999999999996 110.444 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.442 HG23 ' CD1' ' A' ' 77' ' ' TYR . 72.7 mt -108.44 113.47 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.112 -0.949 . . . . 62.109999999999999 110.205 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.562 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.8 mp -97.06 152.63 18.57 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.192 -0.669 . . . . 70.120000000000005 109.192 177.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 77' ' ' TYR . 58.5 t -138.08 118.53 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 110.034 -0.358 . . . . 72.109999999999999 110.034 177.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -95.35 154.59 17.12 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.082 0.468 . . . . 74.340000000000003 110.618 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -126.3 41.14 3.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.716 -0.674 . . . . 72.230000000000004 110.354 173.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.491 ' O ' ' HB3' ' A' ' 53' ' ' CYS . 20.6 m0 -57.94 -44.12 86.76 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.37 -0.377 . . . . 75.140000000000001 111.225 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.56 ' HB1' ' HD2' ' A' ' 51' ' ' PRO . . . 66.93 165.98 0.12 Allowed Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.178 -0.464 . . . . 71.040000000000006 111.018 -178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.56 ' HD2' ' HB1' ' A' ' 50' ' ' ALA . 18.5 Cg_endo -59.38 -32.06 95.95 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.087 1.858 . . . . 74.519999999999996 111.854 176.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -96.25 89.69 5.2 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.072 -0.714 . . . . 73.439999999999998 109.072 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 49' ' ' TRP . 2.5 p -132.46 -67.61 0.64 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.475 -0.33 . . . . 54.140000000000001 111.823 -174.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.56 -94.38 1.03 Allowed Glycine 0 CA--C 1.523 0.56 0 C-N-CA 121.189 -0.529 . . . . 43.450000000000003 112.568 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.78 -16.36 8.35 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.217 2.611 . . . . 72.040000000000006 112.411 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 19.0 p -50.7 -27.73 7.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.424 -0.807 . . . . 65.150000000000006 111.322 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -54.14 -43.45 70.54 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.174 -0.466 . . . . 65.439999999999998 111.307 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 22.7 t -75.96 -46.44 29.69 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-O 121.8 0.81 . . . . 64.140000000000001 110.983 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -61.69 -34.02 75.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.155 -0.93 . . . . 74.019999999999996 112.402 -171.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.48 ' HG2' ' CZ3' ' A' ' 49' ' ' TRP . 38.7 mt-10 -60.27 -62.46 5.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 120.406 -0.518 . . . . 71.349999999999994 110.227 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 19.6 Cg_endo -58.75 -38.87 86.71 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 121.727 1.618 . . . . 55.539999999999999 112.258 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.1 mt-30 -57.44 -55.65 32.04 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 120.834 -0.346 . . . . 70.109999999999999 111.179 176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.475 HD11 HD13 ' A' ' 119' ' ' ILE . 30.2 mt -71.98 -25.29 61.79 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.723 -0.217 . . . . 64.530000000000001 111.313 -176.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.449 ' OE1' HG12 ' A' ' 23' ' ' ILE . 4.5 mm-40 -62.26 -44.98 95.31 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.216 0.531 . . . . 71.409999999999997 109.837 172.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -62.36 -50.64 70.79 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.531 -0.759 . . . . 53.520000000000003 109.909 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 41.2 mt -62.9 -32.02 73.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.63 . . . . 72.239999999999995 110.776 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.82 -53.75 45.84 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.726 -0.472 . . . . 64.420000000000002 109.726 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -58.94 -35.64 73.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.959 -0.564 . . . . 74.140000000000001 110.84 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -65.72 -49.29 69.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.577 -0.738 . . . . 63.310000000000002 110.825 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -104.91 5.18 32.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.625 -0.716 . . . . 72.209999999999994 112.716 -169.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 74' ' ' VAL . 8.9 t -53.18 -19.88 3.43 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.787 0.662 . . . . 62.210000000000001 112.787 -171.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.05 -29.86 65.72 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.291 -0.256 . . . . 72.129999999999995 111.424 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -131.13 -10.63 3.74 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.466 -0.334 . . . . 73.5 111.336 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 71' ' ' THR . 40.9 t -116.96 134.65 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.823 0.344 . . . . 65.129999999999995 111.835 -172.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.552 ' HE2' ' HB2' ' A' ' 24' ' ' GLU . 21.1 tptm -143.59 127.12 16.92 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.128 -0.487 . . . . 63.240000000000002 109.802 173.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.2 mp -99.69 141.05 17.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 109.953 -0.388 . . . . 75.209999999999994 109.953 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.487 ' HB2' HG22 ' A' ' 46' ' ' VAL . 62.9 m-85 -123.67 150.31 44.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.869 -0.605 . . . . 73.420000000000002 109.444 177.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HE3' HG21 ' A' ' 23' ' ' ILE . 39.9 ttmt -129.2 122.14 29.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.672 -0.492 . . . . 74.519999999999996 109.672 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.403 HD13 HG13 ' A' ' 26' ' ' ILE . 42.5 mm -78.91 73.09 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 108.772 -0.825 . . . . 53.109999999999999 108.772 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 25' ' ' GLN . 3.4 p-10 -72.46 -30.4 64.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.525 -0.761 . . . . 55.329999999999998 110.367 -176.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.4 mt -62.68 100.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.989 -0.551 . . . . 74.019999999999996 109.929 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.493 ' HA ' ' HG3' ' A' ' 85' ' ' GLN . 10.5 pt-20 -56.51 -27.94 58.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.744 -0.662 . . . . 74.430000000000007 111.191 -177.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -71.58 -24.52 61.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.758 -0.656 . . . . 74.450000000000003 110.006 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.429 ' HB3' ' H ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -104.08 15.76 27.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.307 -0.86 . . . . 75.219999999999999 111.315 -175.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.493 ' HG3' ' HA ' ' A' ' 82' ' ' GLU . 92.9 mt-30 -71.32 1.42 6.22 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.636 0.255 . . . . 72.019999999999996 111.085 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -46.53 -37.96 8.68 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.977 -0.556 . . . . 71.230000000000004 110.361 172.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.7 t -52.7 -43.28 43.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.562 -0.744 . . . . 74.219999999999999 110.502 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.8 -53.35 58.47 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.642 -0.708 . . . . 74.349999999999994 110.273 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.4 m -59.13 -34.81 72.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.62 . . . . 71.150000000000006 110.985 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.06 -56.66 13.35 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.218 -0.446 . . . . 60.149999999999999 111.163 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -72.3 -15.68 61.89 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.58 0.228 . . . . 55.420000000000002 111.148 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.9 40.01 5.67 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.234 -0.508 . . . . 73.019999999999996 112.724 174.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 93.8 t -66.64 93.9 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 121.111 0.482 . . . . 71.420000000000002 110.562 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.9 t -90.65 -37.14 13.96 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.637 -0.71 . . . . 64.209999999999994 109.536 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.21 136.28 33.58 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.035 -0.728 . . . . 73.439999999999998 109.035 174.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.637 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 50.8 mm -58.87 -58.84 16.38 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 111.411 0.152 . . . . 63.229999999999997 111.411 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.637 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 83.3 Cg_endo -80.77 72.3 6.6 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 121.797 1.665 . . . . 73.400000000000006 112.262 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 86.1 m -102.96 133.07 48.69 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 120.963 0.411 . . . . 62.43 110.796 177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.63 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -116.52 121.0 66.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.537 -0.756 . . . . 73.230000000000004 109.846 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 110' ' ' GLN . 88.7 mt -98.14 123.48 42.22 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.775 -0.454 . . . . 73.329999999999998 109.775 175.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 59.9 mtp -96.06 139.95 31.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.375 -0.602 . . . . 55.409999999999997 109.375 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -138.6 147.69 43.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.904 -0.776 . . . . 72.209999999999994 108.904 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 126' ' ' ASN . 29.0 ttpp -147.47 121.36 9.34 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.306 -0.558 . . . . 70.329999999999998 111.225 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 6.0 t30 61.17 25.69 15.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.542 -0.754 . . . . 62.140000000000001 110.24 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 77.46 6.87 86.95 Favored Glycine 0 CA--C 1.518 0.271 0 CA-C-N 115.727 -0.669 . . . . 33.450000000000003 112.127 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -101.38 150.34 23.12 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 120.701 0.286 . . . . 61.039999999999999 110.61 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -56.49 128.47 36.28 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.076 -0.966 . . . . 73.209999999999994 111.489 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.92 168.54 18.58 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.869 -1.514 . . . . 74.439999999999998 106.932 -177.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.7 m -69.53 157.16 37.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.795 0.807 . . . . 71.230000000000004 112.72 -158.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.485 ' HG3' HD23 ' A' ' 100' ' ' LEU . 53.8 tt0 -114.4 118.41 33.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.136 -0.938 . . . . 70.200000000000003 109.851 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.63 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 44.6 t -96.95 107.17 19.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.185 -0.461 . . . . 72.219999999999999 110.097 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.6 mp -92.35 105.12 16.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.366 -0.605 . . . . 73.25 109.366 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.52 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 105.06 158.55 23.27 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.575 -0.61 . . . . 63.32 111.575 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.45 83.54 3.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.79 0.328 . . . . 61.229999999999997 110.679 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 33.8 t70 -121.51 90.12 3.25 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.703 0.763 . . . . 71.129999999999995 110.262 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.472 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -59.02 -30.63 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 114.795 -1.093 . . . . 43.399999999999999 109.425 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.8 t -56.32 -53.36 58.17 Favored 'General case' 0 CA--C 1.526 0.045 0 CA-C-N 116.13 -0.486 . . . . 64.329999999999998 110.159 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -60.59 -48.03 83.6 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.144 -0.48 . . . . 72.239999999999995 109.941 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.498 ' O ' HG13 ' A' ' 123' ' ' ILE . 65.5 mt -56.69 -56.31 14.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 115.719 -0.673 . . . . 75.129999999999995 111.128 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 116' ' ' ILE . 13.7 tt -64.33 -35.7 74.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 120.767 0.317 . . . . 71.420000000000002 110.247 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 40.4 t -55.82 -52.32 64.42 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.797 -0.638 . . . . 53.140000000000001 110.278 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 125' ' ' ASN . 24.7 mm-40 -74.54 -30.0 61.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.911 -0.586 . . . . 73.439999999999998 111.301 -175.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 119' ' ' ILE . 67.3 mt -58.42 -56.03 18.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.961 0.41 . . . . 74.409999999999997 110.064 174.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -71.33 -29.26 64.8 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.94 -0.304 . . . . 75.420000000000002 110.223 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.478 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 19.7 t30 -61.11 -44.38 97.44 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.103 -0.499 . . . . 73.340000000000003 110.971 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.55 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 32.1 m-80 -84.93 -27.1 26.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 62.210000000000001 112.137 -176.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 66.4 mt -73.71 -48.7 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-O 120.915 0.388 . . . . 75.420000000000002 110.479 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.808 -0.615 . . . . 41.43 110.125 -179.783 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.7 mmm . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.975 0.417 . . . . 52.520000000000003 110.227 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.1 -167.09 2.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.759 -0.655 . . . . 72.239999999999995 109.528 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -136.63 172.18 13.4 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.716 -0.476 . . . . 75.129999999999995 109.716 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -124.34 141.81 51.78 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.865 -0.152 . . . . 64.299999999999997 110.637 -177.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.1 p-80 -75.52 125.91 29.95 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.699 -0.852 . . . . 55.43 108.699 173.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -97.65 -41.13 8.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.571 0.212 . . . . 73.329999999999998 111.571 -175.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.9 138.35 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.617 0.573 . . . . 74.349999999999994 110.379 -174.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.596 ' HB3' HG21 ' A' ' 112' ' ' ILE . 6.2 t60 -139.72 -95.15 0.16 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.043 -0.354 . . . . 73.040000000000006 110.043 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.0 ttm 177.15 154.01 0.24 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.531 -0.544 . . . . 72.430000000000007 109.531 -177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.27 62.93 0.02 OUTLIER Glycine 0 C--O 1.234 0.137 0 N-CA-C 111.343 -0.703 . . . . 55.520000000000003 111.343 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.6 m -93.17 120.45 33.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.847 0.356 . . . . 75.129999999999995 110.666 -176.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.9 tp -137.08 113.05 9.67 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.259 -0.645 . . . . 54.020000000000003 109.259 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -76.62 75.97 3.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.744 0.307 . . . . 71.319999999999993 110.656 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 51' ' ' PRO . . . -162.95 93.41 0.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.861 -0.608 . . . . 71.140000000000001 109.434 177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -91.84 154.68 18.74 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.978 -0.555 . . . . 61.43 111.166 -174.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.5 t -153.52 -179.0 7.38 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.598 -0.728 . . . . 75.209999999999994 109.728 174.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.14 -40.5 0.47 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.137 -0.69 . . . . 72.450000000000003 109.137 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.78 -139.15 44.87 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.571 -0.74 . . . . 61.549999999999997 112.528 177.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.39 -77.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.777 2.318 . . . . 54.32 110.857 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 58.25 36.11 81.31 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 121.384 -0.436 . . . . 73.140000000000001 112.926 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.8 t -68.67 -31.73 71.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.211 0.529 . . . . 72.430000000000007 110.251 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 92.0 mmm -93.23 4.25 54.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.826 -0.624 . . . . 50.299999999999997 110.428 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.499 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 26.7 mm -119.34 104.69 16.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.756 -0.657 . . . . 72.439999999999998 109.826 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -64.34 160.49 18.78 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.336 -0.393 . . . . 61.340000000000003 111.054 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.404 ' HA ' ' H ' ' A' ' 78' ' ' LYS . 26.6 tt0 -137.72 133.81 34.6 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.01 -0.367 . . . . 71.129999999999995 110.01 172.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.543 HG21 ' HG3' ' A' ' 34' ' ' LYS . 32.0 pt -138.86 179.95 2.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 122.53 0.332 . . . . 64.329999999999998 111.211 -174.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.06 176.85 22.96 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.055 -0.521 . . . . 71.010000000000005 112.965 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 12.4 t70 -51.86 -56.62 12.91 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.366 0.666 . . . . 41.439999999999998 111.737 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -62.81 -27.57 69.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.907 -0.588 . . . . 74.129999999999995 111.481 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -79.55 -23.36 42.86 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.806 0.298 . . . . 72.549999999999997 111.806 -174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 35' ' ' VAL . 92.4 t80 -47.68 -61.7 1.81 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.278 0.361 . . . . 71.0 111.85 -174.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.573 ' O ' HG22 ' A' ' 36' ' ' THR . 10.0 m-20 -54.63 -53.59 52.79 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.246 0.546 . . . . 54.149999999999999 110.504 -175.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -55.92 -57.41 12.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.076 -0.965 . . . . 72.439999999999998 111.378 -177.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HG3' HG21 ' A' ' 26' ' ' ILE . 74.2 mmtt -58.51 -35.39 72.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 74.319999999999993 111.055 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 31' ' ' PHE . 40.6 t -64.98 -56.58 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.298 -0.41 . . . . 52.310000000000002 111.336 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 32' ' ' ASP . 7.9 t -86.08 -0.29 55.25 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.145 0.424 . . . . 63.229999999999997 112.145 -175.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.2 t -71.14 -5.93 35.46 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.892 0.377 . . . . 72.150000000000006 111.131 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.867 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 8.5 p -66.14 158.08 29.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.946 -0.57 . . . . 72.519999999999996 111.747 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -77.58 -79.65 0.11 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.903 -0.59 . . . . 63.310000000000002 110.61 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -161.82 148.67 14.06 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.216 -0.447 . . . . 73.430000000000007 109.981 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 63.46 2.28 1.16 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.115 0.566 . . . . 71.319999999999993 111.34 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 42.6 mm -74.93 108.32 6.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 120.88 0.372 . . . . 61.240000000000002 110.276 -178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.498 ' CD2' ' HA ' ' A' ' 123' ' ' ILE . 30.9 tp -80.28 109.05 14.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.627 -0.715 . . . . 73.040000000000006 110.024 174.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 36.9 mt -102.7 116.69 46.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.501 -0.772 . . . . 64.310000000000002 110.376 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.55 ' HB2' HG13 ' A' ' 76' ' ' ILE . 3.4 mp -99.99 153.04 19.51 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.623 -0.881 . . . . 63.210000000000001 108.623 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 77' ' ' TYR . 60.8 t -135.36 104.35 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.311 -0.255 . . . . 72.430000000000007 110.311 175.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.87 96.78 10.6 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.901 -1.148 . . . . 72.540000000000006 107.901 173.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -54.5 -77.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.375 0.509 . . . . 73.299999999999997 112.375 -171.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.42 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 73.1 m95 -108.61 129.11 55.32 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.87 -0.419 . . . . 74.040000000000006 109.87 -177.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -92.33 109.74 40.04 Favored Pre-proline 0 C--O 1.234 0.272 0 CA-C-N 116.466 -0.334 . . . . 72.140000000000001 110.767 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 49' ' ' TRP . 67.5 Cg_endo -90.44 156.41 4.46 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.896 2.397 . . . . 42.240000000000002 112.089 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -97.41 119.32 35.73 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.047 -0.723 . . . . 74.150000000000006 109.047 176.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.491 ' H ' ' HB2' ' A' ' 56' ' ' CYS . 13.1 p -158.35 174.16 15.56 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 110.355 -0.239 . . . . 71.200000000000003 110.355 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.623 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -56.32 -62.86 5.87 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 116.057 -0.52 . . . . 75.129999999999995 112.566 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.415 ' O ' HD23 ' A' ' 59' ' ' LEU . 50.6 Cg_exo -55.74 -34.49 91.02 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.407 2.071 . . . . 74.519999999999996 112.152 176.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.491 ' HB2' ' H ' ' A' ' 53' ' ' CYS . 77.5 m -56.08 -49.91 72.51 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.099 -0.5 . . . . 72.200000000000003 111.773 -176.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.623 ' HG3' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -60.7 -26.42 67.13 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.766 0.317 . . . . 73.239999999999995 110.716 -176.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.572 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 46.8 t -75.6 -49.36 18.75 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 121.752 0.787 . . . . 73.409999999999997 110.494 172.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 55' ' ' PRO . 3.5 mm? -58.89 -43.13 90.92 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.198 -0.91 . . . . 73.010000000000005 112.3 -173.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 40.6 mt-10 -52.82 -60.39 6.71 Favored Pre-proline 0 CA--C 1.545 0.783 0 CA-C-N 117.807 0.276 . . . . 72.120000000000005 111.074 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.462 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 29.9 Cg_endo -64.14 -35.11 54.65 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.616 1.544 . . . . 75.310000000000002 112.254 177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.572 ' HG3' ' O ' ' A' ' 58' ' ' SER . 26.7 mt-30 -61.26 -42.44 98.64 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 120.418 -0.513 . . . . 74.230000000000004 111.1 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 92.1 mt -71.43 -42.99 67.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 73.310000000000002 110.321 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 28.1 mt-10 -63.69 -36.45 83.9 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 120.855 -0.338 . . . . 74.099999999999994 110.415 176.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -57.05 -57.16 13.76 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.464 0.65 . . . . 75.099999999999994 109.819 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 62' ' ' GLN . 36.6 mt -61.52 -36.55 80.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.05 -0.977 . . . . 63.240000000000002 109.909 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.56 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -67.05 -27.97 67.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 33.530000000000001 110.93 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.1 mt-30 -77.01 -48.34 18.2 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.851 0.358 . . . . 65.200000000000003 110.955 177.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -72.63 -37.75 67.95 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.183 0.516 . . . . 64.239999999999995 110.668 -176.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -97.61 5.85 48.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.765 -0.652 . . . . 72.140000000000001 111.891 -175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 12.1 t -52.74 -19.94 2.81 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 112.778 0.659 . . . . 72.519999999999996 112.778 -172.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -68.64 -31.2 70.18 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 122.274 -0.266 . . . . 74.120000000000005 110.794 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.431 ' HA ' HD13 ' A' ' 42' ' ' ILE . 91.6 m-20 -131.75 1.61 4.02 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.048 -0.524 . . . . 64.530000000000001 112.098 -174.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.526 HG23 HD11 ' A' ' 127' ' ' ILE . 72.5 t -131.76 134.03 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 122.257 -0.277 . . . . 74.129999999999995 111.527 -177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 26.8 mmtp -147.08 136.62 22.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.173 -0.467 . . . . 74.439999999999998 110.095 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.55 HG13 ' HB2' ' A' ' 45' ' ' LEU . 4.1 mp -115.83 146.65 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.664 -0.244 . . . . 73.450000000000003 110.636 -177.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.502 ' HB2' HG22 ' A' ' 46' ' ' VAL . 40.4 m-85 -124.53 164.55 19.55 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.038 0.535 . . . . 75.140000000000001 110.516 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.499 ' NZ ' ' O ' ' A' ' 23' ' ' ILE . 33.6 mtmm -143.61 178.82 7.52 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.816 0.446 . . . . 73.340000000000003 110.091 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.4 tt -151.76 158.6 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.839 -0.43 . . . . 72.230000000000004 109.839 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -142.57 -3.26 1.03 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.528 0.204 . . . . 73.439999999999998 111.511 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 40.4 mt -84.52 110.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 74.519999999999996 110.668 -174.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -49.48 -55.4 13.4 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.66 -0.7 . . . . 72.209999999999994 111.851 -176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -76.62 6.72 5.44 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.358 -0.383 . . . . 70.010000000000005 111.876 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.596 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . 0.9 OUTLIER -107.3 22.13 16.46 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.057 0.456 . . . . 74.319999999999993 109.902 176.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -81.12 -10.85 59.59 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.003 -0.544 . . . . 64.439999999999998 111.498 -176.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -45.27 -56.96 4.33 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.709 0.29 . . . . 71.200000000000003 111.219 -177.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.445 ' O ' ' HD1' ' A' ' 91' ' ' TYR . 7.5 p -53.1 -34.19 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.862 -0.608 . . . . 70.129999999999995 111.036 -178.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -67.75 -50.67 55.98 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.085 0.469 . . . . 70.109999999999999 109.967 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.2 m -60.42 -29.62 69.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.598 -0.728 . . . . 65.150000000000006 110.529 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -69.67 -55.89 8.76 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.867 -0.606 . . . . 52.43 111.32 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.445 ' HD1' ' O ' ' A' ' 87' ' ' VAL . 85.6 m-85 -77.22 -9.84 59.04 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.707 0.262 . . . . 72.099999999999994 111.707 -176.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.29 53.61 1.14 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.801 -0.714 . . . . 72.409999999999997 113.391 170.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.496 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 80.6 t -93.92 111.84 25.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.993 -0.373 . . . . 52.149999999999999 109.993 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.5 m -121.97 25.17 9.26 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.362 0.601 . . . . 73.109999999999999 110.065 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.38 154.69 36.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.376 -0.829 . . . . 51.240000000000002 109.661 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.601 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 46.4 mm -67.71 -56.05 12.82 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.758 -0.46 . . . . 51.329999999999998 109.758 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.601 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 90.0 Cg_endo -82.09 67.67 8.08 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 122.007 1.804 . . . . 62.210000000000001 111.813 178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.426 HG21 HG22 ' A' ' 93' ' ' VAL . 67.5 m -105.43 121.36 43.75 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.876 -0.602 . . . . 55.219999999999999 110.456 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.535 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.3 mp -110.27 112.68 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.558 -0.746 . . . . 51.32 110.102 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.449 HD23 ' HG3' ' A' ' 110' ' ' GLN . 36.9 mt -90.23 131.22 36.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.441 -0.577 . . . . 64.019999999999996 109.441 173.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.517 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 38.7 mtp -110.23 138.99 45.86 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.493 -0.558 . . . . 72.349999999999994 109.493 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -144.03 144.54 31.69 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.531 -0.544 . . . . 72.129999999999995 109.531 175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HD3' ' HB3' ' A' ' 126' ' ' ASN . 39.6 ttpt -118.8 104.93 11.02 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.85 -0.34 . . . . 62.049999999999997 110.578 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.867 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 60.6 t30 59.25 30.55 20.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.594 0.711 . . . . 64.219999999999999 110.353 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.8 -16.4 60.36 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.887 -0.597 . . . . 73.420000000000002 112.083 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -73.34 142.72 47.07 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 110.133 -0.321 . . . . 63.219999999999999 110.133 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -63.68 145.77 55.09 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.529 -0.76 . . . . 71.150000000000006 111.181 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.517 ' HB3' ' O ' ' A' ' 101' ' ' MET . 1.3 tp -162.14 169.88 20.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.374 -0.83 . . . . 73.400000000000006 110.563 -164.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.6 m -69.63 167.93 15.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.039 0.935 . . . . 74.510000000000005 113.044 -163.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.449 ' HG3' HD23 ' A' ' 100' ' ' LEU . 57.2 tt0 -126.61 118.66 25.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.674 -1.148 . . . . 71.430000000000007 109.418 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.535 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 23.0 t -96.03 107.23 19.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 109.565 -0.531 . . . . 72.530000000000001 109.565 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.596 HG21 ' HB3' ' A' ' 8' ' ' HIS . 3.8 mp -96.68 101.69 12.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.592 -0.521 . . . . 64.329999999999998 109.592 178.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 111.1 167.29 18.82 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.613 -0.595 . . . . 73.140000000000001 111.613 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.67 86.3 7.15 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.799 -0.236 . . . . 60.25 111.102 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -124.79 86.65 2.59 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-O 121.82 0.819 . . . . 63.43 109.717 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -62.63 -27.64 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 114.887 -1.052 . . . . 54.0 110.048 -174.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -63.42 -47.83 80.31 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.34 -0.391 . . . . 62.119999999999997 110.145 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.538 ' HE2' ' HG2' ' A' ' 122' ' ' GLU . 10.6 tptm -69.38 -39.64 77.91 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.152 -0.314 . . . . 75.319999999999993 110.152 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 123' ' ' ILE . 71.3 mt -55.39 -56.23 12.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-O 121.07 0.462 . . . . 71.549999999999997 110.624 177.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 116' ' ' ILE . 13.5 tt -65.98 -33.81 66.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 116.027 -0.533 . . . . 75.400000000000006 110.569 -178.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.1 t -54.95 -51.85 64.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.03 -0.532 . . . . 44.310000000000002 109.673 176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.538 ' HG2' ' HE2' ' A' ' 118' ' ' LYS . 60.2 mm-40 -63.25 -40.11 96.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.034 -0.53 . . . . 74.219999999999999 110.494 177.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.498 ' HA ' ' CD2' ' A' ' 43' ' ' LEU . 63.9 mt -52.04 -56.43 6.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.719 0.295 . . . . 72.530000000000001 110.889 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 128' ' ' ASN . 10.2 p30 -71.88 -25.39 61.92 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 120.536 -0.466 . . . . 63.299999999999997 110.709 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 122' ' ' GLU . 34.3 t30 -63.21 -33.93 76.55 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.06 0.457 . . . . 72.310000000000002 110.85 177.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.474 ' HB3' ' HD3' ' A' ' 103' ' ' LYS . 38.6 m-80 -94.55 -37.05 11.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.01 -0.541 . . . . 75.129999999999995 111.874 -176.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.526 HD11 HG23 ' A' ' 74' ' ' VAL . 66.7 mt -72.14 -48.98 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 64.140000000000001 110.862 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.513 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.533 -0.746 . . . . 63.130000000000003 110.27 -177.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.54 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 120.611 0.243 . . . . 74.349999999999994 110.495 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.04 96.95 0.72 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.285 -0.416 . . . . 41.520000000000003 110.248 178.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -130.19 92.13 3.23 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.753 -0.462 . . . . 64.430000000000007 109.753 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -129.7 83.47 2.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.245 0.545 . . . . 72.439999999999998 109.946 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -147.78 86.89 1.6 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.353 -0.839 . . . . 73.019999999999996 109.953 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -157.98 130.06 7.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.456 . . . . 75.519999999999996 110.712 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -139.01 161.26 37.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.755 -0.657 . . . . 70.310000000000002 109.245 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -93.92 90.94 6.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.443 -0.577 . . . . 74.219999999999999 109.443 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.4 ptm -139.28 101.46 4.26 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.882 -0.599 . . . . 65.310000000000002 110.38 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.75 53.0 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 111.019 -0.832 . . . . 70.209999999999994 111.019 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.5 t -107.29 151.53 25.35 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.072 0.463 . . . . 62.240000000000002 110.568 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 pp -158.76 161.59 37.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.737 -0.665 . . . . 72.230000000000004 109.761 178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -104.98 -58.1 1.93 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.449 -0.574 . . . . 72.25 109.449 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.81 143.18 32.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 75.140000000000001 110.66 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -100.69 34.36 2.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 63.539999999999999 110.537 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.4 p -58.84 97.29 0.03 OUTLIER 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.093 0.473 . . . . 72.540000000000006 111.252 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -150.27 171.51 16.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.365 -0.834 . . . . 75.430000000000007 109.962 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.43 126.02 5.32 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 121.165 -0.541 . . . . 34.299999999999997 111.99 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -78.67 155.51 27.5 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.628 2.218 . . . . 61.310000000000002 112.119 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.62 36.08 1.09 Allowed Glycine 0 C--O 1.235 0.208 0 N-CA-C 111.614 -0.594 . . . . 60.0 111.614 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.4 p -81.5 168.79 17.89 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.911 0.484 . . . . 53.310000000000002 110.922 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 93.7 mmm -67.42 -29.17 68.58 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.451 -0.574 . . . . 71.319999999999993 109.451 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -73.71 115.79 15.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.678 -0.86 . . . . 73.239999999999995 108.678 171.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -74.38 146.47 42.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.99 0.424 . . . . 74.120000000000005 111.516 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.54 118.86 37.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.602 -0.727 . . . . 74.239999999999995 109.348 -178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.464 HG21 ' HG3' ' A' ' 34' ' ' LYS . 46.9 pt -144.58 175.12 3.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 120.826 0.346 . . . . 73.019999999999996 110.924 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.12 175.17 15.59 Favored Glycine 0 CA--C 1.521 0.406 0 CA-C-N 115.912 -0.585 . . . . 74.340000000000003 112.418 175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.49 ' OD2' HG23 ' A' ' 87' ' ' VAL . 13.5 t70 -51.78 -45.86 63.95 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.466 0.706 . . . . 75.340000000000003 111.623 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 t -66.27 -28.57 68.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.150000000000006 110.806 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 43.0 mt-10 -80.97 -13.33 58.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 61.100000000000001 111.352 -177.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.575 ' O ' HG23 ' A' ' 35' ' ' VAL . 87.2 t80 -51.43 -61.88 1.97 Allowed 'General case' 0 C--N 1.328 -0.336 0 O-C-N 123.13 0.269 . . . . 73.310000000000002 111.14 -176.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -58.18 -48.2 81.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.17 0.51 . . . . 70.209999999999994 110.76 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -60.81 -53.32 58.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.522 -0.763 . . . . 70.319999999999993 111.487 -176.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HG3' HG21 ' A' ' 26' ' ' ILE . 35.0 mmtp -67.28 -31.82 72.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.102 -0.499 . . . . 74.219999999999999 111.293 -175.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.602 HG22 HG21 ' A' ' 44' ' ' ILE . 74.5 t -66.3 -45.49 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 120.899 0.38 . . . . 65.010000000000005 109.979 174.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.5 p -75.11 -16.15 60.56 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.314 -0.403 . . . . 73.409999999999997 111.22 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 t -75.6 0.16 18.43 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.286 -0.415 . . . . 75.349999999999994 111.205 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.754 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.2 p -56.68 122.1 11.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.698 -0.228 . . . . 72.120000000000005 110.633 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -56.07 -76.17 0.03 OUTLIER 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.332 -0.394 . . . . 71.150000000000006 110.889 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -161.98 145.31 12.0 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.358 -0.608 . . . . 72.329999999999998 109.358 176.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 45.0 27.47 0.29 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 124.001 0.813 . . . . 71.129999999999995 111.727 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 47.0 mm -87.84 123.79 40.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-N 115.984 -0.553 . . . . 73.420000000000002 110.221 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -89.97 110.34 21.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.575 -0.738 . . . . 71.349999999999994 109.101 178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.602 HG21 HG22 ' A' ' 35' ' ' VAL . 22.8 mm -89.07 109.11 19.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.59 -0.732 . . . . 54.130000000000003 110.384 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.521 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.5 mp -99.04 146.97 25.5 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.541 -0.911 . . . . 71.209999999999994 108.541 172.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 70.1 t -139.13 113.15 7.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.348 -0.242 . . . . 75.540000000000006 110.348 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' OD2' ' HB3' ' A' ' 78' ' ' LYS . 1.6 p30 -91.69 137.55 32.27 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.716 -0.475 . . . . 52.219999999999999 109.716 176.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.62 ' HE2' ' HG ' ' A' ' 100' ' ' LEU . 79.5 m-85 -93.08 106.94 18.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.352 -0.385 . . . . 74.510000000000005 111.991 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.428 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 63.2 t-105 49.33 51.15 16.85 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.349 -0.841 . . . . 71.439999999999998 111.76 170.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.5 91.1 3.75 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.287 -0.415 . . . . 73.409999999999997 109.996 174.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 52' ' ' TRP . 89.7 Cg_endo -84.76 -31.64 0.41 Allowed 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.674 2.249 . . . . 63.229999999999997 111.794 175.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.469 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 49.2 p-90 170.33 155.18 0.06 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.868 0.867 . . . . 62.409999999999997 109.24 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.531 ' N ' ' HB2' ' A' ' 56' ' ' CYS . 3.7 p -171.99 -177.03 1.81 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.691 -0.855 . . . . 60.43 108.691 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -48.84 -69.47 0.99 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.415 -0.422 . . . . 64.200000000000003 112.561 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.44 ' O ' HD23 ' A' ' 59' ' ' LEU . 30.4 Cg_endo -65.15 -43.61 11.04 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.206 1.937 . . . . 60.140000000000001 112.04 175.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.531 ' HB2' ' N ' ' A' ' 53' ' ' CYS . 13.0 m -51.3 -30.06 16.91 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.967 0.413 . . . . 64.049999999999997 111.195 -176.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 57' ' ' ARG . 43.3 ttt-85 -54.02 -58.22 8.14 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.621 -0.718 . . . . 53.409999999999997 110.853 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 33.0 t -75.75 -40.06 56.06 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.504 0.669 . . . . 55.119999999999997 111.084 174.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.523 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.8 mm? -57.51 -49.74 75.32 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.252 -0.885 . . . . 70.439999999999998 112.918 -171.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.51 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 49.9 mt-10 -56.39 -53.95 58.51 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 117.914 0.324 . . . . 71.439999999999998 111.147 -176.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 31.2 Cg_exo -50.29 -50.98 11.91 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 121.944 1.763 . . . . 63.450000000000003 111.74 172.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.55 ' HG3' ' O ' ' A' ' 58' ' ' SER . 44.0 mt-30 -54.35 -41.98 69.73 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.141 -0.481 . . . . 74.540000000000006 111.798 177.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 75.0 mt -68.36 -38.92 81.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.48 -0.327 . . . . 72.519999999999996 110.42 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 37.7 mt-10 -68.06 -29.59 68.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.145 -0.479 . . . . 63.32 110.26 177.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HE2' ' HA ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -64.91 -54.04 37.08 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.131 -0.692 . . . . 74.519999999999996 109.131 176.178 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.07 -32.78 73.35 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.306 -0.861 . . . . 53.340000000000003 110.068 177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.531 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.54 -50.73 70.21 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.946 -0.57 . . . . 70.140000000000001 109.781 177.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.5 mt-30 -54.63 -47.99 72.79 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.174 0.511 . . . . 74.310000000000002 110.245 178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -63.92 -45.21 90.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.408 -0.815 . . . . 41.420000000000002 111.767 -178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -104.98 4.26 31.53 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 113.239 0.829 . . . . 74.150000000000006 113.239 -170.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 14.0 t -53.33 -24.89 13.08 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.791 0.663 . . . . 54.439999999999998 112.791 -171.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.592 ' HG3' ' ND2' ' A' ' 73' ' ' ASN . 5.6 pt-20 -64.15 -25.41 68.07 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.005 0.431 . . . . 71.450000000000003 111.135 178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.592 ' ND2' ' HG3' ' A' ' 72' ' ' GLU . 5.5 m-80 -127.95 -0.76 5.93 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.334 -0.394 . . . . 74.329999999999998 111.257 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.461 HG23 HD11 ' A' ' 127' ' ' ILE . 25.8 t -130.51 139.12 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.043 0.449 . . . . 72.219999999999999 112.161 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -145.26 119.73 9.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 73.340000000000003 109.801 175.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.521 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.7 mp -98.68 140.06 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.181 -0.674 . . . . 54.32 109.181 174.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 73.7 m-85 -125.95 149.01 49.08 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.107 -0.701 . . . . 72.5 109.107 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HB3' ' OD2' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -133.47 135.06 44.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.885 -0.413 . . . . 72.530000000000001 109.885 176.365 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 57.0 mt -76.9 91.78 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.203 -0.665 . . . . 64.129999999999995 109.203 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -82.16 -18.5 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.917 -0.583 . . . . 65.099999999999994 110.477 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.1 mm -69.53 89.2 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.367 0.603 . . . . 70.230000000000004 109.882 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -48.98 -35.95 16.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.876 -1.057 . . . . 65.230000000000004 111.549 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.79 -22.76 60.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.327 -0.851 . . . . 74.140000000000001 112.313 -173.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -131.06 108.51 9.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.699 0.285 . . . . 71.349999999999994 110.826 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -145.99 32.36 1.02 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.839 -0.619 . . . . 72.409999999999997 110.416 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -52.37 -37.27 55.85 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.558 -0.746 . . . . 64.230000000000004 111.141 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.49 HG23 ' OD2' ' A' ' 28' ' ' ASP . 97.7 t -52.8 -36.28 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.757 -0.656 . . . . 73.439999999999998 111.17 -178.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.49 -54.91 24.99 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.064 0.459 . . . . 74.219999999999999 110.952 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.7 m -63.2 -40.94 98.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.802 -0.636 . . . . 70.319999999999993 110.903 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -67.77 -51.33 50.18 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.257 -0.429 . . . . 65.150000000000006 111.758 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -70.87 -29.13 65.15 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.777 -0.192 . . . . 65.129999999999995 111.286 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.09 57.14 0.57 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.653 -0.784 . . . . 72.329999999999998 112.657 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 90.6 t -92.66 99.63 10.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.937 0.399 . . . . 73.219999999999999 109.989 178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.1 t -79.9 -50.65 10.16 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.848 -0.614 . . . . 72.150000000000006 110.543 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -92.13 136.33 33.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.596 -0.52 . . . . 33.340000000000003 109.596 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.649 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 62.3 mt -51.96 -55.38 31.18 Favored Pre-proline 0 CA--C 1.54 0.559 0 O-C-N 123.21 0.319 . . . . 72.540000000000006 111.56 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.649 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 4.4 Cg_exo -73.61 82.36 1.69 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 121.94 1.76 . . . . 62.32 111.852 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.0 m -122.6 138.89 54.44 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.132 -0.485 . . . . 72.329999999999998 110.03 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.9 mp -119.56 118.81 58.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 116.014 -0.539 . . . . 74.219999999999999 110.235 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HG ' ' HE2' ' A' ' 48' ' ' PHE . 49.4 mt -88.53 141.85 28.19 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.646 -0.502 . . . . 64.109999999999999 109.646 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.586 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 52.6 mtp -114.08 144.92 42.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.204 -0.665 . . . . 73.430000000000007 109.204 175.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.466 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 97.2 m-85 -146.64 160.22 42.47 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.777 -0.823 . . . . 72.430000000000007 108.777 174.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -148.15 109.52 4.37 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 120.077 -0.649 . . . . 73.310000000000002 111.789 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.754 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 4.9 m-20 56.47 31.79 19.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.012 0.434 . . . . 74.310000000000002 111.178 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.55 -15.22 61.96 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.108 -0.568 . . . . 51.130000000000003 112.657 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -67.94 132.67 47.76 Favored 'General case' 0 C--O 1.245 0.816 0 N-CA-C 109.645 -0.502 . . . . 75.230000000000004 109.645 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.6 147.49 45.5 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 124.045 0.841 . . . . 75.049999999999997 108.943 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.586 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.2 tp -156.48 168.44 27.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.093 -0.706 . . . . 63.340000000000003 109.093 -164.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.3 m -69.65 172.31 7.64 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 123.493 0.717 . . . . 74.319999999999993 112.512 -164.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.51 ' HG3' HD23 ' A' ' 100' ' ' LEU . 23.2 tt0 -131.01 131.81 44.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.23 -0.895 . . . . 72.450000000000003 109.91 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.8 t -99.79 111.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.915 -0.402 . . . . 73.219999999999999 109.915 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.52 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.2 mp -85.95 113.54 24.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.245 -0.65 . . . . 65.129999999999995 109.245 177.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.31 142.81 7.0 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.983 -0.627 . . . . 75.420000000000002 111.763 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.523 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -72.07 87.51 1.06 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.701 0.286 . . . . 72.030000000000001 110.765 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.428 ' O ' HG13 ' A' ' 119' ' ' ILE . 14.3 t70 -119.53 111.01 17.56 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.23 -0.441 . . . . 74.109999999999999 110.35 176.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -33.54 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.716 -0.675 . . . . 73.310000000000002 110.549 -175.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -64.82 -53.25 49.73 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.984 0.421 . . . . 65.209999999999994 110.355 -177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -60.79 -45.6 93.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.162 -0.472 . . . . 73.519999999999996 110.331 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 115' ' ' ASP . 81.8 mt -58.66 -56.15 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 116.026 -0.534 . . . . 72.219999999999999 110.972 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -61.2 -36.32 71.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 CA-C-O 120.772 0.32 . . . . 62.340000000000003 110.549 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.6 t -59.63 -52.05 67.19 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.117 -0.492 . . . . 61.520000000000003 110.015 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -62.56 -40.58 97.29 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.32 -0.4 . . . . 74.150000000000006 110.691 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 127' ' ' ILE . 57.3 mt -55.36 -56.11 13.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.288 -0.415 . . . . 64.299999999999997 110.644 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -66.1 -33.18 75.19 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.028 0.442 . . . . 72.510000000000005 110.343 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -69.36 -28.45 66.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 43.149999999999999 111.547 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.536 ' OD1' HD11 ' A' ' 108' ' ' LEU . 65.1 m-80 -107.86 -8.91 15.85 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.789 0.663 . . . . 71.019999999999996 112.789 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.461 HD11 HG23 ' A' ' 74' ' ' VAL . 61.3 mt -85.93 -51.58 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.883 -0.414 . . . . 63.32 109.883 170.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.54 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-N 115.824 -0.626 . . . . 53.210000000000001 109.956 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.7 mmm . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.543 0.211 . . . . 70.409999999999997 110.657 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.66 -169.68 2.68 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.55 -0.296 . . . . 63.399999999999999 110.997 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.3 m170 70.89 10.24 6.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.14 0.576 . . . . 70.420000000000002 111.929 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -84.29 53.99 2.82 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.695 0.759 . . . . 64.340000000000003 109.978 177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.0 105.94 0.19 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.79 -1.095 . . . . 70.200000000000003 111.752 -177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -83.83 -49.27 9.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.517 0.675 . . . . 73.329999999999998 109.203 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -123.7 103.78 8.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.188 -0.915 . . . . 72.109999999999999 109.104 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -97.65 -177.28 3.74 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.175 -0.466 . . . . 71.310000000000002 110.992 -173.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 50.5 ttm -151.48 158.16 43.28 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.927 -0.398 . . . . 72.450000000000003 109.927 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.83 121.24 3.89 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 111.424 -0.67 . . . . 34.299999999999997 111.424 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.7 m -68.71 151.47 46.63 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.6 0.238 . . . . 71.109999999999999 111.114 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.685 ' HG ' HD13 ' A' ' 120' ' ' ILE . 6.3 mp -68.66 87.87 0.34 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.469 -0.332 . . . . 74.319999999999993 110.46 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -90.15 78.74 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 54.210000000000001 111.021 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.28 66.35 4.71 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.354 -0.61 . . . . 72.310000000000002 109.354 175.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -82.24 -177.05 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.355 -0.839 . . . . 72.319999999999993 111.801 -172.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.0 p -77.54 -172.79 2.68 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.681 -0.69 . . . . 64.140000000000001 110.89 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -70.1 89.51 0.63 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.039 0.447 . . . . 72.209999999999994 110.55 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.53 123.82 6.6 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 110.675 -0.97 . . . . 51.409999999999997 110.675 174.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.29 137.12 25.36 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.513 2.142 . . . . 73.549999999999997 112.952 -175.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.06 45.93 0.42 Allowed Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.562 -1.015 . . . . 41.039999999999999 110.562 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.1 m -59.73 88.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.401 0.62 . . . . 75.409999999999997 112.306 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.492 ' SD ' ' HG2' ' A' ' 68' ' ' GLN . 19.2 ptm -124.11 16.77 9.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.1 -0.955 . . . . 70.230000000000004 109.137 173.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -80.44 107.07 12.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.024 -0.989 . . . . 71.409999999999997 109.704 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -62.82 152.52 35.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.258 0.552 . . . . 72.200000000000003 111.762 -172.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 3.6 pt20 -124.67 125.56 44.3 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.613 -0.721 . . . . 72.450000000000003 109.528 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 31' ' ' PHE . 25.6 pt -135.7 158.11 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 120.697 0.284 . . . . 73.420000000000002 111.409 -173.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.52 -179.93 52.34 Favored Glycine 0 CA--C 1.52 0.395 0 CA-C-N 116.202 -0.454 . . . . 74.349999999999994 112.442 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HB2' ' ND2' ' A' ' 84' ' ' ASN . 18.3 t70 -58.9 -56.3 24.06 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.098 0.475 . . . . 72.310000000000002 111.341 -177.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.0 m -69.76 -15.61 63.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.784 -0.644 . . . . 65.310000000000002 111.344 -176.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -84.7 -10.99 56.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 111.4 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 26' ' ' ILE . 79.5 t80 -55.28 -62.47 1.65 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.664 0.246 . . . . 64.409999999999997 111.664 -173.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.95 -45.32 95.18 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.902 0.382 . . . . 72.120000000000005 110.925 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.27 -49.82 76.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.749 -0.66 . . . . 73.25 111.421 -176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HG3' ' CG2' ' A' ' 26' ' ' ILE . 33.1 mmtp -69.34 -33.92 73.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.257 -0.429 . . . . 71.129999999999995 110.944 -176.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 31' ' ' PHE . 72.3 t -65.47 -43.2 94.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 120.876 0.37 . . . . 72.219999999999999 110.4 174.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 38.5 p -75.1 -18.51 60.24 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.878 0.37 . . . . 73.409999999999997 110.898 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.8 t -67.69 -2.79 7.52 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.211 -0.45 . . . . 63.119999999999997 111.329 177.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.757 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 27.3 p -57.8 148.93 23.62 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.639 -0.255 . . . . 62.439999999999998 110.567 177.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.5 -84.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.437 -0.347 . . . . 71.310000000000002 110.32 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -162.07 135.92 6.5 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.237 -0.653 . . . . 73.540000000000006 109.237 173.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.2 m120 65.68 9.43 5.93 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.684 0.615 . . . . 64.420000000000002 110.999 -176.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.757 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.2 mm -76.48 115.97 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 73.340000000000003 110.552 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 102' ' ' PHE . 1.0 OUTLIER -74.7 110.8 9.29 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.121 -0.696 . . . . 74.120000000000005 109.121 175.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.515 HD11 ' HB3' ' A' ' 38' ' ' CYS . 27.9 mm -93.21 106.85 18.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.342 -0.844 . . . . 75.340000000000003 110.037 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.668 ' HB2' HG13 ' A' ' 76' ' ' ILE . 5.3 mp -92.38 149.63 21.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.945 -0.761 . . . . 73.409999999999997 108.945 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 58.5 t -132.23 110.99 17.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.906 -0.775 . . . . 53.109999999999999 108.906 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -94.31 159.95 14.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.259 0.552 . . . . 52.350000000000001 111.123 -173.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -128.54 83.27 2.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.113 -0.949 . . . . 71.540000000000006 109.004 165.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.478 ' CH2' HD12 ' A' ' 63' ' ' LEU . 5.5 m95 -51.37 -35.66 39.64 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.124 -0.489 . . . . 62.310000000000002 110.883 177.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 66.01 112.51 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 115.219 -0.9 . . . . 63.100000000000001 110.201 -175.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.79 -23.5 11.65 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.926 2.417 . . . . 52.409999999999997 112.811 -176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -127.06 88.59 2.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.033 -0.53 . . . . 74.010000000000005 109.866 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 43.3 t -147.39 158.38 43.95 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.081 -0.509 . . . . 73.140000000000001 110.202 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.51 -77.34 1.37 Allowed Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.437 -0.411 . . . . 65.430000000000007 112.701 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.47 -24.61 75.57 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.008 2.472 . . . . 73.329999999999998 112.538 -175.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 97' ' ' PRO . 57.5 m -55.58 -27.38 48.91 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 110.647 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.403 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 26.2 ttt180 -55.28 -45.02 76.17 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.94 -0.573 . . . . 75.299999999999997 111.051 178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.632 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 13.0 m -74.45 -38.35 63.01 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.382 0.61 . . . . 54.149999999999999 110.563 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.529 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 mm? -61.03 -26.86 67.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.673 -0.694 . . . . 73.430000000000007 110.92 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.515 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 30.3 tt0 -56.52 -67.75 0.74 Allowed Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 119.333 -0.365 . . . . 73.140000000000001 110.238 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.477 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 27.8 Cg_endo -61.63 -39.41 54.33 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 121.484 1.456 . . . . 53.340000000000003 112.089 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.632 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.7 mt-30 -53.87 -52.7 59.62 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.74 -0.384 . . . . 70.349999999999994 111.433 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.478 HD12 ' CH2' ' A' ' 49' ' ' TRP . 53.7 mt -76.91 -28.28 55.25 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.792 0.293 . . . . 53.420000000000002 111.792 -175.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 93.2 mt-10 -65.37 -41.75 93.47 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.085 0.469 . . . . 74.530000000000001 109.828 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -67.34 -46.85 72.2 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.062 -0.517 . . . . 72.340000000000003 110.285 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' CD1' HD11 ' A' ' 116' ' ' ILE . 21.3 mt -62.85 -29.78 71.0 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 120.848 -0.341 . . . . 61.210000000000001 110.623 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.74 -51.34 67.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.433 -0.58 . . . . 73.510000000000005 109.433 175.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.492 ' HG2' ' SD ' ' A' ' 22' ' ' MET . 92.2 mt-30 -60.58 -32.2 71.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.837 -0.619 . . . . 72.549999999999997 111.062 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -77.16 -40.34 45.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 75.340000000000003 111.296 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -104.69 4.44 32.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.288 -0.415 . . . . 71.109999999999999 111.833 -174.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.8 t -53.01 -19.67 2.86 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.167 0.432 . . . . 71.109999999999999 112.167 -172.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -54.89 -41.91 71.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.093 -0.503 . . . . 75.239999999999995 110.187 177.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.473 ' HA ' HD13 ' A' ' 42' ' ' ILE . 52.3 m-80 -135.18 11.93 3.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.912 -0.586 . . . . 70.239999999999995 111.721 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.5 HG23 HD11 ' A' ' 127' ' ' ILE . 24.1 t -126.25 139.17 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 122.242 -0.286 . . . . 64.140000000000001 111.506 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -143.67 129.16 19.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.983 -0.747 . . . . 73.439999999999998 108.983 172.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.668 HG13 ' HB2' ' A' ' 45' ' ' LEU . 4.5 mp -105.63 138.28 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.08 0.466 . . . . 73.230000000000004 110.635 178.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 16.0 m-85 -127.42 165.06 20.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.277 -0.874 . . . . 74.420000000000002 108.963 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -161.81 165.01 28.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.344 -0.389 . . . . 74.549999999999997 110.149 173.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.4 tp -68.37 129.53 32.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 75.310000000000002 110.437 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 3.0 t-20 -95.19 -15.98 22.88 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.13 -0.486 . . . . 62.200000000000003 110.554 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 58.4 mt -102.62 103.31 14.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.884 -0.598 . . . . 74.439999999999998 109.908 -178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -63.3 -18.46 63.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.012 0.434 . . . . 72.25 110.901 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -75.43 -14.11 60.43 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.816 -0.629 . . . . 72.439999999999998 111.006 178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 28' ' ' ASP . 24.4 t-20 -102.2 119.52 38.93 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.906 0.384 . . . . 74.120000000000005 111.436 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -119.31 -3.51 10.51 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.543 -0.54 . . . . 73.409999999999997 109.543 169.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 3.2 m-20 -48.08 -49.66 30.88 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.482 -0.781 . . . . 61.299999999999997 111.457 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.8 t -54.97 -38.9 47.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 116.224 -0.443 . . . . 74.329999999999998 110.694 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' A' ' 93' ' ' VAL . . . -69.01 -42.75 76.01 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.221 -0.445 . . . . 53.130000000000003 109.866 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -61.2 -38.44 86.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.564 -0.744 . . . . 62.420000000000002 110.576 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 78.3 mm-40 -69.71 -49.81 49.77 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.079 -0.509 . . . . 75.329999999999998 111.298 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -89.49 -2.45 58.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.286 -0.416 . . . . 71.540000000000006 112.027 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.19 57.09 5.34 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.137 -0.554 . . . . 33.240000000000002 112.977 171.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.42 ' HB ' ' HB1' ' A' ' 88' ' ' ALA . 86.6 t -82.42 92.77 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.698 -0.482 . . . . 74.430000000000007 109.698 175.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.3 t -89.41 -34.12 16.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.775 -0.648 . . . . 75.310000000000002 110.617 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.66 143.83 28.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.415 . . . . 43.329999999999998 110.149 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.742 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 50.2 mm -59.29 -52.64 72.97 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.494 -0.321 . . . . 74.439999999999998 110.691 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.742 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 58.2 Cg_endo -93.52 112.38 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.472 2.115 . . . . 73.120000000000005 111.145 173.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.437 ' C ' HD12 ' A' ' 99' ' ' ILE . 64.2 m -136.97 141.91 42.59 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 120.92 0.39 . . . . 73.340000000000003 111.247 -177.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.569 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -123.44 119.19 56.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 115.606 -0.724 . . . . 71.310000000000002 109.939 174.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.482 HD23 ' HG3' ' A' ' 110' ' ' GLN . 91.3 mt -94.83 129.43 41.81 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.063 -0.717 . . . . 63.240000000000002 109.063 174.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 44.4 mtp -106.47 138.53 42.48 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.036 -0.357 . . . . 73.340000000000003 110.036 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.488 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 100.0 m-85 -143.63 165.44 27.62 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.467 -0.568 . . . . 73.140000000000001 109.467 176.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 40.0 ttmt -151.78 104.87 3.06 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 122.245 -0.284 . . . . 63.100000000000001 110.948 175.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.719 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 57.6 t30 47.68 56.07 7.6 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.368 0.604 . . . . 64.219999999999999 110.914 177.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.88 -16.78 3.11 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 115.441 -0.8 . . . . 54.340000000000003 113.791 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 63.2 tttp -80.88 143.43 32.71 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 117.082 0.441 . . . . 62.219999999999999 110.141 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.5 tptm -71.97 145.59 48.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.58 0.705 . . . . 71.519999999999996 111.076 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -146.39 167.75 22.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.587 -1.264 . . . . 70.329999999999998 107.587 -172.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.1 m -70.19 -177.79 1.49 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.419 0.628 . . . . 72.019999999999996 112.66 -164.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.482 ' HG3' HD23 ' A' ' 100' ' ' LEU . 54.7 tt0 -138.46 129.52 26.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.828 -0.623 . . . . 74.230000000000004 109.51 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.569 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.0 t -100.53 107.51 21.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.069 0.461 . . . . 50.240000000000002 110.231 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.3 mp -86.71 110.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.567 -0.742 . . . . 73.329999999999998 109.435 177.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.409 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 99.43 155.08 28.48 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.56 -0.616 . . . . 30.23 111.56 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.529 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -80.04 72.16 6.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.844 0.354 . . . . 43.439999999999998 110.95 -177.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 119' ' ' ILE . 18.0 t70 -111.08 96.95 6.45 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.598 0.713 . . . . 74.109999999999999 110.505 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.444 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -61.59 -34.41 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 115.141 -0.936 . . . . 73.099999999999994 110.263 -173.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.1 p -63.13 -43.34 98.64 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.274 -0.421 . . . . 62.200000000000003 111.056 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.84 -43.85 78.57 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.715 -0.476 . . . . 75.409999999999997 109.715 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 115' ' ' ASP . 70.8 mt -56.05 -56.48 12.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-N 116.015 -0.539 . . . . 74.140000000000001 110.838 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.685 HD13 ' HG ' ' A' ' 12' ' ' LEU . 15.7 tt -65.52 -33.87 66.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-N 115.854 -0.612 . . . . 45.439999999999998 110.586 -176.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 37.5 t -57.33 -51.93 67.41 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.229 -0.441 . . . . 61.229999999999997 110.111 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -60.66 -45.3 94.63 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.589 -0.278 . . . . 73.409999999999997 110.372 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 119' ' ' ILE . 72.7 mt -52.56 -56.04 8.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 116.107 -0.497 . . . . 71.299999999999997 111.182 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -68.21 -32.96 73.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.658 0.266 . . . . 74.239999999999995 110.632 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -61.75 -36.49 81.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.145 0.498 . . . . 72.129999999999995 110.228 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -85.4 -28.78 24.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.589 . . . . 72.239999999999995 112.144 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.5 HD11 HG23 ' A' ' 74' ' ' VAL . 52.6 mt -103.74 -60.69 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.142 0.496 . . . . 72.409999999999997 112.232 -178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 C--O 1.247 0.961 0 CA-C-N 115.383 -0.826 . . . . 65.439999999999998 110.921 -166.784 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 tpp . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 121.001 0.429 . . . . 63.420000000000002 110.451 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.61 135.69 43.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.019 -0.537 . . . . 61.229999999999997 110.671 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -156.21 145.88 21.0 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.284 -1.006 . . . . 74.129999999999995 108.284 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -83.63 164.68 19.56 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.094 -0.335 . . . . 70.530000000000001 110.094 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -121.98 34.99 5.0 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.23 -1.026 . . . . 74.019999999999996 108.23 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -101.74 91.77 4.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.894 -1.503 . . . . 73.329999999999998 109.754 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -75.24 111.33 10.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 71.310000000000002 109.937 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.2 t60 -93.73 111.82 23.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.488 -0.778 . . . . 73.099999999999994 110.228 -173.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -136.48 158.52 44.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.967 0.413 . . . . 72.349999999999994 110.969 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.12 116.24 0.39 Allowed Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.023 -0.831 . . . . 62.399999999999999 111.023 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -124.83 159.82 30.16 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.84 0.352 . . . . 73.409999999999997 110.836 -176.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.626 ' H ' ' NE2' ' A' ' 85' ' ' GLN . 97.8 mt -131.0 -67.38 0.71 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.946 -0.57 . . . . 64.530000000000001 109.93 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -120.31 154.24 35.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.25 -0.432 . . . . 71.109999999999999 109.918 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.08 129.04 36.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.2 -0.296 . . . . 15.35 110.2 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.498 ' HG3' ' HB3' ' A' ' 82' ' ' GLU . 23.7 mt-30 -99.16 158.33 15.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.573 -0.285 . . . . 72.200000000000003 110.769 -177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 p -83.58 -77.97 0.24 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.176 -0.466 . . . . 74.239999999999995 111.885 -176.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -174.44 -177.5 1.24 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.837 0.351 . . . . 71.129999999999995 110.429 -175.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.27 161.04 20.66 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.263 -0.735 . . . . 62.43 111.263 171.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.05 -10.48 19.55 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.518 2.145 . . . . 70.010000000000005 112.333 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 62.87 68.91 1.47 Allowed Glycine 0 C--N 1.334 0.425 0 N-CA-C 111.109 -0.797 . . . . 75.150000000000006 111.109 -176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -142.51 -167.19 2.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.46 0.172 . . . . 72.329999999999998 110.689 -171.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.421 ' HG3' ' HG2' ' A' ' 68' ' ' GLN . 88.1 mmm -59.73 -16.88 30.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.248 0.547 . . . . 54.299999999999997 110.483 173.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.449 ' CG2' ' HG3' ' A' ' 78' ' ' LYS . 13.0 mm -83.19 123.26 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.367 -0.833 . . . . 51.530000000000001 109.878 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.489 ' HG3' HG23 ' A' ' 26' ' ' ILE . 6.2 tp10 -74.27 160.24 31.38 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 123.165 0.29 . . . . 75.430000000000007 110.245 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 25.4 pt20 -133.85 115.89 15.0 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 110.026 -0.361 . . . . 65.129999999999995 110.026 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.542 HG21 ' HG3' ' A' ' 34' ' ' LYS . 21.5 pt -139.9 179.98 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.305 0.483 . . . . 63.420000000000002 112.305 -170.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.0 -157.14 9.9 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.392 -0.822 . . . . 70.420000000000002 111.293 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.401 ' HB3' ' OD1' ' A' ' 84' ' ' ASN . 12.4 t70 -68.21 -51.03 50.03 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 117.147 0.474 . . . . 64.140000000000001 111.24 -176.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 t -58.21 -43.84 87.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 55.210000000000001 110.356 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -83.12 -13.11 56.29 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.502 -0.317 . . . . 71.209999999999994 111.691 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.5 ' HA ' HD12 ' A' ' 26' ' ' ILE . 89.3 t80 -58.18 -57.7 11.69 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.961 -0.755 . . . . 74.340000000000003 108.961 175.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -58.61 -51.43 69.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.799 -0.637 . . . . 65.319999999999993 110.638 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -52.73 -57.42 10.18 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.307 0.379 . . . . 73.439999999999998 111.215 -177.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HG3' HG21 ' A' ' 26' ' ' ILE . 34.6 mmtp -69.38 -37.02 77.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.351 -0.386 . . . . 62.140000000000001 111.59 -173.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.38 -45.17 82.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 121.197 -0.201 . . . . 70.200000000000003 110.704 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 68.5 p -75.2 -24.7 57.81 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.881 -0.328 . . . . 63.32 111.243 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.7 t -70.04 -7.88 44.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.501 -0.318 . . . . 61.43 111.699 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.929 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 26.8 p -59.35 137.28 58.05 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.652 -0.499 . . . . 63.340000000000003 109.652 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -48.38 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.415 0.447 . . . . 72.409999999999997 111.142 -176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -161.98 145.37 12.04 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.449 -0.574 . . . . 72.450000000000003 109.449 173.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 48.22 13.14 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.084 0.954 . . . . 74.420000000000002 113.32 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.6 mm -64.65 136.66 26.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 110.275 -0.268 . . . . 60.149999999999999 110.275 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -85.35 113.15 21.45 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.459 0.647 . . . . 70.200000000000003 109.301 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.1 mt -106.95 139.39 28.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.152 -0.931 . . . . 73.420000000000002 110.624 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.558 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.1 mp -120.82 139.48 53.09 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.172 -1.047 . . . . 63.310000000000002 108.172 170.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG22 ' HB2' ' A' ' 77' ' ' TYR . 97.1 t -127.26 104.94 13.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.192 -0.67 . . . . 71.409999999999997 109.192 174.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 3.2 p-10 -101.39 150.52 22.94 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.012 -0.54 . . . . 62.130000000000003 109.724 -177.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -85.22 157.39 20.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.426 -0.352 . . . . 72.120000000000005 110.328 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -51.35 -37.98 50.8 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.121 -0.49 . . . . 75.329999999999998 111.866 -174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 68.17 144.09 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.427 0 O-C-N 123.842 0.714 . . . . 73.409999999999997 111.622 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -90.81 -167.58 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.773 2.316 . . . . 65.230000000000004 111.888 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -60.52 97.7 0.06 Allowed 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.533 -0.543 . . . . 74.230000000000004 109.533 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 11.5 t -132.69 127.52 34.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.881 -0.6 . . . . 64.230000000000004 111.016 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.54 -67.8 2.01 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-N 115.909 -0.587 . . . . 61.119999999999997 113.327 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -56.6 -38.49 95.4 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.45 2.1 . . . . 73.519999999999996 111.574 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.604 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 21.7 m -61.76 -32.12 72.35 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.905 -0.589 . . . . 60.439999999999998 110.804 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -54.57 -47.46 73.25 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.975 -0.557 . . . . 65.129999999999995 110.559 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.567 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 47.2 t -74.95 -36.27 62.1 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.518 0.675 . . . . 55.100000000000001 110.52 177.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 56' ' ' CYS . 1.3 mm? -55.03 -44.6 74.8 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.475 -0.784 . . . . 74.140000000000001 112.059 -175.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.05 -56.86 30.68 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 119.374 -0.346 . . . . 72.340000000000003 111.543 -176.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HG2' ' O ' ' A' ' 58' ' ' SER . 10.0 Cg_endo -54.14 -38.14 87.53 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 121.739 1.626 . . . . 61.119999999999997 111.748 174.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 58' ' ' SER . 36.8 mt-30 -61.94 -39.64 92.78 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.753 -0.379 . . . . 74.400000000000006 110.956 174.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 80.3 mt -67.33 -36.92 82.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.425 -0.352 . . . . 63.439999999999998 110.147 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 42.8 mt-10 -59.4 -47.85 83.89 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.491 -0.559 . . . . 71.219999999999999 109.491 174.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -55.31 -50.61 69.13 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.578 -0.737 . . . . 74.209999999999994 110.566 178.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.538 HD11 HD11 ' A' ' 116' ' ' ILE . 23.1 mt -65.43 -37.14 86.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 64.409999999999997 110.443 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.534 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.98 -31.83 72.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 65.409999999999997 110.742 -178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 54.7 mt-30 -76.81 -50.59 13.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.001 0.429 . . . . 65.230000000000004 110.541 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -64.11 -41.19 97.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.745 -0.661 . . . . 74.430000000000007 110.715 -175.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.401 ' HE2' HD22 ' A' ' 66' ' ' LEU . 95.5 m-85 -99.11 5.56 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.879 -0.601 . . . . 72.530000000000001 112.178 -174.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.3 t -52.73 -19.57 2.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.762 0.653 . . . . 55.130000000000003 112.762 -170.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.16 -33.7 75.98 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.839 0.352 . . . . 64.099999999999994 110.971 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -126.2 -4.5 6.77 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.317 -0.401 . . . . 65.25 112.072 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -120.63 138.69 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.956 0.407 . . . . 72.219999999999999 111.726 -174.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -142.95 121.68 12.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.703 -0.68 . . . . 74.030000000000001 109.833 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.558 HG12 ' HB2' ' A' ' 45' ' ' LEU . 47.1 mt -111.55 144.49 19.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 CA-C-O 120.939 0.4 . . . . 73.400000000000006 111.197 -177.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.487 ' CE1' ' HB3' ' A' ' 34' ' ' LYS . 96.3 m-85 -130.56 136.36 48.83 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.558 -0.746 . . . . 75.25 110.213 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HG3' ' CG2' ' A' ' 23' ' ' ILE . 29.4 mtpp -107.97 134.04 51.45 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.582 -0.525 . . . . 64.219999999999999 109.582 173.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.3 mt -73.42 104.65 2.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.805 -0.813 . . . . 71.340000000000003 108.805 172.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 23.9 t-20 -98.95 -39.75 8.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.172 -0.467 . . . . 72.329999999999998 111.685 -173.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.4 mm -79.64 105.24 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.492 -0.322 . . . . 62.119999999999997 110.899 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.498 ' HB3' ' HG3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -59.61 -24.74 64.06 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.795 -0.638 . . . . 75.230000000000004 111.986 -178.536 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -71.4 -5.1 30.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.127 0.489 . . . . 54.340000000000003 110.621 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.401 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 24.0 m-80 -124.59 29.12 6.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.973 -0.558 . . . . 44.539999999999999 111.136 -176.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.626 ' NE2' ' H ' ' A' ' 12' ' ' LEU . 40.3 mt-30 -69.07 -7.34 34.92 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.352 -0.385 . . . . 64.25 110.916 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -47.11 -38.71 11.94 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.047 -0.524 . . . . 71.299999999999997 110.909 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -53.06 -41.67 42.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 115.703 -0.681 . . . . 34.509999999999998 110.894 178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.0 -41.48 96.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.619 -0.719 . . . . 72.129999999999995 110.499 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.5 m -69.5 -38.04 77.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.738 -0.665 . . . . 75.439999999999998 110.454 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -58.5 -51.69 68.79 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.972 -0.558 . . . . 75.219999999999999 110.842 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -77.11 -25.69 52.44 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 121.013 -0.275 . . . . 74.319999999999993 111.201 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.38 51.84 9.35 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.572 -0.823 . . . . 71.049999999999997 111.045 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.413 HG23 HG21 ' A' ' 98' ' ' THR . 7.7 p -59.71 135.77 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 115.258 -0.471 . . . . 71.140000000000001 111.305 -177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.6 t -69.84 -38.12 76.41 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.883 -0.598 . . . . 73.0 111.913 -174.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.42 164.03 34.64 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.464 -0.148 . . . . 73.129999999999995 110.874 -175.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.605 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 48.2 mm -61.41 -48.69 90.21 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.543 -0.299 . . . . 43.299999999999997 110.836 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 3.6 Cg_exo -80.13 101.49 1.35 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.978 1.785 . . . . 75.439999999999998 110.552 172.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.413 HG21 HG23 ' A' ' 93' ' ' VAL . 97.1 m -153.2 146.63 24.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.326 -0.397 . . . . 53.520000000000003 110.576 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.592 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.9 mp -118.37 116.26 50.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.035 -0.53 . . . . 53.100000000000001 110.089 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.441 HD23 ' HG3' ' A' ' 110' ' ' GLN . 89.1 mt -94.91 123.43 38.38 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.21 -0.663 . . . . 61.420000000000002 109.21 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.405 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 51.4 mtp -92.77 147.97 22.42 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.144 -0.317 . . . . 73.019999999999996 110.144 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.456 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.2 m-85 -144.92 161.09 40.2 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.551 -0.537 . . . . 74.420000000000002 109.551 177.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 20.7 ttmm -148.5 105.01 3.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.629 0.252 . . . . 73.120000000000005 110.568 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.929 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 65.7 t30 57.02 39.72 29.13 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.32 0.581 . . . . 71.329999999999998 110.692 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.98 -16.05 23.72 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.944 -0.571 . . . . 61.0 112.768 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 62.1 tttp -75.96 148.93 37.78 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 110.132 -0.321 . . . . 71.430000000000007 110.132 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -65.1 157.25 29.07 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.411 0.624 . . . . 71.099999999999994 110.903 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -162.26 167.9 23.2 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 107.358 -1.349 . . . . 63.0 107.358 -167.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.408 ' H ' HD13 ' A' ' 108' ' ' LEU . 38.7 m -70.44 178.64 2.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.425 0.631 . . . . 54.140000000000001 112.369 -167.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.441 ' HG3' HD23 ' A' ' 100' ' ' LEU . 59.0 tt0 -134.25 130.39 37.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.734 -0.666 . . . . 63.100000000000001 110.621 -176.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.592 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.4 t -101.1 107.31 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.044 -0.724 . . . . 73.439999999999998 109.044 173.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.8 mt -87.48 109.14 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.144 -0.48 . . . . 75.219999999999999 110.095 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 104.8 -147.75 16.42 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 111.395 -0.682 . . . . 62.219999999999999 111.395 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.524 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -132.21 96.26 3.84 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.413 -0.217 . . . . 74.299999999999997 110.413 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -139.56 103.48 4.71 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.213 0.53 . . . . 70.409999999999997 110.473 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.538 HD11 HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -63.34 -28.32 44.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.418 -0.81 . . . . 64.099999999999994 110.143 -175.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.3 m -62.9 -53.45 53.88 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.974 -0.557 . . . . 60.020000000000003 110.224 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -60.8 -44.36 96.95 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.21 -0.45 . . . . 73.120000000000005 110.09 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.475 HD13 HD21 ' A' ' 63' ' ' LEU . 66.0 mt -55.45 -56.12 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.964 -0.562 . . . . 64.299999999999997 111.316 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.6 tp -64.21 -34.46 69.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.526 0.203 . . . . 61.409999999999997 110.717 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.4 m -58.14 -50.69 72.61 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.538 -0.301 . . . . 61.149999999999999 110.468 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -66.82 -38.12 85.83 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.593 -0.276 . . . . 74.319999999999993 111.472 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 60.6 mt -58.65 -56.01 19.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.962 0.41 . . . . 64.299999999999997 110.115 178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -59.78 -39.11 83.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 63.43 110.365 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -60.29 -39.84 88.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.486 -0.779 . . . . 73.120000000000005 111.215 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -100.57 -2.4 33.01 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 112.173 0.434 . . . . 72.409999999999997 112.173 -174.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.0 mt -90.92 -55.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 109.671 -0.492 . . . . 53.32 109.671 168.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--O 1.251 1.149 0 CA-C-N 115.811 -0.631 . . . . 54.509999999999998 109.548 -179.841 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.467 ' SD ' ' HB2' ' A' ' 3' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.874 -0.417 . . . . 71.140000000000001 109.874 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.68 79.91 1.53 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.142 0.496 . . . . 71.530000000000001 110.486 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.467 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 3.9 t-160 -103.97 101.7 11.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.516 -0.766 . . . . 74.519999999999996 110.643 -174.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -67.94 142.56 55.98 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.545 -0.298 . . . . 72.230000000000004 110.273 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -120.14 75.29 1.09 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.709 0.29 . . . . 64.530000000000001 110.292 -176.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.23 149.78 0.16 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.399 0.68 . . . . 65.340000000000003 109.3 177.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 49.4 p-80 -157.49 163.76 38.11 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.861 0.362 . . . . 73.099999999999994 110.782 -179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -128.02 163.97 23.38 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.279 -0.637 . . . . 74.150000000000006 109.279 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.8 tpt -134.08 131.0 38.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.807 0.337 . . . . 74.310000000000002 110.102 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.9 112.34 3.57 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 116.063 -0.517 . . . . 62.020000000000003 112.175 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -92.2 98.97 11.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.661 0.267 . . . . 74.140000000000001 110.554 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.78 133.25 53.35 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.071 0.462 . . . . 74.239999999999995 110.609 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -102.02 -178.63 3.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.63 -0.714 . . . . 74.209999999999994 109.413 176.042 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.14 111.21 5.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.899 0.381 . . . . 63.219999999999999 111.66 -176.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -92.85 108.04 19.69 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.252 -0.647 . . . . 52.43 109.252 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.0 p -122.24 145.74 47.93 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.969 0.414 . . . . 74.450000000000003 111.423 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -133.23 172.83 12.15 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.807 -0.633 . . . . 74.25 109.583 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.87 162.45 28.32 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.921 -0.657 . . . . 62.43 112.726 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.92 -168.95 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.941 2.427 . . . . 71.450000000000003 111.965 178.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 119.99 144.43 7.2 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 121.198 -0.525 . . . . 61.149999999999999 112.203 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.7 t 76.83 14.59 2.08 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.412 0.685 . . . . 64.519999999999996 111.621 172.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 90.7 mmm -80.02 -36.24 36.14 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.556 -0.905 . . . . 73.140000000000001 108.556 172.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.442 ' O ' ' NZ ' ' A' ' 78' ' ' LYS . 10.7 mm -75.89 99.78 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 114.995 -1.002 . . . . 73.150000000000006 108.788 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.03 161.57 24.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.231 -0.44 . . . . 73.430000000000007 110.786 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.677 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 4.3 pm0 -125.67 122.82 37.45 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.885 0.374 . . . . 73.049999999999997 110.24 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 31' ' ' PHE . 34.4 pt -139.09 -179.75 2.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 122.942 0.497 . . . . 73.430000000000007 110.834 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.504 ' HA3' ' ND2' ' A' ' 84' ' ' ASN . . . -129.45 -157.57 9.22 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.904 -0.589 . . . . 64.209999999999994 111.944 176.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.4 -56.7 7.6 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.952 0.406 . . . . 73.209999999999994 111.123 -175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.5 m -62.78 -19.3 63.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 64.310000000000002 111.358 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 21.2 mp0 -96.07 -22.11 17.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.51 -0.314 . . . . 74.030000000000001 110.89 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.588 ' HA ' HD12 ' A' ' 26' ' ' ILE . 93.1 t80 -56.36 -62.32 1.8 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.81 0.338 . . . . 73.439999999999998 111.409 -174.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -59.21 -46.8 87.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.902 -0.59 . . . . 74.430000000000007 110.366 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -54.3 -55.83 24.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.064 -0.971 . . . . 73.200000000000003 111.404 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -65.68 -41.43 92.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.057 -0.519 . . . . 73.349999999999994 111.51 -176.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.54 HG22 HG21 ' A' ' 44' ' ' ILE . 91.1 t -70.04 -29.24 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.116 0.26 . . . . 64.109999999999999 111.646 -177.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 43.5 p -85.95 -31.11 22.28 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.936 0.398 . . . . 74.129999999999995 111.142 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 t -76.86 10.97 1.93 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.031 -0.531 . . . . 75.230000000000004 111.25 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.976 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 9.3 p -73.2 -0.18 13.57 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.864 0.32 . . . . 73.340000000000003 111.864 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.8 t30 70.87 -78.98 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.173 0.589 . . . . 71.040000000000006 111.869 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -162.17 137.35 7.17 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.531 0.567 . . . . 74.420000000000002 112.531 -177.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 61.56 2.72 0.72 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 60.32 113.614 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.799 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 49.9 mm -79.91 114.69 21.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.928 -0.397 . . . . 75.519999999999996 109.928 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tt -79.33 115.99 19.3 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.854 -0.612 . . . . 74.310000000000002 109.662 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.54 HG21 HG22 ' A' ' 35' ' ' VAL . 15.6 mm -99.2 120.04 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.458 -0.792 . . . . 74.400000000000006 110.214 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.6 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.2 mp -107.48 113.75 27.29 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.959 -0.756 . . . . 74.010000000000005 108.959 174.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.9 t -104.82 104.91 17.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 120.862 0.363 . . . . 51.210000000000001 110.963 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.672 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 7.7 t70 -80.55 148.05 30.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.758 -0.656 . . . . 61.210000000000001 109.464 172.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -74.24 -74.55 0.19 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.208 -0.664 . . . . 71.319999999999993 109.208 172.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.523 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 36.9 p90 179.54 138.7 0.11 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.384 -0.826 . . . . 74.340000000000003 109.06 174.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.06 100.7 9.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.544 -0.298 . . . . 73.019999999999996 110.224 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 49' ' ' TRP . 72.2 Cg_endo -92.26 -95.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.936 2.424 . . . . 64.239999999999995 112.277 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 68.0 m95 -104.72 112.1 25.06 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 109.623 -0.51 . . . . 62.409999999999997 109.623 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 56' ' ' CYS . 21.1 t -172.37 167.05 5.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.131 -0.486 . . . . 73.219999999999999 110.327 -175.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.468 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -76.48 -95.94 0.17 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.917 -0.659 . . . . 31.210000000000001 112.171 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.19 -17.4 56.55 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.836 2.357 . . . . 72.120000000000005 112.478 -175.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 53' ' ' CYS . 55.9 m -57.63 -34.95 69.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 74.109999999999999 111.206 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -64.44 -36.98 85.92 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.889 0.376 . . . . 75.420000000000002 110.449 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.539 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 11.5 t -75.26 -26.78 59.09 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.481 0.658 . . . . 65.209999999999994 110.551 177.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 114' ' ' ALA . 9.4 tp -64.22 -41.06 97.18 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.762 -0.653 . . . . 71.129999999999995 111.877 -171.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.502 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 49.2 mt-10 -55.92 -53.22 65.5 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 120.782 -0.367 . . . . 72.010000000000005 110.183 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 12.0 Cg_exo -52.65 -43.13 57.73 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 121.889 1.726 . . . . 63.229999999999997 112.255 170.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.539 ' HG3' ' O ' ' A' ' 58' ' ' SER . 35.3 mt-30 -65.72 -32.9 74.71 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 120.114 -0.635 . . . . 64.540000000000006 110.781 -177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.438 HD21 HD13 ' A' ' 119' ' ' ILE . 53.9 mt -70.11 -37.57 75.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.447 -0.797 . . . . 73.319999999999993 109.715 178.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' OE2' HG12 ' A' ' 23' ' ' ILE . 18.4 mm-40 -58.13 -46.37 85.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.352 -0.385 . . . . 73.0 109.973 171.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -55.87 -54.46 44.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.009 -0.542 . . . . 73.209999999999994 110.392 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.495 HD11 ' CD1' ' A' ' 116' ' ' ILE . 18.8 mt -63.55 -36.56 84.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.022 -0.535 . . . . 63.130000000000003 110.568 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.499 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.79 -33.26 75.27 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 115.784 -0.644 . . . . 65.319999999999993 110.629 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -78.33 -47.67 17.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.247 -0.433 . . . . 65.129999999999995 110.947 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -61.42 -38.94 88.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.079 -0.51 . . . . 74.150000000000006 110.873 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -104.88 5.76 33.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.42 -0.809 . . . . 72.340000000000003 112.269 -173.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.2 t -52.48 -23.26 5.87 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.811 1.041 . . . . 72.450000000000003 113.811 -166.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.95 -36.46 77.96 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.595 -0.442 . . . . 74.340000000000003 110.67 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -114.33 -4.73 12.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 64.140000000000001 111.676 -175.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.7 t -130.34 150.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.005 0.372 . . . . 73.230000000000004 112.005 -174.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -151.69 125.46 9.04 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.905 -0.589 . . . . 75.319999999999993 109.735 172.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.6 HG12 ' HB2' ' A' ' 45' ' ' LEU . 62.3 mt -101.54 142.56 15.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 120.889 0.376 . . . . 75.319999999999993 110.593 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -128.02 168.49 15.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.554 -0.748 . . . . 74.230000000000004 109.188 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 8.4 ptpp? -147.39 163.15 37.37 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.705 -0.48 . . . . 63.25 109.705 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mt -81.87 114.32 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.253 -0.647 . . . . 74.340000000000003 109.253 174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.677 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 11.9 t30 -73.14 -36.79 66.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.927 -0.578 . . . . 74.040000000000006 112.272 -173.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.534 HG13 ' H ' ' A' ' 83' ' ' ASP . 9.2 tp -135.62 143.26 37.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.951 0.405 . . . . 73.209999999999994 111.281 -173.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.46 -18.73 60.3 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.673 -0.694 . . . . 71.209999999999994 112.009 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.534 ' H ' HG13 ' A' ' 81' ' ' ILE . 8.3 m-20 -71.27 -22.64 61.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.313 0.578 . . . . 74.329999999999998 110.288 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.504 ' ND2' ' HA3' ' A' ' 27' ' ' GLY . 92.3 m-20 -96.88 20.9 10.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.778 -0.646 . . . . 74.329999999999998 110.534 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.63 -13.96 61.91 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.813 -0.631 . . . . 70.150000000000006 110.201 177.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -44.69 -42.41 7.56 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.471 -0.786 . . . . 54.210000000000001 111.742 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.4 t -53.17 -42.23 45.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 116.14 -0.482 . . . . 72.510000000000005 111.196 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.22 80.8 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.957 -0.565 . . . . 60.509999999999998 110.495 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.8 m -66.54 -35.46 80.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.711 -0.677 . . . . 64.109999999999999 110.992 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.49 -47.96 71.34 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.253 -0.431 . . . . 74.010000000000005 110.839 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -71.13 -24.12 62.21 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.206 -0.452 . . . . 64.209999999999994 110.984 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.67 39.44 7.65 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 121.071 -0.585 . . . . 73.019999999999996 112.77 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 95' ' ' ALA . 30.8 t -90.66 125.59 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.53 -0.544 . . . . 65.430000000000007 109.53 177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.1 t -104.39 17.64 23.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.701 0.286 . . . . 75.310000000000002 111.362 -174.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.436 ' H ' HG12 ' A' ' 93' ' ' VAL . . . -126.88 139.8 52.81 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.221 -0.289 . . . . 71.420000000000002 110.221 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.553 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 2.2 mp -78.04 -56.45 1.05 Allowed Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 116.663 -0.244 . . . . 74.450000000000003 110.985 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 90.9 Cg_endo -79.87 78.67 3.61 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 121.716 1.611 . . . . 74.510000000000005 111.515 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.6 m -127.34 135.25 50.27 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.864 -0.607 . . . . 63.450000000000003 111.164 -175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 99' ' ' ILE . 2.8 mp -110.22 111.74 37.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.472 -0.786 . . . . 62.119999999999997 109.702 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.4 mp -88.64 141.27 28.65 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.318 -0.623 . . . . 70.030000000000001 109.318 177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.54 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 36.2 mtp -110.18 140.46 44.27 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.854 -0.425 . . . . 65.129999999999995 109.854 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -146.66 144.49 29.52 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.569 -0.9 . . . . 72.299999999999997 108.569 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.509 ' HB2' HD22 ' A' ' 108' ' ' LEU . 38.2 ttpt -126.47 104.91 8.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 120.16 -0.616 . . . . 63.450000000000003 110.596 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.976 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 63.8 t30 50.79 47.51 24.42 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.561 0.696 . . . . 74.010000000000005 110.809 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.26 -16.19 35.39 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.559 -0.746 . . . . 73.299999999999997 112.955 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -70.07 134.25 48.03 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.917 0.358 . . . . 61.520000000000003 110.475 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -61.42 144.32 54.32 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 124.044 0.84 . . . . 71.340000000000003 109.132 175.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.54 ' HB3' ' O ' ' A' ' 101' ' ' MET . 13.6 tp -158.73 168.43 26.86 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.944 -0.571 . . . . 43.109999999999999 109.636 -163.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 101' ' ' MET . 37.8 m -69.47 179.64 2.0 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 123.069 0.548 . . . . 64.319999999999993 111.845 -167.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.406 HE21 HD11 ' A' ' 112' ' ' ILE . 28.3 tt0 -144.44 124.76 13.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 72.329999999999998 110.057 -174.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.3 t -98.43 108.88 22.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.962 0.41 . . . . 73.109999999999999 110.227 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.3 mp -87.55 101.72 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.048 -0.524 . . . . 74.150000000000006 109.651 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.88 -176.76 20.79 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.154 -0.546 . . . . 31.300000000000001 112.816 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.531 ' HA ' HD22 ' A' ' 59' ' ' LEU . . . -92.86 76.82 4.82 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 122.834 0.453 . . . . 73.030000000000001 111.271 -176.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -117.79 83.52 2.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.499 0.666 . . . . 73.209999999999994 109.458 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.539 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.2 OUTLIER -59.14 -30.47 43.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.093 -0.958 . . . . 72.140000000000001 110.241 -174.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 34.6 m -58.66 -53.22 60.84 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.13 -0.487 . . . . 63.009999999999998 110.478 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -65.39 -41.25 93.9 Favored 'General case' 0 CA--C 1.522 -0.109 0 CA-C-N 116.48 -0.327 . . . . 74.129999999999995 110.359 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 123' ' ' ILE . 76.2 mt -55.72 -56.24 13.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 116.246 -0.434 . . . . 63.329999999999998 110.808 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 15.2 tt -66.85 -34.33 69.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 116.443 -0.344 . . . . 75.530000000000001 110.418 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 t -58.7 -52.09 67.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.061 -0.518 . . . . 73.209999999999994 109.736 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -62.33 -40.36 96.09 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.343 -0.389 . . . . 72.010000000000005 111.108 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.467 HD12 HD13 ' A' ' 66' ' ' LEU . 64.9 mt -52.66 -55.76 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-O 120.769 0.319 . . . . 75.129999999999995 110.379 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -68.96 -29.82 68.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.434 -0.348 . . . . 75.299999999999997 110.777 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -68.34 -33.91 75.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.088 -0.505 . . . . 63.329999999999998 111.368 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.508 ' OD1' HD11 ' A' ' 108' ' ' LEU . 66.0 m-80 -98.49 -24.15 15.26 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.119 0.415 . . . . 62.240000000000002 112.119 -175.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 123' ' ' ILE . 61.6 mt -71.49 -59.5 3.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.951 0.405 . . . . 72.219999999999999 110.153 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.726 -0.67 . . . . 71.030000000000001 110.434 -177.713 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 109.88 -0.415 . . . . 73.329999999999998 109.88 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.75 124.0 23.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.984 -0.553 . . . . 61.420000000000002 111.247 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -122.06 99.39 6.41 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.034 -0.728 . . . . 73.400000000000006 109.034 175.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -101.34 152.73 20.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 73.0 111.531 -174.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -133.54 129.69 37.43 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.264 -0.643 . . . . 53.399999999999999 109.264 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -140.28 161.84 36.71 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.975 0.417 . . . . 63.530000000000001 111.464 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -157.46 172.51 18.44 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.422 -0.808 . . . . 74.230000000000004 109.19 175.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -117.46 92.58 3.88 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.258 0.551 . . . . 73.530000000000001 110.661 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptm 176.13 174.3 0.33 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.085 -0.961 . . . . 72.209999999999994 109.028 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.61 48.27 0.92 Allowed Glycine 0 C--O 1.237 0.311 0 C-N-CA 120.702 -0.761 . . . . 41.450000000000003 112.326 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 t -172.15 123.07 0.49 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.185 0.516 . . . . 64.329999999999998 112.309 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.404 ' HG ' ' N ' ' A' ' 13' ' ' GLU . 1.3 pt? -154.52 -50.26 0.09 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.692 -0.685 . . . . 71.0 109.618 167.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.404 ' N ' ' HG ' ' A' ' 12' ' ' LEU . 40.0 tt0 173.22 110.61 0.01 OUTLIER 'General case' 0 C--O 1.235 0.334 0 C-N-CA 122.844 0.458 . . . . 72.340000000000003 110.738 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' A' ' 82' ' ' GLU . . . -154.28 138.17 16.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 71.420000000000002 109.98 174.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -68.67 132.0 46.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.414 -0.357 . . . . 74.049999999999997 110.054 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.6 p -60.4 94.11 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.009 -0.541 . . . . 74.310000000000002 112.408 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 62.61 -169.7 0.18 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.334 -0.848 . . . . 74.239999999999995 112.513 169.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 174.89 -88.86 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 110.644 -0.982 . . . . 60.219999999999999 110.644 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.73 -171.22 0.94 Allowed 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.87 2.38 . . . . 75.310000000000002 111.46 175.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 156.7 63.41 0.01 OUTLIER Glycine 0 C--N 1.33 0.222 0 N-CA-C 111.421 -0.672 . . . . 65.439999999999998 111.421 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -134.53 -138.0 0.17 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.885 -0.413 . . . . 74.540000000000006 109.885 -172.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 91.4 mmm -56.55 -24.79 49.39 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.12 0.486 . . . . 73.530000000000001 110.498 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.5 mm -83.37 105.86 13.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 115.651 -0.704 . . . . 75.129999999999995 109.131 172.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -78.25 161.48 27.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.181 -0.463 . . . . 62.350000000000001 109.994 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.688 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 10.1 pt20 -137.21 133.13 34.8 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.858 0.361 . . . . 74.140000000000001 110.924 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 30' ' ' GLU . 32.6 pt -144.69 179.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.169 -0.469 . . . . 65.319999999999993 110.984 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.562 ' HA3' HD12 ' A' ' 81' ' ' ILE . . . -117.96 -165.54 13.53 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.131 -0.486 . . . . 72.430000000000007 112.02 174.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.426 ' H ' ' HB3' ' A' ' 84' ' ' ASN . 6.8 t70 -67.67 -51.28 51.57 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.693 0.397 . . . . 65.310000000000002 110.687 -177.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 m -56.16 -24.79 43.55 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.879 -0.6 . . . . 74.239999999999995 110.754 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 42.6 mt-10 -95.07 -31.25 13.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.784 -0.644 . . . . 72.239999999999995 110.421 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.487 ' HA ' HD12 ' A' ' 26' ' ' ILE . 92.8 t80 -50.14 -61.91 1.88 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.968 -0.56 . . . . 64.319999999999993 111.843 -171.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.628 ' O ' HG22 ' A' ' 36' ' ' THR . 8.4 t70 -53.56 -56.44 17.05 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 123.382 0.426 . . . . 72.219999999999999 110.516 -178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 37' ' ' SER . 0.9 OUTLIER -54.09 -57.3 11.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.805 -0.634 . . . . 73.400000000000006 111.509 -176.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 75.5 mmtt -56.43 -38.79 72.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.848 0.356 . . . . 73.310000000000002 110.33 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.495 ' HA ' HD12 ' A' ' 44' ' ' ILE . 3.9 t -66.79 -54.81 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.93 -0.577 . . . . 73.319999999999993 111.915 -179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 32' ' ' ASP . 9.4 t -76.51 -7.48 55.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.699 0.285 . . . . 73.0 111.039 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 22.6 t -74.58 -5.0 40.37 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.392 -0.367 . . . . 65.549999999999997 111.667 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 62.1 m -57.11 96.35 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 110.165 -0.309 . . . . 65.299999999999997 110.165 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -51.11 -44.63 61.33 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.502 0.501 . . . . 61.5 111.24 -177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -155.78 121.39 4.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.697 0.284 . . . . 75.329999999999998 110.981 173.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 41.89 24.9 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.547 1.314 . . . . 73.209999999999994 114.547 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.8 mm -70.09 100.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.475 -0.565 . . . . 62.130000000000003 109.475 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.8 tp -67.78 114.88 6.74 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.239 0.542 . . . . 72.209999999999994 110.333 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 35' ' ' VAL . 34.9 mt -104.05 120.5 54.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.299 -0.864 . . . . 74.109999999999999 110.833 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.507 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.5 mp -105.13 110.87 23.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.11 -0.7 . . . . 45.229999999999997 109.11 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 61.1 t -95.55 110.16 23.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 110.525 -0.176 . . . . 73.019999999999996 110.525 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.439 ' CG ' ' HZ2' ' A' ' 78' ' ' LYS . 2.1 p-10 -91.08 129.65 37.06 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.291 0.567 . . . . 43.509999999999998 110.656 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -96.34 85.0 3.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.388 -0.967 . . . . 54.32 108.388 170.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.46 ' HB3' ' HE3' ' A' ' 78' ' ' LYS . 3.7 p-90 -63.73 147.76 50.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.965 -1.016 . . . . 72.129999999999995 112.092 -175.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.34 118.88 28.69 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.326 -0.852 . . . . 53.439999999999998 109.165 172.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.23 162.01 35.08 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.128 1.885 . . . . 74.230000000000004 111.516 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.7 m95 65.17 12.35 7.92 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.74 0.416 . . . . 72.340000000000003 111.246 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 44.0 t -87.19 138.2 31.69 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.343 -0.39 . . . . 40.439999999999998 110.92 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.69 -68.4 1.56 Allowed Glycine 0 CA--C 1.524 0.617 0 CA-C-N 116.113 -0.494 . . . . 73.129999999999995 112.823 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.92 -39.26 82.78 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.619 2.213 . . . . 60.340000000000003 112.386 -177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 18.9 m -54.05 -32.92 56.0 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.239 -0.437 . . . . 74.319999999999993 110.712 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -56.26 -46.4 79.67 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.428 -0.805 . . . . 70.409999999999997 110.908 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.622 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 46.0 t -74.89 -39.09 61.69 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.666 0.746 . . . . 62.420000000000002 110.583 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.523 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 3.3 mm? -52.88 -45.72 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.113 -0.949 . . . . 72.209999999999994 111.989 -175.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 32.3 mt-10 -59.01 -58.57 18.56 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 119.133 -0.46 . . . . 75.239999999999995 111.58 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.78 -40.53 84.4 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 121.81 1.673 . . . . 73.530000000000001 112.165 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' A' ' 58' ' ' SER . 42.3 mt-30 -58.28 -46.49 85.96 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.145 0.497 . . . . 71.549999999999997 110.427 176.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 81.8 mt -69.65 -28.45 65.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.86 -0.609 . . . . 62.130000000000003 110.6 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 44.6 mt-10 -63.78 -44.22 94.01 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.575 -0.528 . . . . 73.239999999999995 109.575 175.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -63.32 -49.93 72.03 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.394 -0.366 . . . . 63.520000000000003 110.211 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.455 HD11 HD11 ' A' ' 116' ' ' ILE . 28.1 mt -60.56 -32.95 72.01 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.455 . . . . 63.329999999999998 110.465 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.28 -50.36 70.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.52 -0.548 . . . . 64.5 109.52 176.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.3 mt-30 -57.78 -39.16 76.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.249 0.547 . . . . 75.519999999999996 110.734 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -70.05 -45.39 67.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.259 -0.882 . . . . 71.120000000000005 111.249 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -104.58 5.02 33.49 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.874 -0.603 . . . . 65.319999999999993 112.373 -171.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.6 t -52.88 -19.85 2.86 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.223 0.824 . . . . 75.219999999999999 113.223 -169.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.12 -37.36 84.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.008 0.432 . . . . 54.310000000000002 110.63 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -124.0 -2.83 8.16 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.771 -0.649 . . . . 71.530000000000001 111.639 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -127.07 136.88 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.184 0.516 . . . . 54.240000000000002 112.209 -173.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 20.6 mmtt -146.1 127.23 14.69 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.345 -0.843 . . . . 62.350000000000001 109.538 173.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 76' ' ' ILE . 3.3 mp -99.23 137.91 25.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 109.692 -0.485 . . . . 73.140000000000001 109.692 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 71.8 m-85 -123.83 144.45 49.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.286 -0.415 . . . . 75.140000000000001 110.031 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' A' ' 49' ' ' TRP . 3.1 ttmp? -121.47 137.96 54.49 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.885 -0.598 . . . . 65.030000000000001 110.05 -177.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.475 HD11 ' HA ' ' A' ' 85' ' ' GLN . 12.4 tt -70.34 117.36 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 109.884 -0.413 . . . . 64.409999999999997 109.884 177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.688 ' HB2' ' HB2' ' A' ' 25' ' ' GLN . 22.9 t-20 -113.9 -50.33 2.83 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.175 -0.466 . . . . 75.040000000000006 111.71 -173.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.562 HD12 ' HA3' ' A' ' 27' ' ' GLY . 52.1 mt -66.47 106.69 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 121.052 0.453 . . . . 73.239999999999995 110.861 -175.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 10.9 pt-20 -49.19 -40.87 34.98 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.961 -1.018 . . . . 71.25 112.907 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -71.38 -25.65 62.45 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.986 0.422 . . . . 53.439999999999998 110.9 -176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.447 ' N ' HD22 ' A' ' 84' ' ' ASN . 0.9 OUTLIER -90.43 30.63 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.876 -0.602 . . . . 74.430000000000007 110.927 -173.184 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.475 ' HA ' HD11 ' A' ' 79' ' ' ILE . 32.4 tt0 -70.5 -12.81 61.81 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.74 -0.664 . . . . 64.319999999999993 110.976 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.412 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 15.7 m-20 -49.81 -30.07 9.05 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.86 -0.609 . . . . 73.140000000000001 112.469 -177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.0 t -52.61 -39.3 29.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.101 0.476 . . . . 72.120000000000005 110.379 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.86 -49.24 75.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.813 -0.63 . . . . 72.510000000000005 110.267 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.1 m -61.29 -41.38 96.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.648 -0.705 . . . . 65.420000000000002 111.077 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 14.1 mm100 -70.78 -44.69 66.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.002 -0.545 . . . . 73.340000000000003 111.454 -174.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -87.44 -9.66 54.05 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.416 -0.356 . . . . 73.400000000000006 111.594 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.31 55.68 5.03 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.801 -0.714 . . . . 21.129999999999999 112.584 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.0 t -81.09 98.82 4.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.203 -0.666 . . . . 70.019999999999996 109.203 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t -60.38 -58.83 6.83 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.012 -0.54 . . . . 74.109999999999999 110.913 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -105.99 136.28 45.93 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.227 -0.657 . . . . 45.25 109.227 175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.432 ' N ' ' HD2' ' A' ' 97' ' ' PRO . 72.9 mt -51.8 -54.36 40.99 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 123.389 0.43 . . . . 73.530000000000001 111.874 -176.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 96' ' ' ILE . 41.6 Cg_endo -65.37 87.58 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.614 1.542 . . . . 61.43 111.866 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 112' ' ' ILE . 56.4 m -151.77 143.02 23.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.737 -0.665 . . . . 72.219999999999999 110.09 178.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 99' ' ' ILE . 2.5 mp -109.83 114.05 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.848 -0.426 . . . . 64.400000000000006 109.848 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.1 mp -95.83 124.91 40.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 109.756 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.42 ' HB2' ' HB3' ' A' ' 108' ' ' LEU . 61.8 mtp -93.25 143.72 25.99 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.682 -0.488 . . . . 73.230000000000004 109.682 -177.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.465 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 96.0 m-85 -146.92 158.17 43.84 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.673 -0.491 . . . . 72.109999999999999 109.673 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -151.21 105.15 3.18 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.943 -0.303 . . . . 61.509999999999998 111.164 176.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.9 t-20 56.6 44.22 24.3 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.363 0.601 . . . . 74.430000000000007 110.381 177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.5 -16.51 7.75 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.82 -0.627 . . . . 61.409999999999997 112.752 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 107' ' ' LYS . 14.0 tmtt? -79.66 139.78 37.28 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.45 -0.574 . . . . 73.120000000000005 109.45 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -68.97 136.74 52.98 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 122.104 0.954 . . . . 72.329999999999998 112.302 -174.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -133.36 168.22 18.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.623 -1.626 . . . . 33.119999999999997 107.794 -175.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.8 m -70.27 -178.77 1.78 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.312 0.486 . . . . 40.009999999999998 112.312 -167.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -138.44 121.83 17.14 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.513 -0.312 . . . . 72.310000000000002 110.497 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.1 t -97.87 107.41 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.83 -0.433 . . . . 73.329999999999998 109.83 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.564 ' HA ' HG23 ' A' ' 98' ' ' THR . 64.7 mt -80.15 135.25 25.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.364 -0.38 . . . . 71.0 110.509 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.5 -137.64 15.54 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.995 -0.622 . . . . 72.030000000000001 111.846 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.523 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -144.6 76.76 1.51 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.93 0.395 . . . . 74.120000000000005 110.375 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.447 ' O ' HG13 ' A' ' 119' ' ' ILE . 9.3 t70 -117.3 103.36 10.08 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 116.128 -0.487 . . . . 61.450000000000003 109.991 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.482 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -63.34 -36.74 77.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.81 -0.632 . . . . 64.129999999999995 110.382 -174.001 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -63.49 -42.94 98.54 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.249 -0.432 . . . . 52.32 110.151 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -66.06 -41.16 91.17 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.363 -0.38 . . . . 54.240000000000002 110.198 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 115' ' ' ASP . 69.1 mt -59.81 -56.35 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.443 -0.344 . . . . 63.009999999999998 111.048 178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.1 tt -62.73 -33.97 62.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-O 120.818 0.342 . . . . 62.039999999999999 110.339 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 t -55.75 -51.66 66.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.86 -0.609 . . . . 74.140000000000001 109.596 175.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -62.01 -40.86 97.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.087 -0.506 . . . . 71.219999999999999 110.891 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 119' ' ' ILE . 73.0 mt -56.04 -55.85 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.663 0.268 . . . . 71.319999999999993 110.934 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -71.67 -29.42 64.58 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.803 -0.359 . . . . 74.109999999999999 110.77 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -68.24 -39.96 82.15 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.031 0.443 . . . . 73.25 111.022 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -90.06 -24.84 21.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.919 -0.582 . . . . 73.0 111.29 -173.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.7 mt -77.75 -54.15 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 120.757 0.313 . . . . 51.439999999999998 110.795 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.569 -0.729 . . . . 75.519999999999996 110.313 -176.471 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptt? . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.794 0.33 . . . . 72.129999999999995 110.665 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.48 110.67 1.75 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.717 0.636 . . . . 72.409999999999997 112.717 -170.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -106.34 36.97 2.41 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.761 -1.2 . . . . 74.519999999999996 107.761 167.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -67.26 -26.12 66.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.412 -1.267 . . . . 64.140000000000001 112.332 -169.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -71.61 96.87 1.61 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.51 0.672 . . . . 70.420000000000002 109.972 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.9 m170 -96.41 142.72 28.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.789 -0.642 . . . . 75.420000000000002 110.159 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -72.44 102.1 3.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 74.209999999999994 109.942 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -72.63 105.51 4.28 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.864 -0.607 . . . . 71.150000000000006 110.282 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.8 ptm -71.83 -26.85 62.55 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 71.439999999999998 109.917 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.83 -176.02 46.64 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.484 -0.78 . . . . 70.420000000000002 112.615 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 t -132.08 124.16 28.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.08 0.467 . . . . 73.209999999999994 110.289 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.0 mm? -97.94 91.55 5.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.581 -0.525 . . . . 73.239999999999995 109.581 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -89.56 95.05 10.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.026 -0.534 . . . . 63.130000000000003 110.348 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -151.87 79.08 1.26 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.34 . . . . 64.409999999999997 111.345 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 25.5 pt20 -84.76 78.19 9.92 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.782 -0.822 . . . . 74.120000000000005 108.782 172.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.6 p -69.66 92.45 0.66 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.206 -0.906 . . . . 55.439999999999998 111.431 -175.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -132.98 152.08 51.99 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.629 -0.714 . . . . 64.239999999999995 109.588 175.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.84 -171.55 32.86 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 116.037 -0.529 . . . . 52.310000000000002 112.254 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.94 19.11 0.92 Allowed 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.907 2.405 . . . . 65.219999999999999 112.716 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -66.64 -58.91 7.73 Favored Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.116 -0.793 . . . . 42.420000000000002 111.116 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.7 t 63.0 23.54 14.07 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.85 0.46 . . . . 52.140000000000001 111.397 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.435 ' HG3' ' HG3' ' A' ' 68' ' ' GLN . 94.0 mmm -78.66 -27.51 45.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.888 0.375 . . . . 74.099999999999994 110.379 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.452 HG12 ' HG2' ' A' ' 64' ' ' GLU . 24.6 mm -87.55 119.69 35.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-N 115.785 -0.643 . . . . 55.539999999999999 109.471 177.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 154.0 18.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.97 0.414 . . . . 72.109999999999999 111.213 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -110.63 141.77 43.4 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.899 -0.591 . . . . 73.349999999999994 110.216 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.536 HG21 ' HG3' ' A' ' 34' ' ' LYS . 34.7 pt -140.31 161.26 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.902 0.382 . . . . 65.120000000000005 110.978 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.38 169.18 37.4 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.825 -0.625 . . . . 34.130000000000003 111.954 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.831 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 18.2 t70 -57.04 -42.43 80.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.116 0.484 . . . . 74.540000000000006 110.763 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.3 t -72.29 -16.19 61.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.729 -0.668 . . . . 65.129999999999995 110.924 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 11.1 mm-40 -83.16 -24.41 32.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.456 -0.338 . . . . 74.510000000000005 111.845 -176.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 35' ' ' VAL . 88.7 t80 -45.33 -61.94 1.46 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.559 0.577 . . . . 71.420000000000002 112.559 -170.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.91 -46.11 91.95 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.727 0.298 . . . . 72.310000000000002 110.653 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -48.37 -57.14 6.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.59 -0.732 . . . . 64.329999999999998 110.588 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 9.8 mmpt? -64.62 -49.64 70.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.827 -0.624 . . . . 44.329999999999998 110.11 -175.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.556 HG12 ' HA2' ' A' ' 105' ' ' GLY . 95.5 t -62.18 -36.8 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.735 -0.666 . . . . 62.119999999999997 111.839 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -77.76 -47.03 19.97 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.838 0.31 . . . . 65.109999999999999 111.838 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.2 p -77.15 11.03 2.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.273 0.842 . . . . 60.329999999999998 113.273 -171.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.517 ' HB3' HD11 ' A' ' 44' ' ' ILE . 24.9 p -76.78 79.93 3.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.289 . . . . 62.329999999999998 111.686 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.9 t30 32.28 -94.62 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.147 0.979 . . . . 73.310000000000002 112.763 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -161.72 140.34 9.49 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.789 -0.449 . . . . 60.32 109.789 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 53.19 21.04 2.04 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.223 0.609 . . . . 73.209999999999994 112.474 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 103' ' ' LYS . 47.9 mm -75.68 128.84 37.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 120.784 0.326 . . . . 64.219999999999999 110.481 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 45' ' ' LEU . 0.3 OUTLIER -84.76 111.12 19.31 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 109.013 -0.736 . . . . 61.399999999999999 109.013 178.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.517 HD11 ' HB3' ' A' ' 38' ' ' CYS . 52.9 mt -106.84 129.12 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.971 -0.559 . . . . 73.439999999999998 110.932 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.544 ' HB2' HG12 ' A' ' 76' ' ' ILE . 4.9 mp -113.97 109.73 18.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.101 -0.703 . . . . 75.140000000000001 109.101 174.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 77' ' ' TYR . 48.7 t -101.54 104.84 16.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.951 -0.388 . . . . 72.420000000000002 109.951 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 17.8 t70 -85.26 146.6 26.98 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.068 0.461 . . . . 74.219999999999999 109.878 175.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.488 ' CD2' ' HB2' ' A' ' 49' ' ' TRP . 43.4 t80 -81.21 -100.07 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.784 -0.644 . . . . 73.310000000000002 111.495 -173.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.488 ' HB2' ' CD2' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -97.73 -83.72 0.39 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.699 0.285 . . . . 74.010000000000005 110.765 -168.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.561 ' N ' ' HD3' ' A' ' 51' ' ' PRO . . . 60.13 36.9 0.27 Allowed Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 114.462 1.282 . . . . 74.530000000000001 114.462 178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 50' ' ' ALA . 45.0 Cg_endo -97.44 -5.06 1.18 Allowed 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 122.215 1.943 . . . . 72.329999999999998 111.373 174.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -141.47 83.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.174 -1.047 . . . . 73.219999999999999 108.174 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.0 t -152.14 151.41 31.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.523 -0.762 . . . . 50.119999999999997 110.467 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 57' ' ' ARG . . . -86.42 -73.86 1.28 Allowed Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.285 -0.483 . . . . 71.349999999999994 112.598 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.75 -22.02 69.61 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.898 2.398 . . . . 74.439999999999998 112.86 -173.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 79.6 m -56.16 -27.3 53.77 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.27 0.471 . . . . 74.019999999999996 112.27 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.565 ' HD3' ' N ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -53.95 -33.9 58.16 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.74 0.274 . . . . 72.239999999999995 111.74 -178.282 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.565 ' N ' ' HD3' ' A' ' 57' ' ' ARG . 20.2 m -75.87 -30.63 58.93 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.569 0.699 . . . . 70.25 110.935 173.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.525 ' HG ' ' HB1' ' A' ' 114' ' ' ALA . 4.5 mm? -66.2 -42.58 88.62 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.479 -0.782 . . . . 74.120000000000005 112.522 -173.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.647 ' HB2' ' HD3' ' A' ' 61' ' ' PRO . 3.0 mp0 -49.72 -57.52 11.97 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 118.697 0.681 . . . . 72.340000000000003 110.255 177.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.647 ' HD3' ' HB2' ' A' ' 60' ' ' GLU . 23.2 Cg_exo -55.43 -55.5 3.04 Favored 'Trans proline' 0 C--N 1.36 1.156 0 C-N-CA 121.885 1.723 . . . . 65.120000000000005 112.327 175.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 58' ' ' SER . 43.5 mt-30 -51.33 -49.7 60.88 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.175 0.435 . . . . 71.219999999999999 112.175 -178.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.73 -40.54 76.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.875 -0.602 . . . . 73.439999999999998 111.058 -173.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 32.4 mt-10 -64.05 -34.84 78.93 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.881 -0.328 . . . . 65.019999999999996 110.307 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -62.54 -54.99 31.62 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.176 0.513 . . . . 73.340000000000003 110.04 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.4 mt -62.08 -32.95 73.54 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.849 -0.614 . . . . 62.140000000000001 109.928 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -61.93 -40.74 96.56 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.993 -0.549 . . . . 62.399999999999999 109.933 176.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 98.0 mt-30 -64.28 -45.45 87.96 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.885 0.374 . . . . 74.430000000000007 110.66 177.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -65.89 -38.18 88.07 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.962 -0.563 . . . . 62.520000000000003 111.225 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -104.63 4.58 32.88 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 112.242 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 15.0 t -53.23 -19.91 3.59 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.07 0.767 . . . . 74.150000000000006 113.07 -169.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.66 -34.54 75.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.988 0.423 . . . . 74.319999999999993 110.824 178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -123.37 -20.41 5.63 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.796 -0.638 . . . . 72.25 111.612 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.14 128.25 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.946 0.403 . . . . 63.420000000000002 112.051 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.515 ' HB3' ' HZ2' ' A' ' 75' ' ' LYS . 2.2 mmmp? -131.69 138.22 48.6 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.99 -0.744 . . . . 61.310000000000002 108.99 173.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.544 HG12 ' HB2' ' A' ' 45' ' ' LEU . 60.6 mt -118.09 114.38 45.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.011 0.434 . . . . 74.540000000000006 110.655 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.503 ' HB2' HG22 ' A' ' 46' ' ' VAL . 56.7 m-85 -101.45 163.99 11.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 72.319999999999993 109.809 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 47' ' ' ASP . 20.5 ttmm -139.16 138.09 36.64 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.869 0.366 . . . . 71.120000000000005 111.279 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.486 HD11 ' O ' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -126.57 100.8 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.472 -0.936 . . . . 73.439999999999998 108.472 174.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -124.47 7.63 8.33 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.045 -0.525 . . . . 72.310000000000002 112.033 -172.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 84' ' ' ASN . 57.5 mt -76.47 112.44 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 110.273 -0.269 . . . . 70.340000000000003 110.273 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.75 -31.19 70.53 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.839 0.352 . . . . 44.439999999999998 111.331 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.29 -23.29 61.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.161 0.505 . . . . 72.329999999999998 110.957 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.831 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 33.5 m-80 -123.92 91.94 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 55.049999999999997 110.509 -174.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -140.25 14.63 2.41 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.537 0.569 . . . . 61.350000000000001 112.537 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.67 -44.77 63.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.206 0.527 . . . . 74.340000000000003 110.043 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.59 -38.92 59.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.272 -0.877 . . . . 73.219999999999999 110.897 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.99 -41.06 91.58 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.213 0.53 . . . . 62.149999999999999 110.269 -175.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.1 m -72.25 -35.91 68.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.51 -0.768 . . . . 62.229999999999997 110.932 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -68.55 -45.96 70.77 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.473 -0.33 . . . . 74.099999999999994 111.841 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -86.86 -23.54 25.23 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.617 0.229 . . . . 62.5 111.617 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.49 80.38 1.51 Allowed Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.717 -0.754 . . . . 72.120000000000005 113.062 173.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 85.4 t -99.63 138.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.271 -0.641 . . . . 61.219999999999999 109.271 172.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.4 m -141.49 18.29 2.21 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.997 0.369 . . . . 75.230000000000004 111.997 -174.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.87 152.53 35.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.652 -0.249 . . . . 51.229999999999997 110.444 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.685 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 60.1 mt -59.68 -50.03 88.93 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.416 -0.356 . . . . 51.240000000000002 110.526 178.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.685 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 73.1 Cg_endo -95.37 112.67 0.15 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.695 2.264 . . . . 72.439999999999998 111.061 169.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.426 HG23 HD13 ' A' ' 112' ' ' ILE . 54.8 m -145.82 118.68 8.7 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.005 -0.369 . . . . 55.310000000000002 110.005 -176.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.534 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.5 mp -109.7 110.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.316 -0.402 . . . . 62.32 110.129 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 100' ' ' LEU . 6.0 mp -90.21 123.31 33.91 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.767 -0.827 . . . . 75.530000000000001 108.767 175.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.441 ' O ' ' HB3' ' A' ' 108' ' ' LEU . 45.2 mtp -101.0 145.43 28.71 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.851 -0.426 . . . . 74.400000000000006 109.851 -176.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.466 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 97.1 m-85 -148.22 160.81 42.56 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.354 -0.609 . . . . 74.549999999999997 109.354 177.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 42' ' ' ILE . 39.3 ttpt -143.93 114.34 7.52 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.917 -0.313 . . . . 75.200000000000003 110.596 175.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.5 t30 62.19 25.68 15.38 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.536 0.684 . . . . 72.129999999999995 109.711 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.556 ' HA2' HG12 ' A' ' 35' ' ' VAL . . . 84.61 -14.41 47.13 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.699 -0.682 . . . . 73.040000000000006 111.965 -176.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -69.33 142.31 54.06 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.832 -0.433 . . . . 74.200000000000003 109.832 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -58.3 150.93 20.68 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 124.1 0.875 . . . . 64.219999999999999 111.097 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.466 ' HB2' ' HA ' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -162.36 168.74 21.68 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.909 -1.042 . . . . 74.010000000000005 108.995 -169.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -70.19 167.71 17.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.384 0.611 . . . . 63.149999999999999 112.356 -167.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -130.48 118.57 21.32 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.81 -0.632 . . . . 70.530000000000001 109.945 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.534 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.0 t -86.8 119.43 34.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 74.430000000000007 110.29 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 98' ' ' THR . 50.0 mm -100.13 102.47 13.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.222 -0.445 . . . . 74.340000000000003 110.2 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.482 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 107.46 166.25 21.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 121.267 -0.492 . . . . 34.229999999999997 112.217 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.525 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -80.79 72.2 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.863 0.363 . . . . 64.120000000000005 111.107 -178.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 118' ' ' LYS . 61.2 t0 -112.07 92.88 4.19 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.374 0.607 . . . . 64.019999999999996 110.185 179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.494 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.2 OUTLIER -59.22 -34.97 55.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 115.276 -0.875 . . . . 75.540000000000006 110.153 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.6 t -62.68 -46.21 89.2 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 110.077 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.473 ' HB2' ' NZ ' ' A' ' 118' ' ' LYS . 0.1 OUTLIER -65.29 -42.96 92.6 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.859 -0.61 . . . . 74.099999999999994 109.937 -179.316 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 123' ' ' ILE . 74.0 mt -57.22 -56.14 16.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 115.419 -0.81 . . . . 71.140000000000001 111.098 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.2 tt -65.4 -35.21 74.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 121.063 -0.255 . . . . 74.219999999999999 110.788 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 35.1 t -56.72 -52.05 66.47 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 116.103 -0.499 . . . . 75.319999999999993 110.027 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -70.46 -31.63 68.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 65.299999999999997 111.477 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 119' ' ' ILE . 62.0 mt -57.34 -56.52 14.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 120.686 -0.406 . . . . 70.549999999999997 110.229 176.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -69.8 -32.82 71.48 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 120.757 -0.377 . . . . 74.25 110.21 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -62.06 -49.67 75.04 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.137 -0.483 . . . . 64.430000000000007 111.153 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -86.98 -20.24 27.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 112.219 -172.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 52.9 mt -78.62 -52.76 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 120.853 -0.339 . . . . 72.239999999999995 110.619 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.536 -0.745 . . . . 70.200000000000003 110.288 -177.392 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 110.085 -0.339 . . . . 62.219999999999999 110.085 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.96 139.41 49.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.223 -0.444 . . . . 73.219999999999999 110.136 178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -86.82 91.12 8.54 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.494 -0.928 . . . . 74.129999999999995 108.494 177.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -47.97 -43.62 29.68 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.422 -0.808 . . . . 73.010000000000005 112.563 -167.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -137.98 144.73 41.29 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.607 -0.516 . . . . 74.109999999999999 109.607 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -54.68 -53.9 48.8 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 123.695 0.622 . . . . 74.230000000000004 111.702 -172.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 56.85 36.48 27.79 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.508 0.671 . . . . 71.230000000000004 110.233 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -113.51 77.05 1.02 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.048 -0.978 . . . . 72.209999999999994 110.402 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -107.48 93.86 4.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.762 0.792 . . . . 72.430000000000007 110.362 177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.34 -60.82 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 109.918 -1.273 . . . . 65.530000000000001 109.918 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.42 HG23 ' HD2' ' A' ' 78' ' ' LYS . 89.2 m -75.02 81.79 2.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.355 -0.609 . . . . 74.109999999999999 109.355 169.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.8 127.01 33.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.756 -0.657 . . . . 71.5 110.062 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -65.88 99.23 0.46 Allowed 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.68 -0.859 . . . . 75.310000000000002 108.68 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.41 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.079 0.77 . . . . 71.209999999999994 113.079 -167.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -134.69 93.4 3.03 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.071 0.462 . . . . 64.140000000000001 111.58 -167.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.2 m 62.36 64.61 0.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.325 -0.852 . . . . 63.240000000000002 111.528 173.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.683 ' NE2' ' H ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -72.1 -32.06 66.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.565 -0.743 . . . . 53.310000000000002 109.696 175.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 136.66 -121.81 2.47 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.542 -0.754 . . . . 65.219999999999999 111.672 -179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.513 ' HG3' ' NE2' ' A' ' 68' ' ' GLN . 90.6 Cg_endo -79.47 -21.99 8.39 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.876 2.384 . . . . 61.229999999999997 112.63 -177.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.32 141.5 3.62 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 110.404 -1.078 . . . . 74.450000000000003 110.404 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.3 p -46.53 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.096 0.776 . . . . 73.420000000000002 113.096 -172.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 80.1 mmm -69.88 -32.64 71.09 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.227 -1.027 . . . . 62.109999999999999 108.227 165.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.581 HG21 ' NZ ' ' A' ' 78' ' ' LYS . 17.2 mm -54.99 107.79 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 114.642 -1.163 . . . . 53.130000000000003 109.222 174.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.48 ' HB3' ' CD1' ' A' ' 77' ' ' TYR . 35.9 tt0 -76.26 112.22 12.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.353 0.597 . . . . 64.319999999999993 110.62 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -70.16 127.22 32.05 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.043 -0.981 . . . . 72.239999999999995 110.873 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.52 HG21 ' HG3' ' A' ' 34' ' ' LYS . 44.3 pt -136.27 159.04 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.04 0.447 . . . . 71.129999999999995 111.274 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.96 176.29 30.58 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.973 -0.558 . . . . 74.120000000000005 112.232 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' CB ' ' HB3' ' A' ' 84' ' ' ASN . 16.9 t70 -55.29 -38.38 68.54 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.157 0.583 . . . . 61.5 111.346 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -84.48 -8.65 58.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.161 -0.472 . . . . 75.140000000000001 112.132 -174.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -94.37 -12.94 26.92 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.267 0.469 . . . . 74.219999999999999 112.267 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.428 ' O ' HG23 ' A' ' 35' ' ' VAL . 31.1 m-85 -50.2 -61.79 1.96 Allowed 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.29 0.478 . . . . 74.150000000000006 112.29 -175.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.08 -36.58 80.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.461 -0.336 . . . . 70.299999999999997 110.544 -174.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -57.48 -57.3 13.26 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.699 0.761 . . . . 74.209999999999994 109.075 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.674 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 10.2 mmpt? -62.52 -39.17 92.67 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.363 -1.29 . . . . 62.310000000000002 111.01 -172.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 31' ' ' PHE . 96.7 t -66.34 -49.8 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.909 -0.587 . . . . 75.209999999999994 110.329 178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -67.85 -17.93 64.65 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 111.711 0.263 . . . . 65.420000000000002 111.711 177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -66.27 -8.88 27.62 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.962 0.356 . . . . 72.420000000000002 111.962 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.725 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 18.8 t -60.72 117.36 5.28 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.726 0.298 . . . . 71.439999999999998 110.823 177.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -76.65 -50.95 12.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.335 -0.393 . . . . 72.230000000000004 110.66 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -161.67 121.9 2.61 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.331 -0.395 . . . . 62.119999999999997 111.21 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 51.42 16.01 0.38 Allowed 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.263 0.838 . . . . 50.520000000000003 113.263 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.724 ' HB ' ' SG ' ' A' ' 38' ' ' CYS . 44.5 mm -70.1 104.48 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 109.629 -0.508 . . . . 72.230000000000004 109.629 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.06 108.04 8.69 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.526 -0.761 . . . . 74.109999999999999 109.032 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.482 HG23 ' CE2' ' A' ' 77' ' ' TYR . 76.0 mt -100.31 113.58 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.965 -1.016 . . . . 72.239999999999995 110.814 -176.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.0 mp -105.24 142.75 34.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.731 -0.668 . . . . 74.329999999999998 109.291 176.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 77' ' ' TYR . 57.6 t -129.96 109.44 17.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.391 -0.596 . . . . 75.140000000000001 109.391 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -90.54 143.83 26.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.072 0.463 . . . . 75.450000000000003 110.111 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -134.66 105.45 6.49 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.954 -0.758 . . . . 70.140000000000001 108.954 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -116.1 128.09 55.39 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.922 -0.399 . . . . 73.530000000000001 109.922 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.694 ' HB3' HG23 ' A' ' 96' ' ' ILE . . . -74.67 140.78 75.2 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.609 -0.515 . . . . 64.329999999999998 109.609 173.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.95 -24.95 11.38 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.843 2.362 . . . . 64.450000000000003 112.852 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -92.73 80.41 4.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 71.010000000000005 109.586 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 42.6 t -153.59 164.59 37.99 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.115 -0.493 . . . . 61.439999999999998 110.507 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -119.43 -66.15 0.29 Allowed Glycine 0 CA--C 1.522 0.484 0 CA-C-N 115.813 -0.63 . . . . 53.100000000000001 112.144 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.86 -28.4 48.37 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.902 2.401 . . . . 51.32 112.632 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 61.1 m -53.58 -27.54 27.09 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.871 -0.604 . . . . 64.120000000000005 111.529 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.434 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 53.9 ttt-85 -56.17 -50.23 71.78 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.313 -0.403 . . . . 70.030000000000001 111.095 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.575 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 15.2 m -65.11 -34.36 78.22 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.736 0.779 . . . . 72.340000000000003 110.905 -177.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.46 HD21 ' HB1' ' A' ' 114' ' ' ALA . 4.2 mm? -65.65 -24.14 66.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.364 -0.835 . . . . 64.239999999999995 111.623 -175.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.439 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 40.7 tt0 -62.69 -63.69 3.89 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 120.578 -0.449 . . . . 63.350000000000001 109.842 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.439 ' CD ' ' HB3' ' A' ' 60' ' ' GLU . 31.0 Cg_endo -63.44 -31.64 71.92 Favored 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.724 1.616 . . . . 53.130000000000003 112.541 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.575 ' HG3' ' O ' ' A' ' 58' ' ' SER . 28.0 mt-30 -66.52 -52.94 40.42 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.38 -0.528 . . . . 60.219999999999999 111.687 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.95 -35.26 80.1 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.176 -0.305 . . . . 74.219999999999999 110.176 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.546 ' HG3' ' HB2' ' A' ' 17' ' ' GLN . 5.2 mm-40 -59.92 -42.92 94.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.877 -0.601 . . . . 65.519999999999996 110.811 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -59.31 -55.14 38.54 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.334 0.588 . . . . 75.129999999999995 109.892 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 34.6 mt -59.47 -33.63 71.55 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.028 -0.987 . . . . 63.130000000000003 110.102 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.574 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.7 -44.73 92.8 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.82 -0.627 . . . . 64.019999999999996 110.105 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.513 ' NE2' ' HG3' ' A' ' 19' ' ' PRO . 51.8 mt-30 -63.82 -47.12 82.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.087 -0.506 . . . . 72.150000000000006 111.134 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -69.42 -41.37 76.44 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.216 -0.447 . . . . 61.229999999999997 111.614 -175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -102.72 5.72 39.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.641 0.608 . . . . 72.420000000000002 112.641 -171.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.35 -19.42 2.11 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.189 0.811 . . . . 62.43 113.189 -169.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.88 -42.3 93.47 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.599 0.238 . . . . 70.430000000000007 110.771 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -128.03 -2.84 5.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.377 -0.374 . . . . 73.040000000000006 111.886 -175.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.9 t -112.36 131.94 62.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.923 0.392 . . . . 74.439999999999998 110.821 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -135.65 120.12 18.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.773 -0.649 . . . . 64.120000000000005 110.201 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.521 HD13 ' HB2' ' A' ' 67' ' ' ALA . 3.6 mp -106.32 137.34 37.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.65 -0.5 . . . . 74.299999999999997 109.65 177.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.541 ' CE1' ' HD3' ' A' ' 34' ' ' LYS . 76.0 m-85 -131.3 165.77 22.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 72.239999999999995 109.993 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.581 ' NZ ' HG21 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -158.16 166.72 31.73 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.158 0.504 . . . . 52.420000000000002 110.91 169.549 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.0 tp -73.0 147.51 9.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 115.077 -0.965 . . . . 61.240000000000002 112.211 -171.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.504 ' C ' HD22 ' A' ' 80' ' ' ASN . 0.2 OUTLIER -108.05 -58.32 2.0 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.402 -0.817 . . . . 61.530000000000001 110.452 175.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.1 mt -70.58 105.43 1.45 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.992 0.425 . . . . 63.310000000000002 111.235 -173.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -56.3 -33.9 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.674 -0.694 . . . . 74.239999999999995 111.2 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -87.83 2.67 50.78 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.193 -0.458 . . . . 73.439999999999998 111.466 -175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.429 ' HB3' ' CB ' ' A' ' 28' ' ' ASP . 11.2 m120 -139.38 90.18 2.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.034 0.445 . . . . 73.319999999999993 110.263 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -117.94 13.59 14.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.486 -0.779 . . . . 73.340000000000003 109.418 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 32.7 t70 -49.52 -50.97 39.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.432 -0.804 . . . . 73.439999999999998 110.943 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 79.2 t -53.15 -37.75 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.655 -0.702 . . . . 73.049999999999997 110.871 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.38 -43.9 84.59 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.294 0.569 . . . . 74.439999999999998 109.828 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.2 m -66.65 -30.1 70.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.489 -0.778 . . . . 61.109999999999999 110.686 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 18.5 mm-40 -74.13 -41.65 61.24 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.893 -0.594 . . . . 73.140000000000001 111.089 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -74.51 -31.34 62.13 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 111.718 0.266 . . . . 74.439999999999998 111.718 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.53 43.58 0.26 Allowed Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.286 -0.959 . . . . 73.450000000000003 113.781 172.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.2 t -90.55 107.38 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.569 -0.53 . . . . 64.019999999999996 109.569 174.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 t -135.2 21.15 3.44 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.203 0.525 . . . . 70.040000000000006 110.551 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -135.66 168.47 19.21 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.065 -0.516 . . . . 72.230000000000004 110.05 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.754 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 48.0 mm -67.86 -53.04 22.37 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.56 -0.291 . . . . 74.010000000000005 110.646 178.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.754 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 58.6 Cg_endo -102.75 107.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.182 0 C-N-CA 123.1 2.533 . . . . 73.109999999999999 111.834 172.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.5 m -132.14 118.92 20.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.791 -0.186 . . . . 61.43 110.798 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.8 mp -110.48 115.25 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 110.262 -0.273 . . . . 74.329999999999998 110.262 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.59 137.3 32.45 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.399 -0.593 . . . . 60.240000000000002 109.399 176.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.409 ' C ' ' HB3' ' A' ' 108' ' ' LEU . 51.6 mtp -115.92 143.48 45.37 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.817 0.28 . . . . 72.010000000000005 110.429 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -142.78 152.86 42.71 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.267 -0.642 . . . . 71.430000000000007 109.267 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -143.49 107.49 4.71 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 120.508 -0.477 . . . . 73.129999999999995 111.597 176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.725 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 10.5 t30 53.0 36.2 21.41 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.48 0.657 . . . . 74.319999999999993 111.584 174.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.41 -16.63 55.63 Favored Glycine 0 N--CA 1.454 -0.117 0 CA-C-N 115.759 -0.655 . . . . 63.130000000000003 112.644 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -81.6 145.17 30.75 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 109.363 -0.606 . . . . 73.120000000000005 109.363 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -61.86 160.5 11.95 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.516 0.674 . . . . 51.119999999999997 110.826 178.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.409 ' HB3' ' C ' ' A' ' 101' ' ' MET . 0.2 OUTLIER -162.28 167.36 24.05 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.364 -1.347 . . . . 74.450000000000003 107.364 -168.509 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.404 ' H ' HD13 ' A' ' 108' ' ' LEU . 73.1 m -70.96 178.29 3.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.958 0.885 . . . . 34.140000000000001 112.687 -165.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -140.84 118.44 11.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.854 -1.067 . . . . 73.150000000000006 108.912 178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 42.5 t -93.81 107.12 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.171 0.51 . . . . 75.230000000000004 110.02 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 66.1 mt -92.72 107.31 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.623 -0.717 . . . . 74.140000000000001 109.471 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.615 ' HA2' ' HG2' ' A' ' 97' ' ' PRO . . . 110.97 158.44 15.49 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.46 -0.656 . . . . 52.520000000000003 111.46 -175.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.46 ' HB1' HD21 ' A' ' 59' ' ' LEU . . . -81.92 78.53 8.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.721 0.296 . . . . 64.109999999999999 110.844 -178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.413 ' O ' HG13 ' A' ' 119' ' ' ILE . 19.3 m-20 -117.1 80.96 1.56 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.079 0.466 . . . . 70.420000000000002 110.048 177.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.428 ' O ' HD13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -59.11 -32.09 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.773 -0.648 . . . . 72.430000000000007 109.799 -177.195 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.8 m -58.36 -50.0 75.22 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.91 -0.587 . . . . 41.039999999999999 110.39 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -69.45 -35.8 76.0 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.219 -0.446 . . . . 75.25 110.313 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 123' ' ' ILE . 76.4 mt -58.33 -56.39 16.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.188 -0.46 . . . . 72.040000000000006 110.513 177.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.31 -34.74 71.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.129 -0.487 . . . . 74.049999999999997 110.346 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 30.5 t -57.06 -49.72 74.98 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.153 -0.476 . . . . 72.150000000000006 109.787 175.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -62.31 -38.54 89.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.476 -0.329 . . . . 63.229999999999997 110.573 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 119' ' ' ILE . 58.3 mt -57.62 -56.5 15.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.672 0.272 . . . . 64.230000000000004 110.938 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -71.33 -25.16 62.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.761 0.315 . . . . 74.200000000000003 110.626 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.48 -44.11 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 73.150000000000006 111.132 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -93.0 -18.06 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 73.200000000000003 111.975 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 57.5 mt -76.78 -53.28 15.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-O 120.929 0.395 . . . . 74.310000000000002 110.054 173.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 13.1 m120 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.377 -0.821 . . . . 75.420000000000002 110.392 -178.664 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.498 0.19 . . . . 71.219999999999999 110.739 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.47 96.15 0.02 OUTLIER 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.931 0.396 . . . . 62.530000000000001 111.023 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -64.82 103.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.82 -0.627 . . . . 72.450000000000003 109.929 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.7 t60 -137.76 90.01 2.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.198 -0.455 . . . . 74.409999999999997 110.606 -176.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -138.67 28.53 2.41 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.109 0.48 . . . . 74.209999999999994 110.269 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -65.53 88.7 0.09 Allowed 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.019 -0.734 . . . . 75.409999999999997 109.019 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -139.16 125.19 19.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.953 -0.567 . . . . 63.310000000000002 111.626 -170.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -170.39 116.51 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.125 -0.694 . . . . 63.140000000000001 109.125 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.433 ' C ' ' SD ' ' A' ' 9' ' ' MET . 1.1 tmt? -150.1 140.04 21.92 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.385 -0.228 . . . . 74.5 110.385 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.36 -55.35 4.63 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.313 -0.47 . . . . 74.540000000000006 112.154 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.1 t -72.51 145.08 47.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.987 0.422 . . . . 54.039999999999999 110.569 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 12' ' ' LEU . 1.5 pt? -133.81 113.62 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.006 -0.543 . . . . 72.519999999999996 109.936 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -84.94 60.32 6.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.575 0.702 . . . . 74.319999999999993 109.706 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.98 87.53 3.51 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.45 -0.795 . . . . 74.5 110.7 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -167.58 147.39 5.11 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.796 -0.638 . . . . 75.120000000000005 110.565 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -173.13 143.32 1.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.488 -0.778 . . . . 74.329999999999998 108.922 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -83.76 87.88 7.07 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.511 -0.552 . . . . 70.319999999999993 109.511 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.14 -175.21 25.74 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.165 -0.925 . . . . 65.230000000000004 111.119 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.63 -20.88 52.86 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.322 2.014 . . . . 31.32 111.725 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.6 -120.44 0.92 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.509 -0.636 . . . . 34.240000000000002 111.509 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -167.2 107.66 0.61 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.805 -0.442 . . . . 73.219999999999999 109.805 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 94.1 mmm -88.11 -36.01 17.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.244 -0.435 . . . . 74.209999999999994 110.664 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.521 HG12 ' OE2' ' A' ' 64' ' ' GLU . 12.9 mm -69.73 97.61 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 109.653 -0.499 . . . . 72.25 109.653 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.8 124.11 24.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 75.530000000000001 110.81 -175.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.576 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -90.72 128.98 36.85 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.687 -0.486 . . . . 72.329999999999998 109.687 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 39.9 pt -141.77 179.85 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.12 -0.491 . . . . 61.539999999999999 110.735 -176.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.2 -177.74 15.15 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 110.643 -0.983 . . . . 75.439999999999998 110.643 171.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 84' ' ' ASN . 13.3 t70 -52.73 -43.12 65.51 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.856 0.36 . . . . 75.439999999999998 110.973 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 p -63.17 -24.01 67.7 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.013 -0.54 . . . . 72.420000000000002 112.26 -177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.407 ' HB2' ' HB ' ' A' ' 26' ' ' ILE . 16.8 mp0 -96.99 -32.39 12.03 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.761 -0.199 . . . . 71.209999999999994 111.117 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.461 ' HA ' HD12 ' A' ' 26' ' ' ILE . 85.0 t80 -41.24 -61.8 0.96 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.002 0.742 . . . . 74.540000000000006 113.002 -166.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -53.4 -50.27 65.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.715 0.293 . . . . 75.409999999999997 111.116 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 33' ' ' ASN . 0.9 OUTLIER -60.36 -51.56 68.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.031 -0.531 . . . . 65.439999999999998 110.734 -177.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.45 ' HG3' HG21 ' A' ' 26' ' ' ILE . 70.7 mmtt -59.45 -36.66 76.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.812 -0.631 . . . . 65.120000000000005 111.049 -176.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.0 t -78.3 -54.66 11.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.13 -0.487 . . . . 55.340000000000003 111.309 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.8 p -62.92 -25.65 68.43 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.564 0.221 . . . . 63.310000000000002 111.559 -176.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.6 t -75.35 5.51 5.6 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.589 -0.278 . . . . 73.409999999999997 111.674 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' HA ' ' A' ' 104' ' ' ASN . 24.4 p -62.52 140.83 58.63 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.875 -0.417 . . . . 44.530000000000001 109.875 175.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -58.41 -83.9 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.556 -0.293 . . . . 61.310000000000002 110.837 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -161.95 152.54 17.44 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.082 -0.71 . . . . 73.5 109.082 174.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.448 HD22 ' ND2' ' A' ' 73' ' ' ASN . 2.1 p-10 45.84 22.07 0.11 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.702 0.801 . . . . 75.140000000000001 112.685 -177.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.7 mm -81.95 127.25 39.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 120.607 0.241 . . . . 75.310000000000002 110.427 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.9 tp -88.43 108.59 19.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.143 0.497 . . . . 63.520000000000003 110.041 176.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 38' ' ' CYS . 57.4 mt -101.33 114.36 40.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.652 -0.704 . . . . 72.5 110.366 178.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 mp -99.04 118.77 36.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.182 -0.673 . . . . 70.129999999999995 109.182 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 67.0 t -104.34 105.02 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 110.002 -0.37 . . . . 54.32 110.002 175.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -85.81 156.53 20.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.95 0.405 . . . . 74.400000000000006 110.526 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -109.61 75.24 0.93 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.118 -0.697 . . . . 74.310000000000002 109.118 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.503 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 62.1 t90 -48.29 -45.52 34.94 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.323 -0.853 . . . . 71.329999999999998 111.154 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 66.55 151.81 0.12 Allowed Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 115.618 -0.719 . . . . 54.439999999999998 112.144 177.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.1 -24.7 27.8 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.184 1.923 . . . . 62.219999999999999 111.883 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -85.56 79.83 9.26 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.427 0.632 . . . . 75.540000000000006 109.353 177.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 35.6 t -85.05 149.9 25.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.159 -0.928 . . . . 65.409999999999997 111.874 -174.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -147.19 -88.0 0.07 OUTLIER Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.278 -0.874 . . . . 42.439999999999998 111.473 177.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.14 17.8 1.41 Allowed 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.917 2.412 . . . . 74.450000000000003 112.7 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 1.1 m -60.77 -30.24 69.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.225 -0.443 . . . . 72.150000000000006 111.164 -175.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.486 ' HD3' ' O ' ' A' ' 57' ' ' ARG . 2.3 tmt_? -54.2 -41.68 68.9 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 116.105 -0.498 . . . . 75.450000000000003 110.637 -174.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.622 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 16.6 m -75.67 -57.12 4.07 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.484 0.659 . . . . 62.43 111.388 175.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.43 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 4.2 mm? -60.57 -42.55 96.86 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.498 -0.774 . . . . 74.530000000000001 112.625 -168.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.1 -59.18 12.52 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 117.917 0.326 . . . . 64.409999999999997 111.226 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.4 -33.24 58.83 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.678 1.585 . . . . 65.439999999999998 112.691 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.622 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.6 mt-30 -59.46 -45.85 90.44 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.021 -0.672 . . . . 75.310000000000002 110.7 173.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 84.5 mt -62.7 -43.74 98.02 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.155 -0.475 . . . . 63.109999999999999 110.33 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.587 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 25.7 mm-40 -53.63 -53.25 54.51 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.053 -0.521 . . . . 70.319999999999993 110.377 174.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -51.34 -52.9 41.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.989 -0.551 . . . . 62.530000000000001 110.709 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.0 -31.69 72.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.1 -0.5 . . . . 75.140000000000001 110.694 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.648 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -71.7 -25.15 61.97 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.267 -0.424 . . . . 75.010000000000005 110.725 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 89.3 mt-30 -85.21 -37.93 19.54 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.992 0.425 . . . . 61.200000000000003 110.493 178.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -74.41 -50.54 18.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.83 -0.623 . . . . 71.209999999999994 110.936 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -90.45 5.09 49.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.553 -0.749 . . . . 74.439999999999998 112.159 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.648 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.6 t -53.04 -24.34 9.57 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.639 0.607 . . . . 63.229999999999997 112.639 -172.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -59.35 -18.79 41.35 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.069 0.462 . . . . 74.010000000000005 110.859 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.448 ' ND2' HD22 ' A' ' 41' ' ' ASN . 26.4 t-20 -133.44 -29.31 1.39 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.748 -0.66 . . . . 72.230000000000004 111.365 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.425 HG23 HD11 ' A' ' 127' ' ' ILE . 66.0 t -105.49 144.36 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 112.285 0.476 . . . . 75.150000000000006 112.285 -169.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 45.6 mmtm -142.53 140.04 31.65 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.689 -0.856 . . . . 74.439999999999998 108.689 170.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.3 mt -117.06 138.3 48.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.012 0.434 . . . . 71.329999999999998 111.027 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 57.0 m-85 -131.29 162.62 29.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.374 -0.83 . . . . 70.349999999999994 109.072 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HD2' ' HB2' ' A' ' 49' ' ' TRP . 17.6 pttp -157.03 136.18 11.93 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.897 0.38 . . . . 75.030000000000001 110.902 173.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.659 HG12 HG11 ' A' ' 87' ' ' VAL . 2.3 mp -71.09 100.2 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.221 -0.659 . . . . 51.530000000000001 109.221 177.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -103.7 -1.64 27.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.761 -0.654 . . . . 64.109999999999999 109.856 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.6 mm -95.93 96.72 5.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.789 -0.642 . . . . 63.43 110.405 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -60.79 -22.1 63.76 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.939 -0.573 . . . . 75.239999999999995 110.921 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.1 -23.57 62.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.113 0.482 . . . . 72.5 110.045 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 30.3 m-80 -111.53 77.82 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.226 -0.657 . . . . 73.450000000000003 109.226 176.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -100.34 -21.84 15.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.683 -0.689 . . . . 73.200000000000003 111.77 -170.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.558 ' O ' ' HG2' ' A' ' 90' ' ' GLN . 4.4 m-20 -52.26 -34.55 46.71 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.703 0.631 . . . . 74.120000000000005 112.703 -174.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.659 HG11 HG12 ' A' ' 79' ' ' ILE . 14.7 p -53.36 -39.79 37.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.155 0.503 . . . . 75.150000000000006 110.543 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.42 -41.13 93.9 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.876 -0.602 . . . . 62.140000000000001 110.274 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 m -62.07 -40.66 96.56 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.553 -0.748 . . . . 62.340000000000003 109.824 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 30.0 mm-40 -64.67 -46.5 82.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.288 -0.869 . . . . 45.049999999999997 110.988 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.43 ' HH ' ' HE2' ' A' ' 31' ' ' PHE . 82.5 m-85 -80.77 -15.54 56.17 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 121.108 -0.237 . . . . 71.239999999999995 111.383 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.18 52.48 31.72 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.059 -0.591 . . . . 64.140000000000001 112.644 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.65 112.5 11.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.958 0.408 . . . . 71.109999999999999 110.36 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.5 t -90.24 -55.97 3.4 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.211 -0.45 . . . . 74.319999999999993 110.641 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.62 155.88 33.14 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.172 -0.467 . . . . 72.239999999999995 110.437 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.743 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 45.1 mm -69.68 -59.77 4.38 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.669 -0.241 . . . . 73.409999999999997 110.741 178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.743 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 1.9 Cg_endo -80.28 74.57 5.48 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.048 1.832 . . . . 72.049999999999997 111.098 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.7 m -113.1 124.92 53.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.81 -0.632 . . . . 70.230000000000004 110.701 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 2.4 mp -110.06 117.5 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.41 -0.359 . . . . 34.340000000000003 110.173 177.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.52 HD23 ' HG3' ' A' ' 110' ' ' GLN . 86.9 mt -88.35 122.98 32.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.907 -0.775 . . . . 73.230000000000004 108.907 174.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 56.9 mtp -96.93 143.66 27.6 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.931 -0.396 . . . . 72.349999999999994 109.931 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -141.38 144.93 34.78 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.283 -0.636 . . . . 64.120000000000005 109.283 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 22.3 tptm -129.68 104.38 7.39 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.194 -0.299 . . . . 74.140000000000001 110.194 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.591 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 65.8 t30 46.22 46.94 13.43 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 122.971 0.508 . . . . 75.25 111.934 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.13 -15.51 57.97 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.401 -0.428 . . . . 73.299999999999997 113.806 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 52.6 tttp -82.84 144.57 30.01 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.622 0.369 . . . . 74.540000000000006 110.894 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -68.97 142.25 54.73 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.021 0.439 . . . . 71.010000000000005 110.098 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.58 169.05 19.18 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.126 0.971 . . . . 75.420000000000002 108.907 -169.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.8 m -69.22 173.2 5.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.529 0.681 . . . . 75.340000000000003 112.539 -162.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.52 ' HG3' HD23 ' A' ' 100' ' ' LEU . 20.0 tt0 -125.9 122.42 35.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 65.140000000000001 109.673 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.555 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 62.4 t -92.73 110.36 22.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.971 -0.381 . . . . 74.329999999999998 109.971 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 112' ' ' ILE . 3.5 mp -94.2 122.15 45.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.74 -0.467 . . . . 64.150000000000006 109.74 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.86 146.7 20.87 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 116.32 -0.4 . . . . 75.239999999999995 112.249 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.64 77.74 1.09 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.929 0.395 . . . . 72.230000000000004 110.203 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -125.2 97.06 5.07 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.366 0.603 . . . . 62.100000000000001 109.905 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -26.42 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.33 -0.85 . . . . 71.239999999999995 109.882 -174.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.7 t -63.4 -47.21 82.94 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 109.881 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -65.37 -43.97 89.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 110.272 177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.508 ' O ' HG13 ' A' ' 123' ' ' ILE . 73.8 mt -55.79 -56.26 13.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 116.17 -0.468 . . . . 60.039999999999999 110.663 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.1 tt -64.31 -33.83 65.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 116.326 -0.397 . . . . 71.239999999999995 110.422 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.4 t -57.3 -52.36 65.66 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.203 -0.453 . . . . 70.400000000000006 110.071 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.2 -37.23 86.65 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.457 -0.338 . . . . 74.439999999999998 110.411 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 119' ' ' ILE . 65.7 mt -56.42 -56.39 13.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 CA-C-O 120.716 0.293 . . . . 61.109999999999999 111.098 179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -71.52 -27.54 63.26 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.991 -0.284 . . . . 74.319999999999993 110.441 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -65.76 -34.55 78.44 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.805 0.336 . . . . 75.450000000000003 110.505 176.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -79.14 -42.94 25.03 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.316 -0.402 . . . . 61.310000000000002 111.339 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 74' ' ' VAL . 56.6 mt -69.74 -46.06 75.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.041 0.448 . . . . 65.319999999999993 110.738 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.426 -0.797 . . . . 74.230000000000004 109.815 -177.329 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.4 tpp . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.659 -0.497 . . . . 72.200000000000003 109.659 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.6 103.66 15.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.883 0.373 . . . . 71.420000000000002 111.691 -173.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -92.14 12.98 20.31 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.125 -0.489 . . . . 70.200000000000003 110.147 173.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -89.03 -70.35 0.66 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.098 -0.501 . . . . 64.530000000000001 109.888 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -155.19 152.99 30.04 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.984 -0.747 . . . . 74.420000000000002 108.984 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.5 m-70 -105.5 174.58 5.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.743 0.306 . . . . 73.219999999999999 111.036 -173.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -117.83 108.38 15.28 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.17 -0.468 . . . . 73.310000000000002 110.551 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -88.4 114.81 25.41 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.001 -0.37 . . . . 73.540000000000006 110.001 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.7 mmt -65.63 157.91 28.69 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.166 -0.47 . . . . 74.310000000000002 111.095 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.44 -66.86 0.01 OUTLIER Glycine 0 C--N 1.331 0.266 0 CA-C-N 115.913 -0.585 . . . . 70.019999999999996 111.929 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.0 t -74.39 173.89 9.66 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 110.228 -0.286 . . . . 72.450000000000003 110.228 176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.4 tp -160.28 -79.44 0.05 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.812 -0.176 . . . . 61.409999999999997 111.276 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.414 ' CG ' ' HB3' ' A' ' 58' ' ' SER . 7.5 tp10 -172.64 158.76 4.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.887 0.375 . . . . 71.019999999999996 111.758 -175.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.36 -154.57 0.41 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.291 0.637 . . . . 63.350000000000001 110.728 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -130.8 82.5 2.06 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.559 0.578 . . . . 71.450000000000003 112.559 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.2 p 47.38 -167.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.077 1.14 . . . . 44.32 114.077 167.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.462 ' HG3' ' HD3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER 178.85 -55.84 0.01 OUTLIER 'General case' 0 C--N 1.344 0.33 0 CA-C-N 115.752 -0.658 . . . . 71.450000000000003 110.464 172.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.548 ' H ' ' HB2' ' A' ' 61' ' ' PRO . . . 167.85 120.26 0.52 Allowed Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.904 -0.665 . . . . 62.32 112.401 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -87.22 165.46 8.28 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.989 2.459 . . . . 62.149999999999999 111.937 176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.7 0.79 0.15 Allowed Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.736 -0.745 . . . . 40.299999999999997 113.674 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.3 p 49.07 59.12 4.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.429 0.633 . . . . 74.200000000000003 110.971 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.3 ptm -114.82 2.19 14.3 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.556 -0.747 . . . . 75.230000000000004 109.884 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.51 129.43 35.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.657 -0.701 . . . . 51.130000000000003 109.906 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -83.4 150.31 26.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.335 -0.393 . . . . 73.25 110.146 -176.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -119.71 130.14 54.86 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.966 0.413 . . . . 72.129999999999995 110.652 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 32.9 pt -138.81 177.01 5.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.795 -0.638 . . . . 74.349999999999994 110.3 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -119.88 -179.06 16.46 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.163 -0.542 . . . . 61.43 112.422 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -54.01 -47.24 71.68 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.301 0.64 . . . . 74.200000000000003 111.173 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.9 t -75.32 -20.45 59.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.821 -0.627 . . . . 23.34 111.711 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -91.61 -8.58 46.89 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.432 0.158 . . . . 74.329999999999998 110.961 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -53.67 -62.5 1.61 Allowed 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 111.938 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -61.24 -47.68 84.95 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.979 0.419 . . . . 52.119999999999997 110.872 -175.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -55.42 -55.3 33.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.591 -0.731 . . . . 71.340000000000003 111.411 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.27 -32.17 68.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.56 -0.291 . . . . 72.120000000000005 111.563 -174.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.93 -38.6 80.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 120.805 0.336 . . . . 64.319999999999993 110.882 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 47.0 p -82.58 -20.6 36.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.812 0.339 . . . . 61.340000000000003 110.994 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -71.67 5.66 2.35 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.21 -0.45 . . . . 41.210000000000001 112.101 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.77 ' HB2' ' HB ' ' A' ' 42' ' ' ILE . 25.5 p -56.95 142.38 41.86 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 110.154 -0.313 . . . . 61.119999999999997 110.154 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -58.93 -74.46 0.07 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.572 0.225 . . . . 72.25 110.53 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -153.12 122.0 6.49 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.874 -0.417 . . . . 43.450000000000003 109.874 175.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 55.48 21.82 4.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.512 0.56 . . . . 74.120000000000005 112.512 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.77 ' HB ' ' HB2' ' A' ' 38' ' ' CYS . 48.0 mm -74.69 113.45 13.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 110.121 -0.326 . . . . 74.0 110.121 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 tt -72.04 113.68 9.33 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.036 -0.728 . . . . 43.25 109.036 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.438 HG23 ' CD1' ' A' ' 77' ' ' TYR . 47.8 mt -106.48 114.4 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.736 -0.665 . . . . 75.239999999999995 110.9 -177.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.44 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.8 mp -92.55 154.21 18.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.266 -0.642 . . . . 71.200000000000003 109.266 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 63.0 t -132.61 104.96 8.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.459 -0.571 . . . . 65.519999999999996 109.459 176.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.477 ' CG ' ' HZ2' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -94.48 161.73 14.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.171 -0.468 . . . . 65.209999999999994 110.459 -176.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -143.83 87.77 1.94 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.742 -0.663 . . . . 70.099999999999994 110.121 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.628 ' HZ3' HD12 ' A' ' 63' ' ' LEU . 1.6 p90 -105.8 169.8 8.27 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.132 -0.486 . . . . 72.049999999999997 109.748 171.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.52 153.21 17.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.483 -0.326 . . . . 54.310000000000002 110.721 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.33 -14.47 29.91 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.871 2.381 . . . . 74.109999999999999 112.359 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -86.79 17.23 4.14 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.034 -0.53 . . . . 71.230000000000004 110.444 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 4.1 t -124.01 150.82 44.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.668 -0.696 . . . . 74.120000000000005 109.964 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.62 -75.29 1.17 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 121.377 -0.439 . . . . 71.439999999999998 113.704 -174.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -59.96 -42.69 42.44 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.615 2.21 . . . . 71.109999999999999 112.291 -173.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 59' ' ' LEU . 19.3 p -60.02 -10.71 4.52 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.734 -0.666 . . . . 50.219999999999999 111.518 -172.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -54.62 -34.18 61.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.97 0.414 . . . . 75.430000000000007 110.309 176.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.667 ' O ' ' HG3' ' A' ' 62' ' ' GLN . 31.5 t -74.89 -38.14 61.94 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.438 0.637 . . . . 63.210000000000001 109.944 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.543 HD13 ' HG ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -55.68 -28.32 54.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.299 -0.864 . . . . 65.409999999999997 110.487 179.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.587 ' HB2' ' CD ' ' A' ' 61' ' ' PRO . 41.2 mt-10 -59.19 -67.7 0.93 Allowed Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.738 -0.21 . . . . 75.129999999999995 110.776 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.587 ' CD ' ' HB2' ' A' ' 60' ' ' GLU . 32.6 Cg_endo -62.62 -28.5 77.08 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 121.518 1.478 . . . . 41.130000000000003 111.972 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' A' ' 58' ' ' SER . 38.0 mt-30 -62.35 -47.3 84.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.711 -0.396 . . . . 63.340000000000003 111.646 175.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.628 HD12 ' HZ3' ' A' ' 49' ' ' TRP . 22.1 mt -66.92 -39.98 87.53 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 120.962 -0.295 . . . . 64.120000000000005 110.561 178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -64.58 -31.13 72.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.455 -0.338 . . . . 75.200000000000003 110.357 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.462 ' HD3' ' HG3' ' A' ' 17' ' ' GLN . 35.3 ttpt -63.6 -53.63 48.66 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.334 0.588 . . . . 74.340000000000003 109.589 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.438 HD11 ' CD1' ' A' ' 116' ' ' ILE . 19.5 mt -61.76 -31.13 71.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.339 -0.846 . . . . 71.409999999999997 110.128 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.433 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -65.73 -53.54 39.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.039 -0.528 . . . . 62.119999999999997 110.11 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -61.78 -34.44 75.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.299 -0.41 . . . . 74.519999999999996 111.202 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -75.87 -40.7 54.1 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.129 -0.487 . . . . 51.25 111.101 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -104.66 5.27 33.45 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.049 0.54 . . . . 75.340000000000003 112.359 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 10.1 t -53.3 -18.89 2.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.37 0.507 . . . . 74.129999999999995 112.37 -173.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -57.15 -43.45 82.51 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.822 0.344 . . . . 74.439999999999998 110.441 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -129.25 8.13 5.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.939 -0.573 . . . . 64.340000000000003 111.73 -175.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t -125.81 138.42 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.008 0.432 . . . . 74.099999999999994 111.774 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 24.4 tptp -141.6 120.0 12.33 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.713 -0.676 . . . . 72.420000000000002 109.217 174.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.44 HG12 ' HB2' ' A' ' 45' ' ' LEU . 55.6 mt -96.92 141.19 16.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 120.757 0.313 . . . . 74.129999999999995 110.855 -177.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.438 ' CD1' HG23 ' A' ' 44' ' ' ILE . 30.6 m-85 -126.13 162.44 25.35 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.614 0.766 . . . . 71.340000000000003 109.784 178.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 4.4 ttmp? -135.62 125.65 26.0 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.543 -0.54 . . . . 75.140000000000001 109.543 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.3 pt -91.4 117.83 35.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.948 0.404 . . . . 73.140000000000001 111.023 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.97 93.3 5.06 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.462 0.649 . . . . 50.329999999999998 110.58 176.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.447 HD12 ' NE2' ' A' ' 85' ' ' GLN . 41.7 pt -54.92 -23.93 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.355 -0.839 . . . . 74.319999999999993 111.969 -177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -48.16 -40.94 25.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 122.729 0.411 . . . . 75.439999999999998 111.631 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.18 -33.75 67.9 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.924 0.392 . . . . 72.239999999999995 110.916 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.9 t30 177.68 144.22 0.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.514 -0.921 . . . . 62.299999999999997 108.514 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.482 HE21 ' HB2' ' A' ' 85' ' ' GLN . 5.7 tt0 -124.48 -0.92 8.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.806 0.298 . . . . 74.230000000000004 111.806 -168.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.557 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 1.2 m-20 -49.08 -48.74 43.97 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.161 -0.472 . . . . 73.310000000000002 111.829 -175.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.8 t -53.79 -38.35 35.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-O 120.909 0.385 . . . . 54.009999999999998 110.934 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.11 -43.06 88.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.138 0.494 . . . . 55.409999999999997 110.064 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.1 m -68.75 -36.75 78.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.679 -0.692 . . . . 75.420000000000002 110.618 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.557 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 97.5 mt-30 -60.82 -57.78 11.21 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.274 -0.421 . . . . 74.400000000000006 110.61 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -75.01 -24.47 58.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 63.0 111.292 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.75 73.19 1.14 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.94 -0.648 . . . . 53.310000000000002 113.08 173.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.0 t -89.72 91.49 3.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.88 -0.785 . . . . 71.219999999999999 108.88 172.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.4 p -74.52 -47.9 30.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.648 -0.706 . . . . 53.210000000000001 111.779 -174.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.16 164.57 11.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 62.329999999999998 110.506 -178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.707 ' HB ' ' HD3' ' A' ' 97' ' ' PRO . 49.2 mm -62.08 -55.45 40.67 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 123.184 0.302 . . . . 72.420000000000002 110.605 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.707 ' HD3' ' HB ' ' A' ' 96' ' ' ILE . 2.1 Cg_endo -81.0 104.44 1.55 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.968 1.779 . . . . 75.409999999999997 110.978 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.425 ' C ' HD12 ' A' ' 99' ' ' ILE . 69.9 m -139.15 138.5 37.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.812 0.339 . . . . 73.540000000000006 110.852 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.463 HG12 HD11 ' A' ' 63' ' ' LEU . 2.0 mp -120.34 114.59 44.4 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 115.829 -0.623 . . . . 62.229999999999997 110.26 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 100' ' ' LEU . 5.9 mp -90.6 156.09 18.39 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.254 -0.647 . . . . 65.019999999999996 109.254 173.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.425 ' CB ' ' HB3' ' A' ' 108' ' ' LEU . 48.8 mtp -126.27 139.5 53.27 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.965 -0.754 . . . . 73.129999999999995 108.965 178.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.45 ' HA ' ' HB2' ' A' ' 108' ' ' LEU . 91.3 m-85 -147.63 157.02 43.37 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.668 -0.493 . . . . 73.319999999999993 109.668 176.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 106' ' ' LYS . 40.6 ttpt -151.1 109.41 3.77 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.491 -0.483 . . . . 74.030000000000001 111.595 175.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.703 ' HA ' ' SG ' ' A' ' 38' ' ' CYS . 66.2 t30 55.9 36.9 28.17 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.485 0.66 . . . . 73.450000000000003 111.24 174.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.66 -16.68 58.65 Favored Glycine 0 CA--C 1.518 0.275 0 CA-C-N 115.647 -0.706 . . . . 71.519999999999996 112.829 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 103' ' ' LYS . 12.8 ttmt -74.33 135.21 42.53 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 116.813 0.306 . . . . 70.239999999999995 110.393 177.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -77.9 88.05 4.1 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 122.19 0.995 . . . . 73.109999999999999 110.751 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.475 HD11 ' CG ' ' A' ' 126' ' ' ASN . 0.3 OUTLIER -71.84 168.85 17.02 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.35 -1.75 . . . . 74.519999999999996 109.782 172.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.9 m -69.87 -177.61 1.34 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.277 0.631 . . . . 74.310000000000002 112.353 -166.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -142.38 121.41 12.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 110.214 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.45 115.81 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 70.200000000000003 110.135 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.1 mt -89.51 128.23 41.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.927 -0.579 . . . . 63.310000000000002 110.38 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.17 -155.77 30.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.172 -0.537 . . . . 64.120000000000005 112.3 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -105.99 112.62 25.75 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.783 -0.451 . . . . 65.450000000000003 109.783 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 119' ' ' ILE . 5.4 t70 -154.05 82.58 1.14 Allowed 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.376 0.608 . . . . 70.099999999999994 110.246 175.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.547 HG13 ' HB3' ' A' ' 62' ' ' GLN . 0.3 OUTLIER -60.24 -29.53 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.356 -0.838 . . . . 74.010000000000005 110.67 -175.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.9 t -66.39 -54.25 26.56 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.124 0.488 . . . . 75.299999999999997 110.086 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -57.77 -46.21 84.88 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.814 -0.63 . . . . 72.329999999999998 110.167 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.504 ' O ' HG13 ' A' ' 123' ' ' ILE . 79.7 mt -56.47 -56.34 14.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.879 -0.601 . . . . 75.230000000000004 111.091 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 13.4 tt -63.21 -34.18 65.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 120.56 0.219 . . . . 75.340000000000003 110.696 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.7 t -60.1 -52.15 66.59 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 116.369 -0.378 . . . . 54.229999999999997 110.063 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.3 -40.31 93.68 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 116.212 -0.449 . . . . 75.099999999999994 110.149 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.555 ' O ' HG13 ' A' ' 127' ' ' ILE . 53.2 mt -57.12 -56.33 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.859 -0.61 . . . . 64.010000000000005 111.273 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -69.82 -33.41 72.29 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 120.42 -0.512 . . . . 65.230000000000004 110.198 -178.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -58.66 -36.26 73.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.12 -0.491 . . . . 62.439999999999998 110.362 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.475 ' CG ' HD11 ' A' ' 108' ' ' LEU . 39.2 m-80 -108.81 1.31 20.87 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.369 0.877 . . . . 50.310000000000002 113.369 -175.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 123' ' ' ILE . 46.6 mt -84.12 -52.95 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.378 -0.971 . . . . 74.340000000000003 108.378 166.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.417 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-N 115.408 -0.814 . . . . 74.109999999999999 109.688 175.035 . . . . . . . . 2 2 . 1 stop_ save_